Alex Ade
Alexander Diehl
Allen Xiang
Asiyah Yu Lin
Daniel Cooper
Helen Parkinson
Hiroshi Masuya
James Malone
Jie Zheng
Sirarat Sarntivijai
Stefanie Seltmann
Yongqun "Oliver" He (YH)
Yue Liu
The Cell Line Ontology (CLO) is a community-based ontology of cell lines. The CLO is developed to unify publicly available cell line entry data from multiple sources to a standardized logically defined format based on consensus design patterns.
OWL-DL
An ontology for the domain of cell lines and cell line cells
CLO: Cell Line Ontology
Citation: Sarntivijai S, Lin Y, Xiang Z, Meehan TF, Diehl AD, Vempati UD, Schürer TC, Pang C, Malone J, Parkinson H, Liu Y, Takatsuki T, Saijo K, Masuya H, Nakamura Y, Brush MH, Haendel MA, Zheng J, Stoeckert CJ, Peters B, Mungall CJ, Carey TE, States DJ, Athey BD, He Y. CLO: The Cell Line Ontology. Journal of Biomedical Semantics. 2014, 5:37. doi:10.1186/2041-1480-5-37. PMID: 25852852. PMCID: PMC4387853.
BFO OWL specification label
Relates an entity in the ontology to the name of the variable that is used to represent it in the code that generates the BFO OWL file from the lispy specification.
Really of interest to developers only
BFO CLIF specification label
Relates an entity in the ontology to the term that is used to represent it in the the CLIF specification of BFO2
An annotation property that represents an ID used in the NIH LINCS project.
LINCS ID
An annotation property that specifies an STR profile of a cell line cell.
STR profile
An annotation property that represents a PubMed BioAssay Identifier accession number.
PubChem AID
An annotation property that describes the information of a problematic cell line.
problematic cell line annotation
An annotation property that describes the origin of a cell line.
cell line cell origin
An annotation property that describes the features of a cell line and cell line cell.
cell line cell feature
An annotation property that describes known mutation(s) about a cell.
Known mutation annotation
Cell culture condition
editor preferred label
editor preferred term
The concise, meaningful, and human-friendly name for a class or property preferred by the ontology developers. (US-English)
PERSON:Daniel Schober
editor preferred term~editor preferred label
example
example of usage
A phrase describing how a class name should be used. May also include other kinds of examples that facilitate immediate understanding of a class semantics, such as widely known prototypical subclasses or instances of the class. Although essential for high level terms, examples for low level terms (e.g., Affymetrix HU133 array) are not
in branch
An annotation property indicating which module the terms belong to. This is currently experimental and not implemented yet.
has curation status
PERSON:Alan Ruttenberg
PERSON:Bill Bug
PERSON:Melanie Courtot
definition
The official OBI definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.
The official definition, explaining the meaning of a class or property. Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions.
2012-04-05: Barry Smith The official OBI definition, explaining the meaning of a class or property: 'Shall be Aristotelian, formalized and normalized. Can be augmented with colloquial definitions' is terrible. Can you fix to something like: A statement of necessary and sufficient conditions explaining the meaning of an expression referring to a class or property. Alan Ruttenberg Your proposed definition is a reasonable candidate, except that it is very common that necessary and sufficient conditions are not given. Mostly they are necessary, occasionally they are necessary and sufficient or just sufficient. Often they use terms that are not themselves defined and so they effectively can't be evaluated by those criteria. On the specifics of the proposed definition: We don't have definitions of 'meaning' or 'expression' or 'property'. For 'reference' in the intended sense I think we use the term 'denotation'. For 'expression', I think we you mean symbol, or identifier. For 'meaning' it differs for class and property. For class we want documentation that let's the intended reader determine whether an entity is instance of the class, or not. For property we want documentation that let's the intended reader determine, given a pair of potential relata, whether the assertion that the relation holds is true. The 'intended reader' part suggests that we also specify who, we expect, would be able to understand the definition, and also generalizes over human and computer reader to include textual and logical definition. Personally, I am more comfortable weakening definition to documentation, with instructions as to what is desirable. We also have the outstanding issue of how to aim different definitions to different audiences. A clinical audience reading chebi wants a different sort of definition documentation/definition from a chemistry trained audience, and similarly there is a need for a definition that is adequate for an ontologist to work with.
editor note
An administrative note intended for its editor. It may not be included in the publication version of the ontology, so it should contain nothing necessary for end users to understand the ontology.
term editor
Name of editor entering the term in the file. The term editor is a point of contact for information regarding the term. The term editor may be, but is not always, the author of the definition, which may have been worked upon by several people
20110707, MC: label update to term editor and definition modified accordingly. See http://code.google.com/p/information-artifact-ontology/issues/detail?id=115.
alternative term
An alternative name for a class or property which means the same thing as the preferred name (semantically equivalent)
definition source
formal citation, e.g. identifier in external database to indicate / attribute source(s) for the definition. Free text indicate / attribute source(s) for the definition. EXAMPLE: Author Name, URI, MeSH Term C04, PUBMED ID, Wiki uri on 31.01.2007
Discussion on obo-discuss mailing-list, see http://bit.ly/hgm99w
curator note
An administrative note of use for a curator but of no use for a user
imported from
For external terms/classes, the ontology from which the term was imported
expand expression to
expand assertion to
OBO foundry unique label
elucidation
person:Alan Ruttenberg
Person:Barry Smith
Primitive terms in a highest-level ontology such as BFO are terms which are so basic to our understanding of reality that there is no way of defining them in a non-circular fashion. For these, therefore, we can provide only elucidations, supplemented by examples and by axioms
has associated axiom(nl)
Person:Alan Ruttenberg
An axiom associated with a term expressed using natural language
has associated axiom(fol)
An axiom expressed in first order logic using CLIF syntax
temporal interpretation
An assertion that holds between an OWL Object Property and a temporal interpretation that elucidates how OWL Class Axioms that use this property are to be interpreted in a temporal context.
tooth SubClassOf 'never in taxon' value 'Aves'
S never_in_taxon T iff: S SubClassOf in_taxon only not T.
x never in taxon T if and only if T is a class, and x does not instantiate the class expression "in taxon some T". Note that this is a shortcut relation, and should be used as a hasValue restriction in OWL.
Chris Mungall
Class: <http://www.w3.org/2002/07/owl#Nothing> EquivalentTo: ?X and (RO_0002162 some ?Y)
Class: ?X DisjointWith: RO_0002162 some ?Y
A is mutually_spatially_disjoint_with B if both A and B are classes, and there exists no p such that p is part_of some A and p is part_of some B.
Class: <http://www.w3.org/2002/07/owl#Nothing> EquivalentTo: (BFO_0000050 some ?X) and (BFO_0000050 some ?Y)
mutually spatially disjoint with
S dubious_for_taxon T if it is probably the case that no instances of S can be found in any instance of T.
this relation lacks a strong logical interpretation, but can be used in place of never_in_taxon where it is desirable to state that the definition of the class is too strict for the taxon under consideration, but placing a never_in_taxon link would result in a chain of inconsistencies that will take time to resolve. Example: metencephalon in teleost
S present_in_taxon T if some instance of T has some S. This does not means that all instances of T have an S - it may only be certain life stages or sexes that have S
present in taxon
An assertion that involves at least one OWL object that is intended to be expanded into one or more logical axioms. The logical expansion can yield axioms expressed using any formal logical system, including, but not limited to OWL2-DL.
logical macro assertion
A logical macro assertion whose domain is an IRI for a class
The domain for this class can be considered to be owl:Class, but we cannot assert this in OWL2-DL
logical macro assertion on a class
A logical macro assertion whose domain is an IRI for a property
logical macro assertion on a property
Used to annotate object properties to describe a logical meta-property or characteristic of the object property.
logical macro assertion on an object property
logical macro assertion on an annotation property
relation p is the direct form of relation q iff p is a subPropertyOf q, p does not have the Transitive characteristic, q does have the Transitive characteristic, and for all x, y: x q y -> exists z1, z2, ..., zn such that x p z1 ... z2n y
The general property hierarchy is: "directly P" SubPropertyOf "P" Transitive(P) Where we have an annotation assertion "directly P" "is direct form of" "P"
If we have the annotation P is-direct-form-of Q, and we have inverses P' and Q', then it follows that P' is-direct-form-of Q'
A shortcut relationship that holds between two entities based on their identity criteria
logical macro assertion involving identity
A shortcut relationship between two entities x and y1, such that the intent is that the relationship is functional and inverse function, but there is no guarantee that this property holds.
in approximate one to one relationship with
'anterior end of organism' is-opposite-of 'posterior end of organism'
'increase in temperature' is-opposite-of 'decrease in temperature'
x is the opposite of y if there exists some distance metric M, and there exists no z such as M(x,z) <= M(x,y) or M(y,z) <= M(y,x).
true if the two properties are disjoint, according to OWL semantics. This should only be used if using a logical axiom introduces a non-simple property violation.
nominally disjoint with
Used to annotate object properties representing a causal relationship where the value indicates a direction. Should be "+", "-" or "0"
part-of is homeomorphic for independent continuants.
R is homemorphic for C iff (1) there exists some x,y such that x R y, and x and y instantiate C and (2) for all x, if x is an instance of C, and there exists some y some such that x R y, then it follows that y is an instance of C.
R homeomorphic-for C expands to: C SubClassOf R only C. Additionally, for any class D that is disjoint with C, we can also expand to C DisjointWith R some D, D DisjointWith R some C.
An alternate textual definition for a class taken unmodified from an external source. This definition may have been used to derive a generalized definition for the new class.
This annotation property may be replaced with an annotation property from an external ontology such as IAO
A textual description of an axiom loss in this ontology compared to an external ontology.
Notes on the homology status of this class.
An alternate comment for a class taken unmodified from an external source. Note that obo format only allows a single comment for a class, and does not provide a structured means of adding provenance info.
Used to connect a class to an adjectival form of its label. For example, a class with label 'intestine' may have a relational adjective 'intestinal'.
Notes on the how instances of this class vary across species.
Notes on the evolved function of instances of this class.
Notes on the structure, composition or histology of instances of this class.
Notes on the ontogenic development of instances of this class.
Notes on how similar or equivalent classes are represented in other ontologies.
Notes on how lexical conventions regarding this class, in particular any issues that may arise due to homonyny or synonymy.
FMA has terms like 'set of X'. In general we do not include set-of terms in uberon, but provide a mapping between the singular form and the FMA set term
Examples of a Contributor include a person, an organisation, or a service. Typically, the name of a Contributor should be used to indicate the entity.
An entity responsible for making contributions to the content of the resource.
Contributor
Examples of a Creator include a person, an organisation, or a service. Typically, the name of a Creator should be used to indicate the entity.
An entity primarily responsible for making the content of the resource.
Creator
Typically, Date will be associated with the creation or availability of the resource. Recommended best practice for encoding the date value is defined in a profile of ISO 8601 [W3CDTF] and follows the YYYY-MM-DD format.
A date associated with an event in the life cycle of the resource.
Date
Description may include but is not limited to: an abstract, table of contents, reference to a graphical representation of content or a free-text account of the content.
An account of the content of the resource.
Description
Typically, Format may include the media-type or dimensions of the resource. Format may be used to determine the software, hardware or other equipment needed to display or operate the resource. Examples of dimensions include size and duration. Recommended best practice is to select a value from a controlled vocabulary (for example, the list of Internet Media Types [MIME] defining computer media formats).
The physical or digital manifestation of the resource.
Format
The present resource may be derived from the Source resource in whole or in part. Recommended best practice is to reference the resource by means of a string or number conforming to a formal identification system.
A reference to a resource from which the present resource is derived.
Source
Typically, a Subject will be expressed as keywords, key phrases or classification codes that describe a topic of the resource. Recommended best practice is to select a value from a controlled vocabulary or formal classification scheme.
The topic of the content of the resource.
Subject and Keywords
Typically, a Title will be a name by which the resource is formally known.
A name given to the resource.
Title
Reference database or publication source.
An identifier is an information content entity that is the outcome of a dubbing process and is used to refer to one instance of entity shared by a group of people to refer to that individual entity.
label
A skos concept mapping used to link two concepts, indicating a high degree of confidence that the concepts can be used interchangeably.
is part of
my brain is part of my body (continuant parthood, two material entities)
my stomach cavity is part of my stomach (continuant parthood, immaterial entity is part of material entity)
this day is part of this year (occurrent parthood)
a core relation that holds between a part and its whole
Everything is part of itself. Any part of any part of a thing is itself part of that thing. Two distinct things cannot be part of each other.
Occurrents are not subject to change and so parthood between occurrents holds for all the times that the part exists. Many continuants are subject to change, so parthood between continuants will only hold at certain times, but this is difficult to specify in OWL. See http://purl.obolibrary.org/obo/ro/docs/temporal-semantics/
Parthood requires the part and the whole to have compatible classes: only an occurrent can be part of an occurrent; only a process can be part of a process; only a continuant can be part of a continuant; only an independent continuant can be part of an independent continuant; only an immaterial entity can be part of an immaterial entity; only a specifically dependent continuant can be part of a specifically dependent continuant; only a generically dependent continuant can be part of a generically dependent continuant. (This list is not exhaustive.) A continuant cannot be part of an occurrent: use 'participates in'. An occurrent cannot be part of a continuant: use 'has participant'. A material entity cannot be part of an immaterial entity: use 'has location'. A specifically dependent continuant cannot be part of an independent continuant: use 'inheres in'. An independent continuant cannot be part of a specifically dependent continuant: use 'bearer of'.
part_of
part of
has part
my body has part my brain (continuant parthood, two material entities)
my stomach has part my stomach cavity (continuant parthood, material entity has part immaterial entity)
this year has part this day (occurrent parthood)
a core relation that holds between a whole and its part
Everything has itself as a part. Any part of any part of a thing is itself part of that thing. Two distinct things cannot have each other as a part.
Occurrents are not subject to change and so parthood between occurrents holds for all the times that the part exists. Many continuants are subject to change, so parthood between continuants will only hold at certain times, but this is difficult to specify in OWL. See https://code.google.com/p/obo-relations/wiki/ROAndTime
Parthood requires the part and the whole to have compatible classes: only an occurrent have an occurrent as part; only a process can have a process as part; only a continuant can have a continuant as part; only an independent continuant can have an independent continuant as part; only a specifically dependent continuant can have a specifically dependent continuant as part; only a generically dependent continuant can have a generically dependent continuant as part. (This list is not exhaustive.) A continuant cannot have an occurrent as part: use 'participates in'. An occurrent cannot have a continuant as part: use 'has participant'. An immaterial entity cannot have a material entity as part: use 'location of'. An independent continuant cannot have a specifically dependent continuant as part: use 'bearer of'. A specifically dependent continuant cannot have an independent continuant as part: use 'inheres in'.
has_part
realized in
this disease is realized in this disease course
this fragility is realized in this shattering
this investigator role is realized in this investigation
is realized by
realized_in
[copied from inverse property 'realizes'] to say that b realizes c at t is to assert that there is some material entity d & b is a process which has participant d at t & c is a disposition or role of which d is bearer_of at t& the type instantiated by b is correlated with the type instantiated by c. (axiom label in BFO2 Reference: [059-003])
Paraphrase of elucidation: a relation between a realizable entity and a process, where there is some material entity that is bearer of the realizable entity and participates in the process, and the realizable entity comes to be realized in the course of the process
realizes
this disease course realizes this disease
this investigation realizes this investigator role
this shattering realizes this fragility
to say that b realizes c at t is to assert that there is some material entity d & b is a process which has participant d at t & c is a disposition or role of which d is bearer_of at t& the type instantiated by b is correlated with the type instantiated by c. (axiom label in BFO2 Reference: [059-003])
Paraphrase of elucidation: a relation between a process and a realizable entity, where there is some material entity that is bearer of the realizable entity and participates in the process, and the realizable entity comes to be realized in the course of the process
preceded by
X preceded_by Y iff: end(Y) before_or_simultaneous_with start(X).
x is preceded by y if and only if the time point at which y ends is before or equivalent to the time point at which x starts. Formally: x preceded by y iff ω(y) <= α(x), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point.
An example is: translation preceded_by transcription; aging preceded_by development (not however death preceded_by aging). Where derives_from links classes of continuants, preceded_by links classes of processes. Clearly, however, these two relations are not independent of each other. Thus if cells of type C1 derive_from cells of type C, then any cell division involving an instance of C1 in a given lineage is preceded_by cellular processes involving an instance of C. The assertion P preceded_by P1 tells us something about Ps in general: that is, it tells us something about what happened earlier, given what we know about what happened later. Thus it does not provide information pointing in the opposite direction, concerning instances of P1 in general; that is, that each is such as to be succeeded by some instance of P. Note that an assertion to the effect that P preceded_by P1 is rather weak; it tells us little about the relations between the underlying instances in virtue of which the preceded_by relation obtains. Typically we will be interested in stronger relations, for example in the relation immediately_preceded_by, or in relations which combine preceded_by with a condition to the effect that the corresponding instances of P and P1 share participants, or that their participants are connected by relations of derivation, or (as a first step along the road to a treatment of causality) that the one process in some way affects (for example, initiates or regulates) the other.
is preceded by
preceded_by
precedes
x precedes y if and only if the time point at which x ends is before or equivalent to the time point at which y starts. Formally: x precedes y iff ω(x) <= α(y), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point.
occurs in
b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t
occurs_in
unfolds in
unfolds_in
Paraphrase of definition: a relation between a process and an independent continuant, in which the process takes place entirely within the independent continuant
site of
[copied from inverse property 'occurs in'] b occurs_in c =def b is a process and c is a material entity or immaterial entity& there exists a spatiotemporal region r and b occupies_spatiotemporal_region r.& forall(t) if b exists_at t then c exists_at t & there exist spatial regions s and s’ where & b spatially_projects_onto s at t& c is occupies_spatial_region s’ at t& s is a proper_continuant_part_of s’ at t
Paraphrase of definition: a relation between an independent continuant and a process, in which the process takes place entirely within the independent continuant
contains process
x anterior_to y iff x is further along the antero-posterior axis than y, towards the head. An antero-posterior axis is an axis that bisects an organism from head end to opposite end of body or tail: bearer.
x distal_to y iff x is further along the proximo-distal axis than y, towards the appendage tip. A proximo-distal axis extends from tip of an appendage (distal) to where it joins the body (proximal).
x dorsal_to y iff x is further along the dorso-ventral axis than y, towards the back. A dorso-ventral axis is an axis that bisects an organism from back (e.g. spinal column) to front (e.g. belly).
x posterior_to y iff x is further along the antero-posterior axis than y, towards the body/tail. An antero-posterior axis is an axis that bisects an organism from head end to opposite end of body or tail.
x ventral_to y iff x is further along the dorso-ventral axis than y, towards the front. A dorso-ventral axis is an axis that bisects an organism from back (e.g. spinal column) to front (e.g. belly).
X in_left_side_of Y <=> if Y is subdivided into left and right portions, X is part_of the left portion.
X in_right_side_of Y <=> if Y is subdivided into left and right portions, X is part_of the right portion.
X posterior_side_of Y <=> if Y is subdivided into two anterior and posterior portions, X is part_of the posterior portion.
X anterior_side_of Y <=> if Y is subdivided into two anterior and posterior portions, X is part_of the anterior portion.
X proximal_side_of Y <=> if Y is subdivided into distal and proximal portions, X is part_of the proximal portion.
X distal_side_of Y <=> if Y is subdivided into distal and proximal portions, X is part_of the distal portion.
X in_lateral_side_of Y <=> if X is in_left_side_of Y or X is in_right_side_of Y. X is often, but not always a paired structure.
X proximalmost_part_of Y <=> X is part_of Y and X is adjacent_to the proximal boundary of Y.
This relation holds when both the deep_to and ajdacent_to relationship similarly hold.
X distalmost_part_of Y <=> X is part_of Y and X is adjacent_to the distal boundary of Y.
a 'derives from' object property between an entity (in CLO case, cell line) and a disease in a patient where the entity is derived from some cell in the patient who has the disease. This is a short cut relation that represents: 'derived from' some (cell and ('part of' some 'organism' and ('has disease' some disease)))
In most cases, the patient in the relation is used to refer human patient. However, an animal patient (or veterinary patient) can also be referred.
derives from patient having disease
a disease disposition has been realized by a bearer.
Jie Zheng, Yongqun He, Yu Lin, Allen Xiang
This is a shortcut relation. It is equivalent to: participates_in some 'disease couse' and realizes some disease
has disease
an object property that specifies a cell line repository for a specifc cell line.
is in cell line repository
an object property that represents a relation between a cell line cell and a disease.
This object property is largely equivalent to the previous term 'is model for' (http://www.ebi.ac.uk/cellline#is_model_for).
is disease model for
HeLa ICRP cell is transfected to express a Initiator caspase reporter protein (IC-RP)
an object property that represents a relation between a cell line cell and a protein where the cell line cell is genetically transfected to stably express a foreign protein in the cell line cell.
transfected to express
a 'cell line cell derives from' object property between an entity (e.g., cell line cell in CLO) and an organism where the cell line cell is derived from some cell from the organism. In CLO, this is a short cut relation that represents: 'derived from' some (cell and ('part of' some organism))
derived from organism
a 'derives from' object property between an entity (i.e., cell line cell in CLO) and an anatomic part from an organism where the cell line cell is derived from some cell in the anatomic part (e.g., tissue or organ). The anatomic part is typically defined by UBERON in CLO. in CLO, this is a short cut relation that represents: 'derived from' some (cell and ('part of' some 'anatomic part'))
derived from anatomic part
derived from cell
derived from cell line
a 'derived from' object property that specifies the domain of the property is a cell line cell.
cell line cell derived from
a 'cell line cell derives from' object property between a cell line cell and an anatomic part from an organism where the cell line cell is derived from some cell in the tissue. The anatomic part is typically defined by UBERON in CLO. This is a short cut relation that represents: 'derived from' some (cell and ('part of' some 'anatomic part'))
cell line cell derived from anatomical part
a 'cell line cell derives from' object property between a cell line cell and an organism where the cell line cell is derived from some cell from the organism. This is a short cut relation that represents: 'derived from' some (cell and ('part of' some organism))
cell line cell derived from organism
induced by cell culture reagent
BIHi005-A-4 stem cell line cell is derived from BIHi005-A cell by knocking out the gene SORT1 from the BIHi005-A cell.
A 'derives from' object property that represents the relation between a cell line cell and a gene where the gene is not present in the cell line cell from a knockout process.
derived from cell with knockout gene
Stem cell line cell BIONi010-C-6 is derived from BIONi010-C where gene APOE has been modified from an isogenic modification.
A 'derives from' object property that represents the relation between a cell line cell and a gene where the gene is modified in the cell line cell via an isogenic modification process. An isogenic cell line is a cell line that has been engineered from a parental line through the introduction of a targeted gene mutation.
derived from cell with isogenic modification of gene
derived from cell with knockin gene
derived from cell with transgenic modification
is about
This document is about information artifacts and their representations
is_about is a (currently) primitive relation that relates an information artifact to an entity.
7/6/2009 Alan Ruttenberg. Following discussion with Jonathan Rees, and introduction of "mentions" relation. Weaken the is_about relationship to be primitive. We will try to build it back up by elaborating the various subproperties that are more precisely defined. Some currently missing phenomena that should be considered "about" are predications - "The only person who knows the answer is sitting beside me" , Allegory, Satire, and other literary forms that can be topical without explicitly mentioning the topic.
Smith, Ceusters, Ruttenberg, 2000 years of philosophy
An information artifact IA mentions an entity E exactly when it has a component/part that denotes E
7/6/2009 Alan Ruttenberg. P4 RC1 munges our GCI so remove it for now: mentions some entity equivalentTo has_part some ('generically denotes' some entity)
7/6/2009 Alan Ruttenberg: Add this relation following conversation with Jonathan Rees that N&S GCI for is_about was too strong. Really it was simply sufficient. To effect this change we introduce this relation, which is subproperty of is_about, and have previous GCI use this relation "mentions" in it's (logical) definition
PERSON: Jonathan Rees
Person: Alan Ruttenberg
mentions
has_specified_input
see is_input_of example_of_usage
A relation between a planned process and a continuant participating in that process that is not created during the process. The presence of the continuant during the process is explicitly specified in the plan specification which the process realizes the concretization of.
8/17/09: specified inputs of one process are not necessarily specified inputs of a larger process that it is part of. This is in contrast to how 'has participant' works.
PERSON: Alan Ruttenberg
is_specified_input_of
some Autologous EBV(Epstein-Barr virus)-transformed B-LCL (B lymphocyte cell line) is_input_for instance of Chromum Release Assay described at https://wiki.cbil.upenn.edu/obiwiki/index.php/Chromium_Release_assay
Alan Ruttenberg
has_specified_output
A relation between a planned process and a continuant participating in that process. The presence of the continuant at the end of the process is explicitly specified in the objective specification which the process realizes the concretization of.
is_manufactured_by
http://www.affymetrix.com/products/arrays/specific/hgu133.affx is_manufactered_by http://www.affymetrix.com/ (if we decide to use these URIs for the actual entities)
c is_manufactured_by o means that there was a process p in which c was built in which a person, or set of people or machines did the work(bore the "Manufacturer Role", and those people/and or machines were members or of directed by the organization to do this.
Liju Fan
has_make
has_manufacturer
is_specified_output_of
A cell sorting process achieves the objective specification 'material separation objective'
This relation obtains between a planned process and a objective specification when the criteria specified in the objective specification are met at the end of the planned process.
modified according to email thread from 1/23/09 in accordince with DT and PPPB branch
the relation of the cells in the finger of the skin to the finger, in which an indeterminate number of grains are parts of the whole by virtue of being grains in a collective that is part of the whole, and in which removing one granular part does not nec- essarily damage or diminish the whole. Ontological Whether there is a fixed, or nearly fixed number of parts - e.g. fingers of the hand, chambers of the heart, or wheels of a car - such that there can be a notion of a single one being missing, or whether, by contrast, the number of parts is indeterminate - e.g., cells in the skin of the hand, red cells in blood, or rubber molecules in the tread of the tire of the wheel of the car.
Discussion in Karslruhe with, among others, Alan Rector, Stefan Schulz, Marijke Keet, Melanie Courtot, and Alan Ruttenberg. Definition take from the definition of granular parthood in the cited paper. Needs work to put into standard form
PAPER: Granularity, scale and collectivity: When size does and does not matter, Alan Rector, Jeremy Rogers, Thomas Bittner, Journal of Biomedical Informatics 39 (2006) 333-349
This relation obtains between a a objective specification and a planned process when the criteria specified in the objective specification are met at the end of the planned process.
inheres in
this fragility inheres in this vase
this fragility is a characteristic of this vase
this red color inheres in this apple
this red color is a characteristic of this apple
a relation between a specifically dependent continuant (the characteristic) and any other entity (the bearer), in which the characteristic depends on the bearer for its existence.
a relation between a specifically dependent continuant (the dependent) and an independent continuant (the bearer), in which the dependent specifically depends on the bearer for its existence
A dependent inheres in its bearer at all times for which the dependent exists.
inheres_in
Note that this relation was previously called "inheres in", but was changed to be called "characteristic of" because BFO2 uses "inheres in" in a more restricted fashion. This relation differs from BFO2:inheres_in in two respects: (1) it does not impose a range constraint, and thus it allows qualities of processes, as well as of information entities, whereas BFO2 restricts inheres_in to only apply to independent continuants (2) it is declared functional, i.e. something can only be a characteristic of one thing.
characteristic of
bearer of
this apple is bearer of this red color
this vase is bearer of this fragility
Inverse of characteristic_of
a relation between an independent continuant (the bearer) and a specifically dependent continuant (the dependent), in which the dependent specifically depends on the bearer for its existence
A bearer can have many dependents, and its dependents can exist for different periods of time, but none of its dependents can exist when the bearer does not exist.
bearer_of
is bearer of
has characteristic
participates in
this blood clot participates in this blood coagulation
this input material (or this output material) participates in this process
this investigator participates in this investigation
a relation between a continuant and a process, in which the continuant is somehow involved in the process
participates_in
has participant
this blood coagulation has participant this blood clot
this investigation has participant this investigator
this process has participant this input material (or this output material)
a relation between a process and a continuant, in which the continuant is somehow involved in the process
Has_participant is a primitive instance-level relation between a process, a continuant, and a time at which the continuant participates in some way in the process. The relation obtains, for example, when this particular process of oxygen exchange across this particular alveolar membrane has_participant this particular sample of hemoglobin at this particular time.
has_participant
concretizes
A journal article is an information artifact that inheres in some number of printed journals. For each copy of the printed journal there is some quality that carries the journal article, such as a pattern of ink. The quality (a specifically dependent continuant) concretizes the journal article (a generically dependent continuant), and both depend on that copy of the printed journal (an independent continuant).
An investigator reads a protocol and forms a plan to carry out an assay. The plan is a realizable entity (a specifically dependent continuant) that concretizes the protocol (a generically dependent continuant), and both depend on the investigator (an independent continuant). The plan is then realized by the assay (a process).
A relationship between a specifically dependent continuant and a generically dependent continuant, in which the generically dependent continuant depends on some independent continuant in virtue of the fact that the specifically dependent continuant also depends on that same independent continuant. Multiple specifically dependent continuants can concretize the same generically dependent continuant.
has function
this enzyme has function this catalysis function (more colloquially: this enzyme has this catalysis function)
a relation between an independent continuant (the bearer) and a function, in which the function specifically depends on the bearer for its existence
A bearer can have many functions, and its functions can exist for different periods of time, but none of its functions can exist when the bearer does not exist. A function need not be realized at all the times that the function exists.
has_function
this apple has quality this red color
a relation between an independent continuant (the bearer) and a quality, in which the quality specifically depends on the bearer for its existence
A bearer can have many qualities, and its qualities can exist for different periods of time, but none of its qualities can exist when the bearer does not exist.
has_quality
has quality
has role
this person has role this investigator role (more colloquially: this person has this role of investigator)
a relation between an independent continuant (the bearer) and a role, in which the role specifically depends on the bearer for its existence
A bearer can have many roles, and its roles can exist for different periods of time, but none of its roles can exist when the bearer does not exist. A role need not be realized at all the times that the role exists.
has_role
derives from
this cell derives from this parent cell (cell division)
this nucleus derives from this parent nucleus (nuclear division)
a relation between two distinct material entities, the new entity and the old entity, in which the new entity begins to exist when the old entity ceases to exist, and the new entity inherits the significant portion of the matter of the old entity
This is a very general relation. More specific relations are preferred when applicable, such as 'directly develops from'.
derives_from
derives into
this parent cell derives into this cell (cell division)
this parent nucleus derives into this nucleus (nuclear division)
a relation between two distinct material entities, the old entity and the new entity, in which the new entity begins to exist when the old entity ceases to exist, and the new entity inherits the significant portion of the matter of the old entity
This is a very general relation. More specific relations are preferred when applicable, such as 'directly develops into'. To avoid making statements about a future that may not come to pass, it is often better to use the backward-looking 'derives from' rather than the forward-looking 'derives into'.
derives_into
is location of
my head is the location of my brain
this cage is the location of this rat
a relation between two independent continuants, the location and the target, in which the target is entirely within the location
Most location relations will only hold at certain times, but this is difficult to specify in OWL. See http://purl.obolibrary.org/obo/ro/docs/temporal-semantics/
location_of
location of
located in
my brain is located in my head
this rat is located in this cage
a relation between two independent continuants, the target and the location, in which the target is entirely within the location
Location as a relation between instances: The primitive instance-level relation c located_in r at t reflects the fact that each continuant is at any given time associated with exactly one spatial region, namely its exact location. Following we can use this relation to define a further instance-level location relation - not between a continuant and the region which it exactly occupies, but rather between one continuant and another. c is located in c1, in this sense, whenever the spatial region occupied by c is part_of the spatial region occupied by c1. Note that this relation comprehends both the relation of exact location between one continuant and another which obtains when r and r1 are identical (for example, when a portion of fluid exactly fills a cavity), as well as those sorts of inexact location relations which obtain, for example, between brain and head or between ovum and uterus
located_in
my body has 2D boundary the surface of my skin
a relation between a material entity and a 2D immaterial entity (the boundary), in which the boundary delimits the material entity
A 2D boundary may have holes and gaps, but it must be a single connected entity, not an aggregate of several disconnected parts.
Although the boundary is two-dimensional, it exists in three-dimensional space and thus has a 3D shape.
has boundary
has_2D_boundary
has 2D boundary
innervated_by
X outer_layer_of Y iff: . X :continuant that bearer_of some PATO:laminar . X part_of Y . exists Z :surface . X has_boundary Z . Z boundary_of Y has_boundary: http://purl.obolibrary.org/obo/RO_0002002 boundary_of: http://purl.obolibrary.org/obo/RO_0002000
A relationship that applies between a continuant and its outer, bounding layer. Examples include the relationship between a multicellular organism and its integument, between an animal cell and its plasma membrane, and between a membrane bound organelle and its outer/bounding membrane.
bounding layer of
A 'has component activity' B if A is A and B are molecular functions (GO_0003674) and A has_component B.
w 'has process component' p if p and w are processes, w 'has part' p and w is such that it can be directly disassembled into into n parts p, p2, p3, ..., pn, where these parts are of similar type.
A relationship between a process and a barrier, where the process occurs in a region spanning the barrier. For cellular processes the barrier is typically a membrane. Examples include transport across a membrane and membrane depolarization.
A 'has effector activity' B if A and B are GO molecular functions (GO_0003674), A 'has component activity' B and B is the effector (output function) of B. Each compound function has only one effector activity.
This relation is designed for constructing compound molecular functions, typically in combination with one or more regulatory component activity relations.
Primitive instance level timing relation between events
before or simultaneous with
Relation between occurrents, shares start and end boundaries.
t1 simultaneous_with t2 iff:= t1 before_or_simultaneous_with t2 and not (t1 before t2)
simultaneous with
X ends_after Y iff: end(Y) before_or_simultaneous_with end(X)
ends after
X immediately_preceded_by Y iff: end(X) simultaneous_with start(Y).
A non-transitive temporal relation in which one process immediately precedes another process, such that there is no interval of time between the two processes[SIO:000251].
immediately preceded by
X immediately_precedes_Y iff: end(X) simultaneous_with start(Y)
immediately precedes
X starts_during Y iff: (start(Y) before_or_simultaneous_with start(X)) AND (start(X) before_or_simultaneous_with end(Y))
starts during
X happens_during Y iff: (start(Y) before_or_simultaneous_with start(X)) AND (end(X) before_or_simultaneous_with end(Y))
happens during
X ends_during Y iff: ((start(Y) before_or_simultaneous_with end(X)) AND end(X) before_or_simultaneous_with end(Y).
ends during
Relation between a neuron and an anatomical structure that its soma is part of.
<http://purl.obolibrary.org/obo/BFO_0000051> some ( <http://purl.obolibrary.org/obo/GO_0043025> and <http://purl.obolibrary.org/obo/BFO_0000050> some ?Y)
has soma location
Every B cell[CL_0000236] has plasma membrane part some immunoglobulin complex[GO_0019814]
Holds between a cell c and a protein complex or protein p if and only if that cell has as part a plasma_membrane[GO:0005886], and that plasma membrane has p as part.
<http://purl.obolibrary.org/obo/BFO_0000051> some (<http://purl.obolibrary.org/obo/GO_0005886> and <http://purl.obolibrary.org/obo/BFO_0000051> some ?Y)
has plasma membrane part
x overlaps y if and only if there exists some z such that x has part z and z part of y
http://purl.obolibrary.org/obo/BFO_0000051 some (http://purl.obolibrary.org/obo/BFO_0000050 some ?Y)
overlaps
Relation between a 'neuron projection bundle' and a region in which one or more of its component neuron projections either synapses to targets or receives synaptic input. T innervates some R Expands_to: T has_fasciculating_neuron_projection that synapse_in some R.
David Osumi-Sutherland
<http://purl.obolibrary.org/obo/RO_0002132> some (<http://purl.obolibrary.org/obo/GO_0043005> that (<http://purl.obolibrary.org/obo/RO_0002131> some (<http://purl.obolibrary.org/obo/GO_0045202> that <http://purl.obolibrary.org/obo/BFO_0000050> some Y?)))
innervates
X continuous_with Y if and only if X and Y share a fiat boundary.
The label for this relation was previously connected to. I relabeled this to "continuous with". The standard notion of connectedness does not imply shared boundaries - e.g. Glasgow connected_to Edinburgh via M8; my patella connected_to my femur (via patellar-femoral joint)
continuous with
two individual entities d1 and d2 stand in a shares_ancestor_with relation if and only if there exists some a such that d1 derived_by_descent_from a and d2 derived_by_descent_from a.
Consider obsoleting and merging with child relation, 'in homology relationship with'
lactation SubClassOf 'only in taxon' some 'Mammalia'
S only_in_taxon T iff: S SubClassOf in_taxon only T.
x only in taxon y if and only if x is in taxon y, and there is no other organism z such that y!=z a and x is in taxon z.
The original intent was to treat this as a macro that expands to 'in taxon' only ?Y - however, this is not necessary if we instead have supplemental axioms that state that each pair of sibling tax have a disjointness axiom using the 'in taxon' property - e.g. 'in taxon' some Eukaryota DisjointWith 'in taxon' some Eubacteria
x is in taxon y if an only if y is an organism, and the relationship between x and y is one of: part of (reflexive), developmentally preceded by, derives from, secreted by, expressed.
Connects a biological entity to its taxon of origin.
A is spatially_disjoint_from B if and only if they have no parts in common
There are two ways to encode this as a shortcut relation. The other possibility to use an annotation assertion between two classes, and expand this to a disjointness axiom.
Note that it would be possible to use the relation to label the relationship between a near infinite number of structures - between the rings of saturn and my left earlobe. The intent is that this is used for parsiomoniously for disambiguation purposes - for example, between siblings in a jointly exhaustive pairwise disjointness hierarchy
a 'toe distal phalanx bone' that is connected to a 'toe medial phalanx bone' (an interphalangeal joint *connects* these two bones).
Binary relationship: x connected_to y if and only if there exists some z such that z connects x and y in a ternary connected_to(x,y,z) relationship.
a is connected to b if and only if a and b are discrete structure, and there exists some connecting structure c, such that c connects a and b
connected to
Binary relationship: z connects x if and only if there exists some y such that z connects x and y in a ternary connected_to(x,y,z) relationship.
c connects a if and only if there exist some b such that a and b are similar parts of the same system, and c connects b, specifically, c connects a with b. When one structure connects two others it unites some aspect of the function or role they play within the system.
this is currently used for both structural relationships (such as between a valve and the chamber it connects) and abstract relationships (anatomical lines and the entities they connect)
connects
a is attached to part of b if a is attached to b, or a is attached to some p, where p is part of b.
attached to part of (anatomical structure to anatomical structure)
attached to part of
Relation between an arterial structure and another structure, where the arterial structure acts as a conduit channeling fluid, substance or energy.
relation between an artery and the structure is supplies with blood.
Individual ontologies should provide their own constraints on this abstract relation. For example, in the realm of anatomy this should hold between an artery and an anatomical structure
supplies
Relation between an collecting structure and another structure, where the collecting structure acts as a conduit channeling fluid, substance or energy away from the other structure.
Individual ontologies should provide their own constraints on this abstract relation. For example, in the realm of anatomy this should hold between a vein and an anatomical structure
drains
w 'has component' p if w 'has part' p and w is such that it can be directly disassembled into into n parts p, p2, p3, ..., pn, where these parts are of similar type.
The definition of 'has component' is still under discussion. The challenge is in providing a definition that does not imply transitivity.
For use in recording has_part with a cardinality constraint, because OWL does not permit cardinality constraints to be used in combination with transitive object properties. In situations where you would want to say something like 'has part exactly 5 digit, you would instead use has_component exactly 5 digit.
has component
x develops from y if and only if either (a) x directly develops from y or (b) there exists some z such that x directly develops from z and z develops from y
Terry Meehan
This is the transitive form of the develops from relation
develops from
develops into
'neural crest cell' SubClassOf expresses some 'Wnt1 gene'
x expressed in y if and only if there is a gene expression process (GO:0010467) that occurs in y, and one of the following holds: (i) x is a gene, and x is transcribed into a transcript as part of the gene expression process (ii) x is a transcript, and the transcription of x is part of the gene expression process (iii) x is a mature gene product such as a protein, and x was translated or otherwise processes from a transcript that was transcribed as part of this gene expression process
expressed in
Candidate definition: x directly_develops from y if and only if there exists some developmental process (GO:0032502) p such that x and y both participate in p, and x is the output of p and y is the input of p, and a substantial portion of the matter of x comes from y, and the start of x is coincident with or after the end of y.
directly develops from
directly develops into
process(P1) regulates process(P2) iff: P1 results in the initiation or termination of P2 OR affects the frequency of its initiation or termination OR affects the magnitude or rate of output of P2.
We use 'regulates' here to specifically imply control. However, many colloquial usages of the term correctly correspond to the weaker relation of 'causally upstream of or within' (aka influences). Consider relabeling to make things more explicit
Regulation precludes parthood; the regulatory process may not be within the regulated process.
regulates
Process(P1) negatively regulates process(P2) iff: P1 terminates P2, or P1 descreases the the frequency of initiation of P2 or the magnitude or rate of output of P2.
negatively regulates (process to process)
negatively regulates
Process(P1) postively regulates process(P2) iff: P1 initiates P2, or P1 increases the the frequency of initiation of P2 or the magnitude or rate of output of P2.
positively regulates (process to process)
positively regulates
'human p53 protein' SubClassOf some ('has prototype' some ('participates in' some 'DNA repair'))
heart SubClassOf 'has prototype' some ('participates in' some 'blood circulation')
x has prototype y if and only if x is an instance of C and y is a prototypical instance of C. For example, every instance of heart, both normal and abnormal is related by the has prototype relation to some instance of a "canonical" heart, which participates in blood circulation.
Experimental. In future there may be a formalization in which this relation is treated as a shortcut to some modal logic axiom. We may decide to obsolete this and adopt a more specific evolutionary relationship (e.g. evolved from)
This property can be used to make weaker forms of certain relations by chaining an additional property. For example, we may say: retina SubClassOf has_prototype some 'detection of light'. i.e. every retina is related to a prototypical retina instance which is detecting some light. Note that this is very similar to 'capable of', but this relation affords a wider flexibility. E.g. we can make a relation between continuants.
has prototype
mechanosensory neuron capable of detection of mechanical stimulus involved in sensory perception (GO:0050974)
osteoclast SubClassOf 'capable of' some 'bone resorption'
A relation between a material entity (such as a cell) and a process, in which the material entity has the ability to carry out the process.
For compatibility with BFO, this relation has a shortcut definition in which the expression "capable of some P" expands to "bearer_of (some realized_by only P)".
capable of
c stands in this relationship to p if and only if there exists some p' such that c is capable_of p', and p' is part_of p.
capable of part of
x surrounded_by y if and only if (1) x is adjacent to y and for every region r that is adjacent to x, r overlaps y (2) the shared boundary between x and y occupies the majority of the outermost boundary of x
x surrounded_by y iff: x is adjacent to y and for every region r adjacent to x, r overlaps y.
surrounded by
A caterpillar walking on the surface of a leaf is adjacent_to the leaf, if one of the caterpillar appendages is touching the leaf. In contrast, a butterfly flying close to a flower is not considered adjacent, unless there are any touching parts.
The epidermis layer of a vertebrate is adjacent to the dermis.
The plasma membrane of a cell is adjacent to the cytoplasm, and also to the cell lumen which the cytoplasm occupies.
The skin of the forelimb is adjacent to the skin of the torso if these are considered anatomical subdivisions with a defined border. Otherwise a relation such as continuous_with would be used.
x adjacent to y if and only if x and y share a boundary.
x adjacent_to y iff: x and y share a boundary.
This relation acts as a join point with BSPO
adjacent to
surrounds
Do not use this relation directly. It is ended as a grouping for relations between occurrents involving the relative timing of their starts and ends.
A relation that holds between two occurrents. This is a grouping relation that collects together all the Allen relations.
temporally related to
Relation between occurrents, shares a start boundary with.
starts
Every insulin receptor signaling pathway starts with the binding of a ligand to the insulin receptor
x starts with y if and only if x has part y and the time point at which x starts is equivalent to the time point at which y starts. Formally: α(y) = α(x) ∧ ω(y) < ω(x), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point.
starts with
x develops from part of y if and only if there exists some z such that x develops from z and z is part of y
develops from part of
Relation between occurrents, shares an end boundary with.
ends
x ends with y if and only if x has part y and the time point at which x ends is equivalent to the time point at which y ends. Formally: α(y) > α(x) ∧ ω(y) = ω(x), where α is a function that maps a process to a start point, and ω is a function that maps a process to an end point.
ends with
x 'has starts location' y if and only if there exists some process z such that x 'starts with' z and z 'occurs in' y
has start location
x 'has end location' y if and only if there exists some process z such that x 'ends with' z and z 'occurs in' y
has end location
p has input c iff: p is a process, c is a material entity, c is a participant in p, c is present at the start of p, and the state of c is modified during p.
has input
p has output c iff c is a participant in p, c is present at the end of p, and c is not present in the same state at the beginning of p.
has output
Mammalian thymus has developmental contribution from some pharyngeal pouch 3; Mammalian thymus has developmental contribution from some pharyngeal pouch 4 [Kardong]
x has developmental contribution from y iff x has some part z such that z develops from y
has developmental contribution from
inverse of has developmental contribution from
developmentally contributes to
t1 developmentally_induced_by t2 if there is a process of organ induction (GO:0001759) with t1 and t2 as interacting participants. t2 causes t1 to change its fate from a precursor tissue type T to T', where T' develops_from T.
t1 induced_by t2 if there is a process of developmental induction (GO:0031128) with t1 and t2 as interacting participants. t2 causes t1 to change its fate from a precursor anatomical structure type T to T', where T' develops_from T
Developmental Biology, Gilbert, 8th edition, figure 6.5(F)
We place this under 'developmentally preceded by'. This placement should be examined in the context of reciprocal inductions[cjm]
sources for developmentally_induced_by relationships in Uberon: Developmental Biology, Gilbert, 8th edition, figure 6.5(F)
developmentally induced by
Inverse of developmentally induced by
developmentally induces
Candidate definition: x developmentally related to y if and only if there exists some developmental process (GO:0032502) p such that x and y both participates in p, and x is the output of p and y is the input of p
In general you should not use this relation to make assertions - use one of the more specific relations below this one
This relation groups together various other developmental relations. It is fairly generic, encompassing induction, developmental contribution and direct and transitive develops from
developmentally preceded by
x developmentally replaces y if and only if there is some developmental process that causes x to move or to cease to exist, and for the site that was occupied by x to become occupied by y, where y either comes into existence in this site or moves to this site from somewhere else
This relation is intended for cases such as when we have a bone element replacing its cartilage element precursor. Currently most AOs represent this using 'develops from'. We need to decide whether 'develops from' will be generic and encompass replacement, or whether we need a new name for a generic relation that encompasses replacement and development-via-cell-lineage
developmentally replaces
developmentally succeeded by
expresses
p results in the developmental progression of s iff p is a developmental process and s is an anatomical structure and p causes s to undergo a change in state at some point along its natural developmental cycle (this cycle starts with its formation, through the mature structure, and ends with its loss).
This property and its subproperties are being used primarily for the definition of GO developmental processes. The property hierarchy mirrors the core GO hierarchy. In future we may be able to make do with a more minimal set of properties, but due to the way GO is currently structured we require highly specific relations to avoid incorrect entailments. To avoid this, the corresponding genus terms in GO should be declared mutually disjoint.
results in developmental progression of
every flower development (GO:0009908) results in development of some flower (PO:0009046)
p 'results in development of' c if and only if p is a developmental process and p results in the state of c changing from its initial state as a primordium or anlage through its mature state and to its final state.
results in development of
an annotation of gene X to anatomical structure formation with results_in_formation_of UBERON:0000007 (pituitary gland) means that at the beginning of the process a pituitary gland does not exist and at the end of the process a pituitary gland exists.
every "endocardial cushion formation" (GO:0003272) results_in_formation_of some "endocardial cushion" (UBERON:0002062)
results in formation of
an annotation of gene X to cell morphogenesis with results_in_morphogenesis_of CL:0000540 (neuron) means that at the end of the process an input neuron has attained its shape.
tongue morphogenesis (GO:0043587) results in morphogenesis of tongue (UBERON:0001723)
The relationship that links an entity with the process that results in the formation and shaping of that entity over time from an immature to a mature state.
results in morphogenesis of
holds between x and y if and only if x is causally upstream of y and the progression of x increases the frequency, rate or extent of y
holds between x and y if and only if x is causally upstream of y and the progression of x decreases the frequency, rate or extent of y
Holds between p and c when p is a localization process (localization covers maintenance of localization as well as its establishment) and the outcome of this process is to regulate the localization of c.
transports or maintains localization of
q characteristic of part of w if and only if there exists some p such that q inheres in p and p part of w.
Because part_of is transitive, inheres in is a sub-relation of characteristic of part of
characteristic of part of
an annotation of gene X to cell differentiation with results_in_maturation_of CL:0000057 (fibroblast) means that at the end of the process the input cell that did not have features of a fibroblast, now has the features of a fibroblast.
The relationship that links a specified entity with the process that results in an unspecified entity acquiring the features and characteristics of the specified entity
results in acquisition of features of
A relationship that holds via some environmental process
Do not use this relation directly. It is ended as a grouping for a diverse set of relations, all involving the process of evolution.
evolutionarily related to
A mereological relationship or a topological relationship
Do not use this relation directly. It is ended as a grouping for a diverse set of relations, all involving parthood or connectivity relationships
mereotopologically related to
A relationship that holds between entities participating in some developmental process (GO:0032502)
Do not use this relation directly. It is ended as a grouping for a diverse set of relations, all involving organismal development
developmentally related to
A grouping relationship for any relationship directly involving a function, or that holds because of a function of one of the related entities.
This is a grouping relation that collects relations used for the purpose of connecting structure and function
functionally related to
holds between two entities when some genome-level process such as gene expression is involved. This includes transcriptional, spliceosomal events. These relations can be used between either macromolecule entities (such as regions of nucleic acid) or between their abstract informational counterparts.
Do not use this relation directly. It is intended as a grouping for a diverse set of relations, all involving the genome of an organism
genomically related to
regulated by
negatively regulated by
positively regulated by
A relationship that holds via some process of localization
Do not use this relation directly. It is a grouping relation.
related via localization to
This relationship holds between p and l when p is a transport or localization process in which the outcome is to move some cargo c from some initial location l to some destination.
has target start location
This relationship holds between p and l when p is a transport or localization process in which the outcome is to move some cargo c from a an initial location to some destination l.
has target end location
Holds between p and l when p is a transportation or localization process and the outcome of this process is to move c from one location to another, and the route taken by c follows a path that is aligned_with l
results in transport along
Holds between p and m when p is a transportation or localization process and the outcome of this process is to move c from one location to another, and the route taken by c follows a path that crosses m.
results in transport across
'mitochondrial transport' results_in_transport_to_from_or_in some mitochondrion (GO:0005739)
results in transport to from or in
has member is a mereological relation between a collection and an item.
has member
input of
output of
formed as result of
a is attached to b if and only if a and b are discrete objects or object parts, and there are physical connections between a and b such that a force pulling a will move b, or a force pulling b will move a
attached to (anatomical structure to anatomical structure)
attached to
A relationship that holds between two material entities in a system of connected structures, where the branching relationship holds based on properties of the connecting network.
Do not use this relation directly. It is ended as a grouping for a diverse set of relations, all involving branching relationships
This relation can be used for geographic features (e.g. rivers) as well as anatomical structures (plant branches and roots, leaf veins, animal veins, arteries, nerves)
in branching relationship with
In the tree T depicted in https://oborel.github.io/obo-relations/branching_part_of.png, B1 is a (direct) branching part of T. B1-1, B1-2, and B1-3 are also branching parts of T, but these are considered indirect branching parts as they do not directly connect to the main stem S
x is a branching part of y if and only if x is part of y and x is connected directly or indirectly to the main stem of y
we need to check if FMA branch_of implies part_of. the relation we intend to use here should - for example, see vestibulocochlear nerve
branching part of
x has developmental potential involving y iff x is capable of a developmental process with output y. y may be the successor of x, or may be a different structure in the vicinity (as for example in the case of developmental induction).
has developmental potential involving
x has potential to developmentrally contribute to y iff x developmentally contributes to y or x is capable of developmentally contributing to y
has potential to developmentally contribute to
x has potential to developmentally induce y iff x developmentally induces y or x is capable of developmentally inducing y
has potential to developmentally induce
x has the potential to develop into y iff x develops into y or if x is capable of developing into y
has potential to develop into
x has potential to directly develop into y iff x directly develops into y or x is capable of directly developing into y
has potential to directly develop into
This relation groups causal relations between material entities and causal relations between processes
This branch of the ontology deals with causal relations between entities. It is divided into two branches: causal relations between occurrents/processes, and causal relations between material entities. We take an 'activity flow-centric approach', with the former as primary, and define causal relations between material entities in terms of causal relations between occurrents. To define causal relations in an activity-flow type network, we make use of 3 primitives: * Temporal: how do the intervals of the two occurrents relate? * Is the causal relation regulatory? * Is the influence positive or negative The first of these can be formalized in terms of the Allen Interval Algebra. Informally, the 3 bins we care about are 'direct', 'indirect' or overlapping. Note that all causal relations should be classified under a RO temporal relation (see the branch under 'temporally related to'). Note that all causal relations are temporal, but not all temporal relations are causal. Two occurrents can be related in time without being causally connected. We take causal influence to be primitive, elucidated as being such that has the upstream changed, some qualities of the donwstream would necessarily be modified. For the second, we consider a relationship to be regulatory if the system in which the activities occur is capable of altering the relationship to achieve some objective. This could include changing the rate of production of a molecule. For the third, we consider the effect of the upstream process on the output(s) of the downstream process. If the level of output is increased, or the rate of production of the output is increased, then the direction is increased. Direction can be positive, negative or neutral or capable of either direction. Two positives in succession yield a positive, two negatives in succession yield a positive, otherwise the default assumption is that the net effect is canceled and the influence is neutral. Each of these 3 primitives can be composed to yield a cross-product of different relation types.
Do not use this relation directly. It is intended as a grouping for a diverse set of relations, all involving cause and effect.
causally related to
p is causally upstream of q if and only if p precedes q and p and q are linked in a causal chain
causally upstream of
p is immediately causally upstream of q iff both (a) p immediately precedes q and (b) p is causally upstream of q. In addition, the output of p must be an input of q.
immediately causally upstream of
p 'causally upstream or within' q iff (1) the end of p is before the end of q and (2) the execution of p exerts some causal influence over the outputs of q; i.e. if p was abolished or the outputs of p were to be modified, this would necessarily affect q.
We would like to make this disjoint with 'preceded by', but this is prohibited in OWL2
inverse of causally upstream of or within
p contributes to morphology of w if and only if a change in the morphology of p entails a change in the morphology of w. Examples: every skull contributes to morphology of the head which it is a part of. Counter-example: nuclei do not generally contribute to the morphology of the cell they are part of, as they are buffered by cytoplasm.
'otolith organ' SubClassOf 'composed primarily of' some 'calcium carbonate'
x composed_primarily_of y if and only if more than half of the mass of x is made from y or units of the same type as y.
x composed_primarily_of y iff: more than half of the mass of x is made from parts of y.
p has part that occurs in c if and only if there exists some p1, such that p has_part p1, and p1 occurs in c.
Do not use this relation directly. It is ended as a grouping for a diverse set of relations, typically connecting an anatomical entity to a biological process or developmental stage.
relation between physical entity and a process or stage
Relation between continuant c and occurrent s, such that every instance of c comes into existing during some s.
x existence starts during y if and only if the time point at which x starts is after or equivalent to the time point at which y starts and before or equivalent to the time point at which y ends. Formally: x existence starts during y iff α(x) >= α(y) & α(x) <= ω(y).
Relation between continuant and occurrent, such that c comes into existence at the start of p.
x starts ends with y if and only if the time point at which x starts is equivalent to the time point at which y starts. Formally: x existence starts with y iff α(x) = α(y).
x existence overlaps y if and only if either (a) the start of x is part of y or (b) the end of x is part of y. Formally: x existence starts and ends during y iff (α(x) >= α(y) & α(x) <= ω(y)) OR (ω(x) <= ω(y) & ω(x) >= α(y))
The relations here were created based on work originally by Fabian Neuhaus and David Osumi-Sutherland. The work has not yet been vetted and errors in definitions may have occurred during transcription.
x exists during y if and only if: 1) the time point at which x begins to exist is after or equal to the time point at which y begins and 2) the time point at which x ceases to exist is before or equal to the point at which y ends. Formally: x existence starts and ends during y iff α(x) >= α(y) & α(x) <= ω(y) & ω(x) <= ω(y) & ω(x) >= α(y)
Relation between continuant c and occurrent s, such that every instance of c ceases to exist during some s, if it does not die prematurely.
x existence ends during y if and only if the time point at which x ends is before or equivalent to the time point at which y ends and after or equivalent to the point at which y starts. Formally: x existence ends during y iff ω(x) <= ω(y) and ω(x) >= α(y).
Relation between continuant and occurrent, such that c ceases to exist at the end of p.
x existence ends with y if and only if the time point at which x ends is equivalent to the time point at which y ends. Formally: x existence ends with y iff ω(x) = ω(y).
x transformation of y if x is the immediate transformation of y, or is linked to y through a chain of transformation relationships
x immediate transformation of y iff x immediately succeeds y temporally at a time boundary t, and all of the matter present in x at t is present in y at t, and all the matter in y at t is present in x at t
x existence starts during or after y if and only if the time point at which x starts is after or equivalent to the time point at which y starts. Formally: x existence starts during or after y iff α (x) >= α (y).
x existence ends during or before y if and only if the time point at which x ends is before or equivalent to the time point at which y ends.
A relationship between a material entity and a process where the material entity has some causal role that influences the process
p is causally related to q if and only if p or any part of p and q or any part of q are linked by a chain of events where each event pair is one of direct activation or direct inhibition. p may be upstream, downstream, part of or a container of q.
Forelimb SubClassOf has_skeleton some 'Forelimb skeleton'
A relation between a segment or subdivision of an organism and the maximal subdivision of material entities that provides structural support for that segment or subdivision.
A relation between a subdivision of an organism and the single subdivision of skeleton that provides structural support for that subdivision.
The skeleton of a structure may be a true skeleton (for example, the bony skeleton of a hand) or any kind of support framework (the hydrostatic skeleton of a sea star, the exoskeleton of an insect, the cytoskeleton of a cell).
Holds between p and c when p is locomotion process and the outcome of this process is the change of location of c
A relation that holds between elements of a musculoskeletal system or its analogs.
Do not use this relation directly. It is ended as a grouping for a diverse set of relations, all involving the biomechanical processes.
x lumen_of y iff x is the space or substance that is part of y and does not cross any of the inner membranes or boundaries of y that is maximal with respect to the volume of the convex hull.
s is luminal space of x iff s is lumen_of x and s is an immaterial entity
Process(P1) directly regulates process(P2) iff: P1 regulates P2 via direct physical interaction between an agent executing P1 (or some part of P1) and an agent executing P2 (or some part of P2). For example, if protein A has protein binding activity(P1) that targets protein B and this binding regulates the kinase activity (P2) of protein B then P1 directly regulates P2.
p results in breakdown of c if and only if the execution of p leads to c no longer being present at the end of p
p results in organization of c iff p results in the assembly, arrangement of constituent parts, or disassembly of c
A relationship that holds between a material entity and a process in which causality is involved, with either the material entity or some part of the material entity exerting some influence over the process, or the process influencing some aspect of the material entity.
causal relation between material entity and a process
a produces b if some process that occurs_in a has_output b, where a and b are material entities. Examples: hybridoma cell line produces monoclonal antibody reagent; chondroblast produces avascular GAG-rich matrix.
Note that this definition doesn't quite distinguish the output of a transformation process from a production process, which is related to the identity/granularity issue.
produces
a produced_by b iff some process that occurs_in b has_output a.
produced by
p 'has primary input ot output' c iff either (a) p 'has primary input' c or (b) p 'has primary output' c.
p has primary output c if (a) p has output c and (b) the goal of process is to modify, produce, or transform c.
p has primary input c if (a) p has input c and (b) the goal of process is to modify, consume, or transform c.
causally upstream of or within, negative effect
causally upstream of or within, positive effect
p acts on population of c iff c' is a collection, has members of type c, and p has participant c
acts on population of
results in fusion of
q1 different_in_magnitude_relative_to q2 if and only if magnitude(q1) NOT =~ magnitude(q2). Here, magnitude(q) is a function that maps a quality to a unit-invariant scale.
q1 increased_in_magnitude_relative_to q2 if and only if magnitude(q1) > magnitude(q2). Here, magnitude(q) is a function that maps a quality to a unit-invariant scale.
This relation is used to determine the 'directionality' of relative qualities such as 'increased strength', relative to the parent type, 'strength'.
q1 decreased_in_magnitude_relative_to q2 if and only if magnitude(q1) < magnitude(q2). Here, magnitude(q) is a function that maps a quality to a unit-invariant scale.
This relation is used to determine the 'directionality' of relative qualities such as 'decreased strength', relative to the parent type, 'strength'.
s3 has_cross_section s3 if and only if : there exists some 2d plane that intersects the bearer of s3, and the impression of s3 upon that plane has shape quality s2.
Example: a spherical object has the quality of being spherical, and the spherical quality has_cross_section round.
p has anatomical participant c iff p has participant c, and c is an anatomical entity
results in changes to anatomical or cellular structure
Relation between biological objects that resemble or are related to each other sufficiently to warrant a comparison.
A relation between a cell and molecule or complex such that every instance of the cell has a high number of instances of that molecule expressed on the cell surface. For the formal definition, see Masci et al (PMID:19243617).
A relation between a cell and molecule or complex such that every instance of the cell has a low number of instances of that molecule expressed on the cell surface. For the formal definition, see Masci et al (PMID:19243617).
http://purl.obolibrary.org/obo/BFO_0000051 exactly 0 ?Y
http://purl.obolibrary.org/obo/BFO_0000051 exactly 0 (http://purl.obolibrary.org/obo/GO_0005886 and http://purl.obolibrary.org/obo/BFO_0000051 some ?Y)
x is a conduit for y iff y passes through the lumen of x.
Relationship between a fluid and a material entity, where the fluid is the output of a realization of a filtration role that inheres in the material entity.
Relationship between a fluid and a filtration barrier, where the portion of fluid arises as a transformation of another portion of fluid on the other side of the barrier, with larger particles removed
x proximally_connected_to y iff the proximal part of x is connected to y. i.e. x connected_to y and x distal_to y.
c site_of p if c is the bearer of a disposition that is realized by a process that has p as part.
placeholder relation. X = 'subdivision of A' and subdivision_of some B means that X is the mereological sum of A and B
Relation between an anatomical structure (including cells) and a neuron that chemically synapses to it.
a relation that indicates a cell line cell is a model for studying a disease. Domain: a cell line cell Range: a disease.
entity
Julius Caesar
Verdi’s Requiem
the Second World War
your body mass index
BFO 2 Reference: In all areas of empirical inquiry we encounter general terms of two sorts. First are general terms which refer to universals or types:animaltuberculosissurgical procedurediseaseSecond, are general terms used to refer to groups of entities which instantiate a given universal but do not correspond to the extension of any subuniversal of that universal because there is nothing intrinsic to the entities in question by virtue of which they – and only they – are counted as belonging to the given group. Examples are: animal purchased by the Emperortuberculosis diagnosed on a Wednesdaysurgical procedure performed on a patient from Stockholmperson identified as candidate for clinical trial #2056-555person who is signatory of Form 656-PPVpainting by Leonardo da VinciSuch terms, which represent what are called ‘specializations’ in [81
Entity doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example Werner Ceusters 'portions of reality' include 4 sorts, entities (as BFO construes them), universals, configurations, and relations. It is an open question as to whether entities as construed in BFO will at some point also include these other portions of reality. See, for example, 'How to track absolutely everything' at http://www.referent-tracking.com/_RTU/papers/CeustersICbookRevised.pdf
An entity is anything that exists or has existed or will exist. (axiom label in BFO2 Reference: [001-001])
continuant
An entity that exists in full at any time in which it exists at all, persists through time while maintaining its identity and has no temporal parts.
BFO 2 Reference: Continuant entities are entities which can be sliced to yield parts only along the spatial dimension, yielding for example the parts of your table which we call its legs, its top, its nails. ‘My desk stretches from the window to the door. It has spatial parts, and can be sliced (in space) in two. With respect to time, however, a thing is a continuant.’ [60, p. 240
Continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. For example, in an expansion involving bringing in some of Ceuster's other portions of reality, questions are raised as to whether universals are continuants
A continuant is an entity that persists, endures, or continues to exist through time while maintaining its identity. (axiom label in BFO2 Reference: [008-002])
if b is a continuant and if, for some t, c has_continuant_part b at t, then c is a continuant. (axiom label in BFO2 Reference: [126-001])
if b is a continuant and if, for some t, cis continuant_part of b at t, then c is a continuant. (axiom label in BFO2 Reference: [009-002])
if b is a material entity, then there is some temporal interval (referred to below as a one-dimensional temporal region) during which b exists. (axiom label in BFO2 Reference: [011-002])
(forall (x y) (if (and (Continuant x) (exists (t) (continuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [009-002]
(forall (x y) (if (and (Continuant x) (exists (t) (hasContinuantPartOfAt y x t))) (Continuant y))) // axiom label in BFO2 CLIF: [126-001]
(forall (x) (if (Continuant x) (Entity x))) // axiom label in BFO2 CLIF: [008-002]
(forall (x) (if (Material Entity x) (exists (t) (and (TemporalRegion t) (existsAt x t))))) // axiom label in BFO2 CLIF: [011-002]
occurrent
An entity that has temporal parts and that happens, unfolds or develops through time.
BFO 2 Reference: every occurrent that is not a temporal or spatiotemporal region is s-dependent on some independent continuant that is not a spatial region
BFO 2 Reference: s-dependence obtains between every process and its participants in the sense that, as a matter of necessity, this process could not have existed unless these or those participants existed also. A process may have a succession of participants at different phases of its unfolding. Thus there may be different players on the field at different times during the course of a football game; but the process which is the entire game s-depends_on all of these players nonetheless. Some temporal parts of this process will s-depend_on on only some of the players.
Occurrent doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. An example would be the sum of a process and the process boundary of another process.
Simons uses different terminology for relations of occurrents to regions: Denote the spatio-temporal location of a given occurrent e by 'spn[e]' and call this region its span. We may say an occurrent is at its span, in any larger region, and covers any smaller region. Now suppose we have fixed a frame of reference so that we can speak not merely of spatio-temporal but also of spatial regions (places) and temporal regions (times). The spread of an occurrent, (relative to a frame of reference) is the space it exactly occupies, and its spell is likewise the time it exactly occupies. We write 'spr[e]' and `spl[e]' respectively for the spread and spell of e, omitting mention of the frame.
An occurrent is an entity that unfolds itself in time or it is the instantaneous boundary of such an entity (for example a beginning or an ending) or it is a temporal or spatiotemporal region which such an entity occupies_temporal_region or occupies_spatiotemporal_region. (axiom label in BFO2 Reference: [077-002])
Every occurrent occupies_spatiotemporal_region some spatiotemporal region. (axiom label in BFO2 Reference: [108-001])
b is an occurrent entity iff b is an entity that has temporal parts. (axiom label in BFO2 Reference: [079-001])
(forall (x) (if (Occurrent x) (exists (r) (and (SpatioTemporalRegion r) (occupiesSpatioTemporalRegion x r))))) // axiom label in BFO2 CLIF: [108-001]
(forall (x) (iff (Occurrent x) (and (Entity x) (exists (y) (temporalPartOf y x))))) // axiom label in BFO2 CLIF: [079-001]
independent continuant
a chair
a heart
a leg
a molecule
a spatial region
an atom
an orchestra.
an organism
the bottom right portion of a human torso
the interior of your mouth
A continuant that is a bearer of quality and realizable entity entities, in which other entities inhere and which itself cannot inhere in anything.
b is an independent continuant = Def. b is a continuant which is such that there is no c and no t such that b s-depends_on c at t. (axiom label in BFO2 Reference: [017-002])
For any independent continuant b and any time t there is some spatial region r such that b is located_in r at t. (axiom label in BFO2 Reference: [134-001])
For every independent continuant b and time t during the region of time spanned by its life, there are entities which s-depends_on b during t. (axiom label in BFO2 Reference: [018-002])
(forall (x t) (if (IndependentContinuant x) (exists (r) (and (SpatialRegion r) (locatedInAt x r t))))) // axiom label in BFO2 CLIF: [134-001]
(forall (x t) (if (and (IndependentContinuant x) (existsAt x t)) (exists (y) (and (Entity y) (specificallyDependsOnAt y x t))))) // axiom label in BFO2 CLIF: [018-002]
(iff (IndependentContinuant a) (and (Continuant a) (not (exists (b t) (specificallyDependsOnAt a b t))))) // axiom label in BFO2 CLIF: [017-002]
spatial region
process
a process of cell-division, \ a beating of the heart
a process of meiosis
a process of sleeping
the course of a disease
the flight of a bird
the life of an organism
your process of aging.
An occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t.
p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])
BFO 2 Reference: The realm of occurrents is less pervasively marked by the presence of natural units than is the case in the realm of independent continuants. Thus there is here no counterpart of ‘object’. In BFO 1.0 ‘process’ served as such a counterpart. In BFO 2.0 ‘process’ is, rather, the occurrent counterpart of ‘material entity’. Those natural – as contrasted with engineered, which here means: deliberately executed – units which do exist in the realm of occurrents are typically either parasitic on the existence of natural units on the continuant side, or they are fiat in nature. Thus we can count lives; we can count football games; we can count chemical reactions performed in experiments or in chemical manufacturing. We cannot count the processes taking place, for instance, in an episode of insect mating behavior.Even where natural units are identifiable, for example cycles in a cyclical process such as the beating of a heart or an organism’s sleep/wake cycle, the processes in question form a sequence with no discontinuities (temporal gaps) of the sort that we find for instance where billiard balls or zebrafish or planets are separated by clear spatial gaps. Lives of organisms are process units, but they too unfold in a continuous series from other, prior processes such as fertilization, and they unfold in turn in continuous series of post-life processes such as post-mortem decay. Clear examples of boundaries of processes are almost always of the fiat sort (midnight, a time of death as declared in an operating theater or on a death certificate, the initiation of a state of war)
(iff (Process a) (and (Occurrent a) (exists (b) (properTemporalPartOf b a)) (exists (c t) (and (MaterialEntity c) (specificallyDependsOnAt a c t))))) // axiom label in BFO2 CLIF: [083-003]
disposition
an atom of element X has the disposition to decay to an atom of element Y
certain people have a predisposition to colon cancer
children are innately disposed to categorize objects in certain ways.
the cell wall is disposed to filter chemicals in endocytosis and exocytosis
BFO 2 Reference: Dispositions exist along a strength continuum. Weaker forms of disposition are realized in only a fraction of triggering cases. These forms occur in a significant number of cases of a similar type.
b is a disposition means: b is a realizable entity & b’s bearer is some material entity & b is such that if it ceases to exist, then its bearer is physically changed, & b’s realization occurs when and because this bearer is in some special physical circumstances, & this realization occurs in virtue of the bearer’s physical make-up. (axiom label in BFO2 Reference: [062-002])
If b is a realizable entity then for all t at which b exists, b s-depends_on some material entity at t. (axiom label in BFO2 Reference: [063-002])
(forall (x t) (if (and (RealizableEntity x) (existsAt x t)) (exists (y) (and (MaterialEntity y) (specificallyDepends x y t))))) // axiom label in BFO2 CLIF: [063-002]
(forall (x) (if (Disposition x) (and (RealizableEntity x) (exists (y) (and (MaterialEntity y) (bearerOfAt x y t)))))) // axiom label in BFO2 CLIF: [062-002]
realizable entity
the disposition of this piece of metal to conduct electricity.
the disposition of your blood to coagulate
the function of your reproductive organs
the role of being a doctor
the role of this boundary to delineate where Utah and Colorado meet
A specifically dependent continuant that inheres in continuant entities and are not exhibited in full at every time in which it inheres in an entity or group of entities. The exhibition or actualization of a realizable entity is a particular manifestation, functioning or process that occurs under certain circumstances.
To say that b is a realizable entity is to say that b is a specifically dependent continuant that inheres in some independent continuant which is not a spatial region and is of a type instances of which are realized in processes of a correlated type. (axiom label in BFO2 Reference: [058-002])
All realizable dependent continuants have independent continuants that are not spatial regions as their bearers. (axiom label in BFO2 Reference: [060-002])
(forall (x t) (if (RealizableEntity x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (bearerOfAt y x t))))) // axiom label in BFO2 CLIF: [060-002]
(forall (x) (if (RealizableEntity x) (and (SpecificallyDependentContinuant x) (exists (y) (and (IndependentContinuant y) (not (SpatialRegion y)) (inheresIn x y)))))) // axiom label in BFO2 CLIF: [058-002]
quality
the ambient temperature of this portion of air
the color of a tomato
the length of the circumference of your waist
the mass of this piece of gold.
the shape of your nose
the shape of your nostril
a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001])
If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001])
(forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001]
(forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001]
specifically dependent continuant
Reciprocal specifically dependent continuants: the function of this key to open this lock and the mutually dependent disposition of this lock: to be opened by this key
of one-sided specifically dependent continuants: the mass of this tomato
of relational dependent continuants (multiple bearers): John’s love for Mary, the ownership relation between John and this statue, the relation of authority between John and his subordinates.
the disposition of this fish to decay
the function of this heart: to pump blood
the mutual dependence of proton donors and acceptors in chemical reactions [79
the mutual dependence of the role predator and the role prey as played by two organisms in a given interaction
the pink color of a medium rare piece of grilled filet mignon at its center
the shape of this hole.
the smell of this portion of mozzarella
A continuant that inheres in or is borne by other entities. Every instance of A requires some specific instance of B which must always be the same.
b is a relational specifically dependent continuant = Def. b is a specifically dependent continuant and there are n > 1 independent continuants c1, … cn which are not spatial regions are such that for all 1 i < j n, ci and cj share no common parts, are such that for each 1 i n, b s-depends_on ci at every time t during the course of b’s existence (axiom label in BFO2 Reference: [131-004])
b is a specifically dependent continuant = Def. b is a continuant & there is some independent continuant c which is not a spatial region and which is such that b s-depends_on c at every time t during the course of b’s existence. (axiom label in BFO2 Reference: [050-003])
Specifically dependent continuant doesn't have a closure axiom because the subclasses don't necessarily exhaust all possibilites. We're not sure what else will develop here, but for example there are questions such as what are promises, obligation, etc.
(iff (RelationalSpecificallyDependentContinuant a) (and (SpecificallyDependentContinuant a) (forall (t) (exists (b c) (and (not (SpatialRegion b)) (not (SpatialRegion c)) (not (= b c)) (not (exists (d) (and (continuantPartOfAt d b t) (continuantPartOfAt d c t)))) (specificallyDependsOnAt a b t) (specificallyDependsOnAt a c t)))))) // axiom label in BFO2 CLIF: [131-004]
(iff (SpecificallyDependentContinuant a) (and (Continuant a) (forall (t) (if (existsAt a t) (exists (b) (and (IndependentContinuant b) (not (SpatialRegion b)) (specificallyDependsOnAt a b t))))))) // axiom label in BFO2 CLIF: [050-003]
role
John’s role of husband to Mary is dependent on Mary’s role of wife to John, and both are dependent on the object aggregate comprising John and Mary as member parts joined together through the relational quality of being married.
the priest role
the role of a boundary to demarcate two neighboring administrative territories
the role of a building in serving as a military target
the role of a stone in marking a property boundary
the role of subject in a clinical trial
the student role
A realizable entity the manifestation of which brings about some result or end that is not essential to a continuant in virtue of the kind of thing that it is but that can be served or participated in by that kind of continuant in some kinds of natural, social or institutional contexts.
BFO 2 Reference: One major family of examples of non-rigid universals involves roles, and ontologies developed for corresponding administrative purposes may consist entirely of representatives of entities of this sort. Thus ‘professor’, defined as follows,b instance_of professor at t =Def. there is some c, c instance_of professor role & c inheres_in b at t.denotes a non-rigid universal and so also do ‘nurse’, ‘student’, ‘colonel’, ‘taxpayer’, and so forth. (These terms are all, in the jargon of philosophy, phase sortals.) By using role terms in definitions, we can create a BFO conformant treatment of such entities drawing on the fact that, while an instance of professor may be simultaneously an instance of trade union member, no instance of the type professor role is also (at any time) an instance of the type trade union member role (any more than any instance of the type color is at any time an instance of the type length).If an ontology of employment positions should be defined in terms of roles following the above pattern, this enables the ontology to do justice to the fact that individuals instantiate the corresponding universals – professor, sergeant, nurse – only during certain phases in their lives.
b is a role means: b is a realizable entity & b exists because there is some single bearer that is in some special physical, social, or institutional set of circumstances in which this bearer does not have to be& b is not such that, if it ceases to exist, then the physical make-up of the bearer is thereby changed. (axiom label in BFO2 Reference: [061-001])
(forall (x) (if (Role x) (RealizableEntity x))) // axiom label in BFO2 CLIF: [061-001]
generically dependent continuant
The entries in your database are patterns instantiated as quality instances in your hard drive. The database itself is an aggregate of such patterns. When you create the database you create a particular instance of the generically dependent continuant type database. Each entry in the database is an instance of the generically dependent continuant type IAO: information content entity.
the pdf file on your laptop, the pdf file that is a copy thereof on my laptop
the sequence of this protein molecule; the sequence that is a copy thereof in that protein molecule.
A continuant that is dependent on one or other independent continuant bearers. For every instance of A requires some instance of (an independent continuant type) B but which instance of B serves can change from time to time.
b is a generically dependent continuant = Def. b is a continuant that g-depends_on one or more other entities. (axiom label in BFO2 Reference: [074-001])
(iff (GenericallyDependentContinuant a) (and (Continuant a) (exists (b t) (genericallyDependsOnAt a b t)))) // axiom label in BFO2 CLIF: [074-001]
function
the function of a hammer to drive in nails
the function of a heart pacemaker to regulate the beating of a heart through electricity
the function of amylase in saliva to break down starch into sugar
BFO 2 Reference: In the past, we have distinguished two varieties of function, artifactual function and biological function. These are not asserted subtypes of BFO:function however, since the same function – for example: to pump, to transport – can exist both in artifacts and in biological entities. The asserted subtypes of function that would be needed in order to yield a separate monoheirarchy are not artifactual function, biological function, etc., but rather transporting function, pumping function, etc.
A function is a disposition that exists in virtue of the bearer’s physical make-up and this physical make-up is something the bearer possesses because it came into being, either through evolution (in the case of natural biological entities) or through intentional design (in the case of artifacts), in order to realize processes of a certain sort. (axiom label in BFO2 Reference: [064-001])
(forall (x) (if (Function x) (Disposition x))) // axiom label in BFO2 CLIF: [064-001]
material entity
a flame
a forest fire
a human being
a hurricane
a photon
a puff of smoke
a sea wave
a tornado
an aggregate of human beings.
an energy wave
an epidemic
the undetached arm of a human being
An independent continuant that is spatially extended whose identity is independent of that of other entities and can be maintained through time.
BFO 2 Reference: Material entities (continuants) can preserve their identity even while gaining and losing material parts. Continuants are contrasted with occurrents, which unfold themselves in successive temporal parts or phases [60
BFO 2 Reference: Object, Fiat Object Part and Object Aggregate are not intended to be exhaustive of Material Entity. Users are invited to propose new subcategories of Material Entity.
BFO 2 Reference: ‘Matter’ is intended to encompass both mass and energy (we will address the ontological treatment of portions of energy in a later version of BFO). A portion of matter is anything that includes elementary particles among its proper or improper parts: quarks and leptons, including electrons, as the smallest particles thus far discovered; baryons (including protons and neutrons) at a higher level of granularity; atoms and molecules at still higher levels, forming the cells, organs, organisms and other material entities studied by biologists, the portions of rock studied by geologists, the fossils studied by paleontologists, and so on.Material entities are three-dimensional entities (entities extended in three spatial dimensions), as contrasted with the processes in which they participate, which are four-dimensional entities (entities extended also along the dimension of time).According to the FMA, material entities may have immaterial entities as parts – including the entities identified below as sites; for example the interior (or ‘lumen’) of your small intestine is a part of your body. BFO 2.0 embodies a decision to follow the FMA here.
A material entity is an independent continuant that has some portion of matter as proper or improper continuant part. (axiom label in BFO2 Reference: [019-002])
Every entity which has a material entity as continuant part is a material entity. (axiom label in BFO2 Reference: [020-002])
every entity of which a material entity is continuant part is also a material entity. (axiom label in BFO2 Reference: [021-002])
(forall (x) (if (MaterialEntity x) (IndependentContinuant x))) // axiom label in BFO2 CLIF: [019-002]
(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt x y t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [021-002]
(forall (x) (if (and (Entity x) (exists (y t) (and (MaterialEntity y) (continuantPartOfAt y x t)))) (MaterialEntity x))) // axiom label in BFO2 CLIF: [020-002]
immaterial entity
A part of a cellular organism that is either an immaterial entity or a material entity with granularity above the level of a protein complex. Or, a substance produced by a cellular organism with granularity above the level of a protein complex.
Following BFO, material anatomical entities may have immaterial parts (the lumen of your stomach is part of your stomach). The granularity limit follows the limits set by the Gene Ontology on the granularity limit for GO:cellular_component. Note that substances produced by an organism (sweat, feaces, urine) do not need to be part of an organism to qualify as an anatomical structure.
anatomical entity
Material anatomical entity that is a single connected structure with inherent 3D shape generated by coordinated expression of the organism's own genome.
Note that the definition does not say 'generated exclusively by the co-ordinated expression of the organism's own genome', so this is still valid for cases where normal morphogenesis requires the actions of a facultative symbiont, or some looser dependency such as the a requirement for the presence of gut flora for normal gut development.
A structure consisting of multiple cell components but which is not itself a cell and does not have (complete) cells as a part.
Examples: a bundle of neuron projections in the brain; a region neuropil in an arthropod central nervous system; a region of cortex (preikaryal rind) in an arthropod brain.
A fasciculated bundle of neuron projections (GO:0043005), largely or completely lacking synapses.
Anatomical structure that is part of a multicellular organism and is at the gross anatomical level, e.g. above the level of a cell. Included are portions of organism substances such as blood, multi-cell-part structures such as axon tracts, acellular anatomical structures such as hair, and organism subdivisions such as head. Excluded is the whole organism and more granular parts of the organism, such as atoms, molecules, macromolecular complexes and cells.
gross anatomical part
Material anatomical entity that is a member of an individual species or is a viral or viroid particle.
An anatomical structure that has more than one cell as a part.
Elementary particle not affected by the strong force having a spin 1/2, a negative elementary charge and a rest mass of 0.000548579903(13) u, or 0.51099906(15) MeV.
A steroid compound with a structure based on a 19-carbon (androstane) skeleton.
A class of carbonyl compound encompassing dicarboxylic acids and any derivatives obtained by substitution of either one or both of the carboxy hydrogens.
dicarboxylic acids and O-substituted derivatives
A carbohydrate acid derivative anion obtained by deprotonation of the carboxy groups of hyaluronic acid; major species at pH 7.3.
An organic group derived from any 3-oxo-Delta(4)-steroid.
Any steroid that has beta-configuration at position 5.
A Bronsted acid derived from one or more inorganic compounds. Inorganic acids (also known as mineral acids) form hydrons and conjugate base ions when dissolved in water.
Any member of a group of hydroxy steroids occuring in bile, where they are present as the sodium salts of their amides with glycine or taurine. In mammals bile acids almost invariably have 5beta-configuration, while in lower vertebrates, some bile acids, known as allo-bile acids, have 5alpha-configuration.
Any main group molecular entity that is gaseous at standard temperature and pressure (STP; 0degreeC and 100 kPa).
An antigenic epitope recognized by an anti-bilirubin monoclonal antibody designated 24G7. A substructure of bilirubin IXalpha, it is the region containing the oxo group at C-1, the methyl group at C-2, C-(4, 5, 6, 9), and N-21 and -22.
An alpha-amino-acid anion that is the conjugate base of glutamic acid, having anionic carboxy groups and a cationic amino group
A molecular entity that can accept an electron, a pair of electrons, an atom or a group from another molecular entity.
A peptide containing ten or more amino acid residues.
A nucleobase-containing molecular entity with a polymeric structure comprised of a linear sequence of 13 or more nucleotide residues.
An azane that consists of a single nitrogen atom covelently bonded to three hydrogen atoms.
A sulfur oxoanion obtained by deprotonation of both OH groups of sulfuric acid.
A mucopolysaccharide composed of N-acetylglucosamine and glucuronic acid subunits. It is found in the connective tissues of vertebrates. A principal constituent of the extracellular matrix (ECM), it mediates the growth and metastasis of tumour cells.
A naturally occurring polypeptide synthesized at the ribosome.
Any member of the class of organooxygen compounds that is a polyhydroxy-aldehyde or -ketone or a lactol resulting from their intramolecular condensation (monosaccharides); substances derived from these by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom; and polymeric products arising by intermolecular acetal formation between two or more such molecules (disaccharides, polysaccharides and oligosaccharides). Carbohydrates contain only carbon, hydrogen and oxygen atoms; prior to any oxidation or reduction, most have the empirical formula Cm(H2O)n. Compounds obtained from carbohydrates by substitution, etc., are known as carbohydrate derivatives and may contain other elements. Cyclitols are generally not regarded as carbohydrates.
Amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc.
Any oligosaccharide, polysaccharide or their derivatives consisting of monosaccharides or monosaccharide derivatives linked by glycosidic bonds. See also http://www.ontobee.org/ontology/GNO?iri=http://purl.obolibrary.org/obo/GNO_00000001.
A member of the class of biladienes that is a linear tetrapyrrole with the dipyrrole units being of both exovinyl and endovinyl type. A product of heme degradation, it is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin.
3,18-diethenyl-2,7,13,17-tetramethyl-1,19-dioxo-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid
1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinylbiline-8,12-dipropionic acid
2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid
2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-1,10,19,22,23,24-hexahydro-21H-biline-8,12-dipropanoic acid
High molecular weight, linear polymers, composed of nucleotides containing deoxyribose and linked by phosphodiester bonds; DNA contain the genetic information of organisms.
A compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H).
A compound in which a carbohydrate component is covalently bound to a protein component.
An androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5..
The carbon oxoanion resulting from the removal of a proton from carbonic acid.
A molecular entity that can transfer ("donate") an electron, a pair of electrons, an atom or a group to another molecular entity.
'Lipids' is a loosely defined term for substances of biological origin that are soluble in nonpolar solvents. They consist of saponifiable lipids, such as glycerides (fats and oils) and phospholipids, as well as nonsaponifiable lipids, principally steroids.
Any polysaccharide containing a substantial proportion of aminomonosaccharide residues.
A biomacromolecule consisting of large numbers of monosaccharide residues linked glycosidically. This term is commonly used only for those containing more than ten monosaccharide residues.
An alpha-amino acid that is glutaric acid bearing a single amino substituent at position 2.
That part of DNA or RNA that may be involved in pairing.
A member of the class of imidazoles that is 1H-imidazole substituted at position C-4 by a 2-aminoethyl group.
An organic group formed by removing one or more hydroxy groups from an oxoacid that has the general structure RkE(=O)l(OH)m (l =/= 0). Although the term is almost always applied to organic compounds, with carboxylic acid as the oxoacid, acyl groups can in principle be derived from other types of acids such as sulfonic acids or phosphonic acids.
A monoatomic or polyatomic species having one or more elementary charges of the electron.
A substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
A molecular entity having an available pair of electrons capable of forming a covalent bond with a hydron (Bronsted base) or with the vacant orbital of some other molecular entity (Lewis base).
A sodium salt of the conjugate of any bile acid with either glycine or taurine.
The univalent carboacyl group formed by loss of -OH from the carboxy group of carbamic acid.
An organic molecule or ion (usually a metal ion) that is required by an enzyme for its activity. It may be attached either loosely (coenzyme) or tightly (prosthetic group).
Any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer etc., identifiable as a separately distinguishable entity.
An azole that is either one of a pair of heterocyclic organic compounds comprising three carbon atoms and two nitrogen atoms arranged in a ring.
Any substance which when absorbed into a living organism may modify one or more of its functions. The term is generally accepted for a substance taken for a therapeutic purpose, but is also commonly used for abused substances.
A compound or agent that combines with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
A chemical entity is a physical entity of interest in chemistry including molecular entities, parts thereof, and chemical substances.
A role played by the molecular entity or part thereof within a biological context.
A defined linked collection of atoms or a single atom within a molecular entity.
A cyclic compound having as ring members atoms of carbon and at least of one other element.
A heterodetic cyclic peptide is a peptide consisting only of amino-acid residues, but in which the linkages forming the ring are not solely peptide bonds; one or more is an isopeptide, disulfide, ester, or other bond.
Originally referring to an endogenous compound that is formed in specialized organ or group of cells and carried to another organ or group of cells, in the same organism, upon which it has a specific regulatory function, the term is now commonly used to include non-endogenous, semi-synthetic and fully synthetic analogues of such compounds.
Hydroxides are chemical compounds containing a hydroxy group or salts containing hydroxide (OH(-)).
Any member of the class of 5beta-cholanic acids carrying at least one hydroxy group at unspecified position.
A five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton.
A compound which contains oxygen, at least one other element, and at least one hydrogen bound to oxygen, and which produces a conjugate base by loss of positive hydrogen ion(s) (hydrons).
A molecular entity that contains no carbon.
A salt is an assembly of cations and anions.
A molecular entity having a net electric charge.
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
A molecule all atoms of which have the same atomic number.
Any polyatomic entity that is an electrically neutral entity consisting of more than one atom.
An oxoacid containing a single carboxy group.
An endogenous compound that is used to transmit information across the synapse between a neuron and another cell.
Any organic ion with a net negative charge.
Compounds of the general formula SO3HOR where R is an organyl group
An oxide is a chemical compound of oxygen with other chemical elements.
Any peptide with hormonal activity in animals, whether endocrine, neuroendocrine, or paracrine.
Any amino acid whose side chain is capable of forming one or more hydrogen bonds.
Any alkali metal salt having sodium(1+) as the cation.
An ester of an alcohol and sulfuric acid.
A sulfur oxoacid that consists of two oxo and two hydroxy groups joined covalently to a central sulfur atom.
A natural pigment containing four pyrrole rings joined by one-carbon units linking position 2 of one pyrrole ring to position 5 of the next.
Any nutrient required in small quantities by organisms throughout their life in order to orchestrate a range of physiological functions.
A univalent carboacyl group is a group formed by loss of OH from the carboxy group of a carboxylic acid.
A neutral compound having formal unit electrical charges of opposite sign on non-adjacent atoms. Sometimes referred to as inner salts, dipolar ions (a misnomer).
A polydisperse, highly branched glucan composed of chains of D-glucopyranose residues in alpha(1->4) glycosidic linkage, joined together by alpha(1->6) glycosidic linkages. A small number of alpha(1->3) glycosidic linkages and some cumulative alpha(1->6) links also may occur. The branches in glycogen typically contain 8 to 12 glucose residues.
A one-carbon compound that is ammonia in which one of the hydrogens is replaced by a carboxy group. Although carbamic acid derivatives are common, carbamic acid itself has never been synthesised.
An onium cation obtained by protonation of ammonia.
A carboxylic acid dianion obtained by deprotonation of both carboxy groups of any dicarboxylic acid.
The conjugate base formed when the carboxy group of a carboxylic acid is deprotonated.
A monoatomic monocation obtained from sodium.
A divalent inorganic anion resulting from the removal of two protons from ammonia.
A dicarboxylic acid dianion that is the conjugate base of glutamate(1-).
Particle of zero charge, zero rest mass, spin quantum number 1, energy hnu and momentum hnu/c (h is the Planck constant, nu the frequency of radiation and c the speed of light), carrier of electromagnetic force.
Any member of a group of hydroxy-5beta-cholanic acids occuring in bile, where they are present as the sodium salts of their amides with glycine or taurine. In mammals bile acids almost invariably have 5beta-configuration.
An amide is a derivative of an oxoacid RkE(=O)l(OH)m (l =/= 0) in which an acidic hydroxy group has been replaced by an amino or substituted amino group.
Intended use of the molecular entity or part thereof by humans.
A particle not known to have substructure.
A monoatomic entity is a molecular entity consisting of a single atom.
An organic fundamental parent is a structure used as a basis for substitutive names in organic nomenclature, containing, in addition to one or more hydrogen atoms, a single atom of an element, a number of atoms (alike or different) linked together to form an unbranched chain, a monocyclic or polycyclic ring system, or a ring assembly or ring/chain system.
Any substituent group which does not contain carbon.
Any substituent group or skeleton containing carbon.
Any organic substituent group, regardless of functional type, having one free valence at a carbon atom.
A chemical entity constituting the smallest component of an element having the chemical properties of the element.
A nucleus is the positively charged central portion of an atom, excluding the orbital electrons.
Heavy nuclear particle: proton or neutron.
A derivative of an oxoacid RkE(=O)l(OH)m (l =/= 0) in which an acidic hydroxy group has been replaced by an amino or substituted amino group.
A molecular entity all atoms of which have the same atomic number.
An anion consisting of more than one atom.
A nutrient is a food component that an organism uses to survive and grow.
A heteroorganic entity is an organic molecular entity in which carbon atoms or organic groups are bonded directly to one or more heteroatoms.
A substance administered to aid diagnosis of a disease.
A molecular entity containing one or more atoms of an alkali metal.
Any p-block element atom that is in group 15 of the periodic table: nitrogen, phosphorus, arsenic, antimony and bismuth.
A p-block molecular entity containing any pnictogen.
Any p-block element belonging to the group 16 family of the periodic table.
Any p-block molecular entity containing a chalcogen.
An atom belonging to one of the main groups (found in the s- and p- blocks) of the periodic table.
An atom of an element that exhibits typical metallic properties, being typically shiny, with high electrical and thermal conductivity.
An amino-acid anion obtained by deprotonation of any alpha-amino acid.
Any main group element atom belonging to the p-block of the periodic table.
A carbon oxoacid acid carrying at least one -C(=O)OH group and having the structure RC(=O)OH, where R is any any monovalent functional group. Carboxylic acids are the most common type of organic acid.
A molecular entity containing one or more atoms from any of groups 1, 2, 13, 14, 15, 16, 17, and 18 of the periodic table.
Any molecule that consists of a series of atoms joined together to form a ring.
A cyclically conjugated molecular entity with a stability (due to delocalization) significantly greater than that of a hypothetical localized structure (e.g. Kekule structure) is said to possess aromatic character.
An s-block molecular entity is a molecular entity containing one or more atoms of an s-block element.
A main group molecular entity that contains one or more atoms of a p-block element.
Hydrides are chemical compounds of hydrogen with other chemical elements.
A macromolecule formed by a living organism.
A macromolecule made up of nucleotide units and hydrolysable into certain pyrimidine or purine bases (usually adenine, cytosine, guanine, thymine, uracil), D-ribose or 2-deoxy-D-ribose and phosphoric acid.
High molecular weight, linear polymers, composed of nucleotides containing ribose and linked by phosphodiester bonds; RNA is central to the synthesis of proteins.
A cation consisting of more than one atom.
An amino acid in which the amino group is located on the carbon atom at the position alpha to the carboxy group.
When two or more amino acids combine to form a peptide, the elements of water are removed, and what remains of each amino acid is called an amino-acid residue.
A carboxylic acid containing one or more amino groups.
An organic compound having at least one hydroxy group attached to a carbon atom.
Any organic molecule that consists of atoms connected in the form of a ring.
A heterocyclic compound formally derived from an arene by replacement of one or more methine (-C=) and/or vinylene (-CH=CH-) groups by trivalent or divalent heteroatoms, respectively, in such a way as to maintain the continuous pi-electron system characteristic of aromatic systems and a number of out-of-plane pi-electrons corresponding to the Hueckel rule (4n+2).
Conjugated protein is a protein that contains a non-peptide component, usually in stoichiometric proportion.
A macromolecule is a molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
A substance used in a chemical reaction to detect, measure, examine, or produce other substances.
Any nutrient required in large quantities by organisms throughout their life in order to orchestrate a range of physiological functions. Macronutrients are usually chemical elements (carbon, hydrogen, nitrogen, oxygen, phosphorus and sulfur) that humans consume in the largest quantities. Calcium, sodium, magnesium and potassium are sometimes included as macronutrients because they are required in relatively large quantities compared with other vitamins and minerals.
Saturated acyclic nitrogen hydrides having the general formula NnHn+2.
A substance that diminishes the rate of a chemical reaction.
A substance that increases the rate of a reaction without modifying the overall standard Gibbs energy change in the reaction.
The zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
A derivative of ammonium, NH4(+), in which one (or more) of the hydrogens bonded to the nitrogen have been replaced with univalent organyl groups. The substituting carbon of the organyl group must not itself be directly attached to a heteroatom (thereby excluding protonated amides, hemiaminals, etc).
Any of naturally occurring compounds and synthetic analogues, based on the cyclopenta[a]phenanthrene carbon skeleton, partially or completely hydrogenated; there are usually methyl groups at C-10 and C-13, and often an alkyl group at C-17. By extension, one or more bond scissions, ring expansions and/or ring contractions of the skeleton may have occurred. Natural steroids are derived biogenetically from squalene which is a triterpene.
A 17-hydroxy steroid in which the hydroxy group at position 17 has a beta-configuration.
Any heteroorganic entity containing at least one carbon-nitrogen bond.
An oxoanion is an anion derived from an oxoacid by loss of hydron(s) bound to oxygen.
A substance that reduces or suppresses inflammation.
A negative ion consisting solely of carbon and oxygen atoms, and therefore having the general formula CxOy(n-) for some integers x, y and n.
Any carboxylic acid containing two carboxy groups.
A compound formally derived from an oxoacid RkE(=O)l(OH)m (l > 0) and an alcohol, phenol, heteroarenol, or enol by linking with formal loss of water from an acidic hydroxy group of the former and a hydroxy group of the latter.
A carboxylic acid anion formed when the carboxy group of a monocarboxylic acid is deprotonated.
A biological macromolecule minimally consisting of one polypeptide chain synthesized at the ribosome.
A steroid acid that consists of cholane having a carboxy group in place of the methyl group at position 24.
(5beta,17beta)-gamma-methylandrostane-17-butanoic acid
Members of the class of cholanic acids based on a 5beta-cholane skeleton.
Lepton is a fermion that does not experience the strong force (strong interaction). The term is derived from the Greek lambdaepsilonpitauomicronsigma (small, thin).
Baryon is a fermion that does experience the strong force (strong interaction). The term is derived from the Greek betaalpharhoupsilonsigma (heavy).
Particle of half-integer spin quantum number following Fermi-Dirac statistics. Fermions are named after Enrico Fermi.
Particle of integer spin quantum number following Bose-Einstein statistics. Bosons are named after Satyendra Nath Bose.
A subatomic particle known to have substructure (i.e. consisting of smaller particles).
Hadron is a subatomic particle which experiences the strong force.
A nucleus or any of its constituents in any of their energy states.
Any molecular entity consisting of more than one atom.
An ion consisting of more than one atom.
Any compound containing the carbonyl group, C=O. The term is commonly used in the restricted sense of aldehydes and ketones, although it actually includes carboxylic acids and derivatives.
Organic compounds containing an oxygen atom, =O, doubly bonded to carbon or another element.
Compounds based on a biladiene skeleton.
A hydroxy steroid carrying a hydroxy group at position 17.
A monoatomic or polyatomic species having one or more elementary charges of the proton.
An organochalcogen compound is a compound containing at least one carbon-chalcogen bond.
An organochalcogen compound containing at least one carbon-oxygen bond.
A polysaccharide composed of glucose residues.
Glycans composed of a single type of monosaccharide residue. They are named by replacing the ending '-ose' of the sugar by '-an'.
Any of the group of polysaccharides composed of alternating units from uronic acids and glycosamines, and commonly partially esterified with sulfuric acid.
An acid is a molecular entity capable of donating a hydron (Bronsted acid) or capable of forming a covalent bond with an electron pair (Lewis acid).
A molecular entity consisting of two or more chemical elements.
An amide of a carboxylic acid, having the structure RC(=O)NR2. The term is used as a suffix in systematic name formation to denote the -C(=O)NH2 group including its carbon atom.
A carboacyl group is a group formed by loss of at least one OH from the carboxy group of a carboxylic acid.
A compound composed of two or more pyrrole units.
Any organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms.
Any dianion containing at least one carboxy group.
A polypeptide hormone produced and secreted by the pituitary gland comprising 39 amino acid residues coupled in a linear sequence. The N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Corticotropin stimulates the cortex of the adrenal gland and boosts the synthesis of corticosteroids, mainly glucocorticoids but also sex steroids (androgens). It is used in the treatment of certain neurological disorders such as infantile spasms and multiple sclerosis, and diagnostically to investigate adrenocortical insufficiency.
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
A molecular entity able to provide a pair of electrons and thus capable of forming a covalent bond with an electron-pair acceptor (Lewis acid), thereby producing a Lewis adduct.
Any oxo steroid where an oxo substituent is located at position 3.
Any steroid substituted by at least one carboxy group.
A 3-oxo steroid conjugated to a C=C double bond at the alpha,beta position.
Substance which binds to cell receptors normally responding to naturally occurring substances and which produces a response of its own.
A compound formally derived from ammonia by replacing one, two or three hydrogen atoms by organyl groups.
Any hormone that is responsible for controlling sexual characteristics and reproductive function.
A sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.
Any anion formed by loss of a proton from a steroid acid.
Mononuclear cations derived by addition of a hydron to a mononuclear parent hydride of the pnictogen, chalcogen and halogen families.
A univalent organyl group obtained by cleaving the bond from C-2 to the side chain of a proteinogenic amino-acid.
proteinogenic amino-acid side-chain groups
proteinogenic amino-acid side-chain group
Any steroid based on an androstane skeleton and its derivatives.
Any molecular entity that contains carbon.
A role is particular behaviour which a material entity may exhibit.
A poison that interferes with the functions of the nervous system.
A role played by the molecular entity or part thereof within a chemical context.
An organic molecule that is electrically neutral carrying a positive and a negative charge in one of its major canonical descriptions. In most dipolar compounds the charges are delocalized; however the term is also applied to species where this is not the case.
Any organic substituent group, regardless of functional type, having two free valences at carbon atom(s).
An alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
A ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) or R(1)C#C-C(=O)R(2) (R(2) =/= H) in which the ketonic C=O function is conjugated to an unsaturated C-C bond at the alpha,beta position.
A biological role played by the molecular entity or part thereof within a biochemical context.
A role played by the molecular entity or part thereof which causes the development of a pathological process.
A biological role which describes how a drug interacts within a biological system and how the interactions affect its medicinal properties.
Any substance introduced into a living organism with therapeutic or diagnostic purpose.
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
A polymer carrying multiple negative charges.
A macromolecule containing ionic groups.
A 29-amino acid peptide hormone consisting of His, Ser, Gln, Gly, Thr, Phe, Thr, Ser, Asp, Tyr, Ser, Lys, Tyr, Leu, Asp, Ser, Arg, Arg, Ala, Gln, Asp, Phe, Val, Gln, Trp, Leu, Met, Asn and Thr residues joined in sequence.
A cyclic compound having as ring members atoms of at least two different elements.
A dicarboxylic acid dianion obtained by deprotonation of the two carboxy groups of bilirubin; major species at pH 7.3.
An ammonium ion that is the conjugate acid of histamine protonated on the side-chain nitrogen.
An organic anion of general formula RS(=O)2O(-) where R is an organyl group.
An organic anion arising from deprotonation of a acyclic tetrapyrrole compound.
A reagent that forms a bond to its reaction partner (the electrophile) by donating both bonding electrons.
A chemical substance is a portion of matter of constant composition, composed of molecular entities of the same type or of different types.
A mixture is a chemical substance composed of multiple molecules, at least two of which are of a different kind.
A polymer is a mixture, which is composed of macromolecules of different kinds and which may be differentiated by composition, length, degree of branching etc..
An ionic polymer is a polymer, composed of ionic macromolecules.
An atom or small molecule with a positive charge that does not contain carbon in covalent linkage, with a valency of one.
Zwitterionic form of any peptide where, in general, the amino terminus is positively charged and the carboxy terminus is negatively charged.
Any compound that has a nucleobase as a part.
nucleobase-containing molecular entities
A polymer, composed of polyanion macromolecules.
Zwitterionic form of a polar amino acid having an anionic carboxy group and a protonated amino group.
A substance that removes electrons from another reactant in a redox reaction.
Any organooxygen compound derived from a carbohydrate by replacement of one or more hydroxy group(s) by an amino group, a thiol group or similar heteroatomic groups. The term also includes derivatives of these compounds.
A carbohydrate derivative that is formally obtained from a carbohydrate acid.
A carboxylic acid anion resulting from the deprotonation of the carboxy group of a carbohydrate acid derivative.
Any substance which is added to food to preserve or enhance its flavour and/or appearance.
An organic amino compound in which an aminoalkyl group is linked to an arene.
A fourteen-membered heterodetic cyclic peptide comprising the sequence Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys cyclised by a disulfide bridge between the two Cys residues at positions 3 and 14.
L-alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine cyclic (3-14) disulfide
Synthetic growth hormone release-inhibiting hormone
An organic molecular entity containing a single carbon atom (C1).
Any organic molecular entity that is acidic and contains carbon in covalent linkage.
Any substance that causes disturbance to organisms by chemical reaction or other activity on the molecular scale, when a sufficient quantity is absorbed by the organism.
A carbohydrate derivative that is any derivative of a polysaccharide.
Any compound that has anti-inflammatory effects.
Any monocyclic heteroarene consisting of a five-membered ring containing nitrogen. Azoles can also contain one or more other non-carbon atoms, such as nitrogen, sulfur or oxygen.
A bicyclic macrolide natural product consisting of a 16-membered bicyclic lactone attached to the rare 2-thiazolidinone moiety. It is obtained from the Red Sea sponge Latrunculia magnifica and from the Fiji Islands sponge Cacospongia mycofijiensis. Latrunculin A inhibits actin polymerisation, microfilament organsation and microfilament-mediated processes.
Any molecule that consists of at least one carbon atom as part of the electrically neutral entity.
A biomacromolecule composed of carbohydrate residues which is secreted by a microorganism into the surrounding environment.
Any metabolite produced during a metabolic reaction in eukaryotes, the taxon that include members of the fungi, plantae and animalia kingdoms.
Any eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
Any animal metabolite produced during a metabolic reaction in mammals.
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
Saccharomyces cerevisiae secondary metabolites
Any metabolite produced during a metabolic reaction in prokaryotes, the taxon that include members of domains such as the bacteria and archaea.
Any enzyme inhibitor that interferes with the action of a hydrolase (EC 3.*.*.*).
Any hydrolase inhibitor that interferes with the action of a hydrolase acting on C-N bonds, other than peptide bonds (EC 3.5.*.*).
EC 3.5.* (hydrolase acting on non-peptide C-N bond) inhibitor
EC 3.5.* (hydrolase acting on non-peptide C-N bond) inhibitors
EC 3.5.* (hydrolases acting on C-N bonds, other than peptide bonds) inhibitor
EC 3.5.* (hydrolases acting on C-N bonds, other than peptide bonds) inhibitors
EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitors
EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor
An EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor that interferes with the action of any non-peptide linear amide C-N hydrolase (EC 3.5.1.*).
EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitors
non-peptide linear amide C-N hydrolase (EC 3.5.1.*) inhibitor
non-peptide linear amide C-N hydrolase (EC 3.5.1.*) inhibitors
EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor
Any eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
An EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the action of amidase (EC 3.5.1.4).
A food additive that is a (generally inert) gas which is used to envelop foodstuffs during packing and so protect them from unwanted chemical reactions such as food spoilage or oxidation during subsequent transport and storage. The term includes propellant gases, used to expel foods from a container.
A physiological role played by any substance that is distributed in foodstuffs. It includes materials derived from plants or animals, such as vitamins or minerals, as well as environmental contaminants.
A substance used in a thermodynamic heat pump cycle or refrigeration cycle that undergoes a phase change from a gas to a liquid and back. Refrigerants are used in air-conditioning systems and freezers or refrigerators and are assigned a "R" number (by ASHRAE - formerly the American Society of Heating, Refrigerating and Air Conditioning Engineers), which is determined systematically according to their molecular structure.
An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of any alpha-amino acid; major species at pH 7.3.
Any organooxygen compound that is a polyhydroxy-aldehyde or -ketone, or a compound derived from one. Carbohydrates contain only carbon, hydrogen and oxygen and usually have an empirical formula Cm(H2O)n; carbohydrate derivatives may contain other elements by substitution or condensation.
carbohydrates and carbohydrate derivatives
Any metabolite produced by all living cells.
Any organic molecular entity that contains at least one C=C bond.
Any inorganic anion with a valency of two.
Any inorganic anion with a valency of one.
An animal metabolite produced by arthropods such as crabs, lobsters, crayfish, shrimps and krill.
A Daphnia metabolite produced by the species Daphnia magna.
A crustacean metabolite produced by the genus of small planktonic arthropods, Daphnia
A family of cyclic nonapeptide hormones found in most mammals. Synthesised in the hypothalamus and stored in the post-pituitary, vasopressins play a key role in homeostasis, particularly in regulating the body's water content. Together with the similar neuropeptide oxytocin, they are believed to influence social cognition and behaviour.
a maintaining cell culture process that keeps cell line cell alive and actively cultured.
A cultured cell that is part of a cell line - a stable and homogeneous population of cells with a common biological origin and propagation history in culture
Yongqun He, Matthew Brush, Sirarat Sarntivijai, Alexander Diehl, Jie Zheng, Yu Lin, Bjoern Peters
A 'cell line cell' is a part of a cell line established through the passaging/selection of a primary cultured cells or the experimental modification of an existing cell line. New types of cell line cells are established after sufficient passaging of a primary culture to establish a stable and homogenous population that qualifies as a line (typically 1-20 passages), or following some spontaneous or experimental modification that confers novel characteristics to an existing line. A cell line cell typically has mutations of five or more genes compared to the original cell that derives the cell line cell. Some gene mutations may turn on some oncogenes. Cell line cells can be in active culture, stored in a quiescent state for future use (e.g. frozen in liquid nitrogen), or applied in experimental procedures.
suspension cell line culturing is a cell line culturing method where cells do not require a surface for growth and differentiation. This method is appropriate for cells that are adapted to suspension culture or cells that are non-adhesive (e.g. hematopoietic cells)
adherent cell line culturing is a cell line culturing method where cells require a surface for growth and differentiation.
a material processing that modifies an existing cell line cell to generate another cell line cell.
a role that inheres in a cell line repository organization.
an organization that serves as a repository of cell lines.
adherent on coated surface cell line culturing is an adherent cell line culturing method that the surface is coated with extracellular matrix component to increase adhesion properties and provide other signals needed for growth and differentiation.
adherent on coated surface cell line culturing
a cell line cell that is in the ATCC cell line repository
a cell line cell that is in the HyperCLDB cell line repository
an immortal human lymphocyte cell line cell that is derived from T cell.
immortal human T cell line cell
adherent on feeder cells cell line culturing
A cell line cell that is capable of replicating a limited number of times in culture before undergoing senescence.
Yongqun He, Matthew Brush, Sirarat Sarntivijai
A cell line cell that is expected to be capable of an unlimited number of divisions, and is thus able to support indefinite propagation in vitro as part of an immortal cell line.
Yongqun He, Matthew Brush, Allen Xiang, Asiyah Yu Lin, Sirarat Sarntivijai, James Malone, Jie Zheng, Tomasz Adamusiak
a immortal cell line that is dervied from human tissue.
immortal human cell line
An immortal skin-derived cell line cell that derives from cat.
immortal cat cell line cell
An immortal skin-derived cell line cell that derives from frog.
immortal frog cell line cell
an immortal cell line cell that is generated by fusing two different types of cells. One of the parent cells is typically a cancer cell.
An immortal cell line cell that derives from zebra fish.
immortal zebra fish cell line cell
a cell line that requires suspension cell cuturing.
a cell line that is cultured through adherence cell culturing.
a cell culture growth mode that indicates a cell needs to adhere to a cell culture plate to grow.
a cell culture growth mode that indicates a cell can grow when the cell is suspended in cell culture medium.
a disposition that represents a mode of cell culture growth, i.e., the cell will grow at a specific cell culture mode. For example, an adherent cell culture growh mode means that the cell will grow when the cell is adhere to a cell culture plate.
cell line
He, Tong-Chuan, et al., Identification of c-MYC as a target of the APC pathway. Science 281.5382 (1998): 1509-1512.: "To evaluate the transcriptional effects of APC, we studied a human colorectal cancer cell line (HT29-APC) containing a zinc-inducible APC gene and a control cell line (HT29–β-Gal) containing an analogous inducible lacZ gene". Note that common usage in the literature is often of the form "a human colorectal cancer cell line", as seen above. But such references to studies in "a line" refer to the fact that discrete populations of cells that are input into culturing or experiments, not an entire lineage of cells. It is these discrete populations that we refer to as 'cell lines'.
A cultured cell population that represents a genetically stable and homogenous population of cultured cells that shares a common propagation history (i.e. has been successively passaged together in culture).
In the spring of 2013, a working group comprised of domain experts and representatives from CLO, OBI, CL, and ReO worked to establish a consensus model and definitions of cultured cells across these efforts. This included a careful characterization of how the term 'cell line' should be defined and applied. Notes about this work and its outcomes can be found on the CLO wiki here: http://code.google.com/p/clo-ontology/wiki/Cell_Lines
The term 'line' is used when a culture has undergone an intentional experimental process to establish a more uniform and stable population of cells (see 'establishing cell line'). This will require one or more passages, but may involve additional selection processes. Through such passaging and/or selection processes, the resulting 'line' attains some level of genetic stability and compositional homogeneity which is typically absent in primary cultures. Because of their relative homogeneity, ‘lines’ are capable of being characterized and stably propagated over a period of time. A new *type* of cell line can be established not only through the passaging/selection of a primary culture, but also through experimental modifications of existing lines (e.g. immortalization, stable genetic modifications, drug selection for a resistant subset, etc.). The definition provided here establishes the 'scale' of cell populations that qualify as cell lines - specifically those with a shared propagation history in culture. In this way, the 'cell line' class demarcates populations that represent what researchers actually use in the practice of science - e.g. as inputs to culturing, experimentation, and sharing. The definition is such that cell lines will exhibit important attributes. For example, they will have a relatively homogenous cell type composition as they have experienced similar selective pressures due to their continuous co-propagation. In addition, these populations can also be characterized by a passage number, again owing to their common passaging history. As defined here, 'cell line' can refer to a population of cells in active culture, applied experimentally, or stored in a quiescent state for future use.
mixed adherent and suspension cell line culturing
clusters in suspension cell line culturing
Oliver Note: this term needs precise definition. will consult term users later.
Ba/F3 Stably co-expresses EpoR and JAK2V617F EpoR and JAK2V617F constructs
Ba/F3 cell line EpoR and JAK2V617F co-expression
CHO Established (in your ontology) Stably transfected with Cre-beta lactamase: Cre Bla CHO cell line
CHO cell line co-expression of lactamase
suspension with feeder cells cell line culturing
suspension-multicell aggregates cell line culturing
a immortal cell line that is dervied from mouse tissue.
immortal mouse cell line
a immortal cell line that is dervied from mouse macrophage.
immortal mouse macrophage cell line
a cell line that is derived from stem cell
a immortal cell line that is dervied from mouse liver.
immortal mouse liver cell line
a immortal cell line that is dervied from a Gorilla gorilla tissue.
immortal Gorilla gorilla cell line
a immortal stem cell line that is derived from somatic stem cell
a immortal somatic stem cell line that is derived from epithelial fate stem cell
immortal epithelial fate stem cell line cell
a immortal epithelial fate stem cell line that is derived from basal cell
a immortal somatic stem cell line that is derived from multi fate stem cell
a immortal multi fate stem cell line that is derived from neuronal stem cell
a immortal neuronal stem cell line that is derived from neuroblast
a immortal multi fate stem cell line that is derived from mesenchymal cell
a cell line that is derived from non-terminally differentiated cell
immortal non-terminally differentiated cell line
immortal non-terminally differentiated cell line cell
a immortal non-terminally differentiated cell line that is derived from osteoblast
a immortal non-terminally differentiated cell line that is derived from muscle precursor cell
immortal muscle precursor cell line cell
a immortal muscle precursor cell line that is derived from myoblast
a immortal myoblast cell line that is derived from fusion competent myoblast
immortal fusion competent myoblast cell line
immortal fusion competent myoblast cell line cell
a cell line that is derived from secretory cell
a immortal secretory cell line that is derived from glandular epithelial cell
immortal glandular epithelial cell line cell
a immortal glandular epithelial cell line cell that is derived from chromophil cell of anterior pituitary gland
immortal anterior pituitary gland chromophil cell line cell
a immortal chromophil cell line cell of anterior pituitary gland that is derived from thyrotroph
a immortal chromophil cell line of anterior pituitary gland that is derived from acidophil cell of pars distalis of adenohypophysis
immortal pars distalis of adenohypophysis acidophil cell line cell
a immortal glandular epithelial cell line that is derived from neck cell
a immortal glandular epithelial cell line that is derived from glandular cell of stomach
immortal glandular cell line of stomach cell
a immortal glandular cell line of stomach that is derived from parietal cell
a immortal secretory cell line that is derived from exocrine cell
a immortal secretory cell line that is derived from endocrine cell
a immortal endocrine cell line that is derived from mast cell
a immortal endocrine cell line cell that is derived from neuroendocrine cell
a immortal endocrine cell line that is derived from Leydig cell
a immortal secretory cell line cell that is derived from Sertoli cell
a immortal secretory cell line that is derived from plasma cell
an immortal cell line cell that is derived from contractile cell
a immortal contractile cell line cell that is derived from myofibroblast cell
a immortal contractile cell line cell that is derived from muscle cell
a immortal muscle cell line cell that is derived from skeletal muscle cell
a immortal muscle cell line cell that is derived from smooth muscle cell
an immortal cell line cell that is derived from electrically active cell
immortal electrically active cell line cell
a immortal electrically active cell line cell that is derived from electrically responsive cell
immortal electrically responsive cell line cell
a immortal electrically responsive cell line cell that is derived from neuron
a immortal neuron cell line cell that is derived from bipolar neuron
a immortal bipolar neuron cell line cell that is derived from ON-bipolar cell
a immortal neuron cell line cell that is derived from peripheral neuron
immortal peripheral neuron cell line cell
a immortal neuron cell line cell that is derived from stellate cell
an immortal cell line cell that is derived from barrier cell
an immortal barrier cell line cell that is derived from lining cell
a immortal lining cell line cell that is derived from mesothelial cell
a immortal mesothelial cell line cell that is derived from seminiferous tubule epithelial cell
immortal seminiferous tubule epithelial cell line cell
a immortal seminiferous tubule epithelial cell line cell that is derived from spermatocyte
a immortal lining cell line cell that is derived from endothelial cell
a immortal barrier cell line cell that is derived from myelinating Schwann cell
immortal myelinating Schwann cell line cell
a cell line that is derived from motile cell
a immortal motile cell line that is derived from phagocyte
a immortal phagocyte cell line that is derived from mononuclear phagocyte
immortal mononuclear phagocyte cell line cell
a immortal phagocyte cell line that is derived from macrophage
a immortal macrophage cell line that is derived from tissue-resident macrophage
immortal tissue-resident macrophage cell line cell
a immortal tissue-resident macrophage cell line that is derived from microglial cell
a immortal tissue-resident macrophage cell line that is derived from peritoneal macrophage
immortal peritoneal macrophage cell line cell
a immortal phagocyte cell line that is derived from polygonal cell
a immortal motile cell line that is derived from amoeboid cell
a immortal motile cell line that is derived from leukocyte
a immortal leukocyte cell line that is derived from dendritic cell
a immortal dendritic cell line that is derived from Langerhans cell
a immortal leukocyte cell line that is derived from myeloid leukocyte
immortal myeloid leukocyte cell line cell
a immortal myeloid leukocyte cell line that is derived from monocyte
a immortal leukocyte cell line that is derived from nongranular leukocyte
immortal nongranular leukocyte cell line
immortal nongranular leukocyte cell line cell
a immortal nongranular leukocyte cell line that is derived from lymphocyte
a immortal lymphocyte cell line that is derived from T cell
a immortal T cell line that is derived from alpha-beta T cell
a immortal alpha-beta T cell line that is derived from immature alpha-beta T cell
immortal immature alpha-beta T cell line
immortal immature alpha-beta T cell line cell
a immortal immature alpha-beta T cell line that is derived from double-positive, alpha-beta thymocyte
immortal double-positive, alpha-beta thymocyte cell line
immortal double-positive, alpha-beta thymocyte cell line cell
a immortal alpha-beta T cell line that is derived from mature alpha-beta T cell
immortal mature alpha-beta T cell line cell
a immortal mature alpha-beta T cell line that is derived from CD4-positive, CD25-positive, alpha-beta regulatory T cell
immortal CD4-positive, CD25-positive, alpha-beta regulatory T cell line
immortal CD4-positive, CD25-positive, alpha-beta regulatory T cell line cell
a immortal CD4-positive, CD25-positive, alpha-beta regulatory T cell line that is derived from induced T-regulatory cell
immortal induced T-regulatory cell line cell
a immortal T cell line that is derived from mature T cell
a immortal mature T cell line that is derived from helper T cell
a immortal T cell line that is derived from immature T cell
a immortal lymphocyte cell line that is derived from B cell
immortal B-cell line cell
a immortal B cell line that is derived from precursor B cell
a immortal lymphocyte cell line that is derived from natural killer cell
a cell line that is derived from single nucleate cell
a cell line that is derived from multinucleate cell
a immortal cell line cell that is derived from eukaryotic cell
a immortal eukaryotic cell line that is derived from vegetative cell (sensu Mycetozoa)
immortal vegetative cell line (sensu Mycetozoa)
immortal vegetative cell line (sensu Mycetozoa) cell
a immortal vegetative cell line (sensu Mycetozoa) that is derived from aggregate cell
a immortal vegetative cell line (sensu Mycetozoa) that is derived from anterior like cell
a immortal eukaryotic cell line that is derived from animal cell
a immortal animal cell line that is derived from epithelial cell
a immortal epithelial cell line that is derived from duct epithelial cell
a immortal epithelial cell line that is derived from columnar/cuboidal epithelial cell
immortal columnar/cuboidal epithelial cell line cell
a immortal columnar/cuboidal epithelial cell line that is derived from neurecto-epithelial cell
immortal neurecto-epithelial cell line cell
a immortal neurecto-epithelial cell line that is derived from melanocyte
a immortal neurecto-epithelial cell line that is derived from pigmented epithelial cell
immortal pigmented epithelial cell line cell
a immortal epithelial cell line that is derived from squamous epithelial cell
immortal squamous epithelial cell line cell
a immortal squamous epithelial cell line that is derived from stratified squamous epithelial cell
immortal stratified squamous epithelial cell line cell
a immortal stratified squamous epithelial cell line that is derived from keratinizing barrier epithelial cell
immortal keratinizing barrier epithelial cell line cell
a immortal keratinizing barrier epithelial cell line that is derived from keratinocyte
a immortal squamous epithelial cell line that is derived from epidermal cell
a immortal epithelial cell line that is derived from stratified epithelial cell
immortal stratified epithelial cell line cell
a immortal epithelial cell line that is derived from epithelial cell of lung
immortal epithelial cell line of lung cell
a immortal epithelial cell line that is derived from epithelial cell of pancreas
immortal epithelial cell line of pancreas cell
a immortal epithelial cell line that is derived from ecto-epithelial cell
a immortal epithelial cell line that is derived from meso-epithelial cell
a immortal animal cell line that is derived from extraembryonic cell
a immortal extraembryonic cell line that is derived from trophoblast cell
a immortal animal cell line that is derived from hematopoietic cell
a immortal hematopoietic cell line that is derived from megakaryocyte-erythroid progenitor cell
immortal megakaryocyte-erythroid progenitor cell line
immortal megakaryocyte-erythroid progenitor cell line cell
a immortal hematopoietic cell line that is derived from blood cell
a immortal hematopoietic cell line that is derived from myeloid cell
a immortal myeloid cell line that is derived from erythroblast
a immortal hematopoietic cell line that is derived from hematopoietic lineage restricted progenitor cell
immortal hematopoietic lineage restricted progenitor cell line
immortal hematopoietic lineage restricted progenitor cell line cell
a immortal hematopoietic lineage restricted progenitor cell line that is derived from pro-B cell
a immortal hematopoietic lineage restricted progenitor cell line that is derived from myeloblast
a immortal myeloblast cell line that is derived from basophilic myeloblast
immortal basophilic myeloblast cell line
immortal basophilic myeloblast cell line cell
a immortal animal cell line that is derived from neural cell
a immortal neural cell line that is derived from glial cell
a immortal glial cell line that is derived from glial cell (sensu Vertebrata)
immortal glial cell line (sensu Vertebrata)
immortal glial cell line (sensu Vertebrata) cell
a immortal glial cell line (sensu Vertebrata) that is derived from astrocyte
a immortal animal cell line that is derived from connective tissue cell
immortal connective tissue cell line cell
a immortal connective tissue cell line that is derived from fibroblast
a immortal connective tissue cell line that is derived from stromal cell
a cell line that is derived from stuff accumulating cell
immortal stuff accumulating cell line cell
a cell line that is derived from parenchymal cell
a cell line that is derived from nucleate cell
a cell line that is derived from somatic cell
a immortal epithelial cell line cell that is derived from HeLa cell
an immortal cell line cell that is established by fusing a specific antibody-producing B cell with a myeloma (B cell cancer) cell that is selected for its ability to produce a monoclonal antibody.
The production of monoclonal antibodies using the hybridoma technology was invented by Cesar Milstein and Georges J. F. Köhler in 1975. They shared the Nobel Prize of 1984 for Medicine and Physiology with Niels Kaj Jerne, who made other contributions to immunology.
WEB: http://en.wikipedia.org/wiki/Hybridoma_technology
a function of a cell that can be passaged in culture medium without death or genetic change.
cell line lineage is a history of the development of a cell line. The cell line lineage may include the original cell type from a tissue and organism that derives the cell line cell. It may also include the cell line passage and cell culturing information.
This term will be a subclass of BFO 2 'history'. The BFO 2 'history' term will be imported to CLO after the BFO 2 is finalized.
cell line lineage
a cell line cell that is in the Coriell cell line repositories.
Coriell cell line cell
a cell line cell that is in the RIKEN Cell bank
RIKEN Cell Bank cell
A cell line comprised of cells which can all be traced back to a single ancestor cell, and which therefore can be treated as identical. This can be used to study just the progeny of single cells.
MHB 2013-07-16: This should be made into a defined class, using an axiom referencing a clonal cell expansion process, or a clonal cell line creation process.
cloned cell line
An immortal B cell line cell that derives from peripheral vein.
immortal peripheral vein-derived B cell line cell
An immortal cell line cell that derives from organism part.
immortal organism part-derived cell line cell
An immortal fibroblast cell line cell that derives from arm.
immortal arm-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from organism part.
immortal organism part-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from tunica albuginea of testis.
immortal tunica albuginea of testis-derived fibroblast cell line cell
An immortal cell line cell that derives from amniotic fluid.
immortal amniotic fluid-derived cell line cell
An immortal T cell line cell that derives from peripheral vein.
immortal peripheral vein-derived T cell line cell
An immortal fibroblast cell line cell that derives from animal ovary.
immortal animal ovary-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from skin.
immortal skin-derived fibroblast cell line cell
An immortal keratinocyte cell line cell that derives from organism part.
immortal organism part-derived keratinocyte cell line cell
An immortal fibroblast cell line cell that derives from testis.
immortal testis-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from liver.
immortal liver-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from lung.
immortal lung-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from embryo.
immortal embryo-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from thoracic aorta.
immortal thoracic aorta-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from gum.
immortal gum-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from digit.
immortal digit-derived fibroblast cell line cell
An immortal cell line cell that derives from skin.
An immortal smooth muscle cell line cell that derives from trachealis.
immortal trachealis-derived smooth muscle cell line cell
An immortal fibroblast cell line cell that derives from neck.
immortal neck-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from umbilical cord.
immortal umbilical cord-derived fibroblast cell line cell
An immortal endothelial cell line cell that derives from abdominal aorta.
immortal abdominal aorta-derived endothelial cell line cell
An immortal endothelial cell line cell that derives from iliac vein.
immortal iliac vein-derived endothelial cell line cell
An immortal endothelial cell line cell that derives from common iliac artery.
immortal common iliac artery-derived endothelial cell line cell
An immortal fibroblast cell line cell that derives from gonad.
immortal gonad-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from amnion.
immortal amnion-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from thigh.
immortal thigh-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from umbilical vein.
immortal umbilical vein-derived fibroblast cell line cell
An immortal cell line cell that derives from vasculature.
immortal vasculature-derived cell line cell
An immortal cell line cell that derives from spleen.
An immortal cell line cell that derives from multi-cellular organism.
immortal multi-cellular organism-derived cell line cell
An immortal cell line cell that derives from fetal membrane.
immortal fetal membrane-derived cell line cell
An immortal cell line cell that derives from dento-alveolar joint.
immortal dento-alveolar joint-derived cell line cell
An immortal cell line cell that derives from mixed endoderm/mesoderm-derived structure.
immortal mixed endoderm/mesoderm-derived structure-derived cell line cell
An immortal cell line cell that derives from late embryo.
immortal late embryo-derived cell line cell
An immortal cell line cell that derives from muscle spindle.
immortal muscle spindle-derived cell line cell
An immortal cell line cell that derives from thymus.
An immortal cell line cell that derives from amnion.
An immortal cell line cell that derives from tongue.
An immortal cell line cell that derives from pair of lungs.
An immortal cell line cell that derives from kidney.
An immortal fibroblast cell line cell that derives from abdominal cavity.
immortal abdominal cavity-derived fibroblast cell line cell
An immortal smooth muscle cell line cell that derives from thoracic aorta.
immortal thoracic aorta-derived smooth muscle cell line cell
An immortal cell line cell that derives from placenta.
immortal placenta-derived cell line cell
An immortal fibroblast cell line cell that derives from pericardium.
immortal pericardium-derived fibroblast cell line cell
An immortal cell line cell that derives from embryo.
An immortal fibroblast cell line cell that derives from foetal structure.
immortal foetal structure-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from external genitalia.
immortal external genitalia-derived fibroblast cell line cell
An immortal cell line cell that derives from prostate gland.
immortal prostate gland-derived cell line cell
An immortal cell line cell that derives from septum of telencephalon.
immortal septum of telencephalon-derived cell line cell
An immortal cell line cell that derives from larva.
An immortal cell line cell that derives from area X.
An immortal cell line cell that derives from somatic nervous system.
immortal somatic nervous system-derived cell line cell
An immortal cell line cell that derives from lymph.
An immortal endothelial cell line cell that derives from thoracic aorta.
immortal thoracic aorta-derived endothelial cell line cell
An immortal cell line cell that derives from liver.
An immortal cell line cell that derives from colon.
An immortal cell line cell that derives from caecum.
An immortal cell line cell that derives from pancreas.
immortal pancreas-derived cell line cell
An immortal cell line cell that derives from brain.
An immortal cell line cell that derives from tail.
An immortal cell line cell that derives from collecting duct of renal tubule.
immortal collecting duct of renal tubule-derived cell line cell
An immortal cell line cell that derives from mesonephros.
immortal mesonephros-derived cell line cell
An immortal cell line cell that derives from female gonad.
immortal female gonad-derived cell line cell
An immortal cell line cell that derives from chorion.
An immortal cell line cell that derives from lymphoid follicle.
immortal lymphoid follicle-derived cell line cell
An immortal fibroblast cell line cell that derives from leg.
immortal leg-derived fibroblast cell line cell
An immortal cell line cell that derives from limb/fin.
immortal limb/fin-derived cell line cell
An immortal cell line cell that derives from testis.
An immortal cell line cell that derives from stomach.
An immortal cell line cell that derives from endothelium.
immortal endothelium-derived cell line cell
An immortal fibroblast cell line cell that derives from foreskin.
immortal foreskin-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from achilles tendon.
immortal achilles tendon-derived fibroblast cell line cell
An immortal cell line cell that derives from bone element.
immortal bone element-derived cell line cell
An immortal cell line cell that derives from thyroid gland.
immortal thyroid gland-derived cell line cell
An immortal cell line cell that derives from urinary bladder.
immortal urinary bladder-derived cell line cell
An immortal cell line cell that derives from acetabular part of hip bone.
immortal acetabular part of hip bone-derived cell line cell
An immortal cell line cell that derives from breast.
An immortal cell line cell that derives from epithelium.
immortal epithelium-derived cell line cell
An immortal cell line cell that derives from comma-shaped body.
immortal comma-shaped body-derived cell line cell
An immortal cell line cell that derives from supra-orbital vein.
immortal supra-orbital vein-derived cell line cell
An immortal fibroblast cell line cell that derives from ear.
immortal ear-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from inguinal region.
immortal inguinal region-derived fibroblast cell line cell
An immortal cell line cell that derives from mesothelium.
immortal mesothelium-derived cell line cell
An immortal cell line cell that derives from uterus.
An immortal cell line cell that derives from endometrium.
immortal endometrium-derived cell line cell
An immortal cell line cell that derives from uterine cervix.
immortal uterine cervix-derived cell line cell
An immortal cell line cell that derives from heart.
An immortal cell line cell that derives from pituitary gland.
immortal pituitary gland-derived cell line cell
An immortal cell line cell that derives from gill.
An immortal cell line cell that derives from follicular fluid.
immortal follicular fluid-derived cell line cell
An immortal cell line cell that derives from eye.
An immortal plasma cell line cell that derives from organism part.
immortal organism part-derived plasma cell line cell
An immortal cell line cell that derives from floating rib.
immortal floating rib-derived cell line cell
An immortal cell line cell that derives from mammary gland.
immortal mammary gland-derived cell line cell
An immortal fibroblast cell line cell that derives from thorax.
immortal thorax-derived fibroblast cell line cell
An immortal cell line cell that derives from paired fin.
immortal paired fin-derived cell line cell
An immortal cell line cell that derives from neural nucleus.
immortal neural nucleus-derived cell line cell
An immortal cell line cell that derives from Ammon's horn.
immortal Ammon's horn-derived cell line cell
An immortal cell line cell that derives from bone marrow.
immortal bone marrow-derived cell line cell
An immortal cell line cell that derives from islet of Langerhans.
immortal islet of Langerhans-derived cell line cell
An immortal cell line cell that derives from pyramid of medulla oblongata.
immortal pyramid of medulla oblongata-derived cell line cell
a hybridoma cell line cell that is established by fusing cells from two mice.
most hybridoma cell line cells are mouse x mouse
mouse x mouse hybridoma cell line cell
An immortal epithelial cell line cell that derives from uterine cervix.
immortal uterine cervix-derived epithelial cell line cell
An immortal cell line cell that derives from ileocecal junction.
immortal ileocecal junction-derived cell line cell
An immortal cell line cell that derives from compact bone.
immortal compact bone-derived cell line cell
An immortal cell line cell that derives from abdominal aorta.
immortal abdominal aorta-derived cell line cell
An immortal cell line cell that derives from bronchus.
immortal bronchus-derived cell line cell
An immortal cell line cell that derives from iliac artery.
immortal iliac artery-derived cell line cell
An immortal cell line cell that derives from synovial membrane of synovial joint.
immortal synovial membrane of synovial joint-derived cell line cell
An immortal cell line cell that derives from iliac vein.
immortal iliac vein-derived cell line cell
An immortal cell line cell that derives from vagina.
An immortal cell line cell that derives from larynx.
An immortal cell line cell that derives from inferior cervical ganglion.
immortal inferior cervical ganglion-derived cell line cell
An immortal cell line cell that derives from esophagus.
immortal esophagus-derived cell line cell
An immortal cell line cell that derives from femoral artery.
immortal femoral artery-derived cell line cell
An immortal cell line cell that derives from prepuce of penis.
immortal prepuce of penis-derived cell line cell
An immortal cell line cell that derives from gingival epithelium.
immortal gingival epithelium-derived cell line cell
An immortal cell line cell that derives from gingiva.
An immortal cell line cell that derives from mouth.
An immortal cell line cell that derives from peripheral vein.
immortal peripheral vein-derived cell line cell
An immortal cell line cell that derives from peritoneum.
immortal peritoneum-derived cell line cell
An immortal cell line cell that derives from round window.
immortal round window-derived cell line cell
An immortal fibroblast cell line cell that derives from conjunctiva structure.
immortal conjunctiva structure-derived fibroblast cell line cell
An immortal cell line cell that derives from intestine.
immortal intestine-derived cell line cell
An immortal cell line cell that derives from rectum.
An immortal cell line cell that derives from pulmonary vein.
immortal pulmonary vein-derived cell line cell
An immortal fibroblast cell line cell that derives from buttock.
immortal buttock-derived fibroblast cell line cell
An immortal cell line cell that derives from tonsil.
An immortal fibroblast cell line cell that derives from umbilicus.
immortal umbilicus-derived fibroblast cell line cell
An immortal cell line cell that derives from posterior commissure.
immortal posterior commissure-derived cell line cell
An immortal cell line cell that derives from soft palate.
immortal soft palate-derived cell line cell
An immortal cell line cell that derives from adrenal gland.
immortal adrenal gland-derived cell line cell
An immortal cell line cell that derives from pronephros.
immortal pronephros-derived cell line cell
An immortal smooth muscle cell line cell that derives from organism part.
immortal organism part-derived smooth muscle cell line cell
An immortal cell line cell that derives from sublingual artery.
immortal sublingual artery-derived cell line cell
An immortal cell line cell that derives from aorta.
An immortal cell line cell that derives from ligament.
immortal ligament-derived cell line cell
An immortal fibroblast cell line cell that derives from uterus.
immortal uterus-derived fibroblast cell line cell
An immortal cell line cell that derives from cerebral lobe.
immortal cerebral lobe-derived cell line cell
An immortal cell line cell that derives from squamous part of temporal bone.
immortal squamous part of temporal bone-derived cell line cell
An immortal fibroblast cell line cell that derives from pronephros.
immortal pronephros-derived fibroblast cell line cell
An immortal cell line cell that derives from mucosa.
An immortal cell line cell that derives from epidermis.
immortal epidermis-derived cell line cell
An immortal cell line cell that derives from submandibular gland.
immortal submandibular gland-derived cell line cell
An immortal mesothelial cell line cell that derives from lung.
immortal lung-derived mesothelial cell line cell
An immortal epithelial cell line cell that derives from eye structure.
immortal eye structure-derived epithelial cell line cell
An immortal fibroblast cell line cell that derives from hip.
immortal hip-derived fibroblast cell line cell
An immortal cell line cell that derives from prostate epithelium.
immortal prostate epithelium-derived cell line cell
An immortal cell line cell that derives from retinal neural layer.
immortal retinal neural layer-derived cell line cell
An immortal cell line cell that derives from ureter.
An immortal smooth muscle cell line cell that derives from iliac vein.
immortal iliac vein-derived smooth muscle cell line cell
An immortal smooth muscle cell line cell that derives from common iliac artery.
immortal common iliac artery-derived smooth muscle cell line cell
An immortal keratinocyte cell line cell that derives from mammary gland.
immortal mammary gland-derived keratinocyte cell line cell
An immortal endothelial cell line cell that derives from umbilical vein.
immortal umbilical vein-derived endothelial cell line cell
An immortal fibroblast cell line cell that derives from scalp.
immortal scalp-derived fibroblast cell line cell
An immortal myoblast cell line cell that derives from skeletal muscle.
immortal skeletal muscle-derived myoblast cell line cell
An immortal endothelial cell line cell that derives from organism part.
immortal organism part-derived endothelial cell line cell
An immortal fibroblast cell line cell that derives from sacrum.
immortal sacrum-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from shoulder.
immortal shoulder-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from placenta.
immortal placenta-derived fibroblast cell line cell
An immortal cell line cell that derives from dermis.
An immortal cell line cell that derives from cornea.
An immortal cell line cell that derives from mammalian vulva.
immortal mammalian vulva-derived cell line cell
An immortal cell line cell that derives from spherical lensed eye.
immortal spherical lensed eye-derived cell line cell
An immortal cell line cell that derives from ileum.
An immortal fibroblast cell line cell that derives from cervix.
immortal cervix-derived fibroblast cell line cell
An immortal myoblast cell line cell that derives from rhomboid.
immortal rhomboid-derived myoblast cell line cell
An immortal cell line cell that derives from abdominal cavity.
immortal abdominal cavity-derived cell line cell
An immortal cell line cell that derives from umbilical vein.
immortal umbilical vein-derived cell line cell
An immortal cell line cell that derives from duodenum.
immortal duodenum-derived cell line cell
An immortal cell line cell that derives from connective tissue.
immortal connective tissue-derived cell line cell
An immortal cell line cell that derives from parotid gland.
immortal parotid gland-derived cell line cell
An immortal fibroblast cell line cell that derives from ischium.
immortal ischium-derived fibroblast cell line cell
An immortal cell line cell that derives from buttock.
An immortal cell line cell that derives from anatomical cluster.
immortal anatomical cluster-derived cell line cell
An immortal cell line cell that derives from thigh.
An immortal cell line cell that derives from chordate pharynx.
immortal chordate pharynx-derived cell line cell
An immortal cell line cell that derives from retina.
An immortal cell line cell that derives from yolk sac.
immortal yolk sac-derived cell line cell
An immortal cell line cell that derives from nasal concha.
immortal nasal concha-derived cell line cell
An immortal cell line cell that derives from arm.
An immortal cell line cell that derives from sacrum.
An immortal cell line cell that derives from conjunctiva.
immortal conjunctiva-derived cell line cell
An immortal cell line cell that derives from trachea.
An immortal cell line cell that derives from respiration organ.
immortal respiration organ-derived cell line cell
An immortal cell line cell that derives from renal glomerulus.
immortal renal glomerulus-derived cell line cell
An immortal cell line cell that derives from nephron tubule.
immortal nephron tubule-derived cell line cell
An immortal cell line cell that derives from sternum.
An immortal cell line cell that derives from hypodermis.
immortal hypodermis-derived cell line cell
An immortal cell line cell that derives from proximal tubule.
immortal proximal tubule-derived cell line cell
An immortal cell line cell that derives from mucosa of vagina.
immortal mucosa of vagina-derived cell line cell
An immortal cell line cell that derives from endocervix.
immortal endocervix-derived cell line cell
An immortal mesothelial cell line cell that derives from organism part.
immortal organism part-derived mesothelial cell line cell
An immortal peripheral vein-derived B cell line cell that derives from human.
immortal human peripheral vein-derived B cell line cell
An immortal cell line cell that derives from pulmonary nerve plexus.
immortal pulmonary nerve plexus-derived cell line cell
An immortal cell line cell that derives from pelvic fin.
immortal pelvic fin-derived cell line cell
An immortal cell line cell that derives from right ureter.
immortal right ureter-derived cell line cell
An immortal cell line cell that derives from superior rostral sulcus.
immortal superior rostral sulcus-derived cell line cell
An immortal cell line cell that derives from gonad.
An immortal fibroblast cell line cell that derives from cornea structure.
immortal cornea structure-derived fibroblast cell line cell
An immortal cell line cell that derives from glomerular capsule.
immortal glomerular capsule-derived cell line cell
An immortal cell line cell that derives from nasal vestibule.
immortal nasal vestibule-derived cell line cell
An immortal cell line cell that derives from adrenal cortex.
immortal adrenal cortex-derived cell line cell
An immortal fibroblast cell line cell that derives from 16914.
immortal 16914-derived fibroblast cell line cell
An immortal epithelial cell line cell that derives from organism part.
immortal organism part-derived epithelial cell line cell
An immortal fibroblast cell line cell that derives from axilla.
immortal axilla-derived fibroblast cell line cell
An immortal endothelial cell line cell that derives from pulmonary artery.
immortal pulmonary artery-derived endothelial cell line cell
An immortal smooth muscle cell line cell that derives from pulmonary artery.
immortal pulmonary artery-derived smooth muscle cell line cell
An immortal epithelial cell line cell that derives from retina structure.
immortal retina structure-derived epithelial cell line cell
An immortal fibroblast cell line cell that derives from calf.
immortal calf-derived fibroblast cell line cell
An immortal fibroblast cell line cell that derives from nose structure.
immortal nose structure-derived fibroblast cell line cell
An immortal smooth muscle cell line cell that derives from carotid artery.
immortal carotid artery-derived smooth muscle cell line cell
An immortal fibroblast cell line cell that derives from brain.
immortal brain-derived fibroblast cell line cell
An immortal peripheral vein-derived B cell line cell that derives from chimpanzee.
immortal chimpanzee peripheral vein-derived B cell line cell
An immortal arm-derived fibroblast cell line cell that derives from human.
immortal human arm-derived fibroblast cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from human.
immortal human organism part-derived fibroblast cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from cattle.
immortal cattle organism part-derived fibroblast cell line cell
An immortal tunica albuginea of testis-derived fibroblast cell line cell that derives from human.
immortal human tunica albuginea of testis-derived fibroblast cell line cell
An immortal amniotic fluid-derived cell line cell that derives from human.
immortal human amniotic fluid-derived cell line cell
An immortal peripheral vein-derived T cell line cell that derives from human.
immortal human peripheral vein-derived T cell line cell
An immortal organism part-derived cell line cell that derives from rat.
immortal rat organism part-derived cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from chimpanzee.
immortal chimpanzee organism part-derived fibroblast cell line cell
An immortal animal ovary-derived fibroblast cell line cell that derives from Chinese hamster.
immortal Chinese hamster ovary-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Bornean orangutan.
immortal Bornean orangutan skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from pig-tailed macaque.
immortal pig-tailed macaque skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Kenya baboon.
immortal Kenya baboon skin-derived fibroblast cell line cell
An immortal organism part-derived cell line cell that derives from long-tailed macaque.
immortal long-tailed macaque organism part-derived cell line cell
An immortal organism part-derived keratinocyte cell line cell that derives from pig-tailed macaque.
immortal pig-tailed macaque organism part-derived keratinocyte cell line cell
An immortal organism part-derived keratinocyte cell line cell that derives from long-tailed macaque.
immortal long-tailed macaque organism part-derived keratinocyte cell line cell
An immortal testis-derived fibroblast cell line cell that derives from human.
immortal human testis-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from pygmy chimpanzee.
immortal pygmy chimpanzee skin-derived fibroblast cell line cell
An immortal liver-derived fibroblast cell line cell that derives from human.
immortal human liver-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from red-bellied lemur.
immortal red-bellied lemur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from black lemur.
immortal black lemur skin-derived fibroblast cell line cell
An immortal organism part-derived keratinocyte cell line cell that derives from Kenya baboon.
immortal Kenya baboon organism part-derived keratinocyte cell line cell
An immortal skin-derived fibroblast cell line cell that derives from variegated lemur.
immortal variegated lemur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from small-eared galago.
immortal small-eared galago skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from western gorilla.
immortal western gorilla skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Angolan colobus.
immortal Angolan colobus skin-derived fibroblast cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from mouse.
immortal mouse organism part-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Colobus guereza.
immortal Colobus guereza skin-derived fibroblast cell line cell
An immortal peripheral vein-derived B cell line cell that derives from pygmy chimpanzee.
immortal pygmy chimpanzee peripheral vein-derived B cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Allen's swamp monkey.
immortal Allen's swamp monkey skin-derived fibroblast cell line cell
An immortal lung-derived fibroblast cell line cell that derives from human.
immortal human lung-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from mongoose lemur.
immortal mongoose lemur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Ring-tailed lemur.
immortal Ring-tailed lemur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from chimpanzee.
immortal chimpanzee skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from rhesus macaque.
immortal rhesus macaque skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from black-handed spider monkey.
immortal black-handed spider monkey skin-derived fibroblast cell line cell
An immortal embryo-derived fibroblast cell line cell that derives from Chinese hamster.
immortal Chinese hamster embryo-derived fibroblast cell line cell
An immortal thoracic aorta-derived fibroblast cell line cell that derives from rat.
immortal rat thoracic aorta-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Charles Island giant tortoise.
immortal Charles Island giant tortoise skin-derived fibroblast cell line cell
An immortal testis-derived fibroblast cell line cell that derives from rat.
immortal rat testis-derived fibroblast cell line cell
An immortal gum-derived fibroblast cell line cell that derives from human.
immortal human gum-derived fibroblast cell line cell
An immortal organism part-derived cell line cell that derives from mouse.
immortal mouse organism part-derived cell line cell
An immortal digit-derived fibroblast cell line cell that derives from human.
immortal human digit-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from human.
immortal human skin-derived fibroblast cell line cell
An immortal skin-derived cell line cell that derives from human.
immortal human skin-derived cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from Indian muntjac.
immortal Indian muntjac organism part-derived fibroblast cell line cell
An immortal organism part-derived cell line cell that derives from human.
immortal human organism part-derived cell line cell
An immortal trachealis-derived smooth muscle cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit trachealis-derived smooth muscle cell line cell
An immortal neck-derived fibroblast cell line cell that derives from human.
immortal human neck-derived fibroblast cell line cell
An immortal umbilical cord-derived fibroblast cell line cell that derives from human.
immortal human umbilical cord-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from lesser panda.
immortal lesser panda skin-derived fibroblast cell line cell
An immortal abdominal aorta-derived endothelial cell line cell that derives from human.
immortal human abdominal aorta-derived endothelial cell line cell
An immortal iliac vein-derived endothelial cell line cell that derives from human.
immortal human iliac vein-derived endothelial cell line cell
An immortal common iliac artery-derived endothelial cell line cell that derives from human.
immortal human common iliac artery-derived endothelial cell line cell
An immortal embryo-derived fibroblast cell line cell that derives from human.
immortal human embryo-derived fibroblast cell line cell
An immortal gonad-derived fibroblast cell line cell that derives from human.
immortal human gonad-derived fibroblast cell line cell
An immortal amnion-derived fibroblast cell line cell that derives from human.
immortal human amnion-derived fibroblast cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from human.
immortal human thigh-derived fibroblast cell line cell
An immortal umbilical vein-derived fibroblast cell line cell that derives from human.
immortal human umbilical vein-derived fibroblast cell line cell
An immortal cell line cell that derives from cattle.
An immortal vasculature-derived cell line cell that derives from cattle.
immortal cattle vasculature-derived cell line cell
An immortal spleen-derived cell line cell that derives from cat.
immortal cat spleen-derived cell line cell
An immortal fibroblast cell line cell that derives from cat.
An immortal cell line cell that derives from cat.
An immortal multi-cellular organism-derived cell line cell that derives from cat.
immortal cat multi-cellular organism-derived cell line cell
An immortal fetal membrane-derived cell line cell that derives from cattle.
immortal cattle fetal membrane-derived cell line cell
An immortal spleen-derived cell line cell that derives from cattle.
immortal cattle spleen-derived cell line cell
An immortal dento-alveolar joint-derived cell line cell that derives from cattle.
immortal cattle dento-alveolar joint-derived cell line cell
An immortal mixed endoderm/mesoderm-derived structure-derived cell line cell that derives from cattle.
immortal cattle mixed endoderm/mesoderm-derived structure-derived cell line cell
An immortal late embryo-derived cell line cell that derives from cat.
immortal cat late embryo-derived cell line cell
An immortal muscle spindle-derived cell line cell that derives from cat.
immortal cat muscle spindle-derived cell line cell
An immortal thymus-derived cell line cell that derives from cat.
immortal cat thymus-derived cell line cell
An immortal amnion-derived cell line cell that derives from human.
immortal human amnion-derived cell line cell
immortal cat skin-derived cell line cell
An immortal lymphocyte cell line cell that derives from human.
immortal human lymphocyte cell line cell
An immortal mixed endoderm/mesoderm-derived structure-derived cell line cell that derives from cat.
immortal cat mixed endoderm/mesoderm-derived structure-derived cell line cell
An immortal tongue-derived cell line cell that derives from cat.
immortal cat tongue-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from cat.
immortal cat pair of lungs-derived cell line cell
An immortal fetal membrane-derived cell line cell that derives from cat.
immortal cat fetal membrane-derived cell line cell
An immortal kidney-derived cell line cell that derives from cat.
immortal cat kidney-derived cell line cell
An immortal lung-derived fibroblast cell line cell that derives from dog.
immortal dog lung-derived fibroblast cell line cell
An immortal abdominal cavity-derived fibroblast cell line cell that derives from dog.
immortal dog abdominal cavity-derived fibroblast cell line cell
An immortal thoracic aorta-derived smooth muscle cell line cell that derives from dog.
immortal dog thoracic aorta-derived smooth muscle cell line cell
An immortal placenta-derived cell line cell that derives from cat.
immortal cat placenta-derived cell line cell
An immortal skin-derived cell line cell that derives from rat.
immortal rat skin-derived cell line cell
An immortal fibroblast cell line cell that derives from human.
immortal human fibroblast cell line cell
An immortal pericardium-derived fibroblast cell line cell that derives from human.
immortal human pericardium-derived fibroblast cell line cell
An immortal embryo-derived cell line cell that derives from cat.
immortal cat embryo-derived cell line cell
An immortal embryo-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit embryo-derived cell line cell
a cell growth where the cell is a cell line cell.
cell line cell growth
An immortal mononuclear phagocyte cell line cell that derives from cat.
immortal cat mononuclear phagocyte cell line cell
An immortal foetal structure-derived fibroblast cell line cell that derives from human.
immortal human foetal structure-derived fibroblast cell line cell
An immortal external genitalia-derived fibroblast cell line cell that derives from human.
immortal human external genitalia-derived fibroblast cell line cell
An immortal prostate gland-derived cell line cell that derives from rat.
immortal rat prostate gland-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from human.
Obsolete - many cell line cells were previously mistakenly assigned under this class. Now no cell line cells available under this class.
immortal human septum of telencephalon-derived cell line cell - Obsolete
An immortal larva-derived cell line cell that derives from cabbage moth.
immortal cabbage moth larva-derived cell line cell
An immortal mixed endoderm/mesoderm-derived structure-derived cell line cell that derives from human.
immortal human mixed endoderm/mesoderm-derived structure-derived cell line cell
An immortal kidney-derived cell line cell that derives from monkey.
immortal monkey kidney-derived cell line cell
An immortal lymphocyte cell line cell that derives from mouse.
immortal mouse lymphocyte cell line cell
An immortal lung-derived cell line cell that derives from human.
immortal human lung-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from mouse.
immortal mouse pair of lungs-derived cell line cell
An immortal area X-derived cell line cell that derives from mouse.
immortal mouse area X-derived cell line cell
An immortal area X-derived cell line cell that derives from Mus musculus x Rattus norvegicus.
immortal Mus musculus x Rattus norvegicus area X-derived cell line cell
An immortal somatic nervous system-derived cell line cell that derives from Chinese hamster.
immortal Chinese hamster somatic nervous system-derived cell line cell
a hybridoma cell line cell that is established by fusing cells from a mouse and a rat.
mouse x rat hybridoma cell line cell
An immortal fibroblast cell line cell that derives from mouse.
immortal mouse fibroblast cell line cell
An immortal cell line cell that derives from common quail.
An immortal lymph-derived cell line cell that derives from mouse.
immortal mouse lymph-derived cell line cell
An immortal multi-cellular organism-derived cell line cell that derives from mouse.
immortal mouse multi-cellular organism-derived cell line cell
An immortal embryo-derived cell line cell that derives from mouse.
immortal mouse embryo-derived cell line cell
An immortal embryo-derived cell line cell that derives from turnip moth.
immortal turnip moth embryo-derived cell line cell
An immortal thoracic aorta-derived endothelial cell line cell that derives from cattle.
immortal cattle thoracic aorta-derived endothelial cell line cell
An immortal lung-derived fibroblast cell line cell that derives from cattle.
immortal cattle lung-derived fibroblast cell line cell
An immortal thoracic aorta-derived smooth muscle cell line cell that derives from cattle.
immortal cattle thoracic aorta-derived smooth muscle cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from cattle.
immortal cattle thigh-derived fibroblast cell line cell
An immortal thoracic aorta-derived smooth muscle cell line cell that derives from pig.
immortal pig thoracic aorta-derived smooth muscle cell line cell
An immortal induced T-regulatory cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster induced T-regulatory cell line cell
An immortal cell line cell that derives from human.
An immortal liver-derived cell line cell that derives from rat.
immortal rat liver-derived cell line cell
An immortal colon-derived cell line cell that derives from human.
immortal human colon-derived cell line cell
An immortal caecum-derived cell line cell that derives from human.
immortal human caecum-derived cell line cell
An immortal pancreas-derived cell line cell that derives from mouse.
immortal mouse pancreas-derived cell line cell
An immortal lung-derived fibroblast cell line cell that derives from pig-tailed macaque.
immortal pig-tailed macaque lung-derived fibroblast cell line cell
An immortal brain-derived cell line cell that derives from human.
immortal human brain-derived cell line cell
An immortal trophoblast cell line cell that derives from human.
immortal human trophoblast cell line cell
An immortal tail-derived cell line cell that derives from mouse.
immortal mouse tail-derived cell line cell
An immortal skin-derived cell line cell that derives from mouse.
immortal mouse skin-derived cell line cell
An immortal collecting duct of renal tubule-derived cell line cell that derives from mouse.
immortal mouse collecting duct of renal tubule-derived cell line cell
An immortal myeloblast cell line cell that derives from mouse.
immortal mouse myeloblast cell line cell
An immortal peripheral neuron cell line cell that derives from human.
immortal human peripheral neuron cell line cell
An immortal arm-derived fibroblast cell line cell that derives from pig-tailed macaque.
immortal pig-tailed macaque arm-derived fibroblast cell line cell
An immortal thoracic aorta-derived smooth muscle cell line cell that derives from pig-tailed macaque.
immortal pig-tailed macaque thoracic aorta-derived smooth muscle cell line cell
An immortal mesonephros-derived cell line cell that derives from mouse.
immortal mouse mesonephros-derived cell line cell
An immortal female gonad-derived cell line cell that derives from Chinese hamster.
immortal Chinese hamster female gonad-derived cell line cell
An immortal chorion-derived cell line cell that derives from human.
immortal human chorion-derived cell line cell
An immortal thoracic aorta-derived smooth muscle cell line cell that derives from horse.
immortal horse thoracic aorta-derived smooth muscle cell line cell
An immortal lymphoid follicle-derived cell line cell that derives from mouse.
immortal mouse lymphoid follicle-derived cell line cell
An immortal fetal membrane-derived cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster fetal membrane-derived cell line cell
An immortal cell line cell that derives from vervet monkey.
An immortal kidney-derived cell line cell that derives from vervet monkey.
immortal vervet monkey kidney-derived cell line cell
An immortal mast cell line cell that derives from mouse.
An immortal epithelial cell line cell that derives from mouse.
immortal mouse epithelial cell line cell
An immortal mixed endoderm/mesoderm-derived structure-derived cell line cell that derives from mouse.
immortal mouse mixed endoderm/mesoderm-derived structure-derived cell line cell
An immortal liver-derived cell line cell that derives from mouse.
immortal mouse liver-derived cell line cell
An immortal embryo-derived cell line cell that derives from Drosophila melanogaster.
immortal Drosophila melanogaster embryo-derived cell line cell
An immortal fetal membrane-derived cell line cell that derives from human.
immortal human fetal membrane-derived cell line cell
An immortal mixed endoderm/mesoderm-derived structure-derived cell line cell that derives from fathead minnow.
immortal fathead minnow mixed endoderm/mesoderm-derived structure-derived cell line cell
An immortal multi-cellular organism-derived cell line cell that derives from human.
immortal human multi-cellular organism-derived cell line cell
An immortal spleen-derived cell line cell that derives from mouse.
immortal mouse spleen-derived cell line cell
An immortal kidney-derived cell line cell that derives from mouse.
immortal mouse kidney-derived cell line cell
An immortal leg-derived fibroblast cell line cell that derives from human.
immortal human leg-derived fibroblast cell line cell
An immortal female gonad-derived cell line cell that derives from mouse.
immortal mouse female gonad-derived cell line cell
An immortal limb/fin-derived cell line cell that derives from mouse.
immortal mouse limb/fin-derived cell line cell
An immortal testis-derived cell line cell that derives from mouse.
immortal mouse testis-derived cell line cell
An immortal arm-derived fibroblast cell line cell that derives from rhesus macaque.
immortal rhesus macaque arm-derived fibroblast cell line cell
An immortal stomach-derived cell line cell that derives from human.
immortal human stomach-derived cell line cell
An immortal abdominal cavity-derived fibroblast cell line cell that derives from human.
immortal human abdominal cavity-derived fibroblast cell line cell
An immortal pancreas-derived cell line cell that derives from human.
immortal human pancreas-derived cell line cell
An immortal thoracic aorta-derived endothelial cell line cell that derives from horse.
immortal horse thoracic aorta-derived endothelial cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from horse.
immortal horse thigh-derived fibroblast cell line cell
An immortal lung-derived fibroblast cell line cell that derives from horse.
immortal horse lung-derived fibroblast cell line cell
An immortal endothelium-derived cell line cell that derives from mouse.
immortal mouse endothelium-derived cell line cell
An immortal foreskin-derived fibroblast cell line cell that derives from human.
immortal human foreskin-derived fibroblast cell line cell
An immortal thoracic aorta-derived smooth muscle cell line cell that derives from rhesus macaque.
immortal rhesus macaque thoracic aorta-derived smooth muscle cell line cell
An immortal lung-derived fibroblast cell line cell that derives from rhesus macaque.
immortal rhesus macaque lung-derived fibroblast cell line cell
An immortal achilles tendon-derived fibroblast cell line cell that derives from human.
immortal human achilles tendon-derived fibroblast cell line cell
An immortal bone element-derived cell line cell that derives from human.
immortal human bone element-derived cell line cell
An immortal cell line cell that derives from rat.
An immortal thyroid gland-derived cell line cell that derives from rat.
immortal rat thyroid gland-derived cell line cell
An immortal epithelial cell line cell that derives from human.
immortal human epithelial cell line cell
An immortal urinary bladder-derived cell line cell that derives from human.
immortal human urinary bladder-derived cell line cell
An immortal liver-derived cell line cell that derives from human.
immortal human liver-derived cell line cell
An immortal acetabular part of hip bone-derived cell line cell that derives from human.
immortal human acetabular part of hip bone-derived cell line cell
An immortal cell line cell that derives from Ovis.
An immortal pair of lungs-derived cell line cell that derives from gray fox.
immortal gray fox pair of lungs-derived cell line cell
An immortal breast-derived cell line cell that derives from mouse.
immortal mouse breast-derived cell line cell
An immortal cell line cell that derives from rhesus macaque.
An immortal fetal membrane-derived cell line cell that derives from rhesus macaque.
immortal rhesus macaque fetal membrane-derived cell line cell
An immortal epithelium-derived cell line cell that derives from human.
immortal human epithelium-derived cell line cell
An immortal kidney-derived cell line cell that derives from dog.
immortal dog kidney-derived cell line cell
An immortal kidney-derived cell line cell that derives from cattle.
immortal cattle kidney-derived cell line cell
An immortal comma-shaped body-derived cell line cell that derives from human.
immortal human comma-shaped body-derived cell line cell
An immortal kidney-derived cell line cell that derives from sheep.
immortal sheep kidney-derived cell line cell
An immortal lymphocyte cell line cell that derives from turkey.
immortal turkey lymphocyte cell line cell
An immortal breast-derived cell line cell that derives from human.
immortal human breast-derived cell line cell
An immortal spleen-derived cell line cell that derives from human.
immortal human spleen-derived cell line cell
An immortal supra-orbital vein-derived cell line cell that derives from human.
immortal human supra-orbital vein-derived cell line cell
An immortal muscle cell line cell that derives from mouse.
An immortal ear-derived fibroblast cell line cell that derives from human.
immortal human ear-derived fibroblast cell line cell
An immortal inguinal region-derived fibroblast cell line cell that derives from human.
immortal human inguinal region-derived fibroblast cell line cell
An immortal mesothelium-derived cell line cell that derives from human.
immortal human mesothelium-derived cell line cell
An immortal uterus-derived cell line cell that derives from human.
immortal human uterus-derived cell line cell
An immortal endometrium-derived cell line cell that derives from human.
immortal human endometrium-derived cell line cell
An immortal kidney-derived cell line cell that derives from human.
immortal human kidney-derived cell line cell
An immortal fibroblast cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster fibroblast cell line cell
An immortal fibroblast cell line cell that derives from rat.
An immortal pair of lungs-derived cell line cell that derives from Mustelinae.
immortal Mustelinae pair of lungs-derived cell line cell
An immortal brain-derived cell line cell that derives from mouse.
immortal mouse brain-derived cell line cell
An immortal cell line cell that derives from chicken.
An immortal cell line cell that derives from Mus musculus x Rattus norvegicus.
immortal Mus musculus x Rattus norvegicus cell line cell
An immortal kidney-derived cell line cell that derives from pig.
immortal pig kidney-derived cell line cell
An immortal peripheral neuron cell line cell that derives from cat.
immortal cat peripheral neuron cell line cell
An immortal uterine cervix-derived cell line cell that derives from human.
immortal human uterine cervix-derived cell line cell
An immortal heart-derived cell line cell that derives from human.
immortal human heart-derived cell line cell
An immortal pituitary gland-derived cell line cell that derives from rat.
immortal rat pituitary gland-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from Mongolian gerbil.
immortal Mongolian gerbil pair of lungs-derived cell line cell
An immortal cell line cell that derives from sheep.
An immortal pair of lungs-derived cell line cell that derives from gecko.
immortal gecko pair of lungs-derived cell line cell
An immortal urinary bladder-derived cell line cell that derives from mouse.
immortal mouse urinary bladder-derived cell line cell
An immortal gill-derived cell line cell that derives from walking catfish.
immortal walking catfish gill-derived cell line cell
An immortal tongue-derived cell line cell that derives from bullfrog.
immortal bullfrog tongue-derived cell line cell
An immortal follicular fluid-derived cell line cell that derives from human.
immortal human follicular fluid-derived cell line cell
An immortal female gonad-derived cell line cell that derives from human.
immortal human female gonad-derived cell line cell
An immortal thyroid gland-derived cell line cell that derives from human.
immortal human thyroid gland-derived cell line cell
An immortal eye-derived cell line cell that derives from torafugu.
immortal torafugu eye-derived cell line cell
An immortal spermatocyte cell line cell that derives from mouse.
immortal mouse spermatocyte cell line cell
An immortal embryo-derived cell line cell that derives from chicken.
immortal chicken embryo-derived cell line cell
An immortal brain-derived cell line cell that derives from cat.
immortal cat brain-derived cell line cell
An immortal fetal membrane-derived cell line cell that derives from mouse.
immortal mouse fetal membrane-derived cell line cell
An immortal organism part-derived plasma cell line cell that derives from mouse.
immortal mouse organism part-derived plasma cell line cell
An immortal floating rib-derived cell line cell that derives from human.
immortal human floating rib-derived cell line cell
An immortal urinary bladder-derived cell line cell that derives from rat.
immortal rat urinary bladder-derived cell line cell
An immortal mammary gland-derived cell line cell that derives from mouse.
immortal mouse mammary gland-derived cell line cell
An immortal blood cell line cell that derives from human.
An immortal megakaryocyte-erythroid progenitor cell line cell that derives from mouse.
immortal mouse megakaryocyte-erythroid progenitor cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from Mustelinae.
immortal Mustelinae septum of telencephalon-derived cell line cell
An immortal colon-derived cell line cell that derives from guinea pig.
immortal guinea pig colon-derived cell line cell
An immortal thorax-derived fibroblast cell line cell that derives from human.
immortal human thorax-derived fibroblast cell line cell
An immortal paired fin-derived cell line cell that derives from bluestriped grunt.
immortal bluestriped grunt paired fin-derived cell line cell
An immortal neural nucleus-derived cell line cell that derives from rat.
immortal rat neural nucleus-derived cell line cell
An immortal Ammon's horn-derived cell line cell that derives from rat.
immortal rat Ammon's horn-derived cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from sheep.
immortal sheep organism part-derived fibroblast cell line cell
An immortal brain-derived cell line cell that derives from ferret.
immortal ferret brain-derived cell line cell
An immortal bone marrow-derived cell line cell that derives from mouse.
immortal mouse bone marrow-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from mouse.
immortal mouse septum of telencephalon-derived cell line cell
An immortal islet of Langerhans-derived cell line cell that derives from mouse.
immortal mouse islet of Langerhans-derived cell line cell
An immortal kidney-derived cell line cell that derives from Miopithecus talapoin.
immortal Miopithecus talapoin kidney-derived cell line cell
An immortal kidney-derived cell line cell that derives from budgerigar.
immortal budgerigar kidney-derived cell line cell
An immortal thyroid gland-derived cell line cell that derives from mouse.
immortal mouse thyroid gland-derived cell line cell
An immortal pyramid of medulla oblongata-derived cell line cell that derives from human.
immortal human pyramid of medulla oblongata-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from squamate.
immortal squamate pair of lungs-derived cell line cell
An immortal aorta-derived cell line cell that derives from mouse.
immortal mouse aorta-derived cell line cell
An immortal uterine cervix-derived epithelial cell line cell that derives from human.
immortal human uterine cervix-derived epithelial cell line cell
An immortal ileocecal junction-derived cell line cell that derives from human.
immortal human ileocecal junction-derived cell line cell
An immortal compact bone-derived cell line cell that derives from human.
immortal human compact bone-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from rat.
immortal rat septum of telencephalon-derived cell line cell
An immortal abdominal aorta-derived cell line cell that derives from human.
immortal human abdominal aorta-derived cell line cell
An immortal bronchus-derived cell line cell that derives from human.
immortal human bronchus-derived cell line cell
An immortal kidney-derived cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster kidney-derived cell line cell
An immortal pancreas-derived cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster pancreas-derived cell line cell
An immortal cell line cell that derives from horse.
An immortal organism part-derived keratinocyte cell line cell that derives from human.
immortal human organism part-derived keratinocyte cell line cell
An immortal iliac artery-derived cell line cell that derives from human.
immortal human iliac artery-derived cell line cell
An immortal synovial membrane of synovial joint-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit synovial membrane of synovial joint-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster septum of telencephalon-derived cell line cell
An immortal female gonad-derived cell line cell that derives from Himalayan Tahr.
immortal Himalayan Tahr female gonad-derived cell line cell
An immortal fetal membrane-derived cell line cell that derives from Himalayan Tahr.
immortal Himalayan Tahr fetal membrane-derived cell line cell
An immortal iliac vein-derived cell line cell that derives from human.
immortal human iliac vein-derived cell line cell
An immortal B cell line cell that derives from human.
immortal human B-cell line cell
An immortal vagina-derived cell line cell that derives from human.
immortal human vagina-derived cell line cell
An immortal larynx-derived cell line cell that derives from human.
immortal human larynx-derived cell line cell
An immortal inferior cervical ganglion-derived cell line cell that derives from human.
immortal human inferior cervical ganglion-derived cell line cell
An immortal esophagus-derived cell line cell that derives from human.
immortal human esophagus-derived cell line cell
An immortal femoral artery-derived cell line cell that derives from human.
immortal human femoral artery-derived cell line cell
An immortal prepuce of penis-derived cell line cell that derives from human.
immortal human prepuce of penis-derived cell line cell
An immortal gingival epithelium-derived cell line cell that derives from human.
immortal human gingival epithelium-derived cell line cell
An immortal gingiva-derived cell line cell that derives from human.
immortal human gingiva-derived cell line cell
An immortal muscle cell line cell that derives from human.
An immortal thymus-derived cell line cell that derives from human.
immortal human thymus-derived cell line cell
An immortal mouth-derived cell line cell that derives from human.
immortal human mouth-derived cell line cell
An immortal neuron cell line cell that derives from rat.
An immortal limb/fin-derived cell line cell that derives from human.
immortal human limb/fin-derived cell line cell
An immortal leukocyte cell line cell that derives from marmoset.
immortal marmoset leukocyte cell line cell
An immortal peritoneal macrophage cell line cell that derives from Chinese hamster.
immortal Chinese hamster peritoneal macrophage cell line cell
An immortal peritoneum-derived cell line cell that derives from Chinese hamster.
immortal Chinese hamster peritoneum-derived cell line cell
An immortal peripheral vein-derived cell line cell that derives from human.
immortal human peripheral vein-derived cell line cell
An immortal brain-derived cell line cell that derives from rat.
immortal rat brain-derived cell line cell
An immortal exocrine cell line cell that derives from rat.
An immortal kidney-derived cell line cell that derives from Atlantic salmon.
immortal Atlantic salmon kidney-derived cell line cell
An immortal round window-derived cell line cell that derives from mouse.
immortal mouse round window-derived cell line cell
An immortal female gonad-derived cell line cell that derives from moth.
immortal moth female gonad-derived cell line cell
An immortal female gonad-derived cell line cell that derives from Antheraea.
immortal Antheraea female gonad-derived cell line cell
An immortal conjunctiva structure-derived fibroblast cell line cell that derives from human.
immortal human conjunctiva structure-derived fibroblast cell line cell
An immortal pancreas-derived cell line cell that derives from rat.
immortal rat pancreas-derived cell line cell
An immortal dento-alveolar joint-derived cell line cell that derives from human.
immortal human dento-alveolar joint-derived cell line cell
An immortal testis-derived cell line cell that derives from human.
immortal human testis-derived cell line cell
An immortal intestine-derived cell line cell that derives from human.
immortal human intestine-derived cell line cell
An immortal rectum-derived cell line cell that derives from human.
immortal human rectum-derived cell line cell
An immortal pulmonary vein-derived cell line cell that derives from human.
immortal human pulmonary vein-derived cell line cell
An immortal islet of Langerhans-derived cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster islet of Langerhans-derived cell line cell
An immortal buttock-derived fibroblast cell line cell that derives from human.
immortal human buttock-derived fibroblast cell line cell
An immortal tonsil-derived cell line cell that derives from human.
immortal human tonsil-derived cell line cell
An immortal thymus-derived cell line cell that derives from mouse.
immortal mouse thymus-derived cell line cell
An immortal umbilicus-derived fibroblast cell line cell that derives from human.
immortal human umbilicus-derived fibroblast cell line cell
An immortal larva-derived cell line cell that derives from mosquito.
immortal mosquito larva-derived cell line cell
An immortal thoracic aorta-derived endothelial cell line cell that derives from pig.
immortal pig thoracic aorta-derived endothelial cell line cell
An immortal kidney-derived cell line cell that derives from African clawed frog.
immortal African clawed frog kidney-derived cell line cell
An immortal cell line cell that derives from dog.
An immortal dento-alveolar joint-derived cell line cell that derives from mouse.
immortal mouse dento-alveolar joint-derived cell line cell
An immortal posterior commissure-derived cell line cell that derives from zebra fish.
immortal zebra fish posterior commissure-derived cell line cell
An immortal soft palate-derived cell line cell that derives from human.
immortal human soft palate-derived cell line cell
An immortal cell line cell that derives from silk moth.
An immortal kidney-derived cell line cell that derives from hamster.
immortal hamster kidney-derived cell line cell
An immortal adrenal gland-derived cell line cell that derives from human.
immortal human adrenal gland-derived cell line cell
An immortal pronephros-derived cell line cell that derives from mouse.
immortal mouse pronephros-derived cell line cell
An immortal fetal membrane-derived cell line cell that derives from rat.
immortal rat fetal membrane-derived cell line cell
An immortal organism part-derived smooth muscle cell line cell that derives from human.
immortal human organism part-derived smooth muscle cell line cell
An immortal blood cell line cell that derives from mouse.
An immortal placenta-derived cell line cell that derives from human.
immortal human placenta-derived cell line cell
An immortal posterior commissure-derived cell line cell that derives from bluegill sunfish.
immortal bluegill sunfish posterior commissure-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from cattle.
immortal cattle septum of telencephalon-derived cell line cell
An immortal embryo-derived cell line cell that derives from gastropod.
immortal gastropod embryo-derived cell line cell
An immortal ON-bipolar cell line cell that derives from mouse.
immortal mouse ON-bipolar cell line cell
An immortal pair of lungs-derived cell line cell that derives from kusimanse.
immortal kusimanse pair of lungs-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from Oryx.
immortal Oryx pair of lungs-derived cell line cell
An immortal kidney-derived cell line cell that derives from Burchell's zebra.
immortal Burchell's zebra kidney-derived cell line cell
An immortal embryo-derived cell line cell that derives from plantain squirrel.
immortal plantain squirrel embryo-derived cell line cell
An immortal fetal membrane-derived cell line cell that derives from sheep.
immortal sheep fetal membrane-derived cell line cell
An immortal brain-derived cell line cell that derives from sheep.
immortal sheep brain-derived cell line cell
An immortal kidney-derived cell line cell that derives from Silvery marmoset.
immortal Silvery marmoset kidney-derived cell line cell
An immortal kidney-derived cell line cell that derives from rhesus macaque.
immortal rhesus macaque kidney-derived cell line cell
An immortal monocyte cell line cell that derives from mouse.
An immortal neural nucleus-derived cell line cell that derives from Mus musculus x Rattus norvegicus.
immortal Mus musculus x Rattus norvegicus neural nucleus-derived cell line cell
An immortal sublingual artery-derived cell line cell that derives from cat.
immortal cat sublingual artery-derived cell line cell
An immortal female gonad-derived cell line cell that derives from cat.
immortal cat female gonad-derived cell line cell
An immortal round window-derived cell line cell that derives from Mus musculus x Rattus norvegicus.
immortal Mus musculus x Rattus norvegicus round window-derived cell line cell
An immortal thyrotroph cell line cell that derives from mouse.
immortal mouse thyrotroph cell line cell
An immortal pair of lungs-derived cell line cell that derives from rat.
immortal rat pair of lungs-derived cell line cell
An immortal kidney-derived cell line cell that derives from rat.
immortal rat kidney-derived cell line cell
An immortal aorta-derived cell line cell that derives from cattle.
immortal cattle aorta-derived cell line cell
An immortal cell line cell that derives from Chinese oak silkmoth.
immortal Chinese oak silkmoth cell line cell
An immortal endothelium-derived cell line cell that derives from cattle.
immortal cattle endothelium-derived cell line cell
An immortal mixed endoderm/mesoderm-derived structure-derived cell line cell that derives from brown bullhead.
immortal brown bullhead mixed endoderm/mesoderm-derived structure-derived cell line cell
An immortal bone marrow-derived cell line cell that derives from cattle.
immortal cattle bone marrow-derived cell line cell
An immortal macrophage cell line cell that derives from mouse.
immortal mouse macrophage cell line cell
An immortal ligament-derived cell line cell that derives from mouse.
immortal mouse ligament-derived cell line cell
An immortal uterus-derived fibroblast cell line cell that derives from human.
immortal human uterus-derived fibroblast cell line cell
An immortal uterus-derived cell line cell that derives from northern raccoon.
immortal northern raccoon uterus-derived cell line cell
An immortal thyroid gland-derived cell line cell that derives from sheep.
immortal sheep thyroid gland-derived cell line cell
An immortal peripheral neuron cell line cell that derives from channel catfish.
immortal channel catfish peripheral neuron cell line cell
An immortal animal ovary-derived fibroblast cell line cell that derives from human.
immortal human ovary-derived fibroblast cell line cell
An immortal kidney-derived cell line cell that derives from Aotus.
immortal Aotus kidney-derived cell line cell
An immortal cerebral lobe-derived cell line cell that derives from crayfish.
immortal crayfish cerebral lobe-derived cell line cell
An immortal B cell line cell that derives from chicken.
immortal chicken B cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from American opossum.
immortal American opossum septum of telencephalon-derived cell line cell
An immortal kidney-derived cell line cell that derives from black-tailed deer.
immortal black-tailed deer kidney-derived cell line cell
An immortal liver-derived cell line cell that derives from black-tailed deer.
immortal black-tailed deer liver-derived cell line cell
An immortal mixed endoderm/mesoderm-derived structure-derived cell line cell that derives from black-tailed deer.
immortal black-tailed deer mixed endoderm/mesoderm-derived structure-derived cell line cell
An immortal vasculature-derived cell line cell that derives from mouse.
immortal mouse vasculature-derived cell line cell
An immortal larva-derived cell line cell that derives from Pacific herring.
immortal Pacific herring larva-derived cell line cell
An immortal cell line cell that derives from pig.
An immortal kidney-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit kidney-derived cell line cell
An immortal liver-derived cell line cell that derives from topminnow.
immortal topminnow liver-derived cell line cell
An immortal thyroid gland-derived cell line cell that derives from pig.
immortal pig thyroid gland-derived cell line cell
An immortal prostate gland-derived cell line cell that derives from human.
immortal human prostate gland-derived cell line cell
An immortal squamous part of temporal bone-derived cell line cell that derives from human.
immortal human squamous part of temporal bone-derived cell line cell
An immortal kidney-derived cell line cell that derives from peccary.
immortal peccary kidney-derived cell line cell
An immortal female gonad-derived cell line cell that derives from northern pike.
immortal northern pike female gonad-derived cell line cell
An immortal pronephros-derived fibroblast cell line cell that derives from human.
immortal human pronephros-derived fibroblast cell line cell
An immortal adrenal gland-derived cell line cell that derives from rat.
immortal rat adrenal gland-derived cell line cell
An immortal precursor B cell line cell that derives from mouse.
immortal mouse precursor B cell line cell
An immortal mucosa-derived cell line cell that derives from pig.
immortal pig mucosa-derived cell line cell
An immortal kidney-derived cell line cell that derives from Potoroo.
immortal Potoroo kidney-derived cell line cell
An immortal embryo-derived cell line cell that derives from swordtail platyfish.
immortal swordtail platyfish embryo-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from Chinese hamster.
immortal Chinese hamster pair of lungs-derived cell line cell
An immortal epidermis-derived cell line cell that derives from human.
immortal human epidermis-derived cell line cell
An immortal submandibular gland-derived cell line cell that derives from human.
immortal human submandibular gland-derived cell line cell
An immortal lung-derived mesothelial cell line cell that derives from rat.
immortal rat lung-derived mesothelial cell line cell
An immortal lung-derived mesothelial cell line cell that derives from cattle.
immortal cattle lung-derived mesothelial cell line cell
An immortal eye structure-derived epithelial cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit eye structure-derived epithelial cell line cell
An immortal hip-derived fibroblast cell line cell that derives from human.
immortal human hip-derived fibroblast cell line cell
An immortal parietal cell line cell that derives from mouse.
An immortal prostate epithelium-derived cell line cell that derives from human.
immortal human prostate epithelium-derived cell line cell
An immortal retinal neural layer-derived cell line cell that derives from Japanese quail.
immortal Japanese quail retinal neural layer-derived cell line cell
An immortal fibroblast cell line cell that derives from Japanese quail.
immortal Japanese quail fibroblast cell line cell
An immortal testis-derived cell line cell that derives from rat.
immortal rat testis-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit pair of lungs-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from rhesus macaque.
immortal rhesus macaque septum of telencephalon-derived cell line cell
An immortal ureter-derived cell line cell that derives from human.
immortal human ureter-derived cell line cell
An immortal pyramid of medulla oblongata-derived cell line cell that derives from rat.
immortal rat pyramid of medulla oblongata-derived cell line cell
An immortal iliac vein-derived smooth muscle cell line cell that derives from human.
immortal human iliac vein-derived smooth muscle cell line cell
An immortal common iliac artery-derived smooth muscle cell line cell that derives from human.
immortal human common iliac artery-derived smooth muscle cell line cell
An immortal mammary gland-derived keratinocyte cell line cell that derives from human.
immortal human mammary gland-derived keratinocyte cell line cell
An immortal skin-derived fibroblast cell line cell that derives from pig.
immortal pig skin-derived fibroblast cell line cell
An immortal lung-derived fibroblast cell line cell that derives from pig.
immortal pig lung-derived fibroblast cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from Chinese hamster.
immortal Chinese hamster organism part-derived fibroblast cell line cell
An immortal umbilical vein-derived endothelial cell line cell that derives from human.
immortal human umbilical vein-derived endothelial cell line cell
An immortal scalp-derived fibroblast cell line cell that derives from human.
immortal human scalp-derived fibroblast cell line cell
An immortal organism part-derived cell line cell that derives from chimpanzee.
immortal chimpanzee organism part-derived cell line cell
An immortal skeletal muscle-derived myoblast cell line cell that derives from chimpanzee.
immortal chimpanzee skeletal muscle-derived myoblast cell line cell
An immortal organism part-derived endothelial cell line cell that derives from chimpanzee.
immortal chimpanzee organism part-derived endothelial cell line cell
An immortal embryo-derived fibroblast cell line cell that derives from mouse.
immortal mouse embryo-derived fibroblast cell line cell
An immortal sacrum-derived fibroblast cell line cell that derives from human.
immortal human sacrum-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from hamadryas baboon.
immortal hamadryas baboon skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from vervet monkey.
immortal vervet monkey skin-derived fibroblast cell line cell
An immortal peripheral vein-derived B cell line cell that derives from siamang.
immortal siamang peripheral vein-derived B cell line cell
An immortal skin-derived fibroblast cell line cell that derives from king colobus.
immortal king colobus skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from South American squirrel monkey.
immortal South American squirrel monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Francois's langur.
immortal Francois's langur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from agile mangabey.
immortal agile mangabey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from gray-cheeked mangabey.
immortal gray-cheeked mangabey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from cotton-top tamarin.
immortal cotton-top tamarin skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from black-cheeked white-nosed monkey.
immortal black-cheeked white-nosed monkey skin-derived fibroblast cell line cell
An immortal shoulder-derived fibroblast cell line cell that derives from Midas tamarin.
immortal Midas tamarin shoulder-derived fibroblast cell line cell
An immortal hip-derived fibroblast cell line cell that derives from Midas tamarin.
immortal Midas tamarin hip-derived fibroblast cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from golden-crowned sifaka.
immortal golden-crowned sifaka thigh-derived fibroblast cell line cell
An immortal arm-derived fibroblast cell line cell that derives from Midas tamarin.
immortal Midas tamarin arm-derived fibroblast cell line cell
An immortal placenta-derived fibroblast cell line cell that derives from human.
immortal human placenta-derived fibroblast cell line cell
An immortal dermis-derived cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster dermis-derived cell line cell
An immortal embryo-derived cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster embryo-derived cell line cell
An immortal cornea-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit cornea-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit septum of telencephalon-derived cell line cell
An immortal mammalian vulva-derived cell line cell that derives from human.
immortal human mammalian vulva-derived cell line cell
An immortal spherical lensed eye-derived cell line cell that derives from human.
immortal human spherical lensed eye-derived cell line cell
An immortal aorta-derived cell line cell that derives from rat.
immortal rat aorta-derived cell line cell
An immortal skeletal muscle-derived myoblast cell line cell that derives from human.
immortal human skeletal muscle-derived myoblast cell line cell
An immortal ileum-derived cell line cell that derives from pig.
immortal pig ileum-derived cell line cell
An immortal larva-derived cell line cell that derives from gypsy moth.
immortal gypsy moth larva-derived cell line cell
An immortal female gonad-derived cell line cell that derives from gypsy moth.
immortal gypsy moth female gonad-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from African buffalo.
immortal African buffalo lung-derived cell line cell
An immortal fibroblast cell line cell that derives from Mongolian gerbil.
immortal Mongolian gerbil fibroblast cell line cell
An immortal skin-derived cell line cell that derives from Muntjacs.
immortal Muntjacs skin-derived cell line cell
An immortal cervix-derived fibroblast cell line cell that derives from human.
immortal human cervix-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from brown lemur.
immortal brown lemur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Wolf's monkey.
immortal Wolf's monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from mandrill.
immortal mandrill skin-derived fibroblast cell line cell
An immortal peripheral vein-derived B cell line cell that derives from Red-cheeked gibbon.
immortal Red-cheeked gibbon peripheral vein-derived B cell line cell
An immortal skin-derived fibroblast cell line cell that derives from red-crowned mangabey.
immortal red-crowned mangabey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Bolivian squirrel monkey.
immortal Bolivian squirrel monkey skin-derived fibroblast cell line cell
An immortal abdominal cavity-derived fibroblast cell line cell that derives from rhesus macaque.
immortal rhesus macaque abdominal cavity-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from brown woolly monkey.
immortal brown woolly monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from moustached monkey.
immortal moustached monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Moholi bushbaby.
immortal Moholi bushbaby skin-derived fibroblast cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from Celebes crested macaque.
immortal Celebes crested macaque thigh-derived fibroblast cell line cell
An immortal rhomboid-derived myoblast cell line cell that derives from human.
immortal human rhomboid-derived myoblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from crowned lemur.
immortal crowned lemur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from white sifaka.
immortal white sifaka skin-derived fibroblast cell line cell
An immortal thorax-derived fibroblast cell line cell that derives from drill.
immortal drill thorax-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from white-faced saki.
immortal white-faced saki skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from aye-aye.
immortal aye-aye skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from bamboo lemur.
immortal bamboo lemur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Goeldi's monkey.
immortal Goeldi's monkey skin-derived fibroblast cell line cell
An immortal peripheral vein-derived B cell line cell that derives from Bornean orangutan.
immortal Bornean orangutan peripheral vein-derived B cell line cell
An immortal peripheral vein-derived B cell line cell that derives from pileated gibbon.
immortal pileated gibbon peripheral vein-derived B cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from dog.
immortal dog organism part-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Bolivian red howler monkey.
immortal Bolivian red howler monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Miopithecus talapoin.
immortal Miopithecus talapoin skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Pere David's macaque.
immortal Pere David's macaque skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from White-cheeked Gibbon.
immortal White-cheeked Gibbon skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from saddlebacked tamarin.
immortal saddlebacked tamarin skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from L'Hoest's monkey.
immortal L'Hoest's monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from proboscis monkey.
immortal proboscis monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from pygmy marmoset.
immortal pygmy marmoset skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Spix's night monkey.
immortal Spix's night monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Nancy Ma's night monkey.
immortal Nancy Ma's night monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from slow loris.
immortal slow loris skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Lesser dwarf lemur.
immortal Lesser dwarf lemur skin-derived fibroblast cell line cell
An immortal abdominal cavity-derived cell line cell that derives from human.
immortal human abdominal cavity-derived cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Red-bellied titi.
immortal Red-bellied titi skin-derived fibroblast cell line cell
An immortal vasculature-derived cell line cell that derives from human.
immortal human vasculature-derived cell line cell
An immortal umbilical vein-derived cell line cell that derives from human.
immortal human umbilical vein-derived cell line cell
An immortal duodenum-derived cell line cell that derives from human.
immortal human duodenum-derived cell line cell
An immortal blood cell line cell that derives from marmoset.
An immortal skin-derived fibroblast cell line cell that derives from Coquerel's mouse lemur.
immortal Coquerel's mouse lemur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from lesser white-nosed monkey.
immortal lesser white-nosed monkey skin-derived fibroblast cell line cell
An immortal ileum-derived cell line cell that derives from rat.
immortal rat ileum-derived cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Yellow baboon.
immortal Yellow baboon skin-derived fibroblast cell line cell
An immortal embryo-derived cell line cell that derives from Neobatrachia.
immortal Neobatrachia embryo-derived cell line cell
An immortal skin-derived fibroblast cell line cell that derives from blue monkey.
immortal blue monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Celebes crested macaque.
immortal Celebes crested macaque skin-derived fibroblast cell line cell
An immortal peripheral vein-derived B cell line cell that derives from agile gibbon.
immortal agile gibbon peripheral vein-derived B cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Hanuman langur.
immortal Hanuman langur skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Geoffroy's marmoset.
immortal Geoffroy's marmoset skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from coppery titi.
immortal coppery titi skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from slender loris.
immortal slender loris skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from liontail macaque.
immortal liontail macaque skin-derived fibroblast cell line cell
An immortal connective tissue-derived cell line cell that derives from human.
immortal human connective tissue-derived cell line cell
An immortal bone marrow-derived cell line cell that derives from human.
immortal human bone marrow-derived cell line cell
An immortal parotid gland-derived cell line cell that derives from human.
immortal human parotid gland-derived cell line cell
An immortal cell line cell that derives from true toad.
An immortal skin-derived cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster skin-derived cell line cell
An immortal follicular fluid-derived cell line cell that derives from rat.
immortal rat follicular fluid-derived cell line cell
An immortal eye-derived cell line cell that derives from human.
immortal human eye-derived cell line cell
An immortal ischium-derived fibroblast cell line cell that derives from human.
immortal human ischium-derived fibroblast cell line cell
An immortal embryo-derived cell line cell that derives from zebra fish.
immortal zebra fish embryo-derived cell line cell
An immortal parenchymal cell line cell that derives from zebra fish.
immortal zebra fish parenchymal cell line cell
An immortal buttock-derived cell line cell that derives from human.
immortal human buttock-derived cell line cell
An immortal anatomical cluster-derived cell line cell that derives from human.
immortal human anatomical cluster-derived cell line cell
An immortal thigh-derived cell line cell that derives from human.
immortal human thigh-derived cell line cell
An immortal heart-derived cell line cell that derives from Iguana.
immortal Iguana heart-derived cell line cell
An immortal chordate pharynx-derived cell line cell that derives from human.
immortal human chordate pharynx-derived cell line cell
An immortal retina-derived cell line cell that derives from human.
immortal human retina-derived cell line cell
An immortal skin-derived cell line cell that derives from chimpanzee.
immortal chimpanzee skin-derived cell line cell
An immortal fibroblast cell line cell that derives from walleye.
immortal walleye fibroblast cell line cell
An immortal neural nucleus-derived cell line cell that derives from mouse.
immortal mouse neural nucleus-derived cell line cell
An immortal yolk sac-derived cell line cell that derives from mouse.
immortal mouse yolk sac-derived cell line cell
An immortal nasal concha-derived cell line cell that derives from cattle.
immortal cattle nasal concha-derived cell line cell
An immortal cell line cell that derives from tick.
An immortal female gonad-derived cell line cell that derives from silk moth.
immortal silk moth female gonad-derived cell line cell
An immortal arm-derived cell line cell that derives from human.
immortal human arm-derived cell line cell
An immortal peripheral vein-derived B cell line cell that derives from Kenya baboon.
immortal Kenya baboon peripheral vein-derived B cell line cell
An immortal sacrum-derived cell line cell that derives from human.
immortal human sacrum-derived cell line cell
An immortal conjunctiva-derived cell line cell that derives from human.
immortal human conjunctiva-derived cell line cell
An immortal epithelial cell line cell that derives from rat.
An immortal submandibular gland-derived cell line cell that derives from mouse.
immortal mouse submandibular gland-derived cell line cell
An immortal single nucleate cell line cell that derives from human.
immortal human single nucleate cell line cell
An immortal trachea-derived cell line cell that derives from human.
immortal human trachea-derived cell line cell
An immortal tongue-derived cell line cell that derives from human.
immortal human tongue-derived cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from pig.
immortal pig thigh-derived fibroblast cell line cell
An immortal trachea-derived cell line cell that derives from dog.
immortal dog trachea-derived cell line cell
An immortal thymus-derived cell line cell that derives from dog.
immortal dog thymus-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from bat.
immortal bat lung-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from free-tailed bat.
immortal free-tailed bat pair of lungs-derived cell line cell
An immortal urinary bladder-derived cell line cell that derives from Bufo.
immortal Bufo urinary bladder-derived cell line cell
An immortal dento-alveolar joint-derived cell line cell that derives from white-tufted-ear marmoset.
immortal white-tufted-ear marmoset dento-alveolar joint-derived cell line cell
An immortal skin-derived cell line cell that derives from anteater.
immortal anteater skin-derived cell line cell
An immortal aorta-derived cell line cell that derives from human.
immortal human aorta-derived cell line cell
An immortal lymphoid follicle-derived cell line cell that derives from human.
immortal human lymphoid follicle-derived cell line cell
An immortal bone element-derived cell line cell that derives from dog.
immortal dog bone element-derived cell line cell
An immortal respiration organ-derived cell line cell that derives from mouse.
immortal mouse respiration organ-derived cell line cell
An immortal fusion competent myoblast cell line cell that derives from human.
immortal human fusion competent myoblast cell line cell
An immortal female gonad-derived cell line cell that derives from channel catfish.
immortal channel catfish female gonad-derived cell line cell
An immortal muscle spindle-derived cell line cell that derives from mouse.
immortal mouse muscle spindle-derived cell line cell
An immortal testis-derived cell line cell that derives from pig.
immortal pig testis-derived cell line cell
An immortal embryo-derived cell line cell that derives from sockeye salmon.
immortal sockeye salmon embryo-derived cell line cell
An immortal renal glomerulus-derived cell line cell that derives from mouse.
immortal mouse renal glomerulus-derived cell line cell
An immortal liver-derived cell line cell that derives from rainbow trout.
immortal rainbow trout liver-derived cell line cell
An immortal nephron tubule-derived cell line cell that derives from Bolivian squirrel monkey.
immortal Bolivian squirrel monkey nephron tubule-derived cell line cell
An immortal larva-derived cell line cell that derives from silk moth.
immortal silk moth larva-derived cell line cell
An immortal sternum-derived cell line cell that derives from geese.
immortal geese sternum-derived cell line cell
An immortal neuron cell line cell that derives from mouse.
An immortal esophagus-derived cell line cell that derives from goat.
immortal goat esophagus-derived cell line cell
An immortal hypodermis-derived cell line cell that derives from human.
immortal human hypodermis-derived cell line cell
An immortal skin-derived cell line cell that derives from goat.
immortal goat skin-derived cell line cell
An immortal embryo-derived cell line cell that derives from Chinook salmon.
immortal Chinook salmon embryo-derived cell line cell
An immortal embryo-derived cell line cell that derives from Salmonidae.
immortal Salmonidae embryo-derived cell line cell
An immortal neuroblast cell line cell that derives from human.
immortal human neuroblast cell line cell
An immortal embryo-derived cell line cell that derives from Chinese hamster.
immortal Chinese hamster embryo-derived cell line cell
An immortal leukocyte cell line cell that derives from carp.
immortal mouse B cell line cell
An immortal heart-derived cell line cell that derives from chum salmon.
immortal chum salmon heart-derived cell line cell
An immortal bone element-derived cell line cell that derives from rat.
immortal rat bone element-derived cell line cell
An immortal monocyte cell line cell that derives from human.
An immortal thorax-derived fibroblast cell line cell that derives from dog.
immortal dog thorax-derived fibroblast cell line cell
An immortal proximal tubule-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit proximal tubule-derived cell line cell
An immortal cell line cell that derives from Chinese hamster.
An immortal fibroblast cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit fibroblast cell line cell
An immortal kidney-derived cell line cell that derives from African green monkey polyomavirus.
immortal African green monkey polyomavirus kidney-derived cell line cell
An immortal aorta-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit aorta-derived cell line cell
An immortal dermis-derived cell line cell that derives from hagfish.
immortal hagfish dermis-derived cell line cell
An immortal embryo-derived cell line cell that derives from white bass.
immortal white bass embryo-derived cell line cell
An immortal colon-derived cell line cell that derives from rat.
immortal rat colon-derived cell line cell
An immortal liver-derived cell line cell that derives from woodchuck.
immortal woodchuck liver-derived cell line cell
An immortal mucosa of vagina-derived cell line cell that derives from human.
immortal human mucosa of vagina-derived cell line cell
An immortal heart-derived cell line cell that derives from Russell's viper.
immortal Russell's viper heart-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from Russell's viper.
immortal Russell's viper septum of telencephalon-derived cell line cell
An immortal fusion competent myoblast cell line cell that derives from rat.
immortal rat fusion competent myoblast cell line cell
An immortal heart-derived cell line cell that derives from Terrapene.
immortal Terrapene heart-derived cell line cell
An immortal cell line cell that derives from cabbage looper.
An immortal larva-derived cell line cell that derives from cabbage looper.
immortal cabbage looper larva-derived cell line cell
An immortal multi-cellular organism-derived cell line cell that derives from mosquito.
immortal mosquito multi-cellular organism-derived cell line cell
An immortal dento-alveolar joint-derived cell line cell that derives from rat.
immortal rat dento-alveolar joint-derived cell line cell
An immortal kidney-derived cell line cell that derives from rainbow trout.
immortal rainbow trout kidney-derived cell line cell
An immortal prostate gland-derived cell line cell that derives from mouse.
immortal mouse prostate gland-derived cell line cell
An immortal embryo-derived cell line cell that derives from rat.
immortal rat embryo-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from deer.
immortal deer pair of lungs-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from horse.
immortal horse septum of telencephalon-derived cell line cell
An immortal dermis-derived cell line cell that derives from horse.
immortal horse dermis-derived cell line cell
An immortal epithelial cell line cell that derives from dog.
An immortal skin-derived cell line cell that derives from camel.
immortal camel skin-derived cell line cell
An immortal embryo-derived cell line cell that derives from duck.
immortal duck embryo-derived cell line cell
An immortal fibroblast cell line cell that derives from dog.
An immortal hematopoietic cell line cell that derives from mouse.
immortal mouse hematopoietic cell line cell
An immortal skin-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit skin-derived cell line cell
An immortal blood cell line cell that derives from Gorilla.
An immortal trachea-derived cell line cell that derives from cattle.
immortal cattle trachea-derived cell line cell
An immortal blood cell line cell that derives from chimpanzee.
immortal chimpanzee blood cell line cell
An immortal blood cell line cell that derives from Sumatran orangutan.
immortal Sumatran orangutan blood cell line cell
An immortal larva-derived cell line cell that derives from Acrea moth.
immortal Acrea moth larva-derived cell line cell
An immortal endocervix-derived cell line cell that derives from human.
immortal human endocervix-derived cell line cell
An immortal adrenal gland-derived cell line cell that derives from cattle.
immortal cattle adrenal gland-derived cell line cell
An immortal cell line cell that derives from Dzhungarian hamster.
immortal Dzhungarian hamster cell line cell
An immortal testis-derived cell line cell that derives from dolphin.
immortal dolphin testis-derived cell line cell
An immortal cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster cell line cell
An immortal pair of lungs-derived cell line cell that derives from vervet monkey.
immortal vervet monkey pair of lungs-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from rhesus macaque.
immortal rhesus macaque pair of lungs-derived cell line cell
An immortal embryo-derived cell line cell that derives from Drosophila hydei.
immortal Drosophila hydei embryo-derived cell line cell
An immortal macrophage cell line cell that derives from dog.
An immortal fetal membrane-derived cell line cell that derives from Bolivian squirrel monkey.
immortal Bolivian squirrel monkey fetal membrane-derived cell line cell
An immortal trachea-derived cell line cell that derives from nine-banded armadillo.
immortal nine-banded armadillo trachea-derived cell line cell
An immortal arm-derived fibroblast cell line cell that derives from Ring-tailed lemur.
immortal Ring-tailed lemur arm-derived fibroblast cell line cell
An immortal organism part-derived mesothelial cell line cell that derives from human.
immortal human organism part-derived mesothelial cell line cell
An immortal arm-derived fibroblast cell line cell that derives from Celebes crested macaque.
immortal Celebes crested macaque arm-derived fibroblast cell line cell
An immortal embryo-derived cell line cell that derives from fruit fly.
immortal fruit fly embryo-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from dog.
immortal dog septum of telencephalon-derived cell line cell
An immortal cell line cell that derives from long-tailed macaque.
immortal long-tailed macaque cell line cell
An immortal cell line cell that derives from gold fish.
immortal gold fish cell line cell
An immortal cell line cell that derives from turnip moth.
An immortal skin-derived cell line cell that derives from Cottontail rabbit.
immortal Cottontail rabbit skin-derived cell line cell
An immortal colon-derived cell line cell that derives from mouse.
immortal mouse colon-derived cell line cell
An immortal fibroblast cell line cell that derives from coho salmon.
immortal coho salmon fibroblast cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from cat.
immortal cat septum of telencephalon-derived cell line cell
An immortal shoulder-derived fibroblast cell line cell that derives from human.
immortal human shoulder-derived fibroblast cell line cell
An immortal thoracic aorta-derived smooth muscle cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster thoracic aorta-derived smooth muscle cell line cell
An immortal abdominal cavity-derived fibroblast cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster abdominal cavity-derived fibroblast cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from cat.
immortal cat organism part-derived fibroblast cell line cell
disease: primary superficial spreading melanoma in vertical growth phase; from lung metastases in mice
disease: immortalized with SV40 large T antigen
disease: liver/pre-B lymphoblast hybridoma
disease: hereditary adenomatosis (Gardner's variant)
disease: somatic cell hybrid; Burkitt's lymphoma
disease: immortalized with SV40 early region
24IA subscript(2) E subscript(2) E subscript(10) D subscript(5)
24IA subscript(2) E subscript(2) E subscript(10) D subscript(5) cell
Human Embryonic Kidney 293
WEB: http://web.expasy.org/cellosaurus/CVCL_0045
WEB: https://www.atcc.org/Products/All/CRL-1573.aspx
BTO: BTO_0000007
EFO: EFO_0001182)
WEB: https://www.atcc.org/Products/All/CRL-10852.aspx#characteristics
disease: transformed with adenovirus 5 DNA
A 293-derived cell line that is stably transfected to secrete the chimeric protein (CHE-Fc), a recombinant soluble chirmeric protein useful as a probe to detect 9-O-Acetylated sialic acids.
WEB: http://web.expasy.org/cellosaurus/CVCL_6352
WEB: https://www.atcc.org/Products/All/CRL-2368.aspx
293/CHE-Fc was established by cotransfecting human embryonic 293 cell (ATCC CRL-1573) with the plasmid pCHE-Fc and a plasmid encoding Genetic (G418) resistance. The cell line is stably transfected to secrete the chimeric protein (CHE-Fc), a recombinant soluble chirmeric protein useful as a probe to detect 9-O-Acetylated sialic acids. CHE-Fc is a bifunctional molecule that can be used either to cleave acetyl groups at the ninth position of sialic acids or as a binding probe for 9-O-sialic acids. https://www.atcc.org/Products/All/CRL-2368.aspx
WEB: https://www.atcc.org/Products/All/CRL-11268.aspx
disease: amphotropic retroviral packaging line
3A-sub E [post crisis of 3A(tPA-30-1)] cell
disease: methylnitrosourea-induced lymphoma
7C subscript(2) C subscript(5) C subscript(12)
7C subscript(2) C subscript(5) C subscript(12) cell
disease: osteoblast; inducible adipocyte differentiation model
ATCC: CRL-7898,COSMIC ID:910921; ATCC CRL-7898
disease: malignant melanoma (skin primary)
Comment: this term is obsolete because it is duplicated with another term 'A-375 cell' (CLO_0001582). -- Oliver He
WEB: http://bioinformatics.hsanmartino.it/hypercldb/cl199.html
WEB: http://www.atcc.org/products/all/CRL-1872
ATCC: COSMIC ID:910697; ATCC CRL-7905,CRL-7905
disease: lymphoma; AMLV transformed lymphoblast
disease: Ehlers-Danlos syndrome, type II
disease: hybridoma fusion partner,T cell
anti-130-kDa Mesothelial-Ciliated Cells cell
disease: Ehlers-Danlos syndrome, presumed heterozygote
disease: nitrosoethylurea-induced neuroblastoma
disease: osteogenesis imperfecta (congenita)
Possible typographic error in 'Organism' field (value 'Antheraea perny') to be considered as 'Antheraea pernyi' (NCBI_Taxon: 7119) [SS]
disease: methylnitrosourea-induced smooth muscle-like tumor
disease: xeroderma pigmentosum, presumed heterozygote
disease: endothelioma; polyoma middle T antigen transformed
disease: Ehlers-Danlos syndrome, type I (autosomal dominant type)
WEB: http://capcelllines.ca/details.asp?id=132
Web: http://www.ncbi.nlm.nih.gov/pubmed/7535634
Possible typographic error in 'Organism' field (value 'insect - Estigmene agrea') to be considered as 'Estigmene agreai' (NCBI_Taxon: 56594) [SS]
disease: endothelial cell differentiation model; stem cell feeder layer
disease: cystic fibrosis; immortalized with Ad12-SV40 hybrid
disease: gliosarcoma; expresses beta-galactosidase
disease: adenocarcinoma; HPV-18 transfected
disease: clear cell carcinoma (kidney primary)
disease: epidermoid carcinoma (lung primary)
disease: unknown, probably lung anaplastic carcinoma
disease: carcinoma, epidermoid, from metastatic site
disease: keratinocyte; HPV-16 E6/E7 transformed
disease: connective tissue; osteosarcoma
disease: ductal adenocarcinoma; cystic fibrosis
DSMZ: ACC 360,COSMIC ID:910568; DSMZ ACC 360
disease: bronchogenic carcinoma (bronchus primary)
disease: expresses IgG1 (kappa) against IL-8
disease: galactosemia; galactose-1-phosphate uridyl transferase deficient
disease: promyeloblast; acute promyelocytic leukemia
Clone 1-5c-4 WKD of Chang Conjunctiva cell
disease: colorectal adenocarcinoma (colon primary)
LCL-1232
Derived from a melanoma of a 47 year old female.
CHEMBL: CHEMBL3308723
COLO-679
COLO679
DSMZ: ACC 264
EFO: EFO_0006372
LINCS_HMS: 50011
duplicate. See http://purl.obolibrary.org/obo/CLO_0037121
disease: T lymphocyte; transformed with REV-T; produces G-CSF
disease: T lymphocyte; transformed with REV-T: produces G-CSF
disease: produces a retrovirus containing the beta-galactosidase gene
disease: carcinoma; model for testing immunotherapy protocols in vivo
disease: expresses CTLA4Ig fusion protein
Possible typographic error in 'Organism' field (value 'Agrothis segetum') to be considered as 'Agrotis segetum' (NCBI_Taxon: 47767) [SS]
disease: acute T cell leukemia; CD4 negative
disease: medulloblastoma (cerebellum primary)
disease: osteogenesis imperfecta (tarda)
disease: Ehlers-Danlos syndrome, variant type
disease: desmoplastic cerebellar medulloblastoma
disease: carcinoma, bronchogenic large cell
Possible typographic error in 'Organism' field (value 'Drosophila, hydnei') to be considered as 'Drosophila hydnei' (NCBI_Taxon: 7224) [SS]
disease: carcinoma; small cell lung cancer
disease: carcinoma; small cell lung cancer (lung primary)
disease: lymphangiectasia (B lymphocyte primary); IL-6 dependent
disease: production of mouse c-myc protein
Possible typographic error in 'Organism' field (value 'insect - Estigmene agrea (saltmarsh catepillar)') to be considered as 'Estigmene agreai' (NCBI_Taxon: 56594) [SS]
Possible mapping of 'Organism' field (value 'orangutang') via synonym of 'Pongo pygmaeus' (NCBI_Taxon: 9600) [SS]
disease: Burkitts lymphoma (B lymphocyte primary)
disease: Ehlers-Danlos syndrome, type VII (arthrochalasia type)
immortal T cell line cell that is derived from blood T cells from mouse C57BL/6 inbred strain that has disease mouse lymphoma.
WEB: http://web.expasy.org/cellosaurus/CVCL_0255
disease: Ehlers-Danlos syndrome, possible heterozygote
disease: defective in single strand break repair
disease: lymphohematopoietic progenitor cell line\
disease: microvascular endothelial cell model
disease: microvascular endothelial cell model; expresses GFP
disease: embryonic carcinoma; testicular teratoma
disease: undifferentiated malignant glioma
disease: positive for FAK but null for p53, integrin signalling pathway
disease: Ehlers-Danlos syndrome, type II (hemorrhagic type)
disease: SV40 large T antigen transfected
disease: fibrous histiocytoma (primary unknown)
disease: monoblast; myelomonoblastic leukemia
disease: generates E1-deleted adenovirus vectors
disease: glomangioma; immortalized with hTERT
disease: ecotropic retroviral packaging line
disease: carcinoma; small cell lung cancer; multidrug resistant
disease: ductal carcinoma (mammary gland primary)
immortal epithelial cell line cell that is derived from some breast epithelial cell from a human patient who had invasive ductal carcinoma.
WEB: http://web.expasy.org/cellosaurus/CVCL_1245
disease: primary acantholytic squamous cell carcinoma
immortal human epithelial cell line cell that was derived from some colon epithelial cell from a human patient with the disease colon carcinoma
WEB: http://web.expasy.org/cellosaurus/CVCL_0291
WEB: https://www.atcc.org/products/all/CCL-247.aspx
disease: ileocecal colorectal adenocarcinoma
an immortal human uterine cervix-derived epithelial cell line that was derived from cervical adenocarcinoma cancer cells taken on February 8, 1951 from Henrietta Lacks, a patient who died of her cancer on October 4, 1951.
WEB: http://www.atcc.org/products/all/CCL-2.aspx
WEB: https://www.ncbi.nlm.nih.gov/pubmed/12001993
disease: HeLa cells transfected with plasmid pSV2neoNR101
WEB: http://web.expasy.org/cellosaurus/CVCL_0027
WEB: https://en.wikipedia.org/wiki/Hep_G2
WEB: https://www.atcc.org/products/all/HB-8065.aspx
disease: hepatocellular carcinoma; transfected with a CYP7 minigene/luciferase construct
obsolete due to duplication http://purl.obolibrary.org/obo/CLO_0003704
disease: produces human gamma interferon
immortal human B cell line cell that derives from some B cell from a human blood sample
WEB: http://web.expasy.org/cellosaurus/CVCL_3714
disease: transfected; polytropic retroviral packaging cell line
disease: amelonotic melanoma (skin primary)
disease: dermatofibrosarcoma protuberans
disease: fibrosarcoma mixed (connective tissue primary)
disease: intestinal carcinoma (unknown primary)
disease: amelanotic melanoma (skin primary)
disease: adenocarcinoma (unknown primary)
disease: adenocar- cinoma (colon primary)
disease: adenocarcinoma (intestines or pancreas primary)
disease: gastric carcinoma (stomach primary
disease: malignant acanthocytosis; keratoacanthoma
disease: fibrosarcoma (connective tissue primary)
disease: fibrosarcoma (unknown primary)
disease: fibrosarcoma (unknown (unknown primary)
disease: stroma; HPV-16 E6/E7 transformed
disease: aspartoacylase deficiency; possible Canavan disease
disease: diffuse mixed lymphoma; B lymphoblast
ATCC: HTB-63,COSMIC ID:907067; ATCC HTB-63
disease: pigmented epithelium; immortalized with hTERT
WEB: https://www.atcc.org/Products/All/CRL-1730.aspx
disease: transfected; xenotropic retroviral packaging cell line
disease: antibody reactive with cell surface membranes of cancer cells
WEB: https://www.atcc.org/products/all/CCL-186.aspx
Possible mapping of 'Organism' field (value 'moth, cabbage') via synonym of 'Plutella xylostella' (NCBI_Taxon: 51655) [SS]
disease: PLC-gamma1 negative; model for T-cell receptor signaling
disease: transfected with PLC-gamma1 expression vector; control for J.?1 cells
immortal mouse monocyte cell line cell that derives from some monocyte immature dendritic cell from the bone marrow of mouse C57BL/6 inbred strain.
WEB: http://web.expasy.org/cellosaurus/CVCL_3727
WEB: https://www.atcc.org/Products/All/CRL-11904.aspx
an immortalized human T lymphocyte cell that was derived in the late 1970s from the peripheral blood of a 14-year-old boy with T cell leukemia
WEB: https://en.wikipedia.org/wiki/Jurkat_cells
disease: chronic myelo- genous leukemia (bone marrow primary)
disease: acute myeloid leukemia, subtype M2
disease: gastric carcinoma (stomach primary)
Possible mapping of 'Organism' field (value 'bear, black') via synonym of 'Ursus americanus' (NCBI_Taxon: 9643) [SS]
disease: promyeloblast; acute lympho- blastic leukemia
disease: overproduces P element transposase
disease: Ehlers-Danlos syndrome, type VI (hemorrhagic type)
DSMZ: COSMIC ID:1161992; DSMZ ACC 673,ACC 673
disease: lacks GlcNAc glycosyl transferase function
disease: reduced transport of CMP-sialic acid into Golgi compartment
disease: reduced transport of UDP-galactose into Golgi compartment
immortal mouse fibroblast cell line cell that was derived from some fibroblasts from a C3H/An mouse connective tissue
WEB: http://web.expasy.org/cellosaurus/CVCL_4535
disease: glioblastoma; apoptosis studies; p53+, p16, p14ARF
disease: glioblastoma; p53 expression under tetracycline-induced promoter
disease: Ehlers-Danlos syndrome, type IV
disease: leukemia, acute megakaryoblastic
disease: expresses rat m1 muscarinic acetylcholine receptor
disease: expresses rat m3 muscarinic acetylcholine receptor
disease: carcinoma (mammary gland primary)
disease: SV40 large T antigen transfected; control for MmB19tsA. clone 2B2
disease: SV40 large T antigen transfected; Cre-lox recombination model
Possible mapping of 'Organism' field (value 'quail') via synonym of 'Odontophoridae' (NCBI_Taxon: 224313) [SS]
disease: undifferentiated lymphoma lymphoblast
disease: transfection host; exogenous gene expression
MCF-10A is a spontaneously immortalized, but nontransformed human mammary epithelial cell line cell that was derived from the breast tissue of a 36-year-old patient with fibrocystic changes
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12798140
PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1975513
WEB: http://web.expasy.org/cellosaurus/CVCL_0598
WEB: https://www.atcc.org/products/all/CRL-10317.aspx
CVCL: CVCL_0598; EFO: EFO_0001200; ChEMBL: CHEMBL3307364; HMSL: HMSL50583
WEB: http://web.expasy.org/cellosaurus/CVCL_3633
This term is obsolete due to duplication. See: CLO_0007606. Oliver He
WEB: http://web.expasy.org/cellosaurus/CVCL_3743
obsolete due to duplication. See: http://purl.obolibrary.org/obo/CLO_0037180
an immortal breast cancer cell line cell isolated in 1970 from a 69-year-old Caucasian woman.
WEB: http://web.expasy.org/cellosaurus/CVCL_0031
WEB: https://en.wikipedia.org/wiki/MCF-7
disease: adenocarcinoma (mammary gland primary)
disease: neuroepithelioma (brain primary)
disease: adenocarcinoma (prostate primary)
disease: luciferase resposive; androgen agonist/antagonist
an immortal breast cancer cell line cell derived from a human patient with breast adenocarcinoma
A model mammalian cell line cell that was genereated from the initial isolation in 1958 of epithelial cells from the kidney tubule of an adult Cocker Spaniel dog by Stewart H. Madin and Norman B. Darby, Jr..
disease: epidermoid carcinoma (cervix primary)
disease: megakaryoblast; chronic myelogenous leukemia
disease: virus-induced myeloid leukemia
disease: acute lympho- blastic leukemia
WEB: http://bioinformatics.hsanmartino.it/cldb/cl3535.html
disease: neutrophil progenitor cell line
disease: mesothelioma, biphasic (lung primary)
WEB: http://web.expasy.org/cellosaurus/CVCL_0005
disease: carcinoma; classic small cell lung cancer (lung primary)
disease: large cell neuro- endocrine carcinoma (lung primary)
disease: squamous cell neuro- endocrine carcinoma (lung primary)
disease: papillary adenocar- cinoma (lung primary)
disease: carcinoma; classic small cell lung cancer
disease: large cell adenocarcinoma; non-small cell lung cancer
disease: squamous cell adenocarcinoma; non-small cell lung cancer
disease: neuroendocrine carc- cinoma; non-small cell lung cancer (lung primary)
disease: adenocarcinoma (lung primary)
disease: squamous cell carcinoma (lung primary)
disease: large cell carcinoma; poorly differentiated (lung primary)
disease: carcinoma; variant small cell lung cancer (lung primary)
disease: mesothelioma (pleura primary)
disease: small cell lung cancer; adenocar- cinoma; squamous cell carcinoma
disease: non-small cell lung cancer (lung primary)
disease: carcinoma; non-small cell lung cancer
disease: squamous cell carcinoma; mesothelioma (lung primary)
disease: small cell lung cancer; adeno- carcinoma; squamous cell carcinoma
disease: mucoepidermoid pulmonary carcinoma
disease: cortex adrenocortical carcinoma
disease: alveolus); bronchioalveolar carcinoma; non-small cell lung cancer
disease: papillary adeno- carcinoma (lung primary)
disease: large cell carci- noma (lung primary)
disease: carcinoma; small cell lung cancer (unknown primary)
disease: mixed adeno- squamous and carcinoma (lung primary)
disease: extrapulmonary small cell carcinoma (prostate primary)
disease: carcinoma; large cell lung cancer (lung primary)
disease: large cell; neuroendocrine; carcinoma; non-small cell lung cancer
disease: papillary adenocarci- noma (lung primary)
disease: adenocarcinoma; non-small cell lung cancer (lung primary)
disease: neuroblastoma x root ganglion neuron hybrid
disease: glial cell; neuron; glioblastoma; neuro- blastoma (hybrid)
disease: adenoma; carboxypeptidase E defective
disease: IL-2 dependent, cytotoxic to a wide range of malignant cells
disease: IL-2 independent, cytotoxic to a wide range of malignant cells
disease: immortalized with SV40 large T plasmid, p129
disease: carcinoma, embryonal pluripotent
WEB: http://web.expasy.org/cellosaurus/CVCL_3407
WEB: https://www.atcc.org/Products/All/CRL-1973.aspx
The parental NTERA-2 lines was established in 1980 from a nude mouse xenograft of the Tera-2 cell line (see ATCC HTB-106). The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line. Ref: https://www.atcc.org/Products/All/CRL-1973.aspx#characteristics
epithelial-like,differentiation changes phenotype. https://www.atcc.org/Products/All/CRL-1973.aspx
disease: cystoadenocarcinoma, low differentiated, papillary serous; G2/3 FIGO stage III c
disease: cystoadenocarcinoma, high grade papillary serous; G3 FIGO stage III c
disease: adenocarcinoma, low differentiated; G3 FIGO stage IV (pleural metastasis)
disease: Ehlers-Danlos syndrome, type III
disease: malignant papillary serous adenocarcinoma (ovary primary)
disease: ZAP-70 negative; model for T cell receptor signaling
disease: transfected with ZAP-70 expression vector; control for P116 cells
disease: teratocarcinoma; embryonic carcinoma
disease: Burkitts lymphoma; B lymphoblast
immortal mouse mast cell line cell that was derived from some lymph node mast cell from a /2 mouse with mast cell neoplasm
WEB: http://www.ncbi.nlm.nih.gov/pubmed/18432777
disease: teratocarcinoma (ovary primary)
PA317 cell line containing JR-gal cell
disease: produces a retrovirus containing the human cyclin E-L gene
disease: produces a retrovirus containing the human cyclin E-S gene
disease: produces amphotropic control retrovirus; G418 resistant
WEB: https://www.atcc.org/Products/All/CRL-1469.aspx
an immortal human prostate epithelium-derived cell line cell that was established in 1979 from bone metastasis of grade IV of prostate cancer in a 62-year-old Caucasian male.
disease: diffuse large cell non-Hodgkins lymphoma (B lymphocyte primary)
disease: embryonic carcinoma; HAT resistant
disease: malignant primitive neuroectodermal tumor
disease: produces an infectious retrovirus with a neomycin resistance gene
disease: galactosyltransferase I deficient
disease: heparin sulfate N-sulfotransferase deficient
Possible typographic error in 'Organism' field (value 'racoon') to be considered as 'raccoon'. Possible mapping of 'raccoon' via synonym of 'Procyon lotor' (NCBI_Taxon: 9654) [SS]
disease: ductal adenocarcinoma; same patient as Panc 10.05 cells
disease: xenotropic retroviral packaging line
disease: immortalized with Ad12-SV40 hybrid virus
disease: chemically induced fibrosarcoma
disease: produces a retrovirus containing the vHa-ras oncogene
disease: brain, undifferentiated malignant glioma
disease: insulinoma; produces somatostatin and L-dopa-decarboxylase but not insulin
disease: insulinoma; produces insulin and L-dopa-decarboxylase but not somatostatin
disease: insulinoma; produces insulin and somatostatin
disease: carcinoma; control for RKO-E6 and RKO-AS45-1 cells
disease: carcinoma; apoptosis model; overexpression of GADD45
disease: carcinoma; apoptosis model; negligible p53 expression
disease: non-Hodgkins lymphoma; B lymphoblast
ATCC: CRL-1671,COSMIC ID:930082; ATCC CRL-1671
disease: 7, 12-dimethylbenz(a)anthracene- induced tumor
disease: xeroderma pigmentosum; presumed heterozygote
disease: squamous cell carcinoma (nasal septum primary)
disease: Hodgkins disease; Cell types: EBV + B-lymphoblastoid cell line
disease: transfected with HPV-18 and Ki-MSV
disease: dibenzanthracene-induced malignant fibrosarcoma
disease: dibenzanthracene-induced fibrosarcoma
disease: pseudoachondroplasia (autosomal dominant)
disease: carcinoma; small cell lung cancer; large cell variant
SIRC (Statens Se- ruminstitut Rabbit Cornea)
SIRC (Statens Se- ruminstitut Rabbit Cornea) cell
disease: rhabdomyosarcoma (muscle primary)
ATCC: HTB-88,COSMIC ID:909720; ATCC HTB-88
WEB: http://www.atcc.org/products/all/HTB-68.aspx
ATCC: COSMIC ID:909725; ATCC HTB-71,HTB-71
AU-Mel
P36
SK MEL 28
SK Mel 28
SK-MEL 28
SK-MEL28
SK-Mel28
SK.MEL.28
SKMEL-28
SKML-28
SKMel-28
SKMel28
SKmel28
ChEMBL: CHEMBL3308494
A melanoma cell line cell. This cell line was established in 1974 from a metastatic site (axillary lymph node) in a 24-year-old Caucasian female with malignant melanoma, expresses mutant B-Raf (V600E) and wildtype N-Ras.
WEB: http://web.expasy.org/cellosaurus/CVCL_1706
WEB: http://www.ncbi.nlm.nih.gov/pubmed/3121170
WEB: https://strap.nci.nih.gov/celline_detail.php?sample_id=56
SK MES 1
SK-MES
Obsolete. See: http://purl.obolibrary.org/obo/CLO_0009049
disease: embryonal neuro- blastoma (brain/neuroblast primary)
disease: retroperitoneal; malignant; primitive neuroectodermal tumor
disease: mesodermal tumor (mixed); consistent with leiomyosarcoma
disease: Steel factor deficient; SV40 large T immortalized
disease: pleomorphic hepatocellular carcinoma
disease: transformed with adenovirus 5 DNA; packaging cell line
disease: large cell immuno- blastic lymphoma (unknown primary)
disease: immortalized with SV40 large T antigen; deficient for Yes and Fyn
disease: ductal carcinoma (pancreas primary)
an immortal human B cell line cell that is derived from a 8-year-old Caucasian male human patient with an acute lymphoblastic leukemia.
WEB: http://www.atcc.org/products/all/CRL-1929.aspx
WEB: http://www.atcc.org/~/ps/CRL-1929.ashx
immortal human T cell line cell that was derived from some human T cell from a patient who had disease T-cell childhood lymphoblastic lymphoma
WEB: https://www.atcc.org/products/all/CRL-1942.aspx
disease: angiomyolipoma; immortalized with SV40 large T antigen and human telomerase
disease: immortalized with SV40 large T antigen; deficient for Src,Yes, and Fyn
an immortal human B cell line cell that was derived some B cell isolated from human blood
WEB: https://www.atcc.org/products/all/CRL-1992.aspx
LCL-1486
T47D cell
WEB: https://www.atcc.org/products/all/HTB-133.aspx
ECACC: 85102201
disease: colorectal carcinoma (colon primary)
Possible mapping of 'Organism' field (value 'toad, tropical') via synonym of 'Bufo' (NCBI_Taxon: 8383) [SS]
disease: HPV-16 E6/E7 and c-Ha-ras cotransformed
disease: model for cytokine (IL-3) signaling pathways and myeloid progenitor cell differentiation
disease: immortalized with SV40 T antigen
disease: lymphoma; Hodgkins disease (lymph node primary)
disease: diffuse large cell lymphoma, non-Hodgkins
disease: primary malignant adenocarcinoma; endometrioid carcinoma
disease: primary malignant adenocarcinoma; clear cell carcinoma
disease: cutaneous; heterozygous for tuberin; tuberous sclerosis model
ATCC: COSMIC ID:930299; ATCC CRL-1803,CRL-1803
disease: osteogenesis imperfecta (severe congenita)
disease: histiocytic lymphoma; neomycin resistant
WEB: https://www.atcc.org/Products/All/HTB-96.aspx
immortal human B cell line cell that was derived from some human B cell isolated from a patient with multiple myeloma
There is a CLO term for the cell line already: http://purl.obolibrary.org/obo/CLO_0009464
Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. See more: http://web.expasy.org/cellosaurus/CVCL_0022.
a immortal human monocyte cell line cell that was derived from the histiocytic lymphoma of a 37-year-old male patient
WEB: https://en.wikipedia.org/wiki/U937_cell
disease: defective in nucleotide excision repair
disease: carcinoma, epithelioid (bone primary)
disease: papilloma virus-induced carcinoma
disease: stroma; assay system for hBMP-2
Possible mapping of 'Organism' field (value 'woodchuck, Eastern') via synonym of 'Marmota monax' (NCBI_Taxon: 9995) [SS]
disease: methylcholanthrene-induced fibrosarcoma
disease: MoMuLV retroviral packaging line
disease: primary superficial spreading melanoma in radial growth phase/vertical growth phase
disease: nodular melanoma in vertical growth phase
disease: primary melanoma in vertical growth phase
disease: primary superficial spreading melanoma in vertical growth phase
disease: adenovirus 12-SV40 hybrid transformed
disease: Rous sarcoma virus-induced tumor
Possible mapping of 'Organism' field (value 'toad, South African') via synonym of 'Bufonidae' (NCBI_Taxon: 8382) [SS]
disease: immortalized with adenovirus12-SV40 virus hybrid
disease: ductal carcinoma (mammary gland epithelium primary)
disease: produces a retrovirus containing the adenovirus 12S E1A gene
disease: produces a retrovirus containing the adenovirus 13S E1A gene
disease: produces a retrovirus containing human alkaline phosphatase gene
An immortal pulmonary nerve plexus-derived cell line cell that derives from cattle.
immortal cattle pulmonary nerve plexus-derived cell line cell
An immortal pelvic fin-derived cell line cell that derives from human.
immortal human pelvic fin-derived cell line cell
An immortal round window-derived cell line cell that derives from human.
immortal human round window-derived cell line cell
An immortal bipolar neuron cell line cell that derives from human.
immortal human bipolar neuron cell line cell
An immortal right ureter-derived cell line cell that derives from human.
immortal human right ureter-derived cell line cell
An immortal larva-derived cell line cell that derives from forest day mosquito.
immortal forest day mosquito larva-derived cell line cell
An immortal rectum-derived cell line cell that derives from mouse.
immortal mouse rectum-derived cell line cell
An immortal endometrium-derived cell line cell that derives from rat.
immortal rat endometrium-derived cell line cell
An immortal multi-cellular organism-derived cell line cell that derives from chicken.
immortal chicken multi-cellular organism-derived cell line cell
An immortal peripheral neuron cell line cell that derives from rat.
immortal rat peripheral neuron cell line cell
An immortal superior rostral sulcus-derived cell line cell that derives from rat.
immortal rat superior rostral sulcus-derived cell line cell
An immortal muscle cell line cell that derives from rat.
An immortal skeletal muscle cell line cell that derives from rat.
immortal rat skeletal muscle cell line cell
An immortal myoblast cell line cell that derives from rat.
An immortal thymus-derived cell line cell that derives from cattle.
immortal cattle thymus-derived cell line cell
An immortal connective tissue-derived cell line cell that derives from rat.
immortal rat connective tissue-derived cell line cell
An immortal follicular fluid-derived cell line cell that derives from mouse.
immortal mouse follicular fluid-derived cell line cell
An immortal late embryo-derived cell line cell that derives from rat.
immortal rat late embryo-derived cell line cell
An immortal mammary gland-derived cell line cell that derives from rat.
immortal rat mammary gland-derived cell line cell
An immortal fetal membrane-derived cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit fetal membrane-derived cell line cell
An immortal aorta-derived cell line cell that derives from Ovis.
immortal Ovis aorta-derived cell line cell
An immortal peripheral neuron cell line cell that derives from pig.
immortal pig peripheral neuron cell line cell
An immortal blood cell line cell that derives from pig.
An immortal dento-alveolar joint-derived cell line cell that derives from rainbow trout.
immortal rainbow trout dento-alveolar joint-derived cell line cell
An immortal gill-derived cell line cell that derives from rainbow trout.
immortal rainbow trout gill-derived cell line cell
An immortal gonad-derived cell line cell that derives from rainbow trout.
immortal rainbow trout gonad-derived cell line cell
An immortal female gonad-derived cell line cell that derives from rainbow trout.
immortal rainbow trout female gonad-derived cell line cell
An immortal cornea structure-derived fibroblast cell line cell that derives from human.
immortal human cornea structure-derived fibroblast cell line cell
An immortal glial cell line cell that derives from rat.
An immortal prepuce of penis-derived cell line cell that derives from rhesus macaque.
immortal rhesus macaque prepuce of penis-derived cell line cell
An immortal endothelial cell line cell that derives from rat.
An immortal liver-derived cell line cell that derives from chicken.
immortal chicken liver-derived cell line cell
An immortal epithelial cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster epithelial cell line cell
An immortal mixed endoderm/mesoderm-derived structure-derived cell line cell that derives from Cottontail rabbit.
immortal Cottontail rabbit mixed endoderm/mesoderm-derived structure-derived cell line cell
An immortal cell line cell that derives from fall armyworm.
An immortal female gonad-derived cell line cell that derives from fall armyworm.
immortal fall armyworm female gonad-derived cell line cell
An immortal glomerular capsule-derived cell line cell that derives from rat.
immortal rat glomerular capsule-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from guinea pig.
immortal guinea pig pair of lungs-derived cell line cell
An immortal septum of telencephalon-derived cell line cell that derives from sheep.
immortal sheep septum of telencephalon-derived cell line cell
An immortal kidney-derived cell line cell that derives from Dasyuridae.
immortal Dasyuridae kidney-derived cell line cell
An immortal nasal vestibule-derived cell line cell that derives from rat.
immortal rat nasal vestibule-derived cell line cell
An immortal epidermal cell line cell that derives from hagfish.
immortal hagfish epidermal cell line cell
An immortal endothelial cell line cell that derives from mouse.
immortal mouse endothelial cell line cell
An immortal spherical lensed eye-derived cell line cell that derives from mouse.
immortal mouse spherical lensed eye-derived cell line cell
An immortal cell line cell that derives from European rabbit, rabbit.
immortal European rabbit, rabbit cell line cell
An immortal adrenal cortex-derived cell line cell that derives from human.
immortal human adrenal cortex-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from Canis.
immortal Canis lung-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from American black bear.
immortal American black bear lung-derived cell line cell
An immortal myeloblast cell line cell that derives from human.
immortal human myeloblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from white-handed gibbon.
immortal white-handed gibbon skin-derived fibroblast cell line cell
An immortal lung-derived fibroblast cell line cell that derives from Chinese hamster.
immortal Chinese hamster lung-derived fibroblast cell line cell
An immortal 16914-derived fibroblast cell line cell that derives from human.
immortal human 16914-derived fibroblast cell line cell
An immortal organism part-derived fibroblast cell line cell that derives from Syrian golden hamster.
immortal Syrian golden hamster organism part-derived fibroblast cell line cell
An immortal peripheral vein-derived B cell line cell that derives from Geoffroy's marmoset.
immortal Geoffroy's marmoset peripheral vein-derived B cell line cell
An immortal peripheral vein-derived B cell line cell that derives from White-cheeked Gibbon.
immortal White-cheeked Gibbon peripheral vein-derived B cell line cell
An immortal thorax-derived fibroblast cell line cell that derives from northern lesser bushbaby.
immortal northern lesser bushbaby thorax-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from Azara's night monkey.
immortal Azara's night monkey skin-derived fibroblast cell line cell
An immortal skin-derived fibroblast cell line cell that derives from De Brazza's monkey.
immortal De Brazza's monkey skin-derived fibroblast cell line cell
An immortal peripheral vein-derived B cell line cell that derives from vervet monkey.
immortal vervet monkey peripheral vein-derived B cell line cell
An immortal organism part-derived epithelial cell line cell that derives from human.
immortal human organism part-derived epithelial cell line cell
An immortal axilla-derived fibroblast cell line cell that derives from human.
immortal human axilla-derived fibroblast cell line cell
An immortal arm-derived fibroblast cell line cell that derives from patas monkey.
immortal patas monkey arm-derived fibroblast cell line cell
An immortal pulmonary artery-derived endothelial cell line cell that derives from cattle.
immortal cattle pulmonary artery-derived endothelial cell line cell
An immortal pulmonary artery-derived smooth muscle cell line cell that derives from cattle.
immortal cattle pulmonary artery-derived smooth muscle cell line cell
An immortal retina structure-derived epithelial cell line cell that derives from human.
immortal human retina structure-derived epithelial cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from Red-bellied titi.
immortal Red-bellied titi thigh-derived fibroblast cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from patas monkey.
immortal patas monkey thigh-derived fibroblast cell line cell
An immortal calf-derived fibroblast cell line cell that derives from human.
immortal human calf-derived fibroblast cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from brown woolly monkey.
immortal brown woolly monkey thigh-derived fibroblast cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from red-chested mustached tamarin.
immortal red-chested mustached tamarin thigh-derived fibroblast cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from South American squirrel monkey.
immortal South American squirrel monkey thigh-derived fibroblast cell line cell
An immortal thigh-derived fibroblast cell line cell that derives from saddlebacked tamarin.
immortal saddlebacked tamarin thigh-derived fibroblast cell line cell
An immortal nose structure-derived fibroblast cell line cell that derives from human.
immortal human nose structure-derived fibroblast cell line cell
An immortal carotid artery-derived smooth muscle cell line cell that derives from cattle.
immortal cattle carotid artery-derived smooth muscle cell line cell
An immortal brain-derived fibroblast cell line cell that derives from human.
immortal human brain-derived fibroblast cell line cell
An immortal eye structure-derived epithelial cell line cell that derives from pig.
immortal pig eye structure-derived epithelial cell line cell
An immortal eye structure-derived epithelial cell line cell that derives from mouse.
immortal mouse eye structure-derived epithelial cell line cell
An immortal mammary gland-derived cell line cell that derives from human.
immortal human mammary gland-derived cell line cell
An immortal pair of lungs-derived cell line cell that derives from Mustelinae (i.e. mink).
immortal mink cell line cell
An immortal cell line cell that derives from Oryzias latipes (i.e., medaka).
immortal medaka cell line cell
a biological process that presents the survival of a microbe inside a cell line cell.
microbial survival inside cell line cell
a microbial survival inside cell line cell where the microbe is a bacterium
bacterial survival inside cell line cell
a biological process that specifies the interaction between cell line cell and a pathogen
cell line cell-pathogen interaction
a biological process that specifies the interaction between cell line cell and a vaccine
cell line cell-vaccine interaction
an gene expression that occurs in a cell line cell.
cell line cell gene expression
immortal cell line
A cell line that is expected to be capable of indefinite propagation in an vitro culture.
OBI-CLO Alignment Working Group (Spring 2013)
A cell line is able to support only a limited number of passages in vitro.
A mortal cell line is not capable of supporting indefinite propagation in vitro, being limited by entry of its cells into senescence.
mortal cell line
We recommend against use of this term, as 'primary' is used also to refer to cultured cell populaitons that have yet to be passaged.
A human glioblastoma cell line cell. The cell line is part of the NCI-60 screening panel.
duplicate. see: http://purl.obolibrary.org/obo/CLO_0009251
A clonal HeLa cell line cell that stably expresses the FRET-based initiator caspase reporter (ICRP).
WEB: http://web.expasy.org/cellosaurus/CVCL_9T98
WEB: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461398/
METHYL-CPG-BINDING PROTEIN 2; MECP2 RETT SYNDROME; RTT
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC
HOLOPROSENCEPHALY TRANSLOCATED CHROMOSOME
RETT SYNDROME; RTT METHYL-CPG-BINDING PROTEIN 2; MECP2
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1
3-@HYDROXY-3-METHYLGLUTARYL-COENZYME A LYASE DEFICIENCY
HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1 HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A
HLA HISTOCOMPATIBILITY TYPE: 142800 THROUGH 142860 & 142880
RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM
NIJMEGEN BREAKAGE SYNDROME NIJMEGEN BREAKAGE SYNDROME GENE; NBS1
SPHEROCYTOSIS, HEREDITARY; HS CHROMOSOME DELETION
ANEUPLOID CHROMOSOME NUMBER - TRISOMY 9 ANEUPLOID CHROMOSOME NUMBER - TRISOMY
FANCONI ANEMIA COMPLEMENTATION GROUP UNDETERMINED
ADDITIONAL HUMAN/MOUSE SOMATIC CELL HYBRIDS
MAJOR AFFECTIVE DISORDER - 125480 OR 309200
CIRRHOSIS, FAMILIAL CIRRHOSIS, FAMILIAL, WITH PULMONARY HYPERTENSION, INCLUDED
BIOTINIDASE; BTD MULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET, INCLUDED
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2
MAJOR AFFECTIVE DISORDER; OLD ORDER AMISH - 125480 OR 309200
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR CYSTIC FIBROSIS; CF
APPARENTLY HEALTHY NON-FETAL TISSUE MAJOR AFFECTIVE DISORDER - 125480 OR 309200
CYSTIC FIBROSIS; CF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN; ACADM
ACYL-CoA DEHYDROGENASE, LONG-CHAIN, DEFICIENCY OF
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN; ACADM ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF
MONOZYGOTIC TWIN PAIRS CYSTIC FIBROSIS; CF
ESTERASE D; ESD S-FORMYLGLUTATHIONE HYDROLASE, INCLUDED; FGH, INCLUDED CHROMOSOME DELETION
FRAGILE SITE MENTAL RETARDATION 1; FMR1 MONOZYGOTIC TWIN PAIRS
MONOZYGOTIC TWIN PAIRS FRAGILE SITE MENTAL RETARDATION 1; FMR1
MONOZYGOTIC TWIN PAIRS CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR CYSTIC FIBROSIS; CF
ACHONDROGENESIS; TYPE 1 - 200600; TYPE 2 - 200610; OR GREBE TYPE - 200700
APPARENTLY HEALTHY NON-FETAL TISSUE TRANSLOCATED CHROMOSOME
ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY CHROMOSOME DELETION
VELOCARDIOFACIAL SYNDROME CHROMOSOME DELETION
MAJOR AFFECTIVE DISORDER - 125480 OR 309200 APPARENTLY HEALTHY NON-FETAL TISSUE
DYSTROPHIN; DMD MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; DMD CHRONIC GRANULOMATOUS DISEASE (XK-RELATED; CGD) - 306400 OR 314850 CHROMOSOME DELETION
GLUCOSIDASE, ACID BETA; GBA GAUCHER DISEASE, TYPE I
HYPOPHOSPHATASIA; PHOSPHOETHANOLAMINURIA - 241500 OR 241510
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME
BURKITT LYMPHOMA; BL TRANSLOCATED CHROMOSOME
MULTIPLE ENDOCRINE NEOPLASIA, TYPE II; MEN2
FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3 THANATOPHORIC DYSPLASIA; TD
ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY
CEROID LIPOFUSCINOSIS, NEURONAL 3, JUVENILE; CLN3
ADRENAL HYPOPLASIA WITH ADDITIONAL CONGENITAL MALFORMATIONS
RETINOBLASTOMA; RB1 OSTEOSARCOMA, RETINOBLASTOMA-RELATED, INCLUDED
WILMS TUMOR 1; WT1 APPARENTLY HEALTHY NON-FETAL TISSUE
OSTEOGENESIS IMPERFECTA: AUTOSOMAL DOMINANT- 166200,166210,166220, OR 166230
GAUCHER DISEASE, TYPE II GLUCOSIDASE, ACID BETA; GBA
PEROXISOME BIOGENESIS FACTOR 26; PEX26 REFSUM DISEASE, INFANTILE FORM
DNA METHYLTRANSFERASE 3B; DNMT3B APPARENTLY HEALTHY NON-FETAL TISSUE IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME APPARENTLY HEALTHY NON-FETAL TISSUE
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME DNA METHYLTRANSFERASE 3B; DNMT3B
GLUCOSIDASE, ACID BETA; GBA GAUCHER DISEASE, TYPE II
ATAXIA-TELANGIECTASIA MUTATED GENE; ATM ATAXIA-TELANGIECTASIA; AT
5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR HEMOPHILIA B; HEMB
NEUROPATHY, CONGENITAL SENSORY, WITH ANHIDROSIS
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF
RECQ PROTEIN-LIKE 3; RECQL3 BLOOM SYNDROME; BLM
ISOCHROMOSOME ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC
ATAXIA-TELANGIECTASIA; AT ATAXIA-TELANGIECTASIA MUTATED GENE; ATM
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR HUMAN GENE MUTATION PANEL - CYSTIC FIBROSIS (VERSION 2) CYSTIC FIBROSIS; CF
CHROMOSOME 21 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME X REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME DELETION PRADER-WILLI SYNDROME; PWS
PRADER-WILLI SYNDROME; PWS CHROMOSOME DELETION
CHROMOSOME 6 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE X CHROMOSOME SOMATIC CELL HYBRIDS
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS CHROMOSOME DELETION
CRIGLER-NAJJAR SYNDROME UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
EPILEPSY, PROGRESSIVE MYOCLONIC 2; EPM2A
NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM
RETINITIS PIGMENTOSA 1; RP1 RETINITIS PIGMENTOSA 1 GENE; RP1
RETINITIS PIGMENTOSA 1 GENE; RP1 RETINITIS PIGMENTOSA 1; RP1
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
THANATOPHORIC DYSPLASIA; TD FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3
ALZHEIMER DISEASE; AD APOLIPOPROTEIN E; APOE
APOLIPOPROTEIN E; APOE ALZHEIMER DISEASE; AD
NDPT081 ISCHEMIC STROKE DNA PANEL ISCHEMIC STROKE
PARKINSON'S DISEASE LATE ONSET PARKINSON'S DNA PANEL, AFFECTED INDIVIDUALS
POPULATION/CONVENIENCE CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL
YOUNG ONSET PARKINSON'S PANEL; AFFECTED INDIVIDUALS PARKINSON'S DISEASE ESSENTIAL TREMOR-MOVEMENT DISORDER
POPULATION/CONVENIENCE CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
EPIDERMOLYSIS BULLOSA: DYSTROPHIC, JUNCTIONAL, OR SIMPLEX TYPES
PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S DISEASE; AFFECTED INDIVIDUALS
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL POPULATION/CONVENIENCE CONTROL
ISCHEMIC STROKE NDPT081 ISCHEMIC STROKE DNA PANEL
PELIZAEUS-MERZBACHER DISEASE; PMD APPARENTLY HEALTHY NON-FETAL TISSUE
PROTEOLIPID PROTEIN 1; PLP1 PELIZAEUS-MERZBACHER DISEASE; PMD
MENTAL RETARDATION, X-LINKED NONSPECIFIC, TYPE 1; MRX1
GIANT CELL HEPATITIS, NEONATAL IDIOPATHIC NEONATAL HEMOCHROMATOSIS, INCLUDED
APPARENTLY HEALTHY NON-FETAL TISSUE NEUROFIBROMATOSIS, TYPE I; NF1
USH1C GENE; USH1C USHER SYNDROME, TYPE IC; USH1C
USHER SYNDROME, TYPE IC; USH1C USH1C GENE; USH1C
RECQ PROTEIN-LIKE 4; RECQL4 ROTHMUND-THOMSON SYNDROME; RTS
ROTHMUND-THOMSON SYNDROME; RTS RECQ PROTEIN-LIKE 4; RECQL4
WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED LAMIN A/C; LMNA
TRISOMY 21 NIA AGING CELL REPOSITORY DNA PANEL - DOWN SYNDROME
TRISOMY 21 ANEUPLOID CHROMOSOME NUMBER - TRISOMY
NIA AGING CELL REPOSITORY DNA PANEL - DOWN SYNDROME TRISOMY 21
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1
CLN2 GENE; CLN2 CEROID LIPOFUSCINOSIS, NEURONAL 2, LATE INFANTILE TYPE; CLN2
INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP GLUCOSIDASE, ACID BETA; GBA HEXOSAMINIDASE A; HEXA NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC XYY SYNDROME
OSTEOGENESIS IMPERFECTA: GENETICS UNCERTAIN; LETHAL
OSTEOGENESIS IMPERFECTA: GENETICS UNCERTAIN; LETHAL INVERTED CHROMOSOME
APPARENTLY HEALTHY NON-FETAL TISSUE MENKES SYNDROME
APPARENTLY HEALTHY NON-FETAL TISSUE VON HIPPEL-LINDAU SYNDROME; VHL
CARBOXYPEPTIDASE N, POLYPEPTIDE 1, 50-KD; CPN1 CARBOXYPEPTIDASE N DEFICIENCY
XERODERMA PIGMENTOSUM: COMPLEMENTATION GROUP UNDETERMINED
CHROMOSOME 6 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
HUMAN VARIATION PANEL - AFRICANS NORTH OF THE SAHARA
HUMAN VARIATION PANEL - PACIFIC SNP500 PANEL
CHROMOSOME 6 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 6 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 7 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
POPULATION/CONVENIENCE CONTROL CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS POPULATION/CONVENIENCE CONTROL
ZELLWEGER SYNDROME; ZS PEROXISOME BIOGENESIS FACTOR 26; PEX26
OSTEOGENESIS IMPERFECTA, TYPE IV; OI4 COLLAGEN, TYPE I, ALPHA-2; COL1A2
REFSUM DISEASE, INFANTILE FORM RETINITIS PIGMENTOSA 1; RP1
CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS SPOUSAL CONTROL CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS POPULATION/CONVENIENCE CONTROL
SNP500 PANEL HUMAN VARIATION PANEL - PACIFIC
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC
COLLAGEN, TYPE I, ALPHA-2; COL1A2 OSTEOGENESIS IMPERFECTA, TYPE IV; OI4
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
PARKINSON'S DISEASE PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL POPULATION/CONVENIENCE CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL
CHROMOSOME X REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 2 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME X REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
GALACTOSEMIA GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; GALT
CHROMOSOME 7 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 22 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 22 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ALS PANEL CAUCASIAN FROM THE US ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS
SPOUSAL CONTROL DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2 TRICHOTHIODYSTROPHY; TTD ICHTHYOSIFORM ERYTHRODERMA WITH HAIR ABNORMALITY AND MENTAL AND GROWTH RETARDATION, INCLUDED XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD
CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS SPOUSAL CONTROL
LATE ONSET PARKINSON'S DNA PANEL, AFFECTED INDIVIDUALS PARKINSON'S DISEASE
PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS
CHROMOSOME 12 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 22 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; GREATER THAN 7 YEARS SURVIVAL ALS PANEL CAUCASIAN FROM THE US
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS
ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
POPULATION/CONVENIENCE CONTROL NDPT031- AFRICAN AMERICAN CONTROL PANEL
NDPT031- AFRICAN AMERICAN CONTROL PANEL POPULATION/CONVENIENCE CONTROL
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL POPULATION/CONVENIENCE CONTROL
POPULATION/CONVENIENCE CONTROL CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 POPULATION/CONVENIENCE CONTROL NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 POPULATION/CONVENIENCE CONTROL NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL
PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S DNA PANEL; AFFECTED INDIVIDUALS
DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS SPOUSAL CONTROL
YOUNG ONSET PARKINSON'S PANEL; AFFECTED INDIVIDUALS PARKINSON'S DISEASE
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS ALS PANEL CAUCASIAN FROM THE US
YOUNG ONSET PARKINSON'S DNA PANEL; AFFECTED INDIVIDUALS PARKINSON'S DISEASE
CHROMOSOME 9 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
SPINOCEREBELLAR ATAXIA 1; SCA1 ATAXIN 1; ATX1
GLUCOKINASE; GCK MATURITY ONSET DIABETES OF THE YOUNG, TYPE II; MODY2
ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 9 SOMATIC CELL HYBRIDS
SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE N; SNRPN PRADER-WILLI SYNDROME; PWS
NEMALINE MYOPATHY 2, AUTOSOMAL RECESSIVE; NEM2 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1; PFIC1
POPULATION/CONVENIENCE CONTROL CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS POPULATION/CONVENIENCE CONTROL
ALS PANEL CAUCASIAN FROM THE US ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS
FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
HEXOSAMINIDASE A; HEXA TAY-SACHS DISEASE; TSD
COCKAYNE SYNDROME TYPE I - 216400 OR TYPE III - 216411
COLLAGEN, TYPE I, ALPHA-2; COL1A2 OSTEOGENESIS IMPERFECTA: GENETICS UNCERTAIN; LETHAL
ANEUPLOID CHROMOSOME NUMBER - TRISOMY 13 ANEUPLOID CHROMOSOME NUMBER - TRISOMY
DIABETES MELLITUS, JUVENILE-ONSET INSULIN-DEPENDENT; IDDM
TRANSLOCATED CHROMOSOME DIGEORGE SYNDROME; DGS
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER; HHT
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG
ADENOSINE DEAMINASE DEFICIENCY WITH NO IMMUNODEFICIENCY ADENOSINE DEAMINASE; ADA
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA
PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; PLOD1 EHLERS-DANLOS SYNDROME, TYPE VI
CHROMOSOME 8 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
PELIZAEUS-MERZBACHER DISEASE; PMD PROTEOLIPID PROTEIN 1; PLP1
HYPERGLYCINEMIA, ISOLATED NONKETOTIC, TYPE I
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME
ADENOSINE DEAMINASE; ADA SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY ADENOSINE DEAMINASE; ADA
CYSTINOSIS, NEPHROPATHIC; CTNS CYSTINOSIN; CTNS
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH
BLOOM SYNDROME; BLM RECQ PROTEIN-LIKE 3; RECQL3
N-ACETYLGLUCOSAMINIDASE, ALPHA-; NAGLU MUCOPOLYSACCHARIDOSIS TYPE IIIB
CHARCOT-MARIE-TOOTH DISEASE 1B; CMT1B MYELIN PROTEIN ZERO; MPZ
SNP500 PANEL HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24
HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 SNP500 PANEL HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24
POPULATION/CONVENIENCE CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
POPULATION/CONVENIENCE CONTROL NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
POPULATION/CONVENIENCE CONTROL DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
CHROMOSOME 3 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 3 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME X REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; GALT GALACTOSEMIA
LIPASE, CONGENITAL ABSENCE OF PANCREATIC
GLYCOGEN STORAGE DISEASE II GLUCOSIDASE, ALPHA, ACID; GAA
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 8
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100
ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16
ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF
ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF
ACYL-CoA DEHYDROGENASE, SHORT/BRANCHED CHAIN; ACADSB
ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 8; ACAD8 ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY
NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL POPULATION/CONVENIENCE CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16
OSTEOGENESIS IMPERFECTA, TYPE IV; OI4 APPARENTLY HEALTHY NON-FETAL TISSUE
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET
TRIFUNCTIONAL PROTEIN DEFICIENCY HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT; HADHB
BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK
LIG4 SYNDROME LIGASE IV, DNA, ATP-DEPENDENT; LIG4
ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1; NCIE1
YOUNG ONSET PARKINSON'S DISEASE; AFFECTED INDIVIDUALS PARKINSON'S DISEASE
CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS SPOUSAL CONTROL
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200
PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S PANEL; AFFECTED INDIVIDUALS
ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM
SPOUSAL CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
17-@BETA-HYDROXYSTEROID DEHYDROGENASE IV; HSD17B4 PEROXISOMAL BIFUNCTIONAL ENZYME DEFICIENCY
PEROXISOMAL BIFUNCTIONAL ENZYME DEFICIENCY
PEROXISOMAL BIFUNCTIONAL ENZYME DEFICIENCY 17-@BETA-HYDROXYSTEROID DEHYDROGENASE IV; HSD17B4
EPILEPSY ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
POPULATION/CONVENIENCE CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1; PFIC1
VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY
NIEMANN-PICK DISEASE, TYPE A SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL; SMPD1
DEMENTIA WITH LEWY BODIES REM BEHAVIOR DISORDER
TRANSLOCATED CHROMOSOME ATAXIA-TELANGIECTASIA; AT ATAXIA-TELANGIECTASIA MUTATED GENE; ATM
CHROMOSOME 4 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC TURNER SYNDROME
HUMAN VARIATION PANEL - SOUTH AMERICA (ANDES)
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL POPULATION/CONVENIENCE CONTROL
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL POPULATION/CONVENIENCE CONTROL
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL POPULATION/CONVENIENCE CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
TRICHOTHIODYSTROPHY; TTD ICHTHYOSIFORM ERYTHRODERMA WITH HAIR ABNORMALITY AND MENTAL AND GROWTH RETARDATION, INCLUDED
HUMAN VARIATION PANEL - SOUTH AMERICA (BRAZIL, GUYANA, AND VENEZUELA) SNP500 PANEL
HUMAN VARIATION PANEL - SOUTH AMERICA (BRAZIL, GUYANA, AND VENEZUELA)
CHROMOSOME 17 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 HUMAN VARIATION PANEL - SOUTH AMERICA (BRAZIL, GUYANA, AND VENEZUELA) SNP500 PANEL
SNP500 PANEL HUMAN VARIATION PANEL - SOUTH AMERICA (BRAZIL, GUYANA, AND VENEZUELA)
DYSTONIA MUSCULORUM DEFORMANS: TYPE UNKNOWN
ADENOSINE MONOPHOSPHATE DEAMINASE 1; AMPD1
MUCOLIPIDOSIS II; ML2; ML II N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, ALPHA/BETA SUBUNITS; GNPTAB
XXY SYNDROME; KLINEFELTER SYNDROME ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC
XERODERMA PIGMENTOSUM WITH NORMAL DNA REPAIR RATES
TAY-SACHS DISEASE; TSD HEXOSAMINIDASE A; HEXA
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
OSTEOGENESIS IMPERFECTA: GENETICS UNCERTAIN; NON-LETHAL
DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK DYSTROPHIA MYOTONICA 1
METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY
NIEMANN-PICK DISEASE, TYPE C1; NPC1 NPC1 GENE; NPC1
NPC1 GENE; NPC1 NIEMANN-PICK DISEASE, TYPE C1; NPC1
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 1 SOMATIC CELL HYBRIDS
HUMAN VARIATION PANEL - MIDDLE EASTERN (VERSION 2)
CHROMOSOME 10 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 16 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 16 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 16 SOMATIC CELL HYBRIDS
FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC
PARKINSONISM, OTHER NEURODEGENERATIVE OVERLAP SYNDROME
NIGMS MAPPING PANEL #2, VERSION 3, HUMAN/RODENT SOMATIC CELL HYBRIDS
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD
HUMAN VARIATION PANEL - ASHKENAZI JEWISH
HUMAN VARIATION PANEL - AFRICANS SOUTH OF THE SAHARA
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
NDPT080 ISCHEMIC STROKE DNA PANEL ISCHEMIC STROKE
CHROMOSOME 12 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB
CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS SPOUSAL CONTROL
SPOUSAL CONTROL CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES
CHROMOSOME 18 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
INTERNATIONAL HAPMAP PROJECT - MAASAI IN KINYAWA, KENYA (PLATE II) INTERNATIONAL HAPMAP PROJECT - MAASAI IN KINYAWA, KENYA
INTERNATIONAL HAPMAP PROJECT - MAASAI IN KINYAWA, KENYA INTERNATIONAL HAPMAP PROJECT - MAASAI IN KINYAWA, KENYA (PLATE I)
INTERNATIONAL HAPMAP PROJECT - MAASAI IN KINYAWA, KENYA
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
INTERNATIONAL HAPMAP PROJECT - MAASAI IN KINYAWA, KENYA INTERNATIONAL HAPMAP PROJECT - MAASAI IN KINYAWA, KENYA (PLATE II)
INTERNATIONAL HAPMAP PROJECT - MAASAI IN KINYAWA, KENYA (PLATE I) INTERNATIONAL HAPMAP PROJECT - MAASAI IN KINYAWA, KENYA
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 SNP500 PANEL
EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HANSTER, 1; ERCC1 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME; MVA
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; GREATER THAN 7 YEARS SURVIVAL
SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 3; ERCC3
ISCHEMIC STROKE NDPT080 ISCHEMIC STROKE DNA PANEL
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL CAUCASIAN FROM THE UNITED STATES
GLYPICAN 3; GPC3 SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1
FRIEDREICH ATAXIA 1; FRDA FRDA GENE; FRDA
ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL CAUCASIAN FROM THE UNITED STATES
CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS POPULATION/CONVENIENCE CONTROL
SPOUSAL CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 50 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 1)
NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL SPOUSAL CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS POPULATION/CONVENIENCE CONTROL CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
HUMAN VARIATION PANEL - SOUTHEAST ASIANS (EXCLUDING JAPANESE AND CHINESE)
SNP500 PANEL HUMAN VARIATION PANEL - SOUTHEAST ASIANS (EXCLUDING JAPANESE AND CHINESE)
HUMAN VARIATION PANEL - SOUTHEAST ASIANS (EXCLUDING JAPANESE AND CHINESE) SNP500 PANEL
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL SPOUSAL CONTROL
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US
ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL EPILEPSY
SPOUSAL CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL
ALS PANEL CAUCASIAN FROM THE US ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS
SNP500 PANEL HUMAN VARIATION PANEL - MEXICAN
SNP500 PANEL HUMAN VARIATION PANEL - JAPANESE
ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS ALS PANEL CAUCASIAN FROM THE US
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS
HUMAN VARIATION PANEL - PUERTO RICAN SNP500 PANEL
SNP500 PANEL HUMAN VARIATION PANEL - PUERTO RICAN
HUMAN VARIATION PANEL - PUERTO RICAN SNP500 PANEL CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
SNP500 PANEL HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 10
HUMAN VARIATION PANEL - MIDDLE EASTERN (VERSION 1)
ALS PANEL CAUCASIAN FROM THE US ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS AMYOTROPHIC LATERAL SCLEROSIS
UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 SNP500 PANEL HUMAN VARIATION PANEL - JAPANESE
UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - JAPANESE SNP500 PANEL CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6
HUMAN VARIATION PANEL - JAPANESE CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
HUMAN VARIATION PANEL - JAPANESE SNP500 PANEL
ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US
CRI-DU-CHAT SYNDROME CHROMOSOME DELETION
HUMAN VARIATION PANEL - INDO PAKISTANI SNP500 PANEL
DUPLICATED CHROMOSOME RECOMBINANT CHROMOSOME
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS
HUMAN VARIATION PANEL - CHINESE (VERSION 2) SNP500 PANEL HUMAN VARIATION PANEL - CHINESE (VERSION 1)
SNP500 PANEL HUMAN VARIATION PANEL - CHINESE (VERSION 2) HUMAN VARIATION PANEL - CHINESE (VERSION 1)
TRANSLOCATED CHROMOSOME CRI-DU-CHAT SYNDROME DERIVATIVE CHROMOSOME
CHROMOSOME DELETION CRI-DU-CHAT SYNDROME
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 10 CYTOCHROME P450, SUBFAMILY IID, POLYPEPTIDE 6; CYP2D6
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 5 SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 18 SOMATIC CELL HYBRIDS
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ
ANEUPLOID CHROMOSOME NUMBER - TRISOMY TRISOMY 21
ANEUPLOID CHROMOSOME NUMBER - TRISOMY 18 ANEUPLOID CHROMOSOME NUMBER - TRISOMY
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
TURCOT SYNDROME ADENOMATOUS POLYPOSIS OF THE COLON; APC (GARDNER SYNDROME INCLUDED)
UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
SPOUSAL CONTROL CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, ALPHA/BETA SUBUNITS; GNPTAB MUCOLIPIDOSIS II; ML2; ML II
EHLERS-DANLOS SYNDROME: TYPE UNCLASSIFIED
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 8
APPARENTLY HEALTHY NON-FETAL TISSUE XX MALE SYNDROME
XX MALE SYNDROME APPARENTLY HEALTHY NON-FETAL TISSUE
XX MALE SYNDROME TRANSLOCATED CHROMOSOME DERIVATIVE CHROMOSOME
INVERTED CHROMOSOME CRI-DU-CHAT SYNDROME DERIVATIVE CHROMOSOME
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 16 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50
HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 24 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 50 HUMAN VARIATION PANEL - AFRICAN AMERICAN PANEL OF 100
PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE LEUCINE-RICH REPEAT KINASE2; LRRK2
PARKINSON'S DISEASE ESSENTIAL TREMOR-MOVEMENT DISORDER PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL SPOUSAL CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL
ESSENTIAL TREMOR-MOVEMENT DISORDER RESTLESS LEG SYNDROME PARKINSON'S DISEASE
PARKINSON'S DISEASE LEUCINE-RICH REPEAT KINASE2; LRRK2
INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 GUJARATI INDIANS IN HOUSTON, TEXAS INTERNATIONAL HAPMAP PROJECT - GUJARATI INDIANS IN HOUSTON, TEXAS
INTERNATIONAL HAPMAP PROJECT - GUJARATI INDIANS IN HOUSTON, TEXAS INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 GUJARATI INDIANS IN HOUSTON, TEXAS
INTERNATIONAL HAPMAP PROJECT - GUJARATI INDIANS IN HOUSTON, TEXAS
ANEUPLOID CHROMOSOME NUMBER - TRISOMY 18
PHOSPHOMANNOMUTASE 2; PMM2 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id ALG3, S. CEREVISIAE, HOMOLOG OF; ALG3
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic ALG6, S. CEREVISIAE, HOMOLOG OF
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia PHOSPHOMANNOMUTASE 2; PMM2
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie DOLICHYL-PHOSPHATE MANNOSYLTRANSFERASE 1, CATALYTIC SUBUNIT; DPM1
DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE; DPAGT1 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN APPARENTLY HEALTHY NON-FETAL TISSUE
VALOSIN-CONTAINING PROTEIN; VCP INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA; IBMPFD
MANNOSE-P-DOLICHOL UTILIZATION DEFECT 1; MPDU1 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If
INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 HAN CHINESE IN METROPOLITAN DENVER, COLORADO INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN METROPOLITAN DENVER, COLORADO
INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN METROPOLITAN DENVER, COLORADO INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 HAN CHINESE IN METROPOLITAN DENVER, COLORADO
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200 HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 2)
INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN METROPOLITAN DENVER, COLORADO
LYMPHOSARCOMA ACUTE LYMPHOCYTIC LEUKEMIA
N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, ALPHA/BETA SUBUNITS; GNPTAB MUCOLIPIDOSIS IIIA
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; DMD DYSTROPHIN; DMD
DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK DYSTROPHIA MYOTONICA 1 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
TRANSLOCATED CHROMOSOME CENTRAL CORE DISEASE OF MUSCLE
RETINITIS PIGMENTOSA - 180100, 268000, OR 312600
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1
SPOUSAL CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL
AMAUROSIS CONGENITA OF LEBER; TYPE I OR II - 204000 OR 204100
SPOUSAL CONTROL CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL SPOUSAL CONTROL
ALKALINE PHOSPHATASE, LIVER; ALPL HYPOPHOSPHATASIA, INFANTILE
ROKITANSKY-KUSTER-HAUSER SYNDROME UROGENITAL ADYSPLASIA, HEREDITARY
EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 3; ERCC3 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB
HUNTINGTON DISEASE; HD APPARENTLY HEALTHY NON-FETAL TISSUE
PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S PANEL; AFFECTED INDIVIDUALS HEMOCHROMATOSIS; HFE
ADENOMATOUS POLYPOSIS OF THE COLON; APC (GARDNER SYNDROME INCLUDED)
HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 100 (SET 2) HUMAN VARIATION PANEL - CAUCASIAN PANEL OF 200
TRANSLOCATED CHROMOSOME KLIPPEL-FEIL SYNDROME; KFS; KFM CERVICAL VERTEBRAL FUSION, TYPE II, INCLUDED
DYSTROPHIA MYOTONICA 1 DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK
APOLIPOPROTEIN C-II DEFICIENCY, TYPE I HYPERLIPOPROTEINEMIA DUE TO
ADENOMATOUS POLYPOSIS OF THE COLON; APC (GARDNER SYNDROME INCLUDED) APPARENTLY HEALTHY NON-FETAL TISSUE
PARKINSONISM, OTHER DEMENTIA WITH LEWY BODIES
ANEUPLOID CHROMOSOME NUMBER - TRISOMY SC PHOCOMELIA SYNDROME
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2; LGMD2
DYSTROPHIA MYOTONICA 1 APPARENTLY HEALTHY NON-FETAL TISSUE
CYSTINOSIN; CTNS CYSTINOSIS, NEPHROPATHIC; CTNS
HERMANSKY-PUDLAK SYNDROME; HPS HERMANSKY-PUDLAK SYNDROME GENE 6
NORMAL CHROMOSOMAL POLYMORPHISM APPARENTLY HEALTHY NON-FETAL TISSUE
CYSTINOSIS, ADULT NONNEPHROPATHIC CYSTINOSIN; CTNS
ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1 HERMANSKY-PUDLAK SYNDROME 2; HPS2
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC XXY SYNDROME; KLINEFELTER SYNDROME
NIEMANN-PICK DISEASE, TYPE C2 NPC2 GENE; NPC2
ACUTE LYMPHOCYTIC LEUKEMIA LYMPHOSARCOMA
OSTEOGENESIS IMPERFECTA: AUTOSOMAL RECESSIVE - 259400, 259410, OR 259420
FSHD GENE 1; FRG1 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A; FSHMD1A (FSHD)
WOLF-HIRSCHHORN SYNDROME; WHS CHROMOSOME DELETION
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; DMD
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP
APPARENTLY HEALTHY NON-FETAL TISSUE OSTEOGENESIS IMPERFECTA, TYPE IV; OI4
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE
FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1A; FSHMD1A (FSHD) FSHD GENE 1; FRG1
HEMOCHROMATOSIS; HFE APPARENTLY HEALTHY NON-FETAL TISSUE APPARENTLY HEALTHY INDIVIDUALS WITH NORMAL PSYCHIATRIC EVALUATIONS
APPARENTLY HEALTHY NON-FETAL TISSUE APPARENTLY HEALTHY INDIVIDUALS WITH NORMAL PSYCHIATRIC EVALUATIONS
CHROMOSOME DELETION CHRONIC GRANULOMATOUS DISEASE (XK-RELATED; CGD) - 306400 OR 314850
PARKINSON'S DISEASE AMYOTROPHIC LATERAL SCLEROSIS LATE ONSET PARKINSON'S DNA PANEL, AFFECTED INDIVIDUALS
HUMAN GENE MUTATION PANEL - CYSTIC FIBROSIS (VERSION 2) CYSTIC FIBROSIS; CF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS
APPARENTLY HEALTHY INDIVIDUALS WITH NORMAL PSYCHIATRIC EVALUATIONS APPARENTLY HEALTHY NON-FETAL TISSUE
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; DMD CHRONIC GRANULOMATOUS DISEASE (XK-RELATED; CGD) - 306400 OR 314850 DYSTROPHIN; DMD
DYSTROPHIN; DMD CHRONIC GRANULOMATOUS DISEASE (XK-RELATED; CGD) - 306400 OR 314850 MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; DMD
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
ANEUPLOID CHROMOSOME NUMBER - TRISOMY ANEUPLOID CHROMOSOME NUMBER - TRISOMY 9
ADRENOLEUKODYSTROPHY; ALD ATP-BINDING CASSETTE, SUBFAMILY D, MEMBER 1; ABCD1
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PKAN; HALLERVORDEN-SPATZ DISEASE INCLUDED PANTOTHENATE KINASE 2; PANK2
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
ANEUPLOID CHROMOSOME NUMBER - TRISOMY ANEUPLOID CHROMOSOME NUMBER - TRISOMY 13
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
MUCOLIPIDOSIS III, COMPLEMENTATION GROUP C
PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
CHEDIAK-HIGASHI SYNDROME; CHS1 LYSOSOMAL TRAFFICKING REGULATOR, INCLUDED; LYST, INCLUDED
SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL; SMPD1 NIEMANN-PICK DISEASE, TYPE B
MUCOPOLYSACCHARIDOSIS TYPE IVB GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I
SPOUSAL CONTROL ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC
EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD
NEUROBLASTOMA; NB NEUROBLASTOMA SUPPRESSOR, INCLUDED; NBS, INCLUDED
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR HUMAN GENE MUTATION PANEL - CYSTIC FIBROSIS (VERSION 2) CYSTIC FIBROSIS; CF
CEPH/UTAH PEDIGREE 13291 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
TUBEROUS SCLEROSIS; TS APPARENTLY HEALTHY NON-FETAL TISSUE
PEROXISOME BIOGENESIS FACTOR 26; PEX26 ZELLWEGER SYNDROME; ZS
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1345
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 SNP500 PANEL HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 CEPH/UTAH PEDIGREE 1345
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 SNP500 PANEL HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 CEPH/UTAH PEDIGREE 1345
CEPH/UTAH PEDIGREE 1345 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1345
CYSTINURIA; CSNU SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1
SOLUTE CARRIER FAMILY 17, MEMBER 5; SLC17A5 SALLA DISEASE
FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; TYPE UNKNOWN (FSHD)
AUTISTIC DISORDER TRANSLOCATED CHROMOSOME
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
SALLA DISEASE SOLUTE CARRIER FAMILY 17, MEMBER 5; SLC17A5
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR APPARENTLY HEALTHY NON-FETAL TISSUE
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1; HPRT LESCH-NYHAN SYNDROME; LNS
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16
HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - HAN PEOPLE OF LOS ANGELES PANEL OF 8
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 SNP500 PANEL
HYPERAMMONEMIA DUE TO CARBAMOYLPHOSPHATE SYNTHETASE I DEFICIENCY
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16 SNP500 PANEL
SNP500 PANEL HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100
HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 16 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 8 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 100 HUMAN VARIATION PANEL - MEXICAN-AMERICAN COMMUNITY OF LOS ANGELES PANEL OF 24
ANEUPLOID CHROMOSOME NUMBER - TRISOMY ANEUPLOID CHROMOSOME NUMBER - TRISOMY 18
DYSTROPHIN; DMD MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; DMD
MYELOMA (PLASMACYTOMA) CELL LINES FOR HYBRIDOMAS
DIGEORGE SYNDROME; DGS TRANSLOCATED CHROMOSOME
PSEUDOHERMAPHRODITISM, MALE, WITH GYNECOMASTIA
PARKINSON'S DISEASE ESSENTIAL TREMOR-MOVEMENT DISORDER
NEPHROSIS 1, CONGENITAL, FINNISH TYPE; NPHS1
NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL POPULATION/CONVENIENCE CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008
FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 9; XRCC9
MULTIPLE ENDOCRINE NEOPLASIA, TYPE II; MEN2 RET PROTOONCOGENE; RET
FACTOR V DEFICIENCY HEMOGLOBIN--BETA LOCUS; HBB
HUMAN VARIATION PANEL - CHINESE (VERSION 2) CHINESE POPULATION
ALS PANEL CAUCASIAN FROM THE UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES
ALZHEIMER DISEASE LATE ONSET PARKINSON'S DNA PANEL, AFFECTED INDIVIDUALS PARKINSON'S DISEASE
CHROMOSOME DELETION MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3
RET PROTOONCOGENE; RET MULTIPLE ENDOCRINE NEOPLASIA, TYPE II; MEN2
CEPH/UTAH PEDIGREE 1355 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CEPH/UTAH PEDIGREE 1353 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
ALS PANEL; GREATER THAN 7 YEARS SURVIVAL AMYOTROPHIC LATERAL SCLEROSIS
PEROXISOME BIOGENESIS FACTOR 1; PEX1 ZELLWEGER SYNDROME; ZS
SOLUTE CARRIER FAMILY 3, MEMBER 1; SLC3A1 CYSTINURIA; CSNU
CEROID LIPOFUSCINOSIS, NEURONAL 2, LATE INFANTILE TYPE; CLN2 CLN2 GENE; CLN2
RETINITIS PIGMENTOSA 1; RP1 REFSUM DISEASE
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 18 SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 4 SOMATIC CELL HYBRIDS
CHROMOSOME 9 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 17 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND CRYPTORCHIDISM
ESSENTIAL TREMOR-MOVEMENT DISORDER POPULATION/CONVENIENCE CONTROL
MELANOMA, CUTANEOUS MALIGNANT, 2; CMM2 CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A
CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A MELANOMA, CUTANEOUS MALIGNANT, 2; CMM2
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS
ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS
ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS AMYOTROPHIC LATERAL SCLEROSIS
FRONTOTEMPORAL DEMENTIA AMYOTROPHIC LATERAL SCLEROSIS
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 CEPH/FRENCH PEDIGREE 12
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 18 SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 1 SOMATIC CELL HYBRIDS
MAJOR AFFECTIVE DISORDER - 125480 OR 309200 TRANSLOCATED CHROMOSOME
ALS PANEL CAUCASIAN FROM THE UNITED STATES FRONTOTEMPORAL DEMENTIA AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
ALS PANEL CAUCASIAN FROM THE UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 14 SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 18 SOMATIC CELL HYBRIDS
CHROMOSOME 2 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE X CHROMOSOME SOMATIC CELL HYBRIDS
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, BASAL GANGLIA DISEASE, AND SEIZURES
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 17 SOMATIC CELL HYBRIDS
CHROMOSOME 17 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME X REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
PHYLOGENETIC SHADOWING PANEL NONHUMAN PRIMATES
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1353
CEPH/FRENCH PEDIGREE 66 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24
HUMAN VARIATION PANEL - CHINESE (VERSION 2) HUMAN VARIATION PANEL - CHINESE (VERSION 1) SNP500 PANEL
HUMAN VARIATION PANEL - CHINESE (VERSION 1) HUMAN VARIATION PANEL - CHINESE (VERSION 2) SNP500 PANEL
HUMAN VARIATION PANEL - NORTHERN EUROPEAN
HUMAN VARIATION PANEL - CHINESE (VERSION 1)
HUMAN VARIATION PANEL - CHINESE (VERSION 2) HUMAN VARIATION PANEL - CHINESE (VERSION 1)
ALS PANEL; GREATER THAN 7 YEARS SURVIVAL ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
ORNITHINE CARBAMOYLTRANSFERASE; OTC ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
POLYCYSTIC KIDNEY AND HEPATIC DISEASE 1; PKHD1
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC CHROMOSOME DELETION
ALS PANEL; GREATER THAN 7 YEARS SURVIVAL AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES
EMERIN; EMD EMERY-DREIFUSS MUSCULAR DYSTROPHY
ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS AMYOTROPHIC LATERAL SCLEROSIS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; GREATER THAN 7 YEARS SURVIVAL
APPARENTLY HEALTHY NON-FETAL TISSUE HUNTINGTON DISEASE; HD
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS
CHIMPANZEE PANEL GREAT APE PANEL NONHUMAN PRIMATES
ALEXANDER DISEASE GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP
GLIAL FIBRILLARY ACIDIC PROTEIN; GFAP ALEXANDER DISEASE
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2
DELETED IN AZOOSPERMIA; DAZ CHROMOSOME DELETION
CYSTINURIA; CSNU SOLUTE CARRIER FAMILY 7, MEMBER 9; SLC7A9
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3 INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP
FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3 INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP MONOZYGOTIC TWIN PAIRS
CEPH/UTAH PEDIGREE 1358 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1358
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1358
NONHUMAN PRIMATES PHYLOGENETIC SHADOWING PANEL
CONGENITAL ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 POPULATION/CONVENIENCE CONTROL NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1; EEC1
ALS PANEL; GREATER THAN 7 YEARS SURVIVAL PRIMARY LATERAL SCLEROSIS
BASQUE POPULATION HUMAN VARIATION PANEL - BASQUE
HUMAN VARIATION PANEL - BASQUE BASQUE POPULATION
SPOUSAL CONTROL NDPT031- AFRICAN AMERICAN CONTROL PANEL
ECTODERMAL DYSPLASIA 1, ANHIDROTIC; ED1 TRANSLOCATED CHROMOSOME
ALS PANEL CAUCASIAN FROM THE UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
ALS PANEL CAUCASIAN FROM THE US ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES
NIJMEGEN BREAKAGE SYNDROME GENE; NBS1 NIJMEGEN BREAKAGE SYNDROME
COAGULATION FACTOR II; F2 HEMOCHROMATOSIS; HFE 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR HUMAN GENE MUTATION PANEL - HEMOCHROMATOSIS HUMAN GENE MUTATION PANEL - DISORDERS OF THROMBOSIS
MONOZYGOTIC TWIN PAIRS EPILEPSY, CHILDHOOD ABSENCE, 1; ECA1
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS
CEROID LIPOFUSCINOSIS, NEURONAL 1, INFANTILE; CLN1 PALMITOYL-PROTEIN THIOESTERASE 1; PPT1
PALMITOYL-PROTEIN THIOESTERASE 1; PPT1 CEROID LIPOFUSCINOSIS, JUVENILE NEURONAL, WITH GRANULAR OSMIOPHILIC DEPOSIT
DERIVATIVE CHROMOSOME TRANSLOCATED CHROMOSOME
HUMAN GENE MUTATION PANEL - HEMOCHROMATOSIS 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR FACTOR V DEFICIENCY HUMAN GENE MUTATION PANEL - DISORDERS OF THROMBOSIS COAGULATION FACTOR II; F2 HEMOCHROMATOSIS; HFE
LIGASE IV, DNA, ATP-DEPENDENT; LIG4 LIG4 SYNDROME
PALMITOYL-PROTEIN THIOESTERASE 1; PPT1 CEROID LIPOFUSCINOSIS, NEURONAL 1, INFANTILE; CLN1
APPARENTLY HEALTHY INDIVIDUALS WITH NORMAL PSYCHIATRIC EVALUATIONS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE APPARENTLY HEALTHY INDIVIDUALS WITH NORMAL PSYCHIATRIC EVALUATIONS
APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY INDIVIDUALS WITH NORMAL PSYCHIATRIC EVALUATIONS
APPARENTLY HEALTHY INDIVIDUALS WITH NORMAL PSYCHIATRIC EVALUATIONS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
TRANSLOCATED CHROMOSOME FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC
CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED; CMTX1 GAP JUNCTION PROTEIN, BETA-1, 32-KD; GJB1
GAP JUNCTION PROTEIN, BETA-1, 32-KD; GJB1 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED; CMTX1
ANEUPLOID CHROMOSOME NUMBER - TRISOMY 8 ANEUPLOID CHROMOSOME NUMBER - TRISOMY
APPARENTLY HEALTHY NON-FETAL TISSUE ANEUPLOID CHROMOSOME NUMBER - TRISOMY 18
INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP PARKINSON'S DISEASE NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3 INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP PARKINSON'S DISEASE
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3 INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP ASPARTOACYLASE; ASPA
INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3 GLUCOSIDASE, ACID BETA; GBA
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1375 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
MYELOMA, MULTIPLE AMYLOIDOSIS, PRIMARY, INCLUDED; AL, INCLUDED
PRIMARY LATERAL SCLEROSIS ALS PANEL; GREATER THAN 7 YEARS SURVIVAL
PRADER-WILLI SYNDROME; PWS DUPLICATED CHROMOSOME
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1334 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1334 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CEPH/UTAH PEDIGREE 1334 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1408
CEPH/UTAH PEDIGREE 1408 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
PERIPHERAL MYELIN PROTEIN 22; PMP22 CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
CEPH/UTAH PEDIGREE 1408 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1416 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1334
FRDA GENE; FRDA FRIEDREICH ATAXIA 1; FRDA
NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM INVERTED CHROMOSOME
KEARNS-SAYRE SYNDROME; KSS COMPLEX I, SUBUNIT ND4; MTND4
APPARENTLY HEALTHY NON-FETAL TISSUE FABRY DISEASE
SUBARACHNOID HEMORRHAGE INTRACRANIAL ANEURYSM - UNRUPTURED
NIEMANN-PICK DISEASE, TYPE B SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL; SMPD1 GLUCOSIDASE, ACID BETA; GBA
SPHINGOMYELIN PHOSPHODIESTERASE 1, ACID LYSOSOMAL; SMPD1 NIEMANN-PICK DISEASE, TYPE A
CEPH/UTAH PEDIGREE 1421 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE; BARTSOCAS-PAPAS SYNDROME; BPS
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1418
CEPH/UTAH PEDIGREE 1418 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] SNP500 PANEL
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1421
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES; RABSON-MENDENHALL SYNDROME LEPRECHAUNISM
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD; SANJAD-SAKATI SYNDROME
FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; TYPE UNKNOWN (FSHD) TURNER SYNDROME
CEPH/UTAH PEDIGREE 1418 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
SICKLE CELL ANEMIA HEMOGLOBIN--BETA LOCUS; HBB
HEMOGLOBIN--BETA LOCUS; HBB SICKLE CELL ANEMIA
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 7 SOMATIC CELL HYBRIDS CHROMOSOME 17 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
HYPOPHOSPHATASIA, INFANTILE ALKALINE PHOSPHATASE, LIVER; ALPL
GLUTARICACIDEMIA I GLUTARYL-COA DEHYDROGENASE; GCDH
GLUTARYL-COA DEHYDROGENASE; GCDH GLUTARICACIDEMIA I
EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; ERCC5 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG
APPARENTLY HEALTHY NON-FETAL TISSUE INVERTED CHROMOSOME
GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA)
BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) APPARENTLY HEALTHY NON-FETAL TISSUE GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
APPARENTLY HEALTHY NON-FETAL TISSUE INVERTED CHROMOSOME BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
APPARENTLY HEALTHY NON-FETAL TISSUE BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
INVERTED CHROMOSOME NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM
GAUCHER DISEASE, TYPE I GLUCOSIDASE, ACID BETA; GBA
CEPH/UTAH PEDIGREE 13281 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CEPH/UTAH PEDIGREE 1328 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1330
CEPH/UTAH PEDIGREE 1330 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 13281
X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 4; XRCC4 CRICETULUS
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; ERCC5
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1354
CEPH/UTAH PEDIGREE 1354 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
AMYOTROPHIC LATERAL SCLEROSIS FRONTOTEMPORAL DEMENTIA
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CYSTIC FIBROSIS; CF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR HUMAN GENE MUTATION PANEL - CYSTIC FIBROSIS (VERSION 2)
CEPH/UTAH PEDIGREE 1349 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1349 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CEPH/UTAH PEDIGREE 1349 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1377
CEPH/UTAH PEDIGREE 1377 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CEPH/UTAH PEDIGREE 1347 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1347 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1350 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CEPH/UTAH PEDIGREE 1350 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1350 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1350 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS ALS PANEL CAUCASIAN FROM THE US
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL CAUCASIAN FROM THE US ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS AMYOTROPHIC LATERAL SCLEROSIS
DNA CONTROL PANEL FOR LATE ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
CEPH/UTAH PEDIGREE 1423 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1423
MYOCLONUS EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERFF TRANSFER RNA, MITOCHONDRIAL, LYSINE; MTTK
CHROMOSOME 11 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 2 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 11 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 16 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 11 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1424
CEPH/UTAH PEDIGREE 1424 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
ALS PANEL; GREATER THAN 7 YEARS SURVIVAL AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1346
CEPH/UTAH PEDIGREE 1346 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1346 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTRACEREBRAL HEMORRHAGE SUBARACHNOID HEMORRHAGE
TRANSLOCATED CHROMOSOME DERIVATIVE CHROMOSOME
LESCH-NYHAN SYNDROME; LNS HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1; HPRT
MEVALONATE KINASE; MVK MEVALONICACIDURIA, INCLUDED
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1420 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CEPH/UTAH PEDIGREE 1420 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1420
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1420 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1362 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1362 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
CEPH/UTAH PEDIGREE 1362 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 SNP500 PANEL INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1362 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CHROMOSOME 21 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 10 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 21 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
18Q- SYNDROME APPARENTLY HEALTHY NON-FETAL TISSUE
ALS PANEL CAUCASIAN FROM THE UNITED STATES PRIMARY LATERAL SCLEROSIS
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS
ADDITIONAL HUMAN/CHINESE HAMSTER SOMATIC CELL HYBRIDS
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1344
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1344 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CEPH/UTAH PEDIGREE 1344 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS
ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS ALS PANEL CAUCASIAN FROM THE US ALS PANEL CAUCASIAN FROM THE UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS
V-KIT HARDY-ZUCKERMAN 4 FELINE SARCOMA VIRAL ONCOGENE HOMOLOG; KIT PIEBALD TRAIT; PBT
CHROMOSOME 7 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 18 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 4 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CANIS CANINE GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1
CHROMOSOME 4 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 12 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 4 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 6 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 2 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ANGELMAN SYNDROME; AS CHROMOSOME DELETION
CHROMOSOME 16 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 17 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
SNP500 PANEL CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 DRUZE POPULATION
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS ALS PANEL CAUCASIAN FROM THE UNITED STATES
ALS PANEL CAUCASIAN FROM THE UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL; GREATER THAN 7 YEARS SURVIVAL
FAMILIAL OPTIC ATROPHY; TYPE UNKNOWN; LEBER-LIKE OPTIC ATROPHY COMPLEX I, SUBUNIT ND1; MTND1
HOLOCARBOXYLASE SYNTHETASE; HLCS HOLOCARBOXYLASE SYNTHETASE DEFICIENCY
CHROMOSOME 13 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 17 SOMATIC CELL HYBRIDS CHROMOSOME 22 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
EWING SARCOMA BREAKPOINT REGION 1; EWSR1, INCLUDED; EWS, INCLUDED; ES, INCLUDED TRANSLOCATED CHROMOSOME
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
NEUROMATA, MUCOSAL, WITH ENDOCRINE TUMORS
ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE
CHROMOSOME 21 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 3 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 7 SOMATIC CELL HYBRIDS CHROMOSOME 3 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
BALTIMORE LONGITUDINAL STUDY ON AGING (BLSA) GERONTOLOGY RESEARCH CENTER (GRC) CELL CULTURE COLLECTION
ALZHEIMER DISEASE; AD NIA AGING CELL REPOSITORY DNA PANEL - LATE ONSET FAMILIAL ALZHEIMER DISEASE APOLIPOPROTEIN E; APOE
NIA AGING CELL REPOSITORY DNA PANEL - CHARACTERIZED MUTATIONS ALZHEIMER DISEASE; AD
APOLIPOPROTEIN E; APOE ALZHEIMER DISEASE; AD NIA AGING CELL REPOSITORY DNA PANEL - LATE ONSET FAMILIAL ALZHEIMER DISEASE
AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM
LAMIN A/C; LMNA HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS LAMIN A/C; LMNA
ANEUPLOID CHROMOSOME NUMBER - TRISOMY 13
LAMIN A/C; LMNA HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS LAMIN A/C; LMNA NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
SV40 VIRUS-TRANSFORMED APPARENTLY HEALTHY: NON-FETAL TISSUE
ALZHEIMER DISEASE; AD NIA AGING CELL REPOSITORY DNA PANEL - EARLY ONSET FAMILIAL ALZHEIMER DISEASE APOLIPOPROTEIN E; APOE
NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM AGED SIB PAIRS COLLECTION
NIA AGING CELL REPOSITORY DNA PANEL - LONGEVITY RESEARCH PROGRAM AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM
AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS
NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS NIA AGING CELL REPOSITORY DNA PANEL - LONGEVITY RESEARCH PROGRAM AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM
NIA AGING CELL REPOSITORY DNA PANEL - LONGEVITY RESEARCH PROGRAM NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM AGED SIB PAIRS COLLECTION
WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED RECQ PROTEIN-LIKE 2; RECQL2
NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS AGED SIB PAIRS COLLECTION
AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS
NIA AGING CELL REPOSITORY DNA PANEL - LONGEVITY RESEARCH PROGRAM NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS
NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS NIA AGING CELL REPOSITORY DNA PANEL - LONGEVITY RESEARCH PROGRAM AGED SIB PAIRS COLLECTION
ALZHEIMER DISEASE, FAMILIAL, TYPE 4 PRESENILIN 2; PSEN2
MRC-5 - SV40 VIRUS-TRANSFORMED FETAL LUNG FIBROBLAST
APOLIPOPROTEIN E; APOE ALZHEIMER DISEASE; AD NIA AGING CELL REPOSITORY DNA PANEL - EARLY ONSET FAMILIAL ALZHEIMER DISEASE
NIA AGING CELL REPOSITORY DNA PANEL - EARLY ONSET FAMILIAL ALZHEIMER DISEASE ALZHEIMER DISEASE; AD APOLIPOPROTEIN E; APOE
NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM APPARENTLY HEALTHY NON-FETAL TISSUE
NIA AGING CELL REPOSITORY DNA PANEL - CHARACTERIZED MUTATIONS PRESENILIN 2; PSEN2 ALZHEIMER DISEASE, FAMILIAL, TYPE 4
PRESENILIN 2; PSEN2 ALZHEIMER DISEASE, FAMILIAL, TYPE 4
AVM-UNRUPTURED AMYOTROPHIC LATERAL SCLEROSIS
INVERTED CHROMOSOME APPARENTLY HEALTHY NON-FETAL TISSUE
ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS PROGRESSIVE MUSCULAR ATROPHY
APPARENTLY HEALTHY NON-FETAL TISSUE NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM
NIA AGING CELL REPOSITORY DNA PANEL - LONGEVITY RESEARCH PROGRAM APPARENTLY HEALTHY NON-FETAL TISSUE NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM
WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED RECQ PROTEIN-LIKE 2; RECQL2 DERIVATIVE CHROMOSOME
RECQ PROTEIN-LIKE 2; RECQL2 WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED
AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM
NIA AGING CELL REPOSITORY DNA PANEL - LONGEVITY RESEARCH PROGRAM AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS
ALZHEIMER DISEASE; AD APOLIPOPROTEIN E; APOE NIA AGING CELL REPOSITORY DNA PANEL - LATE ONSET FAMILIAL ALZHEIMER DISEASE
NIA AGING CELL REPOSITORY DNA PANEL - EARLY ONSET FAMILIAL ALZHEIMER DISEASE APOLIPOPROTEIN E; APOE ALZHEIMER DISEASE; AD
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1458
NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY DNA PANEL - LONGEVITY RESEARCH PROGRAM
CEPH/UTAH PEDIGREE 1358 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CEPH/UTAH PEDIGREE 1358 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1447 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1447 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CEPH/UTAH PEDIGREE 1451 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1451
CEPH/UTAH PEDIGREE 1444 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CEPH/UTAH PEDIGREE 1444 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1444
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1447
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1444
CEPH/UTAH PEDIGREE 1444 SNP500 PANEL INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1454 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 SNP500 PANEL CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1454
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1454
CEPH/UTAH PEDIGREE 1454 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1456
CEPH/UTAH PEDIGREE 1456 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
NIA AGING CELL REPOSITORY DNA PANEL - AGED SIB PAIRS AGED SIB PAIRS COLLECTION NIA AGING CELL REPOSITORY'S LONGEVITY RESEARCH PROGRAM
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1454 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTRACRANIAL ANEURYSM - UNRUPTURED SUBARACHNOID HEMORRHAGE
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CEPH/UTAH PEDIGREE 1400 SNP500 PANEL
CEPH/UTAH PEDIGREE 1459 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1459
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1459 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1459 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CEPH/UTAH PEDIGREE 1459 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CEPH/UTAH PEDIGREE 1463 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1463
CEPH/UTAH PEDIGREE 1463 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1463
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1463 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD
SEX REVERSAL, AUTOSOMAL, 2; SRA2 TRANSLOCATED CHROMOSOME
CEPH/UTAH PEDIGREE 1582 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 SNP500 PANEL
WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED
NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED
WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
GLUCOSIDASE, ALPHA, ACID; GAA GLYCOGEN STORAGE DISEASE II
HPS1 GENE; HPS1 HERMANSKY-PUDLAK SYNDROME; HPS
NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES COCKAYNE SYNDROME TYPE I - 216400 OR TYPE III - 216411
CHROMOSOME 11 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 22 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 22 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 15 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME X REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 2 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME X REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 21 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
MAPLE SYRUP URINE DISEASE (MSUD), TYPE IA
RHODOPSIN; RHO RETINITIS PIGMENTOSA, RHODOPSIN-RELATED, INCLUDED RETINITIS PIGMENTOSA - 180100, 268000, OR 312600
CHROMOSOME 16 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 10 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 16 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 3 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 16 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME X REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1
TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1; TTDN1 TTDN1 GENE; TTDN1 (C7ORF11)
TTDN1 GENE; TTDN1 (C7ORF11) TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1; TTDN1
ALBUMIN; ALB DYSALBUMINEMIC HYPERTHYROXINEMIA, INCLUDED INVERTED CHROMOSOME
ZELLWEGER SYNDROME; ZS INVERTED CHROMOSOME
EHLERS-DANLOS SYNDROME: TYPE IV; ARTERIAL, ECCHYMOTIC TYPE
FELINE EHLERS-DANLOS SYNDROME: TYPE UNCLASSIFIED FELIS
HURLER SYNDROME ALPHA-L-IDURONIDASE; IDUA
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC RING CHROMOSOME
MARKER CHROMOSOME OCULAR ALBINISM WITH CHROMOSOME ABNORMALITY; POSSIBLE AUTO RECESSIVE INHERITANCE
CHROMOSOME 2 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME DELETION GILLES DE LA TOURETTE SYNDROME; GTS
RETINITIS PIGMENTOSA - 180100, 268000, OR 312600 RHODOPSIN; RHO RETINITIS PIGMENTOSA, RHODOPSIN-RELATED, INCLUDED
TRANSLOCATED CHROMOSOME NEUROBLASTOMA; NB NEUROBLASTOMA SUPPRESSOR, INCLUDED; NBS, INCLUDED
TRANSLOCATED CHROMOSOME MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; DMD
OCULAR ALBINISM WITH CHROMOSOME ABNORMALITY; POSSIBLE AUTO RECESSIVE INHERITANCE MARKER CHROMOSOME
CHROMOSOME DELETION GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS
XERODERMIC IDIOCY OF DE SANCTIS AND CACCHIONE EXCISION-REPAIR CROSS-COMPLEMENTING RODENT REPAIR DEFICIENCY, COMPLEMENTATION GROUP 6; ERCC6 COCKAYNE SYNDROME, TYPE B, INCLUDED; CSB, INCLUDED
EXCISION-REPAIR CROSS-COMPLEMENTING RODENT REPAIR DEFICIENCY, COMPLEMENTATION GROUP 6; ERCC6 COCKAYNE SYNDROME, TYPE B, INCLUDED; CSB, INCLUDED XERODERMIC IDIOCY OF DE SANCTIS AND CACCHIONE
APPARENTLY HEALTHY NON-FETAL TISSUE THANATOPHORIC DYSPLASIA; TD
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 22 SOMATIC CELL HYBRIDS
TRANSLOCATED CHROMOSOME CHROMOSOME DELETION
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS RING CHROMOSOME
ATAXIN 3; ATXN3 MACHADO-JOSEPH DISEASE; MJD
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME
MACHADO-JOSEPH DISEASE; MJD ATAXIN 3; ATXN3
APPARENTLY HEALTHY NON-FETAL TISSUE HEMOCHROMATOSIS; HFE 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR HUMAN GENE MUTATION PANEL - HEMOCHROMATOSIS APPARENTLY HEALTHY INDIVIDUALS WITH NORMAL PSYCHIATRIC EVALUATIONS
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS TRANSLOCATED CHROMOSOME
MUCOPOLYSACCHARIDOSIS TYPE IIIA N-SULFOGLUCOSAMINE SULFOHYDROLASE; SGSH
LEBER OPTIC ATROPHY COMPLEX I, SUBUNIT ND4; MTND4
ENDOGLIN; ENG TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER; HHT
MARFAN SYNDROME; MFS APPARENTLY HEALTHY NON-FETAL TISSUE
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 CEPH/UTAH PEDIGREE 1332 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 CEPH/UTAH PEDIGREE 1344
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1350 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1344 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24
CEPH/UTAH PEDIGREE 1346 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 CEPH/UTAH PEDIGREE 1349 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1349
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1420 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1420
CEPH/UTAH PEDIGREE 1424 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 CEPH/UTAH PEDIGREE 1424
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 CEPH/UTAH PEDIGREE 1423
CEPH/UTAH PEDIGREE 1423 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
ADENINE PHOSPHORIBOSYLTRANSFERASE; APRT 2,8-@DIHYDROXYADENINE UROLITHIASIS, INCLUDED
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 CEPH/UTAH PEDIGREE 1408 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1408 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 SNP500 PANEL CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1416 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1347 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] SNP500 PANEL
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 SNP500 PANEL CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CEPH/UTAH PEDIGREE 1347
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] SNP500 PANEL CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1362
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1362 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 SNP500 PANEL
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1346
BOVINE PORPHYRIA, CONGENITAL ERYTHROPOIETIC BOS
CHROMOSOME DELETION RETINOBLASTOMA, SPORADIC
CHROMOSOME 17 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 15 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS CHROMOSOME DELETION
CHROMOSOME DELETION TRANSLOCATED CHROMOSOME
CEROID LIPOFUSCINOSIS, NEURONAL 2, LATE INFANTILE TYPE; CLN2
TRANSLOCATED CHROMOSOME KALLMANN SYN; HYPOGONADOTROPIC HYPOGONADISM, ANOSMIA- 147950, 244200, 308700
ADDITIONAL HUMAN/CHINESE HAMSTER SOMATIC CELL HYBRIDS CHROMOSOME 12 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
THANATOPHORIC DYSPLASIA WITH KLEEBLATTSCHAEDEL
OSTEOCHONDRODYSPLASIA WITH RHIZOMELIA & OTHER FEATURES - UNKNOWN INHERITANCE
CHROMOSOME 17 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 10 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 15 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
TRANSLOCATED CHROMOSOME APPARENTLY HEALTHY NON-FETAL TISSUE
MYOTUBULARIN; MTM1 MYOTUBULAR MYOPATHY 1; MTM1
FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3 INVERTED CHROMOSOME THANATOPHORIC DYSPLASIA; TD
CHROMOSOME INSERTION RETINOBLASTOMA, SPORADIC
MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY FETAL TISSUE
INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE II)
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE II) INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA
INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA (PLATE I) INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I)
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA
KARTAGENER SYNDROME STARGARDT DISEASE 1; STGD1
INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA (PLATE II)
HUMAN ERYTHROLEUKEMIC CELL LINES CHRONIC MYELOGENOUS LEUKEMIA
INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA (PLATE I) INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA (PLATE I)
INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA (PLATE II) INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA
INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - YORUBA IN IBADAN, NIGERIA (PLATE I)
INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I)
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
INTERNATIONAL HAPMAP PROJECT - HAN CHINESE IN BEIJING, CHINA CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I)
HEXOSAMINIDASE A; HEXA CANAVAN DISEASE ASPARTOACYLASE; ASPA
METACHROMATIC LEUKODYSTROPHY, LATE-INFANTILE
METHYLMALONICACIDURIA DUE TO METHYLMALONIC COA MUTASE DEFICIENCY
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A
CHARCOT-MARIE-TOOTH DISEASE, TYPE 1A; CMT1A PERIPHERAL MYELIN PROTEIN 22; PMP22
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; DMD APPARENTLY HEALTHY NON-FETAL TISSUE
APPARENTLY HEALTHY NON-FETAL TISSUE MAPLE SYRUP URINE DISEASE (MSUD), TYPE IA
LPC-1021
only one copy of the SMN2 gene; homozygous for deletion of exons 7 and 8 of the SMN1 gene
GM-232
Cell provider: Coriell Cell Repository; Cell provider catalog number: Coriell Cell Repository
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC XXXY AND XXXXY SYNDROME
OROTICACIDURIA TYPES I OR II - 258900 OR 258920
DICENTRIC CHROMOSOME ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC
METHYLMALONICACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN--CBL A
TRISOMY 21 ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC
MACROCEPHALY, MULTIPLE LIPOMAS, AND HEMANGIOMATA
BETA GLOBIN REGION RESTRICTION POLYMORPHISMS
BETA GLOBIN REGION RESTRICTION POLYMORPHISMS APPARENTLY HEALTHY NON-FETAL TISSUE
APPARENTLY HEALTHY NON-FETAL TISSUE BETA GLOBIN REGION RESTRICTION POLYMORPHISMS
PSEUDOXANTHOMA ELASTICUM, AUTOSOMAL RECESSIVE; PXE ATP-BINDING CASSETTE, SUBFAMILY C, MEMBER 6; ABCC6
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC XXXXX SYNDROME
HARTNUP DISORDER SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER), MEMBER 19; SLC6A19
INTERNATIONAL HAPMAP PROJECT - LUHYA FROM WEBUYE, KENYA INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 LUHYA FROM WEBUYE, KENYA
INTERNATIONAL HAPMAP PROJECT - LUHYA FROM WEBUYE, KENYA
CALCINOSIS, TUMORAL, WITH HYPERPHOSPHATEMIA
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I)
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE II) INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I)
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE II)
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I)
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
GLUCOSIDASE, ACID BETA; GBA TAY-SACHS DISEASE; TSD HEXOSAMINIDASE A; HEXA
INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 LUHYA FROM WEBUYE, KENYA INTERNATIONAL HAPMAP PROJECT - LUHYA FROM WEBUYE, KENYA
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1 TRANSLOCATED CHROMOSOME
MUCOLIPIDOSIS IIIA N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE, ALPHA/BETA SUBUNITS; GNPTAB
APPARENTLY HEALTHY NON-FETAL TISSUE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
MUCOPOLYSACCHARIDOSIS TYPE IIIB N-ACETYLGLUCOSAMINIDASE, ALPHA-; NAGLU
TRANSLOCATED CHROMOSOME XXXY AND XXXXY SYNDROME
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP
APPARENTLY HEALTHY AMNIOTIC FLUID CELL CULTURE
HUMAN GENE MUTATION PANEL - CYSTIC FIBROSIS (VERSION 2) CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR CYSTIC FIBROSIS; CF
GLYCOGEN STORAGE DISEASE VIII (IX, INCLUDED)
ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF
ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM PEROXISOME BIOGENESIS FACTOR 26; PEX26
APPARENTLY HEALTHY NON-FETAL TISSUE GALACTOSEMIA
TRANSLOCATED CHROMOSOME GALACTOSEMIA GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; GALT
INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO, JAPAN INTERNATIONAL HAPMAP PROJECT - JAPANESE IN TOKYO AND HAN CHINESE IN BEIJING (PLATE I) CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
HYPOCHONDROPLASIA; HCH FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3
CYSTIC FIBROSIS; CF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR HUMAN GENE MUTATION PANEL - CYSTIC FIBROSIS (VERSION 2)
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR CYSTIC FIBROSIS; CF HUMAN GENE MUTATION PANEL - CYSTIC FIBROSIS (VERSION 2)
CYSTINOSIN; CTNS CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE
CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE CYSTINOSIN; CTNS
LEUKEMIA, SUB-ACUTE TRANSLOCATED CHROMOSOME
PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES LEUCINE-RICH REPEAT KINASE2; LRRK2 PARKINSON'S DISEASE
ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL SPOUSAL CONTROL
PARKINSON'S DISEASE RESTLESS LEG SYNDROME YOUNG ONSET PARKINSON'S PANEL; AFFECTED INDIVIDUALS
DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL SPOUSAL CONTROL
NEUROFIBROMATOSIS, TYPE I; NF1 APPARENTLY HEALTHY NON-FETAL TISSUE
AT RISK ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
ESSENTIAL TREMOR-MOVEMENT DISORDER ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION
EHLERS-DANLOS SYNDROME, TYPE III GLYCOGEN STORAGE DISEASE VIII (IX, INCLUDED)
EHLERS-DANLOS SYNDROME, TYPE III APPARENTLY HEALTHY NON-FETAL TISSUE GLYCOGEN STORAGE DISEASE VIII (IX, INCLUDED)
APPARENTLY HEALTHY NON-FETAL TISSUE EHLERS-DANLOS SYNDROME, TYPE III GLYCOGEN STORAGE DISEASE VIII (IX, INCLUDED)
INTERNATIONAL HAPMAP PROJECT - COMMUNITIES OF MEXICAN ORIGIN IN LOS ANGELES, CA INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 FROM COMMUNITIES OF MEXICAN ORIGIN IN LOS ANGELES, CA
INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 FROM COMMUNITIES OF MEXICAN ORIGIN IN LOS ANGELES, CA INTERNATIONAL HAPMAP PROJECT - COMMUNITIES OF MEXICAN ORIGIN IN LOS ANGELES, CA
GLYCOGEN STORAGE DISEASE VIII (IX, INCLUDED) EHLERS-DANLOS SYNDROME, TYPE III
INTERNATIONAL HAPMAP PROJECT - AFRICAN ANCESTRY FROM THE SW USA INTERNATIONAL HAPMAP PROJECT - PLATE OF AFRICAN ANCESTRY FROM THE SW USA
INTERNATIONAL HAPMAP PROJECT - PLATE OF AFRICAN ANCESTRY FROM THE SW USA INTERNATIONAL HAPMAP PROJECT - AFRICAN ANCESTRY FROM THE SW USA
DNA POLYMORPHISM DISCOVERY RESOURCE COLLECTION CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9
PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S PANEL; AFFECTED INDIVIDUALS RESTLESS LEG SYNDROME REM BEHAVIOR DISORDER
PROGRESSIVE SUPRANUCLEAR PALSY PARKINSON'S DISEASE
SCHIZOPHRENIA ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
DEMENTIA WITH LEWY BODIES PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES PARKINSON'S DISEASE
ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL SPASMODIC TORTICOLLIS-CERVICAL DYSTONIA
YOUNG ONSET PARKINSON'S PANEL; AFFECTED INDIVIDUALS PARKINSON'S DISEASE DEMENTIA WITH LEWY BODIES
YOUNG ONSET PARKINSON'S DISEASE; AFFECTED INDIVIDUALS RESTLESS LEG SYNDROME DEMENTIA WITH LEWY BODIES PARKINSON'S DISEASE
PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL POPULATION/CONVENIENCE CONTROL
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL SPOUSAL CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL
CHROMOSOME 10 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 7 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 7 SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 6 SOMATIC CELL HYBRIDS
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NDPT031- AFRICAN AMERICAN CONTROL PANEL POPULATION/CONVENIENCE CONTROL
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 3 SOMATIC CELL HYBRIDS CHROMOSOME 7 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 6 SOMATIC CELL HYBRIDS CHROMOSOME 2 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 7 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 6 SOMATIC CELL HYBRIDS
YOUNG ONSET PARKINSON'S PANEL; AFFECTED INDIVIDUALS ESSENTIAL TREMOR-MOVEMENT DISORDER PARKINSON'S DISEASE
CZECHOSLOVAKIAN POPULATION HUMAN VARIATION PANEL - CZECHOSLOVAKIAN
HUMAN VARIATION PANEL - CZECHOSLOVAKIAN CZECHOSLOVAKIAN POPULATION
TRICHOTHIODYSTROPHY; TTD ICHTHYOSIFORM ERYTHRODERMA WITH HAIR ABNORMALITY AND MENTAL AND GROWTH RETARDATION, INCLUDED EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2
EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 2; ERCC2 TRICHOTHIODYSTROPHY; TTD ICHTHYOSIFORM ERYTHRODERMA WITH HAIR ABNORMALITY AND MENTAL AND GROWTH RETARDATION, INCLUDED
ICELANDIC POPULATION HUMAN VARIATION PANEL - ICELAND
HUMAN VARIATION PANEL - ICELAND ICELANDIC POPULATION
CHROMOSOME 10 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 3 SOMATIC CELL HYBRIDS
SYNUCLEIN, ALPHA; SNCA PARKINSON DISEASE,FAMILIAL, TYPE 1; PARK1
NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 POPULATION/CONVENIENCE CONTROL
GLUCOSIDASE, ACID BETA; GBA GAUCHER DISEASE, TYPE III
HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, ALPHA SUBUNIT; HADHA LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY
HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT; HADHB TRIFUNCTIONAL PROTEIN DEFICIENCY
TRANSLOCATED CHROMOSOME NON-HODGKINS LYMPHOMA
PHOSPHATE-REGULATING ENDOPEPTIDASE HOMOLOG; X-LINKED; PHEX HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT
HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2 DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49
DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49 MARVEL DOMAIN-CONTAINING PROTEIN 2; MARVELD2
DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28 TRIO- AND F-ACTIN-BINDING PROTEIN; TRIOBP
TRIO- AND F-ACTIN-BINDING PROTEIN; TRIOBP DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28
SHORT STATURE HOMEOBOX; SHOX LANGER MESOMELIC DYSPLASIA
LANGER MESOMELIC DYSPLASIA SHORT STATURE HOMEOBOX; SHOX
ISODICENTRIC CHROMOSOME AUTISTIC DISORDER
AUTISTIC DISORDER ISODICENTRIC CHROMOSOME
PARKIN; PARK2 PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ PARKINSON'S DISEASE
ADDITIONAL DELETION/DERIVATIVE Y CHROMOSOME SOMATIC CELL HYBRIDS CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D GLYCYL-TRNA SYNTHETASE; GARS
NEUROFIBROMATOSIS, TYPE II; NF2 NEUROFIBROMIN 2; NF2
DERIVATIVE CHROMOSOME DUPLICATED CHROMOSOME
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC DUPLICATED CHROMOSOME DERIVATIVE CHROMOSOME
CHROMOSOME DELETION DUPLICATED CHROMOSOME DERIVATIVE CHROMOSOME
DUPLICATED CHROMOSOME ENCEPHALOPATHY OF CHILDHOOD (LENNOX-GASTAUT SYNDROME)
EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 2; EIF2B2 LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM (OVARIOLEUKODYSTROPHY, INCLUDED)
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig DOLICHYL-P-MANNOSE:MAN-7-GlcNAc-2-PP-DOLICHYL-ALPHA-6-MANNOSYLTRANSFERASE
CORNELIA DE LANGE SYNDROME 1; CDLS1 NIPPED-B-LIKE; NIPBL
SOTOS SYNDROME NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX DOMAIN PROTEIN 1; NSD1
PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S DNA PANEL; AFFECTED INDIVIDUALS ESSENTIAL TREMOR-MOVEMENT DISORDER
POPULATION/CONVENIENCE CONTROL CONTROL PANEL FOR YOUNG ONSET PARKINSON'S; UNAFFECTED INDIVIDUALS RESTLESS LEG SYNDROME
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES
FAMILIAL MULTIPLE CONGENITAL ANOMALIES - UNKNOWN SYNDROME OR INHERITANCE
MUSCULAR DYSTROPHY, PROGRESSIVE WITH CNS INVOLVEMENT & RECESSIVE INHERITANCE
INVERTED CHROMOSOME CRYPTOPHTHALMOS WITH OTHER MALFORMATIONS
CRYPTOPHTHALMOS WITH OTHER MALFORMATIONS
DIGEORGE SYNDROME; DGS CHROMOSOME DELETION
CONGENITAL HEART DISEASE; TRUNCUS ARTERIOSUS
CONGENITAL HEART DISEASE; TRANSPOSITION OF GREAT VESSELS
AMYOTROPHIC LATERAL SCLEROSIS ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
TURNER SYNDROME INVERTED CHROMOSOME ISODICENTRIC CHROMOSOME
EXCISION-REPAIR CROSS-COMPLEMENTING RODENT REPAIR DEFICIENCY, COMPLEMENTATION GROUP 6; ERCC6 COCKAYNE SYNDROME, TYPE B, INCLUDED; CSB, INCLUDED
ALPHA-L-IDURONIDASE; IDUA HURLER SYNDROME
BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, ALPHA POLYPEPTIDE; BCKDHA MAPLE SYRUP URINE DISEASE (MSUD), TYPE IA
INTERNATIONAL HAPMAP PROJECT - TOSCANI IN ITALIA (TUSCANS IN ITALY) INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 TOSCANI IN ITALIA (TUSCANS IN ITALY)
ARH GENE; ARH HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH
INTERNATIONAL HAPMAP PROJECT - PANEL OF 90 TOSCANI IN ITALIA (TUSCANS IN ITALY) INTERNATIONAL HAPMAP PROJECT - TOSCANI IN ITALIA (TUSCANS IN ITALY)
INTERNATIONAL HAPMAP PROJECT - TOSCANI IN ITALIA (TUSCANS IN ITALY)
MAPLE SYRUP URINE DISEASE (MSUD), TYPE II DIHYDROLIPOAMIDE BRANCHED-CHAIN TRANSACYLASE; DBT
RETINOIC ACID-INDUCED GENE 1; RAI1 SMITH-MAGENIS SYNDROME; SMS
5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR FACTOR V DEFICIENCY
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS
SMITH-MAGENIS SYNDROME; SMS RETINOIC ACID-INDUCED GENE 1; RAI1
5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
CHROMOSOME DELETION SMITH-MAGENIS SYNDROME; SMS
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY HOLOCARBOXYLASE SYNTHETASE; HLCS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS ALS PANEL CAUCASIAN FROM THE US
APPARENTLY HEALTHY NON-FETAL TISSUE EPIDERMOLYSIS BULLOSA: DYSTROPHIC, JUNCTIONAL, OR SIMPLEX TYPES
ALS PANEL; GREATER THAN 7 YEARS SURVIVAL ALS PANEL CAUCASIAN FROM THE UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS ALS PANEL CAUCASIAN FROM THE UNITED STATES
ALS PANEL CAUCASIAN FROM THE US ALS PANEL CAUCASIAN FROM THE UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS ALS PANEL CAUCASIAN FROM THE UNITED STATES
CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT
ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
SH2 DOMAIN PROTEIN 1A; SH2D1A LYMPHOPROLIFERATIVE SYNDROME, X-LINKED
TRANSLOCATED CHROMOSOME ANIRIDIA: TYPES 1 OR 2 - 106200 OR 106210
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1
ANIRIDIA: TYPES 1 OR 2 - 106200 OR 106210
ANIRIDIA: TYPES 1 OR 2 - 106200 OR 106210 TRANSLOCATED CHROMOSOME
CORNELIA DE LANGE SYNDROME 1; CDLS1 TRANSLOCATED CHROMOSOME
SPECIFIC ANTIBODY DEFICIENCY WITH NORMAL IMMUNOGLOBULINS AND PEG-TEETH
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER; HHT ENDOGLIN; ENG
WISKOTT-ALDRICH SYNDROME; WAS WAS GENE; WAS
TRANSLOCATED CHROMOSOME CORNELIA DE LANGE SYNDROME 1; CDLS1
IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1 CD40 LIGAND; CD40LG
IMR-90 - NORMAL HUMAN FETAL LUNG FIBROBLAST
TRANSLOCATED CHROMOSOME OROFACIAL CLEFT 1; OFC1
TURNER SYNDROME ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC
CHROMOSOME DELETION ANGELMAN SYNDROME; AS
ESTABLISHMENT OF COHESION 1, S. CERVISIAE, HOMOLOG OF, 2; ESCO2 SC PHOCOMELIA SYNDROME
ANGELMAN SYNDROME; AS COMPLETE PATERNAL UNIPARENTAL DISOMY
PRADER-WILLI SYNDROME; PWS COMPLETE MATERNAL UNIPARENTAL DISOMY
HEMOGLOBIN--DELTA LOCUS; HBD HEMOGLOBIN--BETA LOCUS; HBB
PORPHYRIA, ACUTE INTERMITTENT APPARENTLY HEALTHY NON-FETAL TISSUE
APPARENTLY HEALTHY NON-FETAL TISSUE MUCOPOLYSACCHARIDOSIS TYPE VI
CEROID LIPOFUSCINOSIS, NEURONAL 3, JUVENILE; CLN3 CLN3 GENE; CLN3
METHIONINE ADENOSYLTRANSFERASE DEFICIENCY
ALPERS DIFFUSE DEGENERATION OF CEREBRAL GRAY MATTER WITH HEPATIC CIRRHOSIS POLYMERASE, DNA, GAMMA; POLG
POLYMERASE, DNA, GAMMA; POLG ALPERS DIFFUSE DEGENERATION OF CEREBRAL GRAY MATTER WITH HEPATIC CIRRHOSIS
TRANSLOCATED CHROMOSOME ACUTE LYMPHOCYTIC LEUKEMIA
TRANSLOCATED CHROMOSOME DERIVATIVE CHROMOSOME ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC
CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE
METHYLMALONICACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN--CBL B
GAUCHER DISEASE, TYPE III GLUCOSIDASE, ACID BETA; GBA
ADDITIONAL DELETION/DERIVATIVE Y CHROMOSOME SOMATIC CELL HYBRIDS CHROMOSOME 21 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; DMD TRANSLOCATED CHROMOSOME
ANIRIDIA, GENITOURINARY ABNORMALITIES, & VASCULITIS
TRANSLOCATED CHROMOSOME RETINOBLASTOMA, SPORADIC
LEUCINE-RICH REPEAT KINASE2; LRRK2 PARKINSON'S DISEASE
MULTIPLE SYSTEM ATROPHY PARKINSON'S DISEASE PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 14 SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 11 SOMATIC CELL HYBRIDS
PARKINSON'S DISEASE PAROXYSMAL EXERCISE INDUCED DYSTONIA
TRANSLOCATED CHROMOSOME HOLOPROSENCEPHALY
DEMENTIA WITH LEWY BODIES PARKINSON'S DISEASE
ULCERATIVE COLITIS, SUSCEPTIBILITY TO SPECIFIC ANTIBODY DEFICIENCY WITH NORMAL IMMUNOGLOBULINS
REM BEHAVIOR DISORDER PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S DISEASE; AFFECTED INDIVIDUALS
RETINOBLASTOMA; RB1 OSTEOSARCOMA, RETINOBLASTOMA-RELATED, INCLUDED MONOZYGOTIC TWIN PAIRS
MONOZYGOTIC TWIN PAIRS RETINOBLASTOMA; RB1 OSTEOSARCOMA, RETINOBLASTOMA-RELATED, INCLUDED
N-SULFOGLUCOSAMINE SULFOHYDROLASE; SGSH MUCOPOLYSACCHARIDOSIS TYPE IIIA
BIOCHEMICAL MARKERS GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD BIOCHEMICAL MARKERS
GALACTOSEMIA GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; GALT MONOZYGOTIC TWIN PAIRS
DIABETES MELLITUS: MATURITY ONSET DIABETES - 222100 OR 125850
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 16 SOMATIC CELL HYBRIDS CHROMOSOME 11 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
FAMILIAL MEDITERRANEAN FEVER GENE; MEFV MEDITERRANEAN FEVER, FAMILIAL; MEFV
PARKINSON DISEASE,FAMILIAL, TYPE 1; PARK1 SYNUCLEIN, ALPHA; SNCA
RESTLESS LEG SYNDROME PARKINSON'S DISEASE PARKINSONS PANEL: CAUCASIAN FROM THE UNITED STATES
YOUNG ONSET PARKINSON'S DISEASE; AFFECTED INDIVIDUALS RESTLESS LEG SYNDROME PARKINSON'S DISEASE
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 6 SOMATIC CELL HYBRIDS CHROMOSOME 16 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
THROMBOCYTOPENIA ACUTE LYMPHOCYTIC LEUKEMIA
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 16 SOMATIC CELL HYBRIDS CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 16 SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 6 SOMATIC CELL HYBRIDS
CHROMOSOME 12 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 16 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3 HIRSCHSPRUNG DISEASE
APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
TAY-SACHS DISEASE; TSD ASPARTOACYLASE; ASPA HEXOSAMINIDASE A; HEXA
ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL ESSENTIAL TREMOR-MOVEMENT DISORDER
CHROMOSOME DELETION TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2 (LANGER-GIEDION SYNDROME; LGS)
PERIODIC LIMB MOVEMENT DISORDER ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL RESTLESS LEG SYNDROME
FOCAL DYSTONIA ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
CHROMOSOME INSERTION BASAL CELL NEVUS SYNDROME; BCNS
RESTLESS LEG SYNDROME PERIODIC LIMB MOVEMENT DISORDER ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL
PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S PANEL; AFFECTED INDIVIDUALS SPASMODIC TORTICOLLIS-CERVICAL DYSTONIA
INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP ASPARTOACYLASE; ASPA NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
PROGRESSIVE SUPRANUCLEAR PALSY PARKINSON'S DISEASE LATE ONSET PARKINSON'S DNA PANEL, AFFECTED INDIVIDUALS
PARKINSON DISEASE,FAMILIAL, TYPE 1; PARK1 DEMENTIA WITH LEWY BODIES SYNUCLEIN, ALPHA; SNCA PARKINSON'S DISEASE
ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC XXXX SYNDROME
DNA DAMAGE-BINDING PROTEIN 2; DDB2 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E
APPARENTLY HEALTHY NON-FETAL TISSUE HYPERCHOLESTEROLEMIA, FAMILIAL; FHC
POPULATION/CONVENIENCE CONTROL POPULATION/CONVENIENCE CONTROL
HEMOGLOBIN F, HEREDITARY PERSISTENCE OF, PANCELLULAR
PARKINSON'S DISEASE SYNUCLEIN, ALPHA; SNCA PARKINSON DISEASE,FAMILIAL, TYPE 1; PARK1
HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT LOW DENSITY LIPOPROTEIN RECEPTOR; LDLR
LOW DENSITY LIPOPROTEIN RECEPTOR; LDLR HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT
ALPHA-L-IDURONIDASE; IDUA SCHEIE SYNDROME
MAPLE SYRUP URINE DISEASE (MSUD), TYPE IA BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, ALPHA POLYPEPTIDE; BCKDHA
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET CARNITINE PALMITOYLTRANSFERASE II; CPT2
DYGGVE-MELCHIOR-CLAUSEN DISEASE DYMECLIN; DYM
BULBAR PALSY, PROGRESSIVE, WITH SENSORINEURAL DEAFNESS
APPARENTLY HEALTHY NON-FETAL TISSUE AZOOSPERMIA FACTOR C
AZOOSPERMIA FACTOR C APPARENTLY HEALTHY NON-FETAL TISSUE
SMITH-MAGENIS SYNDROME; SMS CHROMOSOME DELETION
PSEUDOTRISOMY 13 SYNDROME (HOLOPROSENCEPHALY-POLYDACTYLY SYNDROME)
SH3 DOMAIN-BINDING PROTEIN 2; SH3BP2 CHERUBISM
ATAXIA-TELANGIECTASIA AND RAD3-RELATED; ATR SECKEL SYNDROME
NPC2 GENE; NPC2 NIEMANN-PICK DISEASE, TYPE C2
APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS
MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE NON-OBESE CONTROLS
CHROMOSOME 21 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 6 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 22 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 21 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
NON-OBESE CONTROLS MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE
NON-OBESE CONTROLS APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS
APPARENTLY HEALTHY NON-FETAL TISSUE MONOZYGOTIC TWIN PAIRS NON-OBESE CONTROLS
MONOZYGOTIC TWIN PAIRS APPARENTLY HEALTHY NON-FETAL TISSUE
NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: YOUNG AND AGED FOR EACH SPECIES REPRESENTED MACACA ORDER: PRIMATES
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
PRESENILIN 1; PSEN1 ALZHEIMER DISEASE, FAMILIAL, TYPE 3
ALZHEIMER DISEASE; AD APOLIPOPROTEIN E; APOE NIA AGING CELL REPOSITORY DNA PANEL - EARLY ONSET FAMILIAL ALZHEIMER DISEASE
GALACTOSEMIA GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; GALT TRANSLOCATED CHROMOSOME
CYSTIC FIBROSIS; CF HUMAN GENE MUTATION PANEL - CYSTIC FIBROSIS (VERSION 2) CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
ATAXIA-TELANGIECTASIA; AT TRANSLOCATED CHROMOSOME ATAXIA-TELANGIECTASIA MUTATED GENE; ATM
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E
GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I MUCOPOLYSACCHARIDOSIS TYPE IVB
CHROMOSOME 18 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME X REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1; ENPP1
HEMOCHROMATOSIS; HFE FACTOR V DEFICIENCY
BREAST CANCER, TYPE 1; BRCA1 BREAST CANCER INFORMATION CORE (BIC) BRCA1/BRCA2 MUTATION PANEL DNA SAMPLES
BREAST CANCER INFORMATION CORE (BIC) BRCA1/BRCA2 MUTATION PANEL DNA SAMPLES BREAST CANCER 2, EARLY-ONSET; BRCA2
FACTOR V DEFICIENCY HEMOCHROMATOSIS; HFE HUMAN GENE MUTATION PANEL - HEMOCHROMATOSIS
HUMAN GENE MUTATION PANEL - HEMOCHROMATOSIS HEMOCHROMATOSIS; HFE
BREAST CANCER 2, EARLY-ONSET; BRCA2 BREAST CANCER INFORMATION CORE (BIC) BRCA1/BRCA2 MUTATION PANEL DNA SAMPLES
ALS PANEL CAUCASIAN FROM THE US ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS
ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS
ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
APPARENTLY HEALTHY NON-FETAL TISSUE ANEUPLOID CHROMOSOME NUMBER - NON-TRISOMIC
ALS PANEL CAUCASIAN FROM THE US ALS PANEL; GREATER THAN 7 YEARS SURVIVAL AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
POLYDACTYLY WITH NEONATAL CHONDRODYSTROPHY, TYPE II, MAJEWSKI TYPE
CHROMOSOME 2 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 11 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 12 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ECTODERMAL DYSPLASIA, TYPE 4; ED4 POLIOVIRUS RECEPTOR-LIKE 1; PVRL1
CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 17 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
CHROMOSOME 1 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE X CHROMOSOME SOMATIC CELL HYBRIDS
ALS PANEL CAUCASIAN FROM THE US ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
PROTEASE INHIBITOR 1; PI HEMOCHROMATOSIS; HFE
HUMAN GENE MUTATION PANEL - DISORDERS OF THROMBOSIS FACTOR V DEFICIENCY
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; GREATER THAN 7 YEARS SURVIVAL
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS
MENKES SYNDROME ATPASE, CU(2+)-TRANSPORTING, ALPHA POLYPEPTIDE; ATP7A
TOCOPHEROL TRANSFER PROTEIN, ALPHA; TTPA VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED
ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS ALS PANEL CAUCASIAN FROM THE US
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS ALS PANEL CAUCASIAN FROM THE US
MUCOPOLYSACCHARIDOSIS TYPE IIIA TRANSLOCATED CHROMOSOME N-SULFOGLUCOSAMINE SULFOHYDROLASE; SGSH
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL; GREATER THAN 7 YEARS SURVIVAL
NDPT031- AFRICAN AMERICAN CONTROL PANEL SPOUSAL CONTROL
ANEUPLOID CHROMOSOME NUMBER - TRISOMY ANEUPLOID CHROMOSOME NUMBER - TRISOMY 8
TRANSLOCATED CHROMOSOME XX MALE SYNDROME DERIVATIVE CHROMOSOME
ATPASE, CU(2+)-TRANSPORTING, ALPHA POLYPEPTIDE; ATP7A MENKES SYNDROME
BREAST CANCER INFORMATION CORE (BIC) BRCA1/BRCA2 MUTATION PANEL DNA SAMPLES BREAST CANCER, TYPE 1; BRCA1
DRPLA GENE; DRPLA DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA DRPLA GENE; DRPLA
ATAYAL POPULATION HUMAN VARIATION PANEL - ABORIGINAL TRIBE FROM TAIWAN (ATAYAL)
HUMAN GENE MUTATION PANEL - HEMOCHROMATOSIS CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR HUMAN GENE MUTATION PANEL - CYSTIC FIBROSIS (VERSION 2) CYSTIC FIBROSIS; CF HEMOCHROMATOSIS; HFE 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS
ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL CAUCASIAN FROM THE UNITED STATES
ALS PANEL CAUCASIAN FROM THE UNITED STATES ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; GREATER THAN 7 YEARS SURVIVAL
ADYGEI POPULATION HUMAN VARIATION PANEL - RUSSIAN (KRASNODAR IN SOUTHEAST EUROPEAN RUSSIA)
ADYGEI POPULATION SNP500 PANEL HUMAN VARIATION PANEL - RUSSIAN (KRASNODAR IN SOUTHEAST EUROPEAN RUSSIA)
SNP500 PANEL ADYGEI POPULATION HUMAN VARIATION PANEL - RUSSIAN (KRASNODAR IN SOUTHEAST EUROPEAN RUSSIA)
AMI POPULATION HUMAN VARIATION PANEL - ABORIGINAL TRIBE FROM TAIWAN (AMI)
SNP500 PANEL AMI POPULATION HUMAN VARIATION PANEL - ABORIGINAL TRIBE FROM TAIWAN (AMI)
AMI POPULATION SNP500 PANEL HUMAN VARIATION PANEL - ABORIGINAL TRIBE FROM TAIWAN (AMI)
AMI POPULATION HUMAN VARIATION PANEL - ABORIGINAL TRIBE FROM TAIWAN (AMI) SNP500 PANEL
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL POPULATION/CONVENIENCE CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008
APPARENTLY HEALTHY AMNIOTIC FLUID CELL CULTURE CHROMOSOME DELETION
COFFIN-LOWRY SYNDROME; CLS INVERTED CHROMOSOME
TAY-SACHS DISEASE; TSD HEXOSAMINIDASE A; HEXA ASPARTOACYLASE; ASPA
X-RAY REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 9; XRCC9 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG
ASPARTOACYLASE; ASPA INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE-COMPLEX ASSOCIATED PROTEIN; IKBKAP NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
RUSSIAN POPULATION HUMAN VARIATION PANEL - RUSSIAN (ZVERSKY DISTRICT NORTHEAST OF MOSCOW)
GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II, OR JUVENILE TYPE
MUCOLIPIN 1; MCOLN1 GLUCOSIDASE, ACID BETA; GBA MUCOLIPIDOSIS IV
OXALOSIS TYPES I OR II, GLYCOLIC OR GLYCERIC ACIDURIA - 259900 OR 260000
MACACA ORDER: PRIMATES NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: YOUNG AND AGED FOR EACH SPECIES REPRESENTED
NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL UPDATE OF PLATE NDPT008 NDPT079 NEUROLOGICALLY NORMAL CAUCASION CONTROL SPOUSAL CONTROL
HUMAN VARIATION PANEL - RUSSIAN (ZVERSKY DISTRICT NORTHEAST OF MOSCOW) RUSSIAN POPULATION
CHROMOSOME 8 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 21 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
NEMALINE MYOPATHY, AMISH TYPE; ANM TROPONIN T1, SKELETAL, SLOW; TNNT1
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1; PFIC1 NEMALINE MYOPATHY 2, AUTOSOMAL RECESSIVE; NEM2
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 13 SOMATIC CELL HYBRIDS
PARKINSONISM, OTHER AMYOTROPHIC LATERAL SCLEROSIS
CORNELIA DE LANGE SYNDROME 1; CDLS1 MONOZYGOTIC TWIN PAIRS
CLEFT LIP WITH OR WITHOUT CLEFT PALATE, POSSIBLY SYNDROMIC
LOW-GGT PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (NOT FURTHER CHARACTERIZED)
NIA AGING CELL REPOSITORY DNA PANEL - LATE ONSET FAMILIAL ALZHEIMER DISEASE APOLIPOPROTEIN E; APOE ALZHEIMER DISEASE; AD
KALLMANN SYN; HYPOGONADOTROPIC HYPOGONADISM, ANOSMIA- 147950, 244200, 308700
NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: PHYLOGENETIC ORDER: PRIMATES MACACA
CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 9 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 4 SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 5 SOMATIC CELL HYBRIDS
CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 18 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 7 SOMATIC CELL HYBRIDS CHROMOSOME 18 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 5 SOMATIC CELL HYBRIDS ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 4 SOMATIC CELL HYBRIDS
ADDITIONAL DELETION/DERIVATIVE CHROMOSOME 4 SOMATIC CELL HYBRIDS
CHROMOSOME 10 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS CHROMOSOME 5 REGIONAL MAPPING PANEL SOMATIC CELL HYBRIDS
PRIMARY LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS
ALS PANEL; UPPER-LIMB ONSET; PROBABLE AND POSSIBLE ALS ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL; LOWER-LIMB ONSET; DEFINITE AND PROBABLE ALS ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES RECQ PROTEIN-LIKE 2; RECQL2 NIA AGING CELL REPOSITORY DNA PANEL - CHARACTERIZED MUTATIONS WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED
WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED LAMIN A/C; LMNA NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
RECQ PROTEIN-LIKE 4; RECQL4 ROTHMUND-THOMSON SYNDROME; RTS NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS
AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; BULBAR ONSET; ALL DEFINITE ALS ALS PANEL CAUCASIAN FROM THE US
ROTHMUND-THOMSON SYNDROME; RTS NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
MRC-5 - NORMAL HUMAN FETAL LUNG FIBROBLAST
NIA AGING CELL REPOSITORY DNA PANEL - CHARACTERIZED MUTATIONS RECQ PROTEIN-LIKE 3; RECQL3 BLOOM SYNDROME; BLM
SAGUINUS NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: PHYLOGENETIC ORDER: PRIMATES
LAGOTHRIX ORDER: PRIMATES NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: PHYLOGENETIC
NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: YOUNG AND AGED FOR EACH SPECIES REPRESENTED ORDER: PRIMATES ERYTHROCEBUS
TIG-1 - NORMAL HUMAN FETAL LUNG FIBROBLAST
SV40 VIRUS-TRANSFORMED APPARENTLY HEALTHY: FETAL TISSUE
ORDER: PRIMATES NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: YOUNG AND AGED FOR EACH SPECIES REPRESENTED ERYTHROCEBUS
ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS ALS PANEL; UPPER-LIMB ONSET; DEFINITE AND PROBABLE ALS
ALZHEIMER DISEASE, FAMILIAL, TYPE 3 PRESENILIN 1; PSEN1
NIA AGING CELL REPOSITORY DNA PANEL - CHARACTERIZED MUTATIONS WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
WI-38 - NORMAL HUMAN FETAL LUNG FIBROBLAST
NIA AGING CELL REPOSITORY DNA PANEL - CHARACTERIZED MUTATIONS ALZHEIMER DISEASE, FAMILIAL, TYPE 3 PRESENILIN 1; PSEN1
WI-38 - SV40 VIRUS-TRANSFORMED FETAL LUNG FIBROBLAST
MACACA NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: YOUNG AND AGED FOR EACH SPECIES REPRESENTED ORDER: PRIMATES
NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: PHYLOGENETIC MACACA ORDER: PRIMATES
EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8 NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES COCKAYNE SYNDROME, TYPE I; CKN1
LAMIN A/C; LMNA MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
PRIMATE PANEL LEMUR NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: YOUNG AND AGED FOR EACH SPECIES REPRESENTED NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: PHYLOGENETIC ORDER: PRIMATES
NIA AGING CELL REPOSITORY DNA PANEL - PRIMATE PANEL: YOUNG AND AGED FOR EACH SPECIES REPRESENTED LEMUR ORDER: PRIMATES
UNRELATED CONDITION UPON EXAM AMYOTROPHIC LATERAL SCLEROSIS
ALS PANEL; LOWER-LIMB ONSET; PROBABLE AND POSSIBLE ALS ALS PANEL CAUCASIAN FROM THE US AMYOTROPHIC LATERAL SCLEROSIS
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 13291
CEPH/UTAH PEDIGREE 1341 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
FRAGILE SITE MENTAL RETARDATION 1; FMR1 APPARENTLY HEALTHY NON-FETAL TISSUE
ADDITIONAL HUMAN/RAT SOMATIC CELL HYBRIDS
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1341 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 SNP500 PANEL CEPH/UTAH PEDIGREE 1331 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16
CEPH/UTAH PEDIGREE 1340 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
CEPH/UTAH PEDIGREE 1340 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
PRIMARY LATERAL SCLEROSIS ALS PANEL CAUCASIAN FROM THE US
FRAGILE SITE MENTAL RETARDATION 1; FMR1 CHROMOSOME DELETION
CEPH/UTAH PEDIGREE 1341 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
CEPH/UTAH PEDIGREE 13292 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE]
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1341 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
NIJMEGEN BREAKAGE SYNDROME GENE; NBS1 MARKER CHROMOSOME NIJMEGEN BREAKAGE SYNDROME
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1340
HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 8 INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1340 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 16 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 HUMAN VARIATION PANEL - EUROPEAN CAUCASIAN PANEL OF 24
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE II) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 13292
CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 9; CYP2C9 SNP500 PANEL CEPH/UTAH PEDIGREE 1333
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19 CEPH/UTAH PEDIGREE 1341
INTERNATIONAL HAPMAP PROJECT - CEPH (PLATE I) [UTAH RESIDENTS WITH ANCESTRY FROM NORTHERN AND WESTERN EUROPE] CEPH/UTAH PEDIGREE 1340 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 19; CYP2C19
HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS LAMIN A/C; LMNA
TRANSLOCATED CHROMOSOME TETRALOGY OF FALLOT
TRANSLOCATED CHROMOSOME FUMARATE HYDRATASE; FH
EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE
WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES RECQ PROTEIN-LIKE 2; RECQL2
NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES ROTHMUND-THOMSON SYNDROME; RTS
ACUTE MYELOGENOUS LEUKEMIA ATAXIA-TELANGIECTASIA; AT
IMR-90 - SV40 VIRUS-TRANSFORMED FETAL LUNG FIBROBLAST
NIA AGING CELL REPOSITORY DNA PANEL - CHARACTERIZED MUTATIONS RECQ PROTEIN-LIKE 2; RECQL2 WERNER SYNDROME; WRN REPLICATION FOCUS-FORMING ACTIVITY 1, INCLUDED; FFA1, INCLUDED NIA AGING CELL REPOSITORY DNA PANEL - AGING SYNDROMES
ATCC: COSMIC ID:910401; ATCC CRL-1923,CRL-1923
ATCC: HTB-93,COSMIC ID:909759; ATCC HTB-93
ATCC: CRL-7767,COSMIC ID:924248; ATCC CRL-7767
JCRB: COSMIC ID:907314; JCRB IFO50431,IFO50431
Derived from a subcutaneous nodule of a tumour from a 14-year-old male. Cells display remarkable blebbing.
DSMZ: ACC 193
ECACC: 93051123
HyperCLDB: cl852
HyperCLDB: cl853
HyperCLDB: cl854
ICLC: HTL97005
RIKEN: COSMIC ID:925339; Riken RCB1200,RCB1200
Obsolete because of duplication. See: http://purl.obolibrary.org/obo/CLO_0037134
WEB: http://lincs.hms.harvard.edu/db/cells/50018/
WEB: https://www.ncbi.nlm.nih.gov/pubmed/22710073
WEB: https://www.ncbi.nlm.nih.gov/pubmed/9183638
ATCC: COSMIC ID:924247; ATCC HTB-117,HTB-117
ATCC: COSMIC ID:909758; ATCC HTB-118,HTB-118
MCF-12A cell
an immortal T cell line cell that is derived from mouse.
immortal mouse T cell line cell
An immortal human epithelial cell line cell that derives from human breast.
immortal human breast epithelial cell line cell
An immortal human epithelial cell line cell that derives from human colon.
immortal human colon epithelial cell line cell
An immortal human epithelial cell line cell that derives from human uterine cervix.
immortal human uterine cervix epithelial cell line cell
mouse C57BL/6 inbred strain
mouse C3H/An inbred strain
mouse DBA/2 inbred strain
An immortal mouse T cell line cell derived from a mouse lymphoma, specifically a Rauscher virus-induced tumor.This cell line is antigen processing-defective and expresses a very low level of MHC molecules on its surface.
WEB: http://web.expasy.org/cellosaurus/CVCL_J385
RMA cell
WEB: http://web.expasy.org/cellosaurus/CVCL_0108
JY cell
WEB: http://web.expasy.org/cellosaurus/CVCL_8792
MM.1S cell
immortal chicken B cell line cell derives_from some B cell from the peritoneal sac of a chicken having leukosis
WEB: http://web.expasy.org/cellosaurus/CVCL_T444
LSCC-RP9 cell
immortal human epithelial cell line cell derives_from some ovary epithelial cell from a patient having ovary serous adenocarcinoma
WEB: http://web.expasy.org/cellosaurus/CVCL_5381
UCI 107 cell
WEB: http://web.expasy.org/cellosaurus/CVCL_5380
UCI 101 cell
an immortal human fibroblast cell line cell that is derived from BJ cell through a biological process such as cell transformation
BJ-derived cell line cell
BJeLR cell is BJ fibroblast cell line cell transformed with hTERT, genomic SV40 LT and ST oncoproteins, and oncogenic HRASV12.
PubChem probe report: http://www.ncbi.nlm.nih.gov/books/NBK98919/
PubMed: http://www.ncbi.nlm.nih.gov/pubmed/18355723
BJeLR cell
BJeH=BJ derivative transformed only with hTERT (BJ fibroblasts were derived from primary human cells by transformation with hTERT, genomic SV40 Large T (LT) and Ssmall T (ST))
BJeH cell
WEB: http://cellfinder.org/ontology?id=CELDA_00012667
RS-11846 cell
CHO-derived cell line cell
A derivative of the CHO cell line that is adapted to high-density, serum-free suspension culture
WEB: https://www.thermofisher.com/order/catalog/product/R80007
CHO-S cell
DRD=BJ fibroblasts expressing hTERT, SV40 small T oncoprotein, dominant negative p53, cyclin D1, a mutant form of CDK4, along with the oncogene HRASV12
WEB: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683762/
DRD cell
HL2/3 is a derivative of HeLa cells and contains a stably integrated copies of the HIV-1 molecular clone HXB2/3gpt.
WEB: https://www.aidsreagent.org/reagentdetail.cfm?t=cell_lines&id=83
WEB: https://www.ncbi.nlm.nih.gov/pubmed/?term=2078409
HL2/3
HeLa-MAGI-CCR5 cells are derived from HeLa cells and express human CD4, CXCR4 and CCR5, and an integrated gene encoding the b-galactosidase gene expressed from the HIV long terminal repeat.
WEB: http://web.expasy.org/cellosaurus/CVCL_D260
MAGI-CCR5 cells; HeLa-R5-16, engineered to express the Envelope protein (Env) from the CCR5-tropic HIV-1 clinical isolate 92US715, and also to express the Tat protein from HIV-1 NL4 3
HeLa-MAGI-CCR5
HeLa-R5-16 (gift from Roche Palo Alto, LLC) is a derivative of HeLa cells, engineered to express the Envelope protein (Env) from the CCR5-tropic HIV-1 clinical isolate 92US715, and also to express the Tat protein from HIV-1 NL43
WEB: http://www.ncbi.nlm.nih.gov/pubmed/?term=16314403
HeLa-R5-16
RD-HGA16 is derivative of CHO cells stably transfected with the promiscuous G-protein Gα16 gene and hygromycin-resistant. RD-HGA16 is from FLIPR LiveWare Cells (Molecular Devices, Sunnyvale CA), a series of cells and expression vectors successfully used in drug discovery, based on G-protein chimeras developed by Bruce Conklin and colleagues at the Gladstone Institute, UCSF.
WEB: http://go.pardot.com/l/83942/2015-06-17/njr/83942/4464/Data_Sheet__FLIPR_LiveWare_G_protein_Cells_and_Plasmids.pdf
RD-HGA16
Sufu-KO-LIGHT cells were derived from Sufu knockout mouse embryonic fibroblasts according to the method of Chen et al. [Genes Dev. 2009;23(16): 1910-28.] The cells were co-transfected with the zeocin resistance vector (pVgRXR, Invitrogen) and a firefly luciferase reporter driven by eight Gli binding sites and a γ-crystallin basal promoter (8XGHBS-FL). Sufu-KO-LIGHT lacks Sufu and exhibits constitutive Hh target gene expression in response to endogenous Gli activators.
WEB: https://www.google.com/patents/WO2013192301A1?cl=en
Sufu-KO-LIGHT cell
A Hela-derived cell line cell that expresses ubiquitinated GFP (Green Fluroescent Protein)
Ub-G76V-GFP/HeLa
A cell line cell that is cultured in vitro and possesses two capabilities: (1) it can self-renew, which means that it can divide indefinitely while remaining in an undifferentiated state; and (2) it is pluripotent or multipotent, which means that it can differentiate to form a specialized cell type.
Yongqun He, Sirarat Sarntivijai, Alexander Diehl
WEB: https://en.wikipedia.org/wiki/Stem-cell_line
While stem cells hold great promise for biomedical research, the in vitro propagation and maintenance of these cells in an undifferentiated state is essential. Reference: https://www.atcc.org/~/media/7E031EF950594BC3B85A411AE1DC9684.ashx
stem cell line cell
MWCL.1 cell
The GripTite™ 293 MSR Cell Line is a genetically engineered Human Embryonic Kidney (HEK 293) cell line that expresses the human macrophage scavenger receptor and strongly adheres to standard tissue culture plates for dependable results.
GripTite 293 MSR cell
ECC-1 cell line cells have been found to be contaminated and shown to be a Ishikawa 3-H-12 cell line cell (PubMed=22710073).
Ishikawa 3-H-12 cell
WEB: http://genome.ucsc.edu/ENCODE/protocols/cell/human/ECC1_Myers_protocol.pdf
WEB: http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
ECC-1 cell
immortal human vasculature-derived endothelial cell line cell'
immortal human bone element-derived epithelial cell line cell
a SK-N-SH cell that is treated with retinoic acid to make the cell differentiated.
WEB: http://ucscbrowser.genap.ca/cgi-bin/hgEncodeVocab?ra=encode%2Fcv.ra&term=%22SK-N-SH_RA%22
WEB: https://www.ncbi.nlm.nih.gov/pubmed/26295826
WEB: https://www.ncbi.nlm.nih.gov/pubmed/?term=4748425
SK-N-SH-RA cell
immortal human pancreas-derived epithelial cell line cell
immortal human kidney-derived epithelial cell line cell
293-derived cell
WEB: http://web.expasy.org/cellosaurus/CVCL_D585
WEB: http://www.thermofisher.com/order/catalog/product/R71007
HEK293-T-REx cell
MCF 10A-derived cell
The MCF10A-Er-Src cells are derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER).
WEB: http://genome.ucsc.edu/ENCODE/protocols/cell/human/MCF-10A_Struhl_protocol.pdf
MCF10A-Er-Src cell
a hybridoma cell line cell that is obtained by fusing activated mouse T cells with tumor cells.
mouse T-cell hybridoma cell line cell
2B4 cell
A mouse T-cell hybridoma cell line cell that is derived from the murine hybridoma cell line 2B4, stably transfected to overexpress the human protein BCL-2.
2B4/BCL-2 cell
A stem cell line cell that is derived from mouse.
mouse stem cell line cell
A mouse T-cell hybridoma cell line cell that is derived from the murine hybridoma cell line 2B4, stably transfected to overexpress the human protein MCL-1.
2B4/MCL-1 cell
AVA5 cells are derived from the Huh-7 human hepatoma cell line, stably-expressing the HCV replicon (sub-genomic [CON1], genotype 1b); http://www.apath.com/index.html. See also PMID: 27013634, 1110665, 10390360
AVA5 cell
An immortal mouse cell line cell that is derived from leukemia cells.
mouse leukemia cell line cell
A murine leukemia cell line driven by the overexpression of Myc and BCL-2.
BCL-2 1863 cell
A mouse stem cell line cell that is derived from a mouse neural progenitor cell and capable of differentiation in vitro.
immortalized mouse neural progenitor cell
mouse neural progenitor cell line cell
An immortalised mouse neural progenitor cell line cell that is capable of differentiation in vitro and is established by retorviral-mediated transduction of the avian myc oncogene into mitotic progenitor cells of neonatal mouse cerrebellum. Mouse strain CD1 x C57BL/6.
C17.2 cell
CEM.NKR-CCR5 cell
CEM21 (aka CEM#21 or CEM-R5Luc1#21) is derived from CEM.NKR-CCR5 by stable transfecttion of a Tet-activator responsive Luciferase reporter
CEM21 cell
DPX2 (aka DPX-2) is a HepG2-derived cell line stably integrated with a PXR (pregnane X receptor) expression vector plus a luciferase reporter, used to detect PXR activation/ CYP3A induction
DPX2 cell
FA2N-4 is a human hepatocyte cell line. Reference: http://web.expasy.org/cellosaurus/CVCL_0267
FA2N-4 cell
HBL-1 (aka human is an EBV-negative B-cell lymphoma cell line established from the pleural effusion of a patient with malignant lymphoma, diffuse, large cell.
HBL-1 cell
HMC-1-8 is a human breast cancer cell line
HMC-1-8 cell
HMLE_sh_ECAD is a stable cell line mimicking a cancer stem cell (CSC), derived by knocking down E-Cadherin (via shRNA) in human breast epithelial cells to induce epithelial to mesenchymal transition (EMT)
HMLE_sh_ECAD cell
HMLE_sh_eGFP is a human breast epithelial cell line containing shRNA to GFP (green fluorescent reporter); used as an isogenic control line for HMLE_sh_ECAD
HMLE_sh_eGFP cell
HMLE_sh_TWIST is a stable cell line mimicking a cancer stem cell (CSC), derived by knocking down TWIST (via shRNA) in human breast epithelial cells to induce epithelial to mesenchymal transition (EMT); isogenic with another CSC line, HMLE_sh_ECAD
HMLE_sh_TWIST cell
3T3-derived cell
An engineered 3T3 mouse fibroblast cell line, which expresses the firefly luciferase reporter gene under the control of Wnt-responsive promoters (TCF/LEF).
LEADING LIGHT Wnt Reporter cell line cell
MCL-1 1780 is a murine leukemia cell line driven by the overexpression of Myc and MCL-1.
MCL-1 1780 cell
MG213 is a subline of the BRG1/BRM-deficient cell line SW13 (http://purl.obolibrary.org/obo/CLO_0009185) that contains a stably integrated glucocorticoid-responsive MMTV-luciferase reporter.
MG213 cell
A PathHunter Beta-Arrestin GPCR cell line (DiscoverX), engineered to co-express the ProLink (PK) tagged GPCR (DRD2L, long form of human DRD2) and the Enzyme Acceptor (EA) tagged Beta-Arrestin. Activation of DRD2L-PK induces Beta-Arrestin-EA recruitment, forcing complementation of the two Beta-galactosidase enzyme fragments (EA and PK). The resulting functional enzyme hydrolyzes substrate to generate a chemiluminescent signal.
PathHunter CHO-K1 DRD2L Beta-Arrestin cell
A PathHunter Beta-Arrestin GPCR cell line (DiscoverX), engineered to co-express the ProLink (PK) tagged GPCR (human DRD3) and the Enzyme Acceptor (EA) tagged Beta-Arrestin. Activation of DRD3-PK induces Beta-Arrestin-EA recruitment, forcing complementation of the two Beta-galactosidase enzyme fragments (EA and PK). The resulting functional enzyme hydrolyzes substrate to generate a chemiluminescent signal.
PathHunter CHO-K1 DRD3 Beta-Arrestin cell
An immortal mouse moncyte cell line cell that is derived from RAW 264.7 cell line.
RAW 264.7-derived cell
RAW-Blue cells are derived from the murine RAW 264.7 macrophages with chromosomal integration of a secreted embryonic alkaline phosphatase (SEAP) reporter construct inducible by NF-κB and AP-1.
RAW-Blue cell
S16 cell
A mouse melanoma cell line (which harbors N-Ras mutation), isolated from a small amelanotic lung metastasis in a mouse with a s.c. K-1735 tumor.
SW1 cell
'Tango cell' refers to one of many stable cell lines, all based on the parental line HEK293T, designed to work in a 'Tango beta-arrestin' recruitiment assay to measure receptor activation for more than 300 GPCRs. See PMID25895059 and https://pdspdb.unc.edu/prestotango/
Tango cell
Human diffuse large B cell lymphoma cell line derived from a 62-year-old male patient
TMD8 cell
A primary culture cell that is derived from peripheral blood.
primary cultured peripheral blood cell
A primary cultured peripheral blood cell that has one round nucleus.
primary cultured peripheral blood mononuclear cell
U87-EGFRvIII (aka U87/vIII) is a stable cell line derived from U87MG (a human glioblastoma) to overexpress the most common mutation of epidermal growth factor receptor (EGFR) found in human glioblastomas--an in-frame deletion of an 801-bp sequence in the extracellular domain of EGFR termed EGFRvIII. (descr. in PMID 15548697).
U87-EGFRvIII cell
peripheral blood-derived erythroblast
A peripheral blood-derived erythroblast cell that is prepared from fetal liver
peripheral blood-derived erythroblast from fetal liver
A stem cell line cell that is dervied from an embryotic stem cell, a pluripotent stem cell derived from the inner cell mass of a blastocyst, an early-stage perimplantation embryo.
embryonic stem cell line cell
An embryonic stem cell line cell that is dervied from a cell in human embryo.
human embryonic stem cell line cell
A human ES cell line cell that expresses cell surface markers specific to undifferentiated nonhuman primate ES and human EC cells: : stage-specific embryonic antigen (SSEA)–3, SSEA-4, TRA-l-60, TRA-1- 81, and alkaline phosphatase. It has a normal 46, XY karyotype, O+ blood type. Teratomas are formed upon cell injection into SCID mice. These teratomas include cells from all three germ layers.
Line H1 cell
CL-34 cell
SNU-1040 cell
SNU-C4 cell
SNU-C5 cell
HEC-108 cell
COR123 cell
COV644 cell
SKM-1 cell
MDAMB231 cell
SKMEL1
The OV7 cell line was established from solid ovarian tumour tissue taken from a 78-year-old female patient. The tumour was characterised as stage III, mixed tumour type and poorly differentiated.
Immunocytochemical staining of the cells was reported to show strong staining for cytokeratin (CK), no staining for carcinoembryonic antigen (CEA) and strong staining for human milk fat globulin (HMFG-2). Detection of mRNA expression of vascular endothelial growth factor (VEGF) and its receptors flt and KDR has been reported. The patient had received treatment with chlorambucil. (Sigma-Aldrich catalog number 96020764)
OV7 cell
SKBR3 cell
human ovarian cancer cell line cell
This human ovarian adenocarcinoma cell line originated from a 62 year old Japanese female
RMUG-S cell
HEKTE cell
neuron cell derived from H1 embryonic stem cells
H1-neuron
LCL-1005
Ball-1
BALL-1 cell
CHEMBL: CHEMBL3308839
A primary cultured cell that is derived from fibroblast cell in vivo
Oliver He
primary cultured fibroblast cell
A primary cultured fibroblast cell that is from human
primary cultured human fibroblast cell
A stem cell line cell that is multipotent and is isolated and prepared from an juvenile or adult tissue.
adult stem cell line cell
An adult stem cell line cell that is isolated and prepared using bone marrow tissue and is able to generate all cells of the immune system and all blood cell types.
Of the types of adult stem cells have successfully been isolated and identified, only mesenchymal stem cells can successfully be grown in culture for long periods of time. Hematopoietic stem cells are difficult to grow and propagate in vitro.[4] Identifying methods for maintaining hematopoietic stem cells in vitro is an active area of research. Reference: https://en.wikipedia.org/wiki/Stem-cell_line
hematopoetic stem cell line cell
An adult stem cell line cell that is isolated and prepared using umbilical cord blood, amniotic fluid, and adipose tissue and can generate a number of cell types, including osteoblasts, chondrocytes, and adipocytes.
mesenchymal stem cell line cell
A mesenchymal stem cell line cell that is isolated and prepared using umbilical cord blood.
umbilical cord mesenchymal stem cell line cell
A stem cell line cell that is pluripotent and is generated from an adult somatic cell.
induced pluripotent stem cell line cell
An induced pluripotent stem cell line cell that is derived from a human cell.
human induced pluripotent stem cell line cell
non-tumorigenic
A cell growth process that is conducted in the three dimensional direction.
three dimensional cell growth
cell line cell transfection
This human ES cell line expresses cell surface markers specific to undifferentiated nonhuman primate ES and human EC cells: stage-specific embryonic antigen (SSEA)–3, SSEA-4, TRA-l-60, TRA-1- 81, and alkaline phosphatase. It has a normal 46, XX karyotype. Teratomas are formed upon cell injection into SCID mice. These teratomas include cells from all three germ layers.
H9 ES cell
HUES3 ES cell
A embryotic stem cell line cell that is dervied from a cell in mouse embryo.
mouse embryonic stem cell line cell
A stem cell line cell that is dervied from using the somatic cell nuclear transfer method.
somatic cell nuclear transfer-derived stem cell line cell
a human embryonic stem cell line cell that is derived by somatic cell nuclear transfer
human embryonic stem cell line cell derived by SCNT
human embryonic stem cell line cell derived by somatic cell nuclear transfer
human fibroblast-induced pluripotent stem cell line cell
A primary cultured cell that is derived from in vivo connective tissue cell
primary cultured connective tissue cell
A primary cultured cell that is derived from synovial cell in vivo
primary cultured synovial cell
A primary cultured cell that is derived from fat cell in vivo
primary cultured fat cell
A primary cultured cell that is derived from in vivo muscle cell
primary cultured muscle cell
primary cultured cardiac muscle cell
A primary cultured cell that is derived from in vivo bone marrow cell
primary cultured bone marrow cell
A primary cultured cell that is derived from in vivo muscle precursor cell
primary cultured muscle precursor cell
primary cultured myoblast cell
A primary cultured cell that is derived from in vivo liver cell
primary cultured liver cell
A primary cultured cell that is derived from in vivo lymphocyte
primary cultured lymphocyte
A primary cultured cell that is derived from in vivo B cell
primary cultured B cell
A primary cultured cell that is derived from in vivo cell of skeletal muscle
primary cultured cell of skeletal muscle
A stem cell line cell that is derived from human.
human stem cell line cell
human forskin fibroblast-induced pluripotent stem cell line cell
forskin fibroblast-derived hiPSC
BIHi001-A cell
immortal human lung-derived epithelial celll line cell
An organism that provides/donotes a tissue to be used for a biomedical study or a clinical application.
tissue donor
human tissue donor
EDi008-B
an organization that provides a place for registration and search of cell line information.
cell line registry
disease: ovarian carcinoma cancer cell line
Cellosaurus (https://web.expasy.org/cellosaurus/CVCL_6570)
HEK293 cells expressing E1A adenovirus gene, enabling viral promoter expression
ThermoFisher (https://www.thermofisher.com/order/catalog/product/11631017)
BG1 cells modified with a luciferase reporter at the human ESR1 alpha (estrogen receptor) gene and estrogen receptor response elements
Tox21 (https://tripod.nih.gov/tox/apps/assays/assays.jsp)
CHO cells modified with a luciferase reporter at a TET-on controlled Retinoid Orphan Receptor Gamma) transcription factor
GH3 cells modified to express luciferase-reporter tyroid receptor response elements
HCT 116 cells modified to express a beta-lactamase reporter under control of p53
HEK293 cells modified with a beta-lactamase reporter under control of an upstream activator sequence to respond to androgen receptor signalling
HEK293 cells modified with a beta-lactamase reporter under control of an upstream activator sequence to respond to estrogen receptor signalling
HEK293T cells modified with a beta-lactamase reporter under control of an upstream activator sequence to respond to farnesoid-X-receptor signalling
HEK293T cells modified with a beta-lactamase reporter under control of an upstream activator sequence to respond to retinoid-X-receptor signalling
HEK293T cells modified with a beta-lactamase reporter under control of an upstream activator sequence to respond to vitamin D receptor receptor signalling
HeLa cells modified with a beta-lactamase reporter under control of the ER stress response element
Cellosaurus (https://web.expasy.org/cellosaurus/CVCL_KS05)
HeLa cells modified with a beta-lactamase reporter under control of the glucocordicoid receptor
HeLa cells modified with a beta-lactamase reporter under control of the heat shock response elements
HepG2 cells modified with an aryl hydrocarbon receptor (AhR) luciferase reporter and 20 dioxin response elements
HepG2 cells modified with a beta-lactamase reporter under control of the antioxidant response element
HepG2 cells modified with a luciferase reporter responsive responsive to the activation of the contained constituitive androstane receptor and cytochrome 2B6
MCF-7 cells modified with a luciferase reporter and three repeats of the estrogen response element
MDA-kb2 cells modified with a luciferase reporter under control of the MMTV promotor and response elements for androgen receptor and glucocorticoid receptor
ME-180 cells modified with a beta lactamase reporter under control of the activator protein-1 response element
ME-180 cells modified with a beta lactamase reporter under control of thehypoxia response element
ME-180 cells modified with a beta lactamase reporter under control of an NF-kB response element
Cells modified with a reporter gene to respond to estrogen related receptor alpha activity
Cells modified with a reporter gene to respond to activity of the estrogen related receptor alpha and the PPARgamma coactivator
HEK293H cells modified with a beta lactamase reporter under control of an upstream activator sequence and peroxisome proliferator-activated receptor delta
HEK293H cells modified with a beta lactamase reporter under control of an upstream activator sequence and peroxisome proliferator-activated receptor gamma
C3H/10T1/2 clone 8 cells were modified with a luciferase reporter responding to activity of the retinoic acid signalling pathway
HEK293T cell
Human Embryonic Kidney 293T-derived cell
HEK293T-derived cell
HEK293H-derived cell
MEL cell line cell is an erythroid progenitor cell derived from the spleen of a susceptible mouse infected with the Friend virus complex 1. The virally transformed MEL cells are arrested at the proerythroblast stage of development and can be maintained in tissue culture indefinitely.
mouse erythroleukemia cell line cell
An immortal kidney podocyte-derived cell line cell
immortal podocyte cell line cell
An immortal human kidney podocyte-derived cell line cell
immortal human podocyte cell line cell
immortal mouse podocyte cell line cell
immortal rat podocyte cell line cell
E11 [mouse] cell
MPC-1 cell
MPC-5 cell
MPC-8 cell
SVI cell
2DNA1D7 cell
Conditionally Immortalized Human Podocytes-1
CIHP-1 cell
human Amniotic-fluid Kidney Progenitor Cells-Podocyte
hAKPC-P cell
Human Glomerular Visceral Epithelial Cells.SV40 transformed 1
HGVEC.SV1 cell
Human Glomerular Visceral Epithelial Cells.SV40 transformed 1 clone A4
HGVEC.SV1A4 cell
This cell was derived from an African American who had focal segmental glomerulosclerosis
HUPEC 001 G0/G0 cell
HUPEC 002 FSGS G0/G0 cell
HUPEC 003 FSGS G0/G0 cell
HUPEC 005 FSGS G1/G2 cell
This is an induced pluripotent stem cell
STBCi028-A cell
STBCi321-A cell
Cell provider: PromoCell; Cell provider catalog number: PromoCell
Cell provider: Cell Applications, Inc; Cell provider catalog number: Cell Applications, Inc
Donor subject has two copies of the SMN2 and is heterozygous for deletion of exons 7 and 8 in the SMN1 gene
Cell provider: Wasington University; Cell provider catalog number: Wasington University
STBCi322-A cell
donor subject has 2 copies of the SMN2 gene and is homozygous for deletion of exons 7 and 8 of the SMN1 gene
Cell provider: ISMMS; Cell provider catalog number: ISMMS
donor subject is homozygous for a deletion of exons 7 and 8 in the SMN1 gene and has 2 copies of the SMN2 gene
Cell provider: Lonza; Cell provider catalog number: Lonza
Cell provider: CellzDirect; Cell provider catalog number: CellzDirect
Cell provider: Sciencell; Cell provider catalog number: Sciencell
MDCK-II cell
Compared to the parent cell line, has a lower expression of endogenous ABCB1/MDR1.
MDCKII-LE cell
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS14iCTR-n6
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS83iCTR-33n1
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS25iCTR-18n2
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS28iALS-n2A
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS29iALS-n1N
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS30iALS-n1N
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS52iALS-n6A
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS32iSMA-n3
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS83iSMA-n5
Cell provider: Cedars-Sinai Stem Cell Core Laboratory; Cell provider catalog number: CS77iSMA-n5
human pluripotent stem cell medium, includign mTeSR
A immortal cell line cell that has the characteristics: Fibroblast-like cells derived from African Savannah Elephant. Primary cultured cells. Elephant cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Derived from tissue: ear in animal: African Savannah Elephant.
A immortal cell line cell that has the characteristics: Pupal ovary hemocyte.
Derived from tissue: pupal ovary in animal: butterfly,swallow t..
A immortal cell line cell that has the characteristics: Eel hepatocyte. Cell growth is slow.
Derived from tissue: liver in animal: eel.
Derived from tissue: pupal ovary in animal: moth.
A immortal cell line cell that has the characteristics: Highly susceptible to nuclear polyhedrosis virus.
Derived from tissue: fat body, larval in animal: moth, mulberry tiger.
Originator: Mitsuhashi,Jun & Inoue, Hajime
A immortal cell line cell that has the characteristics: Cold water fish cell line. Cultured at 25 C. Relatively large chromosomes (Mode 23).
Derived from tissue: fin, caudal in animal: mudminnow, Central.
A immortal cell line cell that has the characteristics: Lung fibroblastic cell line derived from Tupaia belangeri. Tupaia cell lines require import and export permits according to the Convention on International Trade in Endangered Species (CITES).
Derived from tissue: lung in animal: tupaia.
Originator: Inui, Naomichi & Taketomi, Masako
A immortal human cell line cell that has the characteristics: Human cell line derived from primary effusion lymphoma (PEL).
Derived from tissue: ascites in animal: human.
A immortal human cell line cell that has the characteristics: Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389(Deposited from Tohoku Univ.).
Derived from tissue: bile duct, ascites meta in animal: human.
Originator: Miyagiwa, M. (Okayama Univ.)
A immortal human cell line cell that has the characteristics: Human cell line derived from extrahepatic bile duct carcinoma. TKG0367(Deposited from Tohoku Univ.).
Derived from tissue: common bile duct in animal: human.
A immortal human cell line cell that has the characteristics: High level of EGF receptor
Derived from tissue: epidermoid carcinoma in animal: human.
A immortal human cell line cell that has the characteristics: Human cell line derivd from epidermoid carcinoma. TKG0182 (Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from osteosarcoma.
Derived from tissue: femur in animal: human.
A immortal human cell line cell that has the characteristics: It was initiated from a malignant gestational choriocarcinoma of the fetal placenta. Need to check response to hormones before use. Back up culture of ECA2687.
Derived from tissue: fetal placenta in animal: human.
A immortal human cell line cell that has the characteristics: Japanese gallbladder carcinoma from the same patient of TGBC1TKB.
Derived from tissue: gallbladder in animal: human.
Originator: Todoroki, T. & Ohno, T. & Kim, B.
A immortal human cell line cell that has the characteristics: Japanese gallbladder tumor passed through a nude mouse.
A immortal human cell line cell that has the characteristics: Human cell line derived from gallbladder carcinoma. TKG0642 (Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Japanese gallbladder carcinoma established from metastated ascite. Cell growth is slow.
Derived from tissue: gallbladder, ascites meta in animal: human.
A immortal human cell line cell that has the characteristics: Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Cell growth is slow.
Derived from tissue: gallbladder, lymph node meta in animal: human.
A immortal human cell line cell that has the characteristics: Human lymphoid cell line derived from Burkitt's lymphoma. Tumorigenic in nude mouse.TKG0607 (Deposited from Tohoku Univ.).
Derived from tissue: ileocecal lymph node meta in animal: human.
Originator: Hayashi, Yutaka (Tohoku University)
A immortal human cell line cell that has the characteristics: Human rhabdomyosarcoma showing myogenic differentiation. TGFbeta inhibits it. Cell growth is slow.
Derived from tissue: left forearm in animal: human.
Originator: Ogose, Akira & Motoyama, Teiichi
Derived from tissue: left humerus in animal: human.
A immortal human cell line cell that has the characteristics: Human cell line derived from myxofibrosarcoma.
Derived from tissue: left knee in animal: human.
A immortal human cell line cell that has the characteristics: Lung adenocarcinoma
Derived from tissue: lung in animal: human.
A immortal human cell line cell that has the characteristics: Lung carcinoma, refer to ATCC CCL185
A immortal human cell line cell that has the characteristics: Lung Cancer-1/squamous, floating variant, the same patient as RCB0455 LC-1/sq.
A immortal human cell line cell that has the characteristics: Japanese lung squamous carcinoma.
A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type. See Lu-134-B.
Originator: Terasaki, T. & Shimosato, Y.
A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type. See Lu-134-A.
A immortal human cell line cell that has the characteristics: Small cell carcinoma, variant type
A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type
Originator: Tsumuraya, M. & Nakajima, T.
A immortal human cell line cell that has the characteristics: Small cell carcimoma, classic type
A immortal human cell line cell that has the characteristics: SV40 transformed human lung fibroblast.
A immortal human cell line cell that has the characteristics: Human lung cancer derived cell.
A immortal human cell line cell that has the characteristics: Human cell line derived from lung cancer. Oat cell type.
A immortal human cell line cell that has the characteristics: Human cell line derived from lung cancer. Small cell carcinoma.
A immortal human cell line cell that has the characteristics: Lung giant cell carcinoma cell line derived from human. TKG0495 (Deposited from Tohoku Univ.).
Originator: Hirohashi, S. and Shimosatao, Y.
A immortal human cell line cell that has the characteristics: Human lung squamous cell carcinoma cell line. TKG0481(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from lung cancer. Small cell carcinoma. TKG0503(Deposited from Tohoku Univ.)
A immortal human cell line cell that has the characteristics: Human cell line derived from lung cancer. Small cell carcinoma. Mouse WA-mFib cells are the stromal cells for this cell line.
A immortal human cell line cell that has the characteristics: Human lung giant cell carcinoma cell line. TKG0496 (Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Transformed in vitro with carcinogen
Originator: Huh, Nam, Ho (Nanba, Masayoshi)
A immortal human cell line cell that has the characteristics: SV40-transformed WI-38.
A immortal human cell line cell that has the characteristics: Parent cell line of LC/sq-SFthe same patient as RCB0439 LC-F. Cell growth is slow.
A immortal human cell line cell that has the characteristics: Lung small cell carcinoma producing insulin-like growth factor II. Cell growth is slow.
A immortal human cell line cell that has the characteristics: Japanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI. Cell growth is slow.
A immortal human cell line cell that has the characteristics: Small lung carcinoma. PTHrP producing.
A immortal human cell line cell that has the characteristics: Human cell line derived from lung squamous cell carcinoma. Many granules are found in cytoplasma. HLA-A 11/24. TKG0301 (Deposited from Tohoku Univ.).
Originator: Kobayashi, SyunsukeS. (Tohoku Univ.)
A immortal human cell line cell that has the characteristics: Human cell line derived from lung cancer. Small cell carcinoma. TKG0244(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from lung cancer. Adenocarcinoma. TKG0177 (Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from lung cancer. Small cell carcinoma. TKG0245(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from lung cancer. Large cell carcinoma. TKG0181(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Normal human lung fibroblast.
A immortal human cell line cell that has the characteristics: Normal embryonic lung fibroblast.
A immortal human cell line cell that has the characteristics: Human cell line derived from lung adenosquamous cell carcinoma. HLA A2402/, B5201/, Cw01201/.
A immortal human cell line cell that has the characteristics: Human cell line derived from lung adenocarcinoma. HLA A2402/2402, B5201/5401, C0102/1202.
A immortal human cell line cell that has the characteristics: Human cell line derived from lung large cell carcinoma. HLA A0206/2601, B0702/3501, Cw0702/0801.
A immortal human cell line cell that has the characteristics: Human lung carcinoma cell line. TKG0442(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human lung small cell carcinoma cell line. ADH producing.
A immortal human cell line cell that has the characteristics: SV40-transformed, 6TG-resistant and HAT-sensitive.
A immortal human cell line cell that has the characteristics: Human immortalized cell line derived from MRC5 cells.
A immortal human cell line cell that has the characteristics: Human lung squamous cell carcinoma cell line.TKG0494 (Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from lung adenocarcinoma cells.
A immortal human cell line cell that has the characteristics: Lung Cancer-1/squamous, serum-free cultured
A immortal human cell line cell that has the characteristics: Human cell line derived from lung adenocarcinoma cells. Differentiated type. Previous name:PC-14(RCB0446)
A immortal human cell line cell that has the characteristics: Human lung cancer cell line expressing capsid protein of human adenovirus.
A immortal human cell line cell that has the characteristics: Producing high level of anti-diuretic hormone.
Derived from tissue: lung, lymph node meta in animal: human.
A immortal human cell line cell that has the characteristics: Lung large cell carcinoma producing CSF. Cell growth is slow.
A immortal human cell line cell that has the characteristics: Human cell line derived from synovial sarcoma.
Derived from tissue: lung, pleural effusion in animal: human.
A immortal human cell line cell that has the characteristics: Adenocarcinoma, moderately diffirentiated. Cell growth is slow.
Derived from tissue: lung, pleural fluid in animal: human.
A immortal human cell line cell that has the characteristics: Human large cell lung carcinoma. Taken from skin metastasis. In vivo-in vitro clonogenic assay.
Derived from tissue: lung, skin meta in animal: human.
Originator: Miyamoto, Tadaaki, Takiguchi, Yuichi
A immortal human cell line cell that has the characteristics: Japanese lung large cell carcinoma
Originator: Miyamoto, Tadaaki & Takiguchi,Yuichi
A immortal human cell line cell that has the characteristics: Malignant melanoma from lympho node.
Derived from tissue: lymph node in animal: human.
Originator: Ono, Isao & Isahiwata, Isamu &Isahikawa, Hiroshi
A immortal human cell line cell that has the characteristics: Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis.
Derived from tissue: lymph node, B-lymphoma in animal: human.
Originator: Miyazawa, Keisuke & Uchida, Yoshiko
A immortal human cell line cell that has the characteristics: EB transformed B cell line
Derived from tissue: lymphoblast in animal: human.
A immortal human cell line cell that has the characteristics: Human B lymphoblastoid cell line (RCB2288 211-LCL) transformed with APR-MUC1 and PRC-MUC1 cDNAs. TKG0615(Deposited from Tohoku Univ.).
Derived from tissue: lymphoblastoid in animal: human.
A immortal human cell line cell that has the characteristics: Human derived T cell line. HTLV-1 pro-virus DNA(+). TKG0369 (Deposited from Tohoku Univ.).
Derived from tissue: lymphocytes (T cell ) in animal: human.
A immortal human cell line cell that has the characteristics: Human T cell line derived from acute T cell leukemia. TKG0377 (Deposited from Tohoku Univ.).
Derived from tissue: lymphoid,T-leukemia in animal: human.
A immortal human cell line cell that has the characteristics: Human malignant pleural mesothelioma cell line.
Derived from tissue: malignant pleural mesothelioma, pleural fluid in animal: human.
A immortal human cell line cell that has the characteristics: Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features.
Derived from tissue: maxilla in animal: human.
A immortal human cell line cell that has the characteristics: Japanese maxillary simus squamous carcinoma
Derived from tissue: maxillary sinus in animal: human.
Originator: Wakamatu, Yoshiko & Miyake, Masahiko
A immortal human cell line cell that has the characteristics: Melanin producing. Originated from the same site of HMV-I.
Derived from tissue: melanoma in animal: human.
A immortal human cell line cell that has the characteristics: Human melanoma, spindle-shaped. Said DOPA (+). Cell growth is slow.
Derived from tissue: melanoma, ascites meta in animal: human.
A immortal human cell line cell that has the characteristics: Serum-free medium-adapted MMAc cells. For SF culture, + insulin, hEGF, hydrocortisone, bovine pituit
A immortal human cell line cell that has the characteristics: Human cell line derived from neroblastoma of adrenal gland. TKG0468(Deposited from Tohoku Univ.).
Derived from tissue: neuroblastoma, adrenal gland in animal: human.
A immortal human cell line cell that has the characteristics: G-CSF and IL-1 producing oral squamous cell carcinoma, the same patient as T3M-1 Clone2 and CJM.
Derived from tissue: oral cavity in animal: human.
A immortal human cell line cell that has the characteristics: G-CSF producing oral squamous cell carcinoma, the same patient as T3M-1 Cl-10 and CJM. Cell growth is slow.
A immortal human cell line cell that has the characteristics: Human cell line derived from metastasis of cancer occurred in oral cavity, the same patient as T3M-1 Clone2 and T3M-1 Cl-10.
Derived from tissue: oral, the thoracic cavity meta in animal: human.
A immortal human cell line cell that has the characteristics: v-Ki-ras transformant TE85 cell line. HAT sensitive, neo resistant.
Derived from tissue: osteosarcoma in animal: human.
A immortal human cell line cell that has the characteristics: Human cell line derived from osteosarcoma. TKG0452(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. TKG0492 (Deposited from Tohoku Univ.).
Derived from tissue: pancreas in animal: human.
A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. TKG0227(Deposited from Tohoku Univ.)
A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. Ductal origin. TKG0606(Deposited from Tohoku Univ.)
A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. TKG0630(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. RCB1972 is derived from the same patient. TKG0490 (Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human pancreatic carcinoma cell line. RCB2138 is derived from the same patient.TKG0239(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human pancreatic carcinoma cell line, the same patient as RCB2141. TKG0491(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic carcinoma. RCB1973 is derived from the same patient. TKG0493(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Pancreatic ductal cell carcinoma. PTHrP producing.
Derived from tissue: pancreas, ascites meta in animal: human.
A immortal human cell line cell that has the characteristics: Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3.
A immortal human cell line cell that has the characteristics: Human cell line derived from liver metastasis of pancreas carcinoma. TKG0383 (Deposited from Tohoku Univ.).
Derived from tissue: pancreas, liver meta in animal: human.
A immortal human cell line cell that has the characteristics: Pancreatic adenocarcinoma producing CEA. K-ras activated. Cell growth is slow.
Derived from tissue: pancreas, lymph node meta in animal: human.
A immortal human cell line cell that has the characteristics: 3 cell lines from different metastases were established from the same patient. See TGBC51TKB. Cell growth is slow.
Derived from tissue: papilla vater, liver meta in animal: human.
A immortal human cell line cell that has the characteristics: 3 cell lines from different metastases were established from the same patient. See TGBC50TKB.
Derived from tissue: papilla vater, lymph node meta in animal: human.
A immortal human cell line cell that has the characteristics: 3 cell lines from different metastases were established from the same patient. See TGBC52TKB.
Derived from tissue: papilla vater, peritoneum meta in animal: human.
A immortal human cell line cell that has the characteristics: Isolated from a patient with hiper dopaminemia andnorepinephrinemia.
Derived from tissue: pelvic tumor in animal: human.
RIKEN: COSMIC ID:925342; Riken RCB0803,RCB0803
A immortal human cell line cell that has the characteristics: Benign mature tridermal teratoma.
Derived from tissue: peritoneum in animal: human.
Originator: Ishiwata, I. & Ono, I. & Ishikawa, H.
A immortal human cell line cell that has the characteristics: Methotrexate(MTX)-resistant K562 cell line
Derived from tissue: pleural effusion in animal: human.
A immortal human cell line cell that has the characteristics: Expressing P2U receptor acting in signal transduction pathway.
A immortal human cell line cell that has the characteristics: Subline of K562. Resistant to adriamycin. TKG0211 (Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Cloned U-937, differentiate with TNF
A immortal human cell line cell that has the characteristics: Human CML derived cell line. Deposited directly from the institution that has established this cell.
Originator: Lozzio, C.B. & Lozzio, B.B.
A immortal human cell line cell that has the characteristics: Human cell line derived from chronic myelogenous leukemia. Differentiate into mature erythrocytes. TKG0210 (Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Subline of K562 cell line. Resistant to vincristine. TKG0212 (Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Chronic myelogenous leukemia, sensitive to NK cell. Differentiate to erythroid cells .
A immortal human cell line cell that has the characteristics: Human cell line derived from retinoblastoma.
Derived from tissue: retinoblastoma in animal: human.
A immortal human cell line cell that has the characteristics: Human retinoblastoma cell line.
A immortal human cell line cell that has the characteristics: Human cell line derived from retinoblastoma. Cell growth is slow.
A immortal human cell line cell that has the characteristics: Human retinoblastoma cell line derived from cervical lymph node metastasis.
Derived from tissue: retinoblastoma, cervical lymph node meta in animal: human.
A immortal human cell line cell that has the characteristics: Human cell line derived from schwannoma. TKG0454 (Deposited from Tohoku Univ.).
Derived from tissue: right arm in animal: human.
A immortal human cell line cell that has the characteristics: Human cell line derived from malignant melanoma. Cell growth is slow.
Derived from tissue: right heel in animal: human.
A immortal human cell line cell that has the characteristics: Human cell line derived from malignant peripheral nerve sheath tumor.
Derived from tissue: right thigh in animal: human.
A immortal human cell line cell that has the characteristics: Human sacrococcigeal teratoma.
Derived from tissue: sacrococcygeal in animal: human.
Originator: Ishiwata, I. & Ono, I. & Ishi kawa, H.
A immortal human cell line cell that has the characteristics: Osteogenic sarcoma
Derived from tissue: sarcoma in animal: human.
A immortal human cell line cell that has the characteristics: Rare peripheral neuroectodermal tumor cells. Use collagen-coated dish.
Derived from tissue: scapula, pleural fluid in animal: human.
A immortal human cell line cell that has the characteristics: Rheumatoid fibroblast-like synoviocyte transformed with SV40 T antigen. Respond to IL-1beta.
Derived from tissue: synovial in animal: human.
A immortal human cell line cell that has the characteristics: Human cell line derived from T cell leukemia. TKG0563(Deposited from Tohoku Univ.).
A immortal human cell line cell that has the characteristics: Human cell line derived from Hodgkin's lymphoma. TKG0198(Deposited from Tohoku Univ.).
Derived from tissue: T cell leukemia in animal: human.
A immortal human cell line cell that has the characteristics: Human neuroblastoma cell line. TKG0460(Deposited from Tohoku Univ.).
Derived from tissue: unknown in animal: human.
A immortal human cell line cell that has the characteristics: Human cell line derived from malignant peripheral nerve sheath tumor (MPNST).
A immortal human cell line cell that has the characteristics: Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-1 cell line.
A immortal human cell line cell that has the characteristics: Human cell line derived from epithelioid sarcoma. Derived from a different patient from the patient of HS-ES-2M, 2R cell lines.
Derived from tissue: unknown, lung meta in animal: human.
A immortal human cell line cell that has the characteristics: Squamous carcinoma cells derived from human oral cancer.
Derived from tissue: upper gingiva in animal: human.
A immortal human cell line cell that has the characteristics: Embryonal rhabdomyosarcoma cell line derived from human. Transplantable in nude mouse.
Derived from tissue: urachus in animal: human.
A immortal human cell line cell that has the characteristics: Japanese choriocarcinoma cell line. Cell growth is slow.
Derived from tissue: uterine in animal: human.
A immortal cat cell line cell that has the characteristics: Cat cell line derived from lymphoma.
Derived from tissue: lymphoma in animal: cat.
A immortal frog cell line cell that has the characteristics: Frog (Xenopus laevis) cell line derived from liver.
Derived from tissue: liver in animal: frog.
A immortal frog cell line cell that has the characteristics: Melanophore derived cell line. Derived from Rana nigromaculata. Cell growth is slow.
Derived from tissue: skin in animal: frog.
A immortal frog cell line cell that has the characteristics: Melanophore derived cell line. Derived from Rana porosa brevipoda (albino). Cell growth is slow.
A immortal frog cell line cell that has the characteristics: Frog (Xenopus laevis) cell line derived from subcutaneous tumor.
Derived from tissue: subcutaneous in animal: frog.
A immortal frog cell line cell that has the characteristics: Frog (Xenopus laevis) cell line derived from tadpole.
Derived from tissue: tadpole in animal: frog.
Derived from tissue: skin in animal: frog, albino.
A immortal hybrid cell line cell that has the characteristics: Human hybrid (T and B lymphoblast) cell line. Fusion cll line between 174 and CEM.T2. This hybrid cells do not express MHC class II. HLA-A2 positive.TKG 0599(Deposited from Tohoku Univ.).
Derived from tissue: hybrid cell in animal: human.
A immortal hybrid cell line cell that has the characteristics: Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5, 15, 17.
Derived from tissue: hybrid cell in animal: mouse x rat.
Originator: Lu, Jin & Matsuyama, Mutsushi
A immortal hybrid cell line cell that has the characteristics: Rat thymoma cell line fused to mouse cells during nude-mouse transplantation. Mouse chr. 5,7,15,17.
A immortal zebra fish cell line cell that has the characteristics: Zebrafish fin fibroblast. Cell growth is slow.
Derived from tissue: scale in animal: zebrafish.
A immortal mouse cell line cell that has the characteristics: Human myeloma. Lambda- chain producing.
Derived from tissue: myeloma, subcutaneous in animal: human.
A immortal mouse cell line cell that has the characteristics: Ehrlich's ascite tumor
Derived from tissue: ascites in animal: mouse.
A immortal mouse cell line cell that has the characteristics: 9,10-dimethyl-1,2benzanthracene induced lymphoma. Back up culture of ECA2504.
A immortal mouse cell line cell that has the characteristics: Highly metastatic and drug-resistant mouse tumor
Derived from tissue: lung in animal: mouse.
A immortal mouse cell line cell that has the characteristics: Rapidly growing lymphoma
Derived from tissue: lymph node in animal: mouse.
A immortal mouse cell line cell that has the characteristics: Highly sensitive to X-ray irradiation
A immortal mouse cell line cell that has the characteristics: Resistant to 6TG, isolated from M10
A immortal mouse cell line cell that has the characteristics: Mouse lymphoid tumor, macrophage like. Buck-up culture of ECA85051501.
Derived from tissue: lymphoid tumor in animal: mouse.
A immortal mouse cell line cell that has the characteristics: Natural killer cell-sensitive mouse lymphoma.
Derived from tissue: lymphoma in animal: mouse.
A immortal mouse cell line cell that has the characteristics: IL-3 dependent mouse myeloid cells. MoLV induced.
Derived from tissue: myeloid in animal: mouse.
A immortal mouse cell line cell that has the characteristics: Differentiate to macrophage and granulocyte
Derived from tissue: myeloid leukemia in animal: mouse.
A immortal mouse cell line cell that has the characteristics: Myeloma
Derived from tissue: myeloma in animal: mouse.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from neuroblastoma. TKG0509(Deposited from Tohoku Univ.).
Derived from tissue: neuroblastoma in animal: mouse.
A immortal mouse cell line cell that has the characteristics: Cytotoxic T-cell line. IL-2 dependent.
Derived from tissue: T cell in animal: mouse.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from fibrosarcoma. TNF resistant. BALB/c strain. TKG0281(Deposited from Tohoku Univ.).
Derived from tissue: fibrosarcoma in animal: mouse, BALB/c.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from fibrosarcoma. TNF sensitive. BALB/c strain. TKG0282(Deposited from Tohoku Univ.).
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from spontaneous malignant fibrous histiocytoma. A/J strain. TKG0497(Deposited from Tohoku Univ.).
Derived from tissue: left leg in animal: mouse, A/J.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from neuroblastoma. TKG0307 (Deposited from Tohoku Univ.).
Derived from tissue: neuroblastoma in animal: mouse, A/J.
A immortal mouse cell line cell that has the characteristics: Highly metastatic neuroblastoma
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from lymphoma. A/Sn strain. TKG0387 (Deposited from Tohoku Univ.).
Derived from tissue: lymphoma in animal: mouse, A/Sn.
A immortal mouse cell line cell that has the characteristics: Subline of OP9 cell line, expressing DLL1 and human NGF receptor. See RCB2120 TSt-4/N-DLL1.
Derived from tissue: newborn, calvaria in animal: mouse, B6C3Fe-a/a, op.
A immortal mouse cell line cell that has the characteristics: Subline of OP9 cell line, expressing human NGF receptor. Cell growth is slow. See RCB2119 TSt-4/N.
A immortal mouse cell line cell that has the characteristics: Subline of OP9 cell line, expressing EGFP. Cell growth is slow. See RCB2117 TSt-4/G.
A immortal mouse cell line cell that has the characteristics: Subline of OP9 cell line, expressing DLL1 and EGFP. Cell growth is slow. See RCB2118 TSt-4/G-DLL1.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from ascites. Macrophage-like cells. BALB/c strain. TKG0208(Deposited from Tohoku Univ.).
Derived from tissue: ascites in animal: mouse, BALB/c.
A immortal mouse cell line cell that has the characteristics: Macrophage-like cell
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from lymphoma. Balb/c strain. TKG0571 (Deposited from Tohoku Univ.).
Derived from tissue: lymphoma in animal: mouse, BALB/c.
Derived from tissue: myeloid in animal: mouse, BALB/c.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from myelomonocytic leukemia cells. BALB/c strain. TKG0584(Deposited from Tohoku Univ.).
Derived from tissue: myelomonocyte in animal: mouse, BALB/c.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from bone marrow. Fibroblast-like. 6TG resistant. BALB/c strain. TKG0350(Deposited from Tohoku Univ.).
Derived from tissue: normal bone marrow, tibia, femur in animal: mouse, BALB/c.
A immortal mouse cell line cell that has the characteristics: Mouse osteosarcoma cell line. Transplantable to mouse and form bone tissue in mouse.
Derived from tissue: soft tissue tumor in animal: mouse, BALB/c.
A immortal mouse cell line cell that has the characteristics: A highly metastatic cell line derived from Dunn's osteosarcoma (C3H mouse origin).
Derived from tissue: bone in animal: mouse, C3H.
Originator: Aoki, Yasuaki & Ueda, Ueda, Takafumi
A immortal mouse cell line cell that has the characteristics: Mouse ES (RCB1778 H-1) cell derived cell, useful for study of hematopoiesis.
Derived from tissue: ES cell (H-1) in animal: mouse, C3H.
A immortal mouse cell line cell that has the characteristics: In vivo transplantable highly metastatic sarcoma
Derived from tissue: fibrosarcoma in animal: mouse, C3H.
A immortal mouse cell line cell that has the characteristics: Methylcholanthrene-induced fibrosarcoma. Metastatic to lung.
Derived from tissue: back in animal: mouse, C57BCF1.
A immortal mouse cell line cell that has the characteristics: Mouse osteoblast-like cell line derived from Runx2 deficient mouse.
Derived from tissue: calvaria in animal: mouse, C57BL/6.
A immortal mouse cell line cell that has the characteristics: Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene. Different shape
Derived from tissue: choroid in animal: mouse, C57BL/6.
A immortal mouse cell line cell that has the characteristics: Choroid plexus carcinoma cell line transfected with IgH enhancer-SV40 T fusion gene.
A immortal mouse cell line cell that has the characteristics: Mouse-derived gingival epithelial cell line. Derived from SV40-Large T antigen transgenic mouse.
Derived from tissue: gingival kerarinocyte in animal: mouse, C57BL/6.
A immortal mouse cell line cell that has the characteristics: Differentiate to osteoblasts. Collagen producing.
Derived from tissue: newborn, calvaria in animal: mouse, C57BL/6.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from Swiss Webster Sarcoma 180. CFW strain. TKG0637(Deposited from Tohoku Univ.).
Derived from tissue: sarcoma, ascitic tumor in animal: mouse, CFW.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0672(Deposited from Tohoku Univ.).
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from sarcoma cells in ascites. CFW strain. TKG0638(Deposited from Tohoku Univ.).
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from leukemia. Resistant to 6TG (10 microgram/ml). DBA/2 strain. TKG0478 (Deposited from Tohoku Univ.).
Derived from tissue: leukemia in animal: mouse, DBA/2.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from lung squamous cell carcinoma. TKG0473 (Deposited from Tohoku Univ.).
Derived from tissue: lung in animal: mouse, DBA/2.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from lung squamous cell carcinoma. TKG0214 (Deposited from Tohoku Univ.).
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from lymphoid tumor. DBA/2 strain. TKG0292 (Deposited from Tohoku Univ.).
Derived from tissue: lymphoid tumor in animal: mouse, DBA/2.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from lymphoid tumor. DBA/2 strain. TKG0326(Deposited from Tohoku Univ.).
A immortal mouse cell line cell that has the characteristics: Mouse mastocytoma. Used as a target cells for cytotoxic T cell assays.
Derived from tissue: mastocytoma in animal: mouse, DBA/2.
A immortal mouse cell line cell that has the characteristics: Mouse T cell line transformed by Gross leukemia virus.
Derived from tissue: T cell in animal: mouse, H-2k.
A immortal mouse cell line cell that has the characteristics: Mouse cell line derived from meyloid leukemia. TKG0319 (Deposited from Tohoku Univ.).
Derived from tissue: myeloid leukemia in animal: mouse, SJ.
A immortal endothelial cell line cell that has the characteristics: Mouse vascular endothelial cell line. Transformed by ultraviolet.
Derived from tissue: vascular endothelial cell in animal: mouse,(BALB/c×C57BL/6)(CB6)F1.
A immortal mononuclear phagocyte cell line cell that has the characteristics: T cell line derived from Chimpanzee (Pan troglodytes)
Derived from tissue: peripheral blood mononuclear cells in animal: chimpanzee.
A immortal mononuclear phagocyte cell line cell that has the characteristics: Human B cell line transformed by Epstein-Barr Virus. HLA: A0206 and A2402. TKG0585 (Deposited from Tohoku Univ.).
Derived from tissue: peripheral blood mononuclear cells in animal: human.
Originator: Kudo, T. (IDAC Tohoku Univ.)
A immortal dendritic cell line cell that has the characteristics: Folicular dendritic cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse.
Derived from tissue: anterior pituitary gland in animal: mouse, C57BL.
A immortal blood cell line cell that has the characteristics: Susceptible to nuclear polyhedrosis virus
Derived from tissue: blood, larval in animal: armyworm, cabbage.
Originator: Mitsuhashi,Jun & Shozawa,Akiko
A immortal blood cell line cell that has the characteristics: larval hemocyte
Originator: Mitsuhashi, J. & Shozawa, A.
A immortal blood cell line cell that has the characteristics: Spont. transformant from choroid retina. Only slightly reactive to Factor VIII.
Derived from tissue: blood vessel endothelium in animal: monkey, rhesus.
A immortal connective tissue cell line cell that has the characteristics: Protein- & lipid-free medium growing
Derived from tissue: connective tissue in animal: mouse.
Originator: Katsuta,Hajim Takaoka,Toshiko
A immortal connective tissue cell line cell that has the characteristics: Thymidine kinase defective L cell
A immortal connective tissue cell line cell that has the characteristics: Sanford's original, brought by Katsuta at 7/5/1955. Insensitive to TNFalpha. Possible to culture in MEM medium.
A immortal connective tissue cell line cell that has the characteristics: Mouse fibroblast-like cell line. TKG0217 (Deposited from Tohoku Univ.).
A immortal connective tissue cell line cell that has the characteristics: TNFalpha-sensitive L929. Do not confuse with RCB0081 L929 that is insensitive to TNFalpha.
A immortal connective tissue cell line cell that has the characteristics: Mouse cell line derived from connective tissue. Fibroblast-like. C3H strain. TKG0218 (Deposited from Tohoku Univ.).
Derived from tissue: connective tissue in animal: mouse, C3H.
A immortal connective tissue cell line cell that has the characteristics: A subline of LAG (RCB2758) expressing MUC1. 8-Ag resistant. TKG0466(Deposited from Tohoku Univ.).
A immortal connective tissue cell line cell that has the characteristics: Rat fibroblast-like cell line that can be transformed by oncogenes.
Derived from tissue: connective tissue in animal: rat.
A hybridoma cell line cell that has the characteristics: Mouse T cell hybridoma expressing double HA-tag alone.
Derived from tissue: T cell hybridoma in animal: mouse.
A hybridoma cell line cell that has the characteristics: Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
A hybridoma cell line cell that has the characteristics: Mouse T cell hybridoma (DO-11.10) expressing double Myc-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2 .
A hybridoma cell line cell that has the characteristics: Mouse T cell hybridoma (DO-11.10) expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein).
A hybridoma cell line cell that has the characteristics: Mouse T cell hybridoma ((DO-11.10)expressing double HA-tagged HS1BP3 (HS1 SH3 domain binding protein)-C2.
A hybridoma cell line cell that has the characteristics: IL-5 producing T-cell hybridoma. Culture sup is useful for T88-M cell culture.
A immortal spleen-derived cell line cell that has the characteristics: T cell line derived from Cynomolgus Monkey (Macaca fascicularis)
Derived from tissue: spleen in animal: monkey, cynomolgus.
A immortal kidney-derived cell line cell that has the characteristics: Frog (Xenopus laevis) cell line derived from kidney.
Derived from tissue: kidney in animal: frog.
A immortal kidney-derived cell line cell that has the characteristics: Susceptible to rubella virus, equiv. to ATCC CCL37
Derived from tissue: kidney in animal: rabbit.
A immortal kidney-derived cell line cell that has the characteristics: Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal proximal tubules.
A immortal kidney-derived cell line cell that has the characteristics: Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal distal tubules.
A immortal kidney-derived cell line cell that has the characteristics: Rabbit kidney cell line transformed by SV40 large T antigen. Derived from renal cortical collecting tubules.
A immortal embryo-derived cell line cell that has the characteristics: Highly metastatic sarcoma, synthesize hematoside
Derived from tissue: embryo in animal: hamster.
A immortal embryo-derived cell line cell that has the characteristics: Highly metastatic sarcoma
A immortal embryo-derived cell line cell that has the characteristics: Initially insulin and glucagon producing, but not now. See RCB0795,0796,0797.
Derived from tissue: embryo, pancreas in animal: human.
A immortal embryo-derived cell line cell that has the characteristics: Human embryonic pancreas-derived cell line. See RCB0794,0795,0796.
A immortal embryo-derived cell line cell that has the characteristics: Human embryonic pancreas-derived cell line. See RCB0794,0796,0797.
A immortal embryo-derived cell line cell that has the characteristics: Human embryonic pancreas-derived cell line. See RCB0794,0795,0797.
A immortal embryo-derived cell line cell that has the characteristics: Primary culture of suncus whole embryo
Derived from tissue: embryo in animal: suncus.
A immortal somatic nervous system-derived cell line cell that has the characteristics: N-myc gene amplification
Derived from tissue: nervous system in animal: human.
A immortal somatic nervous system-derived cell line cell that has the characteristics: N-myc gene unamplified tumor. Cell growth is slow.
Derived from tissue: neuroblastoma in animal: human.
A immortal somatic nervous system-derived cell line cell that has the characteristics: N-myc gene amplification. Cell growth is slow.
A immortal somatic nervous system-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma. TKG0448(Deposited from Tohoku Univ.).
A immortal somatic nervous system-derived cell line cell that has the characteristics: Neuroblastoma, a target in CTL assay
A immortal somatic nervous system-derived cell line cell that has the characteristics: Subline of GOTO. Protein-free medium adapted. Cell growth is slow.
A immortal liver-derived cell line cell that has the characteristics: Hepatocyte from the fish, Tilapia (Oreocheomis niloticus). Cell growth is slow.
Derived from tissue: liver in animal: tilapia.
A immortal pituitary gland-derived cell line cell that has the characteristics: Pituitary folliculo-stellate-like cells. GFAP positive and S-100 positive.
Derived from tissue: pituitary in animal: mouse.
A immortal pituitary gland-derived cell line cell that has the characteristics: Macrophage-like tumor dependent on L929 conditioned medium.
A immortal bone marrow-derived cell line cell that has the characteristics: Bone marrow stroma cell line, depositing calcified matrix on the culture surface. TRAP-positive.
Derived from tissue: bone marrow in animal: hamster, Syrian.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-human lung carcinoma mAb (IgM). Possible to culture in serum-free medium.
Derived from tissue: hybridoma in animal: human x human.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing anti-E antigen of the human Rh blood group system
Derived from tissue: hybridoma in animal: human x mouse.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against MuSc.
Derived from tissue: hybridoma in animal: mouse x hamster.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against mouse apolipoprotein E.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybrid cell line of C3H mouse mammary tumor cell, FM3A#2, and 8-Ag resistant L cell. TKG0381(Deposited from Tohoku Univ.).
Derived from tissue: hybrid cell , FM3A#2 x L cell (8-Ag resistant) in animal: mouse x mouse.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma that produce anti-human G1MF (allotype of IgG1) antibody.
Derived from tissue: hybridoma in animal: mouse x mouse.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-SV40 large T antigen mAb (IgG)
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti poly(ADP-ribose) IgG3 kappa producing.
A mouse x mouse hybridoma cell line cell that has the characteristics: MoAb IgM to sea urchin sperm dynein IC2.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG2b). Possible to culture in serum-free medium
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-rabbit muscle glyceraldehyde-3-phosphate dehydrogenase mAb (IgG). Serum-free culturable.
A mouse x mouse hybridoma cell line cell that has the characteristics: Producing anti-human CD36 MoAb.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-chicken IgM antibody secreting. Able to stimulate DT40 cell surface antigen.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-recA protein mAb (IgG1)
A mouse x mouse hybridoma cell line cell that has the characteristics: MoAb IgG1 to sea urchin sperm dynein IC2.
A mouse x mouse hybridoma cell line cell that has the characteristics: MoAb IgM to sea urchin sperm dynein alpha-heavy chain.
A mouse x mouse hybridoma cell line cell that has the characteristics: MoAb IgM to sea urchin sperm dynein beta-heavy chain.
A mouse x mouse hybridoma cell line cell that has the characteristics: MoAb IgG1 to sea urchin sperm dynein IC3.
A mouse x mouse hybridoma cell line cell that has the characteristics: Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH17-4.
A mouse x mouse hybridoma cell line cell that has the characteristics: Producing IgG MoAb against human 29 kDa lectin detectable in many human tumors. Also see HH13-1.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma against differentiated PC-12 cell surface
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-ribonuclease A antibody producing.
Originator: Suga, Ken-ichi & Omasa, Takeshi
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-rabbit muscle lactate dehydrogenase (LDH) mAb (IgG1). Possible to culture in serum-free medium.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-chick αB-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-chick β5-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-chick β6-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-newt γ1-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-pertussis toxin subunit S-2,3 MoAb (IgG1) producing.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-pertussis toxin subunit S-2 MoAb (IgG1) producing.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-pertussis toxin subunit S-3 MoAb (IgG1) producing.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-pertussis toxin subunit S-4 MoAb (IgG1) producing.
A mouse x mouse hybridoma cell line cell that has the characteristics: MoAb to Clostridium perfringens alpha-toxin (phospholipase C).
A mouse x mouse hybridoma cell line cell that has the characteristics: MoAb to Clostridium perfringens theta-toxin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-chick αA-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-lactotetraosylceramide antibody producing. Discriminates metastatic cells from mesothelial cell
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-recA protein mAb (IgG2b)
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against Medaka Vitellogenin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-chick δ-crystallin MoAb producing. Bacteria(+), therefore, must add penicillin+streptomycin.
A mouse x mouse hybridoma cell line cell that has the characteristics: MoAb IgM to sea urchin sperm dynein IC1.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against tetrodotoxin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against domoic acid.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against gonyautoxin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against Broad bean wilt virus 2 22-kDa coat protein.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against N-linked neutral oligosaccharides of glycoproteins.
Register: Kawashima, Ikuo (Tai, Tadashi)
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against F1-linked neutral oligosaccharides of glycoproteins.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against M1-linked neutral oligosaccharides of glycoproteins.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against ganglioside lactones.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GD3 gangliosides).
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against GD2 gangliosides (b-pathway gangliosides).
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against GQ1ba gangliosides.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against 2-3NeuAca-nLc4Cer gangliosides.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against nLc4Cer.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against SGPG.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against GalCer.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against Sulfatide.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against Globoside.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-pertussis toxin subunit S-1 MoAb (IgG2a) producing.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing antibody against the purified basal apparatus of sperm of the an-1 strain of fern Lygodium.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against mouse JDP2.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against differentiated PC-12 cell surface molecules.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against GD1c gangliosides.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against a surface antigen of small cell carcinoma of lung.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-pertussis toxin subunit S-1 MoAb (IgG1) producing.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-human-myeloperoxidase MoAb producing.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and body wall muscle.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on body wall muscle.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that seam cell.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on pharynx basement membrane.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on hypodermis.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on egg shell.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against WASP (Wiscott-Aldolich syndrome protein). TKG0631 (Deposited from Tohoku Univ.).
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on P-granule and pharynx.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on centrosome and P-granule.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against GD1b gangliosides.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti human c-myc p62 mAb (IgG1.kappa)
A mouse x mouse hybridoma cell line cell that has the characteristics: Responding to IL-6 in the bioassay.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against N-glycolylneuraminic acid-containing gangliosides (GM3 gangliosides).
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against latexin.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against C-terminal peptide of rat GSK3-beta.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on intestine.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against oxitocin receptor.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against a peptide, GYPGQV.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-pertussis filamentous hemagglutinin (FHA) MoAb producing.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against mouse JDP2. The antibody recognizes a truncated from of JDP2.
A mouse x mouse hybridoma cell line cell that has the characteristics: Anti-thymine dimer antibody producing. Serum-free cultured hybridoma.
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against an antigen of C. elegans embryo. Antigen is not determined but that on nuclear membrane.
A mouse x mouse hybridoma cell line cell that has the characteristics: S. cerevisiae Endo.Sce I large subunit mAb (IgG2b)
A mouse x mouse hybridoma cell line cell that has the characteristics: Hybridoma. Anti-Rat Carboxypeptidase M MoAb producing.
A immortal cornea-derived cell line cell that has the characteristics: SV40-Adeno vector transformed cornea cells. 64kD keratin producing. Choleratoxin-free medium.
Derived from tissue: cornea in animal: human.
A immortal cornea-derived cell line cell that has the characteristics: This cell line is provided only in Japan.
A immortal cornea-derived cell line cell that has the characteristics: Fibroblast-like cell line derived from rabbit.
Derived from tissue: cornea in animal: rabbit.
A immortal cornea-derived cell line cell that has the characteristics: Normal rabbit cornea cells. Usually transform spontaneously during serial culture.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: A subline of CHO cells. Require proline. TKG0328(Deposited from Tohoku Univ.).
Derived from tissue: ovary in animal: chinese hamster.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: SPB-1 derivative complemented the Serine-palmitoyl transferase deficiency.
Derived from tissue: ovary in animal: hamster, Chinese.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: LY-B derivative complemented the Serine-palmitoyl transferase (LCB1 subunit) deficiency.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT1).
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Subline of CHO-K1 that expresses human leukotriene B4 receptor (BLT2).
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Serine-palmitoyl transferase deficient (temperature-sensitive) cells derived from CHO-K1 cell line.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Serine-palmitoyl transferase (LCB1 subunit) deficient cells derived from CHO-K1 cell line.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Nalidixic acid sensitive mutant. Also sensitive toVP-16 and VM-26 Topo II inhibitors.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Subline of CHO-K1 cell line in which trafficking of ceramide is deficient
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Subline of LY-A in which human CERT cDNA are expressed and trafficking of ceramide is recovered
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: A subline of the CHO-K1 cell line. Widely used for the isolation of repair-deficient mutants. Useful for gene mutation assays at the APRT and HPRT loci.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Chinese hamster ovary cell line. Widely used for the isolation of mutants by mutagenesis.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Subline of CHO cells. Derived from CHO-K1 cell line. Serum-free medium adapted.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: CHO-K1 maintained in suspension culture.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Widely used cell line, especially for biotechnol
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC1 gene deficient.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC3 gene deficient.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: A subline of the CHO-K1 cell line. X-ray-sensitive mutant. XRCC4 gene deficient.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: Subline of CHO-K1 that expresses human platelet activating factor receptor.
A immortal Chinese hamster animal ovary-derived fibroblast cell line cell that has the characteristics: A subline of the CHO-K1 cell line. X-ray-sensitive mutant derived from CHO-AA8 cell line. XRCC7(DNA-PK) gene deficient.
A immortal human umbilical cord-derived fibroblast cell line cell that has the characteristics: Normal umbilical card fibroblast, female
Derived from tissue: umbilical cord in animal: human.
A immortal human umbilical cord-derived fibroblast cell line cell that has the characteristics: Normal umbilical cord fibroblast, female
A immortal human umbilical cord-derived fibroblast cell line cell that has the characteristics: Normal umbilical cord fibroblast, male
A immortal human umbilical cord-derived fibroblast cell line cell that has the characteristics: Human mesenchymal cell line derived from umbilical cord blood. Immortalized by hTERT.
Derived from tissue: umbilical cord blood in animal: human.
A immortal human umbilical cord-derived fibroblast cell line cell that has the characteristics: Human mesenchymal cell line derived from umbilical cord blood. Immortalized by HPV E6, E7, and hTERT.
A immortal human embryo-derived fibroblast cell line cell that has the characteristics: Human fibroblast-like cells derived from embryo. Not immortalized.
Derived from tissue: embryo in animal: human.
A immortal human embryo-derived fibroblast cell line cell that has the characteristics: Human cell line derived from embryonic fibroblasts. Characteristics Embryonal fibroblast immortalized by 60-Co irradiation (400 Rad x 1 time and 200 rad x 12 times). Non-tumorigenic. TKG0482 (Deposited from Tohoku Univ.).
Derived from tissue: embryonal fibroblast in animal: human.
A immortal cattle cell line cell that has the characteristics: Bovine leukemia virus producing. Surface Ig (+).
Derived from tissue: blood in animal: bovine.
A immortal cattle cell line cell that has the characteristics: Bovine B cell leukemia without virus production
A immortal cattle cell line cell that has the characteristics: Bovine granulosa cell line.
Derived from tissue: granulosa cell in animal: bovine.
A immortal cattle cell line cell that has the characteristics: Useful for bovine virus testing
Derived from tissue: lymph node in animal: bovine.
A immortal cattle cell line cell that has the characteristics: Bovine pulmonary artery endothelial cells producing angiotensin-converting enzyme. Bovine Viral Diarrhea Virus (BVDV) positive. Backup of ECA86111401.
Derived from tissue: pulmonary artery endothelium in animal: bovine.
A immortal human lymphocyte cell line cell that has the characteristics: Human cell line derived from B cells in umbilical cord blood. Transformed by EB virus. TKG0305(Deposited from Tohoku Univ.).
Derived from tissue: cord blood lymphocytes in animal: human.
A immortal human lymphocyte cell line cell that has the characteristics: Human cell line derived from p180-BCR-ABL dependent leukemia.
Derived from tissue: peripheral blood lymphocytes in animal: human.
A immortal human lymphocyte cell line cell that has the characteristics: Lymphoblastoid cell line established by EBV infection from XP patient, variant type. TKG0309 (Deposited from Tohoku Univ.).
Originator: Tohda, H. (IDAC Tohoku Univ.)
A immortal human lymphocyte cell line cell that has the characteristics: Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0313(Deposited from Tohoku Univ.).
A immortal human lymphocyte cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0025.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0002.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0012.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus. The same patient as GMC0014.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus.The same patient as GMC0022.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus. The same patient as GMC0024.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome (questionable) patient and transformed by Epstein-Barr Virus. The same patient as GMC0027.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. he same patient as GMC0028.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0031.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from Werner syndrome patient and transformed by Epstein-Barr Virus. The same patient as GMC0036.
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line transformed by Epstein-Barr Virus. TKG0614(Deposited from Tohoku Univ.).
A immortal human lymphocyte cell line cell that has the characteristics: Human B cell line derived from xeroderma pigmentosum (XP) patient and transformed by Epstein-Barr Virus. TKG0312(Deposited from Tohoku Univ.).
A immortal cabbage moth larva-derived cell line cell that has the characteristics: Cabbage armyworm cell line applicable to large scaale production of insect virus.
Derived from tissue: fat body, larval in animal: armyworm, cabbage.
Originator: Inoue, Hajime & Mitsuhashi,Jun
A immortal cabbage moth larva-derived cell line cell that has the characteristics: Larval fat body hemocyte.
Originator: Inoue,Hajime & Mitsuhashi, Jun
A immortal cabbage moth larva-derived cell line cell that has the characteristics: Cabbage armyworm cell line applicable to large scale insect virus production.
Originator: Inoue,Hajime & Mitsuhashi,Jun
A immortal cabbage moth larva-derived cell line cell that has the characteristics: Sensitive to nuclear polyhedrosis virus. Possible to grow in sea-water based low-cost medium.
A immortal cabbage moth larva-derived cell line cell that has the characteristics: Insect cell line derived from Mamestra brassicae
Derived from tissue: larval in animal: armyworm, cabbage.
A immortal cabbage moth larva-derived cell line cell that has the characteristics: Insect cell line derived from Mamestra brassicae. Cell growth is slow.
A immortal cabbage moth larva-derived cell line cell that has the characteristics: Show finely branched cytoplasmic processes
Derived from tissue: pupal ovary in animal: armyworm, cabbage.
A immortal cabbage moth larva-derived cell line cell that has the characteristics: Susceptible to insect viruses.
Derived from tissue: fat body in animal: armyworm, common.
A immortal monkey kidney-derived cell line cell that has the characteristics: Highly susceptible to SV40 infection
Derived from tissue: kidney in animal: monkey, African green.
A immortal monkey kidney-derived cell line cell that has the characteristics: 35 copies of CAG-loxP-neopA-loxP-LacZ were tandemly inserted. Cre will delete neopA and induce LacZ.
A immortal monkey kidney-derived cell line cell that has the characteristics: SV40 large T antigen expressing, derived from CV-1
A immortal monkey kidney-derived cell line cell that has the characteristics: A copy of CAG-loxP-neopA-loxP-LacZ was inserted. Cre will delete neopA and induce LacZ.
A immortal monkey kidney-derived cell line cell that has the characteristics: CAG-loxP-neopA-loxP-LacZ(incomplete) was inserted. Control cell line for 2-2 and 2-7 cells.
A immortal monkey kidney-derived cell line cell that has the characteristics: Expressing SV40 tsA58 large T antigen. Possible to culture in protein-free MEM. G418-resistant.
A immortal monkey kidney-derived cell line cell that has the characteristics: Expressing SV40 tsA58 large T antigen. Verots S3 cultured in protein-free MEM. G418-resistant.
A immortal monkey kidney-derived cell line cell that has the characteristics: Culturable in proein-free MEM supplemented with biotin.
A immortal monkey kidney-derived cell line cell that has the characteristics: No interferon production, best for vaccine product.
A immortal monkey kidney-derived cell line cell that has the characteristics: Subline of COS cell line expressing Fucci, a marker of cell cycle.
A immortal monkey kidney-derived cell line cell that has the characteristics: Cynomolgus monkey cell line. Possible to culture in DMEM medium. See RCB0456.
Derived from tissue: kidney in animal: monkey, cynomolgus.
A immortal monkey kidney-derived cell line cell that has the characteristics: Cynomolgus monkey cell line.
A mouse x rat hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against mouse B7-H1.
Derived from tissue: hybridoma in animal: mouse x rat.
A mouse x rat hybridoma cell line cell that has the characteristics: Hybridoma producing a monoclonal antibody against mouse B7-H1. Possible to culture in RPMI1640 medium.
A mouse x rat hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against GFP. Rat IgG2a monoclonal antibody.
A mouse x rat hybridoma cell line cell that has the characteristics: Hybridoma producing monoclonal antibody against bacterial unknown molecule. Rat IgG2a monoclonal antibody.
A immortal mouse embryo-derived cell line cell that has the characteristics: Non-contact inhibited
Derived from tissue: embryo in animal: mouse.
A immortal mouse embryo-derived cell line cell that has the characteristics: Subline of KOP cell line. Zeocin-resistant.
A immortal mouse embryo-derived cell line cell that has the characteristics: Subline of KOP cell line, expressing FLAG-tagged EXIP. Zeocin-resistant.
A immortal mouse embryo-derived cell line cell that has the characteristics: Subline of KOP cell line, expressing FLAG-tagged p38 MAP kinase. Zeocin-resistant.
A immortal mouse embryo-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line lacking p38 MAP kinase expression.
A immortal mouse embryo-derived cell line cell that has the characteristics: Tioguanine- and ouabain-resistant and HAT-sensitive fibroblasts. Suitable for ES cell feeder layer. Back up culture of ECA85061804.
A immortal mouse embryo-derived cell line cell that has the characteristics: RBP-J deficient mouse fibroblasts
A immortal mouse embryo-derived cell line cell that has the characteristics: Control cell line for OT11 (normal fibroblasts derived from the same mouse strain)
A immortal mouse embryo-derived cell line cell that has the characteristics: Mouse teratoma-derived cell line. Parent cell line of ATDC5.
Derived from tissue: embryo in animal: mouse, 129.
A immortal mouse embryo-derived cell line cell that has the characteristics: Mouse cell line derived from embryonal carcinoma. Expressing laminin alpha-5 exogenously.
Originator: Hayashi, Yoshitake (Nagoys Univ.)
A immortal mouse embryo-derived cell line cell that has the characteristics: Differentiate to chondrocytes, unidentifiable pigment cells. Teratocarcinoma AT805 derived.
A immortal mouse embryo-derived cell line cell that has the characteristics: Mouse cell line derived from embryonal carcinoma. 129 strain. TKG0519(Deposited from Tohoku Univ.).
A immortal mouse embryo-derived cell line cell that has the characteristics: Mouse teratoma-derived cell line.
A immortal mouse embryo-derived cell line cell that has the characteristics: Said to differentiate to parietal endoderm with retinoic acid and dibutyryl cAMP.
A immortal mouse embryo-derived cell line cell that has the characteristics: A subline of mouse ES cell line, F9 (129), lacking Odf2.
A immortal mouse embryo-derived cell line cell that has the characteristics: Siblings of RGB3T3-1, contact-inhibited
Derived from tissue: embryo in animal: mouse, BALB/c.
A immortal mouse embryo-derived cell line cell that has the characteristics: Contact-inhibited semi-normal cell line
Originator: Aaronson, S.A. & Todaro, G.T.
A immortal mouse embryo-derived cell line cell that has the characteristics: Original cloned line from RCB, just like BALB/3T3
A immortal mouse embryo-derived cell line cell that has the characteristics: Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear. The efficiency of differentiation is lower compared to RCB 2318.
Derived from tissue: embryonal carcinoma in animal: mouse, C3H.
A immortal mouse embryo-derived cell line cell that has the characteristics: Mouse cell line derived from embryonal carcinoma. C3H strain. Following differentiation, beating cardiomyocytes appear efficiently.
A immortal mouse embryo-derived cell line cell that has the characteristics: Clone 8, Contact-inhibited semi-normal
Derived from tissue: embryo in animal: mouse, C3H.
A immortal mouse embryo-derived cell line cell that has the characteristics: Subline of A-6. Dependent on SCF and IL-6 for proliferation. Differentiate to erythroid cells by IL-3.
A immortal mouse embryo-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line. TKG0299 (Deposited from Tohoku Univ.).
Derived from tissue: embryo in animal: mouse, NIH Swiss.
A immortal mouse embryo-derived cell line cell that has the characteristics: Spontaneous transformant of NIH3T3
A immortal mouse embryo-derived cell line cell that has the characteristics: SV40 large T (tsA58)-pBR322 tarnsformed NIH3T3.
Originator: Ohno, Tadao & Abe, Shin-ichiro
A immortal mouse embryo-derived cell line cell that has the characteristics: NIH3T3 transformant expressing human activated k-ras-2.
A immortal mouse embryo-derived cell line cell that has the characteristics: pSV2neo-introduced G418-resistant Cle-H3 mutant.
A immortal mouse embryo-derived cell line cell that has the characteristics: Subclone of NIH3T3
A immortal mouse embryo-derived cell line cell that has the characteristics: High-titer producer of MoMLV-derived retrovirus. A subline of ψCRIP.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse GM-CSF cDNA
A immortal mouse embryo-derived cell line cell that has the characteristics: High-titer producer of MoMLV-derived retrovirus including mouse IL-1alpha cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: High-titer producer of MoMLV-derived retrovirus including mouse IL-1 receptor antagonist cDNA
A immortal mouse embryo-derived cell line cell that has the characteristics: High-titer producer of MoMLV-derived retrovirus including mouse IL-2 cDNA
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse IL-3 cDNA
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse IL-6 cDNA
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse IL-7 cDNA
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse IL-10 cDNA
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p40 subunit. Refer RCB1099.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse IL-12 cDNA for p35 subunit. Refer RCB1098.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse TNF-alpha gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including human TNF-alpha cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse lymphotoxin cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse G-CSF gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including human M-CSF gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: High-titer producer of MoMLV-derived retrovirus including mouse IFN-gamma cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including human MIF cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse leukemia inhibitory factor cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse kit ligand (SCF) cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including human oncostatin M cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse B7 (CD80) cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse B7-2 (CD86) cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including the trancated form of mouse IFN-gamma cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including rabbit IL-1 receptor antagonist cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including rat GM-CSF cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including neo gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including HSV thymidine kinase cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.
A immortal mouse embryo-derived cell line cell that has the characteristics: High-titer producer of MoMLV-derived retrovirus including mouse c-src cDNA with ts mutation.
A immortal mouse embryo-derived cell line cell that has the characteristics: High-titer producer of MoMLV-derived retrovirus including SV40 large T temperature-sensitive cDNA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express human VIP receptor and blasticidin S deaminase gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: Producer of MoMLV-derived retrovirus including mouse IL-4 cDNA
A immortal mouse embryo-derived cell line cell that has the characteristics: Retrovirus producer. Produce virus to express human Bax protein.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express angiotensin receptor.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express the human CD82.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express the anti-apoptotic crmA.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express the human endothelin receptor.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express the mouse calcineurin.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express lac Z.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express SV40 large T antigen.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express human MSH receptor.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express Cre recombinase.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express human p53 and blasticidin S deaminase gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express human Bcl-xL and blasticidin S deaminase gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express human FAS and human CD80.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express human secretin receptor and blasticidin S deaminase gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express human somatostatin receptor and blasticidin S deaminase gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: Cell line producing retrovirus to express a truncated form of mouse calcineurin and blasticidin S deaminase gene.
A immortal mouse embryo-derived cell line cell that has the characteristics: Subline of ψCRIP that produce virus to express LacZ possessing nuclear localization signal.
A immortal mouse embryo-derived cell line cell that has the characteristics: A subline of the NIH/3T3 cell line. Transformed lymphoblast-like cells. Swiss strain.TKG0300(Deposited from Tohoku Univ.). TKG0300(Deposited from Tohoku Univ.). Cell growth is slow.
Derived from tissue: embryo in animal: mouse, Swiss.
A immortal mouse embryo-derived cell line cell that has the characteristics: Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses.
Derived from tissue: embryo in animal: mouse, wild.
A immortal rat liver-derived cell line cell that has the characteristics: Capable to form collagen network. Possible to culture in DMEM medium. See RCB0067.
Derived from tissue: liver in animal: rat.
A immortal rat liver-derived cell line cell that has the characteristics: Non tumorigenic in nude mice
A immortal rat liver-derived cell line cell that has the characteristics: Non tumorigenic in nude mice. Possible to culture in DMEM medium.
A immortal rat liver-derived cell line cell that has the characteristics: Liver-derived cell, tumorigenic in nude mice. Possible to culture in DMEM medium.
A immortal rat liver-derived cell line cell that has the characteristics: Epitherial cell from rat liver. Possible to culture in DMEM medium.
A immortal rat liver-derived cell line cell that has the characteristics: Epitherial cell from rat liver
A immortal rat liver-derived cell line cell that has the characteristics: Capable to form collagen network
A immortal rat liver-derived cell line cell that has the characteristics: Liver-derived cell, tumorigenic in nude mice
A immortal rat liver-derived cell line cell that has the characteristics: Rat cell line derived from hepatoma cells in ascites. TKG0535(Deposited from Tohoku Univ.).
Derived from tissue: liver, ascites in animal: rat , Donryu.
A immortal rat liver-derived cell line cell that has the characteristics: Rat cell line derived from hepatoma cells in ascites. TKG0130(Deposited from Tohoku Univ.).
Derived from tissue: liver, ascites in animal: rat, ACI/N.
A immortal rat liver-derived cell line cell that has the characteristics: Rat (Buffalo) cell line derived from hepatoma. TKG0365 (Deposited from Tohoku Univ.).
Derived from tissue: liver in animal: rat, Buffalo.
A immortal rat liver-derived cell line cell that has the characteristics: ES cell differentiation inhibitory activity (DIA)
A immortal rat liver-derived cell line cell that has the characteristics: EJ-ras oncogene transformed ARLJ301-3
Derived from tissue: liver in animal: rat, F344/DuCrj.
A immortal rat liver-derived cell line cell that has the characteristics: Spontaneous transformant of ARLJ301-3
A immortal rat liver-derived cell line cell that has the characteristics: Diploid rat liver epithelial cell line
A immortal rat liver-derived cell line cell that has the characteristics: Rat cell line derived from histiocytic sarcoma. Possessing characteristics of macrophage.
A immortal rat liver-derived cell line cell that has the characteristics: SV40-Adeno Vector transformed hepatocytes. Albumin secretion and urea synthesis were reported.
Derived from tissue: liver in animal: rat, Wistar.
A immortal human colon-derived cell line cell that has the characteristics: Colon carcinoma. CEA-positive, nude mouse-transplantable.
Derived from tissue: colon in animal: human.
A immortal human colon-derived cell line cell that has the characteristics: Human colon carcinoma. Backup of ECA86010202.
A immortal human colon-derived cell line cell that has the characteristics: Described to produce serotonin, epinephrine.
A immortal human colon-derived cell line cell that has the characteristics: Japanese colon carcinoma. Family of the patient also exhibited high risk, but not so-called HNPCC.
A immortal human colon-derived cell line cell that has the characteristics: Human cell line derived from colon cancer. Derived from ascites metastasis. TKG0457(Deposited from Tohoku Univ.). Cell growth is slow.
Derived from tissue: colon, ascites meta in animal: human.
A immortal human colon-derived cell line cell that has the characteristics: Human colon cancer cell line derived from metastasis at ovary. Moderately differentiated adenocarcinoma. Cell growth is slow.
Derived from tissue: colon, ovary meta in animal: human.
A immortal human colon-derived cell line cell that has the characteristics: CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow.
Derived from tissue: colon, supraclavicular meta in animal: human.
A immortal human brain-derived cell line cell that has the characteristics: Human malignant meningioma.
Derived from tissue: brain in animal: human.
Originator: Ishiwata, Isamu & Satou, Zenrou & Ishikawa, Hiroshi
A immortal human brain-derived cell line cell that has the characteristics: Human glioma separated from gliosarcoma.
A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from astrocytoma developed in a patient with NF-1 (neurofibromatosis type 1)
A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471(Deposited from Tohoku Univ.).
A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0183(Deposited from Tohoku Univ.).
A immortal human brain-derived cell line cell that has the characteristics: Human brain derived lymphoma.
Originator: Ishiwata, I. & Sato, E. & Ishikawa, H.
A immortal human brain-derived cell line cell that has the characteristics: Glioma, S-100 Protein producing. Cell growth is slow.
A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0453(Deposited from Tohoku Univ.).
Originator: Kanno H. (Neurosurgery, Yokohama City University).
A immortal human trophoblast cell line cell that has the characteristics: Trophoblastic cell. Producing chorionic gonadotropin, estrogen, progesterone. Cell growth is slow.
Derived from tissue: choriocarcinoma in animal: human.
A immortal human skin-derived cell line cell that has the characteristics: Normal human skin fibroblast
Derived from tissue: skin in animal: human.
A immortal human skin-derived cell line cell that has the characteristics: Normal diploid fibroblast from Japanese
A immortal human skin-derived cell line cell that has the characteristics: SV40-transformed Werner's syndrome fibroblast
A immortal human skin-derived cell line cell that has the characteristics: Ehlers-Danlos syndrome
A immortal human skin-derived cell line cell that has the characteristics: Morquio syndrome
A immortal human skin-derived cell line cell that has the characteristics: Wilson's disease
A immortal human skin-derived cell line cell that has the characteristics: Citrullinemia
A immortal human skin-derived cell line cell that has the characteristics: Cockayne's syndrome
A immortal human skin-derived cell line cell that has the characteristics: Werner's syndrome
A immortal human skin-derived cell line cell that has the characteristics: Werner's syndrome, the same patient as RCB0433 WS1TKB2.
A immortal human skin-derived cell line cell that has the characteristics: Werner's syndrome, the same patient as RCB0409 WS1TKB.
A immortal human skin-derived cell line cell that has the characteristics: OTC(-), X-linked, dominant (XD)
Originator: Ohno, Tadao & Nakamura, Norimasa
A immortal human skin-derived cell line cell that has the characteristics: Control from a nonexposed individual with breast cancer, different specimen from RCB0635
A immortal human skin-derived cell line cell that has the characteristics: Control from a nonexposed individual without cancer
A immortal human skin-derived cell line cell that has the characteristics: Control from a nonexposed individual with stomach cancer
A immortal human skin-derived cell line cell that has the characteristics: Atomic bomb survivor with breast cancer
A immortal human skin-derived cell line cell that has the characteristics: Control from a non-exposed individual without breast cancer but with thyroid & colon cancer.
A immortal human skin-derived cell line cell that has the characteristics: Control from a nonexposed individual with breast cancer
A immortal human skin-derived cell line cell that has the characteristics: Control from a nonexposed individual with uterus cancer
A immortal human skin-derived cell line cell that has the characteristics: Atomic bomb survivor without cancer
A immortal human skin-derived cell line cell that has the characteristics: Atomic bomb survivor with breast cancer, different specimen from RCB0624
A immortal human skin-derived cell line cell that has the characteristics: Atomic bomb survivor with breast cancer, different specimen from RCB0621.
A immortal human skin-derived cell line cell that has the characteristics: Control from a nonexposed individual with chest cancer
A immortal human skin-derived cell line cell that has the characteristics: Control from a nonexposed individual with breast cancer, different specimen from RCB0580.
A immortal human skin-derived cell line cell that has the characteristics: Tay-Sachs' disease
A immortal human skin-derived cell line cell that has the characteristics: Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable.
A immortal human skin-derived cell line cell that has the characteristics: Skin fibroblasts from a familial colon polyposis patient.
A immortal human skin-derived cell line cell that has the characteristics: Skin fibroblasts from a familial colon polyposis patient at Hiroshima.
A immortal human skin-derived cell line cell that has the characteristics: Severe insulin-resistance by uncleaved insulin proreceptor. G->T mutation in interconnecting region.
A immortal human skin-derived cell line cell that has the characteristics: Werner's syndrome fibroblast
A immortal human skin-derived cell line cell that has the characteristics: Once thought Werner's Syndrome, but the life span in vitro was more than 50 PDL.
A immortal human skin-derived cell line cell that has the characteristics: Accelerated aging in vitro, Werner's syndrome
A immortal human skin-derived cell line cell that has the characteristics: Melanoma from a 47 year old female. Backup of ECA87061210.
A immortal human skin-derived cell line cell that has the characteristics: Human melanoma producing melanin up to 50 PDL. Backup of ECA88030401.
A immortal human skin-derived cell line cell that has the characteristics: Questionable Werner's syndrome-like. Life span in vitro was over 60 PDL.
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0001.
A immortal human skin-derived cell line cell that has the characteristics: Chromosomal aberration; 46XX + (11;12)(q23.3, q15). Need confirmation.
A immortal human skin-derived cell line cell that has the characteristics: Japanese cystic fibrosis fibroblast.
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0005.
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0015.
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC00017.
A immortal human skin-derived cell line cell that has the characteristics: Diploid fibroblast from normal Japanese skin.
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome (questionable) patient's skin. The same patient as GMC0020.
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0029.
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0030.
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC00035.
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome (questionable) patient's skin.
A immortal human skin-derived cell line cell that has the characteristics: Prader-Willi syndrome with obesity. del(15) was found in lymphocytes of the patient.
A immortal human skin-derived cell line cell that has the characteristics: Pseudo congenital lactic acidosis.
A immortal human skin-derived cell line cell that has the characteristics: Pyruvate dehydrogenase deficiency fibroblasts.
Originator: Ohno, Tadao & Saijo, Kaoru & Nakamura, Norimasa
A immortal human skin-derived cell line cell that has the characteristics: Atomic bomb survivor without breast cancer but with thyroid cancer.
A immortal human skin-derived cell line cell that has the characteristics: Normal human skin fibroblast, RCB original
A immortal human skin-derived cell line cell that has the characteristics: Human primary adherent cells derived from Werner syndrome patient's skin. The same patient as GMC0016.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line derived from skin. (BALB/c x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
Derived from tissue: skin in animal: mouse, (BALB/c x C57BL/6)F1.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line derived from skin. (BALB/cxC3H)F1 strain. Induced by ultra-violet irradiation.
Derived from tissue: skin in animal: mouse, (BALB/cxC3H)F1.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line derived from skin. (C3H/HeN x C57BL/6)F1 strain. Induced by ultra-violet irradiation.
Derived from tissue: skin in animal: mouse, (C3H/HeN x C57BL/6)F1.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse skin derived cell line. Induced by ultra-violet irradiation.
Derived from tissue: skin in animal: mouse, BALB/c.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line derived from skin. BALB/c strain. Induced by ultra-violet irradiation.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Neuron-like)
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line established by UV irradiation. Derived from Balb/c strain. (Epithelial-like)
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse stromal cell line for human lung small cell carcinoma cell line, WA-ht. Cell growth is slow.
Derived from tissue: skin in animal: mouse, BALB/c(nu/nu).
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line derived from skin. C3H/HeN strain. Induced by ultra-violet irradiation.
Derived from tissue: skin in animal: mouse, C3H/HeN.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse melanoma producing melanin.
Derived from tissue: skin in animal: mouse, C57BL/6.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse melanoma expressing E.coli lac Z. Strongly positive with beta-galactosidase.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line derived from skin. C57BL/6 strain. Induced by ultra-violet irradiation.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast-like cell line derived from skin. C57BL/6 strain.Induced by ultra-violet irradiation.
A immortal mouse skin-derived cell line cell that has the characteristics: Melanin pigment producing mouse melanoma
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse cell line derived from melanoma. TKG0598 (Deposited from Tohoku Univ.).
A immortal mouse skin-derived cell line cell that has the characteristics: Glucosylceramide synthetase-deficient B16 melanoma mutant.
Derived from tissue: skin in animal: mouse, C57BL/6J.
A immortal mouse skin-derived cell line cell that has the characteristics: Not expressing melanoma antigen. Control for GM-95 cell line.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse GM-CSF producing B16 melanoma.
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse cell line derived from melanoma. TKG0348 (Deposited from Tohoku Univ.).
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse cell line derived from melanoma. C57BL/6J strain. TKG0347(Deposited from Tohoku Univ.).
A immortal mouse skin-derived cell line cell that has the characteristics: Mouse fibroblast cell line. Transformed by ultraviolet. Highly immunogenic.
Derived from tissue: skin in animal: mouse,(BALB/c×C57BL/6)(CB6)F1.
A immortal mouse epithelial cell line cell that has the characteristics: Metastatic epithelial cell
Derived from tissue: cheek in animal: mouse, C3H.
A immortal mouse liver-derived cell line cell that has the characteristics: Hepatocytes containing temperature sensitive SV40 large T antigen. P450IA1 inducible.
Derived from tissue: liver in animal: mouse.
A immortal mouse liver-derived cell line cell that has the characteristics: Derived from BW7756 tumor in a C57L mouse. Back up culture of ECA3041.
Derived from tissue: liver in animal: mouse, C57L.
A immortal Drosophila melanogaster embryo-derived cell line cell that has the characteristics: Fruit fly Oregon-R derived cell line. Highly sensitive in RNA interference compared with CHO-K1.
Derived from tissue: embryo in animal: Drosophila.
A immortal mouse spleen-derived cell line cell that has the characteristics: Mast cell precursor, respond to IL-3
Derived from tissue: spleen in animal: mouse.
A immortal mouse spleen-derived cell line cell that has the characteristics: Spontaneous transformant of LT4
A immortal mouse spleen-derived cell line cell that has the characteristics: Mouse cell line derived from erythroleukemia cells transformed by Friend leukemia virus. TKG0370(Deposited from Tohoku Univ.).
A immortal mouse spleen-derived cell line cell that has the characteristics: Friend leukemia cell line from BALB/c mouse. Virusnon-producing.
Derived from tissue: spleen in animal: mouse, BALB/c.
A immortal mouse spleen-derived cell line cell that has the characteristics: Erythroleukemia cell line drived from mouse C3H/He. TER119(+) cells.
Derived from tissue: spleen in animal: mouse, C3H/He.
A immortal mouse spleen-derived cell line cell that has the characteristics: Friend leukemia cell line. High ability to differentiate to erythroblastoid cells.
Derived from tissue: spleen in animal: mouse, DBA/2.
A immortal mouse spleen-derived cell line cell that has the characteristics: Friend leukemia cell line from DBA/2 mouse.
A immortal mouse spleen-derived cell line cell that has the characteristics: Mouse cell line derived from leukemia. Lymphoblastoid cells. DBA/2 strain. TKG0409(Deposited from Tohoku Univ.).
Derived from tissue: spleen, lymphnode, leukemia in animal: mouse, DBA/2.
A immortal mouse spleen-derived cell line cell that has the characteristics: Friend leukemia. Differentiate to erythroblastoid cells.
Derived from tissue: spleen in animal: mouse, DDD.
A immortal mouse spleen-derived cell line cell that has the characteristics: Friend leukemia. Differentiate to erythroblastoid cells with benzidine etc.
A immortal mouse spleen-derived cell line cell that has the characteristics: Friend leukemia. Differentiate to erythroblastoid cells with 1.5% DMSO etc. A clone of TSFAT-3.fl
A immortal mouse spleen-derived cell line cell that has the characteristics: SFFV producing Friend leukemia cell line. Non-differentiating.
A immortal mouse kidney-derived cell line cell that has the characteristics: Kidney epithelial cells containing temperature sensitive SV40 large T antigen. Compared to TKC2.
Derived from tissue: kidney in animal: mouse.
A immortal human stomach-derived cell line cell that has the characteristics: Stomach cancer, but producing hybrid type of alkaline phosphatase. See HuG1-N.
Derived from tissue: stomach in animal: human.
A immortal human stomach-derived cell line cell that has the characteristics: Stomach cancer, but producing Nagao-type alkaline phosphatase. See HuG1-PI.
A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.).
A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from gastric cancer. Signet ring carcinoma. TKG0213 (Deposited from Tohoku Univ.).
A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from gastric cancer. TKG0411 (Deposited from Tohoku Univ.). Cell growth is slow.
A immortal human stomach-derived cell line cell that has the characteristics: Human gastric cancer cell line. TKG0185 (Deposited from Tohoku Univ.).
A immortal human stomach-derived cell line cell that has the characteristics: Stomach cancer (Borrmann IV). Mutin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow.
RIKEN: COSMIC ID:906869; Riken RCB0555,RCB0555
A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from gastric cancer. Established from the cells in ascites.
Derived from tissue: stomach, ascites meta in animal: human.
A immortal human stomach-derived cell line cell that has the characteristics: Human gastric cancer cell line derived from metastasis at liver.
Derived from tissue: stomach, liver meta in animal: human.
A immortal human stomach-derived cell line cell that has the characteristics: Small cell gastrointestinal carcinoma with c-myc overexpression. Cell growth is slow.
RIKEN: COSMIC ID:906848; Riken RCB0983,RCB0983
A immortal human stomach-derived cell line cell that has the characteristics: Poorly differentiated gastric adenocarcinoma. Producing high level of CEA.
A immortal human stomach-derived cell line cell that has the characteristics: Moderately differentiated adenocarcinoma. Once they were hypodiploids. Cell growth is slow.
A immortal human stomach-derived cell line cell that has the characteristics: Gastric cancer undifferentiated, mucin producing
Derived from tissue: stomach, lymph node meta in animal: human.
A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from lymph node metastasis of gastric cancer.
A immortal human stomach-derived cell line cell that has the characteristics: Japanese gastric cancer, lymph node metastated.
RIKEN: RCB1148,COSMIC ID:909770; Riken RCB1148
A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from gastric cancer
A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from stomach cancer.
A immortal human stomach-derived cell line cell that has the characteristics: Potentially differentiatable to both direction of adenomatous and squamous epithelial cells.
A immortal human stomach-derived cell line cell that has the characteristics: c-erbB-2 expressing gastric adenocarcinoma. Differentiated type.
A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from intraperitoneal metastasis of gastric cancer
Derived from tissue: stomach, mesenterium meta in animal: human.
A immortal human stomach-derived cell line cell that has the characteristics: Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow.
Derived from tissue: stomach, subcutis in animal: human.
A immortal human bone element-derived cell line cell that has the characteristics: Osteosarcoma cell line derived from human. High yield of IFN production by induction with poly IC, cyclohexmide, actinomycin D. Antigenically, MG-63 IFN is closely related to human fibroblast IFN. TKG0294 (Deposited from Tohoku Univ.).
Derived from tissue: bone in animal: human.
A immortal human bone element-derived cell line cell that has the characteristics: Human cell line derived from osteosarcoma. TKG0451(Deposited from Tohoku Univ.).
A immortal human bone element-derived cell line cell that has the characteristics: Sensitive to further transformation with both virus and chemicals. Backup of ECA87070202.
A immortal human bone element-derived cell line cell that has the characteristics: Human osteosarcoma producing osteoid in vitro and in vivo(mouse). Cell growth is slow.
Originator: Hotta, Tetsuo & Motoyama, Teiichi
A immortal human bone element-derived cell line cell that has the characteristics: Osteoid producing in vitro and in nude mice. Cell growth is slow.
A immortal rat cell line cell that has the characteristics: Ascites hepatoma.
Derived from tissue: ascites hepatoma in animal: rat.
A immortal rat cell line cell that has the characteristics: Subclone of AH-66, lost transplantability in rats. Possible to culture in DMEM medium. See RCB0063.
A immortal rat cell line cell that has the characteristics: Ascites hepatoma. Possible to culture in DMEM medium. See RCB0065.
A immortal rat cell line cell that has the characteristics: Subclone of AH-66, lost transplantability in rats.
A immortal rat cell line cell that has the characteristics: Rat lung fibroblast once said interferon-producing. Serum-& protein-free culturable.
Derived from tissue: lung in animal: rat.
A immortal rat cell line cell that has the characteristics: Rat lung fibroblast once said interferon-producing. Possible to culture in DMEM medium. See RCB0074 .
A immortal rat cell line cell that has the characteristics: Sticky cell from lymph node.
Derived from tissue: lymph node in animal: rat.
A immortal rat cell line cell that has the characteristics: Sticky cell from lymph node. Possible to culture in DMEM medium.
A immortal rat cell line cell that has the characteristics: Pheochromocytoma, differentiate by NGF stimulation
Derived from tissue: pheochromocytoma in animal: rat.
A immortal rat cell line cell that has the characteristics: A subline of PC-12 lacking synaptotagmin-1.
A immortal rat cell line cell that has the characteristics: A subline of PC-12 expressing synaptotagmin-1, a control cell line for PC12-F7.
A immortal rat cell line cell that has the characteristics: Cell line for titration of murine leukemia virus.
Derived from tissue: rous sarcoma in animal: rat.
A immortal rat cell line cell that has the characteristics: Rat cell line derived from sarcoma cells in ascites. TKG0648(Deposited from Tohoku Univ.).
Derived from tissue: sarcoma, ascitic tumor in animal: rat.
A immortal rat cell line cell that has the characteristics: Rat small intestine epithelial cells. Backup of ECA88071401.
Derived from tissue: small intestine in animal: rat.
A immortal rat cell line cell that has the characteristics: Rat thymoma cell line without mouse chromosome contamination. Compare to MTHC-2 and -3.
Derived from tissue: thymus in animal: rat, BUF/Mna.
A immortal rat cell line cell that has the characteristics: Rat cell line derived from lung cancer. TKG0135(Deposited from Tohoku Univ.).
Derived from tissue: lung in animal: rat, Donryu.
A immortal rat cell line cell that has the characteristics: Rat cell line derived from osteosarcoma. F344 strain.
Derived from tissue: osteosarcoma in animal: rat, F344.
A immortal rat cell line cell that has the characteristics: Subline of KMY-J. Fibroblast-like
Derived from tissue: meninx in animal: rat, F344/DuCrj.
A immortal rat cell line cell that has the characteristics: Subline of KMY-J. Polyploidy
A immortal rat cell line cell that has the characteristics: Subline of KMY-J. Epithelial-like
A immortal rat cell line cell that has the characteristics: Meningioma derived cell line. Derived from rat F344.
A immortal rat cell line cell that has the characteristics: Rat fibrous histiocytoma. Acid phosphatase and nonspecific esterase are weakly positive.
Derived from tissue: subcutis of the head in animal: rat, F344/DuCrj.
A immortal rat cell line cell that has the characteristics: Rat fibrous histiocytoma. Acid phosphatase-, non-specific esterase- & monocytic antigen-positive.
A immortal rat cell line cell that has the characteristics: F344 male rat fibrosarcoma cells, but with histiocytic and/or myofibroblastic characteristics.
Derived from tissue: submandibular salivary gland in animal: rat, F344/DuCrj.
A immortal rat cell line cell that has the characteristics: A subline of NBT-II. Low invasive bladder carcinoma. Relatively high cadherin expression.
Derived from tissue: bladder in animal: rat, Wistar.
A immortal rat cell line cell that has the characteristics: A subline of NBT-II. Almost non-invasive bladder carcinoma. Relatively high cadherin expression.
A immortal rat cell line cell that has the characteristics: A subline of NBT-II. Invasive bladder carcinoma. Relatively low cadherin expression.
A immortal rat cell line cell that has the characteristics: A subline of NBT-II. Highly invasive bladder carcinoma. Relatively low cadherin expression.
A immortal rat cell line cell that has the characteristics: A subline of NBT-II. The most invasive bladder carcinoma. Relatively low cadherin expression.
A immortal rat cell line cell that has the characteristics: So called clear cells from rat stomach mucosa.
Derived from tissue: gastric mucosa in animal: rat, Wistar.
A immortal human urinary bladder-derived cell line cell that has the characteristics: Bladder transitional-cell carcinoma
Derived from tissue: bladder in animal: human.
A immortal human urinary bladder-derived cell line cell that has the characteristics: Human cell line derived from bladder cancer. Transitional cell carcinoma. TKG0443 (Deposited from Tohoku Univ.).
A immortal human urinary bladder-derived cell line cell that has the characteristics: Described to produce SCF, IL-1, IL-3, IL-6, G-CSF, GM-CSF, etc.
A immortal human urinary bladder-derived cell line cell that has the characteristics: Human cell line derived from urinary bladder carcinoma. Derived from ascites.
Derived from tissue: bladder, ascites meta in animal: human.
A immortal human urinary bladder-derived cell line cell that has the characteristics: Human cell line derived from urinary bladder carcinoma. TKG0641 (Deposited from Tohoku Univ.).
Derived from tissue: Urinary bladder in animal: human.
A immortal human liver-derived cell line cell that has the characteristics: Human liver cholangiocarcinoma. Said CEA and CA19-9 producing.
Derived from tissue: liver in animal: human.
A immortal human liver-derived cell line cell that has the characteristics: Spindle cell-type cholangiocarcinoma cell line.
A immortal human liver-derived cell line cell that has the characteristics: Said producing alpha-fetoprotein, alpha-antitrypsin, ceruloplasmin, fibrinogen, fibronectin, etc.
A immortal human liver-derived cell line cell that has the characteristics: Hepatoblastoma. Said albumin and alpha-fetoprotein producing.
A immortal human liver-derived cell line cell that has the characteristics: Human cell line derived from intrahepatic bile duct cancer. TKG0456(Deposited from Tohoku Univ.). Cell growth is slow.
A immortal human liver-derived cell line cell that has the characteristics: Human cell line derived from hepatoma. TKG0206 (Deposited from Tohoku Univ.).
A immortal human liver-derived cell line cell that has the characteristics: Human hepatoma cell line. This cell line was established from nude mouse xenograft tumor (Dr. Hirohashi., National Cancer Center, Tokyo) by Tanno, H. (Tohoku Univ., 1st Surg). AFP producing.TKG0368 (Deposited from Tohoku Univ.).
Originator: Tanno, H. (Tohoku Univ., 1st Surg)
A immortal human liver-derived cell line cell that has the characteristics: Human cell line derived from cholangiocellular carcinoma. TKG0438 (Deposited from Tohoku Univ.). Cell growth is slow.
LCL-1925
A immortal human liver-derived cell line cell that has the characteristics: hepatocellular carcinoma. Produce alpha-fetoprotein, albumin, etc. Back up of ECA2870. Almost equal to RCB0459, but the restriction is a. Information
A immortal human liver-derived cell line cell that has the characteristics: A subline of HepG2. Expressing abundant glutamine synthetase. Information
A immortal human liver-derived cell line cell that has the characteristics: Human cell line derived from hepatocyte carcinoma. TKG0205 (Deposited from Tohoku Univ.). Information
A immortal human liver-derived cell line cell that has the characteristics: Human cell line derived from cholangiocellular carcinoma. Cell growth is slow.
Derived from tissue: liver, ascites meta in animal: human.
A immortal mouse breast-derived cell line cell that has the characteristics: Topoisomerase II inhibitor VP-16 resistant FM3A mutant.
Derived from tissue: breast in animal: mouse, C3H/HeN.
A immortal dog kidney-derived cell line cell that has the characteristics: Canine kidney epithelial. Sensitive to wide range of viruses. Backup of ECA84121903.
Derived from tissue: kidney in animal: dog.
A immortal dog kidney-derived cell line cell that has the characteristics: Dog cell line derived from kidney.
A immortal cattle kidney-derived cell line cell that has the characteristics: Very flat and thin kidney epithelial cell
Derived from tissue: kidney in animal: bovine.
A immortal cattle kidney-derived cell line cell that has the characteristics: Bovine kidney-derived epithelial cell line. FBS independent for culture.
A immortal cattle kidney-derived cell line cell that has the characteristics: Kidney epithelial cell, equiv. to ATCC CRL6071
A immortal human breast-derived cell line cell that has the characteristics: Human malignant mesothelioma. CA19-9, CA125, and hyaluronic acid producing. Cell growth is slow.
Derived from tissue: breast in animal: human.
Originator: Ishiwata, I. & Ishikawa, H. & Ishioka, K.
A immortal human breast-derived cell line cell that has the characteristics: Human breast carcinoma established from an effusion.
A immortal human breast-derived cell line cell that has the characteristics: Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.).
Derived from tissue: brest, pleural fluid in animal: human.
A immortal human spleen-derived cell line cell that has the characteristics: Human cell line derived from splenic B cell lymphoma.
Derived from tissue: spleen in animal: human.
A immortal mouse muscle cell line cell that has the characteristics: A-Jackson mouse-derived histiocyte-like cells from spontaneous sarcoma.
Derived from tissue: muscle in animal: mouse, A/J.
A immortal mouse muscle cell line cell that has the characteristics: Said differentiate to myotubes, but need confirmation. Backup of ECA91031101.
Derived from tissue: muscle in animal: mouse, C3H.
A immortal human uterus-derived cell line cell that has the characteristics: Naturally raised CDDP(cysplatin)-resistant cell line.
Derived from tissue: uterus in animal: human.
A immortal human uterus-derived cell line cell that has the characteristics: Japanese uterine endometrioid adenocarcinoma G2. Said CA125, CEA producing.
A immortal human uterus-derived cell line cell that has the characteristics: Japanese endometrioid adenocarcinoma.
Originator: Ishikawa, H. & Yasuda, M. & Yamada, K.
A immortal human uterus-derived cell line cell that has the characteristics: Human uterus endometrioid adenocarcinoma cell line.
A immortal human uterus-derived cell line cell that has the characteristics: Human uterus endometrial adenocarcinoma cell line.
A immortal human uterus-derived cell line cell that has the characteristics: Human cell line derived from uterus cancer. Endometrioid adenocarcinoma.
A immortal human uterus-derived cell line cell that has the characteristics: Uterine adenosquamous carcinoma. Said CEA and CA125 producing. Cell growth is slow.
Originator: Ishikawa, H. & Yamada, K. & Yasuda, M.
A immortal human uterus-derived cell line cell that has the characteristics: Japanese uterine carcinosarcoma. Nude mouse transplantable.
A immortal human uterus-derived cell line cell that has the characteristics: Glassy cell carcinoma from cervix. Cell growth is slow.
Derived from tissue: uterus, lymph node meta in animal: human.
A immortal human endometrium-derived cell line cell that has the characteristics: Estradiol-17 beta responsive leiomyosarcoma
Derived from tissue: endometrium in animal: human.
A immortal human endometrium-derived cell line cell that has the characteristics: Mixed Mullerian tumor.
A immortal human endometrium-derived cell line cell that has the characteristics: Endometrium-derived fibroblasts.
A immortal human endometrium-derived cell line cell that has the characteristics: So called clear cell carcinoma. Said c-erb2(+), cathepsin D(+), CA125(+).
A immortal human endometrium-derived cell line cell that has the characteristics: Expressing receptor to estrogen and prolaction. Cell growth is slow.
A immortal human endometrium-derived cell line cell that has the characteristics: Poorly differentiated adenocarcinoma. Cell growth is slow.
A immortal human endometrium-derived cell line cell that has the characteristics: Human cell line derived from endometrial adenocarcinoma. Cell growth is slow.
A immortal human endometrium-derived cell line cell that has the characteristics: Human cell line derived from endometrial stromal sarcoma.
A immortal human kidney-derived cell line cell that has the characteristics: Renal tumor cell from a Japanese. Transplantable to nude mice.
Derived from tissue: kidney in animal: human.
A immortal human kidney-derived cell line cell that has the characteristics: Kidney carcinoma from a Japanese patient. Cell growth is slow.
A immortal human kidney-derived cell line cell that has the characteristics: Scarcely found primitive neuroectodermal tumor from a Japanese kidney.
A immortal human kidney-derived cell line cell that has the characteristics: 293 cell line expressing the caspase-inhibiting CrmA gene
A immortal human kidney-derived cell line cell that has the characteristics: Human renal cell carcinoma cell line. TKG0447(Deposited from Tohoku Univ.).
A immortal human kidney-derived cell line cell that has the characteristics: Human cell line expressing SV40 large T antigen abundantly.
immortal human kidney-derived cell line cell that was derived from some human kidney epithelial cells
A immortal human kidney-derived cell line cell that has the characteristics: Japanese kidney carcinoma cells. RCB original. Cell growth is slow.
A immortal human kidney-derived cell line cell that has the characteristics: Japanese renal carcinoma cells expressing HLA-A2402. Cell growth is slow.
A immortal human kidney-derived cell line cell that has the characteristics: Japanese renal carcinoma cells. Cell growth is slow.
A immortal human kidney-derived cell line cell that has the characteristics: Wilms' tumor. CA125 and TPA producing.
Originator: Ono, I. & Ishiwata, I. & Ishikawa, H.
A immortal human kidney-derived cell line cell that has the characteristics: Subline of HEK293 cell line, expressing BtR175b (Cry 1Aa receptor).
A immortal human kidney-derived cell line cell that has the characteristics: Human primitive neuroectodermal tumor cell line derived from kidney.
A immortal human kidney-derived cell line cell that has the characteristics: Retroviral vector packaging cell line expressing MoMLV (Moloney murine leukemia virus) gag/pol. Production of high titer retrovirus by cotransfection of envelope and vector plasmids.
A immortal human kidney-derived cell line cell that has the characteristics: Sheared human Ad5 DNA-transformed cell line. Widely used for production of manipulated adenovirus. Back up culture of ECA2737.
A immortal mouse brain-derived cell line cell that has the characteristics: ori- SV40 DNA transformed C3H mouse brain-derived cells. GFAP+ astrocytes and GFAP- origodendrocytes
Derived from tissue: brain in animal: mouse, C3H/HeN.
A immortal mouse brain-derived cell line cell that has the characteristics: Mouse microglial cell line immortalized by a replication-deficient retroviral vector containing human c-myc gene. No significant production of infectious viral particles from MG6 cells was confirmed by bioassay using SC-1 cells.
Derived from tissue: brain in animal: mouse, C57BL/6.
A immortal pig kidney-derived cell line cell that has the characteristics: Pig kidney (LLC-PK1) cells expressing human P-glycoproteins.
Derived from tissue: kidney in animal: pig.
A immortal pig kidney-derived cell line cell that has the characteristics: Buck-up culture of ECA86103005. Foot & mouth disease.
A immortal human uterine cervix-derived cell line cell that has the characteristics: Human cell line derived from cervical cancer. The cells were converted to HGPRT(-). TKG0191(Deposited from Tohoku Univ.).
Derived from tissue: cervix in animal: human.
A immortal human uterine cervix-derived cell line cell that has the characteristics: Just like ATCC CCL 2, HeLa
A immortal human uterine cervix-derived cell line cell that has the characteristics: Suspension culturable. Useful for JIS medium inspection
A immortal human uterine cervix-derived cell line cell that has the characteristics: Protein- & lipid-free medium growing
A immortal human uterine cervix-derived cell line cell that has the characteristics: Integrating HPV16, neurosecretory granules(+)
A immortal human uterine cervix-derived cell line cell that has the characteristics: Repair deficient (mer~)
A immortal human uterine cervix-derived cell line cell that has the characteristics: MNNG-reistant HeLa.S3(Mer~) cells
A immortal human uterine cervix-derived cell line cell that has the characteristics: MNNG-resistant HeLa.S3(Mer~) cells
A immortal human uterine cervix-derived cell line cell that has the characteristics: Large cell non-keratinizing squamouse carcinoma. Stage Ib. HPV type 18 integrated.
A immortal human uterine cervix-derived cell line cell that has the characteristics: Japanese cervix carcinoma.
A immortal human uterine cervix-derived cell line cell that has the characteristics: Derived from a single human as TCO-1. Said CEA, CA125, TPA (+).
A immortal human uterine cervix-derived cell line cell that has the characteristics: RCB0191 HeLa.S3, that has been cultured in MEM(susp.). This line is cultured in MEM.
A immortal human uterine cervix-derived cell line cell that has the characteristics: A subline of HeLa. 6-thioguanine resistant. TKG0204 (Deposited from Tohoku Univ.).
A immortal human uterine cervix-derived cell line cell that has the characteristics: Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/.TKG0462(Deposited from Tohoku Univ.).
A immortal human uterine cervix-derived cell line cell that has the characteristics: Human cell line derived from cervical cancer. TKG0437(Deposited from Tohoku Univ.).
A immortal human uterine cervix-derived cell line cell that has the characteristics: Human uterus squamous cell carcinoma cell line.
A immortal human uterine cervix-derived cell line cell that has the characteristics: Human cervical cancer cell line.
A immortal human uterine cervix-derived cell line cell that has the characteristics: Supports growth of arvovirus and measles virus. A sabuline of HeLa cell (HeLa contamination). TKG0403 (Deposited from Tohoku Univ.).
A immortal human uterine cervix-derived cell line cell that has the characteristics: Melanoma cells with melanin-granules. Cell growth is slow.
Originator: Ishiwata, I. & Kiguchi, K. & Ishikawa, H.
A immortal human uterine cervix-derived cell line cell that has the characteristics: Thymidine kinase defective HeLa
A immortal human uterine cervix-derived cell line cell that has the characteristics: Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366(Deposited from Tohoku Univ.).
A immortal human uterine cervix-derived cell line cell that has the characteristics: A subline of the HeLa cell line expressing Fucci, a cell cycle marker.
A immortal human uterine cervix-derived cell line cell that has the characteristics: A subline of the HeLa cell line expressing Fucci2, a cell cycle marker.
A immortal human uterine cervix-derived cell line cell that has the characteristics: A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene.
A immortal human uterine cervix-derived cell line cell that has the characteristics: A subline of the HeLa cells. Expressing human CD4 and Neomycin-resistant gene. One copy of the HIV-1 LTR (nt-138 to +80) linked to the β-galactosidase gene is integrated.
A immortal human uterine cervix-derived cell line cell that has the characteristics: A subline of the HeLa cells. HeLa cells contained stably integrated copies of the HIV-1 LTR promoter linked to a synthetic tat gene.
Originator: Barbara K. Felber & George N. Pavlakis
A immortal human uterine cervix-derived cell line cell that has the characteristics: Most famous cultured human cell line
A immortal human uterine cervix-derived cell line cell that has the characteristics: Glassy cell carcinoma. TA-4, CA125, neuron-specific enolase producing.
A immortal human uterine cervix-derived cell line cell that has the characteristics: Keratinizing cervix squamous carcinoma, CEA(+)
Derived from tissue: cervix, lymph node meta in animal: human.
Originator: Izumi, Rikuichi & Kawabata, Masakiyo
A immortal human uterine cervix-derived cell line cell that has the characteristics: Japanese cervix squamous cell carcinoma. Once said TA-4 positive.
Derived from tissue: cervix, Virchow's lymph node in animal: human.
A immortal human uterine cervix-derived cell line cell that has the characteristics: Mother of a Down's syndrome child. 46XX,t(2/q2/q)
Originator: Ishiwata, Isamu & Ishikawa, Hiroshi
A immortal rat pituitary gland-derived cell line cell that has the characteristics: Estrogen-induced pituitary tumor. Compared with MtT/S, MtT/SM, and MtT/Se.
Derived from tissue: pituitary in animal: rat, F344.
A immortal rat pituitary gland-derived cell line cell that has the characteristics: Growth hormone, prolactine producing
Derived from tissue: pituitary in animal: rat, Fischer.
A immortal rat pituitary gland-derived cell line cell that has the characteristics: Estrogen-induced tumor. Growth hormone producing.
A immortal rat pituitary gland-derived cell line cell that has the characteristics: Estradiol-dependent pituitary tumor
A immortal mouse urinary bladder-derived cell line cell that has the characteristics: Murine transitional cell carcinoma induced by FANFT
Derived from tissue: bladder in animal: mouse.
A immortal human thyroid gland-derived cell line cell that has the characteristics: Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin
Derived from tissue: thyroid in animal: human.
A immortal human thyroid gland-derived cell line cell that has the characteristics: Serum-free, protein-free cultured HOTHC cells
A immortal human thyroid gland-derived cell line cell that has the characteristics: G-CSF producing thyroidal squamous carcinoma.
A immortal human thyroid gland-derived cell line cell that has the characteristics: Human thyroid anaplastic carcinoma derived cell line. TKG0446 (Deposited from Tohoku Univ.).
A immortal human thyroid gland-derived cell line cell that has the characteristics: Thyroid tumor. TAF, G-CSF, colloid producing.
A immortal human thyroid gland-derived cell line cell that has the characteristics: Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma. TKG0439(Deposited from Tohoku Univ.).
Derived from tissue: thyroid gland in animal: human.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA, PB2) is possible.
Derived from tissue: mammary in animal: mouse.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP, PA) is possible.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: A subline of C127. PB1 RNA polymerase subunit and nucleoprotein are inducible by dexamethasone.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Host for bovine papiloma virus
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Mammary tumor cell line without C-type virus
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Mouse cell line derived from mammary carcinoma. TKG0597 (Deposited from Tohoku Univ.).
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Mouse cell line derived from mammary carcinoma. Expressing human MUC1 (APR-MUC1) exogenously. TKG0595 (Deposited from Tohoku Univ.).
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Subline of mouse C127 cell line. Inducible expression of influenza virus protein (PB1, NP) is possible. Cell growth is slow.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Temperature-sensitive at chromosome condensation
Derived from tissue: mammary in animal: mouse, C3H.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Temperature-sensitive, forms multiple nuclei
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Temperature-sensitive at DNA polymerase
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Mammary carcinoma, grow in vitro and in vivo
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Newcastle disease virus resistant
Derived from tissue: mammary in animal: mouse, C3H/HeN.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: Murine mammary tumor cell lines. .Higher incidence in lung metastasis.
Derived from tissue: mammary in animal: mouse, JYG.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: murine mammary tumor cell lines. High level MMTV producer line.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: A subline of the NMuMG cell line expressing Fucci, a cell cycle marker.
Derived from tissue: mammary gland in animal: mouse, NAMRU.
A immortal mouse mammary gland-derived cell line cell that has the characteristics: A subline of the NMuMG cell line expressing Fucci2, a cell cycle marker.
A immortal human blood cell line cell that has the characteristics: Bovine derived lymphocyte.
Derived from tissue: peripheral blood lymphocytes in animal: bovine, Holstein-Friesian cow.
A immortal human blood cell line cell that has the characteristics: Human cell line derived from B cell leukemia. TKG0413(Deposited from Tohoku Univ.).
Derived from tissue: blood in animal: human.
A immortal human blood cell line cell that has the characteristics: T cell leukemia
A immortal human blood cell line cell that has the characteristics: Differentiate to granulocytes and monocytes
A immortal human blood cell line cell that has the characteristics: IL-2 dependent ATL cell line. HTLV-1 pro-virus DNA(+).
A immortal human blood cell line cell that has the characteristics: Chronic myelogeneous leukemia, subclone of RCB0495 KU812.
A immortal human blood cell line cell that has the characteristics: APRT(-) EB transformed B cell line
A immortal human blood cell line cell that has the characteristics: Acute lymphatic leukemia
A immortal human blood cell line cell that has the characteristics: Hydrogen peroxide resistant HL60-derived clone.
A immortal human blood cell line cell that has the characteristics: Human T cell line, the same patient as JM. IL-2 productivity of this line was undetermined.
A immortal human blood cell line cell that has the characteristics: B-lineage acute lymphoblastic leukemia.
A immortal human blood cell line cell that has the characteristics: A subclone of RCB1180 Tanoue.
A immortal human blood cell line cell that has the characteristics: RCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF.
A immortal human blood cell line cell that has the characteristics: AML with Ph' chromosome and t(3;3)(q21;q26). Expressing EVI-1 and BCR/ABL mRNA.
A immortal human blood cell line cell that has the characteristics: Acute myeloid leukemia with dek/can chimera mRNA expression. Responding to G-CSF and differentiate.
A immortal human blood cell line cell that has the characteristics: B95-8 EB virus transformed (originally normal) B cell line.
A immortal human blood cell line cell that has the characteristics: Adult T-cell leukemia. HTLV-1 pro-virus DNA(+).
A immortal human blood cell line cell that has the characteristics: Hydrogen peroxide resistant HL60-derived clone. More resistant than HP50-2.
A immortal human blood cell line cell that has the characteristics: Human cell line derived from T cell leukemia. TKG0199(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Chronic myelogeneous leukemia, Ph1 chromosome (+),basophi-like cells.
A immortal human blood cell line cell that has the characteristics: Human myeloid leukemia cell line with chromosome 18 trisomy and mutation in DCC gene. Cell growth is slow.
A immortal human blood cell line cell that has the characteristics: Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011.
A immortal human blood cell line cell that has the characteristics: T cell leukemia, the same patient as RCB1164 MOLT-3.
A immortal human blood cell line cell that has the characteristics: Buck-up culture of ECA86010201. Human T cell line with the ability to grow HIV, the same patient as Jurkat.
A immortal human blood cell line cell that has the characteristics: Human T leukemic cell line (CD4+). CR2 receptor (+). TKG0229(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Burkitt's lymphoma. Sensitive to LAK cells but resistant to NK cells. Back up of culture ECA2673. Resistant to VSV. This cell line carries the latent Epstein-Barr Virus (EBV) genome and is positive for EBNA. RAJI is sometimes referred to as a 'non-producer'; the EBV genome carries deletions attributed to preventing the formation of virus particles.
A immortal human blood cell line cell that has the characteristics: Eosinophilic leukemia. Differenciate by n-butylate treatment. The same patient as RCB2142 EoL-3.
A immortal human blood cell line cell that has the characteristics: Human cell line derived from eosinophilic leukemia. The same patient as RCB0641 EoL-1 cell.
A immortal human blood cell line cell that has the characteristics: Human cell line derived from acute monocytic leukemia. Activeated macrophage activity (+), obtained from long passage of THP-1 (RCB1189 THP-1) cell line. TKG0296(Deposited from Tohoku Univ.).
Originator: Tominaga, T. (1st. Dep. Surg., Tohoku U.).
A immortal human blood cell line cell that has the characteristics: Differentates to macrophage-like cells after treatment with phorbol ester. The variant subline (RCB2128 A-THP-1).
A immortal human blood cell line cell that has the characteristics: Chronic myelogenous leukemia , subclone of RCB0495 KU812.
A immortal human blood cell line cell that has the characteristics: Human T cell leukemia. IL-2 receptor (-). Progeny were cured by Treatments with BM Cycline and MC210. TKG0209 (Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human cell line derived from basophilic leukemia cells. Progeny were cured by Treatments with BM Cycline and MC210. KG0304 (Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: B95-8 EB virus transformed leukemia cell line.
A BALL-1 cell line that is stored in Japan RIKEN cell bank.
A BALL-1 cell line that is stored in Japan RIKEN cell bank. TKG0467 (Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Variant of HL60. Resistant to retinoic acid and active Vit. D derivatives.
A immortal human blood cell line cell that has the characteristics: Human T cell leukemia (derivative of KE-37) . originally described to be established from the peripheral blood of a 61-year-old man with T cell chronic lymphocytic leukemia (CLL) in 1977; ; KE-37 was established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979
Derived from tissue: blood, T-cell leukemia in animal: human.
A immortal human blood cell line cell that has the characteristics: Human T cell leukemia, the same patient as RCB0206 MOLT-4.
A immortal human blood cell line cell that has the characteristics: Human myeloma cell.
Derived from tissue: peripheral blood in animal: human.
A immortal human blood cell line cell that has the characteristics: Human cell line derived from T cell of a patient with Sezary syndrome. Producing IL-2. TKG0375(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human cell line derived from T cell leukemia. TKG0463(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human cell line derived from T cell leukemia. TKG0385(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human B cells transformed by Epstein-Barr virus. RCB2541 is derived from the same patient. TKG0611(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. RCB2083 is derived from the same patient. TKG0634(TKG0499)(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0610(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human B cells transformed by Epstein-Barr virus. TKG0609(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human cell line derived from B cells of healthy volunteer. Transformed by EB virus. TKG0616(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human cell line derived from Bloom syndrome patient. Transformed by EBV. Can express certain antigen on the cell surface, such as cancer-specific antigen.
A immortal human blood cell line cell that has the characteristics: EBV-transformed cell line from a patient (male) with p53 germ line mutation. Mutation was noted at codon 242 (TGC→TAC) by FASAY.TKG0506 (Deposited from Tohoku Univ.).
Originator: Kudo, T. and Ishioka, C. (IDAC)
A immortal human blood cell line cell that has the characteristics: Human B cells derived from a patient of xeroderma pigmentosum. Transformed by Epstein-Barr virus. TKG0311(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: Human cell line derived from B cells of Xeroderma pigmentosum (XP) patient. Transformed by EB virus. TKG0314(Deposited from Tohoku Univ.).
A immortal human blood cell line cell that has the characteristics: IgM (lambda) secreting B cell line. Established from peripheral blood lymphocytes of apparently normal 33-y-o male. HLA profile: A2, Aw33, B7, B14.TKG0464(Deposited from Tohoku Univ.)
A immortal human blood cell line cell that has the characteristics: Human cell line derived from erythroblastic leukemia.
A immortal human blood cell line cell that has the characteristics: Rat cell line derived from basophilic leukemia cells. TKG0321 (Deposited from Tohoku Univ.).
Derived from tissue: peripheral blood in animal: rat.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Bone marrow stroma cell-derived
Derived from tissue: bone marrow in animal: mouse, BALB/c.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Mouse cell line derived from bone marrow. Fibroblast-like cells. BALB/c strain. TKG0355(Deposited from Tohoku Univ.).
Derived from tissue: bone marrow, tibia femur in animal: mouse, BALB/c.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Mouse cell line derived from bone marrow. Fibroblast-like. BudR resistant. BALB/c strain. TKG0356(Deposited from Tohoku Univ.).
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Mouse bone marrow derived fibroblast-like cells line. Differentiates to neuron.
Derived from tissue: bone marrow in animal: mouse, C3H/He.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Mouse bone marrow-derived stromal cells.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Mouse multipotent mesenchymal cells. Derived from bone marrow.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Mouse mesenchymal cell line derived from bone marrow. C3H/He
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Bone marrow stroma cell line, depositing calcified matrix on the culture surface. Cell growth is slow.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Bone marrow stroma cell line, depositing calcified matrix on the culture surface.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Osteoclast-like cell line derived from mouse (C3H/He). Cell growth is slow.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Mouse IL-3 dependent cells cloned from 32D. Differentiate with G-CSF stimulation.
Derived from tissue: bone marrow in animal: mouse, C3H/HeJ.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Subclone of 32D cell line. Differentiate to mature granulocytes by G-CSF.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: IL-3 dependent cells from Friend leukemia virus-infected mouse bone marrow.
A immortal mouse bone marrow-derived cell line cell that has the characteristics: Mouse mesenchymal cell line derived from bone marrow. C57/B6.
Derived from tissue: bone marrow in animal: mouse, C57/B6.
A immortal mouse aorta-derived cell line cell that has the characteristics: Mouse cell line derived from aorta of p53-deficient mouse. Epithelial like.
Derived from tissue: aorta in animal: mouse, C57BL/CBA.
A immortal human B cell line cell that has the characteristics: B lymphocyte isolated from Japanese adenosquamous carcinoma.
Derived from tissue: B cell (uterus) in animal: human.
A immortal human B cell line cell that has the characteristics: B lymphocytes isolated from a colon adenocarcinoma.
Derived from tissue: B cell, (colon) in animal: human.
Originator: Ishikawa, H. & Tabei, I. & Kubo, H.
A immortal human B cell line cell that has the characteristics: Human B cell-like cell line derived from colon adenocarcinoma tisuue.
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. This B cell lines derived from Mongoloid Minority Groups in South America.
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus.
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. This B cell lines derived from Mongoloid Minority Groups in South America. The two B cell lines HSC0087 (WY077) and HSC0091 (WYO071) have identical similar STR patterns.
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. Breast cancer patient.
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06, B*39:01 B*40:02, C*03:04 C*07:02, DRB1*08:02 DRB1*14:06, DQB1*03:01 DQB1*03:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*31:01 A*33:03, B*40:03 B*44:03, C*03:04 C*14:03, DRB1*04:05 DRB1*08:03, DQB1*04:01 DQB1*06:01, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*26:03, B*40:01 B*55:02, C*01:02 C*03:03, DRB1*04:05 DRB1*11:01, DQB1*03:01 DQB1*04:01, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:02, B*07:02 B*13:01, C*03:04 C*07:02, DRB1*01:01 DRB1*12:02, DQB1*03:01 DQB1*05:01, DPB1*02:02 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:01, B*48:01 B*52:01, C*08:03 C*12:02, DRB1*14:07 DRB1*15:02, DQB1*05:02 DQB1*06:01, DPB1*09:01 DPB1*14:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:03, B*15:01 B*59:01, C*01:02 C*03:03, DRB1*04:05 DRB1*15:01, DQB1*04:01 DQB1*06:02, DPB1*02:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*13:01 B*40:02, C*03:04 , DRB1*04:10 DRB1*12:02, DQB1*03:01 DQB1*04:02, DPB1*05:01 DPB1*13:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*02:10, B*39:01 B*40:06, C*07:02 C*08:01, DRB1*14:03 DRB1*15:01, DQB1*03:01 DQB1*06:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*52:01, C*12:02, DRB1*15:01 DRB1*15:02, DQB1*06:01 DQB1*06:02, DPB1*02:01 DPB1*14:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*26:01, B*07:02 B*15:01, C*03:04 C*07:02, DRB1*04:05 DRB1*14:01, DQB1*04:01 DQB1*05:02, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*54:01 B*67:01, C*01:02 C*07:02, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*05:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:03, B*15:01 B*40:06, C*03:03 C*15:02, DRB1*08:02 DRB1*09:01, DQB1*03:03 DQB1*04:02, DPB1*02:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*54:01, C*01:02, DRB1*04:05, DQB1*04:01, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*13:01 B*51:01, C*03:04 C*15:02, DRB1*04:01 DRB1*12:02, DQB1*03:01, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:03, B*15:01 B*51:01, C*03:03 C*14:02, DRB1*11:01 DRB1*15:02, DQB1*03:01 DQB1*06:01, DPB1*09:01 DPB1*13:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*35:01 B*51:01, C*04:01 C*14:02, DRB1*04:05 DRB1*09:01, DQB1*03:03 DQB1*04:01, DPB1*02:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*07:02 B*35:01, C*03:03 C*07:02, DRB1*01:01 DRB1*08:02, DQB1*04:02 DQB1*05:01, DPB1*02:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:01, B*40:01 B*40:03, C*03:04, DRB1*04:05 DRB1*13:01, DQB1*04:01 DQB1*06:03, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*02:07, B*07:02 B*46:01, C*01:02 C*07:02, DRB1*01:01 DRB1*09:01, DQB1*03:03 DQB1*05:01, DPB1*03:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*02:07, B*40:01, B*46:01, C*01:02 C*03:04, DRB1*08:03 DRB1*15:01, DQB1*06:01 DQB1*06:02, DPB1*02:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*40:02 B*59:01, C*01:02 C*03:03, DRB1*04:01 DRB1*13:02, DQB1*03:01 DQB1*06:04, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*46:01 B*55:02, C*01:02, DRB1*08:03, DRB1*15:01, DQB1*06:01 DQB1*06:02, DPB1*02:01 DPB1*02:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*33:03, B*44:03 B*59:01, C*01:02 C*14:03, DRB1*04:05 DRB1*13:02, DQB1*04:01 DQB1*06:04, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*51:01 B*52:01, C*12:02 C*14:02, DRB1*14:03 DRB1*15:02, DQB1*03:01 DQB1*06:01, DPB1*05:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*35:01 B*54:01, C*01:02 C*08:01, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*03:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*26:02 A*33:03, B*40:06 B*44:03, C*08:01 C*14:03, DRB1*08:02 DRB1*09:01, DQB1*03:02 DQB1*03:03, DPB1*03:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*31:01, B*40:02 B*51:01, C*03:04 C*14:02, DRB1*08:02 DRB1*14:03, DQB1*03:01 DQB1*03:02, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*39:01 B*48:01, C*03:03 C*07:02, DRB1*08:03 DRB1*14:01, DQB1*05:03 DQB1*06:01, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*31:01, B*15:11, C*03:03, DRB1*09:01, DQB1*03:03, DPB1*02:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*26:03 A*33:03, B*15:01 B*44:03, C*03:03 C*14:03, DRB1*13:02 DRB1*14:06, DQB1*03:01 DQB1*06:04, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*35:01 B*52:01, C*08:01 C*12:02, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*04:02 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*33:03, B*39:01 B*44:03, C*07:02 C*14:03, DRB1*04:05 DRB1*13:02, DQB1*04:01 DQB1*06:04, DPB1*03:01 DPB1*04:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*35:01 B*52:01, C*03:03 C*12:02, DRB1*12:01 DRB1*15:02, DQB1*03:01 DQB1*06:01 , DPB1*05:01 DPB1*06:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*31:01, B*40:01 B*52:01, C*03:04 C*12:02, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*05:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*07:02 B*56:01, C*04:01 C*07:02, DRB1*01:01 DRB1*09:01, DQB1*03:03 DQB1*05:01, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:01, B*39:04 B*54:01, C*01:02 C*07:02, DRB1*04:03 DRB1*04:05, DQB1*03:02 DQB1*04:01, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*39:01 B*52:01, C*07:02 C*12:02, DRB1*08:02 DRB1*15:02, DQB1*04:02 DQB1*06:01, DPB1*02:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*31:01, B*07:02 B*51:01, C*07:02 C*14:02, DRB1*01:01 DRB1*09:01, DQB1*03:03 DQB1*05:01, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*33:03, B*40:02 B*44:03, C*03:04 C*14:03, DRB1*08:03 DRB1*13:02, DQB1*06:01 DQB1*06:04, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*33:03, B*44:03 B*52:01, C*12:02 C*14:03, DRB1*13:02 DRB1*15:01, DQB1*06:02 DQB1*06:04, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*31:01, B*07:02 B*55:02, C*03:03 C*07:02, DRB1*01:01 DRB1*09:01, DQB1*03:03 DQB1*05:01, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*52:01 B*54:01, C*01:02 C*12:02, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*05:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*02:07, B*15:18 B*46:01, C*01:03 C*08:01, DRB1*09:01 DRB1*12:01, DQB1*03:01 DQB1*03:03, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*31:01, B*54:01, C*01:02 C*03:04, DRB1*04:05 DRB1*14:01, DQB1*04:01 DQB1*05:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*07:02 B*48:01, C*07:02 C*08:01, DRB1*01:01 DRB1*09:01, DQB1*03:01 DQB1*05:01, DPB1*04:02 DPB1*13:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*11:01 B*15:01 B*54:01, C*01:02 C*04:01, DRB1*04:05 DRB1*04:06, DQB1*03:02 DQB1*04:01, DPB1*02:01 DPB1*03:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:01, B*48:01 B*59:01, C*01:02 C*08:03, DRB1*04:05 DRB1*09:01, DQB1*03:03 DQB1*04:01, DPB1*02:01 DPB1*19:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*51:01 B*54:01, C*01:02 C*14:02, DRB1*04:05 DRB1*11:01, DQB1*03:01 DQB1*04:01, DPB1*02:01DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*33:03, B*44:03 B*54:01, C*01:02 C*14:03, DRB1*04:05 DRB1*08:03, DQB1*04:01 DQB1*06:01, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*35:01 B*52:01, C*12:02 C*15:02, DRB1*14:06 DRB1*15:02, DQB1*03:01 DQB1*06:01, DPB1*05:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*33:03, B*44:03 B*56:01, C*04:01 C*14:03, DRB1*04:05 DRB1*09:01, DQB1*03:03 DQB1*04:01, DPB1*02:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*01:01 A*26:01, B*37:01 B*39:01, C*06:02 C*07:02, DRB1*01:01 DRB1*10:01, DQB1*05:01, DPB1*02:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:10 A*24:02, B*40:06 B*52:01, C*08:01 C*12:02, DRB1*14:05 DRB1*15:02, DQB1*05:03 DQB1*06:01, DPB1*02:02 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:01, B*35:01 B*40:02, C*03:04 C*08:01, DRB1*04:10 DRB1*09:01, DQB1*03:03 DQB1*04:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*31:01, B*07:02 B*56:01, C*04:01 C*07:02, DRB1*01:01 DRB1*04:05, DQB1*04:01 DQB1*05:01, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*33:03, B*07:02 B*44:03, C*07:02 C*14:03, DRB1*01:01 DRB1*13:02, DQB1*05:01 DQB1*06:04, DPB1*04:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*46:01 B*67:01, C*01:02 C*07:02, DRB1*08:03 DRB1*09:01, DQB1*03:03 DQB1*06:01, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*26:01, B*40:02 B*54:01, C*01:02 C*03:04, DRB1*09:01 DRB1*15:01, DQB1*03:03 DQB1*06:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*31:01 A*33:03, B*48:01 B*58:01, C*03:02 C*08:01, DRB1*09:01 DRB1*13:02, DQB1*03:03 DQB1*06:09, DPB1*03:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*26:02, B*07:02 B*52:01, C*07:02 C*12:02, DRB1*01:01 DRB1*15:02, DQB1*05:01 DQB1*06:01, DPB1*04:02 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*40:01 B*40:06, C*07:02 C*08:01, DRB1*04:06 DRB1*09:01, DQB1*03:02 DQB1*03:03, DPB1*02:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*15:18 B*52:01, C*08:01 C*12:02, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*02:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*26:01, B*15:01 B*52:01, C*12:02 C*15:02, DRB1*09:01 DRB1*15:02, DQB1*03:03 DQB1*06:01, DPB1*03:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*40:01 B*67:01, C*03:04 C*07:02, DRB1*12:01 DRB1*15:01, DQB1*03:01 DQB1*06:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*33:03, B*15:18 B*44:03, C*08:01 C*14:03, DRB1*04:03 DRB1*13:02, DQB1*03:02 DQB1*06:04, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*39:01 B*55:02, C*01:02 C*07:02, DRB1*04:05 DRB1*08:03, DQB1*04:01 DQB1*06:01, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*40:02 B*59:01, C*01:02 C*03:04, DRB1*04:05 DRB1*09:01, DQB1*03:03 DQB1*04:01, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*33:03, B*35:01 B*44:03, C*03:03 C*14:03, DRB1*04:05 DRB1*15:01, DQB1*04:01 DQB1*06:02, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*54:01 B*59:01, C*01:02, DRB1*04:05 DQB1*04:01, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*39:04 B*40:02, C*03:04 C*07:02, DRB1*04:06 DRB1*09:01, DQB1*03:02 DQB1*03:03, DPB1*02:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:20 A*33:03, B*44:03 B*51:01, C*14:02 C*14:03, DRB1*09:01 DRB1*12:01, DQB1*03:02 DQB1*03:03, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*15:28 B*52:01, C*03:03 C*12:02, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*05:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*15:01 B*52:01, C*07:02 C*12:02, DRB1*15:01 DRB1*15:02, DQB1*06:01 DQB1*06:02, DPB1*02:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*01:01 A*11:01, B*07:02 B*54:01, C*01:02 C*07:02, DRB1*01:01 DRB1*04:05, DQB1*03:03 DQB1*05:01, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*07:02 X, C*03:03 C*07:02, DRB1*01:01 DRB1*09:01, DQB1*03:03 DQB1*05:01, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:18 A*33:03, B*44:03 B*46:01, C*01:02 C*14:03, DRB1*04:05 DRB1*08:03, DQB1*04:01 DQB1*06:01, DPB1*02:01 DPB1*02:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*11:01, B*15:01 B*35:01, C*03:03 C*04:01, DRB1*04:06 DRB1*15:01, DQB1*03:02 DQB1*06:02, DPB1*03:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*54:01 B*55:02, C*01:02, DRB1*09:01 DRB1*11:01, DQB1*03:01 DQB1*03:03, DPB1*05:01 DPB1*13:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*39:02 B*40:06, C*07:02 C*08:01, DRB1*09:01 DRB1*12:01, DQB1*03:01 DQB1*03:03, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*26:03 A*31:01, B*35:01 B*51:01, C*03:03 C*14:02, DRB1*04:03 DRB1*15:02, DQB1*03:02 DQB1*06:01, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*02:06 B*07:02 B*40:01, C*03:03 C*07:02, DRB1*01:01 DRB1*08:03, DQB1*05:01 DQB1*06:01, DPB1*03:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*31:01, B*15:01 B*54:01, C*01:02 C*03:03, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*05:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*33:03, B*40:01 B*44:03, C*03:04 C*14:03, DRB1*13:02 DRB1*14:01, DQB1*05:03 DQB1*06:04, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*15:01 B*39:01, C*04:01 C*07:02, DRB1*04:06 DRB1*12:01, DQB1*03:01 DQB1*03:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*35:01 B*44:02, C*05:01 C*08:01, DRB1*04:10 DRB1*12:01, DQB1*03:03 DQB1*04:02, DPB1*02:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*31:01, B*40:06 B*44:03, C*03:04 C*14:03, DRB1*09:01 DRB1*13:02, DQB1*03:03 DQB1*06:04, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*33:03, B*15:01 B*44:03, C*03:03 C*14:03, DRB1*08:03 DRB1*14:06, DQB1*03:01 DQB1*06:01, DPB1*03:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*52:01 B*54:01, C*01:02 C*12:02, DRB1*08:03 DRB1*15:01, DQB1*06:01 DQB1*06:02, DPB1*05:01 DPB1*14:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01, B*48:01 B*51:01, C*08:01 C*15:02, DRB1*09:01, DQB1*03:03 , DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*31:01 A*33:03, B*44:03 B*51:01, C*14:02 C*14:03, DRB1*13:02 DRB1*14:03, DQB1*03:01 DQB1*06:04, DPB1*02:01 DPB1*04:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*33:03, B*07:02 B*44:03, C*07:02 C*14:03, DRB1*01:01 DRB1*13:02, DQB1*05:01 DQB1*06:04, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*52:01, C*12:02, DRB1*15:02, DQB1*06:01, DPB1*02:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*44:03 B*52:01, C*12:02 C*14:03, DRB1*04:06 DRB1*13:02, DQB1*03:02 DQB1*06:04, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*02:06, B*35:01 B*39:01, C*03:03 C*07:02, DRB1*09:01 DRB1*14:06, DQB1*03:01 DQB1*03:03, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*31:01, B*40:02 B*44:03, C*03:04 C*14:03, DRB1*09:01 DRB1*13:02, DQB1*03:03 DQB1*06:04, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*46:01 B*54:01, C*01:02 , DRB1*04:05 DRB1*08:03, DQB1*04:01 DQB1*06:01, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*26:01, B*35:01 B*52:01, C*03:03 C*12:02, DRB1*15:01 DRB1*15:02, DQB1*06:01 DQB1*06:02, DPB1*02:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*26:01 A*33:03, B*44:03 B*52:01, C*12:02 C*14:03, DRB1*13:02 DRB1*15:02, DQB1*06:01 DQB1*06:04, DPB1*04:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*31:01, B*51:01 B*52:01, C*12:02 C*14:02, DRB1*08:02 DRB1*15:02, DQB1*04:02 DQB1*06:01, DPB1*04:02 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*07:02 B*46:01, C*03:04 C*07:02, DRB1*01:01 DRB1*08:03, DQB1*05:01 DQB1*06:01, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*15:07 B*52:01, C*01:02 C*12:02, DRB1*04:03 DRB1*15:01, DQB1*03:02 DQB1*06:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*38:0201 B*51:01, C*07:02 C*14:02, DRB1*08:03 DRB1*09:01 , DQB1*03:01 DQB1*03:03, DPB1*05:01 DPB1*14:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*07:02 B*39:01, C*07:02, DRB1*01:01 DRB1*04:05, DQB1*04:01 DQB1*05:01, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*24:02, B*13:01 B*48:01, C*03:04 C*08:01, DRB1*09:01 DRB1*12:02, DQB1*03:01 DQB1*03:03, DPB1*02:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:02, B*40:01 B*40:06, C*03:04 C*08:01, DRB1*04:05 DRB1*09:01, DQB1*03:03 DQB1*04:01, DPB1*04:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*26:01, B*40:02 B*51:02, C*03:04 C*08:01, DRB1*09:01 , DQB1*03:03, DPB1*02:01 DPB1*03:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*01:01 A*02:01, B*15:01 B*40:06, C*06:02 C*08:01, DRB1*04:05 DRB1*09:01, DQB1*03:03 DQB1*04:01, DPB1*04:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*39:01 B*55:02, C*01:02 C*07:02, DRB1*04:10 DRB1*15:01, DQB1*04:02 DQB1*06:02, DPB1*02:02 DPB1*03:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*26:01, B*40:02 B*52:01, C*03:04 C*12:02, DRB1*08:02 DRB1*15:02, DQB1*03:02 DQB1*06:01, DPB1*02:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*26:01, B*40:02 B*54:01, C*01:02 C*03:04, DRB1*01:01 DRB1*09:01, DQB1*03:03 DQB1*05:01, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*26:01, B*40:01 B*40:02, C*03:04 C*15:02, DRB1*08:03 DRB1*09:01, DQB1*03:03 DQB1*06:01, DPB1*04:01 DPB1*13:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*11:01, B*13:01 B*48:01 C*03:04 C*08:03, DRB1*12:02 DRB1*15:01, DQB1*03:01 , DPB1*02:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*33:03, B*15:11 B*52:01, C*03:03 C*12:02, DRB1*09:01 DRB1*15:02, DQB1*03:03 DQB1*06:01, DPB1*05:01DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*15:11 B*52:01, C*03:03 C*12:02, DRB1*14:54 DRB1*15:02, DQB1*03:01 DQB1*06:01, DPB1*05:01 DPB1*13:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*31:01, B*35:01 B*52:01, C*04:01 C*12:02, DRB1*09:01 DRB1*15:02, DQB1*03:03 DQB1*06:01, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*40:01 B*52:01, C*03:04 C*12:02, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*02:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*26:01 A*33:03, B*35:01 B*44:03, C*03:03 C*14:03, DRB1*04:01 DRB1*12:01, DQB1*03:01 DQB1*03:03, DPB1*05:01DPB1*14:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*15:01 B*40:06, C*04:01 C*08:01, DRB1*04:06 DRB1*09:01, DQB1*03:02 DQB1*03:03, DPB1*05:01 X
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02 A*31:01, B*52:01 B*59:01, C*01:02 C*12:02, DRB1*04:05 DRB1*15:02, DQB1*04:01 DQB1*06:01, DPB1*04:02 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*15:07 B*15:18, C*03:03 C*07:0401, DRB1*04:01 DRB1*04:03, DQB1*03:01 DQB1*03:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*11:01 A*33:03, B*35:01 B*44:03, C*03:03 C*14:03, DRB1*04:05 DRB1*13:02, DQB1*03:02 DQB1*06:04, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*33:03, B*35:01 B*44:03, C*03:03 C*14:03, DRB1*04:05 DRB1*13:02, DQB1*04:01 DQB1*06:04, DPB1*02:01 DPB1*04:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. Cell growth is slow. HLA A*24:02 A*26:01, B*15:01 B*51:01, C*03:04 C*04:01, DRB1*04:06 DRB1*14:54, DQB1*03:02 DQB1*05:03, DPB1*02:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:07 A*24:20, B*46:01 B*55:02, C*01:02 C*07:02, DRB1*08:03 , DQB1*06:01, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*02:07. B*40:01 B*46:01, C*01:02 C*15:02, DRB1*08:03 DRB1*14:05, DQB1*05:03 DQB1*06:01, DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*24:02, B*07:02 B*13:01, C*03:03 C*07:02, DRB1*01:01 DRB1*12:02, DQB1*03:01 DQB1*05:01 , DPB1*02:01 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:07 A*24:02, B*46:01 B*52:01, C*01:02 C*12:02, DRB1*08:03 DRB1*15:02, DQB1*06:01, DPB1*02:01 DPB1*09:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*15:11 B*59:01, C*01:02 C*03:03, DRB1*04:05 DRB1*12:01, DQB1*03:01 DQB1*04:01, DPB1*02:02 DPB1*04:02
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:06 A*24:02, B*15:27 B*35:01, C*03:03 C*04:01, DRB1*04:03 DRB1*12:01, DQB1*03:01 DQB1*03:02, DPB1*02:01 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:53N A*26:01, B*39:01 B*54:01, C*01:02 C*07:02, DRB1*14:05 DRB1*15:01, DQB1*05:03 DQB1*06:02, DPB1*04:02 DPB1*05:01
A immortal human B cell line cell that has the characteristics: Human B lymphocytes transformed by Epstein-Barr Virus. HLA A*02:01 A*24:02, B*39:01 B*48:01, C*07:02 C*08:01, DRB1*04:05 DRB1*11:01, DQB1*03:01 DQB1*04:01, DPB1*02:01 DPB1*02:02
A immortal human vagina-derived cell line cell that has the characteristics: 47,XX,+X-type chromosome.
Derived from tissue: vagina in animal: human.
A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0462(Deposited from Tohoku Univ.).
Derived from tissue: esophagus in animal: human.
A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer (highly differentiated squamous cell carcinoma). Not transplantable to nude mouse. TKG0266 (Deposited from Tohoku Univ.).
Originator: Nishihira, Tetsuro (Akaishi, T.)
A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259(Deposited from Tohoku Univ.).
A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261(Deposited from Tohoku Univ.).
A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262(Deposited from Tohoku Univ.).
A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0265(Deposited from Tohoku Univ.).
A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.).
A immortal human esophagus-derived cell line cell that has the characteristics: Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cyclin and MC210. TKG0257 (Deposited from Tohoku Univ.).
A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma.TKG0255(Deposited from Tohoku Univ.).
Derived from tissue: esophagus, lymph node meta in animal: human.
A immortal human esophagus-derived cell line cell that has the characteristics: Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing.
A immortal human esophagus-derived cell line cell that has the characteristics: Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.).
Derived from tissue: esophagus, pleural effusion in animal: human.
A immortal human gingiva-derived cell line cell that has the characteristics: Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485(Deposited from Tohoku Univ.).
Derived from tissue: gingiva in animal: human.
A immortal human muscle cell line cell that has the characteristics: Extraskeltal myxoid chondrosarcoma
Derived from tissue: muscle in animal: human.
A immortal human muscle cell line cell that has the characteristics: Mixed mesodermal tumor consists of adenocarcinoma and rhabdomyosarcoma. Cell growth is slow.
Derived from tissue: muscle, bone marrow meta in animal: human.
A immortal human mouth-derived cell line cell that has the characteristics: Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.).
A immortal human mouth-derived cell line cell that has the characteristics: Human cell line derived from squamous cell carcinoma at mouth floor. TKG0455(Deposited from Tohoku Univ.).
Derived from tissue: mouth floor in animal: human.
A immortal rat brain-derived cell line cell that has the characteristics: Astroglia cell line. Possible to culture in DMEM medium. See RCB0075.
Derived from tissue: brain in animal: rat.
A immortal rat brain-derived cell line cell that has the characteristics: Astroglia cell line
A immortal rat brain-derived cell line cell that has the characteristics: Rat cell line derived from glial cell tumor induced by N-nitrosomethylurea. TKG0589(Deposited from Tohoku Univ.).
A immortal rat brain-derived cell line cell that has the characteristics: Rat cell line derived from glioma induced by N-nitrosomethylurea. TKG0242 (Deposited from Tohoku Univ.).
A immortal rat brain-derived cell line cell that has the characteristics: Rat neuronal cell line derived from the ventrolateral region of the suprachiasmatic nucleus
Derived from tissue: brain in animal: rat, Wister (Transgenic rat).
A immortal human testis-derived cell line cell that has the characteristics: Embryonal carcinoma, testis.
Derived from tissue: testis in animal: human.
A immortal human testis-derived cell line cell that has the characteristics: Human cell line derived from embryonal carcinoma of testis.
A immortal human intestine-derived cell line cell that has the characteristics: Small-cell gastrointestinal carcinoma. High levels of creatine kinase brain isoenzyme. Cell growth is slow.
Derived from tissue: intestine in animal: human.
A immortal human rectum-derived cell line cell that has the characteristics: Human rectal cancer cell line.
Derived from tissue: rectum in animal: human.
Originator: Ishikawa, Hiroshi & Tabei, Isao
A immortal human rectum-derived cell line cell that has the characteristics: Human cell line derived from rectal cancer. Cell growth is slow.
A immortal human rectum-derived cell line cell that has the characteristics: Rectal carcinoma from a Japanese patient. Cell growth is slow.
A immortal hamster kidney-derived cell line cell that has the characteristics: SV40 transformed hamster cell line. Fibroblast-like cells.
Derived from tissue: kidney in animal: hamster.
A immortal hamster kidney-derived cell line cell that has the characteristics: The parent cell line used for the temperature sensitive cell line series of BN.
Derived from tissue: kidney in animal: hamster, Syrian.
A immortal hamster kidney-derived cell line cell that has the characteristics: Temperature-sensitive mutant of BHK-21. Complemented with human X-linked CCG1 gene.
A immortal hamster kidney-derived cell line cell that has the characteristics: Temperature-sensitive mutant of BHK-21. Complementation group A. Dye rapidly at 39.5 C.
A immortal hamster kidney-derived cell line cell that has the characteristics: Temperature-sensitive mutant of BHK-21 selected after MNNG treatment.
A immortal hamster kidney-derived cell line cell that has the characteristics: Temperature-senstive mutant of BHK-21. Complemented with ubiquitin-activating enzyme E1 cDNA.
A immortal hamster kidney-derived cell line cell that has the characteristics: Temperature-sensitive mutant of BHK-21. Causing premature chromosome condensation.
A immortal hamster kidney-derived cell line cell that has the characteristics: Temperature-sensitive mutant of BHK-21 with mutated DAD1 gene. Causing apoptosis at 39.5 C.
A immortal hamster kidney-derived cell line cell that has the characteristics: Temperature-sensitive mutant of BHK-21 with defect in RNA polymerase III subunit.
A immortal hamster kidney-derived cell line cell that has the characteristics: Temperature-sensitive mutant of BHK-21. Stop growth after 2-day culture at 39.5 C.
A immortal hamster kidney-derived cell line cell that has the characteristics: Thymidine kinase-defective mutant of ts13
A immortal hamster kidney-derived cell line cell that has the characteristics: Culturable in suspension, cf. ECACC, BHK-21C13-3P
A immortal human adrenal gland-derived cell line cell that has the characteristics: N-myc propagated. Neuron specific enolase producing.
Derived from tissue: adrenal in animal: human.
A immortal human adrenal gland-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma of adrenal gland.TKG0278 (Deposited from Tohoku Univ.).
Derived from tissue: adrenal gland, left in animal: human.
A immortal human adrenal gland-derived cell line cell that has the characteristics: Adrenal neuroblastoma derived from brain metastasis
Derived from tissue: adrenal, brain meta in animal: human.
A immortal human adrenal gland-derived cell line cell that has the characteristics: N-myc gene amplification
Derived from tissue: adrenal, left in animal: human.
A immortal human adrenal gland-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma formed at adrenal gland. TKG0277(Deposited from Tohoku Univ.).
Derived from tissue: right adrenal gland in animal: human.
Originator: Hayashi, T. (Pediat. Surg., Tohoku Univ.).
A immortal human adrenal gland-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486(Deposited from Tohoku Univ.).
Derived from tissue: sympatho adrenal cell in animal: human.
A immortal mouse blood cell line cell that has the characteristics: Secrete growth factors for hemopoietic stem cells
Derived from tissue: blood in animal: mouse, BALB/c.
A immortal mouse blood cell line cell that has the characteristics: IL-3 dependent pro B cell line. Information
Derived from tissue: blood in animal: mouse, C3H.
A immortal mouse blood cell line cell that has the characteristics: Spontaneouly differentiated cell line derived from M1. Non-tumorigenic.
Derived from tissue: blood in animal: mouse, SL.
A immortal rhesus macaque kidney-derived cell line cell that has the characteristics: Highly susceptible to Simian rotavirus SA11. Backup of ECA85102918.
Derived from tissue: fetal, kidney in animal: monkey, rhesus.
A immortal mouse monocyte cell line cell that has the characteristics: Buck-up culture of ECA85062803. Mouse leukemic monocyte. Abelson leukemia virus induced.
Derived from tissue: leukemic monocyte in animal: mouse, BALB/c.
A immortal rat kidney-derived cell line cell that has the characteristics: Contact-inhibited semi-normal, original of NRK49F
Derived from tissue: kidney in animal: rat.
A immortal rat kidney-derived cell line cell that has the characteristics: Contact-inhibited semi-normal cell line
A immortal rat kidney-derived cell line cell that has the characteristics: Rat (Wistar) cell line derived from renal (kidney) tumor.
Derived from tissue: kidney in animal: rat, Wistar.
A immortal rat kidney-derived cell line cell that has the characteristics: Rat renal tumor derived cell line.
A immortal rat kidney-derived cell line cell that has the characteristics: Rat cells derived from kidney carcinoma. After passage 2. Wister rat.
A immortal rat kidney-derived cell line cell that has the characteristics: Rat cell line derived from kidney carcinoma. After passage 100. Wister rat.
A immortal rat kidney-derived cell line cell that has the characteristics: Rat cell line derived from kidney carcinoma. After passage 80. Wister rat.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Krukenberg tumor cell line
Derived from tissue: ovary in animal: human.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Clear cell adenocarcinoma. Said CA125, CA72-4 producing.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Ovary serous adenocarcinoma. Said CA125, CA15-3 producing.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human ovary mucinous adenocarcinoma cell line.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Serous cystadenocarcinoma. CA125 producing. Cell growth is slow.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human ovary serous cyst adenocarcinoma cell line. Cell growth is slow.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human ovary mucinous tubular adenocarcinoma cell line. Cell growth is slow.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human ovary clear cell carcinoma cell line. Cell growth is slow.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human cell line derived from ovary cancer. Clear cell carcinoma. Cell growth is slow.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Mucinous cystadenocarcinoma. Said CA125,CA19-9 (+). Cell growth is slow.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human cell line derived from ovarian squamous cell cancer.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Japanese ovarian serous adenocarcinoma. Said CA125 producing. Cell growth is slow.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human cell line derived from adenocarcinoma of ovary. TKG0602(Deposited from Tohoku Univ.).
Derived from tissue: ovary, ascites meta in animal: human.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.).
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human cell line derived from ovarian endometrioid carcinoma, subclone of RCB1903. TKG0357 (Deposited from Tohoku Univ.).
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow.
Derived from tissue: ovary, peritoneum in animal: human.
Originator: Nishi, Yoshihiro & Nawata, Hajime
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Lymphnode-metastatic ovarian tumor. So called HM-1 cells.
Derived from tissue: ovary in animal: mouse, C57BL x C3H.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Worm cell line established by Grace. Culturable in MGM-450-10%FBS.
Derived from tissue: ovary in animal: silkworm.
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Useful for recombinant BmNPV expression
A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Silkworm (Bombyx mori) cell line derived from ovary. Useful for the identification and analysis of homologous recombination-related genes in the silkworm.
A immortal chicken B cell line cell that has the characteristics: SHP1 deficient DT40 cells
Derived from tissue: B cell in animal: avian.
A immortal chicken B cell line cell that has the characteristics: Ku70 gene deleted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: Rad51B gene deleted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: Rad51C gene deleted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: Rad51D gene deleted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: XRCC2 gene deleted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: Rad52 gene deleted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: Rad54 and Rad54B gene double-deleted DT40 (chicken B cells).
A immortal chicken B cell line cell that has the characteristics: Rad54 gene deleted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: Ku70 and Rad54B gene double-deleted DT40 (chicken B cells).
A immortal chicken B cell line cell that has the characteristics: XRCC3 gene deleted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: BLNK and Grb2 deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: SHIP deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Grb2 deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: SHP1 and SHP2 deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: BLNK and Syk deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Btk deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: PLC-γ2 deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Syk deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Lyn deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Grap deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: IP3R type1 and IP3R type3 deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: IP3R type2and IP3R type3 deficient DT40
A immortal chicken B cell line cell that has the characteristics: Grb2and Grap deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: TRP1 deficient DT40
A immortal chicken B cell line cell that has the characteristics: SHP2 deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Shc deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: BLNK deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Cbl deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: BCAP deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Vav3 deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: PI3Kp110α deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Rad54 gene deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
A immortal chicken B cell line cell that has the characteristics: ATM gene deleted DT40 (chicken B cells).
A immortal chicken B cell line cell that has the characteristics: ATM and Rad54 gene double-deleted DT40 (chicken B cells). Inducible expression of human Rad54 is possible.
A immortal chicken B cell line cell that has the characteristics: Endogenous Ubc9 deficient DT40 cells but expressing Ubc9 exogenously
A immortal chicken B cell line cell that has the characteristics: Ras GRP1 deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Lyn and Sky deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: DNA PK gene deleted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: Rad51 gene deleted and human Rad51 gene inserted DT40 (chicken B cell line).
A immortal chicken B cell line cell that has the characteristics: ATM and Ku70 gene double-deleted DT40 (chicken B cells).
A immortal chicken B cell line cell that has the characteristics: IP3R type1 and IP3R type2 deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1630.
A immortal chicken B cell line cell that has the characteristics: Mre11 gene deleted DT40 (chicken B cell line), subclone of RCB1629.
A immortal chicken B cell line cell that has the characteristics: IP3R(type1,type2,type3) deficient DT40 cells
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 (chicken B cell line), lacking Nbs1 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking DinB expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking Rad18 expression.
A immortal chicken B cell line cell that has the characteristics: Rad54 and Ku70 gene double-deleted DT40 (chicken B cells).
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking Rev3 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking both of Rad52 and XRCC3 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking both of RasGRP1 and RasGRP3 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking RasGRP3 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking Sos1 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking Sos2 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking both Sos1 and Sos2 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking both of DNAPK and Ku70 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking XRCC3 only in one allele.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking BLM (Bloom syndrome gene) expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking both of Rad18 and XPA expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking both of Rad18 and DinB expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking both of WRN (Werner syndrome gene) and BLM (Bloom syndrome gene) expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking both of DinB and XPA expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking WRN (Werner syndrome gene) expression.
A immortal chicken B cell line cell that has the characteristics: Chicken B cell line transformed by avian leukosis virus. c-myc and IgM expressing.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking CARMA1 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking PKC-β expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking TAK1 expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking ligase IV expression.
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, lacking STIM1 expression.
A immortal chicken B cell line cell that has the characteristics: Mre11 and Ku70 gene double-deleted DT40 (chicken B cells).
A immortal chicken B cell line cell that has the characteristics: Subline of DT40 cell line, which lacks XRCC3 inducibly by tamoxifen.
A immortal chicken B cell line cell that has the characteristics: IL-5 dependent early B-cell line. Also grows on IL-3. The population contain non-IL-5-dependent cell
Derived from tissue: B cell in animal: mouse.
A immortal human prostate gland-derived cell line cell that has the characteristics: Human cell line derived from malignant peripheral nerve sheath tumor.
Derived from tissue: prostate in animal: human.
A immortal human prostate gland-derived cell line cell that has the characteristics: Human cell line derived from bone metastasis of prostatic cancer. TKG0600(Deposited from Tohoku Univ.).
Derived from tissue: prostate, bone meta in animal: human.
A immortal human prostate gland-derived cell line cell that has the characteristics: Human cell line derived from brain metastasis of prostate carcinoma. TKG0604(Deposited from Tohoku Univ.).
Derived from tissue: prostate, brain meta in animal: human.
A immortal human prostate gland-derived cell line cell that has the characteristics: Human cell line derived from prostate adenocarcinoma. Derived from lymph node metastasis. TKG0603(Deposited from Tohoku Univ.).
Derived from tissue: prostate, lymph node meta in animal: human.
A immortal human duodenum-derived cell line cell that has the characteristics: Papillotubular adenocarcinoma of the Vater's papilla. Cell growth is slow.
Derived from tissue: duodenum in animal: human.
A immortal human bone marrow-derived cell line cell that has the characteristics: N-myc gene amplification
Derived from tissue: bone marrow in animal: human.
RIKEN: COSMIC ID:910929; Riken RCB0478,RCB0478
A immortal human bone marrow-derived cell line cell that has the characteristics: N-myc gene amplicon analysis
A immortal human bone marrow-derived cell line cell that has the characteristics: Human acute myeloid leukemia derived cell.
A immortal human bone marrow-derived cell line cell that has the characteristics: Japanese AML. Said i(12p)(p11) and unbalanced t(5;12). Need confirmation before use.
A immortal human bone marrow-derived cell line cell that has the characteristics: Subline of F-36P. Erythropoietin-dependent
A immortal human bone marrow-derived cell line cell that has the characteristics: Human cell line derived from bone marrow stromal cells. Useful to propagate hematopoietic stem cells.
A immortal human bone marrow-derived cell line cell that has the characteristics: Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.).
A immortal human bone marrow-derived cell line cell that has the characteristics: Human cell line derived from megakaryoblastic leukemia. TKG0458(Deposited from Tohoku Univ.).
A immortal human bone marrow-derived cell line cell that has the characteristics: GM-CSF- or IL-3-dependent cell line. Differentiate to erythoid cells with erythropoietin.
A immortal human bone marrow-derived cell line cell that has the characteristics: Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6, E7, and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
A immortal human bone marrow-derived cell line cell that has the characteristics: Human mesenchymal cell line derived from bone marrow. Immortalized by bmi-1, HPV E6, and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
A immortal human bone marrow-derived cell line cell that has the characteristics: Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E7 and hTERT. RCB2152- RCB2163 are derived from the same bone marrow.
A immortal human bone marrow-derived cell line cell that has the characteristics: Human mesenchymal cell line derived from bone marrow. Immortalized by HPV E6 and E7. RCB2152- RCB2163 are derived from the same bone marrow.
A immortal human bone marrow-derived cell line cell that has the characteristics: Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+
A immortal human bone marrow-derived cell line cell that has the characteristics: Human cell line derived from acute myelogenous leukemia. The variant subline of KG-1(RCB1166) cell line. TKG0402(Deposited from Tohoku Univ.).
A immortal human bone marrow-derived cell line cell that has the characteristics: p53 deficient mouse bone marrow derived cell. Useful for study of p53 suppressor oncogene. Cell growth is slow.
Derived from tissue: bone marrow in animal: mouse, 129/sv-(p53-/-).
A immortal human eye-derived cell line cell that has the characteristics: Human cell line derived from retinoblastoma. TKG0601(Deposited from Tohoku Univ.).
Derived from tissue: eye in animal: human.
A immortal human eye-derived cell line cell that has the characteristics: Caucasian retinoblastoma. May have reverse transcriptase. Back up culture of ECA2583.
A immortal human eye-derived cell line cell that has the characteristics: alpha, beta-crystaline expressing human lense epithelial cell line. plasmid DNA: pRSV-B-T Ag.
Derived from tissue: eye, lens in animal: human.
A immortal human tongue-derived cell line cell that has the characteristics: Highly sensitive to bleomycin
Derived from tissue: tongue in animal: human.
A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.).
A immortal human tongue-derived cell line cell that has the characteristics: Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470(Deposited from Tohoku Univ.).
A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484(Deposited from Tohoku Univ.).
A immortal mouse B cell line cell that has the characteristics: Mouse cell line derived from B cell lymphoma.
Derived from tissue: B cell lymphoma in animal: mouse.
A immortal mouse B cell line cell that has the characteristics: Mouse cell line derived from B cell leukemia. TKG0435 (Deposited from Tohoku Univ.).
Derived from tissue: B cell leukemia in animal: mouse, BALB/C.
A immortal Chinese hamster cell line cell that has the characteristics: H2O2 resistant Chinese Hamster V79 cells
Derived from tissue: lung in animal: hamster, Chinese.
A immortal Chinese hamster cell line cell that has the characteristics: Chinese hamster lung fibroblast
A immortal Chinese hamster cell line cell that has the characteristics: Pseudodiploid, two marker chromosomes
A immortal Chinese hamster cell line cell that has the characteristics: Widely used in chromosome aberration test
A immortal Chinese hamster cell line cell that has the characteristics: A subline of the V79 cell line following cloning. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
A immortal Chinese hamster cell line cell that has the characteristics: A subline of the V79 cell line. Widely used for radiation biology, mutagenesis and mammalian cell genetics.
A immortal Chinese hamster cell line cell that has the characteristics: X-ray-sensitive mutant derived from the V79 cell line. XRCC8 gene deficient.
A immortal Chinese hamster cell line cell that has the characteristics: A subline of the V79 cell line. X-ray-sensitive mutant. XRCC8 gene deficient.
A immortal Chinese hamster cell line cell that has the characteristics: A subline of the V79 cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
A immortal Chinese hamster cell line cell that has the characteristics: A subline of the V79B cell line. X-ray-sensitive mutant. XRCC5(ku80) gene deficient.
A immortal Chinese hamster cell line cell that has the characteristics: Chinese hamster cell line. Epithelial-like adherent cells.
Derived from tissue: unknown in animal: hamster, Chinese.
A immortal Chinese hamster cell line cell that has the characteristics: Smooth muscle cell sarcoma from Chinese hamster.
Derived from tissue: uterus in animal: hamster, Chinese.
A immortal rat colon-derived cell line cell that has the characteristics: Metastasis to liver
Derived from tissue: colon in animal: rat, F344.
A immortal rat colon-derived cell line cell that has the characteristics: Metastasis to liver, lung
A immortal rat embryo-derived cell line cell that has the characteristics: Suitable as feeders for hybridoma cloning
Derived from tissue: embryo in animal: rat, Wistar.
A immortal Syrian golden hamster cell line cell that has the characteristics: Mutin producing, BHP-induced pancreatic tumor
Derived from tissue: pancreas in animal: hamster, Syrian.
A immortal gold fish blood cell line cell that has the characteristics: Tumor cells derived from Gold Fish red pigment cells.
Derived from tissue: body in animal: gold fish.
A immortal gold fish cell line cell that has the characteristics: Gold fish erythrophoroma with 4n chromosomal mode
Derived from tissue: erythrophoroma in animal: gold fish.
A immortal gold fish cell line cell that has the characteristics: Tumor cells derived from Gold Fish red pigment cells.
Derived from tissue: flank in animal: gold fish.
A immortal gold fish cell line cell that has the characteristics: Pinna fibroblast
Derived from tissue: pinna in animal: gold fish.
A immortal gold fish cell line cell that has the characteristics: Scale fibroblast
Derived from tissue: scale in animal: gold fish.
A immortal gold fish cell line cell that has the characteristics: Scale fibroblast. Possible to culture in DMEM medium. See RCB0082.
A immortal mouse rectum-derived cell line cell that has the characteristics: Mouse cell line derived from rectal cancer. BALB/c strain.TKG0518(Deposited from Tohoku Univ.).
Derived from tissue: rectum in animal: mouse, BALB/c.
A immortal rat mammary gland-derived cell line cell that has the characteristics: Rat cell line derived from mammary gland carcinoma which is induced by DMBA in the transgenic rat expressing human prototype c-Ha-ras gene.
Derived from tissue: mammary gland in animal: rat, c-Ha-ras transgenic.
A immortal rat mammary gland-derived cell line cell that has the characteristics: Rat cell line derived from mammary carcinoma. TKG0132(Deposited from Tohoku Univ.).
Derived from tissue: mammary gland in animal: rat, SD.
A immortal rat mammary gland-derived cell line cell that has the characteristics: Rat cell line derived from mammary carcinoma. TKG0565(Deposited from Tohoku Univ.).
Derived from tissue: mammary gland in animal: rat, Wistar.
A immortal mouse endothelial cell line cell that has the characteristics: Vascular endothelial cells derived from pituitary gland of temperature-sensitive T antigen transgenic mouse.
A immortal human adrenal cortex-derived cell line cell that has the characteristics: Fibroblasts from multiple endocrine neoplasia
Derived from tissue: adrenal cortex in animal: human.
A immortal human adrenal cortex-derived cell line cell that has the characteristics: Buck-up culture of ECA85051002. Mouse steroid hormone secreting adrenal cortex cell line.
Derived from tissue: adrenal cortex in animal: mouse.
A immortal human mammary gland-derived cell line cell that has the characteristics: Same as OCUB-1, OCUB-F. Chromosome = pseudotetraploid.
Derived from tissue: mammary gland, pleural fluid in animal: human.
A immortal human mammary gland-derived cell line cell that has the characteristics: Same as OCUB-1, OCUB-M. Chromosome = pseudodiploid
A immortal mink cell line cell that has the characteristics: Mink (RCB1833) cells transformed by Moloney murine sarcoma virus.
Derived from tissue: lung in animal: mink.
A immortal mink cell line cell that has the characteristics: Lung epithelial cell line derived from mink. Useful for focus forming assays for murine leukemia virus.
A immortal medaka cell line cell that has the characteristics: Medaka cell line derived from HdrR strain.
Derived from tissue: embryo in animal: medaka.
A immortal medaka cell line cell that has the characteristics: Medaka cell line derived from HB32 strain.
A immortal medaka cell line cell that has the characteristics: Medaka cell line derived from HNI strain.
Derived from tissue: caudal fin in animal: medaka.
A immortal medaka cell line cell that has the characteristics: H04C medaka hepatoma pretreated with MAM-acetate
Derived from tissue: liver in animal: medaka.
A immortal medaka cell line cell that has the characteristics: Medaka cell line derived from hepatoma cells.
A immortal medaka cell line cell that has the characteristics: Fish (medaka) fin fibroblast. Cell growth is slow.
Derived from tissue: fin in animal: medaka.
A immortal medaka cell line cell that has the characteristics: HB32C medaka treated with MNNG. From peritoneum. Amelanotic. Cell growth is slow.
Derived from tissue: melanoma in animal: medaka.
Derived from tissue: gums in animal: African Savannah Elephant.
PMID:18089833.Cancer Res. 2007 Dec 15;67(24):12018-25. "...Epithelial cells were harvested from histologically confirmed adenocarcinomas .."
A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.
The definition of cell is intended to represent all cells, and thus a cell is defined as a material entity and not an anatomical structure, which implies that it is part of an organism (or the entirety of one).
EFO_URI: http://www.ebi.ac.uk/efo/EFO_0000324
A cultured cell that is freshly isolated from a organismal source, or derives in culture from such a cell prior to the culture being passaged.
A cell that is found in a natural setting, which includes multicellular organism cells 'in vivo' (i.e. part of an organism), and unicellular organisms 'in environment' (i.e. part of a natural environment).
To accommodate unicellular organisms better, 'cell in vivo' has been re-labeled 'native cell' to better represent its intended meaning - that is, that it is a cell in the context of a multicellular organism or in a natural environment. 'Native' is intended to contrast with 'in vitro', which refers to cells or other biological entities that have been intentionally placed in a controlled, non-natural setting for the purpose of study or manipulation. (MAH 1.12.12).
A cell found in the embryo before the formation of all the gem layers is complete.
Cell that is part of the migratory cranial neural crest population. Migratory cranial neural crest cells develop from premigratory cranial neural crest cells and have undergone epithelial to mesenchymal transition and delamination.
A cell in vitro that is or has been maintained or propagated as part of a cell culture.
Note that this class was re-labeled to 'cultured cell' instead of 'cell line cell', as it intent was clarified to cover any cultured cells of multicellular and unicellular organisms. This includes cells actively being cultured, or cells that have been cultured but are stored in a quiescent state for future use. In having been cultured, cells must establish homeostasis and often replicate in a foreign environment. Accomodation of this stress initiates a selection of cells fit for such challenges, wherein necessary adaptive biochemical and.or genetic changes can occur. These changes can set them apart from the in vivo cells from which they derive, and such changes will typically accumulate and change over increasing time in culture.
Male germ cell is a germ cell that supports male gamete production.
A male germ cell that develops from spermatogonia. The euploid primary spermatocytes undergo meiosis and give rise to the haploid secondary spermatocytes which in turn give rise to spermatids.
A male germ cell that develops from the haploid secondary spermatocytes. Without further division, spermatids undergo structural changes and give rise to spermatozoa.
A mature male germ cell that develops from a spermatid.
An euploid male germ cell of an early stage of spermatogenesis.
Female germ cell is a germ cell that supports female gamete production.
A female germ cell that has entered meiosis.
A female gamete where meiosis has progressed to metaphase II and is able to participate in fertilization.
A cell that will develop into a neuron often after a migration phase.
A relatively undifferentiated cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
This term applies to metazoan. For plant stem cells, consider using PO:0004011 ‘initial cell’ or its parent PO:0004010 ‘meristematic cell’.
A stem cell that self-renews as well as give rise to a single mature cell type.
A stem cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system. Hematopoietic stem cells lack cell markers of effector cells (lin-negative). Lin-negative is defined by lacking one or more of the following cell surface markers: CD2, CD3 epsilon, CD4, CD5 ,CD8 alpha chain, CD11b, CD14, CD19, CD20, CD56, ly6G, ter119.
Markers differ between species, and two sets of markers have been described for mice. HSCs are reportedly CD34-positive, CD45-positive, CD48-negative, CD150-positive, CD133-positive, and CD244-negative.
A progenitor cell committed to the erythroid lineage.
A cell that is within the developmental lineage of gametes and is able to pass along its genetic material to offspring.
Originally this term had some plant germ line cell children.
A myeloid progenitor cell committed to the monocyte lineage. This cell is CD11b-positive, has basophilic cytoplasm, euchromatin, and the presence of a nucleolus.
Morphology: mononuclear cell, diameter 12-20 _M, non-granular, N/C ratio 3/1 - 4/1; markers: CD11b (shared with many other myeloid cells); location: Adult: bone marrow; fetal: liver, Yolk Sac; role or process: hematopoiesis, monocyte development; lineage: hematopoietic, myeloid.
Neural stem cell is characterized as an undifferentiated cell that originates from the neuroectoderm and has the capacity both to perpetually self-renew without differentiating and to generate multiple types of lineage-restricted progenitors.
A stem cell that can give rise to multiple lineages of cells.
A progenitor cell committed to myeloid lineage, including the megakaryocyte and erythroid lineages.
colony forming unit granulocyte, erythrocyte, macrophage, and megakaryocyte
This cell type is intended to be compatible with any vertebrate common myeloid progenitor. For mammalian CMP known to be CD34-positive, please use the term 'common myeloid progenitor, CD34-positive' (CL_0001059).
A progenitor cell committed to the megakaryocyte and erythroid lineages.
colony forming unit erythroid megakaryocyte
MEPs are reportedly CD19-negative, CD34-negative, CD45RA-negative, CD110-positive, CD117-positive, and SCA1-negative and reportedly express the transcription factors GATA-1 and NF-E2.
A oligopotent progenitor cell committed to the lymphoid lineage.
CLP are CD7-positive, CD10-positive, CD19-negative, CD34-positive, CD45RA-positive, CD79a-negative, CD127-positive, AA4.1-positive, RAG-negative, Sca-1-low, sIgM-negative, sIgD-negative, TdT-negative, Vpre-B-negative, and pre-BCR-negative. Expression of transcription factors include E2A-positive, EBF-positive, Ikaros-negative, PU.1-negative, and Pax5-negative.
A stem cell from which all cells of the body can form.
A precursor cell with a limited number of potential fates.
define using PATO mulit-potent or oligopotent?
A cell that is commited to differentiating into a muscle cell. Embryonic myoblasts develop from the mesoderm. They undergo proliferation, migrate to their various sites, and then differentiate into the appropriate form of myocytes. Myoblasts also occur as transient populations of cells in muscles undergoing repair.
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules.
A connective-tissue cell of mesenchymal origin that secretes proteins and especially molecular collagen from which the extracellular fibrillar matrix of connective tissue forms.
A large, flat, oval cell found in connective tissue and responsible for the formation of fibers.
These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
EFO_URI: http://www.ebi.ac.uk/efo/EFO_0000496
URI: http://www.ebi.ac.uk/cellline#fibroblast
Skeletogenic cell that secretes osteoid, is capable of producing mineralized (hydroxyapatite) matrix, is located adjacent to or within osteoid tissue, and arises from the transformation of a preosteoblast cell.
non-encoded relationships from VSAO - capable_of_producing VSAO:0000020
A cell that has a filiform extrusion of the cell surface.
A cell that is usually found in a two-dimensional sheet with a free surface. The cell has a cytoskeleton that allows for tight cell to cell contact and for cell polarity where apical part is directed towards the lumen and the basal part to the basal lamina.
A cell that is usually found in a two-dimensional sheet with a free surface.
Cell that cover the surface of the body and line its cavities.
Cell that line the inner and outer surfaces of the body by forming cellular layers (epithelium) or masses (MSH).
EFO_URI: http://www.ebi.ac.uk/efo/EFO_0000475
URI: http://www.ebi.ac.uk/cellline#epithelial_cell
An epithelial cell that is part of a duct.
An endothelial cell that lines the vasculature.
cuboidal endothelial cell of vascular tree
A columnar/cuboidal epithelial cell is a cell usually found in a two dimensional sheet with a free surface. Columnar/cuboidal epithelial cells take on the shape of a column or cube.
A flattened epithelial cell of mesenchymal origin that lines the serous cavity.
A cell which moves among different tissues of the body, via blood, lymph, or other medium.
A cell found predominately in the blood.
A type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.
A specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue, which typically differentiates from monocytes. This cell has the following markers: tartrate-resistant acid phosphatase type 5-positive, PU.1-positive, c-fos-positive, nuclear factor NF-kappa-B p100 subunit-positive, tumor necrosis factor receptor superfamily member 11A-positive and macrophage colony-stimulating factor 1 receptor-positive.
Morphology: Highly vesicular; markers: Surface: RANK, cFMS (MCSF receptor); Secreted: cathepsin K and TRAP (tartate resistant acid phosphatase); transcription factors: PU.1, cFOS, MITF, NFkB (p52); role or process: tissue remodelling: bone resorption; lineage: hematopoietic, myeloid.
A leukocyte with abundant granules in the cytoplasm.
A cell that is found in almost all tissues containing numerous basophilic granules and capable of releasing large amounts of histamine and heparin upon activation. Progenitors leave bone marrow and mature in connective and mucosal tissue. Mature mast cells are found in all tissues, except the bloodstream. Their phenotype is CD117-high, CD123-negative, CD193-positive, CD200R3-positive, and FceRI-high. Stem-cell factor (KIT-ligand; SCF) is the main controlling signal of their survival and development.
Mast cells are generally integrin beta-7-negative and positive for TLR2, TLR3, TLR4, TLR5, TLR7, TLR9, C3aR, C5aR, CR3, CR4, VEGF, FGF2, and renin. They can express MHC Class I and II on their surface. Activated murine mast cells (IgE+Antigen) were capable of expressing the following co-stimulatory molecules: CD95 (Fas), CD120b, CD137 (4-1BB), CD153 (CD30L), CD154 (CD40L), GITR, ICOSL, OX40L, PD-L1, and PD-L2. Note that there was some mouse strain variation. Mast cells have also been demonstrated to produce bFGF, CCL2, CCL4, CCL5, CCL11, CCL20, CXCL2, CXCL8, CXCL10, GM-CSF, IFN-gamma, IL-1, IL-2, IL-3, IL-8, IL-10, IL-11, IL-12, IL-13, IL-16, IL-25, IL-18, MIP-1, prostaglandin D2, SCF, TGF-beta, TNF-alpha, TSLP, VEGF, and XCL1. They express the transcription factors Transcription factors AP-1, GATA1, MITF, Notch2, PIAS3, PU.1, and STAT5.
Most generally any neuron which is not motor or sensory. Interneurons may also refer to neurons whose axons remain within a particular brain region as contrasted with projection neurons which have axons projecting to other brain regions.
An efferent neuron that passes from the central nervous system or a ganglion toward or to a muscle and conducts an impulse that causes or inhibits movement.
Any neuron having a sensory function; an afferent neuron conveying sensory impulses.
A type of interneuron that has two neurites, usually an axon and a dendrite, extending from opposite poles of an ovoid cell body.
A neuron with three or more neurites, usually an axon and multiple dendrites.
A neuron that is part of nerve found outside the central nervous system.
A vertebrate phagocyte with a single nucleus.
An endothelial cell comprises the outermost layer or lining of anatomical structures and can be squamous or cuboidal. In mammals, endothelial cell has vimentin filaments and is derived from the mesoderm.
From FMA: 9.07.2001: Endothelial cell has always been classified as a kind of epithelial cell, specifically a squamous cell but that is not true. First, endothelial cell can either be squamous or cuboidal (e.g. high-endothelial cell) and secondly, it has different embryological derivation (mesodermal) than a true epithelial cell (ectodermal and endodermal). The basis for present classification is the fact that it comprises the outermost layer or lining of anatomical structures (location-based) but a better structural basis for the differentia is the cytoskeleton of the cell. Endothelial cell has vimentin filaments while an epithelial cell has keratin filaments. [Onard].
The main type of cell found in the inside lining of blood vessels, lymph vessels, and the heart.
EFO_URI: http://www.ebi.ac.uk/efo/EFO_0000467
URI: http://www.ebi.ac.uk/cellline#endothelial_cell
A neuron that has dendritic processes radiating from the cell body forming a star-like shape.
neuron associated cell (sensu Vertebrata)
A non-neuronal cell of the nervous system. They not only provide physical support, but also respond to injury, regulate the ionic and chemical composition of the extracellular milieu. Guide neuronal migration during development, and exchange metabolites with neurons.
A neuroglial cell of ectodermal origin, i.e., the astrocytes and oligodendrocytes considered together.
A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from 'star' cells) are irregularly shaped with many long processes, including those with 'end feet' which form the glial (limiting) membrane and directly and indirectly contribute to the blood-brain barrier. They regulate the extracellular ionic and chemical environment, and 'reactive astrocytes' (along with microglia) respond to injury.
Astrocytes are reportedly CD68-negative, CD121a-positive, CD184-positive, CD192-positive, CRF-positive, EGFR-positive, GFAP-positive, GLUT1-positive, MBP-negative, and NGFR-positive.
A central nervous system macrophage found in the parenchyma of the central nervous system. Marker include CD11b-positive, F4/80-positive, and CD68-positive.
Markers: Mouse: CD11b+, F4/80+, CD68+. They represent ~12% of the cells in the CNS, but they are not uniformly distributed within the CNS. A normal adult mouse brain has approximately 3.5x10e6 microglia. Microglia are also reportedly CD3-negative, CD4-positive, CD8-negative, CD11b-positive, CD11c-high, CD14-negative, CD19-negative, CD45-low, CD56-negative, CD163-negative, CD200R-positive, CD281-positive, CD282-positive, CD283-positive, CD284-positive, CD285-positive, CD286-positive, CD287-positive, CD288-positive, CD289-positive, Gr1-negative, nestin-positive, and PU.1-positive.
A connective tissue cell that normally gives rise to other cells that are organized as three-dimensional masses. In humans, this cell type is CD73-positive, CD90-positive, CD105-positive, CD45-negative, CD34-negative, and MHCII-negative. They may further differentiate into osteoblasts, adipocytes, myocytes, neurons, or chondroblasts in vitro. Originally described as residing in the bone marrow, this cell type is now known to reside in many, if not all, adult organs.
Many but not all mesenchymal cells derive from the mesoderm. MSCs are reportedly CD3-negative, CD4-negative, CD5-negative, CD8-negative, CD11a-negative, CD11b-negative, CD14-negative, CD19-negative, CD29-positive, CD31-negative, CD34-negative, CD38-negative, CD40-negative, CD44-positive, CD45-negative, CD49-positive, CD54-positive, CD66b-negative, CD79a-negative, CD80-negative, CD102-positive, CD106-positive, CD117-positive, CD121a-positive, CD121b-positive, CD123-positive, CD124-positive, CD133-negative, CD146-positive, CD166-positive, CD271-positive, B220-negative, Gr1-negative, MHCI-positive, MHCII-negative, SSEA4-negative, sca1-positive, Ter119-negative, and glycophorin A-negative. Cultured MSCs are capable of producing stem cell factor, IL7, IL8, IL11, TGF-beta, cofilin, galectin-1, laminin-receptor 1, cyclophilin A, and MMP-2.
A fat-storing cell found mostly in the abdominal cavity and subcutaneous tissue of mammals. Fat is usually stored in the form of triglycerides.
A cell capable of processing and presenting lipid and protein antigens to T cells in order to initiate an immune response.
Note change of name; nearly all somatic cells can present antigens to T cells via MHC Class I complexes leading to effector responses, but professional antigen presenting cells constitutively express MHC Class II as well as costimulatory molecules, and thus can initiate immune responses via T cells.
A pigment cell is a cell that contains pigment granules.
A pigment cell derived from the neural crest. Contains melanin-filled pigment granules, which gives a brown to black appearance.
A specialized epithelial cell that is capable of synthesizing and secreting certain biomolecules.
A cell that specializes in controlled release of one or more substances.
A cell of an exocrine gland; i.e. a gland that discharges its secretion via a duct.
A large, oval stomach epithelial cell with a central nucleus; source of gastric acid. Secretes HCl.
A cell of an endocrine gland, ductless glands that secrete substances which are released directly into the circulation and which influence metabolism and other body functions.
An endocrine cell that is located in the epithelium of the gastrointestinal tract or in the pancreas.
An endocrine cell that has the specialized function to produce and secrete hormones in response to neuronal signals.
A cell that stores epinephrine secretory vesicles. During times of stress, the nervous system signals the vesicles to secrete their hormonal content. Their name derives from their ability to stain a brownish color with chromic salts. Characteristically, they are located in the adrenal medulla and paraganglia of the sympathetic nervous system.
A Leydig cell is a testosterone-secreting cell in the interstitial area, between the seminiferous tubules, in the testis.
Note that the Amphibian Anatomy Ontology (AA) has a class 'leydig cells' but this is unrelated
The main structural component of the liver. They are specialized epithelial cells that are organized into interconnected plates called lobules. Majority of cell population of liver, polygonal in shape, arranged in plates or trabeculae between sinusoids; may have single nucleus or binucleated.
Hepatocytes are reportedly MHC Class I-positive and MHC Class II-positive.
A cell whose primary function is to shorten.
An animal cell that has characteristics of both a fibroblast cell and a smooth muscle cell.
Myofibroblasts are alpha-SMA-positive, CD34-negative, CD45-negative. They are reportedly capable of secreting IL-1beta, IL-6, and TNF-alpha.
A mature contractile cell, commonly known as a myocyte. This cell has as part of its cytoplasm myofibrils organized in various patterns.
A somatic cell located in skeletal muscle.
A non-striated, elongated, spindle-shaped cell found lining the digestive tract, uterus, and blood vessels. They develop from specialized myoblasts (smooth muscle myoblast).
A cell that is capable of detection of a stimulus involved in sensory perception.
A cell specialized to detect and transduce light.
A cell whose function is determined by the generation or the reception of an electric signal.
A cell within an epithelial cell sheet whose main function is to act as an internal or external covering for a tissue or an organism.
A cell whose primary function is to prevent the transport of stuff across compartments.
A supporting cell projecting inward from the basement membrane of seminiferous tubules. They surround and nourish the developing male germ cells and secrete androgen binding protein. Their tight junctions with the spermatogonia and spermatocytes provide a blood-testis barrier.
A neuroglial cell of the peripheral nervous system which forms the insulating myelin sheaths of peripheral axons.
A cell that moves by its own activities.
A cell of the outer of the three germ layers of the embryo.
A cell of the middle germ layer of the embryo.
A cell of the inner of the three germ layers of the embryo.
A red blood cell. In mammals, mature erythrocytes are biconcave disks containing hemoglobin whose function is to transport oxygen.
A red blood cell. In mammals, mature erythrocytes are non-nucleated, biconcave disks containing hemoglobin whose function is to transport oxygen.
Any of the hemoglobin-containing cells that carry oxygen to the tissues and are responsible for the red color of vertebrate blood.
EFO_URI: http://www.ebi.ac.uk/efo/EFO_0000477
URI: http://www.ebi.ac.uk/cellline#erythrocyte
Any cell capable of ingesting particulate matter via phagocytosis.
A mononuclear phagocyte present in variety of tissues, typically differentiated from monocytes, capable of phagocytosing a variety of extracellular particulate material, including immune complexes, microorganisms, and dead cells.
Morphology: Diameter 30_M-80 _M, abundant cytoplasm, low N/C ratio, eccentric nucleus. Irregular shape with pseudopods, highly adhesive. Contain vacuoles and phagosomes, may contain azurophilic granules; markers: Mouse & Human: CD68, in most cases CD11b. Mouse: in most cases F4/80+; role or process: immune, antigen presentation, & tissue remodelling; lineage: hematopoietic, myeloid.
A lymphocyte of B lineage that is capable of B cell mediated immunity.
A lymphocyte of B lineage with the phenotype CD19-positive and surface immunoglobulin-positive.
Immunologically important lymphocyte that is not thymus-dependent, is either short-lived and naive or long-lived and of memory phenotype, and resembles the bursa-derived lymphocyte of birds in that it is responsible for the production of immunoglobulins.
EFO_URI: http://www.ebi.ac.uk/efo/EFO_0000101
A cell whose primary function is to provide structural support, to provide strength and physical integrity to the organism.
A peptide hormone secreting cell that produces growth hormone, somatotropin.
A mature sexual reproductive cell having a single set of unpaired chromosomes.
An epidermal cell which synthesizes keratin and undergoes a characteristic change as it moves upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell.
Keratinocytes are reportedly CDw210a-negative, CDw210b-positive, CD281-positive, CD282-positive, CD285-positive, IL22Ra1-positive, Human keratinocytes are reportedly capable of secreting BD-2, BD-3, hCAP-18, CXCL1, CXCL5, CXCL8, elafin, MMP-3, NGAL, PDGF-A, S100A7, S100A8, and S100A9. Transcription factors: STAT3-positive.
Skin cell, of the keratinized layer of epidermis: its characteristic intermediate filament protein is cytokeratin.
EFO_URI: http://www.ebi.ac.uk/efo/EFO_0000560
URI: http://www.ebi.ac.uk/cellline#keratinocyte
Columnar glandular cell with irregular nucleus, copious granular endoplasmic reticulum and supranuclear granules. Secretes a watery fluid containing proteins known as serous fluid.
A cell that is specialised to accumulate a particular substance(s).
A cell derived from the specialized ectoderm flanking each side of the embryonic neural plate, which after the closure of the neural tube, forms masses of cells that migrate out from the dorsal aspect of the neural tube to spread throughout the body.
A mesenchymal cell in embryonic development found in a contracting mass and that gives rise to osteoprogenitors.
An early neural cell developing from the early ependymal cell of the neural tube.
A cell lining the outside of the blastocyst. After binding to the endometrium, trophoblast cells develop into two distinct layers, an inner layer of mononuclear cytotrophoblast cells and an outer layer of continuous multinuclear cytoplasm, the syncytiotrophoblast cells, which form the early fetal-maternal interface.
A cell of the outer layer of a blastula that gives rise to the ectoderm after gastrulation.
An undifferentiated cell produced by early cleavages of the fertilized egg (zygote).
A multifate stem cell found in skeletal muscle than can differentiate into many different cell types, including muscle. Distinct cell type from satellite cell.
Multi-potency demonstrated ex vivo. At the time of writing, it is unclear whether the endogenous population differentiates into multiple cell types in vivo.
An epithelial cell of the integument (the outer layer of an organism).
Diploid cell produced by the fusion of sperm cell nucleus and egg cell.
prohemocyte (sensu Nematoda and Protostomia)
blood cell (sensu Nematoda and Protostomia)
A cell whose function is determined by its response to an electric signal.
A cell that initiates an electrical signal and passes that signal to another cell.
A cell whose nucleus, or nuclei, each contain more than two haploid genomes.
A cell whose nucleus contains a single haploid genome.
A cell involved in the elimination of metabolic and foreign toxins, and in maintaining the ionic, acid-base and water balance of biological fluids.
A peptide hormone secreting cell pituitary that produces luteinizing hormone.
A peptide hormone cell that secretes prolactin.
A cell of the intermediate pituitary that produces melanocyte stimulating hormone.
melanocyte stimulating hormone secreting cell
A cell of hematopoietic origin, typically resident in particular tissues, specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. These cells are lineage negative (CD3-negative, CD19-negative, CD34-negative, and CD56-negative).
Langerhans cell is a conventional dendritic cell that has plasma membrane part CD207. A Langerhans cell is a stellate dendritic cell of myeloid origin, that appears clear on light microscopy and has a dark-staining, indented nucleus and characteristic inclusions (Birbeck granules) in the cytoplasm; Langerhans cells are found principally in the stratum spinosum of the epidermis, but they also occur in other stratified epithelia and have been identified in the lung, lymph nodes, spleen, and thymus.
Originally described in the dendritic cell ontology (DC_CL:0000021 )(PMID:19243617). These cells are also CD1a-high, CD14-negative, CD207-positive (langerin), CD324-positive (E-cadherin), and DCIR-positive. They reside in the epidermis.
A peptide hormone secreting cell that produces adrenocorticotropin, or corticotropin.
adrenocorticotrophic hormone secreting cell
adrenocorticotropic hormone secreting cell
A cell whose primary function is to protect the organism.
A basophil cell of the anterior pituitary that produces thyroid stimulating hormone, thyrotrophin. This cell type is elongated, polygonal and lie in clusters towards the adenohypophyseal center.
thyroid stimulating hormone secreting cell
A connective tissue cell of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.
A cell found throughout the gastrointestinal tract and in the pancreas. They secrete somatostatin in both an endocrine and paracrine manner. Somatostatin inhibits gastrin, cholecystokinin, insulin, glucagon, pancreatic enzymes, and gastric hydrochloric acid. A variety of substances which inhibit gastric acid secretion (vasoactive intestinal peptide, calcitonin gene-related peptide, cholecystokinin, beta-adrenergic agonists, and gastric inhibitory peptide) are thought to act by releasing somatostatin.
An endorphine cell that secretes enkephalin.
A peptide hormone secreting cell that secretes endorphin.
An endocrine cell found in the pyloric gland mucosa (antral mucosa) of the stomach of mammals and responsible for the secretion of gastrin and enkephalin. Most abundant in pyloric antrum, pyramidal in form with a narrow apex bearing long microvilli.
A peptide hormone secreting cell that secretes gastrin.
A peptide hormone secreting cell that secretes androgen binding protein.
A precursor cell destined to differentiate into cardiac muscle cell.
A precursor cell destined to differentiate into smooth muscle myocytes.
A myoblast that differentiates into skeletal muscle fibers.
A phagocyte in vertebrates that is able to phagocytosis.
A phagocyte from organisms in the Nematoda or Protostomia clades.
phagocyte (sensu Nematoda and Protostomia)
A neuron which conveys sensory information centrally from the periphery.
A neuron which sends impulses peripherally to activate muscles or secretory cells.
The basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
These cells are also reportedly CD4-negative and CD200-positive. They are also capable of producing CD40L and IFN-gamma.
A cell that originates from the neural crest and differentiates into a pigment cell.
Derived from UBERON:0002342 neural crest.
A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.
Editors note: consider adding taxon constraint to vertebrata (PMID:18025161)
An immature, nucleated erythrocyte occupying the stage of erythropoeisis that follows formation of erythroid progenitor cells. This cell is CD71-positive, has both a nucleus and a nucleolus, and lacks hematopoeitic lineage markers.
A nucleated immature erythrocyte, having cytoplasm generally similar to that of the earlier proerythroblast but sometimes even more basophilic, and usually regular in outline. The nucleus is still relatively large, but the chromatin strands are thicker and more deeply staining, giving a coarser appearance; the nucleoli have disappeared. This cell is CD71-positive and lacks hematopoeitic lineage markers.
A nucleated, immature erythrocyte in which the nucleus occupies a relatively smaller part of the cell than in its precursor, the basophilic erythroblast. The cytoplasm is beginning to acquire hemoglobin and thus is no longer a purely basophilic, but takes on acidophilic aspects, which becomes progressively more marked as the cell matures. The chromatin of the nucleus is arranged in coarse, deeply staining clumps. This cell is CD71-positive and lacks hematopoeitic lineage markers.
The final stage of the nucleated, immature erythrocyte, before nuclear loss. Typically the cytoplasm is described as acidophilic, but it still shows a faint polychromatic tint. The nucleus is small and initially may still have coarse, clumped chromatin, as in its precursor, the polychromatophilic erythroblast, but ultimately it becomes pyknotic, and appears as a deeply staining, blue-black, homogeneous structureless mass. The nucleus is often eccentric and sometimes lobulated.
The earliest cytologically identifiable precursor in the thrombocytic series. This cell is capable of endomitosis and lacks expression of hematopoieitic lineage markers (lin-negative).
Lineage negative is described here as CD2-negative, CD3-negative, CD4-negative, CD5-negative, CD8a-negative, CD14-negative, CD19-negative, CD20-negative, CD56-negative, Ly6g-negative, and Ter119-negative.
A giant cell 50 to 100 micron in diameter, with a greatly lobulated nucleus, found in the bone marrow; mature blood platelets are released from its cytoplasm.
Megakaryocytes are reportedly CD181-positive and CD182-positive.
A hematopoietic progenitor cell that is committed to the granulocyte and monocyte lineages. These cells are CD123-positive, and do not express Gata1 or Gata2 but do express C/EBPa, and Pu.1.
colony forming unit granulocyte macrophage
Originally described in the dendritic cell ontology (DC_CL:0000042)(PMID:19243617). GMPs are reportedly CD16-positive, CD32-positive, CD34-positive, CD38-positive, CD45RA-positive, CD110-negative, CD117-positive, CD123-positive, and SCA1-negative.
An immature erythrocyte that changes the protein composition of its plasma membrane by exosome formation and extrusion. The types of protein removed differ between species though removal of the transferrin receptor is apparent in mammals and birds.
A precursor in the monocytic series, being a cell intermediate in development between the monoblast and monocyte. This cell is CD11b-positive and has fine azurophil granules.
Morphology: Mononuclear cell, diameter 14-18 _M, fine azurophilic granules; markers: CD11b (shared with many other myeloid cells); location: Adult: bone marrow; Fetal: Liver, Yolk Sac; role or process: hematopoiesis, monocyte development; lineage: hematopoietic, myeloid.
A mesenchymal stem cell capable of developing into blood vessel endothelium.
These cells are reportedly CD31-positive, CD34-positive, CD144-positive, CD309-positive, and TAL1-positive.
A cell that originates in the neural crest, that has certain cytochemical and ultrastructural characteristics and is found scattered throughout the body; types include melanocytes, the cells of the chromaffin system, and cells in the hypothalamus, hypophysis, thyroid, parathyroids, lungs, gastrointestinal tract, and pancreas. This cell type concentrates the amino acid precursors of certain amines and decarboxylate them, forming amines that function as regulators and neurotransmitters. This cell type produces substances such as epinephrine, norepinephrine, dopamine, serotonin, enkephalin, somatostatin, neurotensin, and substance P, the actions of which may affect contiguous cells, nearby groups of cells, or distant cells, thus functioning as local or systemic hormones. The name is an acronym for amine precursor uptake and decarboxylation cell.
amine precursor uptake and decarboxylation cell
One of the two photoreceptor cell types in the vertebrate retina. In cones the photopigment is in invaginations of the cell membrane of the outer segment. Cones are less sensitive to light than rods, but they provide vision with higher spatial and temporal acuity, and the combination of signals from cones with different pigments allows color vision.
Myeloid mononuclear recirculating leukocyte that can act as a precursor of tissue macrophages, osteoclasts and some populations of tissue dendritic cells.
Morphology: Mononuclear cell, diameter, 14 to 20 _M, N/C ratio 2:1-1:1. Nucleus may appear in variety of shapes: round, kidney, lobulated, or convoluted. Fine azurophilic granules present; markers: CD11b (shared with other myeloid cells), human: CD14, mouse: F4/80-mid,GR1-low; location: Blood, but can be recruited into tissues; role or process: immune & tissue remodelling; lineage: hematopoietic, myeloid.
A cell in vitro that has undergone physical changes as a consequence of a deliberate and specific experimental procedure.
This class has been re-labeled to imply reference only to in vitro experimentally modified cells, similarly, the definition has been slightly updated to reflect this. 'experimentally modified cell' refers only to cells in vitro, and not modified in vivo/in environment cells. There is currently no class representing unmodified in vitro cells (other than the parent 'cell in vitro'), or a class representing modified native cells. More granular subclassing of experimentally modified cell can be found in ReO. MHB 1.12.12
A macrophage resident in the peritoneum under non-inflammatory conditions. Markers include F4/80-high, CD11b-high, CD68-positive, SIGNR1-positive, CD115-high, MHC-II-negative, and Dectin-1-positive.
Markers: Mouse: F4/80-high, CD11b-high, CD68+, SIGNR1+, Dectin-1+.
The reproductive cell in multicellular organisms.
One of the two photoreceptor cell types of the vertebrate retina. In rods the photopigment is in stacks of membranous disks separate from the outer cell membrane. Rods are more sensitive to light than cones, but rod mediated vision has less spatial and temporal resolution than cone vision.
A progenitor cell committed to the basophil lineage. This cell lacks hematopoietic lineage markers (lin-negative) and is CD34-positive, T1/ST2-low, CD117-negative, and FceRIa-high. This cell also expresses Gata-1, Gata-2 and C/EBPa.
BaP are also CD13-low and integrin beta-7-low. They are lin-negative (CD2, CD3e, CD4, CD5, CD8, CD11b, CD14, CD19, CD20, ly6g, ly76, and NCAM-1). They also lack expression of mast cell protease 1 (MCP-1) and microphthalmia-associated transcription factor (mitf).
A myoblast that is committed to a myotube-specific program of differentiation but not yet fused. It undergoes very limited additional proliferation. After fusion, it will take on a muscle identity specified by a `muscle founder cell` (CL:0008006).
A secretory cell that is grouped together with other cells of the same type to form grape shaped clusters known as acini (singular acinus).
A lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors and also regulate immune responses via cytokine release and direct contact with other cells.
A mature alpha-beta T cell that expresses an alpha-beta T cell receptor and the CD4 coreceptor.
A cell whose primary function is to support other cell types.
A cell that stains readily in the anterior pituitary gland.
chromophil cell of anterior pituitary gland
An acidophilic chromophil cell that of the anterior pituitary gland.
acidophil cell of pars anterior of adenohypophysis
acidophil of pars anterior of adenohypophysis
acidophil of pars distalis of adenohypophysis
acidophil cell of pars distalis of adenohypophysis
A basophillic chromophil cell that of the anterior pituitary gland.
basophil cell of anterior lobe of hypophysis
basophil cell of pars distalis of adenohypophysis
A supportive cell of the vertebrate pituitary that provides macromolecular transport and secretes hormones.
Undifferentiated; mitotic stem cell for other epithelial cell types; rounded or elliptical with little cytoplasm and few organelles; contain cytokeratin intermediate filament.
A mucus-secreting cell, with numerous apical secretory vesicles containing mucins; nucleus are basally displaced; numerous at the neck of mucus secreting glands
A glomerular visceral epithelial cell is a specialized kidney epithelial cell that contains "feet" that interdigitate with the "feet" of other glomerular epithelial cells.
epithelial cell of visceral layer of glomerular capsule
GO has podocyte as a related synonym due to concern this may refer to more than one cell type. However, this did not turn up in my search. If podocyte does refer to more than one cell type, then we should classify the synonym to 'related'[tfm].
A diploid cell that has derived from a spermatogonium and can subsequently begin meiosis and divide into two haploid secondary spermatocytes.
One of the two haploid cells into which a primary spermatocyte divides, and which in turn gives origin to spermatids.
A mature sexual reproductive cell of the female germline.
A non-terminally differentiated cell that is capable of developing into a muscle cell.
A cell that stores and secretes pancreatic polypeptide hormone.
Epithelial cells derived from neural plate and neural crest.
The term "neuroepithelial cell" is used to describe both this cell type and sensory epithelial cell (CL:0000098).
A stem cell that can give rise to cell types of the body other than those of the germ-line.
Muscle cell which has as its direct parts myofilaments organized into sarcomeres.
An achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.
The set of neurons that receives neural inputs via bipolar, horizontal and amacrine cells. The axons of these cells make up the optic nerve.
Cardiac muscle cells are striated muscle cells that are responsible for heart contraction. In mammals, the contractile fiber resembles those of skeletal muscle but are only one third as large in diameter, are richer in sarcoplasm, and contain centrally located instead of peripheral nuclei.
This class encompasses the muscle cells responsible for heart* contraction in both vertebrates and arthropods. The ultrastucture of a wide range of arthropod heart cells has been examined including spiders, horseshoe crabs, crustaceans (see Sherman, 1973 and refs therein) and insects (see Lehmacher et al (2012) and refs therein). According to these refs, the cells participating in heart contraction in all cases are transversely striated. Insects hearts additionally contain ostial cells, also transversely striated muscle cells, but which do not participate in heart contraction.
A bipolar neuron found in the retina and having connections with photoreceptors cells and neurons in the inner plexiform layer.
A bipolar neuron found in the retina and having connections with photoreceptors cells and neurons in the inner half of the inner plexiform layer. These cells depolarize in response to light stimulation of their corresponding photoreceptors.
A cell of the monocyte, granulocyte, mast cell, megakaryocyte, or erythroid lineage.
A immature or mature cell in the lineage leading to and including erythrocytes.
Note that in FMA erythropoietic cells are types of nucleated erythrocytes and thus don't include erythrocytes.
A nucleated precursor of an erythrocyte that lacks hematopoietic lineage markers.
A cell of the monocyte, granulocyte, or mast cell lineage.
Any of the immature or mature forms of a granular leukocyte that in its mature form has an irregularly shaped, pale-staining nucleus that is partially constricted into two lobes, and with cytoplasm that contains coarse, bluish-black granules of variable size. Basophils contain vasoactive amines such as histamine and serotonin, which are released on appropriate stimulation. A basophil is CD123-positive, CD193-positive, CD203c-positive, and FceRIa-positive.
Matures in the bone marrow and account for <1% of leukocytes in the peripheral blood, spleen, and bone marrow. Basophils are described as being CD11a-positive, CD11b-positive, CD13-positive, CD15-positive, CD18-positive, CD21-positive, CD25-positive, CD29-positive, CD35-positive, CD40-positive, CD40L-positive, CD44-positive, CD45R-negative, CD46-positive, CD49a-positive, CD49b-positive, CD49d-positive, CD55-positive, CD59-positive, CD62L-positive, CD63-positive, CD69-positive, CD90-negative, CD116-positive, CD117-negative, CD124-positive, CD125-positive, CD131-positive, CD161-positive, CD184-positive, CD191-positive, CD192-positive, CD197-positive, CD200R3-positive, CD218-positive, CD282-positive, CD284-positive, CD289-positive, CD290-positive, CD294-positive, natural killer cell receptor 2B4-positive, smad1-positive, CD3-negative, CD4-negative, CD7-negative, CD8-negative, CD14-negative, CD15-negative, CD16-negative, CD19-negative, CD20-negative, CD34-negative, CD36-negative, CD45R-negative, CD56-negative, CD57-negative, CD235a-negative, and GR1-negative. Transcription factors- GATA1-positive, PU.1-positive.
Any of the immature or mature forms of a granular leukocyte that in its mature form has a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.
A dendritic cell of the myeloid lineage.
These cells are CD1a-negative, CD1b-positive, CD11a-positive, CD11c-positive, CD13-positive, CD14-negative, CD20-negative, CD21-negative, CD33-positive, CD40-negative, CD50-positive, CD54-positive, CD58-positive, CD68-negative, CD80-negative, CD83-negative, CD85j-positive, CD86-positive, CD89-negative, CD95-positive, CD120a-negative, CD120b-positive, CD123-negative, CD178-negative, CD206-negative, CD207-negative, CD209-negative, and TNF-alpha-negative. Upon TLR stimulation, they are capable of producing high levels of TNF-alpha, IL-6, CXCL8 (IL-8).
A dendritic cell type of distinct morphology, localization, and surface marker expression (CD123-positive) from other dendritic cell types and associated with early stage immune responses, particularly the release of physiologically abundant amounts of type I interferons in response to infection.
A B cell that is mature, having left the bone marrow. Initially, these cells are IgM-positive and IgD-positive, and they can be activated by antigen.
Mature B cells are also reportedly CD10-negative, CD19-positive, CD22-positive, CD34-negative, CD48-positive, CD79a-positive, CD84-positive, CD127-negative, CD352-positive, RAG-negative, TdT-negative, Vpre-B-negative, and pre-BCR-negative. Transcription factors expressed: Pax5-positive.
A terminally differentiated, post-mitotic, antibody secreting cell of the B cell lineage with the phenotype CD138-positive, surface immunonoglobulin-negative, and MHC Class II-negative. Plasma cells are oval or round with extensive rough endoplasmic reticulum, a well-developed Golgi apparatus, and a round nucleus having a characteristic cartwheel heterochromatin pattern and are devoted to producing large amounts of immunoglobulin.
Plasma cells develop in the spleen and migrate to the bone marrow. Plasma cells are also reportedly CD5-negative, CD10-negative, CD19-positive, CD20-negative, CD21-negative, CD22-negative, CD23-negative, CD24-negative, CD25-negative, CD27-positive, CD34-negative, CD38-positive, CD40-positive, CD43-positive, CD45-positive, CD48-positive, CD53-low, CD80-negative, CD81-positive, CD86-positive, CD95-positive, CD196-negative, CD229-positive, CD270-positive, CD352-positive, CD361-positive, and IgD-negative. Transcription factors: BLIMP1-positive, IRF4-positive, PAX5-negative, SpiB-negative, Ets1-negative, and XBP1-positive.
A T cell that expresses an alpha-beta T cell receptor complex.
An alpha-beta T cell that has an immature phenotype and has not completed T cell selection.
A alpha-beta T cell that has a mature phenotype.
A CD4-positive, CD25-positive, alpha-beta T cell that regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.
CD4-positive, CD25-positive, alpha-beta regulatory T lymphocyte
CD4-positive, CD25-positive, alpha-beta regulatory T-cell
CD4-positive, CD25-positive, alpha-beta regulatory T-lymphocyte
This cell type is compatible with the HIPC Lyoplate markers for 'Treg'. The inclusion of CD127lo in the logical definition is compatible with both human and mouse T cells of this subtype.
CD4-positive, CD25-positive, alpha-beta regulatory T cell
A thymocyte that has the phenotype CD4-negative, CD8-positive, CD44-negative, CD25-negative, and pre-TCR-positive.
Note that this type of thymocyte has passed the beta-selection checkpoint and is rapidly proliferating and rearranging the T cell receptor alpha chain and expressing the CD8 coreceptor. This stage comes between the DN4 and DP stages.
A thymocyte that has the phenotype CD4-negative, CD8-negative, CD44-positive, and CD25-positive.
Note that this type of thymocyte is at the earliest stage of T cell receptor rearrangement of the beta, gamma, and delta T cell receptor chains. Also, there is growing evidence that molecular markers characterizing double negative thymocytes are different across species, especially in mouse versus human thymus. If in doubt, please consider using CL:0002489 'double negative thymocyte'.
A thymocyte that has the phenotype CD4-negative, CD8-negative, CD44-negative, and CD25-positive and expressing the T cell receptor beta-chain in complex with the pre-T cell receptor alpha chain.
There is growing evidence that molecular markers characterizing double negative thymocytes are different across species, especially in mouse versus human thymus. If in doubt, please consider using CL:0002489 'double negative thymocyte'.
A thymocyte that has the phenotype CD4-negative, CD8-negative, CD44-negative, CD25-negative, and pre-TCR-positive.
Note that this type of thymocyte has passed the beta-selection checkpoint and is rapidly proliferating and beginning to rearrange the T cell receptor alpha chain. There is growing evidence that molecular markers characterizing double negative thymocytes are different across species, especially in mouse versus human thymus. If in doubt, please consider using CL:0002489 'double negative thymocyte'.
A thymocyte expressing the alpha-beta T cell receptor complex as well as both the CD4 and CD8 coreceptors.
double-positive, alpha-beta immature T lymphocyte
Thymocytes of this stage are undergoing positive and negative selection.
An immature alpha-beta T cell that is located in the thymus and is CD4-positive and CD8-negative.
CD4-positive, alpha-beta immature T lymphocyte
CD4-positive, alpha-beta immature T-cell
CD4-positive, alpha-beta immature T-lymphocyte
A T cell which regulates overall immune responses as well as the responses of other T cell subsets through direct cell-cell contact and cytokine release.
This cell type may express FoxP3 and CD25 and secretes IL-10 and TGF-beta.
An immature B cell is a B cell that has the phenotype surface IgM-positive and surface IgD-negative, and have not undergone class immunoglobulin class switching or peripheral encounter with antigen and activation.
Immature B cells are also reportedly CD5-positive, CD10-positive, CD19-positive, CD20-positive, CD21-positive, CD22-positive, CD24-positive, CD25-negative, CD27-negative, CD34-negative, CD38-positive, CD40-positive, CD43-negative, CD45-positive, CD48-positive, CD53-positive, CD79a-positive, CD80-negative, CD81-positive, CD86-negative, CD95-negative, CD127-negative, CD138-negative, CD185-positive, CD196-positive, MHCII/HLA-DR-positive, RAG-positive, TdT-negative, Vpre-B-negative, and preBCR-negative. Transcription factors expressed: Pax5-positive.
A precursor B cell is a B cell with the phenotype CD10-positive.
An immature B cell of an intermediate stage between the pre-B cell stage and the mature naive stage with the phenotype surface IgM-positive and CD19-positive, and are subject to the process of B cell selection. A transitional B cell migrates from the bone marrow into the peripheral circulation, and then to the spleen.
This cell type is compatible with the HIPC Lyoplate markers for 'transitional B cell'.
A lymphoid progenitor cell that is committed to the natural killer cell lineage, expressing CD122 (IL-15) receptor, but lacking many of the phenotypic characteristics of later stages of natural killer cell development such as expression of NK activating and inhibitory molecules. In human this cell has the phenotype CD34-positive, CD45RA-positive, CD10-positive, CD117-negative, and CD161 negative.
Most markers only described for human pro NK cells.
A progenitor cell of the B cell lineage, with some lineage specific activity such as early stages of recombination of B cell receptor genes, but not yet fully committed to the B cell lineage until the expression of PAX5 occurs.
Human pro-B cells are reportedly CD10-positive, CD22-positive, CD34-positive, CD38-positive, CD45-low, CD48-positive, CD79a-positive, CD127-positive, CD184-positive, RAG-positive, TdT-positive, Vpre-B-positive, pre-BCR-negative, IgD-negative, and IgM-negative. Transcription factors expressed: Pax5-positive, EBF-positive, E2A-negative, Ikaros-negative, and PU.1-negative.
A lymphoid progenitor cell of the T cell lineage, with some lineage specific marker expression, but not yet fully committed to the T cell lineage.
A myeloblast committed to the basophil lineage.
A progenitor cell of the mast cell lineage. Markers for this cell are FceRIa-low, CD117-positive, CD9-positive, T1/ST2-positive, SCA1-negative, and lineage-negative.
MCP are CD16-positive, CD32-positive, CD34-positive, CD45-positive, integrin beta-7-positive, and lin-negative (CD2, CD3e, CD4, CD5, CD8a, CD14, CD19, CD20, CD27, integrin alpha-M, ly6c, ly6g, NCAM-1, and ter119). These cells also express the transcription factors GATA-1, GATA-2, and MITF, but not C/EBPa.
The most primitive precursor in the granulocytic series, having fine, evenly distributed chromatin, several nucleoli, a high nuclear-to-cytoplasmic ration (5:1-7:1), and a nongranular basophilic cytoplasm. They reside in the bone marrow.
A hematopoietic multipotent progenitor cell is multipotent, but not capable of long-term self-renewal. These cells are characterized as lacking lineage cell surface markers and being CD34-positive in both mice and humans.
hematopoietic multipotent progenitor cell
A progenitor cell restricted to the lymphoid lineage.
Note that this is a class of cell types, not an identified single cell type.
lymphoid lineage restricted progenitor cell
A progenitor cell restricted to the myeloid lineage.
myeloid lineage restricted progenitor cell
An immature cell of the conventional dendritic cell lineage, characterized by high levels of antigen uptake via endocytosis, macropinocytosis, and phagocytosis, and typically found resident in the tissues. Markers for this cell are CD80-low, CD86-low, and MHC-II-low.
A leukocyte with a single non-segmented nucleus in the mature form.
A macrophage constitutively resident in a particular tissue under non-inflammatory conditions, and capable of phagocytosing a variety of extracellular particulate material, including immune complexes, microorganisms, and dead cells.
A tissue-resident macrophage found in the central nervous system.
An immature T cell located in the thymus.
A pro-T cell that has the phenotype CD4-negative, CD8-negative, CD44-positive, and CD25-negative.
An antigen inexperienced CD4-positive, alpha-beta T cell with the phenotype CCR7-positive, CD127-positive and CD62L-positive. This cell type develops in the thymus. This cell type is also described as being CD25-negative, CD62L-high, and CD44-low.
naive thymus-derived CD4-positive, alpha-beta T lymphocyte
naive thymus-derived CD4-positive, alpha-beta T-cell
naive thymus-derived CD4-positive, alpha-beta T-lymphocyte
These cells have not been exposed to antigen following thymic T-cell selection; found in blood and secondary lymphoid organs. This cell type is compatible with the HIPC Lyoplate markers for 'naive CD4+ T cell', but includes additional markers known to be expressed on naive CD4+ T cells.
naive thymus-derived CD4-positive, alpha-beta T cell
A recently activated CD4-positive, alpha-beta T cell with the phenotype CD69-positive, CD62L-negative, CD127-negative, and CD25-positive.
activated CD4-positive, alpha-beta T lymphocyte
activated CD4-positive, alpha-beta T-cell
activated CD4-positive, alpha-beta T-lymphocyte
activated CD4-positive, alpha-beta T cell
Mature T cell not yet exposed to antigen with the phenotype CCR7-positive, CD45RA-positive, and CD127-positive. This cell type is also described as being CD25-negative, CD62L-high and CD44-low.
CD4-positive alpha-beta T cell with the phenotype CD25-positive, CTLA-4-positive, and FoxP3-positive with regulatory function.
A differentiated T cell with ability to traffic to peripheral tissues and is capable of mounting a specific immune response.
A effector T cell that provides help in the form of secreted cytokines to other immune cells.
A lymphocyte of B lineage with the commitment to express an immunoglobulin complex.
Types of B lineage lymphocytes include B cells and antibody secreting cells (plasmablasts and plasma cells). Lymphocytes of B cell lineage can be distinguished from those of T cell lineage by their lack of CD3e (as part of the T cell receptor complex).
A lymphocyte of B lineage that is devoted to secreting large amounts of immunoglobulin.
A small pre-B-II cell is a pre-B-II cell that is Rag1-positive, Rag2-positive, pre-BCR-negative, and BCR-negative, is not proliferating, and carries a DNA rearrangement of one or more immunoglobulin light chain genes.
Small pre-B-II cells are also reportedly CD10-positive, CD19-positive, CD34-negative, CD79a-positive, CD127-negative, TdT-negative, Vpre-B-negative, sIgM-negative, and sIgD-negative. Transcription factors: PU.1-positive, Ikaros-positive, E2A-positive, and PAX5-positive.
A pre-B-II cell is a precursor B cell that expresses immunoglobulin mu heavy chain (IgHmu+), and lack expression of CD34, TdT, immunoglobulin kappa light chain and immunoglobulin lambda light chain.
pre-B-II cell are also reportedly CD19-positive, CD22-positive, CD38-positive, CD45-positive, and CD48-positive.
An activated mature (naive or memory) B cell that is secreting immunoglobulin, typified by being CD27-positive, CD38-positive, CD138-negative.
CD27-positive, CD38-positive, CD20-negative B cell
This cell type is compatible with the HIPC Lyoplate markers for 'plasmablast'. Plasmablasts are also reportedly CD48-positive, CD63-positive, CD229-positive, CD270-positive, CD319-positive, CD352-positive, CD361-positive, and IgD-negative.
Conventional dendritic cell is a dendritic cell that is CD11c-high.
Originally described in the dendritic cell ontology (DC_CL:0000003)(PMID:19243617) These cells are also CD20-negative, MHCII-positive.
CD71-positive common myeloid precursor OR CD7-negative lymphoid precursor OR CD7-positive lymphoid
Originally described in the dendritic cell ontology (DC_CL:1100000)(PMID:19243617).
CD34-positive, CD38-positive common myeloid progenitor OR CD34-positive, CD38-positive common lymphoid progenitor
Originally described in the dendritic cell ontology (DC_CL:1110000)(PMID:19243617).
CD7-negative lymphoid progenitor OR granulocyte monocyte progenitor
Originally described in the dendritic cell ontology (DC_CL:1111000)(PMID:19243617).
CD115-positive monocyte OR common dendritic progenitor
A common lymphoid progenitor that is CD10-positive, CD45RA-positive, CD34-positive and CD38-positive.
CD10-positive common lymphocyte precursor
CD10-positive common lymphocyte progenitor
These markers are associated with human common lymphoid progenitors. Originally described in the dendritic cell ontology (DC_CL:0000032)(PMID:19243617).
CD34-positive, CD38-positive common lymphoid progenitor
CD115-positive monocyte is a monocyte that is CD115-positive and CD11b-positive.
These markers are associated with human cells. Originally described in the dendritic cell ontology (DC_CL:0000033)(PMID:19243617).
CD133-positive hematopoietic stem cell is a hematopoietic stem cell that is CD34-positive, CD90-positive, and CD133-positive.
Cell markers are associated with human hematopoietic stem cells. Originally described in the dendritic cell ontology (DC_CL:0000035)(PMID:19243617).
CD34-positive, CD38-negative hematopoietic stem cell
A common myeloid progenitor that is CD34-positive, CD38-positive, IL3ra-low, CD10-negative, CD7-negative, CD45RA-negative, and IL-5Ralpha-negative.
Markers are associated with human cell type. Originally described in the dendritic cell ontology (DC_CL:0000038)(PMID:19243617).
CD34-positive, CD38-positive common myeloid progenitor
CD7-negative lymphoid progenitor cell is a lymphoid progenitor cell that is CD34-positive, CD7-negative and CD45RA-negative.
These markers are associated with human cells. Originally described in the dendritic cell ontology (DC_CL:0000039)(PMID:19243617).
Common dendritic precursor is a hematopoietic progenitor cell that is CD117-low, CD135-positive, CD115-positive and lacks plasma membrane parts for hematopoietic lineage markers.
Surface markers are for mouse cells. Originally described in the dendritic cell ontology (DC_CL:0000041) CDP are reportedly CD2-negative, CD3-negative, CD4-negative, CD5-negative, CD8a-negative, CD11c-positive, CD14-negative, CD19-negative, CD20-negative, CD56-negative, B220-negative, Ly6g-negative, MHCII-positive, and Ter119-negative. (PMID:19243617).
A cell that is maintained or propagated in a controlled artificial environment for use in an investigation.
'In vitro', translating literally to 'in glass', typically refers to a controlled, often sterile, laboratory setting where cells or other specimens are placed by some agent for the purpose of studying or manipulating them as part of some research investigation. 'In vitro' is intended to contrast with 'native',which refers to cells or other biological entities that are found in a natural setting. It describes unicellular organisms removed from a natural environement and multicellular organism cells removed from an organism, or cells derived in culture from such displaced cells.
A progenitor cell committed to myeloid lineage, including the megakaryocyte and erythroid lineages. These cells are CD34-positive, and express Gata1, Gata2, C/EBPa, and Pu.1.
CMP are reportedly CD16-positive, CD32-positive, CD38-positive, CD45RA-negative, CD110-negative, CD117-positive, CD123-positive, and SCA1-negative.
common myeloid progenitor, CD34-positive
A hematopoietic oligopotent progenitor cell that has the ability to differentiate into limited cell types but lacks lineage cell markers and self renewal capabilities. Cell lacks hematopoeitic lineage markers.
hematopoietic oligopotent progenitor cell, lineage-negative
A lymphocyte that lacks characteristic T cell, B cell, myeloid cell, and dendritic cell markers, that functions as part of the innate immune response to produce cytokines and other effector responses.
An innate lymphoid cell that is capable of producing the type 1 cytokine IFN-gamma, but not Th2 or Th17 cell-associated cytokines.
A lymphocyte of B lineage that is CD19-positive.
A granulocyte monocyte progenitor is CD34-positive, CD38-positive, IL-3receptor-alpha-positive and is CD45RA-negative.
Markers are for human cells. According to different research groups, CD45RA is present or absent on this cell population.
CD34-positive, CD38-positive granulocyte monocyte progenitor
A progenitor cell that can give rise to plasmacytoid and myeloid dendritic cells, and to monocytes and macrophages.
A cell type that can give rise to basophil and mast cells. This cell is CD34-positive, CD117-positive, CD125-positive, FceRIa-negative, and T1/ST2-negative, and expresses Gata-1, Gata-2, C/EBPa
There may be an intermediate cell type. These cells also CD13-positive, CD16-positive, CD32-positive, and integrin beta 7-positive. Transcription factors: GATA1-positive, MCP-1-positive, mitf-positive, PU.1-positive, and CEBP/a-low.
A hematopoietic progenitor cell that is capable of developing into only one lineage of hematopoietic cells.
hematopoietic lineage restricted progenitor cell
A hematopoietic oligopotent progenitor cell that has the ability to differentiate into limited cell types but lacks lineage cell markers and self renewal capabilities.
This cell type is intended to be compatible with any vertebrate hematopoietic oligopotent progenitor cell. For mammalian hematopoietic oligopotent progenitor cells known to be lineage-negative, please use the term 'hematopoietic oligopotent progenitor cell' (CL_0001060).
hematopoietic oligopotent progenitor cell
A hematopoietic multipotent progenitor cell that is CD34-positive, CD38-negative, CD45RA-negative, and CD90-negative.
Cell markers are associated with human hematopoietic multipotent progenitor cells.
CD34-positive, CD38-negative multipotent progenitor cell
A secretory cell found in pancreatic acini that secretes digestive enzymes and mucins. This cell is a typical zymogenic cell, have a basal nucleus and basophilic cytoplasm consisting of regular arrays of granular endoplasmic reticulum with mitochondria and dense secretory granules.
An enteroendocrine cell that produces glucagon.
An epithelial cell derived from endoderm.
An epithelial cell derived from ectoderm.
Epithelial cell derived from mesoderm or mesenchyme.
A cell found in the bone marrow. This can include fibroblasts, macrophages, adipocytes, osteoblasts, osteoclasts, endothelial cells and hematopoietic cells.
MH consider whether bone marrow cells are bone cells in the structural sense vs. being part of bone organ sense.
An endothelial cell of the vascular tree, which includes blood vessels and lymphatic vessels.
cubodial endothelial cell of vascular tree
These cells are reportedly CD31-positive, CD34-positive, CD144-positive, TAL1-positive.
Epithelial cells derived from general body ectoderm and ectoderm placodes.
An epithelial cell found in the lining of the stomach.
A mucous cell in the epithelium of the stomach.
A cell involved in the formation of a granulocyte.
A cell involved in the formation of a monocyte (monopoiesis).
An epithelial cell of the musculomembranous digestive tube extending from the mouth to the anus.
An epithelial cell of the thymus. Epithelial reticular cells are pleomorphic, stellate, non-phagocytic cells which seem to be supportive in function and are held together by desmosomes. They replace the fibroblastoid reticular cells found in other lymphoid organs. Other epithelial cells in the medulla have the ultrastructure of secretory cells. Although different epithelial cells throughout the thymus appear alike by light microscopy their ultrastructure and function varies.
An acidophilic cell of the anterior pituitary that produces growth hormone, somatotropin.
A cell that is part of the nervous system.
A cell of the supporting or framework tissue of the body, arising chiefly from the embryonic mesoderm and including adipose tissue, cartilage, and bone.
A cell of an organism that does not pass on its genetic material to the organism's offspring (i.e. a non-germ line cell).
A transversely striated, synctial muscle cell, formed by the fusion of myoblasts.
A giioblast cell that develops from a migratory neural crest cell. The SCP is embedded among neurons (axons) with minimal extracellular spaces separating them from nerve cell membranes and has no basal lamina. In rodents SCPs are the only cells in the Schwann cell linage that expresses Cdh19.
A glial cell that develops from a Schwann cell precursor. The immature Schwann cell is embedded among neurons (axons) with minimal extracellular spaces separating them from nerve cell membranes and has a basal lamina. Cells can survive without an axon present. Immature Schwann cell can be found communally ensheathing large groups of axons.
A T cell that expresses a T cell receptor complex and has completed T cell selection.
A T cell that has not completed T cell selection.
A pro-T cell that is lin-negative, CD25-negative, CD127-negative, CD44-positive and kit-positive.
ETPs are reportedly CD1a-negative, CD4-negative, CD7-positive, CD8a-negative, CD8b-negative, CD33-low, CD34-high, CD38-low, CD45RA-positive, and CD45RO-negative.
A double-positive, alpha-beta thymocyte that is small and not proliferating.
A double-positive thymocyte that is large (i.e. has a high forward scatter signal in flow cytometry) and is actively proliferating.
A double-positive thymocyte that is CD69-positive and has begun positive selection.
A double-positive thymocyte that is undergoing positive selection, has high expression of the alpha-beta T cell receptor, is CD69-positive, and is in the process of down regulating the CD8 co-receptor.
CD4-positive, CD8-intermediate double-positive thymocyte
A CD4-positive, CD8-negative thymocyte that is CD24-positive and expresses high levels of the alpha-beta T cell receptor.
CD24-positive, CD4 single-positive semimature thymocyte
Described in the immgene database as being CD24-intermediate.
CD24-positive, CD4 single-positive thymocyte
A CD4-positive, CD8-negative thymocyte that expresses high levels of the alpha-beta T cell receptor and is CD69-positive.
CD69-positive, CD4-positive single-positive thymocyte
A mature CD4-positive, CD8-negative alpha-beta T cell found in the thymus that is CD24-low and has high expression of the T cell receptor.
A progenitor cell of the central nervous system that can differentiate into oligodendrocytes or type-2 astrocytes. This cell originates from multiple structures within the developing brain including the medial ganglion eminence and the lateral ganglionic eminence. These cells migrate throughout the central nervous system and persist into adulthood where they play an important role in remyelination of injured neurons.
oligodendrocyte-type 2 astrocyte (O-2A) progenitor cell
oligodendrocyte/type-2 astrocyte progenitor cell
This cell type can be purified from optic nerves and other regions of the embryonic, postnatal and adult rat CNS and can be differentiated in vitro to oligodendrocytes and type-2 astrocytes. Some references use the terms 'oligodendrocyte precursor cell' and 'oligodendrocyte type-2 astrocyte (O-2A) progenitor' to refer to the same entity (e.g., PMID:10704434), while others describe an oligodendrocyte type-2 astrocyte (O-2A) progenitor cell as the precurosr to oligodendrocyte- and type-2 astrocyte- progenitor cells (e.g, ISBN:9780702028991).
A thymocyte that lacks expression of CD4 and CD8.
These are precursors to mature T cells; normally, they do not circulate, but are found in the thymus and they have not undergone rearrangement of the alpha and beta T cell receptor genes.
A cell located in the heart, including both muscle and non muscle cells.
From Onard of the FMA: Cardiac muscle cell or cardiac myocyte is a striated muscle cell. Cardiocyte on the other hand is any cell in the heart which includes cells other than muscle cells (e.g. endothelial cell of endocardium). Unless there is a consensus among anatomists that cardiocytes refer only to muscle cells, we will treat them as a general class of cells in the heart.
A renal filtration cell is a specialized cell of the renal system that filter fluids by charge, size or both.
An endothelial progenitor cell that participates in angiogenesis during development.
embryonic blood vessel endothelial progenitor cell
A glial cell that ensheathes axons of neuron in the peripheral nervous system and are necessary for their maintainance and function.
An epithelial cell of the kidney cortex.
A cell of the seminiferous tubule epithelium.
A glandular epithelial cell that is part of the stomach.
A multi-fate stem cell that can give rise to different retinal cell types including rod and cone cells.
A CNS interneuron located in the spinal cord.
Is_a interneuron, part_of UBERON:0002240.
Multi fate stem cell that gives rise to both hepatocytes and cholangiocytes as descendants.
hepatoblast
Cell that has the potential to form a skeletal cell type (e.g. cells in periosteum, cells in marrow) and produce extracellular matrix (often mineralized) and skeletal tissue (often mineralized).
Needs logical definition. Should be capable_of skeletal system morphogenesis? or skeletal tissue development? needs to be added to GO. NOTES:a cell type of the early embryo (see also: mesenchymal cells) that will give rise to mineralized connective tissue. Scleroblasts can differentiate into osteoblasts (bone-forming cells), chondroblasts (cartilage-forming cells), odontoblasts (dentin-forming cells), ameloblasts (enamel-forming cells). The mesenchymal cells developing into osteoblasts and chondroblasts are derived from the mesoderm. Those developing into odontoblasts are neural crest cells. Those developing into ameloblasts are derived from the ectoderm. (http://www.copewithcytokines.de/cope.cgi?key=scleroblasts)
Cell that is part of the neural crest region of the neuroepithelium, prior to migration. Note that not all premigratory neural crest cells may become migratory neural crest cells.
Skeletogenic cell that has the potential to transform into an osteoblast, and develops from neural crest or mesodermal cells.
Any muscle cell in which the fibers are not organised into sarcomeres.
Any hematopoietic cell that is a precursor of some other hematopoietic cell type.
A transversely striated, synctial cell of skeletal muscle. It is formed when proliferating myoblasts exit the cell cycle, differentiate and fuse.
skeletal muscle fiber
A myotube that is part of some somatic muscle. Examples include arthropod somatic muscle cells.
A muscle cell that is part of some somatic muscle.
somatic muscle cell
A muscle cell that is part of some visceral muscle
visceral muscle cell
A myoblast that is commited to developing into a somatic muscle.
A non-polarised cell precursor cell that is part of some mesenchyme, is associated with the cell matrix but is not connected to other cells and is capable of migration.
Any cell in the retina, the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.
zygote
A cell of the neural crest. Neural crest cells are multipotent. Premigratory neural crest cells are found at the neural plate boarder, some of which will undergo ectomesynchymal transition and delamination to form migratory neural crest cells.
A precursor cell that has a tendency to differentiate into a specific type of cell. They are descendants of stem cells, only they are more constrained in their differentiation potential or capacity for self-renewal, and are often more limited in both senses.
A cell that, by division or terminal differentiation, can give rise to other cell types.
Work is needed on GO 'cell differentiation' before it is clear whether the equivalent class definition 'native cell' that capable_of some 'cell differentiation' works. Also, may want to consider merging this with non-terminally differentiated cell.
Cytoplasm that exhibits a characteristic staining and color, pale-pink, with Wright-Giemsa stain.
Cytoplasm that exhibits a characteristic staining and color, red or pink, with Eosin stain.
Cytoplasm that exhibits molecular interaction for basic dyes under specific pH conditions.
Cytoplasm that exhibits affinity for both basic and acid stains under specific pH conditions.
A nucleus size quality which is relatively high compared to the amount of cytoplasm present in the same cell.
Heterochromatin that is arranged in a carthwheel pattern.
An epithelial cell that is part of the nephron.
An epithelial cell that is part of the glomerular capsule.
An epithelial cell that is part of the bile duct. Cholangiocytes contribute to bile secretion via net release of bicarbonate and water. They are cuboidal epithelium in the small interlobular bile ducts, but become columnar and mucus secreting in larger bile ducts approaching the porta hepatis and the extrahepatic ducts.
An epithelial cell of the exocrine pancreas.
Glandular cell of exocrine pancreas epithelium. Example: pancreatic acinar cell, glandular cells in pancreatic canaliculi, glandular cells in pancreatic ducts.
Hematopoietic cells resident in the bone marrow. Include: hematopoietic stem cells (lymphoid stem cells and myeloid stem cells) and the precursor cells for thrombocytes, erythrocytes, basophils, neutrophils, eosinophils, monocytes and lymphocytes.
A leukocyte with a single non-segmented nucleus in the mature form found in the circulatory pool of blood.
Any cell that is part of a pituitary gland.
Any neuron that is part of a central nervous system.
URI: http://www.ebi.ac.uk/cellline#disease_of_vascular_tissue
URI: http://www.ebi.ac.uk/cellline#pterygium
"Communicable disease (disorder)" EXACT [SNOMEDCT_2005_07_31:191415002]
"Communicable disease [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:35500006]
"Communicable disease" EXACT [MTH:NOCODE]
"Communicable disease, NOS" EXACT [SNOMEDCT_2005_07_31:367443006]
"Contagious disease (disorder)" EXACT [SNOMEDCT_2005_07_31:189822004]
"Cross infection (disorder)" EXACT [SNOMEDCT_2005_07_31:36406009]
"INFECTION localIZED" EXACT [MTH:NOCODE]
"Infective disorder" EXACT [SNOMEDCT_2005_07_31:40733004]
"Latent Infection" EXACT [NCI2004_11_17:C9494]
"Opportunistic infectious disease (disorder)" EXACT [SNOMEDCT_2005_07_31:61274003]
"Sweating Fever" EXACT [NCI2004_11_17:C35052]
"Sweating disease" EXACT [MTHICD9_2006:078.2]
"Sweating fever (finding)" EXACT [SNOMEDCT_2005_07_31:186694006]
"Sweating fever" EXACT [ICD9CM_2006:078.2]
"Transmissible disease (disorder)" EXACT [SNOMEDCT_2005_07_31:190563008]
"anatomy site specific infection" EXACT []
"localized infection (disorder)" EXACT [SNOMEDCT_2005_07_31:10443009]
"opportunistic infection" EXACT [CSP2005:0715-7200, NCI2004_11_17:C3289]
"sequelae of infectious and parasitic disease" EXACT []
"systemic infection (disorder)" EXACT [SNOMEDCT_2005_07_31:91302008]
"A disease that is the consequence of the presence of pathogenic microbial agents, including pathogenic viruses, pathogenic bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions." [DO:wk]
URI: http://www.ebi.ac.uk/cellline#disease_by_infectious_agent
"A syndrome that is characterized by an expansion of the monocyte-macrophage population and intense hemophagocytosis. It can occur de novo, but more often occurs in the setting of another disorder, usually an infection or a malignancy. A clinical picture of fever, hepatosplenomegaly, lymphadenopathy and peripheral pancytopenia. The morphologic hallmark of this syndrome is the phagocytosis of hematopoietic elements by morphologically normal macrophages." [url:http\://www.mayoclinicproceedings.com/inside.asp?AID=57&UID=, url:http\://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801997000500007&lng=pt&nrm=iso]
URI: http://www.ebi.ac.uk/cellline#hemophagocytic_syndrome
"A syndrome consisting of triad of sinusitis, bronchiectasis and situs inversus with dextrocardia." [url:http\://www.ncbi.nlm.nih.gov/pubmed/19529061]
URI: http://www.ebi.ac.uk/cellline#Kartagener_syndrome
"A body system disease which is located in a part of the nervous system responsible for processing sensory information that consists of sensory receptors, neural pathways, and parts of the brain involved in sensory perception. Commonly recognized sensory systems are those for vision, hearing, somatic sensation (touch), taste and olfaction (smell)." [url:http\://en.wikipedia.org/wiki/Sensory_system]
URI: http://www.ebi.ac.uk/cellline#sensory_system_disease
"A respiratory system disease which involves the lower respiratory tract." [url:http\://en.wikipedia.org/wiki/lower_respiratory_tract]
URI: http://www.ebi.ac.uk/cellline#lower_respiratory_tract_disease
"A hereditary disease that is the result of one or more abnormal alleles and may be dominant (a single copy of the abnormal allele is sufficient to give rise to the disease), semi-dominant, or recessive (requiring both copies of the gene to have an abnormal allele)." [DO:wk\,ls]
URI: http://www.ebi.ac.uk/cellline#simple_genetic_disease
"A disorder that has an available objective mechanical test (such as chemical tests or brain scans), and are diagnosed only by behavioral syndrome (such as those in the Diagnostic and Statistical Manual of Mental Disorders (DSM)." [url:http\://en.wikipedia.org/wiki/Physical_disorder]
URI: http://www.ebi.ac.uk/cellline#physical_disorder
"A disorder that is caused by abnormalities in an individual's genetic material (genome)." [url:http\://www.ornl.gov/sci/techresources/Human_Genome/medicine/assist.shtml]
URI: http://www.ebi.ac.uk/cellline#genetic_disorder
"A disorder that impairs the normal function of a bodily process." [url:http\://en.wikipedia.org/wiki/Functional_disorder]
URI: http://www.ebi.ac.uk/cellline#functional_disorder
URI: http://www.ebi.ac.uk/cellline#familial_adenomatous_polyposis
URI: http://www.ebi.ac.uk/cellline#restless_legs_syndrome
URI: http://www.ebi.ac.uk/cellline#xeroderma_pigmentosum
"Muscle-Liver-Brain-Eye Nanism" EXACT []
"PERICARDIAL CONSTRICTION AND GROWTH FAILURE" EXACT []
URI: http://www.ebi.ac.uk/cellline#Mulibrey_nanism
URI: http://www.ebi.ac.uk/cellline#Usher_syndrome
"Sulfatidosis, Juvenile, Austin Type" EXACT []
URI: http://www.ebi.ac.uk/cellline#multiple_sulfatase_deficiency_disease
"Niemann-Pick Disease, Acute Neuronopathic Form" EXACT []
"Niemann-Pick Disease, Acute Neurovisceral Form" EXACT []
"Sphingomyelinase Deficiency Disease" EXACT []
URI: http://www.ebi.ac.uk/cellline#Niemann-Pick_disease_type_A
"Niemann-Pick Disease, Adult Non-Neuronopathic" EXACT []
"Niemann-Pick Disease, Non-Neuronopathic Type" EXACT []
URI: http://www.ebi.ac.uk/cellline#Niemann-Pick_disease_type_B
"INFANTILE PHYTANIC ACID STORAGE DISEASE" EXACT []
"REFSUM DISEASE, INFANTILE FORM" EXACT []
URI: http://www.ebi.ac.uk/cellline#infantile_refsum_disease
"Hypophosphatemia, Vitamin D-Resistant Rickets" EXACT []
"Vitamin D-Resistant Rickets, X-Linked" EXACT []
hypophosphatemic rickets X-linked dominant
URI: http://www.ebi.ac.uk/cellline#hypophosphatemic_rickets_X-linked_dominant
URI: http://www.ebi.ac.uk/cellline#mevalonic_aciduria
"CHROMOSOME 4p16.3 DELETION SYNDROME" EXACT []
URI: http://www.ebi.ac.uk/cellline#Wolf-Hirschhorn_Syndrome
"ASPARTYLGLUCOSAMINIDASE DEFICIENCY" EXACT []
URI: http://www.ebi.ac.uk/cellline#aspartylglucosaminuria
"Acampomelic Campomelic Dysplasia" EXACT []
URI: http://www.ebi.ac.uk/cellline#campomelic_dysplasia
"N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY" EXACT []
URI: http://www.ebi.ac.uk/cellline#Farber_lipogranulomatosis
URI: http://www.ebi.ac.uk/cellline#Donohue_Syndrome
An Ewing sarcoma that arises from the soft tissues of the chest wall that tend to recur locally and not widely disseminated.
Askin tumor
Askin tumour
Askin's tumour
An organ system cancer located_in the respiratory system that is characterized by uncontrolled cellular proliferation in the respiratory tract.
An organ system benign neoplasm that is located_in reproductive system organs.
A cancer that is classified based on the organ it starts in.
A cancer that is classified by the type of cell from which it is derived.
A B-cell lymphocytic neoplasm characterized by an uncontrolled increase of B-cells.
A colorectal carcinoma that derives_from epithelial cells of glandular origin.
"A combined T cell and B cell immunodeficiency that is caused by a mutatino in the LIG4 gene, a DNA ligase, encoding a protein essential for V(D)J recombination and DNA double-strand break (DSB) repair through nonhomologous end joining (NHEJ). Patients present with immunodeficiency and developmental and growth delay." [url:http\://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=606593, url\]:http\://www.ncbi.nlm.nih.gov/gene/3981?]
URI: http://www.ebi.ac.uk/cellline#DNA_ligase_IV_deficiency
"type 3 hyper-IgM immunodeficiency " EXACT []
"A combined T cell and B cell immunodeficiency that is caused by mutation in TNFRSF5 resulting in type 3 hyper-IgM immunodeficiency characterized by an inability of B cells to undergo isotype switching, an inability to mount an antibody-specific immune response, and a lack of germinal center formation." [url:http\://bioinf.uta.fi/CD40base/]
URI: http://www.ebi.ac.uk/cellline#CD40_deficiency
"A disease that involves a disturbance of function, structure, or both of any part, organ, or system of the body resulting from a genetic or embryonic failure in development." [url:http\://en.wikipedia.org/wiki/Diseases#Disorder, url:http\://www.medilexicon.com/medicaldictionary.php?t=25959]
URI: http://www.ebi.ac.uk/cellline#disorder
A hematologic cancer that affects lymphocytes that reside in the lymphatic system and in blood-forming organs.
lymphoid cancer
A lymphoma that is characterized as any kind of lymphoma except Hodgkin's lymphoma.
A non-Hodgkin's lymphoma that has_material_basis_in a mutation of T cells.
cutaneous T-cell lymphoma
primary cutaneous T-cell non-Hodgkin lymphoma
A disease of cellular proliferation that results in abnormal growths in the body which lack the ability to metastasize.
An immune system cancer that is located_in the lymphatic system and is characterized by uncontrolled cellular proliferation of lymphoid tissue.
A thoracic benign neoplasm that is characterized by lack of malignancy.
An organ system cancer located_in the immune system that is characterized by uncontrolled cellular proliferation in organs of the immune system.
A benign neoplasm that is classified by the organ system from which it is arising from.
A reproductive organ benign neoplasm that is characterized by a lack of malignancy located_in the male reproductive system.
An organ system benign neoplam that is located_in the thoracic cavity.
An organ system cancer located_in the muscular and skeletal organs and characterized by uncontrolled cellular proliferation of the musculoskeletal organs.
skeletal system cancer
A brain cancer that has_material_basis_in glial cells.
lower grade glioma
A disease of anatomical entity that is located_in the thoracic cavity.
An organ system cancer that is located_in the skin, hair and nails.
"A cancer that results_from malignant growth located_in immature blood forming cells called blast cells. Blast cells are also referred to as bone marrow precursor cells or simply precursor cells." [url:en.wikipedia.org/wiki/Blastoma]
URI: http://www.ebi.ac.uk/cellline#blastoma
"A bone marrow cancer that affects plasma cells in which abnormal plasma cells multiply uncontrollably in the bone marrow and occasionally in other parts of the body." [url:http\://www.merck.com/mmhe/sec14/ch175/ch175c.html#sec14-ch175-ch175c-328]
URI: http://www.ebi.ac.uk/cellline#myeloma
A musculoskeletal system disease that affects the muscles.
A connective tissue disease that affects the structure or development of bone or causes an impairment of normal bone function.
skeletal disease
URI: http://www.ebi.ac.uk/cellline#bone_disease
A colorectal cancer that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa.
colorectal carcinoma
A gastrointestinal system cancer that is located_in the hepatobiliary system.
hepatobiliary system cancer
A thyroid gland carcinoma that derives_from epithelial cells of glandular origin.
thyroid gland adenocarcinoma
A thyroid gland adenocarcinoma characterized by extensive evidence of follicular cell differentiation.
differentiated thyroid gland carcinoma
A bone cancer that has_material_basis_in abnormally proliferating cells derives from embryonic mesoderm.
"Bilateral Deafness" EXACT [NCI2004_11_17:C36193]
"Bilateral deafness (finding)" EXACT [SNOMEDCT_2005_07_31:162344009]
"Complete deafness (finding)" EXACT [SNOMEDCT_2005_07_31:8531006]
"Deafness NOS (finding)" EXACT [SNOMEDCT_2005_07_31:267678002]
"Deafness NOS" EXACT [MTHICD9_2006:389.9]
"Total Deafness" EXACT [NCI2004_11_17:C36194]
URI: http://www.ebi.ac.uk/cellline#deafness
"Polyglandular activity in multiple endocrine adenomatosis (disorder)" EXACT [SNOMEDCT_2005_07_31:46724008]
polyglandular activity in multiple endocrine adenomatosis
URI: http://www.ebi.ac.uk/cellline#polyglandular_activity_in_multiple_endocrine_adenomatosis
"Polyglandular dysfunction and/or related disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:26572003]
polyglandular dysfunction and related disorder
URI: http://www.ebi.ac.uk/cellline#polyglandular_dysfunction_and_related_disorder
URI: http://www.ebi.ac.uk/cellline#polyglandular_dysfunction
"MEN type IIB" EXACT [NCI2004_11_17:C3227]
"Multiple endocrine neoplasia, type 3 (disorder)" EXACT [SNOMEDCT_2005_07_31:61530001]
"mucosal neuroma syndrome" EXACT [CSP2005:2009-6300]
URI: http://www.ebi.ac.uk/cellline#multiple_endocrine_neoplasia_type_2b
"Multiple endocrine neoplasia, type 1 (disorder)" EXACT [SNOMEDCT_2005_07_31:30664006]
"Wermer syndrome" EXACT [CSP2005:2009-6300]
"Wermer's syndrome" EXACT [MTHICD9_2006:258.0]
"Wermer's syndrome" EXACT [SNOMEDCT_2005_07_31:190566000]
URI: http://www.ebi.ac.uk/cellline#multiple_endocrine_neoplasia_type_1
A small intestine cancer that is located_in the beginning section of the small intestine.
Duodenal cancer
cancer of duodenum
duodenal neoplasm
URI: http://www.ebi.ac.uk/cellline#pigmentation_disorder
URI: http://www.ebi.ac.uk/cellline#corneal_disease
"Conjunctival degeneration (disorder)" EXACT [SNOMEDCT_2005_07_31:40787005]
"Conjunctival degeneration, unspecified" EXACT [ICD9CM_2006:372.50]
"Unspecified conjunctival degeneration (disorder)" EXACT [SNOMEDCT_2005_07_31:193886006]
URI: http://www.ebi.ac.uk/cellline#Conjunctival_degeneration
A gastrointestinal system cancer that is located_in the intestine.
malignant intestinal tumors
malignant neoplasm of intestine
URI: http://www.ebi.ac.uk/cellline#autosomal_deletion_syndrome
URI: http://www.ebi.ac.uk/cellline#frontotemporal_dementia
"neoplasm of pelvis (disorder)" EXACT [SNOMEDCT_2005_07_31:126644004]
"pelvis neoplasm" EXACT [CSP2005:2005-4862]
"A cancer by anatomical entity that is manifested in the pelvic region." [url:http\://www.wrongdiagnosis.com/p/pelvic_cancer/intro.htm]
URI: http://www.ebi.ac.uk/cellline#pelvic_cancer
"malignant neoplasm of pelvis NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188370005]
"malignant neoplasm of pelvis, NOS" EXACT [SNOMEDCT_2005_07_31:93953009]
"malignant tumor of pelvis (disorder)" EXACT [SNOMEDCT_2005_07_31:363484005]
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_pelvis
"Sickle-cell thalassemia with crisis" EXACT [ICD9CM_2006:282.42]
"Sickle-cell thalassemia without crisis" EXACT [ICD9CM_2006:282.41]
"thalassemia Hb-S disease with crisis" EXACT []
"thalassemia Hb-S disease without crisis" EXACT []
URI: http://www.ebi.ac.uk/cellline#thalassemia
"Conjunctival degenerations and deposits (disorder)" EXACT [SNOMEDCT_2005_07_31:193885005]
URI: http://www.ebi.ac.uk/cellline#Conjunctival_degenerations_and_deposits
A male reproductive organ cancer that is located_in the prostate.
"malignant tumor of prostate (disorder)" EXACT [SNOMEDCT_2005_07_31:363448003]
"malignant tumor of prostate (disorder)" EXACT [SNOMEDCT_2005_07_31:399068003]
"malignant tumor of the prostate" EXACT [NCI2004_11_17:C7378]
"prostatic cancer" EXACT [CSP2005:2016-2641]
NGP - new growth of prostate
hereditary prostate cancer
malignant tumor of the prostate
prostate cancer, familial
prostate neoplasm
prostatic cancer
prostatic neoplasm
tumor of the prostate
Xref MGI. OMIM mapping confirmed by DO. [SN].
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_prostate
"malignant neoplasm of male genital organ, NOS" EXACT [SNOMEDCT_2005_07_31:93885006]
"malignant neoplasm of male genital organ, site unspecified" EXACT [ICD9CM_2006:187.9]
"malignant neoplasm of male genital organ, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:190130007]
"malignant neoplasm of male genital organs (disorder)" EXACT [SNOMEDCT_2005_07_31:190127000]
"malignant tumor of male Reproductive system" EXACT [NCI2004_11_17:C8561]
"malignant tumor of male genital organ (disorder)" EXACT [SNOMEDCT_2005_07_31:363515000]
"malignant tumor of male genital organ" EXACT [MTH:U001031]
malignant neoplasm of male genital organ or tract
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_male_genital_organ_or_tract
A prostate cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
cancer of prostate
carcinoma of prostate
"lymphoid neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:414628006]
"lymphoid neoplasm" EXACT [CSP2005:2004-6589]
"lymphoid tumor" EXACT [NCI2004_11_17:C7065]
"A hematologic cancer that is located_in lymphocytes which is composed_of white blood cell." [url:http\://www.cancer.gov/dictionary/?CdrID=46298]
URI: http://www.ebi.ac.uk/cellline#lymphoid_cancer
A breast benign neoplasm that has_material_basis in fibrous tissue and is characterized by the development of cystic spaces.
Diffuse cystic mastopathy
Fibrocystic disease of breast
breast Fibrocystic Change
A leukemia that has_material_basis_in a B-cell or T-cell lineage involving primarily the bone marrow and the peripheral blood.
lymphoblastic leukaemia
lymphoblastic leukemia
lymphocytic leukaemia
URI: http://www.ebi.ac.uk/cellline#lymphoblastic_leukemia
A lymphocytic leukemia characterized by over production of B-cells and their accumulation in bone marrow and blood.
B-cell chronic lymphocytic leukaemia
B-cell chronic lymphocytic leukemia
CLL
chronic lymphatic leukaemia
chronic lymphatic leukemia
chronic lymphocytic leukaemia
lymphoplasmacytic leukaemia
lymphoplasmacytic leukemia
B-cell chronic lymphoid leukemia
"Congenital dystrophia brevicollis" EXACT [SNOMEDCT_2005_07_31:388981000]
"Klippel-Feil and Turner syndrome" EXACT [SNOMEDCT_2005_07_31:129581007]
"Klippel-Feil sequence (disorder)" EXACT [SNOMEDCT_2005_07_31:5601008]
"Klippel-Feil syndrome NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:205441002]
"Klippel-Feil syndrome" EXACT [ICD9CM_2006:756.16]
"Klippel-Feil syndrome" EXACT [SNOMEDCT_2005_07_31:157003009]
"Klippel-Feil syndrome" EXACT [SNOMEDCT_2005_07_31:268349005]
URI: http://www.ebi.ac.uk/cellline#Klippel-Feil_syndrome
"Aganglionic Megacolon" EXACT [NCI2004_11_17:C34700]
"Aganglionosis" EXACT [MTHICD9_2006:751.3]
"Aganglionosis" EXACT [SNOMEDCT_2005_07_31:204738000]
"Congenital megacolon (disorder)" EXACT [SNOMEDCT_2005_07_31:360436002]
"Hirschsprung's disease (disorder)" EXACT [SNOMEDCT_2005_07_31:204739008]
"Hirschsprung's disease NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:204742002]
"Hirschsprung's disease [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:6687001]
"Macrocolon (disorder)" EXACT [SNOMEDCT_2005_07_31:367495003]
"pelvirectal achalasia" EXACT [CSP2005:0724-7702]
URI: http://www.ebi.ac.uk/cellline#Hirschsprung's_disease
"Adrenal Cortical Insufficiency" EXACT [NCI2004_11_17:C27150]
"Adrenal cortical hypofunction (disorder)" EXACT [SNOMEDCT_2005_07_31:386584007]
"Adrenal cortical hypofunction (disorder)" EXACT [SNOMEDCT_2005_07_31:68588005]
"Corticoadrenal insufficiency NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267398003]
"Corticoadrenal insufficiency NOS" EXACT [SNOMEDCT_2005_07_31:190527008]
"Corticoadrenal insufficiency" EXACT [ICD9CM_2006:255.4]
"Corticoadrenal insufficiency" EXACT [SNOMEDCT_2005_07_31:154707007]
"Corticoadrenal insufficiency" EXACT [SNOMEDCT_2005_07_31:267483004]
URI: http://www.ebi.ac.uk/cellline#adrenal_cortical_hypofunction
A gastrointestinal system cancer that is located_in the stomach.
gastric cancer
gastric neoplasm
Lymphoma of the stomach
"Lowe syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:79385002]
"oculocerebrorenal syndrome of Lowe" EXACT [CSP2005:1849-1861]
URI: http://www.ebi.ac.uk/cellline#oculocerebrorenal_syndrome
URI: http://www.ebi.ac.uk/cellline#inborn_amino_acid_transport_disorder
"Avitaminosis D NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190649007]
"Avitaminosis D" EXACT [MTHICD9_2006:268.9]
"Unspecified vitamin D deficiency" EXACT [ICD9CM_2006:268.9]
"deficiency of vitamin D (disorder)" EXACT [SNOMEDCT_2005_07_31:124886009]
"vitamin D deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:34713006]
"vitamin D deficiency" EXACT [CSP2005:2116-7610]
"vitamin D deficiency" EXACT [ICD9CM_2006:268]
"vitamin D deficiency" EXACT [SNOMEDCT_2005_07_31:154728003]
"vitamin D deficiency" EXACT [SNOMEDCT_2005_07_31:190639009]
URI: http://www.ebi.ac.uk/cellline#vitamin_D_deficiency
URI: http://www.ebi.ac.uk/cellline#calcium_metabolism_disorder
"Leucodystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:192781003]
"Leucodystrophy NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:192785007]
"Leukodystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:5101009]
"Leukodystrophy" EXACT [ICD9CM_2006:330.0]
"leukodystrophy" EXACT [CSP2005:1849-5479]
URI: http://www.ebi.ac.uk/cellline#leukodystrophy
"Amino acid transport disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:16784003]
"Amino acid transport disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190686008]
"Disturbances of amino-acid transport" EXACT [ICD9CM_2006:270.0]
"disorder of amino acid transport -RETIRED-" EXACT [SNOMEDCT_2005_07_31:123292000]
URI: http://www.ebi.ac.uk/cellline#amino_acid_transport_disorder
"Arylsulfatase A deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:238031009]
"Metachromatic leucodystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:192784006]
"Metachromatic leucodystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:396338004]
"Metachromatic leukodystrophy (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:3621006]
"Scholz cerebral sclerosis" EXACT [SNOMEDCT_2005_07_31:44359008]
"Sulfatide lipidosis" EXACT [MTHICD9_2006:330.0]
"deficiency of cerebroside-sulfatase (disorder)" EXACT [SNOMEDCT_2005_07_31:66521008]
"sulfatide lipoidosis" EXACT [CSP2005:1849-5593]
URI: http://www.ebi.ac.uk/cellline#metachromatic_leukodystrophy
"HMSN type IV" EXACT [CSP2005:2042-7949]
"Heredopathia atactica polyneuritiformis" EXACT [MTHICD9_2006:356.3]
"Refsum's disease" EXACT [ICD9CM_2006:356.3]
URI: http://www.ebi.ac.uk/cellline#Refsum_disease
"Lipid storage disease (disorder)" EXACT [SNOMEDCT_2005_07_31:10741005]
"Lipidoses (disorder)" EXACT [SNOMEDCT_2005_07_31:267437005]
"Lipidoses NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267438000]
"Lipidoses: [familial xanthomatosis] or [NOS]" EXACT [SNOMEDCT_2005_07_31:190797004]
"Lipoid storage disease NOS" EXACT [MTHICD9_2006:272.7]
"Lipoidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:11455007]
"inborn lipid storage disorder" EXACT [CSP2005:1849-5707]
URI: http://www.ebi.ac.uk/cellline#lipoidosis
"Retinitis pigmentosa (disorder)" EXACT [SNOMEDCT_2005_07_31:28835009]
"Retinitis pigmentosa" EXACT [MTHICD9_2006:362.74]
"Retinitis pigmentosa" EXACT [SNOMEDCT_2005_07_31:155113002]
URI: http://www.ebi.ac.uk/cellline#retinitis_pigmentosa
hereditary and idiopathic peripheral neuropathy
URI: http://www.ebi.ac.uk/cellline#hereditary_and_idiopathic_peripheral_neuropathy
"Diffuse globoid body sclerosis" EXACT [SNOMEDCT_2005_07_31:189979005]
"Galactosylceramide beta-galactosidase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:192782005]
"Krabbe's disease" EXACT [MTHICD9_2006:330.0]
"Krabbe's leukodystrophy" EXACT [SNOMEDCT_2005_07_31:5710006]
"beta galactocerebrosidase deficiency" EXACT [CSP2005:1849-5536]
URI: http://www.ebi.ac.uk/cellline#globoid_cell_leukodystrophy
"Adrenoleukodystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:65389002]
"X-linked adrenoleukodystrophy" EXACT [MTHICD9_2006:277.86]
URI: http://www.ebi.ac.uk/cellline#adrenoleukodystrophy
URI: http://www.ebi.ac.uk/cellline#mental_retardation
"CMT - Charcot-Marie-Tooth disease" EXACT [SNOMEDCT_2005_07_31:128202008]
"CMT - Charcot-Marie-Tooth disease" EXACT [SNOMEDCT_2005_07_31:193158000]
"Charcot Marie Tooth muscular atrophy" EXACT [CSP2005:2042-7637]
"Charcot-Marie-Tooth disease (disorder)" EXACT [SNOMEDCT_2005_07_31:50548001]
"Charcot-Marie-Tooth disease" EXACT [MTHICD9_2006:356.1]
"Peroneal muscular atrophy NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:193162006]
"Peroneal muscular atrophy" EXACT [ICD9CM_2006:356.1]
URI: http://www.ebi.ac.uk/cellline#Charcot-Marie-Tooth_disease
"Hartnup disease" EXACT [MTHICD9_2006:270.0]
"Neutral 1 amino acid transport defect (disorder)" EXACT [SNOMEDCT_2005_07_31:80902009]
"deficiency of tryptophan oxygenase" EXACT [SNOMEDCT_2005_07_31:124208000]
"neutral amino acid transport defect" EXACT [CSP2005:1849-4235]
"An inborn metabolic brain disease that is the result of an inherited metabolic disease that is caused by abnormalities of the renal tubules and is characterized especially by aminoaciduria involving only monocarboxylic monoamines, a dry red scaly rash, and episodic muscular incoordination due to the effects of the disease on the cerebellum." [url:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=Hartnup]
URI: http://www.ebi.ac.uk/cellline#Hartnup_disease
"Rickets (disorder)" EXACT [SNOMEDCT_2005_07_31:41345002]
URI: http://www.ebi.ac.uk/cellline#rickets
"inborn renal aminoaciduria" EXACT [CSP2005:1849-1462]
URI: http://www.ebi.ac.uk/cellline#renal_minoaciduria
"Congenital Fanconi syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:236466005]
"De Toni-Fanconi syndrome" EXACT [SNOMEDCT_2005_07_31:111398009]
"Fanconi syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:40488004]
"Fanconi-de Toni syndrome" EXACT [MTHICD9_2006:270.0]
"Fanconi-de Toni-Debre syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:253060009]
"Fanconi-de-Toni syndrome" EXACT [SNOMEDCT_2005_07_31:190683000]
"Infantile nephropathic cystinosis (disorder)" EXACT [SNOMEDCT_2005_07_31:62332007]
"Infantile nephropathic cystinosis [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:267415003]
"Lignac-Fanconi syndrome" EXACT [NCI2004_11_17:C3034]
"Lignac-Fanconi syndrome" EXACT [SNOMEDCT_2005_07_31:190681003]
"Lignac-Fanconi syndrome" EXACT [SNOMEDCT_2005_07_31:367374009]
"deToni Fanconi syndrome" EXACT [CSP2005:1849-2203]
URI: http://www.ebi.ac.uk/cellline#Fanconi_syndrome
"primary optic atrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:21098003]
URI: http://www.ebi.ac.uk/cellline#primary_optic_atrophy
"Interstitial Nephritis" EXACT [NCI2004_11_17:C26834]
"Interstitial nephritis (disorder)" EXACT [SNOMEDCT_2005_07_31:28689008]
"Interstitial nephritis (qualifier value)" EXACT [SNOMEDCT_2005_07_31:264536006]
"interstitial nephritis" EXACT [CSP2005:1682-1281]
"renal tubulo-interstitial disease" EXACT [SNOMEDCT_2005_07_31:198506002]
URI: http://www.ebi.ac.uk/cellline#interstitial_nephritis
"Diabetes mellitus AND insipidus with optic atrophy AND deafness (disorder)" EXACT [SNOMEDCT_2005_07_31:70694009]
"Wolfram syndrome" EXACT [CSP2005:0977-5687]
"Wolfram syndrome" EXACT [CSP2005:2042-6601]
URI: http://www.ebi.ac.uk/cellline#Wolfram_syndrome
"Cystine storage disease" EXACT [SNOMEDCT_2005_07_31:190683000]
"Cystinosis (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:111398009]
"Cystinosis (disorder)" EXACT [SNOMEDCT_2005_07_31:190681003]
"Cystinosis [dup] (disorder)" EXACT [SNOMEDCT_2005_07_31:367374009]
"cystine storage disease" EXACT [CSP2005:1849-0607]
URI: http://www.ebi.ac.uk/cellline#cystinosis
A duodenum cancer that derives_from epithelial cells of glandular origin.
Duodenal adenocarcinoma
A mouth disease located_in the salivary gland.
Non-neoplastic Salivary gland disease
Salivary gland disease
URI: http://www.ebi.ac.uk/cellline#congenital_chromosomal_disease
URI: http://www.ebi.ac.uk/cellline#spinal_dysraphism
"Tooth disease" EXACT [SNOMEDCT_2005_07_31:155631000]
"Tooth disease" EXACT [SNOMEDCT_2005_07_31:266485001]
"Tooth disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:234947003]
"Tooth disorder" EXACT [NCI2004_11_17:C35077]
"dental disorder" EXACT [CSP2005:0828-0533]
"disease of teeth (disorder)" EXACT [SNOMEDCT_2005_07_31:367503003]
"disease of teeth [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:72722003]
URI: http://www.ebi.ac.uk/cellline#tooth_disease
"Amnestic disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:3298001]
"Amnestic disorder NOS" EXACT [MTHICD9_2006:294.8]
"Amnestic disorder in conditions classified elsewhere" EXACT [ICD9CM_2006:294.0]
"Amnestic syndrome" EXACT [NCI2004_11_17:C35764]
"Korsakoff's psychosis or syndrome" EXACT [MTHICD9_2006:294.0]
URI: http://www.ebi.ac.uk/cellline#amnestic_disorder
"Korsakoff's psychosis (disorder)" EXACT [SNOMEDCT_2005_07_31:69482004]
"Korsakoff's syndrome" EXACT [CSP2005:2042-6017]
"Korsakov psychosis" EXACT [SNOMEDCT_2005_07_31:191470004]
"Korsakov's psychosis" EXACT [SNOMEDCT_2005_07_31:154854002]
"Korsakov's psychosis" EXACT [SNOMEDCT_2005_07_31:268745002]
"Wernicke-Korsakoff syndrome" EXACT [MTHICD9_2006:291.1]
"Wernicke-Korsakov syndrome" EXACT [SNOMEDCT_2005_07_31:191472007]
URI: http://www.ebi.ac.uk/cellline#Wernicke-Korsakoff_syndrome
"Alcohol amnestic disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:73097000]
"Alcohol amnestic syndrome NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:191473002]
"Alcohol-Induced Wernicke-Korsakoff's syndrome" EXACT [NCI2004_11_17:C34366]
"Alcohol-induced persisting amnestic disorder" EXACT [ICD9CM_2006:291.1]
"Korsakoff's psychosis, alcoholic" EXACT [MTHICD9_2006:291.1]
"Korsakov syndrome - alcoholic" EXACT [SNOMEDCT_2005_07_31:69482004]
"Mental and behavioral disorder due to use of alcohol: amnesic syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:192213005]
URI: http://www.ebi.ac.uk/cellline#alcohol_amnestic_disorder
"intracranial aneurysm (disorder)" EXACT [SNOMEDCT_2005_07_31:128609009]
"intracranial aneurysm" EXACT [CSP2005:0617-5365]
"intracranial aneurysm, NOS" EXACT [SNOMEDCT_2005_07_31:42994005]
URI: http://www.ebi.ac.uk/cellline#intracranial_aneurysm
nephritis, nephrosis and nephrotic syndrome
URI: http://www.ebi.ac.uk/cellline#nephritis,_nephrosis_and_nephrotic_syndrome
"Nephritis (disorder)" EXACT [SNOMEDCT_2005_07_31:52845002]
"Nephritis NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:274107001]
"Nephritis NOS" EXACT [MTHICD9_2006:583.9]
"Nephritis NOS" EXACT [SNOMEDCT_2005_07_31:155853001]
"Nephritis NOS" EXACT [SNOMEDCT_2005_07_31:266615001]
URI: http://www.ebi.ac.uk/cellline#nephritis
"Alpha thalassaemia" EXACT [SNOMEDCT_2005_07_31:191186002]
"Hemoglobin H disease (disorder)" EXACT [SNOMEDCT_2005_07_31:48553001]
"Hemoglobin H disease" EXACT [NCI2004_11_17:C34368]
"alpha Thalassemia (disorder)" EXACT [SNOMEDCT_2005_07_31:68913001]
"Alpha thalassemia is a thalassemia involving the genes HBA1and HBA2 hemoglobin genes." [url:http\://en.wikipedia.org/wiki/Alpha_Thalassemia]
URI: http://www.ebi.ac.uk/cellline#alpha_thalassemia
A female reproductive system disease that is located_in the ovary.
An urinary system cancer that results_in malignant growth located_in the urinary bladder.
bladder cancer
tumor of the bladder
A esophageal cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
cancer of esophagus
cancer of oesophagus
carcinoma OF ESOPHAGUS
carcinoma of esophagus
carcinoma of oesophagus
"(Psychogenic tics) or (Gilles de la Tourette's syndrome)" EXACT [SNOMEDCT_2005_07_31:154936002]
"Gilles de la Tourette's syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:5158005]
"Guinon's disease" EXACT [CSP2005:2042-5068]
"Psychogenic tics" EXACT [SNOMEDCT_2005_07_31:268778009]
"Tourette's disorder -RETIRED-" EXACT [SNOMEDCT_2005_07_31:39098006]
"Tourette's disorder" EXACT [ICD9CM_2006:307.23]
"Tourette's syndrome" EXACT [NCI2004_11_17:C35078]
"motor-verbal tic disorder" EXACT [MTHICD9_2006:307.23]
URI: http://www.ebi.ac.uk/cellline#Gilles_de_la_Tourette_syndrome
A cell type cancer that has_material_basis_in abnormally proliferating cells derives from embryonic mesoderm.
connective and soft tissue neoplasm
tumor of soft tissue and skeleton
"A viral skin infectious disease that is caused by Verruca vulgaris. This infection produces a a raised wart with roughened surface, most common on hands, but can grow anywhere on the body." [url:http\://en.wikipedia.org/wiki/Wart]
URI: http://www.ebi.ac.uk/cellline#common_wart
"Human papilloma Virus Infection" EXACT [NCI2004_11_17:C27851]
"Human papilloma virus infection (disorder)" EXACT [SNOMEDCT_2005_07_31:240532009]
"Human papilloma virus infection, NOS" EXACT [SNOMEDCT_2005_07_31:367507002, SNOMEDCT_2005_07_31:75003008]
"human papilloma virus infectious disease" EXACT []
URI: http://www.ebi.ac.uk/cellline#papillomavirus_infectious_disease
"Eagle-Barrett syndrome" EXACT [MTHICD9_2006:756.71]
"Prune belly syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:5187006]
"Prune belly syndrome" EXACT [ICD9CM_2006:756.71]
URI: http://www.ebi.ac.uk/cellline#Prune_Belly_syndrome
"DiGeorge sequence (disorder)" EXACT [SNOMEDCT_2005_07_31:77128003]
"DiGeorge syndrome" EXACT [SNOMEDCT_2005_07_31:190991007]
"DiGeorge's syndrome" EXACT [ICD9CM_2006:279.11]
"DiGeorge's syndrome" EXACT [NCI2004_11_17:C2989]
"Pharyngeal pouch syndrome" EXACT [MTHICD9_2006:279.11]
"pharyngeal pouch syndrome" EXACT [CSP2005:0427-9991]
"A T cell deficiency disease that is the result of a large deletion of chromosome 22 which includes the DGS gene needed for development of the thymus and related glands with subsequent lack of T-cell production." [url:http\://www.merriam-webster.com/medlineplus/DiGeorge%20syndrome, url:http\://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gnd&part=digeorgesyndrome]
URI: http://www.ebi.ac.uk/cellline#DiGeorge_syndrome
URI: http://www.ebi.ac.uk/cellline#T_cell_deficiency
URI: http://www.ebi.ac.uk/cellline#congenital_osteodystrophy
"Congenital Ectopic Lens" EXACT [NCI2004_11_17:C34566]
"Congenital ectopic lens (disorder)" EXACT [SNOMEDCT_2005_07_31:74969002]
"Congenital ectopic lens" EXACT [ICD9CM_2006:743.37]
"Congenital lens: [ectopic] or [displaced] or [dislocation]" EXACT [SNOMEDCT_2005_07_31:204136005]
URI: http://www.ebi.ac.uk/cellline#Ectopia_Lentis
"Megacolon NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:197144003]
"Megacolon excluding Hirschsprung's disease (disorder)" EXACT [SNOMEDCT_2005_07_31:266459000]
"Megacolon excluding Hirschsprung's disease" EXACT [SNOMEDCT_2005_07_31:155789001]
"Megacolon excluding Hirschsprung's disease" EXACT [SNOMEDCT_2005_07_31:197138002]
"Megacolon excluding Hirschsprung's disease" EXACT [SNOMEDCT_2005_07_31:266528000]
"Megacolon, not Hirschsprung's (disorder)" EXACT [SNOMEDCT_2005_07_31:33995003]
"Megacolon, other than Hirschsprung's" EXACT [ICD9CM_2006:564.7]
URI: http://www.ebi.ac.uk/cellline#megacolon
URI: http://www.ebi.ac.uk/cellline#heart_disease
"autonomic nervous system disorder" EXACT []
URI: http://www.ebi.ac.uk/cellline#autonomic_nervous_system_disease
"Hereditary sensory and autonomic neuropathy (disorder)" EXACT [SNOMEDCT_2005_07_31:128205005]
hereditary sensory and autonomic neuropathy
URI: http://www.ebi.ac.uk/cellline#hereditary_sensory_and_autonomic_neuropathy
"Riley-Day syndrome" EXACT [MTHICD9_2006:742.8]
"familial autonomic nervous dysfunction" EXACT [CSP2005:0725-5371]
"familial dysautonomia" EXACT [SNOMEDCT_2005_07_31:204087006]
URI: http://www.ebi.ac.uk/cellline#familial_dysautonomia
URI: http://www.ebi.ac.uk/cellline#color_vision_defect
"hyperlipemia" EXACT [CSP2005:1744-2444]
"hyperlipidaemia" EXACT [SNOMEDCT_2005_07_31:154739000]
"hyperlipidaemia" EXACT [SNOMEDCT_2005_07_31:267499005]
"hyperlipidemia (disorder)" EXACT [SNOMEDCT_2005_07_31:55822004]
"hyperlipidemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190782002]
"hyperlipidemia NOS" EXACT [MTHICD9_2006:272.4]
"hyperlipidemia NOS" EXACT [SNOMEDCT_2005_07_31:154743001]
URI: http://www.ebi.ac.uk/cellline#hyperlipidemia
"Gestational diabetes mellitus" EXACT [SNOMEDCT_2005_07_31:199232003]
"Gestational diabetes mellitus" EXACT [SNOMEDCT_2005_07_31:237629002]
"Gestational diabetes mellitus" EXACT [SNOMEDCT_2005_07_31:393568003]
"Maternal gestational diabetes mellitus" EXACT [SNOMEDCT_2005_07_31:11687002]
"Maternal gestational diabetes mellitus" EXACT [SNOMEDCT_2005_07_31:359964007]
URI: http://www.ebi.ac.uk/cellline#gestational_diabetes
"Glycogen storage disease, type VII (disorder)" EXACT [SNOMEDCT_2005_07_31:89597008]
"Muscle phosphofructokinase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:234406005]
"phosphofructokinase myopathy" EXACT [CSP2005:1849-4121]
URI: http://www.ebi.ac.uk/cellline#glycogen_storage_disease_type_VII
"Dystrophia myotonica" EXACT [MTHICD9_2006:359.2]
"Dystrophia myotonica" EXACT [SNOMEDCT_2005_07_31:155096007]
"Dystrophia myotonica" EXACT [SNOMEDCT_2005_07_31:267713009]
"Steinert myotonic dystrophy syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:77956009]
"Steinert's disease" EXACT [CSP2005:1849-6719]
URI: http://www.ebi.ac.uk/cellline#myotonic_dystrophy
"Brachmann de Lange syndrome" EXACT [CSP2005:0944-7801]
"Brachmann de Lange syndrome" EXACT [CSP2005:1354-8678]
"Brachmann de Lange syndrome" EXACT [CSP2005:2403-8925]
"Congenital muscular hypertrophy-cerebral syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:55016009]
"De Lange syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:40354009]
URI: http://www.ebi.ac.uk/cellline#Bruck-de_Lange_syndrome
"Hypochromic Anemia" EXACT [NCI2004_11_17:C34380]
"Hypochromic anaemia" EXACT [SNOMEDCT_2005_07_31:44452003]
"hypochromic anemia" EXACT [CSP2005:0427-2389]
URI: http://www.ebi.ac.uk/cellline#hypochromic_anemia
URI: http://www.ebi.ac.uk/cellline#nephrotic_syndrome
"Dementia in Pick's disease (disorder)" EXACT [SNOMEDCT_2005_07_31:192174003]
"Pick's disease (disorder)" EXACT [SNOMEDCT_2005_07_31:13092008]
"Pick's disease" EXACT [CSP2005:0485-6612]
"Pick's disease" EXACT [ICD9CM_2006:331.11]
URI: http://www.ebi.ac.uk/cellline#Pick's_disease
"Dystonia lenticularis (disorder)" EXACT [SNOMEDCT_2005_07_31:52274002]
"Dystonia, deformans progressiva" EXACT [MTHICD9_2006:333.6]
"Idiopathic Torsion Dystonia" EXACT [NCI2004_11_17:C34564]
"Idiopathic torsion dystonia (disorder)" EXACT [SNOMEDCT_2005_07_31:22451001]
"Idiopathic torsion dystonia" EXACT [ICD9CM_2006:333.6]
"Idiopathic torsion dystonia" EXACT [SNOMEDCT_2005_07_31:155008004]
"dystonia deformans progressiva" EXACT [CSP2005:2057-3370]
URI: http://www.ebi.ac.uk/cellline#dystonia_musculorum_deformans
A nervous system cancer that is located in the peripheral nervous system.
"neoplasm of peripheral nerve (disorder)" EXACT [SNOMEDCT_2005_07_31:126980002]
"tumor of PNS" EXACT [NCI2004_11_17:C3321]
neoplasm of peripheral nerve
nerve sheath neoplasm
tumor of PNS
URI: http://www.ebi.ac.uk/cellline#peripheral_nervous_system_neoplasm
URI: http://www.ebi.ac.uk/cellline#congenital_abnormal_synostosis
"Prader - Willi syndrome" EXACT [SNOMEDCT_2005_07_31:205794007]
"Prader Willi syndrome" EXACT [CSP2005:1849-7731]
"Prader-Willi syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:89392001]
"Prader-Willi syndrome" EXACT [ICD9CM_2006:759.81]
URI: http://www.ebi.ac.uk/cellline#Prader-Willi_syndrome
A reproductive organ cancer that is manifested in the female genitals. This includes organs such as the ovaries, fallopian tubes, uterus, cervix, vagina and vulva.
female reproductive cancer
malignant Gynecologic tumor
malignant neoplasm of female genital organ
"A cancer of reproductive system that is manifested in the female genitals. This includes organs such as the ovaries, fallopian tubes, uterus, cervix, vagina and vulva." [url:http\://en.wikipedia.org/wiki/Template\:Female_genital_neoplasia, url:http\://www.wrongdiagnosis.com/g/genital_system_cancer/intro.htm]
URI: http://www.ebi.ac.uk/cellline#female_genital_cancer
URI: http://www.ebi.ac.uk/cellline#X-linked_mental_retardation
URI: http://www.ebi.ac.uk/cellline#pervasive_development_disorder
"abdomen neoplasm" EXACT [CSP2005:2005-4146]
"neoplasm of abdomen (disorder)" EXACT [SNOMEDCT_2005_07_31:128050000]
"tumor of abdomen (disorder)" EXACT [SNOMEDCT_2005_07_31:255060007]
"A cancer by anatomical entitiy that affects the organs in the abdominal cavity." [url:http\://www.wrongdiagnosis.com/a/abdominal_cancer/intro.htm]
URI: http://www.ebi.ac.uk/cellline#abdominal_cancer
"Senile Dementia" EXACT [NCI2004_11_17:C34524]
"Senile dementia (disorder)" EXACT [SNOMEDCT_2005_07_31:15662003]
"Senile dementia NOS" EXACT [MTHICD9_2006:290.0]
"Senile dementia, uncomplicated" EXACT [ICD9CM_2006:290.0]
"Uncomplicated senile dementia (disorder)" EXACT [SNOMEDCT_2005_07_31:191449005]
"Uncomplicated senile dementia" EXACT [SNOMEDCT_2005_07_31:154846004]
"senile dementia" EXACT [CSP2005:0485-6612]
URI: http://www.ebi.ac.uk/cellline#senile_dementia
"Dementia with Lewy bodies" EXACT [ICD9CM_2006:331.82]
"Diffuse Lewy body disease (disorder)" EXACT [SNOMEDCT_2005_07_31:80098002]
"Lewy body dementia" EXACT [MTHICD9_2006:331.82]
"Lewy body disease" EXACT [SNOMEDCT_2005_07_31:192808003]
"Lewy body disease" EXACT [SNOMEDCT_2005_07_31:230275004]
"Lewy body disease" EXACT [SNOMEDCT_2005_07_31:230276003]
"Lewy body disease" EXACT [SNOMEDCT_2005_07_31:230277007]
"Senile dementia of the Lewy body type (disorder)" EXACT [SNOMEDCT_2005_07_31:312991009]
URI: http://www.ebi.ac.uk/cellline#Lewy_body_disease
"Auditory dysfunction (disorder)" EXACT [SNOMEDCT_2005_07_31:362989003]
"Hearing disorder (finding)" EXACT [SNOMEDCT_2005_07_31:128540005]
"Hearing disorder" EXACT [NCI2004_11_17:C3078]
"Hearing problem (finding)" EXACT [SNOMEDCT_2005_07_31:300228004]
"disorder of auditory system (disorder)" EXACT [SNOMEDCT_2005_07_31:362966006]
"hearing disorder" EXACT [CSP2005:0977-5687]
URI: http://www.ebi.ac.uk/cellline#hearing_disorder
"Congenital Adrenal hyperplasia" EXACT [NCI2004_11_17:C34360]
"Congenital adrenal hyperplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:237751000]
"Congenital adrenal hyperplasia, NOS" EXACT [SNOMEDCT_2005_07_31:27037004]
"congenital adrenal hyperplasia" EXACT [CSP2005:0060-3730]
URI: http://www.ebi.ac.uk/cellline#congenital_adrenal_hyperplasia
"Congenital factor IX deficiency" EXACT [SNOMEDCT_2005_07_31:154817006]
"Congenital factor IX disorder" EXACT [ICD9CM_2006:286.1]
"Factor IX deficiency" EXACT [NCI2004_11_17:C26721]
"Factor IX deficiency" EXACT [SNOMEDCT_2005_07_31:234443007]
"Hemophilia B (disorder)" EXACT [SNOMEDCT_2005_07_31:41788008]
"deficiency, functional factor IX" EXACT [MTHICD9_2006:286.1]
"factor IX deficiency" EXACT [CSP2005:0438-3499]
URI: http://www.ebi.ac.uk/cellline#hemophilia_B
"Aniridia (disorder)" EXACT [SNOMEDCT_2005_07_31:69278003]
"Aplasia of iris (disorder)" EXACT [SNOMEDCT_2005_07_31:204161008]
URI: http://www.ebi.ac.uk/cellline#aniridia
"Incontinentia pigmenti (disorder)" EXACT [SNOMEDCT_2005_07_31:205567005]
"Incontinentia pigmenti syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:367520004]
URI: http://www.ebi.ac.uk/cellline#Bloch_Sulzberger_syndrome
"Vitiligo (disorder)" EXACT [SNOMEDCT_2005_07_31:56727007]
URI: http://www.ebi.ac.uk/cellline#vitiligo
"Infertility, male" EXACT [ICD9CM_2006:606]
"male infertility (finding)" EXACT [SNOMEDCT_2005_07_31:2904007]
"male infertility NOS (finding)" EXACT [SNOMEDCT_2005_07_31:198018002]
"male infertility" EXACT [SNOMEDCT_2005_07_31:155924001]
"male infertility, unspecified" EXACT [ICD9CM_2006:606.9]
URI: http://www.ebi.ac.uk/cellline#male_infertility
"Fragilitas ossium" EXACT [SNOMEDCT_2005_07_31:157008000]
"Fragilitas ossium" EXACT [SNOMEDCT_2005_07_31:268352002]
"Osteogenesis imperfecta (disorder)" EXACT [SNOMEDCT_2005_07_31:78314001]
"Osteogenesis imperfecta NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:205498009]
"Osteogenesis imperfecta" EXACT [ICD9CM_2006:756.51]
"Osteogenesis imperfecta" EXACT [SNOMEDCT_2005_07_31:205493000]
"Osteogenesis imperfecta" EXACT [SNOMEDCT_2005_07_31:254105005]
"Osteogenesis imperfecta" EXACT [SNOMEDCT_2005_07_31:254106006]
"Osteogenesis imperfecta" EXACT [SNOMEDCT_2005_07_31:254107002]
"Osteogenesis imperfecta" EXACT [SNOMEDCT_2005_07_31:254108007]
"Osteogenesis imperfecta" EXACT [SNOMEDCT_2005_07_31:254109004]
"Osteopsathyrosis (disorder)" EXACT [SNOMEDCT_2005_07_31:205494006]
"Osteopsathyrosis" EXACT [MTHICD9_2006:756.51]
"Vrolik's disease" EXACT [SNOMEDCT_2005_07_31:205492005]
"brittle bone disease" EXACT [CSP2005:1849-7175]
URI: http://www.ebi.ac.uk/cellline#osteogenesis_imperfecta
URI: http://www.ebi.ac.uk/cellline#spinal_muscular_atrophy
A cancer that affects the blood or bone marrow characterized by an abnormal proliferation of blood cells.
URI: http://www.ebi.ac.uk/cellline#globe_disease
"Cerebral Arteriovenous Malformation" EXACT [NCI2004_11_17:C2936]
"Cerebral arteriovenous malformation (disorder)" EXACT [SNOMEDCT_2005_07_31:234142008]
"Congenital cerebral arteriovenous malformation" EXACT [SNOMEDCT_2005_07_31:204499006]
URI: http://www.ebi.ac.uk/cellline#Arteriovenous_Malformations,_Cerebral
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_female_genital_organ
URI: http://www.ebi.ac.uk/cellline#aplastic_anemia
A female reproductive organ cancer that is located_in the vulva.
Ca vulva
Vulvar tumor
malignant Vulvar tumor
malignant neoplasm of vulva
malignant tumor of vulva
neoplasm of vulva
vulval cancer
vulval neoplasm
vulvar neoplasm
"Pancytopenia (disorder)" EXACT [SNOMEDCT_2005_07_31:127034005]
"Pancytopenia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267528007]
"Pancytopenia NOS" EXACT [SNOMEDCT_2005_07_31:191250008]
URI: http://www.ebi.ac.uk/cellline#pancytopenia
"postpartum coagulation defect with delivery" EXACT []
"postpartum coagulation defect" EXACT []
URI: http://www.ebi.ac.uk/cellline#blood_coagulation_disorder
"5p deletion syndrome" EXACT [NCI2004_11_17:C34518]
"5p partial monosomy syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:70173007]
"Cri-du-chat syndrome" EXACT [ICD9CM_2006:758.31]
"chromosome 5 short arm deletion syndrome" EXACT [CSP2005:1254-8011]
"chromosome 5p deletion syndrome" EXACT [MTHICD9_2006:758.31]
URI: http://www.ebi.ac.uk/cellline#Cri-Du-Chat_syndrome
"VCF-Velocardiofacial syndrome" EXACT [SNOMEDCT_2005_07_31:83092002]
"Velo-cardio-facial syndrome" EXACT [ICD9CM_2006:758.32]
"deletion 22q11.2 syndrome" EXACT [MTHICD9_2006:758.32]
"velocardiofacial syndrome" EXACT [CSP2005:5004-0080]
URI: http://www.ebi.ac.uk/cellline#Shprintzen_syndrome
A lymphoid leukemia that occurs when a hematopoietic stem cell undergoes malignant transformation into a primitive, undifferentiated cell with abnormal longevity producing large numbers of white blood cells to be produced and enter the blood stream.
Stem cell Leukemia
Stem cell leukaemia
malignant neoplasm of genitourinary organ
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_genitourinary_organ
"Madelung's deformity (disorder)" EXACT [SNOMEDCT_2005_07_31:4530000]
"Madelung's deformity" EXACT [ICD9CM_2006:755.54]
"Madelung's deformity" EXACT [SNOMEDCT_2005_07_31:205256008]
URI: http://www.ebi.ac.uk/cellline#Carpus_curvus
"Hereditary haemorrhagic telangiectasia" EXACT [SNOMEDCT_2005_07_31:155449008]
"Hereditary haemorrhagic telangiectasia" EXACT [SNOMEDCT_2005_07_31:266324004]
"Osler hemorrhagic telangiectasia syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:21877004]
"Osler-Weber-Rendu disease" EXACT [NCI2004_11_17:C35064]
"Rendu-Osler-Weber disease" EXACT [MTHICD9_2006:448.0]
URI: http://www.ebi.ac.uk/cellline#hereditary_hemorrhagic_telangiectasia
"Ataxia-telangiectasia syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:68504005]
"Louis Bar syndrome" EXACT [CSP2005:0485-2495]
"Louis-Bar syndrome" EXACT [MTHICD9_2006:334.8]
"Louis-Bar syndrome" EXACT [NCI2004_11_17:C2887]
URI: http://www.ebi.ac.uk/cellline#ataxia_telangiectasia
"Friedreich ataxia" EXACT [SNOMEDCT_2005_07_31:155011003]
"Friedreich's ataxia (disorder)" EXACT [SNOMEDCT_2005_07_31:10394003]
"Friedreich's ataxia" EXACT [ICD9CM_2006:334.0]
"Friedreich's tabes" EXACT [CSP2005:0485-3493]
URI: http://www.ebi.ac.uk/cellline#Friedreich_ataxia
URI: http://www.ebi.ac.uk/cellline#capillary_disease
"Chondroectodermal dysplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:62501005]
"Chondroectodermal dysplasia" EXACT [ICD9CM_2006:756.55]
"Ellis-van Creveld syndrome" EXACT [MTHICD9_2006:756.55]
URI: http://www.ebi.ac.uk/cellline#Ellis-Van_Creveld_syndrome
"Telangiectasia (disorder)" EXACT [SNOMEDCT_2005_07_31:276328002]
"Telangiectasia disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:247479008]
"Telangiectasia" EXACT [SNOMEDCT_2005_07_31:155449008]
"Telangiectasia" EXACT [SNOMEDCT_2005_07_31:266324004]
"Telangiectasis (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:112641009]
"telangiectasia" EXACT [CSP2005:0571-7751]
"telangiectasia" EXACT [NCI2004_11_17:C28194]
URI: http://www.ebi.ac.uk/cellline#telangiectasis
"Unspecified disorder of eye movements" EXACT [ICD9CM_2006:378.9]
"disorder of eye movements (disorder)" EXACT [SNOMEDCT_2005_07_31:45030009]
"eye movement disorder" EXACT [CSP2005:1115-2778]
URI: http://www.ebi.ac.uk/cellline#ocular_motility_disorder
"Mucopolysaccharidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:11380006]
"Mucopolysaccharidosis NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190942001]
"Mucopolysaccharidosis [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:267452003]
"Mucopolysaccharidosis" EXACT [ICD9CM_2006:277.5]
"Mucopolysaccharidosis" EXACT [SNOMEDCT_2005_07_31:190936000]
"mucopolysaccharidosis" EXACT [CSP2005:1849-6106]
"Mucopolysaccharidosis is a lysosomal storage disease described as any of a group of genetically determined disorder (as Hunter's syndrome and Hurler's syndrome) of glycosaminoglycan metabolism that are characterized by the accumulation of glycosaminoglycans in the tissues and their excretion in the urine." [URL:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=Mucopolysaccharidosis]
URI: http://www.ebi.ac.uk/cellline#mucopolysaccharidosis
"Hunter's syndrome" EXACT [MTHICD9_2006:277.5]
"Hunter's syndrome" EXACT [SNOMEDCT_2005_07_31:190936000]
"Mucopolysaccharidosis, MPS-II (disorder)" EXACT [SNOMEDCT_2005_07_31:70737009]
"deficiency of iduronate-2-sulphatase" EXACT [SNOMEDCT_2005_07_31:61413000]
"mucopolysaccharidosis type II" EXACT [CSP2005:1849-6220]
URI: http://www.ebi.ac.uk/cellline#mucopolysaccharidosis_II
"Maroteaux - Lamy syndrome" EXACT [SNOMEDCT_2005_07_31:190936000]
"Maroteaux-Lamy syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:69463008]
"Maroteaux-Lamy syndrome" EXACT [MTHICD9_2006:277.5]
"arylsulfatase B deficiency" EXACT [CSP2005:1849-6512]
"deficiency of N-acetylgalactosamine-4-sulfatase (disorder)" EXACT [SNOMEDCT_2005_07_31:52677002]
URI: http://www.ebi.ac.uk/cellline#mucopolysaccharidosis_VI
"HEPARAN SULFATE SULFATASE DEFICIENCY" EXACT []
"Mucopolysaccharidosis, MPS-III" EXACT [SNOMEDCT_2005_07_31:88393000]
"N-sulphoglucosamine sulphohydrolase deficiency" EXACT [SNOMEDCT_2005_07_31:41572006]
"Sanfilippo's syndrome" EXACT [MTHICD9_2006:277.5]
"Sanfilippo's syndrome" EXACT [SNOMEDCT_2005_07_31:190936000]
"mucopolysaccharidosis type III" EXACT [CSP2005:1849-6548]
"mucopolysaccharidosis type IIIA" EXACT []
URI: http://www.ebi.ac.uk/cellline#mucopolysaccharidosis_type_IIIA
"Lipochondrodystrophy" EXACT [MTHICD9_2006:277.5]
"Mucopolysaccharidosis type I [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:267453008]
"Mucopolysaccharidosis, MPS-I (disorder)" EXACT [SNOMEDCT_2005_07_31:75610003]
"Mucopolysaccharidosis, type 1" EXACT [SNOMEDCT_2005_07_31:190938004]
"iduronidase deficiency disease" EXACT [CSP2005:1849-6334]
URI: http://www.ebi.ac.uk/cellline#mucopolysaccharidosis_I
"Mucopolysaccharidosis, MPS-VII (disorder)" EXACT [SNOMEDCT_2005_07_31:43916004]
"deficiency of beta-glucuronidase (disorder)" EXACT [SNOMEDCT_2005_07_31:124470009]
"mucopolysaccharidosis type VII" EXACT [CSP2005:1849-6106]
"mucopolysaccharidosis type VII" EXACT [CSP2005:4001-0049]
URI: http://www.ebi.ac.uk/cellline#mucopolysaccharidosis_VII
"GALACTOSAMINE-6-SULFATASE DEFICIENCY" EXACT []
"Mucopolysaccharidosis, MPS-IV" EXACT [SNOMEDCT_2005_07_31:378007]
"Mucopolysaccharidosis, MPS-IV-A (disorder)" EXACT [SNOMEDCT_2005_07_31:7259005]
"Osteochondrodystrophy" EXACT [MTHICD9_2006:277.5]
"Osteochondrodystrophy" EXACT [SNOMEDCT_2005_07_31:190936000]
"chondroosteodystrophy" EXACT [CSP2005:1849-6163]
"deficiency of N-acetylgalactosamine-6-sulphatase" EXACT [SNOMEDCT_2005_07_31:78856008]
"deficiency of chondroitinsulphatase" EXACT [SNOMEDCT_2005_07_31:124449003, SNOMEDCT_2005_07_31:130197005]
"mucopolysaccharidosis type IVA" EXACT []
URI: http://www.ebi.ac.uk/cellline#mucopolysaccharidosis_IV
"Autistic disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:38763009]
"Autistic disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:408856003]
"Autistic disorder of childhood onset (disorder)" EXACT [SNOMEDCT_2005_07_31:43614003]
"Autistic disorder" EXACT [ICD9CM_2006:299.0]
"Infantile autism (disorder)" EXACT [SNOMEDCT_2005_07_31:408857007]
"Infantile autism NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:191691000]
"Infantile psychosis (disorder)" EXACT [SNOMEDCT_2005_07_31:408858002]
"Kanner's syndrome" EXACT [CSP2005:2484-9506]
"Kanner's syndrome" EXACT [MTHICD9_2006:299.0]
"childhood autism [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:271450003]
"childhood autism" EXACT [SNOMEDCT_2005_07_31:154878007]
"childhood autism" EXACT [SNOMEDCT_2005_07_31:191688000]
"childhood autism" EXACT [SNOMEDCT_2005_07_31:192581001]
URI: http://www.ebi.ac.uk/cellline#autistic_disorder
"degenerative disease" EXACT [NCI2004_11_17:C27090]
"degenerative disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:362975008]
"A disease of biological process that results_in the progressive deterioration of tissue or organ function or structure, whether due to normal bodily wear or lifestyle choices." [url:http\://en.wikipedia.org/wiki/Degenerative_disease]
URI: http://www.ebi.ac.uk/cellline#degenerative_disease
A vulva cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
Vulvar carcinoma
carcinoma of vulva
"Congenital spherocytic hemolytic anemia" EXACT [MTHICD9_2006:282.0]
"Hereditary spherocytosis (disorder)" EXACT [SNOMEDCT_2005_07_31:55995005]
"Hereditary spherocytosis" EXACT [ICD9CM_2006:282.0]
"Hereditary spherocytosis" EXACT [SNOMEDCT_2005_07_31:154795009]
"Minkowski Chauffard syndrome" EXACT [CSP2005:0427-1870]
URI: http://www.ebi.ac.uk/cellline#hereditary_spherocytosis
"Conduct disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:192597006]
"Conduct disorder, unspecified" EXACT [SNOMEDCT_2005_07_31:192603009]
"Disturbance of conduct NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:192106002]
"Disturbance of conduct NOS" EXACT [SNOMEDCT_2005_07_31:154945001]
"Disturbance of conduct NOS" EXACT [SNOMEDCT_2005_07_31:268782006]
"Disturbance of conduct NOS" EXACT [SNOMEDCT_2005_07_31:268785008]
"Unspecified disturbance of conduct (disorder)" EXACT [SNOMEDCT_2005_07_31:192104004]
"Unspecified disturbance of conduct" EXACT [ICD9CM_2006:312.9]
"conduct disorder" EXACT [CSP2005:4005-0013]
URI: http://www.ebi.ac.uk/cellline#conduct_disorder
URI: http://www.ebi.ac.uk/cellline#dementia
URI: http://www.ebi.ac.uk/cellline#intracranial_arterial_disease
"HMN (Hereditary motor Neuropathy) Proximal type I" EXACT []
"Werdnig-Hoffman disease" EXACT [SNOMEDCT_2005_07_31:155016008]
"Werdnig-Hoffman disease" EXACT [SNOMEDCT_2005_07_31:267694009]
"Werdnig-Hoffmann disease (disorder)" EXACT [SNOMEDCT_2005_07_31:64383006]
"Werdnig-Hoffmann disease" EXACT [ICD9CM_2006:335.0]
"infantile muscular atrophy" EXACT [CSP2005:2057-3620]
"progressive muscular atrophy of infancy" EXACT [MTHICD9_2006:335.0]
hereditary motor neuropathy proximal type I
URI: http://www.ebi.ac.uk/cellline#hereditary_motor_neuropathy_proximal_type_I
"malignant neoplasm of central nervous system (disorder)" EXACT [SNOMEDCT_2005_07_31:372062007]
"malignant neoplasm of central nervous system NOS" EXACT [MTHICD9_2006:192.9]
"malignant neoplasm of central nervous system, NOS" EXACT [SNOMEDCT_2005_07_31:93744007]
"malignant neoplasm of central nervous system, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:190135002]
"malignant tumor of CNS" EXACT [NCI2004_11_17:C4627]
malignant neoplasm of central nervous system
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_central_nervous_system
A central nervous system cancer that is characterized by the growth of abnormal cells in the tissues of the brain.
"BT - Brain tumour" EXACT [SNOMEDCT_2005_07_31:254935002]
"brain neoplasm" EXACT [CSP2005:2006-2736]
"neoplasm of brain (disorder)" EXACT [SNOMEDCT_2005_07_31:126952004]
"neoplasm of unspecified nature of brain (disorder)" EXACT [SNOMEDCT_2005_07_31:189537005]
"neoplasm of unspecified nature of brain" EXACT [ICD9CM_2006:239.6]
"tumor of the Brain" EXACT [NCI2004_11_17:C2907]
BT - Brain tumour
adult brain tumor
adult malignant brain neoplasm
brain neoplasm
brain neoplasm, adult
malignant brain tumour
malignant primary brain neoplasm
malignant primary brain tumor
malignant tumor of Brain
malignant tumor of adult brain
neoplasm of brain
primary brain neoplasm
primary brain tumor
primary malignant neoplasm of brain
tumor of the Brain
URI: http://www.ebi.ac.uk/cellline#brain_neoplasm
A respiratory system cancer that is located_in the lung.
lung neoplasm
"Coproporphyrinogen oxidase deficiency" EXACT [SNOMEDCT_2005_07_31:238055004]
"Hereditary coproporphyria (disorder)" EXACT [SNOMEDCT_2005_07_31:7425008]
"Hereditary coproporphyria" EXACT [MTHICD9_2006:277.1]
"hereditary coproporphyria porphyria" EXACT [CSP2005:1849-7674]
URI: http://www.ebi.ac.uk/cellline#hereditary_coproporphyria
"EPP (erythropoietic protoporphyria porphyria)" EXACT [CSP2005:1849-7560]
"Erythropoietic protoporphyria (disorder)" EXACT [SNOMEDCT_2005_07_31:51022005]
"Protoporphyria" EXACT [MTHICD9_2006:277.1]
URI: http://www.ebi.ac.uk/cellline#erythropoietic_protoporphyria
"Congenital erythropoietic porphyria (disorder)" EXACT [SNOMEDCT_2005_07_31:22935002]
"Congenital porphyria (disorder)" EXACT [SNOMEDCT_2005_07_31:190913009]
"Erythropoietic porphyria (disorder)" EXACT [SNOMEDCT_2005_07_31:67312003]
"congenital photosensitive porphyria" EXACT [CSP2005:1849-7617]
URI: http://www.ebi.ac.uk/cellline#erythropoietic_porphyria
"Cutis hyperelastica" EXACT [SNOMEDCT_2005_07_31:238848002]
"Ehlers-Danlos syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:2300005]
"Ehlers-Danlos syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:398114001]
"Ehlers-Danlos syndrome" EXACT [ICD9CM_2006:756.83]
"Ehlers-Danlos syndrome" EXACT [SNOMEDCT_2005_07_31:157008000]
"Ehlers-Danlos syndrome" EXACT [SNOMEDCT_2005_07_31:268352002]
"elastic skin" EXACT [CSP2005:1849-3115]
"type unspecified autosomal dominant Ehlers-Danlos syndrome" EXACT []
URI: http://www.ebi.ac.uk/cellline#Ehlers-Danlos_syndrome
"Myositis Ossificans Progressiva" EXACT [NCI2004_11_17:C3040]
"Myositis ossificans progressiva" EXACT [SNOMEDCT_2005_07_31:205527009]
"Myositis ossificans progressiva" EXACT [SNOMEDCT_2005_07_31:240121004]
"progressive myositis ossificans (disorder)" EXACT [SNOMEDCT_2005_07_31:82725007]
"progressive myositis ossificans" EXACT [ICD9CM_2006:728.11]
"progressive ossifying myositis" EXACT [CSP2005:1982-9828]
URI: http://www.ebi.ac.uk/cellline#fibrodysplasia_ossificans_progressiva
"Congenital anemia (disorder)" EXACT [SNOMEDCT_2005_07_31:63565007]
"Congenital anemia" EXACT [ICD9CM_2006:776.5]
URI: http://www.ebi.ac.uk/cellline#congenital_anemia
"Congenital hypoplastic anaemia" EXACT [SNOMEDCT_2005_07_31:188588001]
"Congenital hypoplastic anaemia" EXACT [SNOMEDCT_2005_07_31:191236003]
"Congenital hypoplastic anaemia" EXACT [SNOMEDCT_2005_07_31:88854002]
"Constitutional aplastic anaemia" RELATED [SNOMEDCT_2005_07_31:154808006]
"Constitutional aplastic anemia (disorder)" RELATED []
"Constitutional aplastic anemia NOS (disorder)" RELATED []
"Constitutional aplastic anemia [dup] (disorder)" RELATED []
"congenital aplastic anemia" EXACT [CSP2005:0427-0659]
"congenital hypoplastic anemia" EXACT [CSP2005:0427-0659]
"constitutional aplastic anemia" RELATED []
URI: http://www.ebi.ac.uk/cellline#congenital_hypoplastic_anemia
"Thanatophoric dysplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:29352008]
URI: http://www.ebi.ac.uk/cellline#thanatophoric_dysplasia
"Proteus syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:23150001]
"Proteus syndrome" EXACT [SNOMEDCT_2005_07_31:394527003]
URI: http://www.ebi.ac.uk/cellline#Proteus_syndrome
"Moebius congenital oculofacial paralysis" EXACT [SNOMEDCT_2005_07_31:393607001]
"Oromandibular-limb hypogenesis spectrum (disorder)" EXACT [SNOMEDCT_2005_07_31:89444000]
URI: http://www.ebi.ac.uk/cellline#Mobius_syndrome
"Bourneville's disease" EXACT [NCI2004_11_17:C3424]
"Tuberose sclerosis" EXACT [SNOMEDCT_2005_07_31:157033002]
"Tuberose sclerosis" EXACT [SNOMEDCT_2005_07_31:268359006]
"Tuberous sclerosis syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:7199000]
"Tuberous sclerosis" EXACT [ICD9CM_2006:759.5]
"Tuberous sclerosis" EXACT [SNOMEDCT_2005_07_31:157027006]
"cerebral sclerosis" EXACT [CSP2005:0727-2535]
URI: http://www.ebi.ac.uk/cellline#tuberous_sclerosis
"Albers-Scho@nberg syndrome" EXACT [SNOMEDCT_2005_07_31:367489004]
"Albers-Schonberg syndrome" EXACT [SNOMEDCT_2005_07_31:63941000]
"Osteopetrosis (disorder)" EXACT [SNOMEDCT_2005_07_31:1926006]
"Osteopetrosis - congenita type" EXACT [SNOMEDCT_2005_07_31:205502002]
"Osteopetrosis [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:205500005]
"Osteopetrosis [dup] (disorder)" EXACT [SNOMEDCT_2005_07_31:360504006]
"Osteopetrosis" EXACT [ICD9CM_2006:756.52]
"Osteopetrosis" EXACT [NCI2004_11_17:C26840]
URI: http://www.ebi.ac.uk/cellline#Albers-Schonberg_disease
"Cholestasis (finding)" EXACT [SNOMEDCT_2005_07_31:33688009]
"Obstruction of bile duct (disorder)" EXACT [SNOMEDCT_2005_07_31:30144000]
"Obstruction of bile duct NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:197447004]
"Obstruction of bile duct" EXACT [ICD9CM_2006:576.2]
"Occlusion of bile duct (disorder)" EXACT [SNOMEDCT_2005_07_31:197446008]
"bile occlusion" EXACT [CSP2005:0413-4023]
URI: http://www.ebi.ac.uk/cellline#cholestasis
"Fanconi's anemia (disorder)" EXACT [SNOMEDCT_2005_07_31:30575002]
"Fanconi's anemia" EXACT [CSP2005:0427-0659]
"Fanconi's anemia" EXACT [MTHICD9_2006:284.0]
"Panmyelopathy, Fanconi" EXACT [NCI2004_11_17:C3034]
URI: http://www.ebi.ac.uk/cellline#Fanconi's_anemia
"Epidermodysplasia verruciformis (disorder)" EXACT [SNOMEDCT_2005_07_31:19138001]
URI: http://www.ebi.ac.uk/cellline#epidermodysplasia_verruciformis
A uterine cancer that is located_in tissues lining the uterus.
endometrial Ca
endometrial neoplasm
malignant endometrial neoplasm
malignant neoplasm of endometrium
neoplasm of endometrium
primary malignant neoplasm of endometrium
tumor of Endometrium
"Fredrickson type IIa hyperlipoproteinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:397915002]
"Fredrickson type IIa hyperlipoproteinemia" EXACT [MTHICD9_2006:272.0]
"Fredrickson type IIa lipidaemia" EXACT [SNOMEDCT_2005_07_31:190772003]
"familial hyperbetalipoproteinaemia" EXACT [SNOMEDCT_2005_07_31:190775001]
"familial hyperbetalipoproteinaemia" EXACT [SNOMEDCT_2005_07_31:190776000]
"familial hyperbetalipoproteinaemia" EXACT [SNOMEDCT_2005_07_31:389985001]
"familial hypercholesteremia" EXACT [CSP2005:1849-4634]
"familial hypercholesterolemia (disorder)" EXACT [SNOMEDCT_2005_07_31:31654005]
"familial hypercholesterolemia (disorder)" EXACT [SNOMEDCT_2005_07_31:398036000]
"hyperbetalipoproteinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:190773008]
"type II hyperlipidemia" EXACT [NCI2004_11_17:C34704]
URI: http://www.ebi.ac.uk/cellline#familial_hypercholesterolemia
"Abetalipoproteinemia (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:83123000]
"Abetalipoproteinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:190787008]
"familial hypobetalipoproteinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:60193003]
"familial hypobetalipoproteinemia" EXACT [MTHICD9_2006:272.5]
"microsomal triglyceride transfer protein deficiency disease" EXACT [CSP2005:1849-5137]
URI: http://www.ebi.ac.uk/cellline#abetalipoproteinemia
"Hypolipoproteinaemia (disorder)" EXACT [SNOMEDCT_2005_07_31:363140000]
"Lipoprotein deficiencies" EXACT [ICD9CM_2006:272.5]
"Lipoprotein deficiencies" EXACT [SNOMEDCT_2005_07_31:190783007]
"Lipoprotein deficiency NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190788003]
"Lipoprotein deficiency disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:267436001]
"hypolipoproteinemia" EXACT [CSP2005:1749-1322]
URI: http://www.ebi.ac.uk/cellline#hypolipoproteinemia
"Sick sinus syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:36083008]
"Sick sinus syndrome" EXACT [SNOMEDCT_2005_07_31:155373001]
"Sick sinus syndrome" EXACT [SNOMEDCT_2005_07_31:266307005]
"syndrome, sick sinus" EXACT [MTHICD9_2006:427.81]
URI: http://www.ebi.ac.uk/cellline#sick_sinus_syndrome
"Polyneuropathy (disorder)" EXACT [SNOMEDCT_2005_07_31:42345000]
"Polyneuropathy unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:307326004]
"Polyneuropathy unspecified" EXACT [SNOMEDCT_2005_07_31:193204000]
"Polyneuropathy, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:194530007]
URI: http://www.ebi.ac.uk/cellline#polyneuropathy
"Monochromatism" EXACT [MTHICD9_2006:368.54]
"achromatopsia (disorder)" EXACT [SNOMEDCT_2005_07_31:56852002]
"achromatopsia" EXACT [CSP2005:1114-9741]
URI: http://www.ebi.ac.uk/cellline#achromatopsia
URI: http://www.ebi.ac.uk/cellline#visual_pathway_disease
"Cleidocranial dysostosis (disorder)" EXACT [SNOMEDCT_2005_07_31:65976001]
"Cleidocranial dysostosis" EXACT [MTHICD9_2006:755.59]
"Cleidocranial dysostosis" EXACT [SNOMEDCT_2005_07_31:240193006]
URI: http://www.ebi.ac.uk/cellline#cleidocranial_dysplasia
URI: http://www.ebi.ac.uk/cellline#neoplastic_pregnancy_complications
"Fredrickson type I hyperlipoproteinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:238086005]
"Fredrickson type I lipaemia" EXACT [SNOMEDCT_2005_07_31:190781009]
"familial LPL deficiency" EXACT [SNOMEDCT_2005_07_31:238039006]
"familial hyperchylomicronemia (disorder)" EXACT [SNOMEDCT_2005_07_31:267435002]
"familial hyperlipoproteinemia type I" EXACT [CSP2005:1849-4577]
"familial lipoprotein lipase deficiency (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:34171006]
"familial lipoprotein lipase deficiency with type I phenotype" EXACT [SNOMEDCT_2005_07_31:403827000]
"hypercholesterinaemic xanthomatosis" EXACT [SNOMEDCT_2005_07_31:275598004]
"hyperchylomicronemia" EXACT [ICD9CM_2006:272.3]
"mixed hyperglyceridemia" EXACT [MTHICD9_2006:272.3]
URI: http://www.ebi.ac.uk/cellline#familial_lipoprotein_lipase_deficiency
"Gyrate atrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:314467007]
"Gyrate atrophy of the choroid and/or retina (disorder)" EXACT [SNOMEDCT_2005_07_31:367536002]
"Gyrate atrophy of the choroid and/or retina" EXACT [SNOMEDCT_2005_07_31:87126009]
"Ornithinemia with gyrate atrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:314466003]
"gyrate atrophy of the retina" EXACT [CSP2005:1849-9719]
URI: http://www.ebi.ac.uk/cellline#Gyrate_atrophy
URI: http://www.ebi.ac.uk/cellline#hereditary_eye_disease
"Choroid disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:193480005]
"Choroid disorder" EXACT [NCI2004_11_17:C34468]
"Choroidal disorder" EXACT [SNOMEDCT_2005_07_31:193431000]
"Unspecified disorder of choroid" EXACT [ICD9CM_2006:363.9]
"choroid disorder" EXACT [CSP2005:1114-9583]
URI: http://www.ebi.ac.uk/cellline#choroid_disease
"Hippel Lindau syndrome" EXACT [CSP2005:5000-0055]
"Von Hippel-Lindau syndrome (VHL)" EXACT [NCI2004_11_17:C3105]
"Von Hippel-Lindau syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:46659004]
"von Hippel-Lindau syndrome" EXACT [MTHICD9_2006:759.6]
URI: http://www.ebi.ac.uk/cellline#von_Hippel-Lindau_disease
"Hypophosphatasia (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:70848009]
"Hypophosphatasia (disorder)" EXACT [SNOMEDCT_2005_07_31:190859005]
"deficiency of alkaline phosphatase (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:124431003]
"deficiency of alkaline phosphatase (disorder)" EXACT [SNOMEDCT_2005_07_31:360792001]
"hypophosphatasia" EXACT [CSP2005:1849-5251]
URI: http://www.ebi.ac.uk/cellline#hypophosphatasia
URI: http://www.ebi.ac.uk/cellline#endocrine_pancreas_disorder
"Generalized lentiginosis (disorder)" EXACT [SNOMEDCT_2005_07_31:403537000]
"LEOPARD syndrome" EXACT [CSP2005:0723-1051]
"LEOPARD syndrome" EXACT [CSP2005:0944-7801]
"LEOPARD syndrome" EXACT [CSP2005:1254-7727]
"LEOPARD syndrome" EXACT [CSP2005:2328-1390]
"Multiple lentigines syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:111306001]
URI: http://www.ebi.ac.uk/cellline#LEOPARD_syndrome
"Marfan syndrome" EXACT [CSP2005:1849-5992]
"Marfan's syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:19346006]
"Marfan's syndrome" EXACT [ICD9CM_2006:759.82]
"Marfan's syndrome" EXACT [NCI2004_11_17:C34807]
"Marfan's syndrome" EXACT [SNOMEDCT_2005_07_31:157024004]
"Marfan's syndrome" EXACT [SNOMEDCT_2005_07_31:157033002]
"Marfan's syndrome" EXACT [SNOMEDCT_2005_07_31:268359006]
URI: http://www.ebi.ac.uk/cellline#marfan_syndrome
"Cryptophthalmos (disorder)" EXACT [SNOMEDCT_2005_07_31:400951005]
"Globe of eye vestigial (disorder)" EXACT [SNOMEDCT_2005_07_31:62589005]
URI: http://www.ebi.ac.uk/cellline#Cryptophthalmos
"Azorean disease (disorder)" EXACT [SNOMEDCT_2005_07_31:91952008]
URI: http://www.ebi.ac.uk/cellline#Machado-Joseph_disease
"Alper's syndrome" EXACT [NCI2004_11_17:C35257]
"Alpers' disease or gray-matter degeneration" EXACT [MTHICD9_2006:330.8]
"progressive sclerosing poliodystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:20415001]
URI: http://www.ebi.ac.uk/cellline#Alpers_syndrome
"Brain degeneration (& [cerebral])" EXACT [SNOMEDCT_2005_07_31:154994001]
"Brain degeneration" EXACT [SNOMEDCT_2005_07_31:267686002]
"Cerebral degeneration -RETIRED-" EXACT [SNOMEDCT_2005_07_31:73768007]
"Cerebral degeneration NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267579001]
"Cerebral degeneration NOS" EXACT [SNOMEDCT_2005_07_31:192824002]
"Cerebral degeneration, unspecified" EXACT [ICD9CM_2006:331.9]
"Cerebral degenerations NOS" EXACT [SNOMEDCT_2005_07_31:154998003]
"Cerebral degenerations NOS" EXACT [SNOMEDCT_2005_07_31:267688001]
"degenerative brain disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:52522001]
URI: http://www.ebi.ac.uk/cellline#cerebral_degeneration
"Gonadal dysgenesis (disorder)" EXACT [SNOMEDCT_2005_07_31:205681004]
"Gonadal dysgenesis NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:205695001]
"Gonadal dysgenesis NOS" EXACT [SNOMEDCT_2005_07_31:205692003]
"Gonadal dysgenesis syndrome" EXACT [SNOMEDCT_2005_07_31:38804009]
"Gonadal dysgenesis" EXACT [ICD9CM_2006:758.6]
"Gonadal dysgenesis" EXACT [SNOMEDCT_2005_07_31:157020008]
"Gonadal dysgenesis" EXACT [SNOMEDCT_2005_07_31:268356004]
"gonadal dysgenesis" EXACT [CSP2005:1254-8447]
URI: http://www.ebi.ac.uk/cellline#gonadal_dysgenesis
"Pure gonadal dysgenesis 46,XY (disorder)" EXACT [SNOMEDCT_2005_07_31:95218005]
URI: http://www.ebi.ac.uk/cellline#46_XY_gonadal_dysgenesis
URI: http://www.ebi.ac.uk/cellline#46_XX_gonadal_dysgenesis
"Maternal phenylketonuria (disorder)" EXACT [SNOMEDCT_2005_07_31:297225000]
URI: http://www.ebi.ac.uk/cellline#maternal_phenylketonuria
"Acid esterase deficiency" EXACT [SNOMEDCT_2005_07_31:190795007]
"Acid lipase deficiency, NOS" EXACT [SNOMEDCT_2005_07_31:37896002]
"Wolman xanthomatosis" EXACT [CSP2005:1849-5821]
"Wolman's disease (disorder)" EXACT [SNOMEDCT_2005_07_31:82500001]
"Wolman's or triglyceride storage type III disease" EXACT [MTHICD9_2006:272.7]
"Xanthomatosis, familial (disorder)" EXACT [SNOMEDCT_2005_07_31:238074007]
"Xanthomatosis, familial" EXACT [SNOMEDCT_2005_07_31:190797004]
URI: http://www.ebi.ac.uk/cellline#Wolman_disease
"Lipid proteinosis (disorder)" EXACT [SNOMEDCT_2005_07_31:38692000]
"Lipoid proteinosis" EXACT [SNOMEDCT_2005_07_31:238950006]
URI: http://www.ebi.ac.uk/cellline#lipoidproteinosis
"Alpha-galactosidase A deficiency" EXACT [SNOMEDCT_2005_07_31:190796008]
"Alpha-galactosidase A deficiency" EXACT [SNOMEDCT_2005_07_31:236536000]
"Angiokeratoma Corporis Diffusum" EXACT [NCI2004_11_17:C27528]
"Fabry's disease (disorder)" EXACT [SNOMEDCT_2005_07_31:16652001]
"Fabry's disease" EXACT [MTHICD9_2006:272.7]
"Fabry's disease" EXACT [SNOMEDCT_2005_07_31:190792005]
"alpha galactosidase deficiency" EXACT [CSP2005:1849-9034]
"deficiency of melibiase" EXACT [SNOMEDCT_2005_07_31:124464003]
URI: http://www.ebi.ac.uk/cellline#Fabry_disease
"A-fucosidase deficiency" EXACT [SNOMEDCT_2005_07_31:190937009]
"Fucosidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:64716005]
"alpha fucosidase deficiency" EXACT [CSP2005:1849-8519]
URI: http://www.ebi.ac.uk/cellline#fucosidosis
"Sjogren Larsson syndrome" EXACT [CSP2005:0726-9470]
"Sjogren Larsson syndrome" EXACT [CSP2005:1840-2225]
"Sjogren Larsson syndrome" EXACT [CSP2005:2057-3666]
"Sjogren-Larsson syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:111303009]
"Sjogren-Larsson's syndrome" EXACT [SNOMEDCT_2005_07_31:205549003]
URI: http://www.ebi.ac.uk/cellline#Sjogren-Larsson_syndrome
"hereditary ceroid lipofuscinosis" EXACT [CSP2005:1849-6833]
"neuronal ceroid lipofuscinosis (disorder)" EXACT [SNOMEDCT_2005_07_31:42012007]
URI: http://www.ebi.ac.uk/cellline#neuronal_ceroid-lipofuscinosis
"Niemann-Pick disease" EXACT [MTHICD9_2006:272.7]
"Sphingomyelin/cholesterol lipidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:58459009]
"lipoid histiocytosis (classical phosphatide)" EXACT [CSP2005:1849-9151]
URI: http://www.ebi.ac.uk/cellline#Niemann-Pick_disease
A disease that is characterized by abnormally rapid cell division.
cell process disease
neoplasm
"A disease of biological process that is characterized by abnormally rapid cell division." [url:http\://en.wikipedia.org/w/index.php?title=Cell_proliferation]
URI: http://www.ebi.ac.uk/cellline#disease_of_cellular_proliferation
"Batten disease" EXACT [CSP2005:1849-6833]
"Juvenile neuronal ceroid lipofuscinosis (disorder)" EXACT [SNOMEDCT_2005_07_31:61663001]
"disease, Batten" EXACT [MTHICD9_2006:330.1]
URI: http://www.ebi.ac.uk/cellline#AMAUROTIC_FAMILY_IDIOCY,_JUVENILE_type
"Galactosemia II" EXACT [SNOMEDCT_2005_07_31:18612007]
"deficiency of galactokinase (disorder)" EXACT [SNOMEDCT_2005_07_31:124302001]
URI: http://www.ebi.ac.uk/cellline#galactokinase_deficiency
"MENTAL RETARDATION, X-LINKED 18, INCLUDED; MRX18, INCLUDED" EXACT []
"MENTAL RETARDATION, X-LINKED 1; MRX1" EXACT []
"MENTAL RETARDATION, X-LINKED NONSPECIFIC, type 1" EXACT []
URI: http://www.ebi.ac.uk/cellline#X-linked_mental_retardation_1
"PROPIONYL-CoA CARBOXYLASE DEFICIENCY" EXACT []
URI: http://www.ebi.ac.uk/cellline#propionic_acidemia
"Lobstein's syndrome" EXACT [SNOMEDCT_2005_07_31:205492005]
"Osteogenesis imperfecta type I (disorder)" EXACT [SNOMEDCT_2005_07_31:385482004]
"Osteogenesis imperfecta with blue sclerae (disorder)" EXACT [SNOMEDCT_2005_07_31:3508009]
"osteogenesis imperfecta with blue sclerae" EXACT []
URI: http://www.ebi.ac.uk/cellline#osteogenesis_imperfecta_type_I
"Hypochondrodysplasia" EXACT [SNOMEDCT_2005_07_31:45818004]
"Hypochondroplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:205468002]
"Hypochondroplasia" EXACT [SNOMEDCT_2005_07_31:205469005]
"hypochondroplasia" EXACT [CSP2005:1849-1975]
URI: http://www.ebi.ac.uk/cellline#HYPOCHONDROPLASIA
"Centronuclear myopathy" EXACT [MTH:NOCODE]
"Centronuclear myopathy" EXACT [SNOMEDCT_2005_07_31:193223007]
"Myotubular myopathy (disorder)" EXACT [SNOMEDCT_2005_07_31:82077006]
"Myotubular myopathy" EXACT [MTHICD9_2006:359.0]
URI: http://www.ebi.ac.uk/cellline#centronuclear_myopathy
"Ectrodactyly-ectodermal dysplasia-clefting syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:39788007]
URI: http://www.ebi.ac.uk/cellline#EEC_SYNDROME
"Ehlers-Danlos syndrome, type 1 (disorder)" EXACT [SNOMEDCT_2005_07_31:83470009]
URI: http://www.ebi.ac.uk/cellline#type_I_Ehlers-Danlos_syndrome
"Glutaric aciduria, type 1 (disorder)" EXACT [SNOMEDCT_2005_07_31:76175005]
"Glutaryl-CoA dehydrogenase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:360416003]
"Glutaryl-CoA dehydrogenase deficiency [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:237930005]
"Glutaryl-CoA dehydrogenase deficiency" EXACT [SNOMEDCT_2005_07_31:190730004]
URI: http://www.ebi.ac.uk/cellline#GLUTARICACIDEMIA_I
"Mucopolysaccharidosis, MPS-III-B (disorder)" EXACT [SNOMEDCT_2005_07_31:59990008]
"N-ACETYL-ALPHA-D-GLUCOSAMINIDASE DEFICIENCY" EXACT []
URI: http://www.ebi.ac.uk/cellline#mucopolysaccharidosis_type_IIIB
URI: http://www.ebi.ac.uk/cellline#Weaver_syndrome
"Sotos' syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:75968004]
"A genetic disorder that occurs rarely and is characterized by excessive physical growth during the first 2 to 3 years of life." [url:http\://en.wikipedia.org/wiki/Cerebral_gigantism]
URI: http://www.ebi.ac.uk/cellline#cerebral_gigantism
"METHYLMALONIC ACIDEMIA, cblA TYPE" EXACT []
"METHYLMALONIC ACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN, cblA TYPE" EXACT []
"METHYLMALONICACIDURIA, vitamin B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN--cbl A" EXACT []
URI: http://www.ebi.ac.uk/cellline#methylmalonic_aciduria_cblA_type
URI: http://www.ebi.ac.uk/cellline#VERTEBRAL_ANOMALIES
"Isovaleryl-CoA dehydrogenase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:87827003]
"isovaleric acidemia" EXACT [CSP2005:1849-0949]
URI: http://www.ebi.ac.uk/cellline#isovalericacidemia
"Argininosuccinate lyase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:41013004]
"Argininosuccinic aciduria" EXACT [MTHICD9_2006:270.6]
"arginosuccinase deficiency" EXACT [CSP2005:1849-9435]
"deficiency of argininosuccinate lyase (disorder)" EXACT [SNOMEDCT_2005_07_31:124630007]
URI: http://www.ebi.ac.uk/cellline#argininosuccinicaciduria
autosomal dominant type IV Ehlers-Danlos syndrome
URI: http://www.ebi.ac.uk/cellline#autosomal_dominant_type_IV_Ehlers-Danlos_syndrome
"Ehlers-Danlos syndrome, type 3 (disorder)" EXACT [SNOMEDCT_2005_07_31:30652003]
URI: http://www.ebi.ac.uk/cellline#type_III_Ehlers-Danlos_syndrome
"childhood hypophosphatasia (disorder)" EXACT [SNOMEDCT_2005_07_31:30174008]
URI: http://www.ebi.ac.uk/cellline#hypophospatasia,_childhood
URI: http://www.ebi.ac.uk/cellline#hereditary_urogenital_adysplasia
"NIEMANN-PICK DISEASE WITH CHOLESTEROL ESTERIFICATION BLOCK" EXACT []
"NIEMANN-PICK DISEASE, SUBACUTE JUVENILE FORM" EXACT []
"Niemann-Pick disease, type C (disorder)" EXACT [SNOMEDCT_2005_07_31:66751000]
URI: http://www.ebi.ac.uk/cellline#Niemann-Pick_disease_type_C
"McKusick type metaphyseal chondrodysplasia" EXACT []
"Metaphyseal chondrodysplasia, McKusick type (disorder)" EXACT [SNOMEDCT_2005_07_31:7720002]
"Metaphyseal chondrodysplasia, McKusick type" EXACT [SNOMEDCT_2005_07_31:234421004]
URI: http://www.ebi.ac.uk/cellline#cartilage-hair_hypoplasia
"Kyphoscoliosis type" EXACT [SNOMEDCT_2005_07_31:25606004]
URI: http://www.ebi.ac.uk/cellline#type_VI_Ehlers-Danlos_syndrome
"MCAD deficiency" EXACT [SNOMEDCT_2005_07_31:74351001]
"Medium chain acyl CoA dehydrogenase deficiency (MCAD)" EXACT [MTHICD9_2006:277.85]
"Medium chain acyl-CoA dehydrogenase deficiency" EXACT [SNOMEDCT_2005_07_31:393571006]
"Medium chain acyl-CoA dehydrogenase deficiency" EXACT [SNOMEDCT_2005_07_31:394513008]
"Medium-chain acyl-coenzyme A dehydrogenase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:128596003]
URI: http://www.ebi.ac.uk/cellline#ACYL-CoA_DEHYDROGENASE,_MEDIUM-CHAIN,_deficiency_OF
"METHYLMALONIC ACIDEMIA, cblB TYPE" EXACT []
"METHYLMALONIC ACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN, cblB TYPE" EXACT []
"METHYLMALONICACIDURIA, vitamin B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN--cbl B" EXACT []
URI: http://www.ebi.ac.uk/cellline#methylmalonic_aciduria_cblB_type
URI: http://www.ebi.ac.uk/cellline#FRYNS_SYNDROME
"AMAUROSIS CONGENITA OF LEBER I" EXACT []
"Leber's amaurosis (disorder)" EXACT [SNOMEDCT_2005_07_31:193413001]
"Leber's congenital amaurosis" EXACT [CSP2005:1114-9698]
"Leber's disease" EXACT [CSP2005:2042-6601]
"Leber's disease" EXACT [CSP2005:5000-0048]
URI: http://www.ebi.ac.uk/cellline#Leber_congenital_amaurosis
"Walker-Warburg congenital muscular dystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:111504002]
"Warburg syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:91064002]
HYDROCEPHALUS, AGYRIA, AND RETINAL DYSPLASIA
URI: http://www.ebi.ac.uk/cellline#HYDROCEPHALUS,_AGYRIA,_AND_RETINAL_DYSPLASIA
"Christ-Siemens-Touraine Syndrome" EXACT []
"Ectodermal Dysplasia 1, Anhydrotic" EXACT []
"Hypohidrotic X-linked ectodermal dysplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:239007005]
"Hypohidrotic ectodermal dysplasia syndrome (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:4826006]
"Hypohidrotic ectodermal dysplasia syndrome" EXACT [SNOMEDCT_2005_07_31:7731005]
URI: http://www.ebi.ac.uk/cellline#hypohidrotic_ectodermal_dysplasia
URI: http://www.ebi.ac.uk/cellline#ADRENOLEUKODYSTROPHY,_AUTOSOMAL_NEONATAL_FORM
"Dubowitz's syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:2593002]
URI: http://www.ebi.ac.uk/cellline#Dubowitz_Syndrome
"long chain acyl-CoA dehydrogenase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:237996001]
URI: http://www.ebi.ac.uk/cellline#ACYL-CoA_DEHYDROGENASE,_long-CHAIN,_deficiency_OF
"SPONDYLOEPIPHYSEAL DYSPLASIA, PSEUDOACHONDROPLASTIC" EXACT []
URI: http://www.ebi.ac.uk/cellline#pseudoachondroplastic_dysplasia
URI: http://www.ebi.ac.uk/cellline#ALBINISM_I
"METHYLMALONIC ACIDEMIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY MMA DUE TO MCM DEFICIENCY" EXACT []
"METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY" EXACT []
"METHYLMALONIC ACIDURIA, mut TYPE" EXACT []
"METHYLMALONICACIDURIA DUE TO METHYLMALONIC CoA MUTASE deficiency" EXACT []
URI: http://www.ebi.ac.uk/cellline#methylmalonic_aciduria_mut_type
A syndrome that is characterized by the buildup of thick, sticky mucus that can damage many organs.
mucoviscidosis
URI: http://www.ebi.ac.uk/cellline#eye_and_adnexa_disease
A disease of anatomical entity that is located_in reproductive system organs.
genital system disease
URI: http://www.ebi.ac.uk/cellline#substance-induced_psychoses
URI: http://www.ebi.ac.uk/cellline#alcohol-induced_disorder
"Alcohol-induced organic mental disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:29212009]
"Alcohol-related disorder NOS" EXACT [MTHICD9_2006:291.9]
URI: http://www.ebi.ac.uk/cellline#alcohol-related_disorder
A cecum cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
Caecum carcinoma
Cecal cancer
carcinoma of cecum
A colon cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
Colonic carcinoma
carcinoma of colon
A large intestine cancer that is located_in the cecum.
malignant neoplasm of caecum
malignant tumor of the cecum
"mixed tumor" EXACT [NCI2004_11_17:C6930]
"A cancer that involves the growth of two germinal layers of tissue." [url:http\://medical-dictionary.thefreedictionary.com/mixed+neoplasm]
URI: http://www.ebi.ac.uk/cellline#mixed_cell_type_cancer
URI: http://www.ebi.ac.uk/cellline#glandular_and_epithelial_neoplasm
"Diabetes mellitus in the pueperium - baby delivered during previous episode of care (disorder)" EXACT [SNOMEDCT_2005_07_31:199228009]
"Diabetes mellitus, postpartum" EXACT []
gestational diabetes complicating pregnancy, childbirth, or the puerperium
URI: http://www.ebi.ac.uk/cellline#gestational_diabetes_complicating_pregnancy,_childbirth,_or_the_puerperium
"Organic Mental disorder" EXACT [MTH:535]
"Organic Mental disorder" EXACT [NCI2004_11_17:C34870]
"Organic mental disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:111479008]
"Organic mental disorder of unknown etiology (disorder)" EXACT [SNOMEDCT_2005_07_31:106014008]
delirium, dementia, amnestic, cognitive disorder
URI: http://www.ebi.ac.uk/cellline#delirium,_dementia,_amnestic,_cognitive_disorder
"Unspecified epithelial neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189559007]
"epithelial neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:118285006]
"epithelial neoplasm NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189546004]
"epithelial neoplasm, NOS" EXACT [NCI2004_11_17:C3709]
"epithelial tumor (qualifier value)" EXACT [SNOMEDCT_2005_07_31:134207000]
"skin Epithelium tumor" EXACT [NCI2004_11_17:C7342]
"tumor of surface epithelium (disorder)" EXACT [SNOMEDCT_2005_07_31:254649008]
"A carcinoma that derives_from the cells that line an organ." [url:http\://www.cancer.gov/dictionary/?CdrID=46422]
URI: http://www.ebi.ac.uk/cellline#epithelial_carcinoma
"Alcohol Abuse" EXACT [NCI2004_11_17:C20701]
"Alcohol abuse (disorder)" EXACT [SNOMEDCT_2005_07_31:15167005]
"Alcohol abuse, unspecified drinking behavior" EXACT [ICD9CM_2006:305.00]
"Ethanol abuse" EXACT [SNOMEDCT_2005_07_31:304606004]
"alcohol abuse" EXACT [CSP2005:0080-8925]
URI: http://www.ebi.ac.uk/cellline#alcohol_abuse
A disease of anatomical entity that located_in the respiratory system which extends from the nasal sinuses to the diaphragm.
"Platelet count below reference range" EXACT [SNOMEDCT_2005_07_31:415116008]
"Thrombocytopenia (disorder)" EXACT [SNOMEDCT_2005_07_31:70786006]
"Thrombocytopenia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:191326009]
"Thrombocytopenia NOS" EXACT [SNOMEDCT_2005_07_31:154827000]
"Thrombocytopenia, unspecified" EXACT [ICD9CM_2006:287.5]
"Thrombocytopenic disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:302215000]
"thrombocytopenia" EXACT [CSP2005:0446-5652]
"thrombocytopenia" EXACT [NCI2004_11_17:C3408]
URI: http://www.ebi.ac.uk/cellline#thrombocytopenia
URI: http://www.ebi.ac.uk/cellline#chronic_alcoholic_intoxication
A disease of anatomical entity that is located_in the integumentary system comprising the skin and its appendages.
URI: http://www.ebi.ac.uk/cellline#integumentary_system_disease
"Keratosis (disorder)" EXACT [SNOMEDCT_2005_07_31:254666005]
URI: http://www.ebi.ac.uk/cellline#keratosis
A thoracic cancer that originates in the mammary gland.
"breast tumor" EXACT [NCI2004_11_17:C2910]
"mammary tumor" EXACT [CSP2005:2016-0671]
"neoplasm of breast (disorder)" EXACT [SNOMEDCT_2005_07_31:126926005]
breast tumor
malignant neoplasm of breast
malignant tumor of the breast
mammary cancer
mammary tumor
primary breast cancer
mammary neoplasm
"A cancer of reproductive system that originates in the mammary gland." [url:http\://en.wikipedia.org/wiki/Mammary_tumor]
URI: http://www.ebi.ac.uk/cellline#mammary_cancer
A disease of cellular proliferation that is malignant and primary, characterized by uncontrolled cellular proliferation, local cell invasion and metastasis.
malignant neoplasm
malignant tumor
primary cancer
"A neoplastic disease that is malignant and characterized by uncontrolled cellular proliferation, local cell invasion and metastasis." [stedman:rlc, url:http\://en.wikipedia.org/wiki/cancer, url:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=cancer]
URI: http://www.ebi.ac.uk/cellline#cancer
"embryonal tumor of the CNS" EXACT [NCI2004_11_17:C6990]
"An embryonal cancer that are masses of rapidly growing cells that originates in embryonic (fetal) tissue in the brain and spinal cord." [url:http\://www.cancer.gov/cancertopics/childCNSembryonal]
URI: http://www.ebi.ac.uk/cellline#embryonal_cancer_of_CNS
"primary carnitine deficiency" EXACT [ICD9CM_2006:277.81]
"renal carnitine transport defect (disorder)" EXACT [SNOMEDCT_2005_07_31:21764004]
URI: http://www.ebi.ac.uk/cellline#carnitine_uptake_defect
"primitive neuroectodermal tumour" EXACT [SNOMEDCT_2005_07_31:189925001]
URI: http://www.ebi.ac.uk/cellline#primitive_neuroectodermal_tumor
"Congenital Heart Defects" EXACT [MTH:NOCODE]
"Congenital anomaly of heart NOS" EXACT [MTHICD9_2006:746.9]
"Congenital anomaly of heart" EXACT [SNOMEDCT_2005_07_31:13213009]
"Congenital heart anomaly NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:204413006]
"Congenital heart anomaly NOS" EXACT [SNOMEDCT_2005_07_31:156926008]
"Congenital heart anomaly NOS" EXACT [SNOMEDCT_2005_07_31:204405005]
"Congenital heart anomaly NOS" EXACT [SNOMEDCT_2005_07_31:268318000]
"Heart Malformation" EXACT [NCI2004_11_17:C34666]
"Heart-congenital defect" EXACT [SNOMEDCT_2005_07_31:156911006]
"Heart-congenital defect" EXACT [SNOMEDCT_2005_07_31:268315002]
"Unspecified congenital anomaly of heart" EXACT [ICD9CM_2006:746.9]
"heart defect" EXACT [CSP2005:0724-8315]
URI: http://www.ebi.ac.uk/cellline#congenital_heart_defect
"neuroendocrine neoplasm" EXACT [NCI2004_11_17:C3809]
"neuroendocrine neoplasm" EXACT [SNOMEDCT_2005_07_31:128928004]
"neuroendocrine tumor (disorder)" EXACT [SNOMEDCT_2005_07_31:255046005]
URI: http://www.ebi.ac.uk/cellline#neuroendocrine_tumor
"(Congenital ichthyosiform erythroderma) or (alligator skin) or (ichthyosis congenita NOS)" EXACT [SNOMEDCT_2005_07_31:205556009]
"Congenital ichthyosis of skin (disorder)" EXACT [SNOMEDCT_2005_07_31:13059002]
"Congenital ichthyosis, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:205547001]
"Ichthyosis congenita NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:268283000]
"Ichthyosis congenita" EXACT [ICD9CM_2006:757.1]
"Ichthyosis congenita" EXACT [SNOMEDCT_2005_07_31:157017000]
"Ichthyosis congenita" EXACT [SNOMEDCT_2005_07_31:268355000]
"ichthyosis congenita" EXACT [CSP2005:0726-9470]
URI: http://www.ebi.ac.uk/cellline#congenital_ichthyosis
"Alligator skin" EXACT [SNOMEDCT_2005_07_31:205556009]
"Congenital ichthyosiform erythroderma (disorder)" EXACT [SNOMEDCT_2005_07_31:254156001]
"Ichthyosiform erythroderma (disorder)" EXACT [SNOMEDCT_2005_07_31:268282005]
"Ichthyosiform erythroderma" EXACT [MTHICD9_2006:757.1]
"Ichthyosiform erythroderma" EXACT [SNOMEDCT_2005_07_31:205549003]
URI: http://www.ebi.ac.uk/cellline#congenital_ichthyosiform_erythroderma
URI: http://www.ebi.ac.uk/cellline#ichthyosis
"Genodermatosis (disorder)" EXACT [SNOMEDCT_2005_07_31:239001006]
"Genodermatosis, NOS" EXACT [SNOMEDCT_2005_07_31:199879009]
"Genodermatosis, NOS" EXACT [SNOMEDCT_2005_07_31:5613003]
URI: http://www.ebi.ac.uk/cellline#genetic_skin_disease
"Congenital non bullous ichthyosiform erythroderma (disorder)" EXACT [SNOMEDCT_2005_07_31:267372009]
"Congenital non bullous ichthyosiform erythroderma" EXACT [SNOMEDCT_2005_07_31:12215009]
"Lamellar desquamation of the newborn" EXACT [SNOMEDCT_2005_07_31:268245001]
"Lamellar desquamation of the newborn" EXACT [SNOMEDCT_2005_07_31:35970001]
"Lamellar ichthyosis (disorder)" EXACT [SNOMEDCT_2005_07_31:205550003]
"lamellar ichthyosis" EXACT [CSP2005:0726-9470]
nonbullous congenital ichthyosiform erythroderma
URI: http://www.ebi.ac.uk/cellline#nonbullous_congenital_ichthyosiform_erythroderma
A disease of anatomical entity that occurs in the muscular and/or skeletal system.
"Musculo-skeletal disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:274149006]
"Musculo-skeletal disorder NOS" EXACT [SNOMEDCT_2005_07_31:156881000]
"Musculo-skeletal disorder NOS" EXACT [SNOMEDCT_2005_07_31:268142006]
"Musculoskeletal disease" EXACT [MTH:NOCODE]
"Musuloskeletal disease" EXACT [SNOMEDCT_2005_07_31:268047003]
"disorder of musculoskeletal system (disorder)" EXACT [SNOMEDCT_2005_07_31:928000]
"musculoskeletal disorder" EXACT [CSP2005:4000-0257]
URI: http://www.ebi.ac.uk/cellline#musculoskeletal_system_disease
An organ system cancer located_in endocrine system that is characterized by uncontrolled cellular proliferation of the hormone producing glands of the endocrine system.
"Endocrine tumor" EXACT [NCI2004_11_17:C3010]
"endocrine neoplasm" EXACT [CSP2005:2009-5861]
"neoplasm of endocrine gland (disorder)" EXACT [SNOMEDCT_2005_07_31:127015005]
"neoplasm of endocrine gland (disorder)" EXACT [SNOMEDCT_2005_07_31:387922007]
"neoplasm of endocrine system (disorder)" EXACT [SNOMEDCT_2005_07_31:387927001]
Endocrine tumor
endocrine neoplasm
malignant Endocrine tumor
malignant neoplasm of endocrine gland
malignant tumour of endocrine gland
neoplasm of endocrine gland
neoplasm of endocrine system
"A cancer by anatomical entity that affects any gland in the endocrine system." [url:http\://www.wrongdiagnosis.com/e/endocrine_system_cancer/basics.htm]
URI: http://www.ebi.ac.uk/cellline#endocrine_gland_cancer
"X-linked ichthyosis with steryl-sulphatase deficiency" EXACT [SNOMEDCT_2005_07_31:72523005]
"X-linked placental steryl-sulphatase deficiency" EXACT [SNOMEDCT_2005_07_31:3944006]
"X-linked recessive ichthyosis (disorder)" EXACT [SNOMEDCT_2005_07_31:402771003]
"X-linked recessive ichthyosis [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:254160003]
"X-linked recessive ichthyosis" EXACT [SNOMEDCT_2005_07_31:205552006]
URI: http://www.ebi.ac.uk/cellline#X-linked_ichthyosis
URI: http://www.ebi.ac.uk/cellline#inborn_errors_steroid_metabolism
"Neuroectodermal tumour" EXACT [SNOMEDCT_2005_07_31:253096008]
"Neuroectodermal tumour" EXACT [SNOMEDCT_2005_07_31:73676002]
"primitive Neuroectodermal neoplasm" EXACT [NCI2004_11_17:C3716]
URI: http://www.ebi.ac.uk/cellline#neuroectodermal_tumor
A carcinoma that derives_from squamous epithelial cells.
epidermoid carcinoma
malignant squamous cell tumor
squamous carcinoma
squamous cell Epithelioma
squamous cell cancer
URI: http://www.ebi.ac.uk/cellline#facial_nerve_disease
"bone Development disorder" EXACT [NCI2004_11_17:C34432]
"bone development disorder" EXACT [CSP2005:2715-1497]
"disorder of bone development (disorder)" EXACT [SNOMEDCT_2005_07_31:371521007]
URI: http://www.ebi.ac.uk/cellline#developmental_bone_disease
"neoplasm of soft tissue (disorder)" EXACT [SNOMEDCT_2005_07_31:387837005]
"neoplasm of soft tissues (disorder)" EXACT [SNOMEDCT_2005_07_31:126600002]
"tumor of the soft tissue" EXACT [NCI2004_11_17:C3377]
URI: http://www.ebi.ac.uk/cellline#soft_tissue_neoplasm
URI: http://www.ebi.ac.uk/cellline#vascular_disease
An endocrine gland cancer located in the thryoid gland located in the neck below the thyroid cartilage.
Thyroid gland neoplasm
malignant neoplasm of thyroid gland
malignant tumour of thyroid gland
neoplasm of thyroid gland
thyroid neoplasm
A cell type cancer that has_material_basis_in mesothelial tissue that develops from the thin layer of tissue that covers many of the internal organs.
Diffuse malignant Mesothelioma
advanced malignant mesothelioma
asbestos-related malignant mesothelioma
malignant tumor of Mesothelium
An endocrine gland cancer located_in the pancreas.
Ca body of pancreas
Ca head of pancreas
Ca tail of pancreas
malignant neoplasm of body of pancreas
malignant neoplasm of head of pancreas
malignant neoplasm of tail of pancreas
pancreas neoplasm
pancreatic neoplasm
pancreatic tumor
"Islet cell neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:261713004]
"Islet cell neoplasm" EXACT [SNOMEDCT_2005_07_31:399528006]
"Islet cell tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:128878003]
"Islet cell tumor" EXACT [MTHICD9_2006:211.7]
"Islet cell tumour" EXACT [SNOMEDCT_2005_07_31:154609001]
"Islet cell tumour" EXACT [SNOMEDCT_2005_07_31:269636003]
"Islet cell tumour, benign" EXACT [SNOMEDCT_2005_07_31:76345009]
"benign islet cell tumor (disorder)" EXACT [SNOMEDCT_2005_07_31:269480005]
"benign islet cell tumour" EXACT [SNOMEDCT_2005_07_31:188855000]
"pancreatic Endocrine neoplasm" EXACT [NCI2004_11_17:C27031]
"tumor of endocrine pancreas (disorder)" EXACT [SNOMEDCT_2005_07_31:237596009]
URI: http://www.ebi.ac.uk/cellline#islet_cell_tumor
A disease of anatomical entity that is located_in kidney, ureter, bladder and urethra.
Non-neoplastic urinary tract disease
urinary tract disease
URI: http://www.ebi.ac.uk/cellline#urinary_system_disease
"Juvenile absence epilepsy (disorder)" EXACT [SNOMEDCT_2005_07_31:230413002]
"Juvenile absence epilepsy" EXACT [SNOMEDCT_2005_07_31:192983009]
"Petit Mal epilepsy" EXACT [NCI2004_11_17:C3023]
"absence seizure (disorder)" EXACT [SNOMEDCT_2005_07_31:79631006]
"absence seizure" EXACT [SNOMEDCT_2005_07_31:140805008]
"absence seizure" EXACT [SNOMEDCT_2005_07_31:163596002]
"childhood absence epilepsy (disorder)" EXACT [SNOMEDCT_2005_07_31:50866000]
"childhood absence epilepsy" EXACT [SNOMEDCT_2005_07_31:155037000]
"childhood absence epilepsy" EXACT [SNOMEDCT_2005_07_31:192980007]
"petit mal seizure" EXACT [CSP2005:0485-7316]
URI: http://www.ebi.ac.uk/cellline#absence_epilepsy
"Generalised epilepsy [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:192989008]
"Generalised epilepsy" EXACT [SNOMEDCT_2005_07_31:155038005]
"Generalised epilepsy" EXACT [SNOMEDCT_2005_07_31:155043003]
"Generalised epilepsy" EXACT [SNOMEDCT_2005_07_31:192994008]
"Generalized epilepsy (disorder)" EXACT [SNOMEDCT_2005_07_31:19598007]
"Generalized epilepsy" EXACT [NCI2004_11_17:C3021]
URI: http://www.ebi.ac.uk/cellline#generalized_epilepsy
URI: http://www.ebi.ac.uk/cellline#bone_tissue_neoplasm
"Menkes kinky-hair syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:59178007]
"steely hair syndrome" EXACT [CSP2005:1849-5365]
URI: http://www.ebi.ac.uk/cellline#Menkes_kinky_hair_syndrome
"Metabolic bone disease (disorder)" EXACT [SNOMEDCT_2005_07_31:50279003]
"bone metabolism disorder" EXACT [CSP2005:2715-1618]
URI: http://www.ebi.ac.uk/cellline#metabolic_bone_disease
A connective tissue cancer that is located_in bone and is characterized by uncontrolled cellular proliferation that destroys normal bone tissue.
CA - bone cancer
bone neoplasm
bone tumour
malignant bone neoplasm
malignant bone tumour
malignant neoplasm of bone
malignant osseous tumor
neoplasm of bone
osseous tumor
"Intrahepatic cholestasis (finding)" EXACT [SNOMEDCT_2005_07_31:4637005]
URI: http://www.ebi.ac.uk/cellline#intrahepatic_cholestasis
URI: http://www.ebi.ac.uk/cellline#jaw_disease
"Cherubism (disorder)" EXACT [SNOMEDCT_2005_07_31:53432004]
URI: http://www.ebi.ac.uk/cellline#cherubism
"fibrous Dysplasia of bone" EXACT [NCI2004_11_17:C34609]
"fibrous dysplasia of bone (disorder)" EXACT [SNOMEDCT_2005_07_31:10623005]
URI: http://www.ebi.ac.uk/cellline#osteitis_fibrosa_disseminata
URI: http://www.ebi.ac.uk/cellline#jaw_abnormality
"disorder of optic nerve (disorder)" EXACT [SNOMEDCT_2005_07_31:77157004]
"disorder of the second nerve" EXACT [SNOMEDCT_2005_07_31:194037001]
"optic nerve disorder" EXACT [CSP2005:2042-6601]
"optic nerve disorder" EXACT [SNOMEDCT_2005_07_31:267741008]
"optic neuropathy (disorder)" EXACT [SNOMEDCT_2005_07_31:312964007]
URI: http://www.ebi.ac.uk/cellline#optic_nerve_disease
"malignant mixed neoplasm" EXACT [NCI2004_11_17:C3729]
"mixed tumor, malignant (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:8145008]
"mixed tumor, malignant, NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189802003]
"A mixed cell type cancer that derives_from multiple tissue types." [url:http\://en.wikipedia.org/wiki/Mixed_tumor]
URI: http://www.ebi.ac.uk/cellline#malignant_mixed_cancer
A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from melanocytes which are found in skin, the bowel and the eye.
Naevocarcinoma
malignant melanoma
"melanocytic neoplasm (disorder)" EXACT [SNOMEDCT_2005_07_31:399956005]
"melanocytic neoplasm" EXACT [NCI2004_11_17:C7058]
URI: http://www.ebi.ac.uk/cellline#melanocytic_neoplasm
"Complete hypoxanthine-guanine phosphoribosyltransferase deficiency" EXACT [SNOMEDCT_2005_07_31:190921003]
"HG-PRT deficiency" EXACT [MTHICD9_2006:277.2]
"Hypoxanthine-guanine phosphoribosyltransferase deficiency (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:90924007]
"Hypoxanthine-guanine phosphoribosyltransferase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:267451005]
"Hypoxanthine-guanine-phosphoribosyltransferase deficiency (& [Lesch - Nyhan syndrome])" EXACT [SNOMEDCT_2005_07_31:190918000]
"Lesch - Nyhan syndrome" EXACT [SNOMEDCT_2005_07_31:190917005]
"Lesch-Nyhan syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:10406007]
"X-linked hyperuricemia (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:68655008]
"deficiency of IMP pyrophosphorylase" EXACT [SNOMEDCT_2005_07_31:124275001]
"hypoxanthine guanine phosphoribosyltransferase deficiency" EXACT [CSP2005:1849-8105]
URI: http://www.ebi.ac.uk/cellline#Lesch-Nyhan_syndrome
"(Blood urate raized) or (hyperuricemia)" EXACT [SNOMEDCT_2005_07_31:166733000]
"Uricacidaemia" EXACT [SNOMEDCT_2005_07_31:35885006]
"hyperuricaemia [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:237857006]
"hyperuricaemia" EXACT [SNOMEDCT_2005_07_31:144021008]
"hyperuricaemia" EXACT [SNOMEDCT_2005_07_31:271198001]
"hyperuricemia" EXACT [NCI2004_11_17:C3961]
"uricacidemia" EXACT [CSP2005:1849-8097]
URI: http://www.ebi.ac.uk/cellline#hyperuricemia
"disorder of sexual differentiation (disorder)" EXACT [SNOMEDCT_2005_07_31:39179006]
"sex differentiation disorder" EXACT [CSP2005:2586-8784]
URI: http://www.ebi.ac.uk/cellline#sex_differentiation_disease
"Hypogonadism (disorder)" EXACT [SNOMEDCT_2005_07_31:48130008]
"hypogonadism" EXACT [CSP2005:2586-8835]
URI: http://www.ebi.ac.uk/cellline#hypogonadism
"Gaucher's disease [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:2859005]
"Gaucher's disease" EXACT [MTHICD9_2006:272.7]
"Glucosylceramide beta-glucosidase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:190794006]
"Kerasin thesaurismosis (disorder)" EXACT [SNOMEDCT_2005_07_31:180485001]
"lipoid histiocytosis (kerasin type)" EXACT [CSP2005:1849-8920]
URI: http://www.ebi.ac.uk/cellline#Gaucher's_disease
"Sphingolipidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:238028008]
"Sphingolipidosis, NOS" EXACT [SNOMEDCT_2005_07_31:58459009]
URI: http://www.ebi.ac.uk/cellline#sphingolipidosis
"Supra-valvular aortic stenosis" EXACT [MTHICD9_2006:747.22]
"Supra-valvular aortic stenosis" EXACT [SNOMEDCT_2005_07_31:204436002]
"Supravalvar aortic stenosis (disorder)" EXACT [SNOMEDCT_2005_07_31:268185002]
URI: http://www.ebi.ac.uk/cellline#supravalvular_aortic_stenosis
An organ system cancer that is manifested in the reproductive organs.
"Reproductive tumor" EXACT [NCI2004_11_17:C3674]
"malignant reproductive system neoplasm" EXACT []
"reproductive system neoplasm" EXACT [CSP2005:2016-0492]
Reproductive tumor
malignant reproductive system neoplasm
cancer of reproductive system
"A cancer by anatomical entity that is manifested in the reproductive system." [url:http\://en.wikipedia.org/wiki/Reproductive_system#Examples_of_cancers]
URI: http://www.ebi.ac.uk/cellline#cancer_of_reproductive_system
"Hypothalamus disorder" EXACT [SNOMEDCT_2005_07_31:190463005]
"Hypothalamus disorder" EXACT [SNOMEDCT_2005_07_31:88108008]
"disorder of hypothalamus (disorder)" EXACT [SNOMEDCT_2005_07_31:399100005]
URI: http://www.ebi.ac.uk/cellline#hypothalamic_disease
"Angelman syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:76880004]
"puppetlike syndrome" EXACT [CSP2005:4008-0043]
URI: http://www.ebi.ac.uk/cellline#Angelman_syndrome
"Rubinstein-Taybi syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:45582004]
"Rubinstein-Taybi syndrome" EXACT [SNOMEDCT_2005_07_31:157032007]
URI: http://www.ebi.ac.uk/cellline#Rubinstein-Taybi_syndrome
"Dysostosis (disorder)" EXACT [SNOMEDCT_2005_07_31:109420003]
URI: http://www.ebi.ac.uk/cellline#dysostosis
"Bardet-Biedl syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:5619004]
"Laurence-Moon-Biedl syndrome" EXACT [SNOMEDCT_2005_07_31:232060005]
"syndrome, Bardet-Biedl" EXACT [MTH:125]
URI: http://www.ebi.ac.uk/cellline#Bardet-Biedl_syndrome
"glandular cell Epithelium neoplasm" EXACT [NCI2004_11_17:C7132]
URI: http://www.ebi.ac.uk/cellline#glandular_cell_epithelial_neoplasm
A rectum cancer that derives_from epithelial cells of glandular origin.
Rectal adenocarcinoma
A musculoskeletal system cancer that is located_in connective tissue.
"Tumour of connective tissue" EXACT [SNOMEDCT_2005_07_31:254821003]
"connective tissue neoplasm" EXACT [CSP2005:2008-3809]
"neoplasm of connective tissues (disorder)" EXACT [SNOMEDCT_2005_07_31:126598008]
Tumour of connective tissue
connective tissue neoplasm
neoplasm of connective tissues
URI: http://www.ebi.ac.uk/cellline#connective_tissue_neoplasm
A female reproductive organ cancer that is located_in the placenta.
Placental tumors
malignant Placental tumor
malignant neoplasm of placenta
neoplasm of placenta
placental cancer
primary malignant neoplasm of placenta
"Socialized behavior disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:386820009]
"Socialized behavior disorder (finding)" EXACT [SNOMEDCT_2005_07_31:112083000]
"Socialized conduct disorder NOS (finding)" EXACT [SNOMEDCT_2005_07_31:192093004]
"Socialized conduct disorder" EXACT [ICD9CM_2006:312.2]
"Socialized conduct disorder" EXACT [SNOMEDCT_2005_07_31:192600007]
"Socialized conduct disorder, unspecified degree" EXACT [ICD9CM_2006:312.20]
URI: http://www.ebi.ac.uk/cellline#socialized_conduct_disorder
"Communication disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:278919001]
"Communication disorder NOS" EXACT [MTHICD9_2006:307.9]
"Communication disorder" EXACT [NCI2004_11_17:C2958]
"Communication disorder, NOS" EXACT [SNOMEDCT_2005_07_31:74825008]
"communication disorder" EXACT [CSP2005:1579-2995]
URI: http://www.ebi.ac.uk/cellline#communication_impairment
URI: http://www.ebi.ac.uk/cellline#urogenital_abnormality
"Multiple congenital exostosis" EXACT [SNOMEDCT_2005_07_31:205479007]
"Multiple exostoses syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:84852005]
"Multiple exostoses type I" EXACT [SNOMEDCT_2005_07_31:254044004]
"Multiple exostosis syndromes" EXACT [SNOMEDCT_2005_07_31:240186007]
"Osteochondromatosis syndrome (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:16535008]
"multiple exostosis" EXACT [CSP2005:1849-1975]
URI: http://www.ebi.ac.uk/cellline#hereditary_multiple_exostoses
"Familiar neoplastic syndrome" EXACT [NCI2004_11_17:C3266]
URI: http://www.ebi.ac.uk/cellline#hereditary_neoplastic_syndrome
A vulva carcinoma and has_material_basis_in squamous cells and is located_in the epidermis of the vulvar tissue.
Vulvar Epidermoid carcinoma
vulvar squamous cell carcinoma
squamous cell carcinoma of vulva
"B cell (antibody) deficiencies" EXACT []
"Immunoglobulin heavy chain deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:234539005]
"immunoglobulin heavy chain deletion" EXACT []
"A primary immunnodeficiency disease that is caused by a lack of infection-fighting antibody producing B cells (immunoglobulins) or B cells that are not functioning properly." [url:http\://www.ncbi.nlm.nih.gov/pmc/articles/PMC2601718/pdf/nihms57213.pdf, url:http\://www.nichd.nih.gov/publications/pubs/primary_immuno.cfm#WhatisPrimaryImmunodeficiency]
URI: http://www.ebi.ac.uk/cellline#B_cell_deficiency
"Congenital ectodermal defect (disorder)" EXACT [SNOMEDCT_2005_07_31:254154003]
"Congenital ectodermal defect" EXACT [SNOMEDCT_2005_07_31:205610005]
"Congenital ectodermal dysplasia" EXACT [ICD9CM_2006:757.31]
"Ectodermal dysplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:8654005]
URI: http://www.ebi.ac.uk/cellline#ectodermal_dysplasia
"intracranial central nervous system tumors" EXACT [NCI2004_11_17:C4953]
"intracranial tumor (disorder)" EXACT [SNOMEDCT_2005_07_31:254935002]
URI: http://www.ebi.ac.uk/cellline#intracranial_neoplasm
URI: http://www.ebi.ac.uk/cellline#teeth_hard_tissue_disease
An ovarian cancer that is derives_from ovarian surface epithelium.
Ovarian Surface epithelial-Stromal tumor
"Ocular tumor" EXACT [NCI2004_11_17:C3030]
"eye neoplasm" EXACT [CSP2005:2018-3273]
"neoplasm of eye (disorder)" EXACT [SNOMEDCT_2005_07_31:126995000]
"neoplasm of eye proper" EXACT [SNOMEDCT_2005_07_31:371486001]
URI: http://www.ebi.ac.uk/cellline#eye_neoplasm
"Asymptomatic bacteriuria antepartum" EXACT []
"Asymptomatic bacteriuria in pregnancy, with delivery" EXACT []
"Asymptomatic bacteriuria postpartum" EXACT []
"Gonorrhea + pregnancy" EXACT [SNOMEDCT_2005_07_31:267316003]
"Infectious and parasitic conditions in the mother classifiable elsewhere, but complicating pregnancy, childbirth, or the puerperium" EXACT []
"Syphilis + pregnancy" EXACT [SNOMEDCT_2005_07_31:267316003]
"Syphilis complicating pregnancy, childbirth, or the puerperium" EXACT []
"gonorrhea complicating pregnancy, childbirth, or the puerperium" EXACT []
"gonorrhea of mother with delivery" EXACT []
"malaria complicating pregnancy, childbirth, or the puerperium" EXACT []
"malaria of mother with delivery" EXACT []
"syphilis of mother, complicating pregnancy, with delivery" EXACT []
complications mainly related to pregnancy
URI: http://www.ebi.ac.uk/cellline#complications_mainly_related_to_pregnancy
A colorectal cancer that is located_in the colon.
URI: http://www.ebi.ac.uk/cellline#coagulation_protein_disorder
"HEMORRHAGIC DISORDER" EXACT [MTH:NOCODE]
"Haemorrhagic condition, unspecified" EXACT [SNOMEDCT_2005_07_31:191327000]
"Hemorrhagic condition NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:191331006]
"Hemorrhagic condition, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:191437009]
"Hemorrhagic diathesis" EXACT [MTHICD9_2006:287.9]
"Hemorrhagic disease" EXACT [SNOMEDCT_2005_07_31:268884000]
"Unspecified hemorrhagic conditions" EXACT [ICD9CM_2006:287.9]
"hemorrhagic disorder" EXACT [CSP2005:0427-4811]
URI: http://www.ebi.ac.uk/cellline#hemorrhagic_disorder
URI: http://www.ebi.ac.uk/cellline#inherited_blood_coagulation_disorder
"Factor VII deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:37193007]
"Factor VII deficiency" EXACT [SNOMEDCT_2005_07_31:154820003]
"deficiency, stable" EXACT [MTHICD9_2006:286.3]
URI: http://www.ebi.ac.uk/cellline#factor_VII_deficiency
"Factor V deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:4320005]
"Factor V deficiency [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:191284007]
"Hereditary hypoproaccelerinaemia" EXACT [SNOMEDCT_2005_07_31:88776002]
"Labile factor deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:366160003]
"Proaccelerin deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:365157004]
"deficiency, labile" EXACT [MTHICD9_2006:286.3]
URI: http://www.ebi.ac.uk/cellline#factor_V_deficiency
"Bernard - Soulier thrombopathy" EXACT [SNOMEDCT_2005_07_31:191309003]
"Bernard Soulier syndrome" EXACT [CSP2005:4001-0130]
"Giant platelet syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:234478007]
"Hemorrhagic dystrophic thrombocytopenia" EXACT [SNOMEDCT_2005_07_31:54569005]
"Thrombopathy, Bernard-Soulier" EXACT [MTHICD9_2006:287.1]
URI: http://www.ebi.ac.uk/cellline#Bernard-Soulier_syndrome
"Platelet disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:22716005]
"Thrombocytopathy" EXACT [MTHICD9_2006:287.1]
"platelet disorder" EXACT [CSP2005:0446-1413]
"thrombocytopathy" EXACT [CSP2005:0446-4239]
URI: http://www.ebi.ac.uk/cellline#blood_platelet_disorder
"Factor X deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:76642003]
"disease, Stuart-Prower" EXACT [MTHICD9_2006:286.3]
URI: http://www.ebi.ac.uk/cellline#factor_X_deficiency
"Dense body defect (disorder)" EXACT [SNOMEDCT_2005_07_31:234474009]
"Platelet dense granule deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:9417000]
"Platelet storage pool defect" EXACT [SNOMEDCT_2005_07_31:128099001]
URI: http://www.ebi.ac.uk/cellline#platelet_storage_pool_deficiency
malignant neoplasm of lymphatic and hemopoietic tissue
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_lymphatic_and_hemopoietic_tissue
"Hemophilia (disorder)" EXACT [SNOMEDCT_2005_07_31:90935002]
"Hemophilia NOS" EXACT [MTHICD9_2006:286.0]
"hemophilia" EXACT [NCI2004_11_17:C3093]
URI: http://www.ebi.ac.uk/cellline#hemophilia
"Coagulation Factor deficiency" EXACT [NCI2004_11_17:C27215]
URI: http://www.ebi.ac.uk/cellline#coagulation_factor_deficiency
"Focal epilepsy" EXACT [SNOMEDCT_2005_07_31:155041001]
"Focal epilepsy" EXACT [SNOMEDCT_2005_07_31:193007004]
"Focal epilepsy" EXACT [SNOMEDCT_2005_07_31:29753000]
"epilepsy, focal NOS" EXACT [MTHICD9_2006:345.5]
"focal epilepsy" EXACT [CSP2005:0485-7151]
"localisation-related epilepsy -RETIRED-" EXACT [SNOMEDCT_2005_07_31:67139004]
"localisation-related epilepsy" EXACT [SNOMEDCT_2005_07_31:155044009]
"localization-related epilepsy (disorder)" EXACT [SNOMEDCT_2005_07_31:230381009]
URI: http://www.ebi.ac.uk/cellline#partial_epilepsy
"Factor II deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:73975000]
"Factor II deficiency" EXACT [NCI2004_11_17:C26799]
"Factor II deficiency" EXACT [SNOMEDCT_2005_07_31:191283001]
"HYPOPROTHROMBINEMIA" EXACT [MTH:NOCODE]
"deficiency, prothrombin" EXACT [MTHICD9_2006:286.3]
"hypoprothrombinemia" EXACT [CSP2005:0438-7564]
URI: http://www.ebi.ac.uk/cellline#hypoprothrombinemia
"A syndrome is a disease comprised of a group of signs and symptoms that occur together and characterize a particular abnormality." [URL:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=syndrome]
URI: http://www.ebi.ac.uk/cellline#syndrome
"short rib polydactyly syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:205484001]
URI: http://www.ebi.ac.uk/cellline#short_rib-polydactyly_syndrome
"Osteochondrodysplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:240190009]
"Osteochondrodysplasia syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:105985007]
"Osteochondrodysplasia" EXACT [SNOMEDCT_2005_07_31:205510001]
URI: http://www.ebi.ac.uk/cellline#osteochondrodysplasia
An endocrine system disease that is located_in the gonads.
URI: http://www.ebi.ac.uk/cellline#gonadal_disease
A reproductive system disease that impairs the ability to reproduce and is located in the uterus, vagina, cervix, ovaries or fallopian tubes.
URI: http://www.ebi.ac.uk/cellline#female_reproductive_system_disease
URI: http://www.ebi.ac.uk/cellline#motor_neuron_disease
"Crouzon syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:28861008]
"Crouzon's disease" EXACT [CSP2005:0725-9662]
"Crouzon's disease" EXACT [MTHICD9_2006:756.0]
URI: http://www.ebi.ac.uk/cellline#Crouzon_syndrome
A colon carcinoma that derives_from epithelial cells of glandular origin.
Colonic adenocarcinoma
adenocarcinoma of colon
adenocarcinoma of the colon
"Craniosynostosis syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:57219006]
"Premature closure of cranial sutures" EXACT [MTHICD9_2006:756.0]
"synostosis (cranial)" EXACT [CSP2005:0726-0275]
URI: http://www.ebi.ac.uk/cellline#craniosynostosis
URI: http://www.ebi.ac.uk/cellline#disorder_of_plasma_protein_metabolism
"Iron overload (disorder)" EXACT [SNOMEDCT_2005_07_31:60737008]
URI: http://www.ebi.ac.uk/cellline#iron_overload
"Iron disorder" EXACT [SNOMEDCT_2005_07_31:154751003]
"Iron disorder" EXACT [SNOMEDCT_2005_07_31:267504005]
"disorder of iron metabolism (disorder)" EXACT [SNOMEDCT_2005_07_31:30913008]
"disorder of iron metabolism NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190851008]
"disorder of iron metabolism" EXACT [ICD9CM_2006:275.0]
"iron disorder" EXACT [CSP2005:1630-2859]
URI: http://www.ebi.ac.uk/cellline#iron_metabolism_disorder
"Bronze diabetes (disorder)" EXACT [SNOMEDCT_2005_07_31:399144008]
"Bronzed diabetes" EXACT [MTHICD9_2006:275.0]
"Haemochromatosis" EXACT [SNOMEDCT_2005_07_31:154751003]
"Haemochromatosis" EXACT [SNOMEDCT_2005_07_31:267504005]
"Hemochromatosis (disorder)" EXACT [SNOMEDCT_2005_07_31:399187006]
"Hemochromatosis (disorder)" EXACT [SNOMEDCT_2005_07_31:86781004]
"diabetes bronze" EXACT [CSP2005:1849-4292]
"iron storage disorder" EXACT [CSP2005:1630-3927]
URI: http://www.ebi.ac.uk/cellline#hemochromatosis
URI: http://www.ebi.ac.uk/cellline#anemia
"Neuroaxonal dystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:230365004]
URI: http://www.ebi.ac.uk/cellline#neuroaxonal_dystrophy
"Gangliosidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:50967008]
"disease, Gangliosidosis" EXACT [MTHICD9_2006:330.1]
"gangliosidosis" EXACT [CSP2005:1849-8576]
URI: http://www.ebi.ac.uk/cellline#gangliosidosis
"Generalized multiple sclerosis (disorder)" EXACT [SNOMEDCT_2005_07_31:192928003]
"Multiple sclerosis (disorder)" EXACT [SNOMEDCT_2005_07_31:24700007]
"Multiple sclerosis NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:192930001]
"Multiple sclerosis" EXACT [ICD9CM_2006:340]
"Multiple sclerosis" EXACT [SNOMEDCT_2005_07_31:155023009]
"insular sclerosis" EXACT [CSP2005:2042-2324]
"multiple sclerosis" EXACT [NCI2004_11_17:C3243]
URI: http://www.ebi.ac.uk/cellline#multiple_sclerosis
"Thiamin deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:35843007]
"Thiamin deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:399357009]
"Thiamine deficiency" EXACT [SNOMEDCT_2005_07_31:154725000]
"Thiamine deficiency" EXACT [SNOMEDCT_2005_07_31:267491008]
"Thiamine deficiency, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:191088004]
"Thiamine deficiency, unspecified" EXACT [SNOMEDCT_2005_07_31:190628006]
"thiamine deficiency" EXACT [CSP2005:2116-7354]
"vitamin B1 deficiency" EXACT [SNOMEDCT_2005_07_31:190624008]
URI: http://www.ebi.ac.uk/cellline#Thiamine_deficiency
A female reproductive organ cancer that is located_in the ovary.
malignant Ovarian tumor
malignant tumour of ovary
ovarian neoplasm
ovary neoplasm
primary ovarian cancer
tumor of the Ovary
"neural tumor of the skin" EXACT [NCI2004_11_17:C4479]
"skin tumor of neural origin (disorder)" EXACT [SNOMEDCT_2005_07_31:254758008]
URI: http://www.ebi.ac.uk/cellline#skin_tumor_of_neural_origin
"melanocytic neoplasm of skin" EXACT [NCI2004_11_17:C7161]
"melanocytic tumor of skin (disorder)" EXACT [SNOMEDCT_2005_07_31:276728004]
URI: http://www.ebi.ac.uk/cellline#cutaneous_melanocytic_neoplasm
"Glomus neoplasm" EXACT [NCI2004_11_17:C3060]
"Glomus tumor (disorder)" EXACT [SNOMEDCT_2005_07_31:403969002]
"Glomus tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:10438002]
"Glomus tumour" EXACT [SNOMEDCT_2005_07_31:189193002]
"Glomus tumour" EXACT [SNOMEDCT_2005_07_31:393567008]
URI: http://www.ebi.ac.uk/cellline#glomus_tumor
"neoplasm of Dermis" EXACT [NCI2004_11_17:C4475]
"tumor of dermis (disorder)" EXACT [SNOMEDCT_2005_07_31:254735005]
URI: http://www.ebi.ac.uk/cellline#tumor_of_Dermis
URI: http://www.ebi.ac.uk/cellline#non-neoplastic_retinal_disorder
URI: http://www.ebi.ac.uk/cellline#psychotic_disorder
"HSMN - Hereditary sensory and motor neuropathy" EXACT [SNOMEDCT_2005_07_31:193158000]
"Hereditary motor and sensory neuropathy [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:193161004]
"Hereditary motor and sensory neuropathy" EXACT [SNOMEDCT_2005_07_31:155081008]
"Hereditary motor and sensory neuropathy" EXACT [SNOMEDCT_2005_07_31:193160003]
"Neuropathic muscular atrophy" EXACT [MTHICD9_2006:356.1]
"Neuropathic muscular atrophy" EXACT [SNOMEDCT_2005_07_31:50548001]
"neuropathic muscular atrophy" EXACT [CSP2005:2042-7637]
URI: http://www.ebi.ac.uk/cellline#hereditary_motor_and_sensory_neuropathy
URI: http://www.ebi.ac.uk/cellline#spinocerebellar_degeneration
"hyperCHOLESTEROLEMIA" EXACT [MTH:NOCODE]
"hypercholesteremia" EXACT [CSP2005:1744-1643]
"hypercholesterolaemia" EXACT [SNOMEDCT_2005_07_31:154740003]
"hypercholesterolaemia" EXACT [SNOMEDCT_2005_07_31:267500001]
"hypercholesterolemia (disorder)" EXACT [SNOMEDCT_2005_07_31:13644009]
URI: http://www.ebi.ac.uk/cellline#hypercholesterolemia
"congenital neurologic anomaly" EXACT []
URI: http://www.ebi.ac.uk/cellline#congenital_nervous_system_abnormality
"Sensory neuropathy (disorder)" EXACT [SNOMEDCT_2005_07_31:95662005]
"peripheral Sensory Neuropathy" EXACT [NCI2004_11_17:C3501]
"sensory neuropathy" EXACT [CSP2005:4007-0113]
URI: http://www.ebi.ac.uk/cellline#sensory_neuropathy
"Hereditary peripheral neuropathy (disorder)" EXACT [SNOMEDCT_2005_07_31:65017003]
"Hereditary peripheral neuropathy NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:193159008]
URI: http://www.ebi.ac.uk/cellline#Hereditary_peripheral_neuropathy
URI: http://www.ebi.ac.uk/cellline#alcohol-induced_mental_disorder
"Gorlin syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:69408002]
"Naevoid basal cell carcinoma syndrome" EXACT [SNOMEDCT_2005_07_31:188145001]
"Naevoid basal cell carcinoma syndrome" EXACT [SNOMEDCT_2005_07_31:254704004]
URI: http://www.ebi.ac.uk/cellline#nevoid_basal_cell_carcinoma_syndrome
"BASAL CELL carcinoma OF SKIN" EXACT [MTH:100]
"Basal cell cancer" EXACT [NCI2004_11_17:C2921]
"Basal cell carcinoma (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:1338007]
"Basal cell carcinoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189573003]
"Basal cell carcinoma of skin (disorder)" EXACT [SNOMEDCT_2005_07_31:254701007]
"Basal cell neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189572008]
"Basal cell neoplasm NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189574009]
"Basal cell tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:30649006]
"Basal cell tumor" EXACT [NCI2004_11_17:C3784]
"Epithelioma basal cell (disorder)" EXACT [SNOMEDCT_2005_07_31:275265005]
"basal cell carcinoma" EXACT [CSP2005:2000-2719]
"malignant Basal cell neoplasm" EXACT [NCI2004_11_17:C7586]
"malignant basal cell tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:252995000]
URI: http://www.ebi.ac.uk/cellline#basal_cell_carcinoma
disorder of testis
testis disorder
"Alcohol-induced psychosis (disorder)" EXACT [SNOMEDCT_2005_07_31:42344001]
"Alcoholic psychoses" EXACT [SNOMEDCT_2005_07_31:154852003]
"Alcoholic psychosis NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:191482008]
"Alcoholic psychosis NOS" EXACT [SNOMEDCT_2005_07_31:192212000]
"Alcoholism with psychosis" EXACT [MTHICD9_2006:291.9]
"Mental and behavioral disorder due to use of alcohol: psychotic disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:268684002]
"Unspecified alcohol-induced mental disorder" EXACT [ICD9CM_2006:291.9]
"alcoholic psychosis" EXACT [CSP2005:0080-9468]
URI: http://www.ebi.ac.uk/cellline#alcoholic_psychosis
A prostate carcinoma that derives_from epithelial cells of glandular origin.
"nephrosis NOS" EXACT [MTHICD9_2006:581.9]
"nephrosis, NOS" EXACT [SNOMEDCT_2005_07_31:90708001]
URI: http://www.ebi.ac.uk/cellline#nephrosis
An organ system cancer located in the hematological system that is characterized by uncontrolled cellular proliferation in blood, bone marrow and lymph nodes.
"Hematologic malignancy (disorder)" EXACT [SNOMEDCT_2005_07_31:127221002]
"Hematologic malignancy" EXACT [SNOMEDCT_2005_07_31:269475001]
"Hematologic neoplasm (disorder)" EXACT [SNOMEDCT_2005_07_31:129154003]
"Hematological tumors" EXACT [NCI2004_11_17:C27134]
"blood cancer" EXACT [CSP2005:2004-0139]
"hematopoietic and lymphoid system tumor" EXACT []
"hematopoietic neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:414388001]
"hematopoietic tumors" EXACT [NCI2004_11_17:C27134]
"malignant hematopoietic neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:414644002]
Hematologic malignancy
Hematologic neoplasm
Hematological tumors
blood cancer
hematopoietic and lymphoid system tumor
hematopoietic cancer
hematopoietic neoplasm
hematopoietic tumors
malignant hematopoietic neoplasm
"A cancer that affects the blood or bone marrow." [url:http\://www.cancer.gov/dictionary/?CdrID=45708]
URI: http://www.ebi.ac.uk/cellline#hematologic_cancer
URI: http://www.ebi.ac.uk/cellline#nervous_system_alcohol-induced_disorder
URI: http://www.ebi.ac.uk/cellline#hemangioma
"Letterer-Siwe disease involving intra-abdominal lymph nodes" EXACT [ICD9CM_2006:202.53]
"Letterer-Siwe disease involving intrapelvic lymph nodes" EXACT [ICD9CM_2006:202.56]
"Letterer-Siwe disease involving intrathoracic lymph nodes" EXACT [ICD9CM_2006:202.52]
"Letterer-Siwe disease involving lymph nodes of axilla and upper limb" EXACT [ICD9CM_2006:202.54]
"Letterer-Siwe disease involving lymph nodes of head, face and neck" EXACT []
"Letterer-Siwe disease involving lymph nodes of head, face, and neck" EXACT [ICD9CM_2006:202.51]
"Letterer-Siwe disease involving lymph nodes of inguinal region and lower limb" EXACT [ICD9CM_2006:202.55]
"Letterer-Siwe disease involving lymph nodes of multiple sites" EXACT [ICD9CM_2006:202.58]
"Letterer-Siwe disease involving spleen" EXACT [ICD9CM_2006:202.57]
"Letterer-Siwe disease of intra-abdominal lymph nodes (disorder)" EXACT [SNOMEDCT_2005_07_31:93133006]
"Letterer-Siwe disease of intra-abdominal lymph nodes" EXACT []
"Letterer-Siwe disease of intrapelvic lymph nodes (disorder)" EXACT [SNOMEDCT_2005_07_31:93134000]
"Letterer-Siwe disease of intrapelvic lymph nodes" EXACT []
"Letterer-Siwe disease of intrathoracic lymph nodes (disorder)" EXACT [SNOMEDCT_2005_07_31:93135004]
"Letterer-Siwe disease of intrathoracic lymph nodes" EXACT []
"Letterer-Siwe disease of lymph nodes of axilla and upper limb (disorder)" EXACT [SNOMEDCT_2005_07_31:188657006]
"Letterer-Siwe disease of lymph nodes of axilla and/or upper limb (disorder)" EXACT [SNOMEDCT_2005_07_31:93136003]
"Letterer-Siwe disease of lymph nodes of axilla and/or upper limb" EXACT []
"Letterer-Siwe disease of lymph nodes of head, face and neck (disorder)" EXACT [SNOMEDCT_2005_07_31:188656002]
"Letterer-Siwe disease of lymph nodes of head, face and/or neck (disorder)" EXACT [SNOMEDCT_2005_07_31:93137007]
"Letterer-Siwe disease of lymph nodes of inguinal region amd/or lower limb" EXACT []
"Letterer-Siwe disease of lymph nodes of inguinal region and lower limb (disorder)" EXACT [SNOMEDCT_2005_07_31:188658001]
"Letterer-Siwe disease of lymph nodes of inguinal region and/or lower limb (disorder)" EXACT [SNOMEDCT_2005_07_31:93138002]
"Letterer-Siwe disease of lymph nodes of multiple sites (disorder)" EXACT [SNOMEDCT_2005_07_31:93139005]
"Letterer-Siwe disease of lymph nodes of multiple sites" EXACT []
"Letterer-Siwe disease of spleen (disorder)" EXACT [SNOMEDCT_2005_07_31:93140007]
"Letterer-Siwe disease of spleen" EXACT []
"A Langerhans-cell histiocytosis and malignant histiocytic disorder and malignant neoplasm of abdomen that results_in an abnormal increase in the number of immune cells called histiocytes." [url:https\://health.google.com/health/ref/Histiocytosis]
URI: http://www.ebi.ac.uk/cellline#Letterer-Siwe_disease
"Macular Corneal Dystrophy" EXACT [NCI2004_11_17:C34793]
"Macular corneal dystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:60258001]
URI: http://www.ebi.ac.uk/cellline#macular_corneal_dystrophy
"Corneal Dystrophy" EXACT [NCI2004_11_17:C34513]
"Corneal dystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:5587004]
"corneal dystrophy" EXACT [CSP2005:1114-8656]
"corneal dystrophy" EXACT [CSP2005:1254-7727]
URI: http://www.ebi.ac.uk/cellline#Corneal_dystrophy
"malignant histiocytic disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:127070008]
URI: http://www.ebi.ac.uk/cellline#malignant_histiocytic_disorder
"Histiocytosis X , unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:190956004]
"Histiocytosis X syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:190955000]
"Histiocytosis X" EXACT [MTHICD9_2006:277.89]
"Histiocytosis X" EXACT [SNOMEDCT_2005_07_31:154583006]
"Histiocytosis X" EXACT [SNOMEDCT_2005_07_31:269628007]
"Langerhan's cell histiocytosis (disorder)" EXACT [SNOMEDCT_2005_07_31:234439008]
"Langerhans cell Granulomatosis" EXACT [NCI2004_11_17:C3107]
"Langerhans cell granulomatosis" EXACT [CSP2005:0427-5330]
"Langerhans cell histiocytosis (disorder)" EXACT [SNOMEDCT_2005_07_31:65399007]
"Langerhans cell histiocytosis, no ICD-O subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:128809007]
"Langerhans' cell histiocytosis (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:110450007]
"A disease of metabolism and histiocytic and dendritic cell cancer and histiocytosis and interstitial lung disease that results_in the proliferation of Langerhans cells." [url:http\://en.wikipedia.org/wiki/Langerhans_cell_histiocytosis]
URI: http://www.ebi.ac.uk/cellline#Langerhans-cell_histiocytosis
"Rhizomelic chondrodysplasia punctata syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:56692003]
"Rhizomelic chrondrodysplasia punctata" EXACT [MTHICD9_2006:277.86]
URI: http://www.ebi.ac.uk/cellline#rhizomelic_chondrodysplasia_punctata
"Chondrodysplasia calcificans congenita" EXACT [SNOMEDCT_2005_07_31:22932004]
"Chondrodysplasia punctata (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:42778005]
"Chondrodysplasia punctata (disorder)" EXACT [SNOMEDCT_2005_07_31:205486004]
"Chondrodysplasia punctata (stippled epiphyses) group (disorder)" EXACT [SNOMEDCT_2005_07_31:278715001]
"Chondrodysplasia punctata congenita (disorder)" EXACT [SNOMEDCT_2005_07_31:360507004]
URI: http://www.ebi.ac.uk/cellline#chondrodysplasia_punctata
"Acatalasemia (disorder)" EXACT [SNOMEDCT_2005_07_31:267454002]
"Acatalasia (disorder)" EXACT [SNOMEDCT_2005_07_31:111393000]
"deficiency of catalase (disorder)" EXACT [SNOMEDCT_2005_07_31:124202004]
URI: http://www.ebi.ac.uk/cellline#acatalasia
"Agammaglobulinaemia -RETIRED-" EXACT [SNOMEDCT_2005_07_31:81282009]
"Agammaglobulinemia (finding)" EXACT [SNOMEDCT_2005_07_31:119249001]
"Agammaglobulinemia NOS" EXACT [MTHICD9_2006:279.00]
"HYPOGAMMAGLOBULINEMIA" EXACT [MTH:NOCODE]
"Hypogammaglobulinemia (finding)" EXACT [SNOMEDCT_2005_07_31:119250001]
"Hypogammaglobulinemia NOS (finding)" EXACT [SNOMEDCT_2005_07_31:190978006]
"Hypogammaglobulinemia, NOS" EXACT [SNOMEDCT_2005_07_31:81282009]
"Hypogammaglobulinemia, unspecified" EXACT [ICD9CM_2006:279.00]
"agammaglobulinemia" EXACT [CSP2005:0449-3787]
"hypogammaglobulinemia" EXACT [CSP2005:0449-3787]
"A B cell deficiency that is caused by a reduction in all types of gamma globulins." [url:http\://en.wikipedia.org/wiki/Dysgammaglobulinemia]
URI: http://www.ebi.ac.uk/cellline#agammaglobulinemia
URI: http://www.ebi.ac.uk/cellline#pancreas_disease
URI: http://www.ebi.ac.uk/cellline#neuroblastic_tumor
"neuronal and Glio-neuronal tumor" EXACT [NCI2004_11_17:C4747]
"neuronal and mixed neuronal-glial tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:302831000]
URI: http://www.ebi.ac.uk/cellline#neuronal_and_glio-neuronal_neoplasm
A urinary system cancer that is located_in the kidney.
"kidney neoplasm" EXACT [CSP2005:2021-1116]
"neoplasm of kidney (disorder)" EXACT [SNOMEDCT_2005_07_31:126880001]
"renal tumors" EXACT [NCI2004_11_17:C3150]
malignant neoplasm of kidney except pelvis
malignant tumour of kidney
renal cancer
URI: http://www.ebi.ac.uk/cellline#kidney_neoplasm
A carcinoma that derives_from transitional epithelial cells.
transitional carcinoma
transitional cell tumor
urothelial cell carcinoma
transitional cell neoplasm
"Bloom syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:4434006]
"Bloom-Torre-Machacek syndrome" EXACT [CSP2005:1254-7913]
"Congenital Telangiectatic Erythema syndrome" EXACT [NCI2004_11_17:C2903]
URI: http://www.ebi.ac.uk/cellline#bloom_syndrome
"Dermatitis (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:4979002]
"Dermatitis (disorder)" EXACT [SNOMEDCT_2005_07_31:182782007]
"Dermatitis NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:200884006]
"Dermatitis NOS" EXACT [SNOMEDCT_2005_07_31:156358005]
"Dermatitis NOS" EXACT [SNOMEDCT_2005_07_31:267847004]
"Dermatitis, NOS" EXACT [MTHICD9_2006:692.9]
"Other chronic dermatitis due to solar radiation" EXACT []
"Other dermatitis due to solar radiation" EXACT []
"dermatitis" EXACT [NCI2004_11_17:C2983]
"skin inflammation NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267856007]
"skin inflammation NOS" EXACT [SNOMEDCT_2005_07_31:156388001]
URI: http://www.ebi.ac.uk/cellline#dermatitis
"Dyskeratosis congenita (disorder)" EXACT [SNOMEDCT_2005_07_31:74911008]
URI: http://www.ebi.ac.uk/cellline#dyskeratosis_congenita
"Epidermolysis bullosa (disorder)" EXACT [SNOMEDCT_2005_07_31:61003004]
"Epidermolysis bullosa" EXACT [MTHICD9_2006:757.39]
"Epidermolysis bullosa" EXACT [SNOMEDCT_2005_07_31:205580008]
"acantholysis bullosa" EXACT [CSP2005:0726-9169]
URI: http://www.ebi.ac.uk/cellline#epidermolysis_bullosa
URI: http://www.ebi.ac.uk/cellline#vesiculobullous_skin_disease
"Congenital poikiloderma" EXACT [MTHICD9_2006:757.33]
"Rothmund-Thomson syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:69093006]
URI: http://www.ebi.ac.uk/cellline#Rothmund-Thomson_syndrome
"Atrophoderma (disorder)" EXACT [SNOMEDCT_2005_07_31:399979006]
"Atrophoderma" EXACT [MTHICD9_2006:701.9]
"Atrophoderma" EXACT [SNOMEDCT_2005_07_31:201090001]
"atrophic condition of skin (disorder)" EXACT [SNOMEDCT_2005_07_31:16343004]
"atrophic condition of skin (disorder)" EXACT [SNOMEDCT_2005_07_31:400190005]
"skin Atrophy" EXACT [NCI2004_11_17:C35163]
URI: http://www.ebi.ac.uk/cellline#atrophic_condition_of_skin
"Pseudoxanthoma elasticum (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:7109007]
"Pseudoxanthoma elasticum (disorder)" EXACT [SNOMEDCT_2005_07_31:252246005]
"Pseudoxanthoma elasticum [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:205574000]
"Pseudoxanthoma elasticum" EXACT [SNOMEDCT_2005_07_31:157017000]
"Pseudoxanthoma elasticum" EXACT [SNOMEDCT_2005_07_31:239140003]
"Pseudoxanthoma elasticum" EXACT [SNOMEDCT_2005_07_31:268355000]
"pseudoxanthoma elasticum" EXACT [CSP2005:1849-8016]
URI: http://www.ebi.ac.uk/cellline#pseudoxanthoma_elasticum
"Bilirubinemia, NOS" EXACT [SNOMEDCT_2005_07_31:20505009]
"hyperbilirubinaemia" EXACT [SNOMEDCT_2005_07_31:154770008]
"hyperbilirubinaemia" EXACT [SNOMEDCT_2005_07_31:267509000]
"hyperbilirubinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:14783006]
"hyperbilirubinemia [dup] (disorder)" EXACT [SNOMEDCT_2005_07_31:235904007]
"hyperbilirubinemia" EXACT [CSP2005:1653-7010]
URI: http://www.ebi.ac.uk/cellline#hyperbilirubinemia
"hereditary hyperbilirubinemia" EXACT [CSP2005:1654-1020]
URI: http://www.ebi.ac.uk/cellline#hereditary_hyperbilirubinemia
"Glycogen storage disease, type V (disorder)" EXACT [SNOMEDCT_2005_07_31:55912009]
"McArdle's disease" EXACT [MTHICD9_2006:271.0]
"myophosphorylase deficiency" EXACT [CSP2005:1849-4007]
URI: http://www.ebi.ac.uk/cellline#glycogen_storage_disease_type_V
"Glycogen storage disease (disorder)" EXACT [SNOMEDCT_2005_07_31:29633007]
"Glycogen storage disease" EXACT [MTHICD9_2006:271.0]
"Glycogen storage disease" EXACT [SNOMEDCT_2005_07_31:154738008]
"Glycogen storage disease" EXACT [SNOMEDCT_2005_07_31:267498002]
"Glycogenosis NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190744005]
"Glycogenosis" EXACT [ICD9CM_2006:271.0]
"glycogenosis" EXACT [CSP2005:4000-0193]
URI: http://www.ebi.ac.uk/cellline#glycogen_storage_disease
"Glycogen storage disease, type III (disorder)" EXACT [SNOMEDCT_2005_07_31:66937008]
"amylo 1,6 glucosidase deficiency" EXACT [CSP2005:1849-3893]
"deficiency of debranching enzyme" EXACT [SNOMEDCT_2005_07_31:124474000]
"deficiency of dextrin" EXACT [SNOMEDCT_2005_07_31:124472001]
URI: http://www.ebi.ac.uk/cellline#glycogen_storage_disease_type_III
"Glycogen storage disease, type I (disorder)" EXACT [SNOMEDCT_2005_07_31:7265005]
"deficiency of glucose-6-phosphatase (disorder)" EXACT [SNOMEDCT_2005_07_31:124437004]
"glycogenosis type I" EXACT [CSP2005:1849-3779]
"von Gierke disease" EXACT [SNOMEDCT_2005_07_31:154738008]
"von Gierke disease" EXACT [SNOMEDCT_2005_07_31:267498002]
"von Gierke's disease" EXACT [MTHICD9_2006:271.0]
URI: http://www.ebi.ac.uk/cellline#glycogen_storage_disease_type_I
"Amylopectinosis" EXACT [MTHICD9_2006:271.0]
"Branching-transferase deficiency glycogenosis (disorder)" EXACT [SNOMEDCT_2005_07_31:190742009]
"Glycogen storage disease, type IV (disorder)" EXACT [SNOMEDCT_2005_07_31:11179002]
"brancher deficiency glycogenosis" EXACT [CSP2005:1849-3950]
"deficiency of 1,4-alpha-glucan branching enzyme" EXACT [SNOMEDCT_2005_07_31:124267007]
URI: http://www.ebi.ac.uk/cellline#glycogen_storage_disease_type_IV
"Glycogen storage disease type VIII (disorder)" EXACT [SNOMEDCT_2005_07_31:41527003]
"glycogenosis type VIII" EXACT [CSP2005:1849-4178]
"hepatic glycogen phosphorylase kinase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:297255007]
URI: http://www.ebi.ac.uk/cellline#glycogen_storage_disease_type_VIII
"Generalized glycogenosis (disorder)" EXACT [SNOMEDCT_2005_07_31:267424007]
"Glycogen storage disease, type II (disorder)" EXACT [SNOMEDCT_2005_07_31:274864009]
"Glycogen storage disease, type II [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:76219003]
"Glycogenosis, type 2" EXACT [SNOMEDCT_2005_07_31:190741002]
"Lysosomal alpha-1,4-glucosidase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:237967002]
"Pompe's disease" EXACT [MTHICD9_2006:271.0]
"Pompe's disease" EXACT [SNOMEDCT_2005_07_31:237968007]
"acid maltase deficiency" EXACT [CSP2005:1849-3836]
"deficiency of glucoamylase" EXACT [SNOMEDCT_2005_07_31:124454007]
"deficiency of maltase" EXACT [SNOMEDCT_2005_07_31:124462004]
URI: http://www.ebi.ac.uk/cellline#glycogen_storage_disease_type_II
nervous system lysosomal storage disease
URI: http://www.ebi.ac.uk/cellline#nervous_system_lysosomal_storage_disease
"Glycogen storage disease, type VI (disorder)" EXACT [SNOMEDCT_2005_07_31:29291001]
"hepatic glycogen phosphorylase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:237971004]
"hepatophosphorylase deficiency glycogenosis" EXACT [CSP2005:1849-4064]
URI: http://www.ebi.ac.uk/cellline#glycogen_storage_disease_type_VI
"Tic disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:568005]
"Tic disorder (finding)" EXACT [SNOMEDCT_2005_07_31:192621007]
"Tic disorder NOS" EXACT [MTHICD9_2006:307.20]
"Tic disorder unspecified (finding)" EXACT [SNOMEDCT_2005_07_31:191989005]
"Tic disorder unspecified" EXACT [SNOMEDCT_2005_07_31:192626002]
"Tic disorder, unspecified" EXACT [ICD9CM_2006:307.20]
URI: http://www.ebi.ac.uk/cellline#tic_disorder
"Cerebellar deficiency syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:224186005]
"Cerebellar disease (disorder)" EXACT [SNOMEDCT_2005_07_31:307361005]
"Cerebellar disease" EXACT [SNOMEDCT_2005_07_31:155010002]
"Cerebellar disease" EXACT [SNOMEDCT_2005_07_31:192867005]
"Cerebellar disease" EXACT [SNOMEDCT_2005_07_31:267691001]
"Cerebellar disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:223176004]
"Cerebellar disorder [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:49784007]
"cerebellar disorder" EXACT [CSP2005:0485-3992]
URI: http://www.ebi.ac.uk/cellline#cerebellar_disease
A disease of anatomical entity that is located_in endocrine glands which secretes a type of hormone directly into the bloodstream to regulate the body.
"malignant tumor of abdomen (disorder)" EXACT [SNOMEDCT_2005_07_31:188366002]
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_abdomen
"Addiction (finding)" EXACT [SNOMEDCT_2005_07_31:32709003]
"Addiction -RETIRED-" EXACT [SNOMEDCT_2005_07_31:123088001]
URI: http://www.ebi.ac.uk/cellline#addictive_behavior
"Academic skill disorder, NOS" EXACT [SNOMEDCT_2005_07_31:1855002]
"Learning disorder NOS" EXACT [MTHICD9_2006:315.9]
"learning disorder" EXACT [CSP2005:2483-6402]
URI: http://www.ebi.ac.uk/cellline#learning_disorder
URI: http://www.ebi.ac.uk/cellline#hemoglobinopathy
"Arterial disease" EXACT [SNOMEDCT_2005_07_31:155413007]
"Arterial disease" EXACT [SNOMEDCT_2005_07_31:266317000]
"Arterial disease" EXACT [SNOMEDCT_2005_07_31:367395004]
"Arterial disorder" EXACT [NCI2004_11_17:C35317]
"Arteriopath" EXACT [SNOMEDCT_2005_07_31:39823006]
"disease of artery [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:77735004]
"disorder of artery (disorder)" EXACT [SNOMEDCT_2005_07_31:359557001]
"disorder of artery [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:271948001]
"disorder of artery" EXACT [SNOMEDCT_2005_07_31:359560008]
URI: http://www.ebi.ac.uk/cellline#arteriopathy
"disorder of vision (disorder)" EXACT [SNOMEDCT_2005_07_31:95677002]
"vision disorder" EXACT [CSP2005:1114-9612]
"visual disorder" EXACT [NCI2004_11_17:C35126]
"visual disorder" EXACT [SNOMEDCT_2005_07_31:40031005]
"visual disorder" EXACT [SNOMEDCT_2005_07_31:7973008]
"visual system disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:128127008]
URI: http://www.ebi.ac.uk/cellline#vision_disorder
A endometrial cancer that is located_in the tissue lining the uterus.
carcinoma of the Endometrium
endometrioid carcinoma
endometrioid carcinoma of female Reproductive system
A cervical cancer that is located_in the cervix uteri or located_in the cervical area and that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
cancer of cervix
carcinoma cervix uteri
carcinoma of cervix
carcinoma of the Cervix Uteri
A disease of anatomical entity that is located_in the immune system.
"Immunoproliferative disease - morphology" EXACT [SNOMEDCT_2005_07_31:134363002]
"Immunoproliferative disease, no ICD-O subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:86295000]
"Immunoproliferative disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:127071007]
URI: http://www.ebi.ac.uk/cellline#immunoproliferative_disorder
"Paraproteinaemia" EXACT [SNOMEDCT_2005_07_31:35601003]
"Paraproteinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:278501001]
"Paraproteinemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190816000]
"Paraproteinemia" EXACT [NCI2004_11_17:C27468]
"Paraproteinemia" EXACT [SNOMEDCT_2005_07_31:123061006]
"paraproteinemia" EXACT [CSP2005:0449-2705]
URI: http://www.ebi.ac.uk/cellline#paraproteinemia
"Anomaly or syndrome, Chediak-Steinbrinck" EXACT [MTHICD9_2006:288.2]
"Chdiak-Higashi syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:111396008]
"Chediak - Steinbrinck anomaly" EXACT [SNOMEDCT_2005_07_31:191356000]
"Chediak Higashi anomaly" EXACT [CSP2005:1849-1918]
"Chediak-Higashi syndrome -RETIRED-" EXACT [SNOMEDCT_2005_07_31:123309000]
"Chediak-Higashi syndrome" EXACT [NCI2004_11_17:C2941]
"Chediak-Higashi syndrome" EXACT [SNOMEDCT_2005_07_31:190696004]
"chediak-higashi syndrome" EXACT [MTH:U001801]
URI: http://www.ebi.ac.uk/cellline#Chediak-Higashi_syndrome
URI: http://www.ebi.ac.uk/cellline#tumor_virus_infectious_disease
"BIDS syndrome" EXACT [SNOMEDCT_2005_07_31:403796005]
"trichothiodystrophy" EXACT [NCI2004_11_17:C4924]
URI: http://www.ebi.ac.uk/cellline#IBIDS_syndrome
"DNA Repair disorder" EXACT [NCI2004_11_17:C7757]
"deficiency of DNA repair (finding)" EXACT [SNOMEDCT_2005_07_31:28965003]
"A simple genetic disease that results from a reduced functionality of DNA repair." [url:http\://en.wikipedia.org/wiki/DNA_repair-deficiency_disorder]
URI: http://www.ebi.ac.uk/cellline#DNA_repair_deficiency
"cystic disease of kidney (disorder)" EXACT [SNOMEDCT_2005_07_31:236439005]
"cystic kidney disease" EXACT [NCI2004_11_17:C34750]
"cystic kidney disease" EXACT [SNOMEDCT_2005_07_31:156973002]
"cystic kidney disease" EXACT [SNOMEDCT_2005_07_31:268332003]
"cystic kidney" EXACT [CSP2005:1682-0412]
URI: http://www.ebi.ac.uk/cellline#cystic_kidney
"disorder of carbohydrate transport and metabolism" EXACT []
"inborn carbohydrate metabolism disorder" EXACT [CSP2005:0551-8201]
URI: http://www.ebi.ac.uk/cellline#inborn_errors_carbohydrate_metabolism
"benign paroxysmal peritonitis" EXACT [MTHICD9_2006:277.3]
"familial Mediterranean fever (disorder)" EXACT [SNOMEDCT_2005_07_31:12579009]
"familial Mediterranean fever" EXACT [CSP2005:1254-7727]
"familial Mediterranean fever" EXACT [CSP2005:1849-1519]
"familial Mediterranean fever" EXACT [CSP2005:2871-4310]
URI: http://www.ebi.ac.uk/cellline#familial_Mediterranean_fever
A carcinoma that has_material_basis_in abnormally proliferating cells, derives_from epithelial cells, which originate in glandular tissue.
"adenocarcinoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189582009]
"adenocarcinoma" EXACT [CSP2005:2000-0386]
"adenocarcinoma" EXACT [NCI2004_11_17:C2852]
"adenocarcinoma, no subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:35917007]
"adenocarcinomas" EXACT [SNOMEDCT_2005_07_31:189578007]
URI: http://www.ebi.ac.uk/cellline#adenocarcinoma
A male reproductive system cancer that is located_in the testicles.
childhood neoplasm of the testis
neoplasm of testis
pediatric testicular neoplasm
testicular tumor
testis cancer
testis neoplasm
"environmentally induced disease" EXACT []
"A disease that has an etiology of environment, such as nutrition, chemical exposure, or other environmental factors excluding infectious agents." [DO:wk\,ls, URL:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=environment]
URI: http://www.ebi.ac.uk/cellline#disease_by_environmental_origin
A breast carcinoma that derives_from the lining of milk ducts.
duct carcinoma
A breast ductal carcinoma that is characterized by infiltration into the fibrous or fatty tissue of the breast outside of the duct where it originated.
Infiltrating ductal carcinoma of breast
Invasive ductal carcinoma, NST
ductal adenocarcinoma
URI: http://www.ebi.ac.uk/cellline#drug_abuse
URI: http://www.ebi.ac.uk/cellline#complication_of_the_puerperium
URI: http://www.ebi.ac.uk/cellline#substance-related_disorder
A cecum carcinoma that derives_from epithelial cells of glandular origin.
Cecal adenocarcinoma
A cell type cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
"carcinoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189549006]
"carcinoma, no subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:68453008]
"epithelial carcinoma" EXACT [NCI2004_11_17:C2916]
epithelial cancer
epithelioma
malignant Epithelioma
"A cancer that derives_from epithelial cells." [url:http\://en.wikipedia.org/wiki/Carcinoma]
URI: http://www.ebi.ac.uk/cellline#carcinoma
A malignant astrocytoma characterized by the presence of small areas of necrotizing tissue that is surrounded by anaplastic cells as well as the presence of hyperplastic blood vessels, and that has_material_basis_in abnormally proliferating cells derives_from multiple cell types including astrocytes and oligondroctyes.
GBM
adult glioblastoma multiforme
grade IV adult Astrocytic tumor
primary glioblastoma multiforme
spongioblastoma multiforme
A malignant glioma that is has_material_basis_in astrocyte cells, a type of star-shaped glial cell, located in the brain and spinal cord.
Astrocytic tumor
astrocytoma of Cerebrum
astrocytoma of brain
astroglioma
cerebral astrocytoma
A cell type cancer that has_material_basis_in glial cells and is located in brain or located in spine.
"glioma, malignant" EXACT [SNOMEDCT_2005_07_31:189909006]
"glioma, malignant, no ICD-O subtype" EXACT [SNOMEDCT_2005_07_31:74532006]
"malignant Neuroglial tumor" EXACT [NCI2004_11_17:C4822]
"malignant glioma (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:269505000]
"malignant glioma - category" EXACT [SNOMEDCT_2005_07_31:416500007]
Neuroglial tumor
glial cell tumor
glioma, malignant
malignant Neuroglial tumor
URI: http://www.ebi.ac.uk/cellline#malignant_glioma
"Epileptic seizures - myoclonic (disorder)" EXACT [SNOMEDCT_2005_07_31:192992007]
"Epileptic seizures, myoclonic" EXACT [MTHICD9_2006:345.1]
"Myoclonic seizure disorder" EXACT [SNOMEDCT_2005_07_31:37356005]
"Myoclonic seizure" EXACT [SNOMEDCT_2005_07_31:192847001]
"myoclonia epileptica" EXACT [CSP2005:0485-7984]
URI: http://www.ebi.ac.uk/cellline#myoclonic_epilepsy
"Interstitial lung disease (disorder)" EXACT [SNOMEDCT_2005_07_31:233703007]
"Interstitial lung disease" EXACT [SNOMEDCT_2005_07_31:64667001]
URI: http://www.ebi.ac.uk/cellline#interstitial_lung_disease
An organ system cancer located_in the nervous system that affects the central or peripheral nervous system.
"neoplasm of nervous system (disorder)" EXACT [SNOMEDCT_2005_07_31:126950007]
"nervous system neoplasm" EXACT [CSP2005:2012-5157]
"tumor of the nervous system" EXACT [NCI2004_11_17:C3268]
malignant neoplasm of nervous system
neoplasm of nervous system
nervous system neoplasm
neural neoplasm
neural tumor
tumor of the nervous system
"A cancer that affects the nervous system." [url:http\://emedicine.medscape.com/oncology]
URI: http://www.ebi.ac.uk/cellline#cancer_of_the_nervous_system
"tumor of Neuroepithelium" EXACT [NCI2004_11_17:C3787]
URI: http://www.ebi.ac.uk/cellline#neuroepithelial_neoplasm
"germ cell and embryonal neoplasm" RELATED []
URI: http://www.ebi.ac.uk/cellline#germ_cell_and_embryonal_cancer
"Fukuhara syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:57254004]
"Myoclonic epilepsy - ragged red fibers (disorder)" EXACT [SNOMEDCT_2005_07_31:230426003]
"Myoclonus epilepsy AND ragged red fibers (disorder)" EXACT [SNOMEDCT_2005_07_31:68448003]
"Myoclonus with epilepsy and with Ragged Red Fibers (MERRF syndrome)" EXACT [MTHICD9_2006:277.87]
URI: http://www.ebi.ac.uk/cellline#MERRF_syndrome
"renal and ureteral tumor" EXACT [NCI2004_11_17:C7514]
renal and ureteral tumor
URI: http://www.ebi.ac.uk/cellline#kidney_and_Ureter_tumor
A gastrointestinal system disease that is located_in the liver and/or biliary tract.
liver and biliary tract disease
URI: http://www.ebi.ac.uk/cellline#liver_and_biliary_tract_disease
An organ system cancer located_in gastrointestinal tract that is manifested in organs of the gastrointestinal system.
"gastrointestinal neoplasm" EXACT [CSP2005:2010-0179]
"neoplasm of gastrointestinal tract" EXACT [SNOMEDCT_2005_07_31:126768004]
"tumor of gastrointestinal tract (disorder)" EXACT [SNOMEDCT_2005_07_31:276806006]
GI tumor
digestive system cancer
gastrointestinal tract cancer
URI: http://www.ebi.ac.uk/cellline#gastrointestinal_neoplasm
A biliary tract cancer that is located_in the gallbladder.
gallbladder Ca
gallbladder neoplasm
localized malignant gallbladder neoplasm
malignant neoplasm of gallbladder
malignant tumor of the gallbladder
malignant tumour of gallbladder
tumor of the gallbladder
"MEA - Multiple endocrine adenomatosis" EXACT [SNOMEDCT_2005_07_31:46724008]
"Multiple endocrine adenomas (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:60549007]
"Multiple endocrine adenomatosis" EXACT [SNOMEDCT_2005_07_31:190566000]
"multiple endocrine neoplasia syndrome" EXACT [NCI2004_11_17:C6432]
URI: http://www.ebi.ac.uk/cellline#multiple_endocrine_neoplasia
"hepatic porphyria (disorder)" EXACT [SNOMEDCT_2005_07_31:55056006]
URI: http://www.ebi.ac.uk/cellline#hepatic_porphyria
"Mucinosis (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:11528001]
URI: http://www.ebi.ac.uk/cellline#mucinoses
"Cutis laxa (disorder)" EXACT [SNOMEDCT_2005_07_31:58588007]
URI: http://www.ebi.ac.uk/cellline#cutis_laxa
"Remnant hyperlipidemia" EXACT [NCI2004_11_17:C34710]
"carbohydrate induced hyperlipemia" EXACT [CSP2005:1849-4681]
"carbohydrate induced hyperlipemia" EXACT [CSP2005:1849-4738]
"familial hypercholesterolaemia with hyperlipaemia" EXACT [SNOMEDCT_2005_07_31:398796005]
"familial type 3 hyperlipoproteinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:42569002]
URI: http://www.ebi.ac.uk/cellline#hyperlipoproteinemia_type_III
URI: http://www.ebi.ac.uk/cellline#inborn_errors_lipid_metabolism
"hyperlipoproteinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:3744001]
"hyperlipoproteinemia NOS" EXACT [MTHICD9_2006:272.4]
"hyperlipoproteinemia" EXACT [CSP2005:1749-0698]
URI: http://www.ebi.ac.uk/cellline#hyperlipoproteinemia
A skin carcinoma that has_material_basis_in squamous cells.
Epidermoid skin carcinoma
squamous cell carcinoma of skin
"neoplasm of skin (disorder)" EXACT [SNOMEDCT_2005_07_31:126488004]
"neoplasm of skin by site" EXACT [SNOMEDCT_2005_07_31:363230005]
"skin neoplasm" EXACT [CSP2005:2020-0536]
"tumor of the skin" EXACT [NCI2004_11_17:C3372]
URI: http://www.ebi.ac.uk/cellline#skin_neoplasm
oligodendroglial neoplasm
oligodendroglial tumor
URI: http://www.ebi.ac.uk/cellline#spinal_cord_disease
"Nemaline body disease" EXACT [MTHICD9_2006:359.0]
"Nemaline myopathy (disorder)" EXACT [SNOMEDCT_2005_07_31:75072002]
URI: http://www.ebi.ac.uk/cellline#nemaline_myopathy
"neural tumor" EXACT [NCI2004_11_17:C35562]
URI: http://www.ebi.ac.uk/cellline#neural_neoplasm
URI: http://www.ebi.ac.uk/cellline#sensation_disorder
"Leukodystrophy, sudanophilic" EXACT [MTHICD9_2006:330.0]
"Pelizaeus Merzbacher brain sclerosis" EXACT [CSP2005:1849-5479]
"Pelizaeus-Merzbacher disease (disorder)" EXACT [SNOMEDCT_2005_07_31:64855000]
URI: http://www.ebi.ac.uk/cellline#Pelizaeus-Merzbacher_disease
"disorder of lysosomal enzyme (disorder)" EXACT [SNOMEDCT_2005_07_31:23585005]
"inborn lysosomal enzyme disorder" EXACT [CSP2005:1849-5878]
URI: http://www.ebi.ac.uk/cellline#lysosomal_storage_disease
hereditary central nervous system demyelinating disease
URI: http://www.ebi.ac.uk/cellline#hereditary_central_nervous_system_demyelinating_disease
"demyelinating disorder" EXACT [NCI2004_11_17:C34527]
URI: http://www.ebi.ac.uk/cellline#demyelinating_disease
A skeletal muscle cancer that arise from skeletal muscle progenitors.
"phagocytic dysfunction" EXACT [CSP2005:0427-7579]
URI: http://www.ebi.ac.uk/cellline#phagocyte_bactericidal_dysfunction
"Partial albinism (disorder)" EXACT [SNOMEDCT_2005_07_31:6479008]
URI: http://www.ebi.ac.uk/cellline#piebaldism
An embryonal cancer that is a type of germ cell tumour that is located_in the ovaries or located_in the testes.
primary extragonadal embryonal carcinoma
A nervous system disease that affects either the spinal cord (myelopathy) or brain (encephalopathy) of the central nervous system.
"A nervous system disease that affects either the spinal cord (myelopathy) or brain (encephalopathy) of the central nervous system." [url:http\://en.wikipedia.org/wiki/Central_nervous_system_disease]
URI: http://www.ebi.ac.uk/cellline#central_nervous_system_disease
URI: http://www.ebi.ac.uk/cellline#perivascular_tumor
A motor neuron disease that is characterized by muscle spasticity, rapidly progressive weakness due to muscle atrophy, difficulty in speaking, swallowing, and breathing.
ALS
Lou Gehrig's disease
motor neuron disease, bulbar
"Tay-Sachs disease (disorder)" EXACT [SNOMEDCT_2005_07_31:111385000]
"disease, Tay-Sachs" EXACT [MTHICD9_2006:330.1]
"hexosaminidase A deficiency" EXACT [CSP2005:1849-8690]
URI: http://www.ebi.ac.uk/cellline#Tay-Sachs_disease
"GM>2< gangliosidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:33316007]
URI: http://www.ebi.ac.uk/cellline#gangliosidoses_GM2
"Beta-galactosidase deficiency" EXACT [SNOMEDCT_2005_07_31:238044004]
"GM1 gangliosidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:238025006]
"GM>1< gangliosidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:32917001]
"Landing syndrome" EXACT [CSP2005:1849-8633]
"beta-Galactosidase deficiency" EXACT [SNOMEDCT_2005_07_31:33164006]
"deficiency of beta-galactosidase (disorder)" EXACT [SNOMEDCT_2005_07_31:124465002]
URI: http://www.ebi.ac.uk/cellline#gangliosidosis_GM1
"Sandhoff Jatzkewitz disease" EXACT [CSP2005:1849-8747]
"Sandhoff disease (disorder)" EXACT [SNOMEDCT_2005_07_31:23849003]
URI: http://www.ebi.ac.uk/cellline#Sandhoff_disease
"Mucolipidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:70528007]
URI: http://www.ebi.ac.uk/cellline#mucolipidosis
"Xanthomatosis (disorder)" EXACT [SNOMEDCT_2005_07_31:63103006]
"xanthelasmatosis" EXACT [CSP2005:1746-8555]
URI: http://www.ebi.ac.uk/cellline#xanthomatosis
A bone sarcoma that is located_in bone that has_material_basis_in cells of mesenchymal origin.
Osteogenic sarcoma
Skeletal sarcoma
bone tissue neoplasm
osteoid sarcoma
"Osteogenic tumor" EXACT [NCI2004_11_17:C6603]
URI: http://www.ebi.ac.uk/cellline#osteogenic_neoplasm
"mesenchymal tumor" EXACT [NCI2004_11_17:C7059]
URI: http://www.ebi.ac.uk/cellline#mesenchymal_cell_neoplasm
A connective tissue cancer that has_material_basis_in fibrous connective tissue and characterized by the presence of immature proliferating fibroblasts or undifferentiated anaplastic spindle cells in a storiform pattern.
Fibrocytic tumor
fibrosarcoma of soft tissue
fibrous tissue neoplasm
A peripheral primitive neuroectodermal tumor that is located_in bone.
Ewing's sarcoma/bone peripheral primitive neuroectodermal tumor
bone Ewing sarcoma
bone localized Ewing sarcoma
bone localized Ewing's sarcoma
localized Skeletal Ewing's sarcoma
Ewing's sarcoma of bone
bone Ewing's sarcoma
A connective tissue cancer that has_material_basis in neural crest cells derives_from undeveloped, undifferentiated neuroectoderm.
Ewing's family localized tumor
Ewing's sarcoma/peripheral primitive neuroectodermal tumor
Ewing's tumor
Ewings sarcoma
Ewings sarcoma-primitive neuroectodermal tumor
PNET of Thoracopulmonary Region
localized Ewing sarcoma
localized Ewing's sarcoma
localized Ewing's sarcoma/peripheral primitive neuroectodermal tumor
localized Ewing's tumor
localized peripheral primitive neuroectodermal tumor
peripheral primitive neuroectodermal tumor
A bone sarcoma that has_material_basis_in cells derived from transformed cells that produce cartilage.
Cartilaginous cancer
chondrosarcoma of bone
primary chondrosarcoma of the bone
A connective tissue cancer that arises in fat cells in deep soft tissue retroperitoneum and the extremities.
"Histiocytosis (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:60657004]
"Histiocytosis, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:190957008]
"A reticuloendotheliosis that is characterized by an excessive number of histiocytes." [url:http\://en.wikipedia.org/wiki/Histiocytosis]
URI: http://www.ebi.ac.uk/cellline#histiocytosis
URI: http://www.ebi.ac.uk/cellline#peripheral_vascular_disease
"Alpha-D-mannosidosis" EXACT [SNOMEDCT_2005_07_31:65524005]
"deficiency of alpha-mannosidase (disorder)" EXACT [SNOMEDCT_2005_07_31:124466001]
URI: http://www.ebi.ac.uk/cellline#alpha-mannosidase_deficiency
"Mannosidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:65524005]
"Mannosidosis" EXACT [MTHICD9_2006:271.8]
"Mannosidosis" EXACT [SNOMEDCT_2005_07_31:190937009]
"mannosidase deficiency" EXACT [CSP2005:1849-6504]
URI: http://www.ebi.ac.uk/cellline#mannosidase_deficiency_disease
"A disease that involves any biological process (GO:0008150) specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms." [DO:wk\,ls]
URI: http://www.ebi.ac.uk/cellline#disease_of_biological_process
A female reproductive system disease that is located_in the uterus.
A skin cancer that is located_in tissues of the skin and develops from epithelial cells.
"Non-melanoma skin cancer" EXACT [NCI2004_11_17:C4914]
carcinoma of skin
"A carcinoma that is located_in tissues of the skin." [url:http\://www.cancer.gov/cancertopics/types/skin]
URI: http://www.ebi.ac.uk/cellline#skin_carcinoma
A breast carcinoma that originates in the milk ducts and/or lobules (glandular tissue) of the breast.
Mammary adenocarcinoma
adenocarcinoma of breast
A breast cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
Mammary carcinoma
carcinoma of breast
"hamartoma (disorder)" EXACT [SNOMEDCT_2005_07_31:400006008]
"hamartoma (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:51398009]
"hamartomatous polyp (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:27391005]
URI: http://www.ebi.ac.uk/cellline#hamartoma
A thoracic disease that is located_in the breast.
"Uveal disorder" EXACT [NCI2004_11_17:C26908]
"disorder of uveal tract (disorder)" EXACT [SNOMEDCT_2005_07_31:95678007]
"uvea disorder" EXACT [CSP2005:1114-9583]
URI: http://www.ebi.ac.uk/cellline#uveal_disease
URI: http://www.ebi.ac.uk/cellline#metabolic_skin_disease
"Reticuloendothelial hyperplasia" EXACT [NCI2004_11_17:C34977]
"reticuloendotheliosis" EXACT [CSP2005:0427-8963]
URI: http://www.ebi.ac.uk/cellline#reticuloendotheliosis
URI: http://www.ebi.ac.uk/cellline#cerebral_arterial_disease
"central core disease (disorder)" EXACT [SNOMEDCT_2005_07_31:43152001]
"central core disease" EXACT [MTHICD9_2006:359.0]
URI: http://www.ebi.ac.uk/cellline#central_Core_Myopathy
"Lafora Progressive Myoclonic Epilepsy" EXACT []
"Lafora disease (disorder)" EXACT [SNOMEDCT_2005_07_31:230425004]
"Lafora's disease" EXACT [CSP2005:0485-7984]
URI: http://www.ebi.ac.uk/cellline#Lafora_disease
A hepatobiliary system cancer that is located_in the liver.
Ca liver - primary
Resectable malignant neoplasm of Liver
ca liver - primary
hepatic cancer
hepatic neoplasm
malignant hepato-biliary neoplasm
malignant neoplasm of liver
malignant neoplasm of liver, not specified as primary or secondary
malignant neoplasm of liver, primary
malignant tumor of liver
neoplasm of liver
non-resectable primary hepatic malignant neoplasm
primary liver cancer
primary malignant neoplasm of Liver
primary malignant neoplasm of liver
resectable malignant neoplasm of the liver
"neoplasm of pancreas (disorder)" EXACT [SNOMEDCT_2005_07_31:126859007]
"pancreas neoplasm" EXACT [CSP2005:2014-4876]
"pancreatic neoplasm" EXACT [MTH:NOCODE]
"pancreatic tumor" EXACT [NCI2004_11_17:C3305]
URI: http://www.ebi.ac.uk/cellline#pancreatic_neoplasm
"Gestational trophoblastic disease (disorder)" EXACT [SNOMEDCT_2005_07_31:416402001]
"Gestational trophoblastic neoplasm (disorder)" EXACT [SNOMEDCT_2005_07_31:417475006]
"Gestational trophoblastic neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:416441004]
"Gestational trophoblastic tumor (disorder)" EXACT [SNOMEDCT_2005_07_31:237251001]
"Trophoblastic disease (& [various moles])" EXACT [SNOMEDCT_2005_07_31:198610008]
"Trophoblastic disease (disorder)" EXACT [SNOMEDCT_2005_07_31:5759005]
"Trophoblastic disease NOS" EXACT [MTHICD9_2006:630]
"gestational trophoblastic neoplasia" EXACT [NCI2004_11_17:C4699]
URI: http://www.ebi.ac.uk/cellline#Gestational_trophoblastic_neoplasm
A placenta cancer that has_material_basis_in trophoblastic cells.
Chorioepithelioma
A cystadenocarcinoma that derives_from epithelial cells originating in glandular tissue, with a capsulated structure and mucus-producing cells.
Pseudomucinous cystadenocarcinoma
"Spongy degeneration of central nervous system (disorder)" EXACT [SNOMEDCT_2005_07_31:80544005]
URI: http://www.ebi.ac.uk/cellline#Canavan_disease
"Hypogonadism with anosmia (disorder)" EXACT [SNOMEDCT_2005_07_31:93559003]
"Kallman syndrome" EXACT [SNOMEDCT_2005_07_31:33927004]
"Kallman's syndrome" EXACT [SNOMEDCT_2005_07_31:190559001]
"familial hypogonadism with anosmia" EXACT [CSP2005:2586-8846]
URI: http://www.ebi.ac.uk/cellline#Kallmann_syndrome
A nervous system cancer that is located_in the central nervous system.
"CNS neoplasm" EXACT [CSP2005:2012-5421]
"central nervous system tumors" EXACT [NCI2004_11_17:C9293]
"neoplasm of central nervous system (disorder)" EXACT [SNOMEDCT_2005_07_31:126951006]
CNS neoplasm
central nervous system tumor
central nervous system tumors
malignant tumor of CNS
neoplasm of central nervous system
URI: http://www.ebi.ac.uk/cellline#central_nervous_system_neoplasm
A female reproductive organ cancer that is located_in the uterus.
CA - cancer of uterus
Tumour of uterus
malignant neoplasm of uterus
malignant uterine tumor
neoplasm of uterus
uterine tumor
uterus neoplasm
"Inborn error of pyruvate metabolism (disorder)" EXACT [SNOMEDCT_2005_07_31:53210006]
URI: http://www.ebi.ac.uk/cellline#inborn_errors_pyruvate_metabolism
"Lactic acidosis (disorder)" EXACT [SNOMEDCT_2005_07_31:91273001]
"Lactic acidosis" EXACT [MTHICD9_2006:276.2]
"lactic acidosis" EXACT [CSP2005:1849-5394]
URI: http://www.ebi.ac.uk/cellline#lactic_acidosis
"deficiency of pyruvic carboxylase" EXACT [SNOMEDCT_2005_07_31:124716008]
"deficiency of pyruvic carboxylase" EXACT [SNOMEDCT_2005_07_31:87694001]
URI: http://www.ebi.ac.uk/cellline#pyruvate_carboxylase_deficiency_disease
"Infantile necrotizing encephalomyelopathy" EXACT [MTHICD9_2006:330.8]
"Leigh's disease (disorder)" EXACT [SNOMEDCT_2005_07_31:29570005]
"subacute necrotizing encephalomyelopathy" EXACT [CSP2005:1254-7727]
"subacute necrotizing encephalomyelopathy" EXACT [CSP2005:1849-5394]
"subacute necrotizing encephalomyelopathy" EXACT [CSP2005:5000-0048]
URI: http://www.ebi.ac.uk/cellline#Leigh_disease
"Sialuria (disorder)" EXACT [SNOMEDCT_2005_07_31:238051008]
URI: http://www.ebi.ac.uk/cellline#sialuria
A hematologic cancer that has_material_basis_in mast cells.
Mast cell Proliferative disease
mast cell tumor
mastocytoma
"malignant neoplasm of kidney NOS" EXACT [MTHICD9_2006:189.0]
"malignant neoplasm of kidney, NOS" EXACT [SNOMEDCT_2005_07_31:93849006]
"malignant renal neoplasm" EXACT [NCI2004_11_17:C7548]
"malignant tumor of kidney (disorder)" EXACT [SNOMEDCT_2005_07_31:363518003]
"malignant tumour of kidney" EXACT [SNOMEDCT_2005_07_31:154542008]
"renal cancer" EXACT [CSP2005:2021-1116]
"renal malignant neoplasm" EXACT [SNOMEDCT_2005_07_31:188249002]
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_kidney
URI: http://www.ebi.ac.uk/cellline#skin_disease
A cervix carcinoma that derives_from epithelial cells of glandular origin.
adenocarcinoma cervix uteri
adenocarcinoma of cervix
adenocarcinoma of the uterine Cervix
An ovarian carcinoma that derives_from epithelial cells of glandular origin.
Ovarian adenocarcinoma
ovarian adenoacanthoma
adenocarcinoma of the ovary
A stomach carcinoma that derives_from epithelial cells of glandular origin.
adenocarcinoma of stomach
stomach adenocarcinoma
"Myeloma - solitary" EXACT [SNOMEDCT_2005_07_31:189507001]
"Myeloma, solitary" EXACT [SNOMEDCT_2005_07_31:154644004]
"Myeloma, solitary" EXACT [SNOMEDCT_2005_07_31:269652000]
"Plasma cell tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:274907000]
"Plasma cell tumor NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:190019006]
"Plasma cell tumors (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:190016004]
"Solitary myeloma (clinical)" EXACT [SNOMEDCT_2005_07_31:109987008]
"Solitary myeloma" EXACT [MTHICD9_2006:238.6]
"Solitary plasmacytoma of bone (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:10639003]
"Solitary plasmacytoma" EXACT [NCI2004_11_17:C6932]
"plasma cell neoplasm" EXACT [CSP2005:2004-8110]
"plasmacytoma - disorder" EXACT [SNOMEDCT_2005_07_31:302852008]
"plasmacytoma - disorder" EXACT [SNOMEDCT_2005_07_31:415112005]
"plasmacytoma NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:308122007]
"plasmacytoma NOS" EXACT [SNOMEDCT_2005_07_31:188720009]
"plasmacytoma NOS" EXACT [SNOMEDCT_2005_07_31:190017008]
"plasmacytoma" EXACT [NCI2004_11_17:C9349]
URI: http://www.ebi.ac.uk/cellline#plasmacytoma
"disorder of puerperium (disorder)" EXACT [SNOMEDCT_2005_07_31:362973001]
"disorder of the puerperium" EXACT [SNOMEDCT_2005_07_31:156262002]
"puerperal disorder" EXACT [CSP2005:2404-6473]
URI: http://www.ebi.ac.uk/cellline#puerperal_disease
A carcinoma of bladder that is manifested in squamous cells of the bladder.
Epidermoid carcinoma of the urinary bladder
squamous cell carcinoma of bladder
A cervix carcinoma that has_material_basis_in squamous cells of the cervix.
squamous cell carcinoma of cervix
squamous cell carcinoma of the Cervix Uteri
An esophageal carcinoma that derives_from epithelial squamous cells located_in the esophagus.
SCC of esophagus
SCC of oesophagus
oesophagus squamous cell carcinoma
"A nephroblastoma that derives_from an abnormality in the WT1 gene (Wilms' tumor suppressor gene)." [url:http\://do-wiki.nubic.northwestern.edu/index.php/Relations_in_DO]
URI: http://www.ebi.ac.uk/cellline#Denys-Drash_syndrome
"Coffin-Lowry syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:15182000]
URI: http://www.ebi.ac.uk/cellline#Coffin-Lowry_syndrome
"Bilirubin UDP glucuronyl transferase deficiency" EXACT [SNOMEDCT_2005_07_31:190933008]
"Crigler Najjar syndrome" EXACT [CSP2005:1654-1020]
"Crigler-Najjar syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:28259009]
"Crigler-Najjar syndrome" EXACT [MTHICD9_2006:277.4]
"Crigler-Najjar syndrome, type I (disorder)" EXACT [SNOMEDCT_2005_07_31:8933000]
URI: http://www.ebi.ac.uk/cellline#Crigler-Najjar_syndrome
"Ankylosis of joint of ankle and/or foot (disorder)" EXACT [SNOMEDCT_2005_07_31:57137004]
"Ankylosis of joint of forearm (disorder)" EXACT [SNOMEDCT_2005_07_31:39147002]
"Ankylosis of joint of hand (disorder)" EXACT [SNOMEDCT_2005_07_31:56923001]
"Ankylosis of joint of lower leg (disorder)" EXACT [SNOMEDCT_2005_07_31:43534008]
"Ankylosis of joint of multiple sites (disorder)" EXACT [SNOMEDCT_2005_07_31:90242006]
"Ankylosis of joint of shoulder region (disorder)" EXACT [SNOMEDCT_2005_07_31:2890007]
"Ankylosis of joint of upper arm (disorder)" EXACT [SNOMEDCT_2005_07_31:9064009]
"Ankylosis of multiple joints" EXACT [SNOMEDCT_2005_07_31:156560006]
"Joint ankylosis of the ankle and foot" EXACT [SNOMEDCT_2005_07_31:156567009, SNOMEDCT_2005_07_31:202304009]
"Joint ankylosis of the ankle and/or foot (disorder)" EXACT [SNOMEDCT_2005_07_31:267936005]
"Joint ankylosis of the forearm (disorder)" EXACT [SNOMEDCT_2005_07_31:267933002]
"Joint ankylosis of the forearm" EXACT [SNOMEDCT_2005_07_31:202300000]
"Joint ankylosis of the hand" EXACT [SNOMEDCT_2005_07_31:156564002]
"Joint ankylosis of the lower leg (disorder)" EXACT [SNOMEDCT_2005_07_31:267935009]
"Joint ankylosis of the lower leg" EXACT [SNOMEDCT_2005_07_31:202303003]
"Joint ankylosis of the pelvic region and thigh (disorder)" EXACT [SNOMEDCT_2005_07_31:267934008]
"Joint ankylosis of the pelvic region and thigh" EXACT [SNOMEDCT_2005_07_31:202301001]
"Joint ankylosis of the shoulder region (disorder)" EXACT [SNOMEDCT_2005_07_31:202298000]
"Joint ankylosis of the shoulder region" EXACT [SNOMEDCT_2005_07_31:156561005]
"Joint ankylosis of the upper arm (disorder)" EXACT [SNOMEDCT_2005_07_31:267932007]
"Joint ankylosis of the upper arm" EXACT [SNOMEDCT_2005_07_31:202299008]
"ankylosis of ankle and foot joint" EXACT []
"ankylosis of joint of multiple sites" EXACT []
"ankylosis of joint of pelvic region and thigh" EXACT []
"ankylosis of joint of shoulder region" EXACT []
URI: http://www.ebi.ac.uk/cellline#arthropathy
"Hemangiopericytic neoplasm NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189867006]
"Hemangiopericytic neoplasm" EXACT [SNOMEDCT_2005_07_31:189866002]
URI: http://www.ebi.ac.uk/cellline#hemangiopericytic_tumor
A reproductive organ cancer that is manifested in the male genital system. This includes organs such as the penis and scrotum.
"male reproductive system neoplasm" EXACT [CSP2005:2016-2462]
"neoplasm of male genital organ" EXACT [SNOMEDCT_2005_07_31:126895004]
"tumor of male Reproductive system" EXACT [NCI2004_11_17:C3054]
male genital cancer
male reproductive system neoplasm
malignant neoplasm of male genital organ
malignant neoplasm of male genital organs
malignant tumor of male Reproductive system
malignant tumor of male genital organ
neoplasm of male genital organ
tumor of male Reproductive system
male genital neoplasm
"A cancer of reproductive system that is manifested in the male genital system. This includes organs such as the penis and scrotum." [url:http\://en.wikipedia.org/wiki/Template\:Male_genital_neoplasia, url:http\://www.wrongdiagnosis.com/g/genital_system_cancer/intro.htm]
URI: http://www.ebi.ac.uk/cellline#male_genital_cancer
"AIP - acute intermittent porphyria" EXACT [SNOMEDCT_2005_07_31:190914003]
"Pyrroloporphyria" EXACT [MTHICD9_2006:277.1]
"acute intermittent porphyria (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:90842001]
"acute intermittent porphyria (disorder)" EXACT [SNOMEDCT_2005_07_31:234422006]
"porphyria intermittent acute" EXACT [CSP2005:0944-4849]
"porphyria intermittent acute" EXACT [CSP2005:1849-7674]
URI: http://www.ebi.ac.uk/cellline#acute_intermittent_porphyria
A lung cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells and is located_in the lungs and has_symptom cough and has_symptom chest discomfort or pain and has_symptom weight loss and has_symptom hemoptysis.
cancer of lung
carcinoma of lung
A non-small cell lung carcinoma that has_material_basis_in the squamous cell.
Epidermoid cell carcinoma of the lung
squamous cell carcinoma of lung
A lung carcinoma that is characterized as any type of epithelial lung cancer other than small cell lung carcinoma.
NSCLC
Non-small cell lung cancer
non-small cell lung carcinoma
A lung non-small cell carcinoma that derives_from epithelial cells of glandular origin.
bronchogenic lung adenocarcinoma
nonsmall cell adenocarcinoma
adenocarcinoma of lung
"malignant Thoracic tumor" EXACT [NCI2004_11_17:C3576]
"malignant neoplasm of thorax NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188365003]
"malignant tumor of thorax (disorder)" EXACT [SNOMEDCT_2005_07_31:188361007]
"thoracic cancer" EXACT [CSP2005:2005-5041]
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_thorax
An adrenal cortex cancer that forms in the outer layer of tissue of the adrenal gland and that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
Adrenal cortical carcinoma
carcinoma of the Adrenal cortex
"disorder of adrenal cortex (disorder)" EXACT [SNOMEDCT_2005_07_31:129636003]
URI: http://www.ebi.ac.uk/cellline#adrenal_cortex_disease
An endocrine gland cancer located_in the adrenal glands which are located above the kidneys.
adrenal cancer
adrenal neoplasm
malignant Adrenal tumor
malignant neoplasm of adrenal gland
neoplasm of adrenal gland
tumor of the Adrenal gland
An adrenocortical carcinoma that originates in the cortex of the adrenal gland and derives_from epithelial cells of glandular origin.
Adrenal cortex adenocarcinoma
Adrenal cortical adenocarcinoma
A differentiated thyroid gland carcinoma that has_material_basis_in follicular cells.
Follicular adenocarcinoma
Follicular adenocarcinoma, well differentiated
Follicular carcinoma
Thyroid adenocarcinoma
follicular thyroid carcinoma
A thyroid gland cancer that has_material_basis_in epithelial cells.
head and neck cancer, Thyroid
A differentiated thyroid gland carcinoma that is characterized by the small mushroom shape of the tumor which has a stem attached to the epithelial layer abd arises from the follicular cells of the thyroid gland.
Papillary carcinoma of the Thyroid gland
"Hallervorden-Spatz disease" EXACT [MTHICD9_2006:333.0]
"Pigmentary pallidal degeneration (disorder)" EXACT [SNOMEDCT_2005_07_31:2992000]
"brain Iron Accumulation type I syndrome" EXACT [NCI2004_11_17:C8967]
URI: http://www.ebi.ac.uk/cellline#Hallervorden-Spatz_syndrome
An organ system cancer that is located_in the kidneys, ureteres, bladder or urethra.
URI: http://www.ebi.ac.uk/cellline#cancer_of_urinary_tract
A disease is a disposition (i) to undergo pathological processes that (ii) exists in an organism because of one or more disorders in that organism.
An ovarian cancer that has_material_basis_in epithelial tissue and is located_in the ovary.
Ovarian carcinoma
A bladder carcinoma that has_material_basis_in transitional cells located_in the lining of the bladder.
bladder transitional cell carcinoma
transitional cell carcinoma of bladder
urinary bladder urothelial carcinoma
urothelial bladder carcinoma
A urinary bladder cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
carcinoma of urinary bladder
"psychomotor disorder" EXACT [CSP2005:2484-1601]
URI: http://www.ebi.ac.uk/cellline#psychomotor_disorder
"vitamin E deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:54137008]
"vitamin E deficiency" EXACT [CSP2005:2116-7687]
"vitamin E deficiency" EXACT [MTHICD9_2006:269.1]
URI: http://www.ebi.ac.uk/cellline#vitamin_E_deficiency
A gastrointestinal system disease that is located_in the mouth.
URI: http://www.ebi.ac.uk/cellline#mouth_disease
A musculoskeletal system cancer that is located_in muscle.
malignant neoplasm of muscle
malignant tumor of muscle
malignant tumor of the Muscle
myosarcoma
A pancreatic carcinoma that derives_from epithelial cells of glandular origin.
pancreas adenocarcinoma
adenocarcinoma of the pancreas
"Heart valve disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:368009]
"Valvular heart disease (disorder)" EXACT [SNOMEDCT_2005_07_31:195013005]
"heart valve disorder" EXACT [CSP2005:1393-3757]
"Heart valve disease is a heart disease described as any disease process involving one or more of the valves of the heart (the aortic and mitral valves on the left and the pulmonary and tricuspid valves on the right). Valve problems may be congenital (inborn) or acquired (due to another cause later in life)." [url:http\://en.wikipedia.org/wiki/Heart_valve_disease]
URI: http://www.ebi.ac.uk/cellline#heart_valve_disease
"Trophoblastic neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:115234004]
"Trophoblastic neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189855009]
"Trophoblastic neoplasm NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189858006]
"Trophoblastic tumor (qualifier value)" EXACT [SNOMEDCT_2005_07_31:134334000]
"Trophoblastic tumor" EXACT [NCI2004_11_17:C3422]
URI: http://www.ebi.ac.uk/cellline#Trophoblastic_neoplasm
"bile duct disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:197455006]
"disorder of bile duct (disorder)" EXACT [SNOMEDCT_2005_07_31:118926004]
URI: http://www.ebi.ac.uk/cellline#bile_duct_disease
URI: http://www.ebi.ac.uk/cellline#gastrointestinal_neuroendocrine_tumor
"peripheral Neuroectodermal neoplasm" EXACT [NCI2004_11_17:C9341]
"peripheral neuroectodermal tumor (disorder)" EXACT [SNOMEDCT_2005_07_31:253096008]
"peripheral neuroectodermal tumor (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:73676002]
"peripheral neuroepithelioma (disorder)" EXACT [SNOMEDCT_2005_07_31:254764001]
Ewings sarcoma-primitive neuroectodermal tumor (PNET)
URI: http://www.ebi.ac.uk/cellline#Ewings_sarcoma-primitive_neuroectodermal_tumor_(PNET)
An integumentary system cancer located_in the skin that is the uncontrolled growth of abnormal skin cells.
"malignant neoplasm of skin (disorder)" EXACT [SNOMEDCT_2005_07_31:372130007]
"malignant neoplasm of skin NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:188143008]
"malignant neoplasm of skin" EXACT [MTH:NOCODE]
"malignant neoplasm of skin, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:190107001]
"melanoma and Non-melanoma skin cancer" EXACT [NCI2004_11_17:C2920]
CA - skin cancer
malignant neoplasm of skin
melanoma and Non-melanoma skin cancer
cancer of skin
URI: http://www.ebi.ac.uk/cellline#cancer_of_skin
URI: http://www.ebi.ac.uk/cellline#autoimmune_disease
"Albright hereditary osteodystrophy -RETIRED-" EXACT [SNOMEDCT_2005_07_31:123057000]
"Albright's hereditary osteodystrophy" EXACT [CSP2005:1849-7959]
"Pseudo-hypoparathyroidism" EXACT [SNOMEDCT_2005_07_31:154697005]
"Pseudo-hypoparathyroidism" EXACT [SNOMEDCT_2005_07_31:267479004]
"Pseudohypoparathyroidism (disorder)" EXACT [SNOMEDCT_2005_07_31:58976002]
"Pseudohypoparathyroidism type I A (disorder)" EXACT [SNOMEDCT_2005_07_31:58833000]
"Pseudohypoparathyroidism type Ia" EXACT [SNOMEDCT_2005_07_31:278716000]
URI: http://www.ebi.ac.uk/cellline#pseudohypoparathyroidism
"disorder of glucose metabolism (disorder)" EXACT [SNOMEDCT_2005_07_31:126877002]
URI: http://www.ebi.ac.uk/cellline#glucose_metabolism_disorder
"neoplasm of cerebellum" EXACT [SNOMEDCT_2005_07_31:126960003]
"tumor of Cerebellum" EXACT [NCI2004_11_17:C2935]
URI: http://www.ebi.ac.uk/cellline#cerebellar_neoplasm
"Hair disorder" EXACT [NCI2004_11_17:C34656]
"Hair/hair follicle disease" EXACT [SNOMEDCT_2005_07_31:156407009]
"Hair/hair follicle disease" EXACT [SNOMEDCT_2005_07_31:267862002]
"disorder of hair (disorder)" EXACT [SNOMEDCT_2005_07_31:279425004]
URI: http://www.ebi.ac.uk/cellline#hair_disease
URI: http://www.ebi.ac.uk/cellline#congenital_structural_myopathy
An endometrial stromal tumor that has_material_basis in connective tissue.
ESS
Undifferentiated endometrial sarcoma
endometrial stromal sarcoma, high grade
"Ca breast - NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:269595005]
"breast cancer" EXACT [CSP2005:2016-0671]
"malignant neoplasm of breast (disorder)" EXACT [SNOMEDCT_2005_07_31:190121004]
"malignant neoplasm of breast, unspecified" EXACT [MTHICD9_2006:174.9]
"malignant tumor of breast (disorder)" EXACT [SNOMEDCT_2005_07_31:254837009]
"malignant tumor of the breast" EXACT [NCI2004_11_17:C9335]
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_breast
"Gerstmann Straussler syndrome" EXACT [CSP2005:2042-5006]
"Gerstmann-Straussler-Scheinker syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:67155006]
"Gerstmann-straussler-scheinker disease is a prion disease where the disease is very rare, usually familial, fatal neurodegenerative disease that affects patients from 20 to 60 years in age. This extremely rare disease is classified as a transmissible spongiform encephalopathy (TSE)." [url:http\://en.wikipedia.org/wiki/Gerstmann-straussler-scheinker_disease]
URI: http://www.ebi.ac.uk/cellline#Gerstmann-Straussler-Scheinker_disease
certain conditions originating in the perinatal period
URI: http://www.ebi.ac.uk/cellline#certain_conditions_originating_in_the_perinatal_period
URI: http://www.ebi.ac.uk/cellline#conjunctival_disease
"Alexander's disease (disorder)" EXACT [SNOMEDCT_2005_07_31:81854007]
"Alexander's disease" EXACT [CSP2005:1849-5479]
URI: http://www.ebi.ac.uk/cellline#Alexander_disease
"Osteosclerosis (disorder)" EXACT [SNOMEDCT_2005_07_31:49347007]
"osteosclerosis" EXACT [CSP2005:2715-2940]
URI: http://www.ebi.ac.uk/cellline#osteosclerosis
URI: http://www.ebi.ac.uk/cellline#rheumatism
complications of pregnancy, childbirth and the puerperium
URI: http://www.ebi.ac.uk/cellline#complications_of_pregnancy,_childbirth_and_the_puerperium
URI: http://www.ebi.ac.uk/cellline#respiratory_system_abnormality
"Polyradiculoneuropathy (disorder)" EXACT [SNOMEDCT_2005_07_31:128078004]
URI: http://www.ebi.ac.uk/cellline#polyradiculoneuropathy
"Non-Langerhans cell histiocytosis" EXACT [SNOMEDCT_2005_07_31:127069007]
URI: http://www.ebi.ac.uk/cellline#non-langerhans-cell_histiocytosis
"Hypophosphatemia, familial" EXACT [MTH:U000306]
"familial hypophosphataemia" EXACT [SNOMEDCT_2005_07_31:237901003]
URI: http://www.ebi.ac.uk/cellline#familial_hypophosphatemia
"Protocoproporphyria" EXACT [MTHICD9_2006:277.1]
"Protoporphyrinogen oxidase deficiency" EXACT [SNOMEDCT_2005_07_31:276264004]
"Variegate porphyria (disorder)" EXACT [SNOMEDCT_2005_07_31:58275005]
URI: http://www.ebi.ac.uk/cellline#variegate_porphyria
A female reproductive organ cancer that is located_in the cervix.
cervical neoplasm
cervix cancer
cervix uteri cancer
neoplasm of uterine cervix
tumor of the Cervix Uteri
uterine cervical neoplasm
"Smith-Lemli-Opitz syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:43929004]
"Smith-Opitz-Inborn syndrome" EXACT [CSP2005:5002-0023]
URI: http://www.ebi.ac.uk/cellline#Smith-Lemli-Opitz_syndrome
"Myasthenia gravis (disorder)" EXACT [SNOMEDCT_2005_07_31:91637004]
"Myasthenia gravis NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:193208002]
"Myasthenia gravis with (acute) exacerbation" EXACT []
"Myasthenia gravis without (acute) exacerbation" EXACT []
"Myasthenia gravis" EXACT [ICD9CM_2006:358.0]
"Myasthenia gravis" EXACT [SNOMEDCT_2005_07_31:155092009]
"myasthenia gravis" EXACT [CSP2005:2057-3613]
URI: http://www.ebi.ac.uk/cellline#myasthenia_gravis
"autoimmune nervous system disorder" EXACT [CSP2005:1560-5548]
"autoimmune nervous system disorder" EXACT [CSP2005:2042-2001]
"autoimmune nervous system disorder" EXACT [CSP2005:2042-6653]
"autoimmune nervous system disorder" EXACT [CSP2005:2057-3403]
autoimmune disease of the nervous system
URI: http://www.ebi.ac.uk/cellline#autoimmune_disease_of_the_nervous_system
"Neuromuscular junction disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:128213006]
URI: http://www.ebi.ac.uk/cellline#neuromuscular_junction_disease
URI: http://www.ebi.ac.uk/cellline#tissue_disease
URI: http://www.ebi.ac.uk/cellline#neuromuscular_disease
"Sea-blue histiocyte syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:37821003]
URI: http://www.ebi.ac.uk/cellline#sea-blue_histiocyte_syndrome
Somatostatin cell neoplasm
Somatostatin cell tumour
A renal carcinoma that has_material_basis_in the lining of the proximal convoluted renal tubule of the kidney.
RCC
adenocarcinoma of kidney
hypernephroma
A kidney cancer that derives_from the lining of the proximal convoluted tubule (the very small tubes in the kidney that filter the blood and remove waste products).
carcinoma of kidney
kidney carcinoma
A renal cell carcinoma that has_material_basis_in cells that appear very pale or clear when examined under microscope.
Clear cell carcinoma of kidney
clear cell kidney carcinoma
conventional (Clear cell) renal cell carcinoma
conventional renal cell carcinoma
renal clear cell carcinoma
Clear-cell metastatic renal cell carcinoma
MESH:C538445 added from NeuroDevNet [WAK].
"inborn renal tubular transport disorder" EXACT [CSP2005:1849-8301]
URI: http://www.ebi.ac.uk/cellline#inborn_errors_renal_tubular_transport
"Achondroplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:86268005]
"Achondroplastic dwarf" EXACT [SNOMEDCT_2005_07_31:205467007]
"Achondroplastic dwarf" EXACT [SNOMEDCT_2005_07_31:268273004]
"Achondroplastic physique (finding)" EXACT [SNOMEDCT_2005_07_31:248299001]
"Achondroplastic physique" EXACT [SNOMEDCT_2005_07_31:190584003]
"Chondrodystrophia" EXACT [MTHICD9_2006:756.4]
"achondroplasia" EXACT [CSP2005:1849-0171]
"osteosclerosis congenita" EXACT [CSP2005:2715-2940]
URI: http://www.ebi.ac.uk/cellline#achondroplasia
"Myotonic disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:193237003]
"Myotonic disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:193240003]
"Myotonic disorder" EXACT [ICD9CM_2006:359.2]
"Myotonic disorder" EXACT [SNOMEDCT_2005_07_31:155096007]
"Myotonic disorder" EXACT [SNOMEDCT_2005_07_31:267713009]
URI: http://www.ebi.ac.uk/cellline#myotonic_disorder
URI: http://www.ebi.ac.uk/cellline#orofaciodigital_syndrome
A thyroid gland cancer that is located_in the supporting cells of the thyroid.
sarcoma of the Thyroid gland
URI: http://www.ebi.ac.uk/cellline#Endocardial_Cushion_Defects
"Amnesia (finding)" EXACT [SNOMEDCT_2005_07_31:48167000]
"Amnesia symptom" EXACT [SNOMEDCT_2005_07_31:162199006]
"Memory loss NOS" EXACT [MTHICD9_2006:780.93]
URI: http://www.ebi.ac.uk/cellline#amnesia
large cell carcinoma of lung
large cell lung carcinoma
A biliary tract cancer that is located_in the bile duct.
Ca extrahepatic bile ducts
bile duct tumor
malignant neoplasm of the extrahepatic bile duct
A hepatobiliary system cancer that results_in malignant growth located_in the gallbladder or located_in the bile duct.
malignant tumour of biliary tract
"malignant neoplasm of aortic body and other paraganglia (disorder)" EXACT [SNOMEDCT_2005_07_31:188343003]
"malignant neoplasm of aortic body and other paraganglia" EXACT []
"A cancer that affects an anatomical entity." [DO:lh]
URI: http://www.ebi.ac.uk/cellline#cancer_by_anatomical_entity
"Holoprosencephaly sequence (disorder)" EXACT [SNOMEDCT_2005_07_31:30915001]
"familial alobar holoprosencephaly -RETIRED-" EXACT [SNOMEDCT_2005_07_31:44519006]
"holoprosencephaly" EXACT [CSP2005:0723-2277]
URI: http://www.ebi.ac.uk/cellline#holoprosencephaly
"Retinal tumor" EXACT [NCI2004_11_17:C4800]
"neoplasm of retina" EXACT [SNOMEDCT_2005_07_31:127002001]
URI: http://www.ebi.ac.uk/cellline#retinal_neoplasm
"A retinoblastoma that refers to bilateral retinoblastoma associated with an intracranial primitive neuroectodermal tumor located_in the pineal or suprasellar region." [url:http\://www.ncbi.nlm.nih.gov/pubmed/10391573]
URI: http://www.ebi.ac.uk/cellline#trilateral_retinoblastoma
A breast carcinoma that represents a mixed group of malignant neoplasms characterized by the histologic presence of two or more cellular types.
Metaplastic carcinoma of the breast
metaplastic carcinoma of breast
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_nervous_system
URI: http://www.ebi.ac.uk/cellline#prostate_disease
"brain neoplasm, Infratentorial" EXACT [NCI2004_11_17:C3139]
URI: http://www.ebi.ac.uk/cellline#Infratentorial_neoplasm
"Angioma of the skin" EXACT [NCI2004_11_17:C4905]
"Angiomatous naevus of skin" EXACT [SNOMEDCT_2005_07_31:254773009]
"hemangioma of skin (disorder)" EXACT [SNOMEDCT_2005_07_31:93471006]
"skin hemangioma" EXACT [SNOMEDCT_2005_07_31:189195009]
URI: http://www.ebi.ac.uk/cellline#hemangioma_of_skin
"memory disorder" EXACT [CSP2005:2483-6413]
URI: http://www.ebi.ac.uk/cellline#memory_disorder
"Angiokeratoma (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:26810009]
"angiokeratoma" EXACT [CSP2005:2007-0683]
URI: http://www.ebi.ac.uk/cellline#angiokeratoma
"Tay-Sachs disease, variant AB (disorder)" EXACT [SNOMEDCT_2005_07_31:71253000]
URI: http://www.ebi.ac.uk/cellline#Tay-Sachs_disease_AB_variant
A reproductive system disease that affects male reproductive organs.
URI: http://www.ebi.ac.uk/cellline#male_reproductive_system_disease
"Movement disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:60342002]
"movement disorder" EXACT [CSP2005:2057-3596]
"movement disorder" EXACT [CSP2005:2057-3603]
URI: http://www.ebi.ac.uk/cellline#movement_disorder
hereditary degenerative disease of central nervous system
URI: http://www.ebi.ac.uk/cellline#hereditary_degenerative_disease_of_central_nervous_system
"vascular hemostatic disease (disorder)" EXACT [SNOMEDCT_2005_07_31:21112004]
URI: http://www.ebi.ac.uk/cellline#vascular_hemostatic_disorder
URI: http://www.ebi.ac.uk/cellline#anterior_horn_cell_disease
"Neurodegenerative disease" EXACT [NCI2004_11_17:C4802]
"A degenerative disease that results_in the progressive loss of structure or function of neurons, including death of neurons." [url:http\://en.wikipedia.org/wiki/Neurodegeneration]
URI: http://www.ebi.ac.uk/cellline#neurodegenerative_disease
"Juvenile myoclonic epilepsy (disorder)" EXACT [SNOMEDCT_2005_07_31:6204001]
"juvenile myoclonic epilepsy" EXACT [CSP2005:0485-7984]
URI: http://www.ebi.ac.uk/cellline#juvenile_myoclonic_epilepsy
A bile duct cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
"adenocarcinoma in adenomatous polyp (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:43233001]
"adenocarcinoma in adenomatous polyp" EXACT [NCI2004_11_17:C7676]
URI: http://www.ebi.ac.uk/cellline#adenocarcinoma_in_a_polyp
A pancreas cancer that derives_from epithelial cells located_in the exocrine pancreas.
Exocrine pancreas carcinoma
carcinoma of pancreas
Pancreatic carcinoma, familial
exocrine cancer
An esophageal carcinoma that derives_from epithelial cells of glandular origin.
Oesophageal adenocarcinoma
carcinoma of kidney Pelvis
malignant neoplasm of renal pelvis
malignant renal Pelvis neoplasm
malignant tumor of renal pelvis
renal pelvis cancer
A gallbladder cancer that has_material_basis_in abnormally proliferating cells derives_from epithelial cells.
cancer of the gallbladder
carcinoma gallbladder
carcinoma of gallbladder
A hematopoietic cancer that derives_from the blood-forming stem cells of the bone marrow.
"Myeloid neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:414792005]
"Myeloproliferative disease NOS" EXACT [MTHICD9_2006:238.7]
"Myeloproliferative disease, NOS" EXACT [SNOMEDCT_2005_07_31:20921005]
"Myeloproliferative disease, no ICD-O subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:128925001]
"Myeloproliferative disorder (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:414794006]
"Myeloproliferative disorder" EXACT [SNOMEDCT_2005_07_31:188772004]
"Myeloproliferative tumors" EXACT [NCI2004_11_17:C9290]
"bone Marrow tumor" EXACT [NCI2004_11_17:C35370]
"bone marrow neoplasm" EXACT [CSP2005:2004-0492]
"malignant bone Marrow tumor" EXACT [NCI2004_11_17:C35501]
"malignant neoplasm of bone marrow" EXACT []
"myeloproliferative neoplasm" EXACT [CSP2005:2004-0893]
"neoplasm of bone marrow (disorder)" EXACT [SNOMEDCT_2005_07_31:414824005]
"primary malignant neoplasm of bone marrow (disorder)" EXACT [SNOMEDCT_2005_07_31:93720005]
bone Marrow tumor
bone marrow neoplasm
malignant bone Marrow tumor
malignant neoplasm of bone marrow
"A bone marrow disease and hematopoietic cancer that derives_from the blood-forming stem cells of the bone marrow." [url:http\://nci.nih.gov/dictionary/?CdrID=430857]
URI: http://www.ebi.ac.uk/cellline#bone_marrow_cancer
"bone Marrow disorder" EXACT [NCI2004_11_17:C34433]
"bone marrow disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:127035006]
"bone marrow disorder" EXACT [CSP2005:0427-3773]
URI: http://www.ebi.ac.uk/cellline#bone_marrow_disease
"Adrenal gland hyperplasia" EXACT [NCI2004_11_17:C35408]
"Adrenal hypertrophy or hyperplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:237775000]
URI: http://www.ebi.ac.uk/cellline#adrenal_hyperplasia
"Langer-Giedion syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:41069008]
"Trichorhinophalangeal dysplasia type II" EXACT [SNOMEDCT_2005_07_31:239017000]
URI: http://www.ebi.ac.uk/cellline#Langer-Giedion_syndrome
URI: http://www.ebi.ac.uk/cellline#thyroid_gland_disease
A gastrointestinal system cancer that is located_in the esophagus.
Ca lower third oesophagus
Ca middle third oesophagus
esophagus cancer
malignant neoplasm of distal third of esophagus
malignant neoplasm of lower third of oesophagus
malignant neoplasm of middle third of oesophagus
malignant neoplasm of proximal third of esophagus
malignant neoplasm of upper third esophagus
malignant tumor of Distal Third of esophagus
malignant tumor of Proximal Third of esophagus
malignant tumor of abdominal esophagus
malignant tumor of the middle Third of the esophagus
neuronal and mixed neuronal-glial tumor of cerebellum
URI: http://www.ebi.ac.uk/cellline#neuronal_and_mixed_neuronal-glial_tumor_of_cerebellum
mixed Neuroglial tumor
mixed gliomas
An organ system cancer located_in the thoracic cavity that develops in the different types of cells within the lungs, as well as less common cancers of the esophagus, the trachea, or the chest wall.
"Thoracic tumor" EXACT [NCI2004_11_17:C3406]
"thorax neoplasm" EXACT [CSP2005:2005-5041]
"tumor of thorax (disorder)" EXACT [SNOMEDCT_2005_07_31:255058005]
Thoracic tumor
thorax cancer
thorax neoplasm
tumor of thorax
"A cancer by anatomical entity that develops in the different types of cells within the lungs, as well as less common cancers of the esophagus, the trachea, or the chest wall." [url:http\://www.advocatehealth.com/cmc/body.cfm?id=203]
URI: http://www.ebi.ac.uk/cellline#thoracic_cancer
URI: http://www.ebi.ac.uk/cellline#deficiency_disease
"NGP - New growth of prostate" EXACT [SNOMEDCT_2005_07_31:363448003]
"neoplasm of prostate (disorder)" EXACT [SNOMEDCT_2005_07_31:126906006]
"prostate neoplasm" EXACT [CSP2005:2016-2641]
"tumor of the prostate" EXACT [NCI2004_11_17:C3343]
URI: http://www.ebi.ac.uk/cellline#prostatic_neoplasm
An uterine corpus cancer that is located_in the muscles of the uterus or located_in other tissues that support the uterus.
sarcoma of Corpus Uteri
sarcoma of uterus
Nonanaplastic renal Wilm's tumor
Nonanaplastic renal Wilm's tumour
renal Wilms' tumour
nonanaplastic renal wilms tumor
"Fructose-biphosphatase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:28183005]
"fructose 1 phosphate aldolase deficiency" EXACT [CSP2005:1849-3494]
URI: http://www.ebi.ac.uk/cellline#fructose-1,6-diphosphatase_deficiency
URI: http://www.ebi.ac.uk/cellline#inborn_errors_fructose_metabolism
"Carbohydrate-deficient glycoprotein syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:238049009]
carbohydrate-deficient glycoprotein syndrome
URI: http://www.ebi.ac.uk/cellline#carbohydrate-deficient_glycoprotein_syndrome
URI: http://www.ebi.ac.uk/cellline#hepatoerythropoietic_porphyria
URI: http://www.ebi.ac.uk/cellline#peritoneal_and_retroperitoneal_tumors
"Capillary Hemangioblastoma" EXACT [NCI2004_11_17:C3801]
"Hemangioblastoma (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:81201000]
URI: http://www.ebi.ac.uk/cellline#hemangioblastoma
URI: http://www.ebi.ac.uk/cellline#visual_alteration
An ovary sarcoma that arises from smooth muscle progenitors.
leiomyosarcoma of Ovary
A gastrointestinal system disease that is located_in the intestine.
"Diverticula of intestine (disorder)" EXACT [SNOMEDCT_2005_07_31:63532004]
"Diverticula of the intestine NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:197116004]
"Diverticular disease(& [of intestine])" EXACT [SNOMEDCT_2005_07_31:197081001]
"Diverticular disorder of intestine (disorder)" EXACT [SNOMEDCT_2005_07_31:271365001]
"Diverticular disorder of intestine" EXACT [SNOMEDCT_2005_07_31:197082008]
"Diverticulosis of small intestine" EXACT []
"GIT vascular insuffic. NOS" EXACT [SNOMEDCT_2005_07_31:155768005]
"Ischemic Bowel disease" EXACT [NCI2004_11_17:C35212]
"Non-infective enteritis and colitis (disorder)" EXACT [SNOMEDCT_2005_07_31:197533001, SNOMEDCT_2005_07_31:307418008]
"Other and unspecified noninfectious gastroenteritis and colitis" EXACT []
"Unspecified vascular insufficiency of intestine" EXACT []
"angiodysplasia of intestine with hemorrhage" EXACT []
"gastrointestinal tract vascular insufficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:312607004]
"gastrointestinal tract vascular insufficiency NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:266521006]
"intestinal ISCHEMIA" EXACT [MTH:NOCODE]
"intestinal vascular insufficiency NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:197009002]
"noninfectious enteritis and colitis" EXACT []
"vascular insuff.- intestine" EXACT [SNOMEDCT_2005_07_31:266518009]
"vascular insufficiency of intestine (disorder)" EXACT [SNOMEDCT_2005_07_31:82196007]
"vascular insufficiency of intestine" EXACT [ICD9CM_2006:557]
URI: http://www.ebi.ac.uk/cellline#intestinal_disease
A cervical adenocarcinoma that derives_from epithelial cells which have clear cytoplasm.
Clear cell carcinoma of the Cervix Uteri
A ovarian adenocarcinoma that derives_from epithelial cells which have clear cytoplasm.
"Hypomelia Hypotrichosis Facial hemangioma syndrome" EXACT [NCI2004_11_17:C4681]
"Roberts-SC phocomelia syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:48718006]
URI: http://www.ebi.ac.uk/cellline#Roberts-SC_phocomelia_syndrome
"Diverticular disease of colon" EXACT []
"colon disorder" EXACT [CSP2005:1248-3971]
"disorder of colon (disorder)" EXACT [SNOMEDCT_2005_07_31:128524007]
URI: http://www.ebi.ac.uk/cellline#colonic_disease
"Pregnancy disorder" EXACT [SNOMEDCT_2005_07_31:156069003]
"Pregnancy disorder" EXACT [SNOMEDCT_2005_07_31:267293009]
"disease of pregnancy [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:23288008]
"disorder of pregnancy (disorder)" EXACT [SNOMEDCT_2005_07_31:173300003]
"disorder of pregnancy" EXACT [SNOMEDCT_2005_07_31:172422001]
"pregnancy disorder" EXACT [CSP2005:2403-8085]
URI: http://www.ebi.ac.uk/cellline#pregnancy_disease
"Ophthalmoplegia (disorder)" EXACT [SNOMEDCT_2005_07_31:16110005]
"Ophthalmoplegia NOS" EXACT [MTHICD9_2006:378.9]
"Ophthalmoplegia NOS" EXACT [SNOMEDCT_2005_07_31:155196009]
"Ophthalmoplegia NOS" EXACT [SNOMEDCT_2005_07_31:267745004]
"Total ophthalmoplegia (disorder)" EXACT [SNOMEDCT_2005_07_31:78097002]
"oculomotor paralysis" EXACT [CSP2005:1115-2778]
URI: http://www.ebi.ac.uk/cellline#ophthalmoplegia
A lung carcinoma that has_material_basis_in primitive-appearing cells that are smaller than normal cells and is located_in the lung.
Oat cell carcinoma
oat cell carcinoma
URI: http://www.ebi.ac.uk/cellline#schizoaffective_disorder
"Dystonia (disorder)" EXACT [SNOMEDCT_2005_07_31:15802004]
"Dystonia, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:194478005]
URI: http://www.ebi.ac.uk/cellline#dystonic_disorder
A synovium cancer which develops in the synovial membrane of the joints.
A stomach cancer that is located_in the stomach.
cancer of the stomach
carcinoma of stomach
gastric carcinoma
A testicular cancer that has_material_basis_in germ cells.
germ cell tumor of testis
testicular germ cell neoplasm
Xref MGI. OMIM mapping confirmed by DO. [LS].
A teratoma that is located_in the mediastinum.
teratoma of mediastinum
A urinary system disease that is located_in the kidney.
nephropathy
URI: http://www.ebi.ac.uk/cellline#kidney_disease
"Beckwith-Wiedemann syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:81780002]
"Wiedemann's syndrome" EXACT [SNOMEDCT_2005_07_31:36193003]
URI: http://www.ebi.ac.uk/cellline#Beckwith-Wiedemann_syndrome
A lung carcinoma that is located_in large undifferentiated cells.
Giant cell carcinoma
Giant cell lung carcinoma
An acute lymphoblastic leukemia that is characterized by too many T-cell lymphoblasts found in the bone marrow and blood.
Precursor T Lymphoblastic Leukemia
T Acute Lymphoblastic Leukemia
T-cell acute lymphocytic leukaemia
acute T cell leukaemia
precursor T-lymphoblastic lymphoma/leukemia
An acute lymphocytic leukemia occurring during adulthood.
adult acute lymphoid Leukemia
"eye infection (disorder)" EXACT [SNOMEDCT_2005_07_31:128351009]
"eye infection" EXACT [CSP2005:1115-1009]
URI: http://www.ebi.ac.uk/cellline#eye_disease
"Myotonic Chondrodystrophy" EXACT [NCI2004_11_17:C35008]
"Schwartz syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:8632008]
"Schwartz-Jampel syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:29145002]
URI: http://www.ebi.ac.uk/cellline#Schwartz-Jampel_syndrome
"histiocytic and dendritic cell " RELATED []
"A sarcoma and hematologic cancer that derives_from follicular lymphoma." [url:http\://www.springerlink.com/content/h9wrn7p72x26q035/]
URI: http://www.ebi.ac.uk/cellline#histiocytic_and_dendritic_cell_cancer
Adenosquamous carcinoma of stomach
"Cranial nerve disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:73013002]
"Cranial nerve disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267598004]
"Cranial nerve disorder NOS" EXACT [SNOMEDCT_2005_07_31:193104009]
"Cranial nerve disorder NOS" EXACT [SNOMEDCT_2005_07_31:267709002]
"Cranial nerve disorder" EXACT [NCI2004_11_17:C26733]
"Unspecified disorder of cranial nerves" EXACT [ICD9CM_2006:352.9]
"disorder of cranial nerve" EXACT [SNOMEDCT_2005_07_31:276379008]
URI: http://www.ebi.ac.uk/cellline#cranial_nerve_disease
An intestinal cancer that effects the long, tube-like organ that is connected to the small intestine at one end and the anus at the other.
A breast carcinoma that is characterized by an irregular cribriform growth pattern, nuclear grade I in at least 90% of cells, and absent myoepithelial cells.
Cribriform carcinoma
ductal carcinoma, cribriform type
"Retinal disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:29555009]
"Retinal disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:193430004]
"Retinal disorder" EXACT [NCI2004_11_17:C26875]
"Retinopathies" EXACT [SNOMEDCT_2005_07_31:267715002]
"Retinopathy (disorder)" EXACT [SNOMEDCT_2005_07_31:399625000]
"Retinopathy, NOS" EXACT [SNOMEDCT_2005_07_31:35426003]
"Unspecified retinal disorder" EXACT [ICD9CM_2006:362.9]
"retina disorder" EXACT [CSP2005:1114-9311]
URI: http://www.ebi.ac.uk/cellline#retinal_disease
"Bannayan syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:234138005]
"Bannayan syndrome" EXACT [SNOMEDCT_2005_07_31:205795008]
"Bannayan syndrome" EXACT [SNOMEDCT_2005_07_31:238906005]
"Bannayan-Riley-Ruvalcaba syndrome" EXACT [NCI2004_11_17:C3939]
"Riley-Smith syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:21984008]
"Ruvalcaba-Myhre syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:46011003]
"Ruvalcaba-Myhre syndrome [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:277916005]
"Ruvalcaba-Myhre syndrome" EXACT [SNOMEDCT_2005_07_31:234137000]
Macrocephaly with Multiple Lipomas and hemangiomas
URI: http://www.ebi.ac.uk/cellline#Macrocephaly_with_Multiple_Lipomas_and_hemangiomas
"Werner syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:51626007]
"Werner's syndrome" EXACT [MTHICD9_2006:259.8]
"Werner's syndrome" EXACT [SNOMEDCT_2005_07_31:190592007]
"adult premature ageing syndrome" EXACT [SNOMEDCT_2005_07_31:190590004]
"adult progeria" EXACT [CSP2005:1849-9804]
URI: http://www.ebi.ac.uk/cellline#Werner_syndrome
An adrenal gland cancer that derives_from immature neuroblastic cells.
neuroblastoma of Adrenal gland
"Atrophy of optic disc (disorder)" EXACT [SNOMEDCT_2005_07_31:95774001]
"Unspecified optic atrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:194042009]
"optic atrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:76976005]
"optic atrophy NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:194046007]
"optic atrophy" EXACT [CSP2005:2042-6601]
"optic atrophy" EXACT [ICD9CM_2006:377.1]
"optic atrophy" EXACT [SNOMEDCT_2005_07_31:155188004]
"optic atrophy" EXACT [SNOMEDCT_2005_07_31:267742001]
"optic atrophy, unspecified" EXACT [ICD9CM_2006:377.10]
URI: http://www.ebi.ac.uk/cellline#optic_atrophy
"DISORDER OF THE peripheral nervous system" EXACT [ICD9CM_2006:350-359.99]
"Non-neoplastic peripheral nervous system disease" EXACT [NCI2004_11_17:C27587]
"PN - peripheral neuropathy" EXACT [SNOMEDCT_2005_07_31:264554005]
"disorder of the peripheral nervous system (disorder)" EXACT [SNOMEDCT_2005_07_31:42658009]
"peripheral Neuropathy" EXACT [MTH:NOCODE]
"peripheral nerve disease (disorder)" EXACT [SNOMEDCT_2005_07_31:302226006]
"peripheral nerve disease" EXACT [MTH:516]
"peripheral nerve disease" EXACT [MTH:575]
"peripheral nervous system disease" EXACT [NCI2004_11_17:C27580]
"peripheral nervous system disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:193088006]
"peripheral nervous system disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:193264002]
"peripheral nervous system disorder NOS" EXACT [SNOMEDCT_2005_07_31:155100008]
"peripheral nervous system disorder" EXACT [CSP2005:2042-6505]
"peripheral nervous system disorder" EXACT [SNOMEDCT_2005_07_31:155064004]
"peripheral neuropathy" EXACT [CSP2005:2042-6617]
"peripheral neuropathy" EXACT [NCI2004_11_17:C4731]
"peripheral neuropathy" EXACT [SNOMEDCT_2005_07_31:155080009]
"peripheral neuropathy" EXACT [SNOMEDCT_2005_07_31:267706009]
URI: http://www.ebi.ac.uk/cellline#peripheral_nervous_system_disease
An ovary adenocarcinoma that derives_from the lining of a cavity that produces a serum-like fluid (a serous cavity).
malignant ovarian serous tumor
serous carcinoma of Ovary
"pulmonary valve disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:76267008]
"pulmonary valve disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:195001000]
"pulmonary valve disorder" EXACT [ICD9CM_2006:424.3]
URI: http://www.ebi.ac.uk/cellline#pulmonary_valve_disease
"Adenosine Deaminase deficiency" EXACT [NCI2004_11_17:C3962]
"Adenosine deaminase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:44940001]
"Adenosine deaminase deficiency" EXACT [SNOMEDCT_2005_07_31:190999009]
"Adenosine-deaminase deficiency" EXACT [SNOMEDCT_2005_07_31:190738006]
"adenosine deaminase deficiency" EXACT [CSP2005:1560-6660]
"deficiency of adenosine deaminase (disorder)" EXACT [SNOMEDCT_2005_07_31:124523006]
"A severe combined immunodeficiency that is caused by a defective enzyme, adenosine deaminase (ADA), necessary for the breakdown of purines. Lack of ADA causes accumulation of dATP." [url:http\://en.wikipedia.org/wiki/Severe_combined_immunodeficiency]
URI: http://www.ebi.ac.uk/cellline#adenosine_deaminase_deficiency
"X-Linked Severe Combined Immunodeficiency" EXACT [NCI2004_11_17:C4682]
"X-linked severe combined immunodeficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:203592006]
"X-linked severe combined immunodeficiency [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:234569003]
URI: http://www.ebi.ac.uk/cellline#thymic_epithelial_hypoplasia
"Hemolytic anemia (disorder)" EXACT [SNOMEDCT_2005_07_31:61261009]
"Hemolytic anemias (disorder)" EXACT [SNOMEDCT_2005_07_31:191416001]
"Hemolytic anemias NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:191231008]
"hemolytic anemia" EXACT [CSP2005:0427-1005]
URI: http://www.ebi.ac.uk/cellline#hemolytic_anemia
"neoplasm of retroperitoneum" EXACT [SNOMEDCT_2005_07_31:359767009]
"neoplasm of the retroperitoneum" EXACT [SNOMEDCT_2005_07_31:126872008]
"neoplasm of the retroperitoneum" EXACT [SNOMEDCT_2005_07_31:359770008]
"retroperitoneal neoplasm" EXACT [CSP2005:2005-3788]
"retroperitoneal neoplasm" EXACT [NCI2004_11_17:C3357]
"tumor of retroperitoneum (disorder)" EXACT [SNOMEDCT_2005_07_31:254617008]
URI: http://www.ebi.ac.uk/cellline#retroperitoneal_neoplasm
URI: http://www.ebi.ac.uk/cellline#congenital_cystic_kidney_disease
URI: http://www.ebi.ac.uk/cellline#congenital_hemolytic_anemia
"PCK - Polycystic kidney disease" EXACT [SNOMEDCT_2005_07_31:82525005]
"Polycystic kidney disease NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:268233005]
"Polycystic kidney disease NOS" EXACT [SNOMEDCT_2005_07_31:204956007]
"Polycystic kidney disease" EXACT [SNOMEDCT_2005_07_31:204955006]
"Polycystic kidney" EXACT [SNOMEDCT_2005_07_31:156973002]
"Polycystic kidney" EXACT [SNOMEDCT_2005_07_31:204954005]
"Polycystic kidney" EXACT [SNOMEDCT_2005_07_31:268332003]
"Polycystic kidney, unspecified type" EXACT [ICD9CM_2006:753.12]
"polycystic kidney" EXACT [CSP2005:0725-1693]
URI: http://www.ebi.ac.uk/cellline#polycystic_kidney_disease
"Autosomal Recessive Polycystic kidney disease" EXACT [MTH:NOCODE]
"Polycystic kidney disease, infantile type (disorder)" EXACT [SNOMEDCT_2005_07_31:28770003]
"Polycystic kidney, autosomal recessive" EXACT [ICD9CM_2006:753.14]
URI: http://www.ebi.ac.uk/cellline#autosomal_recessive_polycystic_kidney
"Polycystic kidney disease, adult type (disorder)" EXACT [SNOMEDCT_2005_07_31:28728008]
"Polycystic kidney, autosomal dominant" EXACT [ICD9CM_2006:753.13]
URI: http://www.ebi.ac.uk/cellline#autosomal_dominant_polycystic_kidney
Urothelial cell carcinoma of renal Pelvis
renal pelvis transitional cell carcinoma
URI: http://www.ebi.ac.uk/cellline#skin_abnormality
"Immunodeficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:64431000]
"Immunodeficiency disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:234532001]
"Immunodeficiency" EXACT [NCI2004_11_17:C39725]
"Unspecified immunity deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:191005003]
"Unspecified immunity deficiency" EXACT [ICD9CM_2006:279.3]
"hypoimmunity" EXACT [CSP2005:1553-9570]
"immune deficiency disorder" EXACT [CSP2005:1560-5885]
"immunodeficiency syndrome" EXACT [NCI2004_11_17:C3131]
"An immune system disease that results when one or more essential parts of the immune system is missing or not working properly at birth due to a genetic mutation." [url:http\://www.nichd.nih.gov/publications/pubs/primary_immuno.cfm#PrimaryImmunoDiseases]
URI: http://www.ebi.ac.uk/cellline#primary_immunodeficiency_disease
"Leukopenia (disorder)" EXACT [SNOMEDCT_2005_07_31:84828003]
"A leukocyte disorder that is a decrease in the number of white blood cells (leukocytes) found in the blood, which places individuals at increased risk of infection." [url:http\://en.wikipedia.org/wiki/Leukopenia]
URI: http://www.ebi.ac.uk/cellline#leukopenia
"Duncan's syndrome" EXACT [SNOMEDCT_2005_07_31:77121009]
"Lymphoproliferative disease NOS" EXACT [MTHICD9_2006:238.7]
"Lymphoproliferative disease, no ICD-O subtype (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:84631004]
"Lymphoproliferative disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:277466009]
"Lymphoproliferative disorder (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:414629003]
"Lymphoproliferative disorder" EXACT [NCI2004_11_17:C9308]
URI: http://www.ebi.ac.uk/cellline#lymphoproliferative_disorder
URI: http://www.ebi.ac.uk/cellline#aortic_valve_disease
"blood protein disorder" EXACT [CSP2005:0449-0541]
URI: http://www.ebi.ac.uk/cellline#blood_protein_disorder
"Severe combined immunodeficiency disease (disorder)" EXACT [SNOMEDCT_2005_07_31:31323000]
"Severe combined immunodeficiency" EXACT [SNOMEDCT_2005_07_31:190994004]
"combined T and B cell inborn immunodeficiency" EXACT [CSP2005:1560-6660]
"A combined T cell and B cell immunodeficiency that is caused by a defect in several genes encoding for B and T lymphocytes resulting in individuals with non-functional immune systems." [url:http\://www.merriam-webster.com/medlineplus/severe%20combined%20immunodeficiency, url:http\://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gnd&part=severecombinedimmunodeficiency, url:http\://www.scid.net/]
URI: http://www.ebi.ac.uk/cellline#severe_combined_immunodeficiency
"Combined immunity deficiency NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:191003005]
"Congenital Combined Immunodeficiency" EXACT [NCI2004_11_17:C27871]
combined T cell and B cell immunodeficiency
URI: http://www.ebi.ac.uk/cellline#combined_T_cell_and_B_cell_immunodeficiency
URI: http://www.ebi.ac.uk/cellline#congenital_disorder_of_natural_immunity
"Hereditary disease (disorder)" EXACT [SNOMEDCT_2005_07_31:32895009]
"Hereditary disease" EXACT [SNOMEDCT_2005_07_31:264530000]
"Molecular disease" EXACT [NCI2004_11_17:C3101]
"hereditary disorder" EXACT [CSP2005:1254-7727]
URI: http://www.ebi.ac.uk/cellline#hereditary_disease
"Metabolic encephalopathy (disorder)" EXACT [SNOMEDCT_2005_07_31:50122000]
"Metabolic encephalopathy" EXACT [ICD9CM_2006:348.31]
"Metabolic encephalopathy" EXACT [SNOMEDCT_2005_07_31:276258006]
URI: http://www.ebi.ac.uk/cellline#metabolic_brain_disease
demyelinating disease of central nervous system
URI: http://www.ebi.ac.uk/cellline#demyelinating_disease_of_central_nervous_system
URI: http://www.ebi.ac.uk/cellline#CNS_demyelinating_autoimmune_disease
"Tetralogy of Fallot (disorder)" EXACT [SNOMEDCT_2005_07_31:86299006]
"Tetralogy of Fallot NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:204307003]
"Tetralogy of Fallot, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:268177006]
"Tetralogy of Fallot, unspecified" EXACT [SNOMEDCT_2005_07_31:204305006]
"Ventricular septal defect with pulmonary stenosis or atresia, dextraposition of aorta, and hypertrophy of right ventricle" EXACT [MTHICD9_2006:745.2]
"tetralogy of Fallot" EXACT [CSP2005:0724-9541]
URI: http://www.ebi.ac.uk/cellline#tetralogy_of_Fallot
"Pulmonic stenosis NOS" EXACT [MTHICD9_2006:424.3]
"Pulmonic valve stenosis (disorder)" EXACT [SNOMEDCT_2005_07_31:56786000]
"pulmonary stenosis NOS" EXACT [SNOMEDCT_2005_07_31:266300007]
"pulmonary stenosis, cause unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:194999004]
"pulmonary valve stenosis" EXACT [CSP2005:1393-3827]
URI: http://www.ebi.ac.uk/cellline#pulmonary_valve_stenosis
"Haemophagocytic lymphohistiocytosis" EXACT [SNOMEDCT_2005_07_31:190958003]
"Hemophagocytic Lymphohistiocytosis" EXACT [NCI2004_11_17:C34792]
"Hemophagocytic lymphohistiocytosis (disorder)" EXACT [SNOMEDCT_2005_07_31:234437005]
"Hemophagocytic syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:127069007]
"Hemophagocytic syndrome" EXACT [NCI2004_11_17:C35439]
URI: http://www.ebi.ac.uk/cellline#hemophagocytic_lymphohistiocytosis
"Lhermitte-Duclos disease (disorder)" EXACT [SNOMEDCT_2005_07_31:67944007]
"dysplastic Gangliocytoma of Cerebellum" EXACT [NCI2004_11_17:C8419]
URI: http://www.ebi.ac.uk/cellline#Lhermitte-Duclos_disease
"Dermatitis due to Unspecified Substance taken Internally" EXACT [NCI2004_11_17:C35224]
"Dermatitis due to substances taken internally (disorder)" EXACT [SNOMEDCT_2005_07_31:13582007]
"Dermatitis due to substances taken internally" EXACT [ICD9CM_2006:693]
"Dermatitis due to unspecified substance taken internally (disorder)" EXACT [SNOMEDCT_2005_07_31:201367002]
"Dermatitis due to unspecified substance taken internally" EXACT []
URI: http://www.ebi.ac.uk/cellline#skin_and_subcutaneous_tissue_disease
"Prion disease (disorder)" EXACT [SNOMEDCT_2005_07_31:20484008]
"Prion disease pathway" EXACT [NCI2004_11_17:C38853]
"Prion protein disease" EXACT [SNOMEDCT_2005_07_31:193172009]
"Spongiform Encephalopathy" EXACT [NCI2004_11_17:C27585]
"Spongiform encephalopathy (disorder)" EXACT [SNOMEDCT_2005_07_31:230284004]
"prion induced disorder" EXACT [CSP2005:2042-5006]
"prion induced disorder" EXACT [CSP2005:2042-5040]
URI: http://www.ebi.ac.uk/cellline#prion_disease
A musculoskeletal system disease that affects tissues such as skin, tendons, and cartilage.
"Connective tissue dis." EXACT [SNOMEDCT_2005_07_31:268048008]
"Connective tissue disease" EXACT [MTH:NOCODE]
"Connective tissue disease" EXACT [SNOMEDCT_2005_07_31:201432001]
"Connective tissue disorder" EXACT [NCI2004_11_17:C26729]
"Other musculoskelet/connectiv" EXACT [SNOMEDCT_2005_07_31:268126004]
"connective tissue disorder" EXACT [CSP2005:0729-7208]
"disorder of connective tissue (disorder)" EXACT [SNOMEDCT_2005_07_31:105969002]
connective tissue disorder
disorder of connective tissue
URI: http://www.ebi.ac.uk/cellline#connective_tissue_disease
"Congenital malformation and deformation of the musculoskeletal system (disorder)" EXACT [SNOMEDCT_2005_07_31:73573004]
"Congenital malformations and deformations of the musculoskeletal system (disorder)" EXACT [SNOMEDCT_2005_07_31:205947008]
"Congenital musculoskeletal anomalies NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:268281003]
"Congenital musculoskeletal anomalies NOS" EXACT [SNOMEDCT_2005_07_31:156998001]
"Congenital musculoskeletal anomalies NOS" EXACT [SNOMEDCT_2005_07_31:205535007]
"Congenital musculoskeletal deformities" EXACT [SNOMEDCT_2005_07_31:205033007]
"Congenital musculoskeletal deformity NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:205117007]
"Skeletal anomaly-congen" EXACT [SNOMEDCT_2005_07_31:268336000]
"congenital musculoskeletal anomaly" EXACT []
URI: http://www.ebi.ac.uk/cellline#congenital_musculoskeletal_abnormality
inborn errors purine-pyrimidine metabolism
URI: http://www.ebi.ac.uk/cellline#inborn_errors_purine-pyrimidine_metabolism
"Plasma cell disorder (disorder)" EXACT [SNOMEDCT_2005_07_31:277576009]
"Plasma cell dyscrasia (disorder)" EXACT [SNOMEDCT_2005_07_31:71390001]
"Plasma cell neoplasm (disorder)" EXACT [SNOMEDCT_2005_07_31:415111003]
"Plasma cell neoplasm (morphology)" EXACT [SNOMEDCT_2005_07_31:127580003]
"Plasma cell tumour" EXACT [SNOMEDCT_2005_07_31:274907000]
"Plasmacytic tumor" EXACT [NCI2004_11_17:C4665]
URI: http://www.ebi.ac.uk/cellline#plasma_cell_neoplasm
URI: http://www.ebi.ac.uk/cellline#overnutrition
"Inborn Errors of Metabolism" EXACT [NCI2004_11_17:C34816]
"Inborn error of metabolism (disorder)" EXACT [SNOMEDCT_2005_07_31:86095007]
"Metabolic hereditary disorder" EXACT [SNOMEDCT_2005_07_31:363205007]
"inborn metabolism disorder" EXACT [CSP2005:1849-0057]
"A simple genetic disease that comprises a large class of genetic diseases involving disorders of metabolism." [url:http\://en.wikipedia.org/wiki/Inborn_errors_of_metabolism]
URI: http://www.ebi.ac.uk/cellline#inborn_errors_of_metabolism
tubular adenocarcinoma of stomach
URI: http://www.ebi.ac.uk/cellline#muscle_tissue_disease
Adrenal cortical tumors
malignant Adrenocortical tumor
malignant neoplasm of adrenal cortex
malignant tumour of adrenal cortex
neoplasm of adrenal cortex
"Angiokeratoma of skin (disorder)" EXACT [SNOMEDCT_2005_07_31:254788004]
"Cutaneous Angiokeratoma" EXACT [NCI2004_11_17:C4488]
URI: http://www.ebi.ac.uk/cellline#angiokeratoma_of_skin
"Muscular calcification, NOS" EXACT [SNOMEDCT_2005_07_31:57879007]
"Muscular ossification (disorder)" EXACT [SNOMEDCT_2005_07_31:44551007]
"Myisitis ossificans" EXACT [MTHICD9_2006:728.12]
"Ossification - muscle" EXACT [SNOMEDCT_2005_07_31:156720008]
"Ossification - muscle" EXACT [SNOMEDCT_2005_07_31:203030008]
URI: http://www.ebi.ac.uk/cellline#myositis_ossificans
"Cerebro-oculo-facio-skeletal syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:41283003]
"Cerebrooculofacioskeletal syndrome" EXACT [NCI2004_11_17:C3817]
URI: http://www.ebi.ac.uk/cellline#COFS_syndrome
"antepartum cerebrovascular disorder" EXACT []
"postpartum cerebrovascular disorder" EXACT []
URI: http://www.ebi.ac.uk/cellline#cerebrovascular_disease
"(Palatoschisis) or (unspecified cleft palate)" EXACT [SNOMEDCT_2005_07_31:204593009]
"Palatoschisis (disorder)" EXACT [SNOMEDCT_2005_07_31:253986002]
"Uranostaphyloschisis (disorder)" EXACT [SNOMEDCT_2005_07_31:63567004]
"cleft palate (disorder)" EXACT [SNOMEDCT_2005_07_31:87979003]
"cleft palate NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:204605001]
"cleft palate" EXACT [CSP2005:0725-9049]
"cleft palate" EXACT [ICD9CM_2006:749.0]
"cleft palate, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:268196005]
"cleft palate, unspecified" EXACT [ICD9CM_2006:749.00]
URI: http://www.ebi.ac.uk/cellline#cleft_palate
"basal ganglia disease" EXACT [CSP2005:2057-3403]
"disorder of basal ganglia (disorder)" EXACT [SNOMEDCT_2005_07_31:70835005]
URI: http://www.ebi.ac.uk/cellline#basal_ganglia_disease
"A dimentia that results_from the pathological aggregation of tau protein in so-called neurofibrillary tangles (NFT) in the human brain." [url:http\://en.wikipedia.org/wiki/Tauopathy]
URI: http://www.ebi.ac.uk/cellline#tauopathy
A liver carcinoma that has_material_basis_in undifferentiated hepatocytes and located_in the liver.
Hepatoma
A liver cancer that has_material_basis_in epithelial cells.
Liver and Intrahepatic bile duct carcinoma
"embryo neoplasm" EXACT [CSP2005:2000-3997]
"embryonal neoplasm" EXACT [NCI2004_11_17:C3264]
"A germ cell cancer that is associated with an embryo." [url:http\://www.cancer.gov/dictionary/?CdrID=44250]
URI: http://www.ebi.ac.uk/cellline#embryonal_cancer
"mitochondrial cytopathy (disorder)" EXACT [SNOMEDCT_2005_07_31:240096000]
"mitochondrial myopathy (disorder)" EXACT [SNOMEDCT_2005_07_31:16851005]
"mitochondrial myopathy" EXACT [CSP2005:5000-0048]
URI: http://www.ebi.ac.uk/cellline#mitochondrial_myopathy
A disease that manifests in a defined anatomical structure.
"acellular anatomical structure disease" EXACT []
"disease of anatomical structure" EXACT []
"disease of material anatomical entity" EXACT []
"disease of physical anatomical entity" EXACT []
"disease of set of heterogenous clusters" EXACT []
"A disease that manifests in a defined anatomical structure." [DO:wk\,ls, URL:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=anatomic]
URI: http://www.ebi.ac.uk/cellline#disease_of_anatomical_entity
"Dentin dysplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:109492001]
"Dentinal dysplasia" EXACT [MTHICD9_2006:520.5]
"Dentinal dysplasia" EXACT [SNOMEDCT_2005_07_31:45742009]
URI: http://www.ebi.ac.uk/cellline#dentin_dysplasia
"Hereditary optic Atrophy" EXACT [NCI2004_11_17:C34864]
"Hereditary optic atrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:26360005]
"Hereditary optic atrophy NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267656009]
"Hereditary optic atrophy NOS" EXACT [SNOMEDCT_2005_07_31:194045006]
"Hereditary optic atrophy" EXACT [ICD9CM_2006:377.16]
URI: http://www.ebi.ac.uk/cellline#hereditary_optic_atrophy
"Leber's hereditary optic neuropathy" EXACT [CSP2005:2042-6601]
"Leber's hereditary optic neuropathy" EXACT [CSP2005:5000-0048]
"Leber's hereditary optic neuropathy" EXACT [SNOMEDCT_2005_07_31:230510002]
"Leber's optic atrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:58610003]
"Leber's optic atrophy" EXACT [SNOMEDCT_2005_07_31:194045006]
"optic atrophy, Leber's" EXACT [MTHICD9_2006:377.16]
URI: http://www.ebi.ac.uk/cellline#leber_hereditary_optic_atrophy
URI: http://www.ebi.ac.uk/cellline#mature_B-cell_lymphocytic_neoplasm
A non-Hodgkin lymphoma that has_material_basis_in B cells.
"B-cell neoplasm (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:413616009]
B-cell lymphocytic neoplasm
URI: http://www.ebi.ac.uk/cellline#B-cell_lymphocytic_neoplasm
"Normocytic anemia (disorder)" EXACT [SNOMEDCT_2005_07_31:300980002]
URI: http://www.ebi.ac.uk/cellline#normocytic_anemia
An organ system benign neoplasm that is located_in the kidneys, ureteres, bladder or urethra.
"neoplasm of urinary system (disorder)" EXACT [SNOMEDCT_2005_07_31:126879004]
"tumor of the urinary system" EXACT [NCI2004_11_17:C3431]
"tumor of urinary tract (disorder)" EXACT [SNOMEDCT_2005_07_31:254913005]
"urinary tract neoplasm" EXACT [CSP2005:2021-0179]
neoplasm of urinary system
tumor of the urinary system
tumor of urinary tract
urinary tract neoplasm
URI: http://www.ebi.ac.uk/cellline#Urologic_neoplasm
A disease of anatomical entity that has_material_basis_in hematopoietic cells.
"Blood disease (disorder)" EXACT [SNOMEDCT_2005_07_31:267552000]
"Blood disease NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267573000]
"Blood disease NOS" EXACT [SNOMEDCT_2005_07_31:154842002]
"Blood disease" EXACT [SNOMEDCT_2005_07_31:154785002]
"Blood dyscrasia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:191402006]
"Blood dyscrasia NOS" EXACT [MTHICD9_2006:289.9]
"Blood/blood forming organ NOS" EXACT [SNOMEDCT_2005_07_31:191446003]
"DISEASE OF THE BLOOD AND BLOOD-FORMING ORGANS" EXACT [ICD9CM_2006:280-289.99]
"Hematological disease" EXACT [MTH:NOCODE]
"Unspecified disease of blood and blood-forming organs" EXACT [ICD9CM_2006:289.9]
"blood disorder" EXACT [CSP2005:0427-3600]
"disease of blood and/or blood-forming organ (navigational concept)" EXACT [SNOMEDCT_2005_07_31:191124002]
"disease of hematopoietic system" EXACT []
"disorder of hematopoietic system (navigational concept)" EXACT [SNOMEDCT_2005_07_31:34093004]
Blood disease
Blood dyscrasia
DISEASE OF THE BLOOD AND BLOOD-FORMING ORGANS
Hematological disease
blood disorder
disease of haematopoietic system
disease of hematopoietic system
haematopoietic system disease
URI: http://www.ebi.ac.uk/cellline#hematopoietic_system_disease
"Microcephaly, normal intelligence and immunodeficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:234638009]
"Nijmegen Breakage syndrome" EXACT [NCI2004_11_17:C4692]
"Seemanova syndrome" EXACT [CSP2005:5005-0018]
URI: http://www.ebi.ac.uk/cellline#Seemanova_syndrome_II
URI: http://www.ebi.ac.uk/cellline#Muscle_calcification_and_ossification
"Lymphangiopathy, NOS" EXACT [SNOMEDCT_2005_07_31:3305006]
"Lymphatic disease" EXACT [SNOMEDCT_2005_07_31:155452000]
"Lymphatic disease" EXACT [SNOMEDCT_2005_07_31:266326002]
"Lymphatic disorder" EXACT [NCI2004_11_17:C3206]
"disorder of lymph node and lymphatics (disorder)" EXACT [SNOMEDCT_2005_07_31:234087005]
"disorder of lymphatic system" EXACT [SNOMEDCT_2005_07_31:362971004]
"disorder of lymphoid system" EXACT [SNOMEDCT_2005_07_31:111590001]
"lymphatic disorder" EXACT [CSP2005:0427-7757]
URI: http://www.ebi.ac.uk/cellline#lymphatic_system_disease
URI: http://www.ebi.ac.uk/cellline#congenital_disorder
"Amyotrophia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:203036002]
"Amyotrophia NOS" EXACT [MTHICD9_2006:728.2]
"Muscle atrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:88092000]
"Muscle wasting" EXACT [SNOMEDCT_2005_07_31:249827008]
"Muscular atrophy" EXACT [SNOMEDCT_2005_07_31:155014006]
"Muscular atrophy" EXACT [SNOMEDCT_2005_07_31:267693003]
"Wasting - muscle" EXACT [SNOMEDCT_2005_07_31:156721007]
"Wasting - muscle" EXACT [SNOMEDCT_2005_07_31:268104000]
URI: http://www.ebi.ac.uk/cellline#muscular_atrophy
"RB - Retinoblastoma" EXACT [SNOMEDCT_2005_07_31:134191003]
"Retinoblastoma (disorder)" EXACT [SNOMEDCT_2005_07_31:370967009]
"Retinoblastoma (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:19906005]
"Retinoblastoma NOS (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189935007]
"Retinoblastomas (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:189934006]
"neuroblastoma of Retina" EXACT [NCI2004_11_17:C6956]
"retinoblastoma" EXACT [CSP2005:2018-3452]
"A retinal cell cancer and malignant neoplasm of retina and neuroblastoma and neuroendocrine tumors that derives_from the tissues of the retina." [url:http\://www.cancer.gov/cancertopics/types/retinoblastoma]
URI: http://www.ebi.ac.uk/cellline#retinoblastoma
An autonomic nervous system neoplasm that derives_from immature nerve cells.
A disease of anatomical entity that is located_in the gastrointestinal tract.
"GIT disorder NOS" EXACT [SNOMEDCT_2005_07_31:155806004]
"GIT disorder NOS" EXACT [SNOMEDCT_2005_07_31:266534007]
"Gastroenteropathy" EXACT [SNOMEDCT_2005_07_31:25374005]
"Non-neoplastic gastrointestinal disorder" EXACT [NCI2004_11_17:C27550]
"disease of digestive tract (disorder)" EXACT [SNOMEDCT_2005_07_31:84410009]
"disorder of gastrointestinal tract (disorder)" EXACT [SNOMEDCT_2005_07_31:119292006]
"gastrointestinal disease and Manifestations" EXACT [NCI2004_11_17:C2990]
"gastrointestinal disorder" EXACT [CSP2005:1248-3545]
"gastrointestinal tract disorder NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:286978000]
"gastrointestinal tract disorder NOS" EXACT [SNOMEDCT_2005_07_31:155799006]
GIT disease
Gastroenteropathy
alimentary system disease
digestive system disorder
gastrointestinal disease
gastrointestinal disorder
URI: http://www.ebi.ac.uk/cellline#gastrointestinal_system_disease
"malignant Retinal neoplasm" EXACT [NCI2004_11_17:C3216]
"malignant tumor of retina (disorder)" EXACT [SNOMEDCT_2005_07_31:363465007]
URI: http://www.ebi.ac.uk/cellline#malignant_neoplasm_of_retina
"A blastoma and retinal neoplasm that derives_from the retina." [url:http\://www.wrongdiagnosis.com/medical/retinal_cancer.htm]
URI: http://www.ebi.ac.uk/cellline#retinal_cell_cancer
Signet Ring cell adenocarcinoma of the stomach
"adenocarcinoma in adenomatous polyposis Coli" EXACT [NCI2004_11_17:C4134]
"adenocarcinoma in adenomatous polyposis coli (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:57513006]
adenocarcinoma in adenomatous polyposis coli
URI: http://www.ebi.ac.uk/cellline#adenocarcinoma_in_adenomatous_polyposis_coli
"Digestive system neoplasm" EXACT [MTH:NOCODE]
"digestive neoplasm" EXACT [CSP2005:4000-0164]
"neoplasm of digestive system (disorder)" EXACT [SNOMEDCT_2005_07_31:128348002]
"neoplasm of digestive tract" EXACT [SNOMEDCT_2005_07_31:128415001]
"neoplasm of unspecified nature of digestive system (disorder)" EXACT [SNOMEDCT_2005_07_31:189527000]
"neoplasm of unspecified nature of digestive system" EXACT [ICD9CM_2006:239.0]
"A cancer by anatomical entitiy that is manifested in any part of the digestive system." [url:http\://www.wrongdiagnosis.com/d/digestive_system_cancer/intro.htm]
URI: http://www.ebi.ac.uk/cellline#digestive_system_cancer
Angiomyolipoma of kidney
renal Angiomyolipoma
URI: http://www.ebi.ac.uk/cellline#vitamin_B_deficiency
"Avitaminosis, NOS" EXACT [SNOMEDCT_2005_07_31:85670002]
URI: http://www.ebi.ac.uk/cellline#avitaminosis
URI: http://www.ebi.ac.uk/cellline#vitamin_deficiency
URI: http://www.ebi.ac.uk/cellline#malnutrition
"degeneration of retina (disorder)" EXACT [SNOMEDCT_2005_07_31:95695004]
"retina degeneration" EXACT [CSP2005:1114-9354]
URI: http://www.ebi.ac.uk/cellline#retinal_degeneration
"Arthritis (disorder)" EXACT [SNOMEDCT_2005_07_31:3723001]
"Arthritis (finding)" EXACT [SNOMEDCT_2005_07_31:372091005]
"Inflammation of joint NOS" EXACT [MTHICD9_2006:716.9]
"Inflammatory disorder of joint" EXACT [SNOMEDCT_2005_07_31:363178003]
URI: http://www.ebi.ac.uk/cellline#arthritis
"Amebic lung abscess (disorder)" EXACT [SNOMEDCT_2005_07_31:65095005]
"Amebic lung abscess" EXACT [ICD9CM_2006:006.4]
"Non-neoplastic pulmonary disorder" EXACT [NCI2004_11_17:C27557]
"abscess of lung (disorder)" EXACT [SNOMEDCT_2005_07_31:73452002]
"abscess of lung NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:196113000]
"abscess of lung" EXACT [ICD9CM_2006:513.0]
"A lower respiratory tract disease in which the function of the lungs is adversely affected by narrowing or blockage of the airways resulting in poor air flow, a loss of elasticity in the lungs that produces a decrease in the total volume of air that the lungs are able to hold, and clotting, scarring, or inflammation of the blood vessels that affect the ability of the lungs to take up oxygen and to release carbon dioxide." [url:http\://www.niehs.nih.gov/health/topics/conditions/lung-disease/index.cfm, url:http\://www.nlm.nih.gov/medlineplus/ency/article/000066.htm]
URI: http://www.ebi.ac.uk/cellline#lung_disease
URI: http://www.ebi.ac.uk/cellline#Hereditary_retinal_dystrophy
"Retinal Dystrophy" EXACT [NCI2004_11_17:C35625]
"Retinal dystrophy (disorder)" EXACT [SNOMEDCT_2005_07_31:314407005]
URI: http://www.ebi.ac.uk/cellline#retinal_dystrophy
URI: http://www.ebi.ac.uk/cellline#encephalopathy
"Collagen disease (disorder)" EXACT [SNOMEDCT_2005_07_31:81573002]
"Collagen disease NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:201454004]
"Collagen disease NOS" EXACT [MTHICD9_2006:710.9]
"Collagen disease NOS" EXACT [SNOMEDCT_2005_07_31:156458006]
"Collagen disease" EXACT [SNOMEDCT_2005_07_31:201434000]
"Collagen disease" EXACT [SNOMEDCT_2005_07_31:268048008]
"collagen disorder" EXACT [CSP2005:0729-7550]
URI: http://www.ebi.ac.uk/cellline#collagen_disease
A myeloid leukemia that is characterized by over production of white blood cells.
CML
CML - chronic Myelogenous Leukemia
Myeloid Leukemia, chronic
chronic granulocytic leukaemia
chronic granulocytic leukemia
chronic myelogenous leukaemia
chronic myelogenous leukemia
chronic myeloid leukaemia
"Biotinidase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:8808004]
"deficiency of biotinidase (disorder)" EXACT [SNOMEDCT_2005_07_31:124513002]
URI: http://www.ebi.ac.uk/cellline#biotinidase_deficiency
A lymphoma that is marked by the presence of a type of cell called the Reed-Sternberg cell.
Hodgkin disease
Hodgkin lymphoma
Hodgkin's sarcoma
Hodgkins lymphoma
stage I Subdiaphragmatic Hodgkin Lymphoma
stage II Subdiaphragmatic Hodgkin Lymphoma
URI: http://www.ebi.ac.uk/cellline#multiple_carboxylase_deficiency
"Disturbance of branched chain amino acid metabolism NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190705002]
"Disturbances of branched-chain amino-acid metabolism" EXACT [ICD9CM_2006:270.3]
"disorder of branched-chain amino acid metabolism (disorder)" EXACT [SNOMEDCT_2005_07_31:116020001]
"inborn branched chain aminoaciduria" EXACT [CSP2005:1849-1063]
disturbance of metabolism of leucine, isoleucine and valine
URI: http://www.ebi.ac.uk/cellline#disturbance_of_metabolism_of_leucine,_isoleucine_and_valine
A mature B-cell neoplasm of B-cells found in the germinal center.
Burkitt lymphoma/leukaemia
Burkitt's Lymphoma
Burkitt's tumor
Burkitt's tumor or lymphoma
malignant lymphoma, Burkitt's type
small Non-Cleaved cell Lymphoma, Burkitt's type
"Biotin-(propionyl-CoA-carboxylase) ligase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:15307001]
"Holocarboxylase synthase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:360369003]
"Holocarboxylase synthase deficiency [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:237956003]
"Multiple carboxylase deficiency - neonatal onset (disorder)" EXACT [SNOMEDCT_2005_07_31:360367001]
URI: http://www.ebi.ac.uk/cellline#holocarboxylase_synthetase_deficiency
malignant Gingival tumor
malignant neoplasm of gum
malignant neoplasm of other sites of gum
malignant tumor of gum
malignant tumour of gingiva
A gastrointestinal system cancer that is located_in the oral cavity.
malignant neoplasm of floor of mouth
A disease of anatomical entity that is located_in the central nervous system or located_in the peripheral nervous system.
URI: http://www.ebi.ac.uk/cellline#nervous_system_disease
URI: http://www.ebi.ac.uk/cellline#organic_psychosis
malignant neoplasm of tongue
A sarcoma that has_material_basis in lymphatic tissue.
lymphosarcoma has been obsoleted in NCI.
A leukemia that is located_in myeloid tissue.
Non-Lymphocytic Leukemia
leukaemia myelogenous
leukemia myelogenous
myeloid granulocytic leukaemia
myeloid granulocytic leukemia
myeloid leukaemia
"Neuropathy (disorder)" EXACT [SNOMEDCT_2005_07_31:264554005]
"Neuropathy (disorder)" EXACT [SNOMEDCT_2005_07_31:386033004]
"Neuropathy, NOS" EXACT [SNOMEDCT_2005_07_31:42658009]
URI: http://www.ebi.ac.uk/cellline#neuropathy
"Neurofibromatosis 1" EXACT [MTH:U003314]
"Neurofibromatosis, type 1 (disorder)" EXACT [SNOMEDCT_2005_07_31:92824003]
"Neurofibromatosis, type 1" EXACT [MTHICD9_2006:237.71]
"Recklinghausen's neurofibromatosis" EXACT [CSP2005:2012-7338]
"Von Recklinghausen's disease" EXACT [SNOMEDCT_2005_07_31:81669005]
"peripheral Neurofibromatosis" EXACT [NCI2004_11_17:C3273]
"von Recklinghausen's disease" EXACT [MTHICD9_2006:237.7]
URI: http://www.ebi.ac.uk/cellline#neurofibromatosis_type_1
"Neurofibromatosis (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:81669005]
"Neurofibromatosis syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:19133005]
"Neurofibromatosis" EXACT [ICD9CM_2006:237.7]
"Neurofibromatosis" EXACT [NCI2004_11_17:C6727]
"Neurofibromatosis" EXACT [SNOMEDCT_2005_07_31:154642000]
"neurofibromatosis" EXACT [CSP2005:2012-7338]
URI: http://www.ebi.ac.uk/cellline#neurofibromatosis
"Lymphosarcoma and reticulosarcoma (disorder)" EXACT [SNOMEDCT_2005_07_31:188487008]
"Other named variants of lymphosarcoma and reticulosarcoma involving intra-abdominal lymph nodes" EXACT []
"Other named variants of lymphosarcoma and reticulosarcoma involving intrapelvic lymph nodes" EXACT []
"Other named variants of lymphosarcoma and reticulosarcoma involving intrathoracic lymph nodes" EXACT []
"Other named variants of lymphosarcoma and reticulosarcoma involving lymph nodes of axilla and upper limb" EXACT []
"Other named variants of lymphosarcoma and reticulosarcoma involving lymph nodes of head, face and neck" EXACT [MTHICD9_2006:200.81]
"Other named variants of lymphosarcoma and reticulosarcoma involving lymph nodes of head, face, and neck" EXACT []
"Other named variants of lymphosarcoma and reticulosarcoma involving lymph nodes of inguinal region and lower limb" EXACT []
"Other named variants of lymphosarcoma and reticulosarcoma involving lymph nodes of multiple sites" EXACT []
"Other named variants of lymphosarcoma and reticulosarcoma involving spleen" EXACT []
"Other named variants of lymphosarcoma and reticulosarcoma" EXACT []
"Other named variants of lymphosarcoma and reticulosarcoma, unspecified site" EXACT []
URI: http://www.ebi.ac.uk/cellline#lymphosarcoma_and_reticulosarcoma
"Connective and soft tissue disease" EXACT [NCI2004_11_17:C27574]
"Connective and soft tissue disorder" EXACT [MTH:NOCODE]
"disease of deep fascial system" EXACT []
URI: http://www.ebi.ac.uk/cellline#soft_tissue_disease
An oral cavity cancer that is located_in the salivary gland.
malignant neoplasm of salivary gland
A monocytic leukemia where the majority of monocytic cells are promonocytes.
acute Monoblastic Leukemia and acute Monocytic Leukemia
acute monocytic leukaemia
acute monocytic leukaemia without mention of remission
acute monocytic leukemia without mention of remission
acute monocytic leukemia, FAB M5
acute monocytic leukemia, morphology
URI: http://www.ebi.ac.uk/cellline#inborn_metabolic_brain_disease
"mitochondrial encephalomyopathy" EXACT [CSP2005:5000-0048]
URI: http://www.ebi.ac.uk/cellline#mitochondrial_encephalomyopathy
"progressive Myoclonus epilepsy" EXACT [NCI2004_11_17:C7636]
"progressive myoclonic epilepsy (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:89480000]
"progressive myoclonic epilepsy (disorder)" EXACT [SNOMEDCT_2005_07_31:267581004]
"progressive myoclonic epilepsy" EXACT [MTHICD9_2006:333.2]
"progressive myoclonic epilepsy" EXACT [SNOMEDCT_2005_07_31:192844008]
URI: http://www.ebi.ac.uk/cellline#progressive_myoclonic_epilepsy
"Cerebral pseudosclerosis (disorder)" EXACT [SNOMEDCT_2005_07_31:192640001]
"Westphal pseudosclerosis" EXACT [CSP2005:1849-4349]
"Westphal-Strumpell syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:190823004]
"Wilson's disease (disorder)" EXACT [SNOMEDCT_2005_07_31:88518009]
"Wilson's disease * (disorder)" EXACT [SNOMEDCT_2005_07_31:191710006]
"Wilson's disease" EXACT [MTHICD9_2006:275.1]
"Wilson's disease" EXACT [SNOMEDCT_2005_07_31:154751003]
"Wilson's disease" EXACT [SNOMEDCT_2005_07_31:267504005]
URI: http://www.ebi.ac.uk/cellline#hepatolenticular_degeneration
nervous system heredodegenerative disease
URI: http://www.ebi.ac.uk/cellline#nervous_system_heredodegenerative_disease
"Copper disorder" EXACT [SNOMEDCT_2005_07_31:154751003]
"Copper disorder" EXACT [SNOMEDCT_2005_07_31:267504005]
"disorder of copper metabolism (disorder)" EXACT [SNOMEDCT_2005_07_31:79886009]
"disorder of copper metabolism NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190854000]
"disorder of copper metabolism" EXACT [ICD9CM_2006:275.1]
URI: http://www.ebi.ac.uk/cellline#disorder_of_copper_metabolism
"ANEMIA SIDEROBLASTIC" EXACT [MTH:NOCODE]
"Anemia, hypochromic with iron loading" EXACT [MTHICD9_2006:285.0]
"Sideroblastic Anemia" EXACT [NCI2004_11_17:C36078]
"Sideroblastic anaemia" EXACT [SNOMEDCT_2005_07_31:154810008]
"Sideroblastic anemia (disorder)" EXACT [SNOMEDCT_2005_07_31:41841004]
"Sideroblastic anemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:191263002]
"sideroblastic anemia" EXACT [CSP2005:0427-3427]
URI: http://www.ebi.ac.uk/cellline#sideroblastic_anemia
"inborn metal metabolism disorder" EXACT [CSP2005:4000-0215]
URI: http://www.ebi.ac.uk/cellline#inborn_errors_metal_metabolism
"Zellweger syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:88469006]
"Zellweger syndrome" EXACT [MTHICD9_2006:277.86]
"congenital iron overload" EXACT [CSP2005:1849-1804]
URI: http://www.ebi.ac.uk/cellline#Zellweger_syndrome
"peroxisomal disorder" EXACT [ICD9CM_2006:277.86]
URI: http://www.ebi.ac.uk/cellline#peroxisomal_disorder
A myeloid leukemia that is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells.
AML - acute Myeloid Leukemia
Leukemia, Myelocytic, acute
acute myeloblastic leukaemia
acute myeloblastic leukemia
acute myelogenous leukaemia
acute myelogenous leukemia
acute myeloid leukaemia
URI: http://www.ebi.ac.uk/cellline#atrophic_muscular_disorder
"Acoustic neurofibromatosis" EXACT [MTHICD9_2006:237.72]
"Neurofibromatosis 2" EXACT [MTH:NOCODE]
"Neurofibromatosis, type 2 (disorder)" EXACT [SNOMEDCT_2005_07_31:92503002]
"central Neurofibromatosis" EXACT [NCI2004_11_17:C3274]
"neurofibromatosis type 2 [acoustic neurofibromatosis]" EXACT []
URI: http://www.ebi.ac.uk/cellline#neurofibromatosis_type_2
"Wiskott syndrome" EXACT [CSP2005:1849-0285]
"Wiskott-Aldrich syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:36070007]
"Wiskott-Aldrich syndrome" EXACT [NCI2004_11_17:C3448]
URI: http://www.ebi.ac.uk/cellline#Wiskott-Aldrich_syndrome
malignant neoplasm of submaxillary gland
malignant tumor of submandibular gland
malignant tumor of the Submandibular gland
URI: http://www.ebi.ac.uk/cellline#pregnancy_complication
"Alagille syndrome" EXACT [NCI2004_11_17:C35139]
"Alagille-Watson syndrome" EXACT [CSP2005:5005-0002]
"Arteriohepatic dysplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:31742004]
URI: http://www.ebi.ac.uk/cellline#Alagille_syndrome
"Greig cephalopolysyndactyly syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:32985001]
URI: http://www.ebi.ac.uk/cellline#Greig_cephalopolysyndactyly_syndrome
URI: http://www.ebi.ac.uk/cellline#inborn_errors_of_amino_acid_metabolism
A large intestine cancer that is located_in the colon and/or located_in the rectum.
"Cerebellar hypoplasia" EXACT [SNOMEDCT_2005_07_31:204055008]
"Congenital cerebellar hypoplasia (disorder)" EXACT [SNOMEDCT_2005_07_31:16026008]
URI: http://www.ebi.ac.uk/cellline#Congenital_cerebellar_hypoplasia
"Homocystinuria (disorder)" EXACT [SNOMEDCT_2005_07_31:11282001]
"Homocystinuria [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:190709008]
"cystathionine synthase deficiency" EXACT [CSP2005:1849-0835]
URI: http://www.ebi.ac.uk/cellline#homocystinuria
"Disturbance of sulfur-bearing amino acid metabolism NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267421004]
"Disturbance of sulphur-bearing amino-acid metabolism NOS" EXACT [SNOMEDCT_2005_07_31:190712006]
"Disturbances of sulphur-bearing amino-acid metabolism" EXACT [ICD9CM_2006:270.4]
"Sulphuraminoacidaemia" EXACT [SNOMEDCT_2005_07_31:28882002]
URI: http://www.ebi.ac.uk/cellline#sulfuraminoacidemia
"Cystinuria (disorder)" EXACT [SNOMEDCT_2005_07_31:85020001]
URI: http://www.ebi.ac.uk/cellline#cystinuria
"disorder of metabolism of ornithine, citrulline, argininosuccinic acid, arginine and ammonia" EXACT []
"disorder of the urea cycle metabolism (disorder)" EXACT [SNOMEDCT_2005_07_31:36444000]
"disorder of urea cycle metabolism" EXACT [ICD9CM_2006:270.6]
URI: http://www.ebi.ac.uk/cellline#inborn_urea_cycle_disorder
"Non-ketotic hyperglycinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:237939006]
"nonketotic hyperglycinemia" EXACT [CSP2005:1849-0664]
URI: http://www.ebi.ac.uk/cellline#nonketotic_hyperglycinemia
"Ketoacidaemia" EXACT [SNOMEDCT_2005_07_31:27718001]
"Maple syrup urine disease" EXACT [MTHICD9_2006:270.3]
"branched chain ketoaciduria" EXACT [CSP2005:1849-1063]
"Maple syrup urine disease is a hereditary aminoaciduria caused by a deficiency of decarboxylase leading to high concentrations of valine, leucine, isoleucine, and alloisoleucine in the blood, urine, and cerebrospinal fluid and characterized by an odor of maple syrup to the urine, vomiting, hypertonicity, severe mental retardation, seizures, and eventually death unless the condition is treated with dietary measures." [URL:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=maple%20syrup%20urine%20disease]
URI: http://www.ebi.ac.uk/cellline#maple_syrup_urine_disease
"Alcaptonuria (disorder)" EXACT [SNOMEDCT_2005_07_31:367388008]
"Alkaptonuria (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:24250001]
"Alkaptonuria (finding)" EXACT [SNOMEDCT_2005_07_31:360381004]
"Homogentisate 1,2-dioxygenase deficiency [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:267418001]
"deficiency of homogentisicase" EXACT [SNOMEDCT_2005_07_31:124207005]
"deficiency of homogentisicase" EXACT [SNOMEDCT_2005_07_31:360378009]
URI: http://www.ebi.ac.uk/cellline#alkaptonuria
"deficiency of citrulline phosphorylase" EXACT [SNOMEDCT_2005_07_31:124249000]
"deficiency of citrulline phosphorylase" EXACT [SNOMEDCT_2005_07_31:80908008]
"ornithine transcarbamylase deficiency" EXACT [CSP2005:1849-9662]
ornithine carbamoyltransferase deficiency
URI: http://www.ebi.ac.uk/cellline#ornithine_carbamoyltransferase_deficiency
"ASS deficiency" EXACT [CSP2005:1849-9492]
"Citrullinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:15489004]
"Citrullinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:398680004]
"Citrullinuria (finding)" EXACT [SNOMEDCT_2005_07_31:398630005]
"deficiency of citrulline-aspartate ligase" EXACT [SNOMEDCT_2005_07_31:124711003]
URI: http://www.ebi.ac.uk/cellline#citrullinemia
"hyperlysinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:58558003]
"hyperlysinemia" EXACT [CSP2005:1849-0342]
"hyperlysinemia" EXACT [MTHICD9_2006:270.7]
URI: http://www.ebi.ac.uk/cellline#hyperlysinemia
"Tyrosinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:190694001]
"hypertyrosinemia (disorder)" EXACT [SNOMEDCT_2005_07_31:56595005]
"hypertyrosinemia" EXACT [MTHICD9_2006:270.2]
URI: http://www.ebi.ac.uk/cellline#tyrosinemia
"Arginase deficiency (disorder)" EXACT [SNOMEDCT_2005_07_31:23501004]
"deficiency of canavanase" EXACT [SNOMEDCT_2005_07_31:124518006]
URI: http://www.ebi.ac.uk/cellline#hyperargininemia
carbamoyl-phosphate synthase I deficiency disease
URI: http://www.ebi.ac.uk/cellline#carbamoyl-phosphate_synthase_I_deficiency_disease
"Phenylketonuria [PKU]" EXACT [ICD9CM_2006:270.1]
"Phenylketonuria" EXACT [SNOMEDCT_2005_07_31:154735006]
"Phenylketonuria" EXACT [SNOMEDCT_2005_07_31:190687004]
"phenylalaninemia" EXACT [CSP2005:1849-1177]
URI: http://www.ebi.ac.uk/cellline#phenylketonuria
"Complete unilateral cleft lip (disorder)" EXACT [SNOMEDCT_2005_07_31:62696001]
"Labium leporinum" EXACT [MTHICD9_2006:749.1]
"cleft lip (disorder)" EXACT [SNOMEDCT_2005_07_31:80281008]
"cleft lip NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:204609007]
"cleft lip, unilateral, complete" EXACT [ICD9CM_2006:749.11]
"cleft lip, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:204606000]
"cleft lip, unspecified" EXACT [ICD9CM_2006:749.10]
"complete unilateral cleft lip" EXACT []
URI: http://www.ebi.ac.uk/cellline#cleft_lip
"Lip disorder" EXACT [NCI2004_11_17:C26818]
"disease of lips NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:196563002]
"disease of lips" EXACT [ICD9CM_2006:528.5]
"disorder of lip (disorder)" EXACT [SNOMEDCT_2005_07_31:90678009]
URI: http://www.ebi.ac.uk/cellline#lip_disease
"Viral Infection" EXACT [NCI2004_11_17:C3439]
"Viral disease (disorder)" EXACT [SNOMEDCT_2005_07_31:34014006]
"Viral disease" EXACT [SNOMEDCT_2005_07_31:154319002]
"Viral disease" EXACT [SNOMEDCT_2005_07_31:266188005]
"Viral infection NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:266116004]
"Viral infection NOS" EXACT [MTHICD9_2006:079.99]
"Viral infection NOS" EXACT [SNOMEDCT_2005_07_31:154372003]
"Viral infection, unspecified (disorder)" EXACT [SNOMEDCT_2005_07_31:187471008]
"Viral: [infection NOS] or [illness]" EXACT [SNOMEDCT_2005_07_31:186754003]
"virus infection" EXACT [CSP2005:3099-7852]
"virus infection" EXACT [CSP2005:3099-8150]
URI: http://www.ebi.ac.uk/cellline#viral_infectious_disease
"Complete unilateral cleft palate with cleft lip (disorder)" EXACT [SNOMEDCT_2005_07_31:50484006]
"Unilateral complete cleft palate with cleft lip (disorder)" EXACT [SNOMEDCT_2005_07_31:204612005]
"Unilateral complete cleft palate with cleft lip" EXACT []
"Unilateral incomplete cleft palate with cleft lip (disorder)" EXACT [SNOMEDCT_2005_07_31:204613000]
"Unilateral incomplete cleft palate with cleft lip" EXACT []
"cleft palate with cleft lip, unilateral, complete" EXACT [ICD9CM_2006:749.21]
"cleft palate with cleft lip, unilateral, incomplete" EXACT [ICD9CM_2006:749.22]
"incomplete unilateral cleft palate with cleft lip (disorder)" EXACT [SNOMEDCT_2005_07_31:18474007]
URI: http://www.ebi.ac.uk/cellline#cheilopalatoschisis
URI: http://www.ebi.ac.uk/cellline#brain_disease
URI: http://www.ebi.ac.uk/cellline#DNA_virus_infectious_disease
URI: http://www.ebi.ac.uk/cellline#lipid_disorder
URI: http://www.ebi.ac.uk/cellline#leukocyte_disease
multiple myeloma and immunoproliferative neoplasm
URI: http://www.ebi.ac.uk/cellline#multiple_myeloma_and_immunoproliferative_neoplasm
A myeloid neoplasm that is located_in the plasma cells in bone marrow.
"skin vascular disorder" EXACT [NCI2004_11_17:C35254]
"vascular disease of the skin (disorder)" EXACT [SNOMEDCT_2005_07_31:11263005]
"vascular disorder of skin NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:267820009]
"vascular disorder of skin NOS" EXACT [SNOMEDCT_2005_07_31:201306008]
"vascular disorder of skin" EXACT [ICD9CM_2006:709.1]
URI: http://www.ebi.ac.uk/cellline#vascular_skin_disease
URI: http://www.ebi.ac.uk/cellline#adrenal_gland_hypofunction
An endocrine system disease that is located_in the adrenal gland.
URI: http://www.ebi.ac.uk/cellline#adrenal_gland_disease
URI: http://www.ebi.ac.uk/cellline#biliary_tract_disease
hematological disorder of fetus and newborn
URI: http://www.ebi.ac.uk/cellline#hematological_disorder_of_fetus_and_newborn
URI: http://www.ebi.ac.uk/cellline#Hereditary_choroidal_atrophy
URI: http://www.ebi.ac.uk/cellline#degenerative_disorder_of_eye
"Choroidal degeneration (disorder)" EXACT [SNOMEDCT_2005_07_31:406446000]
"Choroidal degeneration (disorder)" EXACT [SNOMEDCT_2005_07_31:47638000]
"Choroidal degeneration, unspecified" EXACT [ICD9CM_2006:363.40]
"Choroidal degenerations NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:193464000]
"Choroidal degenerations" EXACT [ICD9CM_2006:363.4]
"Choroidal sclerosis (finding)" EXACT [SNOMEDCT_2005_07_31:247199007]
"Sclerosis of choroid NOS" EXACT [SNOMEDCT_2005_07_31:193461008]
"Unspecified choroidal degeneration (disorder)" EXACT [SNOMEDCT_2005_07_31:267617003]
URI: http://www.ebi.ac.uk/cellline#choroidal_sclerosis
"Choroideremia (disorder)" EXACT [SNOMEDCT_2005_07_31:75241009]
"choroideremia" EXACT [CSP2005:1114-9583]
"progressive Choroidal Atrophy" EXACT [NCI2004_11_17:C34469]
URI: http://www.ebi.ac.uk/cellline#choroideremia
"Galactosaemia" EXACT [SNOMEDCT_2005_07_31:154738008]
"Galactosaemia" EXACT [SNOMEDCT_2005_07_31:267498002]
"Galactose intolerance" EXACT [SNOMEDCT_2005_07_31:190749000]
"Galactosemia (disorder) [Ambiguous]" EXACT [SNOMEDCT_2005_07_31:38177000]
"Galactosemia (disorder)" EXACT [SNOMEDCT_2005_07_31:190745006]
"Galactosemia NOS (disorder)" EXACT [SNOMEDCT_2005_07_31:190747003]
"Galactosemia" EXACT [ICD9CM_2006:271.1]
"galactosemia" EXACT [CSP2005:1849-3608]
URI: http://www.ebi.ac.uk/cellline#galactosemia
A acute leukemia that is characterized by over production of lymphoblasts.
acute lymphoblastic leukaemia
acute lymphocytic leukaemia
precursor lymphoblastic lymphoma/leukemia
"Hypoplastic left heart syndrome (disorder)" EXACT [SNOMEDCT_2005_07_31:62067003]
"Hypoplastic left heart syndrome" EXACT [ICD9CM_2006:746.7]
URI: http://www.ebi.ac.uk/cellline#hypoplastic_left_heart_syndrome
URI: http://www.ebi.ac.uk/cellline#malignant_eye_neoplasm
The production of new individuals that contain some portion of genetic material inherited from one or more parent organisms.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising microtubules and their associated proteins.
microtubule cytoskeleton organization and biogenesis
The chemical reactions and pathways resulting in the formation of a polysaccharide, a polymer of many (typically more than 10) monosaccharide residues linked glycosidically.
The chemical reactions and pathways resulting in the breakdown of a polysaccharide, a polymer of many (typically more than 10) monosaccharide residues linked glycosidically.
multicellular organismal polysaccharide catabolic process
Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent.
Note that this term should not be confused with 'GO:0140014 ; mitotic nuclear division'. 'GO:0000278 ; mitotic cell cycle represents the entire mitotic cell cycle, while 'GO:0140014 ; mitotic nuclear division' specifically represents the actual nuclear division step of the mitotic cell cycle.
The division of a cell nucleus into two nuclei, with DNA and other nuclear contents distributed between the daughter nuclei.
A vacuole that is maintained at an acidic pH and which contains degradative enzymes, including a wide variety of acid hydrolases.
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
Chromosomes include parts that are not part of the chromatin. Examples include the kinetochore.
A dispersed and relatively uncompacted form of chromatin that is in a transcription-competent conformation.
A compact and highly condensed form of chromatin that is refractory to transcription.
Any process that modulates levels of neurotransmitter.
A process in which membrane potential cycles through a depolarizing spike, triggered in response to depolarization above some threshold, followed by repolarization. This cycle is driven by the flow of ions through various voltage gated channels with different thresholds and ion specificities.
Action potentials typically propagate across excitable membranes. This class covers both action potentials that propagate and those that fail to do so.
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
blood vessel formation from pre-existing blood vessels
Cell motility due to movement of eukaryotic cilia or bacterial-type flagella or archaeal-type flagella.
ciliary or bacterial-type flagellar motility
Note that we deem eukaryotic cilia and microtubule-based flagella to be equivalent, while the bacterial- and archaeal-type flagella have a different structure. The former are microtubule-based structures that lash back and forth and are present only in eukaryotes, while the latter achieve motility by rotation. Bacterial- and archaeal-type flagella are superficially similar but have a different molecular composition and fine structure. These three structures never co-exist in the same organism. Therefore, GO:0001539 'cilium or flagellum-dependent cell motility' is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term. Direct annotations to GO:0001539 'cilium or flagellum-dependent cell motility' may be amended during annotation QC.
cilium or flagellum-dependent cell motility
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
A process that results in a parallel arrangement of microtubules.
Cell migration that is accomplished by extension and retraction of a pseudopodium.
Note that this term refers to a mode of migration rather than to any particular cell type.
A structure in the head of a spermatozoon that contains acid hydrolases, and is concerned with the breakdown of the outer membrane of the ovum during fertilization. It lies just beneath the plasma membrane and is derived from the lysosome.
The formation of the acrosome from the spermatid Golgi.
Formation of a complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2 (either eIF2 in eukaryotes, or IF2 in prokaryotes). In prokaryotes, fMet-tRNA (initiator) is used rather than Met-tRNA (initiator).
translation initiation ternary complex assembly
formation of translation initiation ternary complex
The regulated release of gastric acid (hydrochloric acid) by parietal or oxyntic cells during digestion.
The formation of the ectoderm, mesoderm and endoderm during gastrulation.
The formation of ectoderm during gastrulation.
The formation of the endoderm during gastrulation.
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
The process in which the anatomical structures of branches are generated and organized. A branch is a division or offshoot from a main stem. Examples in animals would include blood vessels, nerves, lymphatics and other endothelial or epithelial tubes.
The change in morphology and behavior of a dendritic cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select one of the 'regulation' children terms.
The regulated release of histamine by a cell or tissue. It is formed by decarboxylation of histidine and it acts through receptors in smooth muscle and in secretory systems.
The morphogenesis of an embryonic epithelium into a tube-shaped structure.
The formation of a tube from the flat layer of ectodermal cells known as the neural plate. This will give rise to the central nervous system.
A homeostatic process involved in the maintenance of an internal steady state within a defined tissue of an organism, including control of cellular proliferation and death and control of metabolic function.
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
The process in which hormones modulate the force with which blood passes through the circulatory system. A hormone is one of a group of substances formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells, in the same organism, upon which they have a specific regulatory action.
regulation of systemic arterial blood pressure by hormone
The regulation of blood pressure mediated by the signaling molecule vasopressin. Vasopressin is produced in the hypothalamus, and affects vasoconstriction, and renal water transport.
blood pressure regulation by vasopressin
regulation of systemic arterial blood pressure by vasopressin
The process in which the anatomical structures of epithelia are generated and organized. An epithelium consists of closely packed cells arranged in one or more layers, that covers the outer surfaces of the body or lines any internal cavity or tube.
Any process that modulates the frequency or rate of heart contraction.
The somatic process allowing for the production of immune receptors whose specificity is not encoded in the germline genomic sequences.
Note that this process covers somatic recombination, gene conversion, hypermutation, N-region addition, and alternate splicing processes of immune receptor diversification.
somatic diversification of immune receptors
The process in which immunoglobulin genes are formed through recombination of the germline genetic elements, also known as immunoglobulin gene segments, within a single locus following the induction of and contributing to an immune response.
somatic recombination of antibody genes during immune response
somatic recombination of immunoglobulin genes during immune response
somatic recombination of immunoglobulin genes involved in immune response
The somatic process that results in the generation of sequence diversity of immunoglobulins after induction, and contributes to an immune response.
somatic diversification of antibodies during immune response
somatic diversification of immunoglobulins during immune response
somatic diversification of immunoglobulins involved in immune response
The promotion of an immune response by natural killer cells through direct recognition of target cells or through the release of cytokines.
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
haematopoietic progenitor cell differentiation
haemopoietic progenitor cell differentiation
hemopoietic progenitor cell differentiation
hematopoietic progenitor cell differentiation
An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
An immune response taking place in an organ or tissues such as the liver, brain, mucosa, or nervous system tissues.
organ or tissue specific immune response
Any process of the immune system that executes a component of an immune response. An effector immune process takes place after its activation.
The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response.
cell activation involved in immune response
A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand.
A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
lymphocyte activation during immune response
lymphocyte activation involved in immune response
The change in morphology and behavior of a mature or immature B cell during an immune response, resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
B cell activation during immune response
B lymphocyte activation during immune response
B-cell activation during immune response
B-lymphocyte activation during immune response
B cell activation involved in immune response
The process in which transitional stage B cells acquire the specialized features of mature B cells in the spleen.
Note that immunologists typically use the word 'development' to refer to cells of B or T cell lineages undergoing the process that GO describes as 'cell differentiation'.
The synthesis or release of histamine following a stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
histamine production involved in acute inflammatory response
histamine production involved in inflammatory response
A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response.
immune cell activation during immune response
leucocyte activation during immune response
leukocyte activation during immune response
leukocyte activation involved in immune response
Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
Note that this term is a direct child of 'biological_process ; GO:0008150' because some immune system processes are types of cellular process (GO:0009987), whereas others are types of multicellular organism process (GO:0032501).
The appearance of immunoglobulin due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
The appearance of immunoglobulin due to biosynthesis or secretion following a cellular stimulus during an immune response, resulting in an increase in its intracellular or extracellular levels.
immunoglobulin production involved in immunoglobulin mediated immune response
immunoglobulin biosynthetic process involved in immune response
immunoglobulin secretion involved in immune response
antibody production during immune response
antibody secretion during immune response
immunoglobulin production during immune response
immunoglobulin production involved in immune response
immunoglobulin production involved in immunoglobulin-mediated immune response
An immune response taking place in the liver.
The synthesis or release of any molecular mediator of the immune response, resulting in an increase in its intracellular or extracellular levels.
production of cellular mediator of immune response
production of molecular mediator of immune response
Any process involved in the carrying out of an immune response by a leukocyte.
Any process involved in the carrying out of an immune response by a lymphocyte.
Any process involved in the carrying out of an immune response by a T cell.
An immune response mediated by lymphocytes expressing specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains. Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies) produced by B cells. The first encounter with antigen elicits a primary immune response that is slow and not of great magnitude. T and B cells selected by antigen become activated and undergo clonal expansion. A fraction of antigen-reactive T and B cells become memory cells, whereas others differentiate into effector cells. The memory cells generated during the primary response enable a much faster and stronger secondary immune response upon subsequent exposures to the same antigen (immunological memory). An example of this is the adaptive immune response found in Mus musculus.
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Tolerance induction dependent upon an immune response, typically a response by a mature T or B cell in the periphery resulting tolerance towards an antigen via induction of anergy, cellular deletion, or regulatory T cell activation.
immune response-dependent tolerance induction
tolerance induction dependent upon immune response
Tolerance induction in the peripheral lymphoid tissues: blood, lymph nodes, spleen, and mucosal-associated lymphoid tissues.
The process in which an antigen-presenting cell expresses antigen (peptide or polysaccharide) on its cell surface in association with an MHC class II protein complex.
peptide or polysaccharide antigen processing and presentation of via MHC class II
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II
A process that directly activates any of the steps required for tolerance, a physiologic state in which the immune system does not react destructively against the components of an organism that harbors it or against antigens that are introduced to it.
The process whose specific outcome is the progression of an organismal system whose objective is to provide calibrated responses by an organism to a potential internal or invasive threat, over time, from its formation to the mature structure. A system is a regularly interacting or interdependent group of organs or tissues that work together to carry out a given biological process.
The process in which a relatively unspecialized hemopoietic precursor cell acquires the specialized features of a leukocyte. A leukocyte is an achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue.
The synthesis or release of any molecular mediator of the inflammatory response following an inflammatory stimulus, resulting in an increase in its intracellular or extracellular levels.
production of molecular mediator involved in acute inflammatory response
production of cellular mediator of acute inflammation
production of molecular mediator involved in inflammatory response
The synthesis or release of products of arachidonic acid metabolism following a stimulus as part of an inflammatory response, resulting in an increase in their intracellular or extracellular levels.
arachidonic acid metabolite production involved in acute inflammatory response
production of arachidonic acid metabolites involved in acute inflammatory response
production of arachidonic acid metabolites involved in inflammatory response
arachidonic acid metabolite production involved in inflammatory response
The synthesis or release of any prostaglandin following a stimulus as part of an inflammatory response, resulting in an increase in its intracellular or extracellular levels.
prostaglandin production involved in acute inflammatory response
prostaglandin production involved in inflammatory response
The process in which immune receptor genes are diversified through recombination of the germline genetic elements within a single genetic locus.
somatic diversification of immune receptors via germline recombination within a single locus
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte lineage.
Any process that modulates the frequency, rate, or extent of tolerance induction.
Any process that activates or increases the frequency, rate, or extent of tolerance induction.
positive regulation of tolerance induction
Any process that modulates the frequency, rate, or extent of tolerance induction dependent upon immune response.
regulation of immune response-dependent tolerance induction
regulation of tolerance induction dependent upon immune response
Any process that activates or increases the frequency, rate, or extent of tolerance induction dependent upon immune response.
positive regulation of immune response-dependent tolerance induction
up regulation of tolerance induction dependent upon immune response
up-regulation of tolerance induction dependent upon immune response
upregulation of tolerance induction dependent upon immune response
activation of tolerance induction dependent upon immune response
stimulation of tolerance induction dependent upon immune response
positive regulation of tolerance induction dependent upon immune response
Any process that modulates the frequency, rate, or extent of peripheral tolerance induction.
regulation of peripheral tolerance induction
Any process that activates or increases the frequency, rate, or extent of peripheral tolerance induction.
up regulation of peripheral tolerance induction
up-regulation of peripheral tolerance induction
upregulation of peripheral tolerance induction
activation of peripheral tolerance induction
stimulation of peripheral tolerance induction
positive regulation of peripheral tolerance induction
Any process that modulates the frequency, rate, or extent of an immune system process.
Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune system process.
down regulation of immune system process
down-regulation of immune system process
negative regulation of immune system process
Any process that activates or increases the frequency, rate, or extent of an immune system process.
positive regulation of immune system process
Any process that modulates the frequency, rate, or extent of leukocyte migration.
Any process that activates or increases the frequency, rate, or extent of leukocyte migration.
positive regulation of immune cell migration
positive regulation of leucocyte migration
positive regulation of leukocyte migration
Any process that modulates the frequency, rate, or extent of leukocyte chemotaxis.
Any process that activates or increases the frequency, rate, or extent of leukocyte chemotaxis.
positive regulation of immune cell chemotaxis
positive regulation of leucocyte chemotaxis
positive regulation of leukocyte chemotaxis
Any process that modulates the frequency, rate, or extent of leukocyte activation.
The synthesis or release of an antimicrobial peptide during an immune response, resulting in an increase in intracellular or extracellular levels. Such peptides may have protective properties against bacteria, fungi, viruses, or protozoa.
The regulated release of an antimicrobial peptide from a cell or a tissue. Such peptides may have protective properties against bacteria, fungi, viruses, or protozoa.
The controlled release of a peptide from a cell or a tissue.
Any process that modulates the frequency, rate, or extent of an adaptive immune response.
Any process that activates or increases the frequency, rate, or extent of an adaptive immune response.
up regulation of adaptive immune response
up-regulation of adaptive immune response
upregulation of adaptive immune response
positive regulation of adaptive immune response
Any process that modulates the frequency, rate, or extent of an adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. An example of this process is found in the Gnathostomata.
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Any process that activates or increases the frequency, rate, or extent of an adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. An example of this process is found in the Gnathostomata.
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Any process that modulates the frequency, rate, or extent of a type 2 immune response.
regulation of T-helper 2 type immune response
Any process that activates or increases the frequency, rate, or extent of a type 2 immune response.
positive regulation of T-helper 2 type immune response
positive regulation of Th2 immune response
positive regulation of type 2 immune response
A developmental process in which a progressive change in the state of some part of an organism, germline or somatic, specifically contributes to its ability to form offspring.
developmental process involved in reproduction
A multicellular organismal process carried out by any of the organs or tissues in an organ system. An organ system is a regularly interacting or interdependent group of organs or tissues that work together to carry out a biological objective.
A organ system process carried out at the level of a muscle. Muscle tissue is composed of contractile cells or fibers.
A organ system process carried out by any of the organs or tissues of the circulatory system. The circulatory system is an organ system that moves extracellular fluids to and from tissue within a multicellular organism.
A organ system process carried out by any of the organs or tissues of the renal system. The renal system maintains fluid balance, and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels; in other species, the renal system may comprise related structures (e.g., nephrocytes and malpighian tubules in Drosophila).
A circulatory system process carried out by the heart. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
A process carried out by the organs or tissues of the respiratory system. The respiratory system is an organ system responsible for respiratory gaseous exchange.
The regulation of blood pressure mediated by biochemical signaling: hormonal, autocrine or paracrine.
blood pressure regulation mediated by a chemical signal
regulation of systemic arterial blood pressure mediated by a chemical signal
The process that modulates the force with which blood travels through the systemic arterial circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
regulation of systemic arterial blood pressure
The process in which plasma is filtered through the glomerular membrane which consists of capillary endothelial cells, the basement membrane, and epithelial cells. The glomerular filtrate is the same as plasma except it has no significant amount of protein.
The directed, self-propelled movement of a cilium.
Note that we deem cilium and microtubule-based flagellum to be equivalent.
A molecular process that can be carried out by the action of a single macromolecular machine, usually via direct physical interactions with other molecular entities. Function in this sense denotes an action, or activity, that a gene product (or a complex) performs. These actions are described from two distinct but related perspectives: (1) biochemical activity, and (2) role as a component in a larger system/process.
Note that, in addition to forming the root of the molecular function ontology, this term is recommended for use for the annotation of gene products whose molecular function is unknown. When this term is used for annotation, it indicates that no information was available about the molecular function of the gene product annotated as of the date the annotation was made; the evidence code 'no data' (ND), is used to indicate this. Despite its name, this is not a type of 'function' in the sense typically defined by upper ontologies such as Basic Formal Ontology (BFO). It is instead a BFO:process carried out by a single gene product or complex.
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
transmembrane signalling receptor activity
This term includes intracellular membrane receptors, e.g. IP3 triggered release of Ca2+ from intracellular stores.
transmembrane signaling receptor activity
Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
Epstein-Barr Virus-induced receptor activity
G-protein coupled receptor activity, unknown ligand
orphan G protein coupled receptor activity
orphan G-protein coupled receptor activity
super conserved receptor expressed in brain receptor activity
Enables the directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells.
Some transporters, such as certain members of the SLC family, are referred to as 'carriers'; however GO uses carrier with a different meaning: a carrier binds to and transports the substance (see GO:0140104 molecular carrier activity), whereas a transporter forms some pore that allows the passing of molecules.
The selective, non-covalent, often stoichiometric, interaction of a molecule with one or more specific sites on another molecule.
Note that this term is in the subset of terms that should not be used for direct, manual gene product annotation. Please choose a more specific child term, or request a new one if no suitable term is available. For ligands that bind to signal transducing receptors, consider the molecular function term 'receptor binding ; GO:0005102' and its children.
A location, relative to cellular compartments and structures, occupied by a macromolecular machine when it carries out a molecular function. There are two ways in which the gene ontology describes locations of gene products: (1) relative to cellular structures (e.g., cytoplasmic side of plasma membrane) or compartments (e.g., mitochondrion), and (2) the stable macromolecular complexes of which they are parts (e.g., the ribosome).
Note that, in addition to forming the root of the cellular component ontology, this term is recommended for use for the annotation of gene products whose cellular component is unknown. When this term is used for annotation, it indicates that no information was available about the cellular component of the gene product annotated as of the date the annotation was made; the evidence code 'no data' (ND), is used to indicate this.
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
Note that this term is intended to annotate gene products that are not attached to the cell surface. For gene products from multicellular organisms which are secreted from a cell but retained within the organism (i.e. released into the interstitial fluid or blood), consider the cellular component term 'extracellular space ; GO:0005615'.
A highly soluble, elongated protein complex found in blood plasma and involved in clot formation. It is converted into fibrin monomer by the action of thrombin. In the mouse, fibrinogen is a hexamer, 46 nm long and 9 nm maximal diameter, containing two sets of nonidentical chains (alpha, beta, and gamma) linked together by disulfide bonds.
A protein complex consisting of three collagen chains assembled into a left-handed triple helix. These trimers typically assemble into higher order structures.
A collagen heterotrimer containing type IV alpha chains; [alpha1(IV)]2alpha2(IV) trimers are commonly observed, although more type IV alpha chains exist and may be present in type IV trimers; type IV collagen triple helices associate to form 3 dimensional nets within basement membranes.
A collagen-containing extracellular matrix consisting of a thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers.
Note that this term has no relationship to 'membrane ; GO:0016020' because the basement membrane is not a lipid bilayer.
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
Note that for multicellular organisms, the extracellular space refers to everything outside a cell, but still within the organism (excluding the extracellular matrix). Gene products from a multi-cellular organism that are secreted from a cell into the interstitial fluid or blood can therefore be annotated to this term.
A component of a cell contained within (but not including) the plasma membrane. In eukaryotes it includes the nucleus and cytoplasm.
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information.
A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
A lysosome before it has fused with a vesicle or vacuole.
A closed structure, found only in eukaryotic cells, that is completely surrounded by unit membrane and contains liquid material. Cells contain one or several vacuoles, that may have different functions from each other. Vacuoles have a diverse array of functions. They can act as a storage organelle for nutrients or waste products, as a degradative compartment, as a cost-effective way of increasing cell size, and as a homeostatic regulator controlling both turgor pressure and pH of the cytosol.
A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Note that the Golgi apparatus can be located in various places in the cytoplasm. In plants and lower animal cells, the Golgi apparatus exists as many copies of discrete stacks dispersed throughout the cytoplasm, while the Golgi apparatus of interphase mammalian cells is a juxtanuclear, often pericentriolar reticulum, where the discrete Golgi stacks are stitched together to form a compact and interconnected ribbon, sometimes called the Golgi ribbon.
Any vesicle associated with the Golgi complex and involved in mediating transport within the Golgi or between the Golgi and other parts of the cell.
Note that this definition includes vesicles that are transiently associated with the Golgi.
An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.
Any of the various filamentous elements that form the internal framework of cells, and typically remain after treatment of the cells with mild detergent to remove membrane constituents and soluble components of the cytoplasm. The term embraces intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles.
Any of the long, generally straight, hollow tubes of internal diameter 12-15 nm and external diameter 24 nm found in a wide variety of eukaryotic cells; each consists (usually) of 13 protofilaments of polymeric tubulin, staggered in such a manner that the tubulin monomers are arranged in a helical pattern on the microtubular surface, and with the alpha/beta axes of the tubulin subunits parallel to the long axis of the tubule; exist in equilibrium with pool of tubulin monomers and can be rapidly assembled or disassembled in response to physiological stimuli; concerned with force generation, e.g. in the spindle.
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
A cell junction that forms a connection between two or more cells of an organism; excludes direct cytoplasmic intercellular bridges, such as ring canals in insects.
A specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface and of some cytoplasmic parts. Each cilium is largely bounded by an extrusion of the cytoplasmic (plasma) membrane, and contains a regular longitudinal array of microtubules, anchored to a basal body.
Note that we deem cilium and microtubule-based flagellum to be equivalent. In most eukaryotic species, intracellular sub-components of the cilium, such as the ciliary base and rootlet, are located near the plasma membrane. In Diplomonads such as Giardia, instead, the same ciliary parts are located further intracellularly. Also, 'cilium' may be used when axonemal structure and/or motility are unknown, or when axonemal structure is unusual. For all other cases, please refer to children of 'cilium'. Finally, note that any role of ciliary proteins in sensory events should be captured by annotating to relevant biological process terms.
The bundle of microtubules and associated proteins that forms the core of cilia (also called flagella) in eukaryotic cells and is responsible for their movements.
Note that cilia and eukaryotic flagella are deemed to be equivalent. In diplomonad species, such as Giardia, the axoneme may extend intracellularly up to 5um away from the plane of the plasma membrane.
The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule.
multicellular organismal carbohydrate metabolic process
single-organism carbohydrate metabolic process
The chemical reactions and pathways involving a polysaccharide, a polymer of many (typically more than 10) monosaccharide residues linked glycosidically.
multicellular organismal polysaccharide metabolic process
The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha-(1->4) glycosidic linkage, joined together by alpha-(1->6) glycosidic linkages.
The chemical reactions and pathways resulting in the formation of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues.
The chemical reactions and pathways resulting in the breakdown of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues.
The chemical reactions and pathways involving aminoglycans, any polymer containing amino groups that consists of more than about 10 monosaccharide residues joined to each other by glycosidic linkages.
The chemical reactions and pathways resulting in the formation of aminoglycans, any polymer containing amino groups that consists of more than about 10 monosaccharide residues joined to each other by glycosidic linkages.
The chemical reactions and pathways resulting in the formation of glycosaminoglycans, any of a group of polysaccharides that contain amino sugars.
The chemical reactions and pathways involving glucans, polysaccharides consisting only of glucose residues, occurring at the level of an individual cell.
The chemical reactions and pathways involving organic acids, any acidic compound containing carbon in covalent linkage.
The chemical reactions and pathways resulting in the formation of precursor metabolites, substances from which energy is derived, and any process involved in the liberation of energy from these substances.
generation of precursor metabolites and energy
The chemical reactions and pathways by which a cell derives energy from stored compounds such as fats or glycogen.
Any cellular metabolic process involving nucleobases, nucleosides, nucleotides and nucleic acids.
cellular nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
cellular nucleobase, nucleoside, nucleotide and nucleic acid metabolism
nucleobase, nucleoside, nucleotide and nucleic acid metabolism
nucleobase, nucleoside and nucleotide metabolic process
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
nucleobase-containing compound metabolic process
Any cellular metabolic process involving deoxyribonucleic acid. This is one of the two main types of nucleic acid, consisting of a long, unbranched macromolecule formed from one, or more commonly, two, strands of linked deoxyribonucleotides.
Any process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents. In eukaryotes genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination. Interchromosomal recombination occurs by crossing over. In bacteria it may occur by genetic transformation, conjugation, transduction, or F-duction.
Any process in which DNA and associated proteins are formed into a compact, orderly structure.
The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the ribosome, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome.
The process preceding formation of the peptide bond between the first two amino acids of a protein. This includes the formation of a complex of the ribosome, mRNA or circRNA, and an initiation complex that contains the first aminoacyl-tRNA.
The successive addition of amino acid residues to a nascent polypeptide chain during protein biosynthesis.
The process resulting in the release of a polypeptide chain from the ribosome, usually in response to a termination codon (UAA, UAG, or UGA in the universal genetic code).
The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.
The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
The chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus; includes de novo formation and steroid interconversion by modification.
The chemical reactions and pathways resulting in the formation of bile acids, any of a group of steroid carboxylic acids occurring in bile.
The chemical reactions and pathways involving aromatic compounds, any organic compound characterized by one or more planar rings, each of which contains conjugated double bonds and delocalized pi electrons, as carried out by individual cells.
cellular aromatic compound metabolic process
The chemical reactions and pathways involving the nonmetallic element sulfur or compounds that contain sulfur, such as the amino acids methionine and cysteine or the tripeptide glutathione.
The chemical reactions and pathways involving organic or inorganic compounds that contain nitrogen.
The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein.
Note that this term should not be used for direct annotation. It should be possible to make a more specific annotation to one of the children of this term, for e.g. to transmembrane transport, to microtubule-based transport or to vesicle-mediated transport.
The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of cations, atoms or small molecules with a net positive charge, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
di-, tri-valent inorganic cation transport
The directed movement of anions, atoms or small molecules with a net negative charge, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Neurotransmitters are any chemical substance that is capable of transmitting (or inhibiting the transmission of) a nerve impulse from a neuron to another cell.
The directed movement of amino acids, organic acids containing one or more amino substituents, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
A process of secretion by a cell that results in the release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle. Exocytosis can occur either by full fusion, when the vesicle collapses into the plasma membrane, or by a kiss-and-run mechanism that involves the formation of a transient contact, a pore, between a granule (for exemple of chromaffin cells) and the plasma membrane. The latter process most of the time leads to only partial secretion of the granule content. Exocytosis begins with steps that prepare vesicles for fusion with the membrane (tethering and docking) and ends when molecules are secreted from the cell.
The process in which vesicles are directed to specific destination membranes. Targeting involves coordinated interactions among cytoskeletal elements (microtubules or actin filaments), motor proteins, molecules at the vesicle membrane and target membrane surfaces, and vesicle cargo.
Fusion of the membrane of a transport vesicle with its target membrane.
A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
The breakdown of structures such as organelles, proteins, or other macromolecular structures during apoptosis.
cellular component disassembly involved in apoptotic process
cellular component disassembly involved in apoptosis
cellular component disassembly involved in execution phase of apoptosis
The directed, self-propelled movement of a cell or subcellular component without the involvement of an external agent such as a transporter or a pore.
Note that in GO cellular components include whole cells (cell is_a cellular component).
movement of cell or subcellular component
The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
A process in which force is generated within muscle tissue, resulting in a change in muscle geometry. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
Note that this term is in the subset of terms that should not be used for direct gene product annotation. Instead, select a child term or, if no appropriate child term exists, please request a new term. Direct annotations to this term may be amended during annotation QC.
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
An immune response mediated through a body fluid.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an organelle within a cell. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nucleus.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures.
cytoskeletal organization and biogenesis
cytoskeleton organization and biogenesis
Any cellular process that depends upon or alters the microtubule cytoskeleton, that part of the cytoskeleton comprising microtubules and their associated proteins.
A microtubule-based process that results in the movement of organelles, other microtubules, or other cellular components. Examples include motor-driven movement along microtubules and movement driven by polymerization or depolymerization of microtubules.
The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.
A mitotic cell cycle in which chromosomes are replicated and sister chromatids separate, but spindle formation, nuclear membrane breakdown and nuclear division do not occur, resulting in an increased number of chromosomes in the cell.
Note that this term should not be confused with 'abortive mitotic cell cycle ; GO:0033277'. Although abortive mitosis is sometimes called endomitosis, GO:0033277 refers to a process in which a mitotic spindle forms and chromosome separation begins.
The second nuclear division of meiosis, in which the two chromatids in each chromosome are separated, resulting in four daughter nuclei from the two nuclei produced in meiosis II.
A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the male germline.
A cell cycle process comprising the steps by which a cell progresses through male meiosis II, the second meiotic division in the male germline.
A cell cycle process by which the cell nucleus divides as part of a meiotic cell cycle in the female germline.
Note that female germ lines can be found in female or hermaphroditic organisms, so this term can be used to annotate gene products from hermaphrodites such as those of C. elegans. See also the biological process term 'meiotic nuclear division; GO:0140013'.
Any process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment.
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
signal transduction by cis-phosphorylation
signal transduction by conformational transition
signal transduction by protein phosphorylation
signal transduction by trans-phosphorylation
Note that signal transduction is defined broadly to include a ligand interacting with a receptor, downstream signaling steps and a response being triggered. A change in form of the signal in every step is not necessary. Note that in many cases the end of this process is regulation of the initiation of transcription. Note that specific transcription factors may be annotated to this term, but core/general transcription machinery such as RNA polymerase should not.
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
cell surface receptor linked signal transduction
cell surface receptor linked signaling pathway
cell surface receptor linked signalling pathway
A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane.
G protein coupled receptor protein signaling pathway
G protein coupled receptor protein signalling pathway
G-protein coupled receptor protein signal transduction
G-protein coupled receptor protein signaling pathway
G-protein coupled receptor signalling pathway
G-protein-coupled receptor protein signalling pathway
G-protein coupled receptor signaling pathway via GPCR dimer
dimeric G-protein coupled receptor signaling pathway
dimeric G-protein coupled receptor signalling pathway
G protein-coupled receptor signaling pathway
Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
The regulated release of neurotransmitter from the presynapse into the synaptic cleft via calcium-regulated exocytosis during synaptic transmission.
A neurotransmitter is any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. Among the many substances that have the properties of a neurotransmitter are acetylcholine, noradrenaline, adrenaline, dopamine, glycine, gamma-aminobutyrate, glutamic acid, substance P, enkephalins, endorphins and serotonin.
The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
Note that this term was 'developmental process'.
The generation and maintenance of gametes in a multicellular organism. A gamete is a haploid reproductive cell.
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
The developmental process by which male germ line stem cells self renew or give rise to successive cell types resulting in the development of a spermatozoa.
The process whose specific outcome is the progression of a spermatid over time, from its formation to the mature structure.
The assembly and organization of the sperm flagellar axoneme, the bundle of microtubules and associated proteins that forms the core of the eukaryotic sperm flagellum, and is responsible for movement.
The specialization of the spermatid nucleus during the development of a spermatid into a mature male gamete competent for fertilization.
See also the Cell Ontology term 'spermatid ; CL:0000018'.
Generation of the female gamete; specialised haploid cells produced by meiosis and along with a male gamete takes part in sexual reproduction.
A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
The process whose specific outcome is the progression of the ectoderm over time, from its formation to the mature structure. In animal embryos, the ectoderm is the outer germ layer of the embryo, formed during gastrulation.
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
The process of gaseous exchange between an organism and its environment. In plants, microorganisms, and many small animals, air or water makes direct contact with the organism's cells or tissue fluids, and the processes of diffusion supply the organism with dioxygen (O2) and remove carbon dioxide (CO2). In larger animals the efficiency of gaseous exchange is improved by specialized respiratory organs, such as lungs and gills, which are ventilated by breathing mechanisms.
respiratory gaseous exchange by respiratory system
The whole of the physical, chemical, and biochemical processes carried out by multicellular organisms to break down ingested nutrients into components that may be easily absorbed and directed into metabolism.
The elimination by an organism of the waste products that arise as a result of metabolic activity. These products include water, carbon dioxide (CO2), and nitrogenous compounds.
The controlled release of a fluid by a cell or tissue in an animal.
The series of events required for an organism to receive a sensory stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
The series of events required for an organism to receive a visual stimulus, convert it to a molecular signal, and recognize and characterize the signal. Visual stimuli are detected in the form of photons and are processed to form an image.
The pairwise union of individuals for the purpose of sexual reproduction, ultimately resulting in the formation of zygotes.
The act of sexual union between male and female, involving the transfer of sperm.
The flow of blood through the body of an animal, enabling the transport of nutrients to the tissues and the removal of waste products.
Any process that modulates the frequency, rate or extent of heart contraction. Heart contraction is the process in which the heart decreases in volume in a characteristic way to propel blood through the body.
Any process in which a protein is transported to, or maintained in, a specific location.
establishment and maintenance of asymmetric protein localization
establishment and maintenance of protein localization
A biological process represents a specific objective that the organism is genetically programmed to achieve. Biological processes are often described by their outcome or ending state, e.g., the biological process of cell division results in the creation of two daughter cells (a divided cell) from a single parent cell. A biological process is accomplished by a particular set of molecular functions carried out by specific gene products (or macromolecular complexes), often in a highly regulated manner and in a particular temporal sequence.
Any process specifically pertinent to the functioning of integrated living units: cells, tissues, organs, and organisms. A process is a collection of molecular events with a defined beginning and end.
Note that, in addition to forming the root of the biological process ontology, this term is recommended for use for the annotation of gene products whose biological process is unknown. When this term is used for annotation, it indicates that no information was available about the biological process of the gene product annotated as of the date the annotation was made; the evidence code 'no data' (ND), is used to indicate this.
Note that, in addition to forming the root of the biological process ontology, this term is recommended for use for the annotation of gene products whose biological process is unknown. Note that when this term is used for annotation, it indicates that no information was available about the biological process of the gene product annotated as of the date the annotation was made; the evidence code ND, no data, is used to indicate this.
The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
metabolic process resulting in cell growth
multicellular organism metabolic process
Note that metabolic processes do not include single functions or processes such as protein-protein interactions, protein-nucleic acids, nor receptor-ligand interactions.
The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
The chemical reactions and pathways involving bile acids, a group of steroid carboxylic acids occurring in bile, where they are present as the sodium salts of their amides with glycine or taurine.
Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
This term should not be used for direct annotation. The only exception should be when experimental data (e.g., staining with trypan blue or propidium iodide) show that cell death has occurred, but fail to provide details on death modality (accidental versus programmed). When information is provided on the cell death mechanism, annotations should be made to the appropriate descendant of 'cell death' (such as, but not limited to, GO:0097300 'programmed necrotic cell death' or GO:0006915 'apoptotic process'). Also, if experimental data suggest that a gene product influences cell death indirectly, rather than being involved in the death process directly, consider annotating to a 'regulation' term.
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
This term was moved out from being a child of 'cellular process' because it is a cell population-level process, and cellular processes are restricted to those processes that involve individual cells. Also note that this term is intended to be used for the proliferation of cells within a multicellular organism, not for the expansion of a population of single-celled organisms.
The activity of binding selectively and non-covalently to and distorting the original structure of DNA, typically a straight helix, into a bend, or increasing the bend if the original structure was intrinsically bent due to its sequence.
Enables the transfer of a negatively charged ion from one side of a membrane to the other.
anion transmembrane transporter activity
Enables the transfer of organic anions from one side of a membrane to the other. Organic anions are atoms or small molecules with a negative charge which contain carbon in covalent linkage.
organic anion transmembrane transporter activity
The chemical reactions and pathways resulting in the formation of lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
The chemical reactions and pathways resulting in the breakdown of substances, including the breakdown of carbon compounds with the liberation of energy for use by the cell or organism.
multicellular organismal catabolic process
The chemical reactions and pathways resulting in the breakdown of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
multicellular organismal macromolecule catabolic process
The chemical reactions and pathways resulting in the formation of substances; typically the energy-requiring part of metabolism in which simpler substances are transformed into more complex ones.
multicellular organismal biosynthetic process
The chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
The chemical reactions and pathways resulting in the formation of glucans, polysaccharides consisting only of glucose residues.
The chemical reactions and pathways resulting in the breakdown of glucans, polysaccharides consisting only of glucose residues.
The controlled release of proteins from a cell.
protein secretion during cell fate commitment
protein secretion resulting in cell fate commitment
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
response to electromagnetic radiation stimulus
Note that 'radiation' refers to electromagnetic radiation of any wavelength.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a light stimulus, electromagnetic radiation of wavelengths classified as infrared, visible or ultraviolet light.
The union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy).
The series of events in which an external stimulus is received by a cell and converted into a molecular signal.
The series of events in which an (non-living) abiotic stimulus is received by a cell and converted into a molecular signal.
The series of events in which a light stimulus (in the form of photons) is received and converted into a molecular signal.
The series of events in which a visible light stimulus is received by a cell and converted into a molecular signal. A visible light stimulus is electromagnetic radiation that can be perceived visually by an organism; for organisms lacking a visual system, this can be defined as light with a wavelength within the range 380 to 780 nm.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a biotic stimulus, a stimulus caused or produced by a living organism.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an abiotic (not derived from living organisms) stimulus.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
The process in which anatomical structures are generated and organized. Morphogenesis pertains to the creation of form.
The process whose specific outcome is the progression of an embryo from its formation until the end of its embryonic life stage. The end of the embryonic stage is organism-specific. For example, for mammals, the process would begin with zygote formation and end with birth. For insects, the process would begin at zygote formation and end with larval hatching. For plant zygotic embryos, this would be from zygote formation to the end of seed dormancy. For plant vegetative embryos, this would be from the initial determination of the cell or group of cells to form an embryo until the point when the embryo becomes independent of the parent plant.
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
The process whose specific outcome is the progression of an embryo over time, from zygote formation until the end of the embryonic life stage. The end of the embryonic life stage is organism-specific and may be somewhat arbitrary; for mammals it is usually considered to be birth, for insects the hatching of the first instar larva from the eggshell.
embryo development ending in birth or egg hatching
The process whose specific outcome is the progression of a tissue over time, from its formation to the mature structure.
The directed movement of hormones into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
Any process that is carried out at the cellular level, but not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the endomembrane system.
The process in which a gene's sequence is converted into a mature gene product (protein or RNA). This includes the production of an RNA transcript and its processing, translation and maturation for protein-coding genes.
The process in which a gene's sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
Any process that modulates the levels of hormone within an organism or a tissue. A hormone is any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action.
Any process in which a lipid is transported to, or maintained in, a specific location.
The cellular component assembly that is part of the initial shaping of the component during its developmental progression.
cellular component assembly involved in morphogenesis
The movement of organelles or other particles from one location in the cell to another along microtubules, driven by motor activity.
establishment of localization by movement along microtubule
A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell.
Note that this term should be used to annotate gene products in the organism undergoing the programmed cell death. To annotate genes in another organism whose products modulate programmed cell death in a host organism, consider the term 'modulation by symbiont of host programmed cell death ; GO:0052040'. Also, note that 'programmed cell death ; GO:0012501' should be used to refer to instances of caspase-independent cell death mechanisms, in the absence of further indications on the process taking place. At present, caspase-independent cell death is not yet represented in GO due to the lack of consensus and in-depth research on the topic. 'programmed cell death ; GO:0012501' may also be used to annotate gene products in taxa where apoptosis as defined in GO:0006915 does not occur, such as plants. You may also consider these specific children: GO:0097468 'programmed cell death in response to reactive oxygen species' (with descendants GO:0010421 'hydrogen peroxide-mediated programmed cell death' and GO:0010343 'singlet oxygen-mediated programmed cell death'), and GO:0009626 'plant-type hypersensitive response' and its children.
A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles.
The lipid bilayer surrounding any membrane-bounded vesicle in the cell.
The controlled release of glutamate by a cell. The glutamate is the most abundant excitatory neurotransmitter in the nervous system.
The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
Enables the transfer of an ion from one side of a membrane to the other.
Enables the transfer of bicarbonate from one side of a membrane to the other. Bicarbonate is the hydrogencarbonate ion, HCO3-.
bicarbonate transmembrane transporter activity
The part of the cytoskeleton (the internal framework of a cell) composed of microtubules and associated proteins.
The directed movement of substances that are gaseous in normal living conditions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of oxygen (O2) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of bicarbonate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of organic anions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Organic anions are atoms or small molecules with a negative charge which contain carbon in covalent linkage.
The directed movement of monocarboxylic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of bile acid and bile salts into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of acidic amino acids, amino acids with a pH below 7, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of organic acids, any acidic compound containing carbon in covalent linkage, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The directed movement of an organic hydroxy compound (organic alcohol) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. An organic hydroxy compound is an organic compound having at least one hydroxy group attached to a carbon atom.
The chemical reactions and pathways by which a cell derives energy from organic compounds; results in the oxidation of the compounds from which energy is released.
energy derivation by oxidation of organic compounds
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
A process that results in the assembly, arrangement of constituent parts, or disassembly of a cellular component.
cellular component organisation at cellular level
cellular component organisation in other organism
cellular component organization at cellular level
cellular component organization in other organism
The process in which a cell irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present.
non-developmental growth of a unicellular organism
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a vesicle.
The chemical reactions and pathways resulting in the formation of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y.
catabolic carbohydrate metabolic process
multicellular organismal carbohydrate catabolic process
single-organism carbohydrate catabolic process
The chemical reactions and pathways resulting in the formation of organic acids, any acidic compound containing carbon in covalent linkage.
An immune response mediated by immunoglobulins, whether cell-bound or in solution.
A cellular transport process in which transported substances are moved in membrane-bounded vesicles; transported substances are enclosed in the vesicle lumen or located in the vesicle membrane. The process begins with a step that directs a substance to the forming vesicle, and includes vesicle budding and coating. Vesicles are then targeted to, and fuse with, an acceptor membrane.
The process in which the anatomical structures of embryonic epithelia are generated and organized.
Recombination occurring within or between DNA molecules in somatic cells.
The somatic process that results in the generation of sequence diversity of immunoglobulins.
somatic diversification of immunoglobulins
The process in which immunoglobulin genes are formed through recombination of the germline genetic elements, as known as immunoglobulin gene segments, within a single locus.
somatic recombination of antibody gene segments
somatic recombination of immunoglobulin gene segments
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
The self-renewing division of a stem cell. A stem cell is an undifferentiated cell, in the embryo or adult, that can undergo unlimited division and give rise to one or several different cell types.
The neurological system process in which a signal is transmitted through the nervous system by a combination of action potential propagation and synaptic transmission.
The chemical reactions and pathways involving a protein. Includes protein modification.
protein metabolic process and modification
multicellular organismal protein metabolic process
Any process involved with the carrying out of an immune response by a B cell, through, for instance, the production of antibodies or cytokines, or antigen presentation to T cells.
B lymphocyte mediated immune effector process
B-lymphocyte mediated immune effector process
An immune response against microbes mediated through a body fluid. Examples of this process are seen in the antimicrobial humoral response of Drosophila melanogaster and Mus musculus.
The chemical reactions and pathways involving carboxylic acids, any organic acid containing one or more carboxyl (COOH) groups or anions (COO-).
A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.
Note that an immunoglobulin complex has the function of antigen binding if a suitable antigen is available.
An immunoglobulin complex that is present in the plasma membrane of B cells and that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains and a signaling subunit, a heterodimer of the Ig-alpha and Ig-beta proteins.
B cell receptor accessory molecule complex
The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
A reproduction process that creates a new organism by combining the genetic material of two gametes, which may come from two organisms or from a single organism, in the case of self-fertilizing hermaphrodites, e.g. C. elegans, or self-fertilization in plants. It occurs both in eukaryotes and prokaryotes: in multicellular eukaryotic organisms, an individual is created anew; in prokaryotes, the initial cell has additional or transformed genetic material. In a process called genetic recombination, genetic material (DNA) originating from two gametes join up so that homologous sequences are aligned with each other, and this is followed by exchange of genetic information. After the new recombinant chromosome is formed, it is passed on to progeny.
Sexual reproduction may be seen as the regular alternation, in the life cycle of haplontic, diplontic and diplohaplontic organisms, of meiosis and fertilization which provides for the production offspring. In diplontic organisms there is a life cycle in which the products of meiosis behave directly as gametes, fusing to form a zygote from which the diploid, or sexually reproductive polyploid, adult organism will develop. In diplohaplontic organisms a haploid phase (gametophyte) exists in the life cycle between meiosis and fertilization (e.g. higher plants, many algae and Fungi); the products of meiosis are spores that develop as haploid individuals from which haploid gametes develop to form a diploid zygote; diplohaplontic organisms show an alternation of haploid and diploid generations. In haplontic organisms meiosis occurs in the zygote, giving rise to four haploid cells (e.g. many algae and protozoa), only the zygote is diploid and this may form a resistant spore, tiding organisms over hard times.
The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
The cellular process that ensures successive accurate and complete genome replication and chromosome segregation.
The initial attachment of a membrane or protein to a target membrane. Docking requires only that the proteins come close enough to interact and adhere.
A cellular process that results in the breakdown of a cellular component.
cellular component disassembly at cellular level
A process, occurring at the cellular level, that is involved in the reproductive function of a multicellular organism.
reproductive cellular process in multicellular organism
cellular process involved in reproduction in multicellular organism
A biological process that directly contributes to the process of producing new individuals by one or two organisms. The new individuals inherit some proportion of their genetic material from the parent or parents.
A physical, chemical, or biochemical process carried out by living organisms to break down ingested nutrients into components that may be easily absorbed and directed into metabolism.
The aggregation, arrangement and bonding together of a cellular component.
cellular component assembly at cellular level
A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a complex containing RNA and proteins. Includes the biosynthesis of the constituent RNA and protein molecules, and those macromolecular modifications that are involved in synthesis or assembly of the ribonucleoprotein complex.
ribonucleoprotein complex biogenesis and assembly
The aggregation, arrangement and bonding together of proteins and RNA molecules to form a ribonucleoprotein complex.
Enables the transfer of a substance, usually a specific substance or a group of related substances, from one side of a membrane to the other.
substrate-specific transmembrane transporter activity
uptake transmembrane transporter activity
The entirety of a process in which information is transmitted within a biological system. This process begins with an active signal and ends when a cellular response has been triggered.
Note that a signal is any variable property or parameter that serves to convey information, and may be a physical entity such as a gene product or small molecule, a photon, or a change in state such as movement or voltage change.
The process in which a signal is secreted or discharged into the extracellular medium from a cellular source.
The contractile element of skeletal and cardiac muscle; a long, highly organized bundle of actin, myosin, and other proteins that contracts by a sliding filament mechanism.
The repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a prolongation or process extending from a cell, e.g. a flagellum or axon.
cell projection organization and biogenesis
cell surface structure organization and biogenesis
Formation of a prolongation or process extending from a cell, e.g. a flagellum or axon.
Disassembly of actin filaments by the removal of actin monomers from a filament.
A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella.
The regulated release of a peptide hormone from a cell.
The regulated release of proinsulin from secretory granules accompanied by cleavage of proinsulin to form mature insulin. In vertebrates, insulin is secreted from B granules in the B cells of the vertebrate pancreas and from insulin-producing cells in insects.
The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates.
The process in which a relatively unspecialized precursor cell acquires specialized features of a lymphocyte. A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin.
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages.
The regulated release of vasopressin from secretory granules into the blood.
Any of the vesicles of the constitutive secretory pathway, which carry cargo from the endoplasmic reticulum to the Golgi, between Golgi cisternae, from the Golgi to the ER (retrograde transport) or to destinations within or outside the cell.
constitutive secretory pathway transport vesicle
Note that the term 'secretory vesicle' is sometimes used in this sense, but can also mean 'secretory granule ; GO:0030141'.
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
Note that the term 'secretory vesicle' is sometimes used in this sense, but can also mean 'transport vesicle ; GO:0030133'.
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
The chemical reactions and pathways involving heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells. They are similar to heparan sulfates but are of somewhat higher average Mr (6000-20000) and contain fewer N-acetyl groups and more N-sulfate and O-sulfate groups; they may be attached in the same manner to protein, forming proteoglycans. They consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
The chemical reactions and pathways involving glycosaminoglycans, any of a group of polysaccharides that contain amino sugars.
The chemical reactions and pathways resulting in the formation of heparin, any member of a group of glycosaminoglycans of average Mr (6000-20000), consisting predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
Note that the term 'thymocyte differentiation' was merged into this term because thymocytes are T cells, and thus the term was essentially redundant. Note that immunologists typically use the word 'development' to refer to cells of B or T cell lineages undergoing the process that GO describes as 'cell differentiation'.
The process in which a myeloid precursor cell acquires specializes features of an erythrocyte.
The process in which a myeloid precursor cell acquires specializes features of a megakaryocyte.
The process in which a relatively unspecialized myeloid precursor cell acquires specialized features of a basophil cell.
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a monocyte.
The process in which a relatively unspecialized monocyte acquires the specialized features of a macrophage.
The regulated release of growth hormone from secretory granules into the blood.
The progressive compaction of dispersed interphase chromatin into threadlike chromosomes prior to mitotic or meiotic nuclear division, or during apoptosis, in eukaryotic cells.
Alterations undergone by nuclei at the molecular and morphological level as part of the execution phase of apoptosis.
The compaction of chromatin during apoptosis.
A structure that lies outside the plasma membrane and surrounds the entire cell or cells. This does not include the periplasmic space.
The outer membrane (of gram negative bacteria) or cell wall (of yeast or Gram positive bacteria) are defined as parts of this structure, see 'external encapsulating structure part'.
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
The directed, self-propelled movement of a cilium (aka flagellum) that contributes to the movement of a flagellated sperm.
sperm flagellum movement involved in flagellated sperm motility
sperm flagellum movement involved in flagellated sperm movement
Any process that modulates the frequency, rate or extent of cell migration.
Any process that activates or increases the frequency, rate or extent of cell migration.
The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
The movement of a leukocyte in response to an external stimulus.
The lipid bilayer surrounding a cytoplasmic vesicle.
The lipid bilayer surrounding a secretory granule.
The directed movement of substances along cytoskeletal fibers such as microfilaments or microtubules within a cell.
cytoskeleton-dependent intracellular transport
The process in which a myeloid precursor cell acquires the specialized features of a granulocyte. Granulocytes are a class of leukocytes characterized by the presence of granules in their cytoplasm. These cells are active in allergic immune reactions such as arthritic inflammation and rashes. This class includes basophils, eosinophils and neutrophils.
A nonmembrane-bound oligomeric protein complex that participates in bidirectional transport of molecules (cargo) along axonemal microtubules.
Note that we deem cilia and microtubule-based flagella to be equivalent.
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
A membrane that is one of the two lipid bilayers of an organelle envelope or the outermost membrane of single membrane bound organelle.
A temporary protrusion or retractile process of a cell, associated with flowing movements of the protoplasm, and serving for locomotion and feeding.
The component of a membrane consisting of the gene products having some covalently attached portion, for example part of a peptide sequence or some other covalently attached group such as a GPI anchor, which spans or is embedded in one or both leaflets of the membrane.
Note that proteins intrinsic to membranes cannot be removed without disrupting the membrane, e.g. by detergent.
The component of the plasma membrane consisting of the gene products and protein complexes having either part of their peptide sequence embedded in the hydrophobic region of the membrane or some other covalently attached group such as a GPI anchor that is similarly embedded in the membrane.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a pseudopodium, a temporary protrusion or retractile process of a cell, associated with cellular movement.
pseudopodium organization and biogenesis
A vesicle found in the cytoplasm of a cell.
A localization process that acts on a protein complex; the complex is transported to, or maintained in, a specific location.
establishment and maintenance of protein complex localization
cellular protein-containing complex localization
establishment and maintenance of cellular protein complex localization
A cilium which may have a variable arrangement of axonemal microtubules and also contains molecular motors. It may beat with a whip-like pattern that promotes cell motility or transport of fluids and other cells across a cell surface, such as on epithelial cells that line the lumenal ducts of various tissues; or they may display a distinct twirling motion that directs fluid flow asymmetrically across the cellular surface to affect asymmetric body plan organization. Motile cilia can be found in single as well as multiple copies per cell.
The enclosed volume within a sealed membrane or between two sealed membranes. Encompasses the volume enclosed by the membranes of a particular organelle, e.g. endoplasmic reticulum lumen, or the space between the two lipid bilayers of a double membrane surrounding an organelle, e.g. nuclear envelope lumen.
The volume enclosed by the nuclear inner membrane.
Any small, fluid-filled, spherical organelle enclosed by membrane.
A cell extension caused by localized decoupling of the cytoskeleton from the plasma membrane and characterized by rapid formation, rounded shape, and scarcity of organelles within the protrusion. Blebs are formed during apoptosis and other cellular processes, including cell locomotion, cell division, and as a result of physical or chemical stresses.
The assembly of a bleb, a cell extension caused by localized decoupling of the cytoskeleton from the plasma membrane and characterized by rapid formation, rounded shape, and scarcity of organelles within the protrusion. Plasma membrane blebbing occurs during apoptosis and other cellular processes, including cell locomotion, cell division, and as a result of physical or chemical stresses.
Any process that modulates the frequency, rate or extent of a response to an external stimulus.
regulation of response to external stimulus
Any process that activates, maintains or increases the rate of a response to an external stimulus.
up regulation of response to external stimulus
up-regulation of response to external stimulus
upregulation of response to external stimulus
activation of response to external stimulus
stimulation of response to external stimulus
positive regulation of response to external stimulus
The regulated release of a gonadotropin, any hormone that stimulates the gonads, especially follicle-stimulating hormone and luteinizing hormone.
The regulated release of luteinizing hormone, a gonadotropic glycoprotein hormone secreted by the anterior pituitary.
Any biological process, occurring at the level of a multicellular organism, pertinent to its function.
A biological process whose specific outcome is the progression of an integrated living unit: an anatomical structure (which may be a subcellular structure, cell, tissue, or organ), or organism over time from an initial condition to a later condition.
The biological process in which new individuals are produced by one or two multicellular organisms. The new individuals inherit some proportion of their genetic material from the parent or parents.
The appearance of type I interferon due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
The appearance of interferon-gamma due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Interferon-gamma is also known as type II interferon.
The regulated release of bile acid, composed of any of a group of steroid carboxylic acids occurring in bile, by a cell or a tissue.
The chemical reactions and pathways involving monocarboxylic acids, any organic acid containing one carboxyl (COOH) group or anion (COO-).
All of the contents of a plasma membrane bounded cell projection, excluding the plasma membrane surrounding the projection.
plasma membrane bounded cell projection cytoplasm
Any process that modulates the frequency, rate or extent of any process in which a cell, a substance, or a cellular entity is transported to, or maintained in, a specific location.
The controlled release of a substance by a cell.
The controlled release of a substance by a tissue.
The disaggregation of a protein-containing macromolecular complex into its constituent components.
The disaggregation of a macromolecular complex into its constituent components.
cellular macromolecular complex disassembly
cellular macromolecule complex disassembly
The process in which cellular structures, including whole cells or cell parts, are generated and organized.
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
A protein complex in this context is meant as a stable set of interacting proteins which can be co-purified by an acceptable method, and where the complex has been shown to exist as an isolated, functional unit in vivo. Acceptable experimental methods include stringent protein purification followed by detection of protein interaction. The following methods should be considered non-acceptable: simple immunoprecipitation, pull-down experiments from cell extracts without further purification, colocalization and 2-hybrid screening. Interactions that should not be captured as protein complexes include: 1) enzyme/substrate, receptor/ligand or any similar transient interactions, unless these are a critical part of the complex assembly or are required e.g. for the receptor to be functional; 2) proteins associated in a pull-down/co-immunoprecipitation assay with no functional link or any evidence that this is a defined biological entity rather than a loose-affinity complex; 3) any complex where the only evidence is based on genetic interaction data; 4) partial complexes, where some subunits (e.g. transmembrane ones) cannot be expressed as recombinant proteins and are excluded from experiments (in this case, independent evidence is necessary to find out the composition of the full complex, if known). Interactions that may be captured as protein complexes include: 1) enzyme/substrate or receptor/ligand if the complex can only assemble and become functional in the presence of both classes of subunits; 2) complexes where one of the members has not been shown to be physically linked to the other(s), but is a homologue of, and has the same functionality as, a protein that has been experimentally demonstrated to form a complex with the other member(s); 3) complexes whose existence is accepted based on localization and pharmacological studies, but for which experimental evidence is not yet available for the complex as a whole.
Any process in which a macromolecule is transported to, or maintained in, a specific location.
The process in which immune receptor V, D, and J, or V and J gene segments, depending on the specific receptor, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).
The process in which immunoglobulin gene segments are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS). For immunoglobulin heavy chains V, D, and J gene segments are joined, and for immunoglobulin light chains V and J gene segments are joined.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a secretory granule. A secretory granule is a small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion.
secretory granule organization and biogenesis
A process in which a protein is transported to, or maintained in, a location within an organelle.
The chemical reactions and pathways resulting in the formation of polysaccharides, polymers of many (typically more than 10) monosaccharide residues linked glycosidically, occurring at the level of an individual cell.
cellular polysaccharide biosynthetic process
Any process of regulating the production and elimination of erythrocytes within an organism.
A process in which an ion is transported across a membrane.
ATP hydrolysis coupled ion transmembrane transport
Note that this term is not intended for use in annotating lateral movement within membranes.
Any process in which a protein is transported to, and/or maintained in, a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell.
The chemical reactions and pathways resulting in the formation of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, carried out by individual cells.
cellular carbohydrate biosynthetic process
The chemical reactions and pathways involving various organic and inorganic nitrogenous compounds, as carried out by individual cells.
cellular nitrogen compound metabolic process
The chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass, carried out by individual cells.
cellular biopolymer biosynthetic process
cellular macromolecule biosynthetic process
Events resulting in the formation of a multilayered cellular sheath surrounding an invader and thus preventing its development. This defense mechanism is often seen in insects in response to nematodes or parasitoids, which are too large to be phagocytosed by individual hemocytes. In some organisms the capsule is blackened due to melanization.
The assembly and organization of an axoneme, the bundle of microtubules and associated proteins that forms the core of cilia (also called flagella) in eukaryotic cells and is responsible for their movements.
Note that cilia and eukaryotic flagella are deemed to be equivalent.
Creation of the central hole of a tube in an anatomical structure through which gases and/or liquids flow.
lumen formation in an anatomical structure
The process in which the anatomical structures of a tube are generated and organized. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system.
The vesicular release of glutamate from a presynapse, across a chemical synapse, the subsequent activation of glutamate receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse.
The process whose specific outcome is the progression of a tube over time, from its initial formation to a mature structure. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues including lung and trachea, kidney, the mammary gland, the vascular system and the gastrointestinal and urinary-genital tracts.
An immunoglobulin-like complex that is present in at least the plasma membrane of pre-B cells, and that is composed of two identical immunoglobulin heavy chains and two surrogate light chains, each composed of the lambda-5 and VpreB proteins, and a signaling subunit, a heterodimer of the Ig-alpha and Ig-beta proteins.
Despite its name, the pre-BCR is not a receptor complex, as it appears to provide a low level of signal not dependent on a ligand, but rather simply on correct assembly of the complex as a measure for correct Ig heavy chain recombination and folding. A significant proportion of pre-BCR complexes fail to reach the cell surface, and in some cases may provide their signaling function from the trans-Golgi network or lysosome.
The directed movement of a protein to a specific location within the extracellular region.
establishment of protein localisation in extracellular region
establishment of protein localization in extracellular region
establishment of protein localization to extracellular region
The transfer of information occurring at the level of a multicellular organism.
The bidirectional movement of large protein complexes along microtubules within a cilium that contributes to cilium assembly.
intraciliary transport involved in cilium morphogenesis
intraflagellar transport involved in cilium morphogenesis
intraciliary transport involved in cilium assembly
A region of the cilium between the basal body and proximal segment that is characterized by Y-shaped assemblages that connect axonemal microtubules to the ciliary membrane. The ciliary transition zone appears to function as a gate that controls ciliary membrane composition and separates the cytosol from the ciliary plasm.
Depending on the species, this region may have a distinct geometrically shaped electron-dense structure within the axonemal lumen visible in electron microscopy images; most animals don't display this inner structure. The axoneme extends through the ciliary transition zone, but only consists of the outer doublets. The central pair, axonemal spokes, and dynein complexes are not found in this part of the ciliary shaft. Note that the connecting cilium of the photoreceptor cells is thought to be equivalent to the transition zone.
The regulated release of testosterone into the circulatory system. Testosterone is an androgen having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.
The regulated release of a melanocyte-stimulating hormone, any of a group of peptide hormones that are produced by cells in the intermediate lobe of the pituitary gland, and stimulate the production of melanin to increase pigmentation.
melanocyte-stimulating hormone secretion
The region of a neuron that includes the cell body (cell soma) and dendrite(s), but excludes the axon.
Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
receptor activity involved in signal transduction
Self-propelled movement of a cell or organism from one location to another.
Any process that modulates the frequency, rate or extent of locomotion of a cell or organism.
The first few specialized divisions of an activated animal egg.
Any process that activates or increases the frequency, rate or extent of locomotion of a cell or organism.
The bidirectional movement of large protein complexes along microtubules within a cilium, mediated by motor proteins.
intraflagellar transport involved in cilium organization
intraflagellar transport involved in microtubule-based flagellum organisation
An immune response which is associated with resistance to extracellular organisms such as helminths and pathological conditions such as allergy, which is orchestrated by the production of particular cytokines, most notably IL-4, IL-5, IL-10, and IL-13, by any of a variety of cell types including T-helper 2 cells, eosinophils, basophils, mast cells, and nuocytes, resulting in enhanced production of certain antibody isotypes and other effects.
A protein complex that contains a disulfide-linked heterodimer of T cell receptor (TCR) chains, which are members of the immunoglobulin superfamily, and mediates antigen recognition, ultimately resulting in T cell activation. The TCR heterodimer is associated with the CD3 complex, which consists of the nonpolymorphic polypeptides gamma, delta, epsilon, zeta, and, in some cases, eta (an RNA splice variant of zeta) or Fc epsilon chains.
A T cell receptor complex in which the TCR heterodimer comprises alpha and beta chains, associated with the CD3 complex; recognizes a complex consisting of an antigen-derived peptide bound to a class I or class II MHC protein.
alpha-beta T lymphocyte receptor complex
alpha-beta T-lymphocyte receptor complex
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus.
The directed movement of a motile cell or organism in response to an external stimulus.
directed movement in response to stimulus
Any process that modulates the establishment or extent of a membrane potential, the electric potential existing across any membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells.
An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component.
Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.
A membrane-bounded, cytoplasmic secretory granule found in enzyme-secreting cells and visible by light microscopy. Contain zymogen, an inactive enzyme precursor, often of a digestive enzyme.
The lipid bilayer surrounding a zymogen granule.
Any biological process involved in the maintenance of an internal steady state.
negative regulation of homeostatic process
positive regulation of homeostatic process
A transmembrane protein complex composed of an MHC alpha chain and, in most cases, either an MHC class II beta chain or an invariant beta2-microglobin chain, and with or without a bound peptide, lipid, or polysaccharide antigen.
A transmembrane protein complex composed of an MHC class II alpha and MHC class II beta chain, and with or without a bound peptide or polysaccharide antigen.
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
defense response to bacterium, incompatible interaction
resistance response to pathogenic bacteria
resistance response to pathogenic bacterium
The directed movement of an amide, any compound containing one, two, or three acyl groups attached to a nitrogen atom, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
A prolongation or process extending from a cell, e.g. a flagellum or axon.
A prolongation or process extending from a nerve cell, e.g. an axon or dendrite.
The process whose specific outcome is the progression of the embryo over time, from zygote formation through a stage including a notochord and neural tube until birth or egg hatching.
The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
Note that 'cell body' and 'cell soma' are not used in the literature for cells that lack projections, nor for some cells (e.g. yeast with mating projections) that do have projections.
The chemical reactions and pathways resulting in the formation of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. This may include the translation of a precursor protein and its subsequent processing into a functional peptide.
The nucleus of a germ cell, a reproductive cell in multicellular organisms.
The chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.
multicellular organismal macromolecule metabolic process
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external biotic stimulus, an external stimulus caused by, or produced by living things.
Organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, and prokaryotic structures such as anammoxosomes and pirellulosomes. Excludes the plasma membrane.
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane. Includes ribosomes, the cytoskeleton and chromosomes.
Organized structure of distinctive morphology and function, occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.
Organized structure of distinctive morphology and function, occurring outside the cell. Includes, for example, extracellular membrane vesicles (EMVs) and the cellulosomes of anaerobic bacteria and fungi.
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
intracellular membrane-enclosed organelle
intracellular membrane-bounded organelle
Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane and occurring within the cell. Includes ribosomes, the cytoskeleton and chromosomes.
intracellular non-membrane-enclosed organelle
intracellular non-membrane-bounded organelle
The internal volume enclosed by the membranes of a particular organelle; includes the volume enclosed by a single organelle membrane, e.g. endoplasmic reticulum lumen, or the volume enclosed by the innermost of the two lipid bilayers of an organelle envelope, e.g. nuclear lumen.
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
The disaggregation of a protein complex into its constituent components. Protein complexes may have other associated non-protein prosthetic groups, such as nucleic acids, metal ions or carbohydrate groups.
Fibers, composed of actin, myosin, and associated proteins, found in cells of smooth or striated muscle.
The process of sparing immature T cells which react with self-MHC protein complexes with low affinity levels from apoptotic death.
A receptor complex found on immature T cells consisting of a T cell receptor beta chain and the pre-TCR-alpha chain, along with additional signaling components including CD3 family members and additional signaling proteins.
The chemical reactions and pathways involving any oxoacid; an oxoacid is a compound which contains oxygen, at least one other element, and at least one hydrogen bound to oxygen, and which produces a conjugate base by loss of positive hydrogen ion(s) (hydrons).
Any process that modulates the frequency, rate or extent of the process of gaseous exchange between an organism and its environment.
regulation of respiratory gaseous exchange
The chemical reactions and pathways involving an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group, as carried out by individual cells.
The chemical reactions and pathways resulting in the formation of an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group.
Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a protein complex.
Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a macromolecular complex.
cellular macromolecular complex organization
cellular macromolecular complex subunit organisation
cellular macromolecular complex subunit organization
macromolecular complex subunit organisation
macromolecular complex subunit organization
protein-containing complex subunit organization
The chemical reactions and pathways involving glucans, polysaccharides consisting only of glucose residues.
Any process that modulates the frequency, rate or extent of a system process, a multicellular organismal process carried out by any of the organs or tissues in an organ system.
Any process that modulates the frequency, rate or extent of a digestive system process, a physical, chemical, or biochemical process carried out by living organisms to break down ingested nutrients into components that may be easily absorbed and directed into metabolism.
A process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a cellular component. Includes biosynthesis of constituent macromolecules, and those macromolecular modifications that are involved in synthesis or assembly of the cellular component.
cellular component biogenesis at cellular level
A ribonucleoprotein complex that contains aminoacylated initiator methionine tRNA, GTP, and initiation factor 2 (either eIF2 in eukaryotes, or IF2 in prokaryotes). In prokaryotes, fMet-tRNA (initiator) is used rather than Met-tRNA (initiator).
translation initiation (ternary) complex
The chemical reactions and pathways by which individual cells transform chemical substances.
The chemical reactions and pathways involving those compounds which are formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism.
The chemical reactions and pathways resulting in the breakdown of polysaccharides, polymers of many (typically more than 10) monosaccharide residues linked glycosidically, as carried out by individual cells.
cellular polysaccharide catabolic process
The chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells.
The chemical reactions and pathways resulting in the formation of substances, carried out by individual cells.
The chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass, as carried out by individual cells.
cellular macromolecule metabolic process
The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.
main pathways of carbohydrate metabolic process
main pathways of carbohydrate metabolism
The chemical reactions and pathways involving polysaccharides, polymers of more than 10 monosaccharide residues joined by glycosidic linkages, as carried out by individual cells.
cellular polysaccharide metabolic process
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
The chemical reactions and pathways resulting in the formation of organic and inorganic nitrogenous compounds.
cellular nitrogen compound biosynthetic process
The chemical reactions and pathways resulting in the formation of compounds that contain sulfur, such as the amino acids methionine and cysteine or the tripeptide glutathione.
The chemical reactions and pathways resulting in the breakdown of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, as carried out by individual cells.
The chemical reactions and pathways involving small molecules, any low molecular weight, monomeric, non-encoded molecule.
Small molecules in GO include monosaccharides but exclude disaccharides and polysaccharides.
The chemical reactions and pathways resulting in the formation of small molecules, any low molecular weight, monomeric, non-encoded molecule.
The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
Any process evolved to enable an interaction with an organism of a different species.
interspecies interaction between organisms
interspecies interaction with other organisms
biological process involved in interspecies interaction between organisms
The aggregation, arrangement and bonding together of a set of components to form a motile cilium.
A biological process that directly contributes to the process of producing new individuals, involving another organism.
Any process that is carried out at the cellular level, occurring within a single organism.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cilium, a specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface. Each cilium is bounded by an extrusion of the cytoplasmic membrane, and contains a regular longitudinal array of microtubules, anchored basally in a centriole.
microtubule-based flagellum organization
The process in which T cells that express T cell receptors that are restricted by self MHC protein complexes and tolerant to self antigens are selected for further maturation.
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
The directed movement of a protein to a specific location.
The switching of activated B cells from IgM biosynthesis to biosynthesis of other isotypes of immunoglobulin, accomplished through a recombination process involving an intrachromosomal deletion involving switch regions that reside 5' of each constant region gene segment in the immunoglobulin heavy chain locus.
Note that IgM and IgD can be coexpressed by B cells via an alternate splicing mechanism, but true recombinational isotype switching to IgD has been demonstrated as well. Note that this term is best used to annotate gene products which are involved in the mechanism of DNA recombination used in isotype switching, like the B cell specific Swap70 factor in the mouse, rather than gene products which promote isotype switching such as cytokines or co-stimulatory molecules, which should instead be annotated to 'regulation of isotype switching ; GO:0045191'.
The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor.
The process in which specialized cells known as osteoclasts degrade the organic and inorganic portions of bone, and endocytose and transport the degradation products.
Any process that modulates the frequency, rate or extent of T cell differentiation.
regulation of T lymphocyte differentiation
regulation of T-lymphocyte differentiation
Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
Any process that modulates the frequency, rate or extent of lymphocyte differentiation.
regulation of lymphocyte differentiation
The chemical reactions and pathways resulting in the formation of carboxylic acids, any organic acid containing one or more carboxyl (-COOH) groups.
The chemical reactions and pathways involving heterocyclic compounds, those with a cyclic molecular structure and at least two different atoms in the ring (or rings).
A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor.
The controlled release of acid by a cell or a tissue.
The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis.
The regulated release of hormones, substances with a specific regulatory effect on a particular organ or group of cells.
The controlled release of a substance by a cell or a tissue.
The directed movement of substances within a cell.
The directed movement of carboxylic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Carboxylic acids are organic acids containing one or more carboxyl (COOH) groups or anions (COO-).
The self-renewing division of a somatic stem cell, a stem cell that can give rise to cell types of the body other than those of the germ-line.
The meiotic divisions undergone by the primary and secondary spermatocytes to produce haploid spermatids.
The directed movement of substances into, out of or within the Golgi apparatus, mediated by vesicles.
The process in which vesicles are directed to specific destination membranes during transport to, from or within the Golgi apparatus; mediated by the addition of specific coat proteins, including COPI and COPII proteins and clathrin, to the membrane during vesicle formation.
vesicle targeting, to, from or within dictyosome
vesicle targeting, to, from or within Golgi
Generation of the male gamete; specialised haploid cells produced by meiosis and along with a female gamete takes part in sexual reproduction.
The creation of a single organelle from two or more organelles.
The creation of two or more organelles by division of one organelle.
The process in which the anatomical structures of the mesoderm are generated and organized.
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster.
Development of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
The process whose specific outcome is the progression of a spermatid over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
Any process that activates or increases the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.
positive regulation of physiological process
positive regulation of biological process
Any process that stops, prevents, or reduces the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.
negative regulation of physiological process
negative regulation of biological process
Any process that activates or increases the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.
positive regulation of cellular physiological process
The process whose specific outcome is the progression of any organ involved in hematopoiesis (also known as hemopoiesis) or lymphoid cell activation over time, from its formation to the mature structure. Such development includes differentiation of resident cell types (stromal cells) and of migratory cell types dependent on the unique microenvironment afforded by the organ for their proper differentiation.
haematopoietic or lymphoid organ development
haemopoietic or lymphoid organ development
hemopoietic or lymphoid organ development
hematopoietic or lymphoid organ development
Any process that modulates the frequency, rate or extent of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus.
Any process that activates, maintains or increases the rate of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus.
positive regulation of response to stimulus
Any process that stops, prevents, or reduces the frequency, rate or extent of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus.
negative regulation of response to stimulus
The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
embryonic anatomical structure morphogenesis
The process, occurring above the cellular level, that is pertinent to the reproductive function of a multicellular organism. This includes the integrated processes at the level of tissues and organs.
reproductive process in a multicellular organism
multicellular organismal reproductive process
The developmental process pertaining to the initial formation of an anatomical structure from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
formation of an anatomical structure involved in morphogenesis
Note that, for example, the formation of a pseudopod in an amoeba would not be considered formation involved in morphogenesis because it would not be thought of as the formation of an anatomical structure that was part of the shaping of the amoeba during its development. The formation of an axon from a neuron would be considered the formation of an anatomical structure involved in morphogenesis because it contributes to the creation of the form of the neuron in a developmental sense.
anatomical structure formation involved in morphogenesis
The process in which the anatomical structures of a tissue are generated and organized.
The process whose specific outcome is the progression of an organismal system over time, from its formation to the mature structure. A system is a regularly interacting or interdependent group of organs or tissues that work together to carry out a given biological process.
The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
branching morphogenesis of an epithelial tube
A small, subcellular membrane-bounded vesicle containing pigment and/or pigment precursor molecules. Pigment granule biogenesis is poorly understood, as pigment granules are derived from multiple sources including the endoplasmic reticulum, coated vesicles, lysosomes, and endosomes.
The reorganization or renovation of existing tissues. This process can either change the characteristics of a tissue such as in blood vessel remodeling, or result in the dynamic equilibrium of a tissue such as in bone remodeling.
The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
A biological process whose specific outcome is the progression of a cell over time from an initial condition to a later condition.
Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another.
Any process involved in the maintenance of an internal steady state at the level of the multicellular organism.
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells.
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule.
Any process that modulates the frequency, rate or extent of development, the biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
Any process that modulates the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level.
regulation of cellular physiological process
Any process that modulates the frequency, rate or extent of T cell activation.
Any process that modulates the frequency, rate or extent of cell activation, the change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
A organ system process carried out by any of the organs or tissues of neurological system.
Any process that modulates the levels of body fluids.
The process that involves the secretion of or response to endocrine hormones. An endocrine hormone is a hormone released into the circulatory system.
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism.
The movement of a leukocyte within or between different tissues and organs of the body.
The series of events involved in sensory perception in which a sensory stimulus is received and converted into a molecular signal.
sensory perception, sensory transduction of stimulus
detection of stimulus involved in sensory perception
Any process that modulates the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
The series of events required for an organism to receive a sensory light stimulus, convert it to a molecular signal, and recognize and characterize the signal. This is a neurological process.
The series of events in which a light stimulus is received by a cell and converted into a molecular signal as part of the sensory perception of light.
sensory detection of light stimulus during sensory perception
sensory perception, sensory detection of light stimulus
sensory perception, sensory transduction of light stimulus
sensory transduction of light stimulus during sensory perception
detection of light stimulus involved in sensory perception
Any process in which a cell, a substance, or a cellular entity, such as a protein complex or organelle, is transported, tethered to or otherwise maintained in a specific location. In the case of substances, localization may also be achieved via selective degradation.
establishment and maintenance of localization
establishment and maintenance of position
establishment and maintenance of cellular component location
establishment and maintenance of substance location
establishment and maintenance of substrate location
Any process that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation.
Any process that modulates the frequency, rate or extent of a multicellular organismal process, the processes pertinent to the function of a multicellular organism above the cellular level; includes the integrated processes of tissues and organs.
regulation of multicellular organismal process
Any process that activates or increases the frequency, rate or extent of an organismal process, any of the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs.
up regulation of multicellular organismal process
up-regulation of multicellular organismal process
upregulation of multicellular organismal process
activation of multicellular organismal process
stimulation of multicellular organismal process
positive regulation of multicellular organismal process
Any process that modulates the frequency, rate or extent of lymphocyte activation.
Any process that modulates the frequency, rate or extent of the movement of a cellular component.
regulation of cellular component movement
Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.
positive regulation of cellular component motion
positive regulation of cellular component movement
A process that is carried out at the cellular level that results in the assembly, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information. This term covers covalent modifications at the molecular level as well as spatial relationships among the major components of a chromosome.
The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
Note that this term differs from 'cytokinesis ; GO:0000910' in that cytokinesis does not include nuclear division.
Progression through the phases of the meiotic cell cycle, in which canonically a cell replicates to produce four offspring with half the chromosomal content of the progenitor cell via two nuclear divisions.
Note that this term should not be confused with 'GO:0140013 ; meiotic nuclear division'. 'GO:0051321 ; meiotic cell cycle represents the entire mitotic cell cycle, while 'GO:0140013 meiotic nuclear division' specifically represents the actual nuclear division step of the mitotic cell cycle.
The regulated release of corticotropin by a cell. Corticotropin hormone is a polypeptide hormone synthesized and secreted from corticotropes in the anterior lobe of the pituitary gland in response to corticotropin-releasing hormone (CRH) released by the hypothalamus.
The series of events in which a stimulus is received by a cell or organism and converted into a molecular signal.
The directed movement of histamine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Histamine is a physiologically active amine, found in plant and animal tissue and released from mast cells as part of an allergic reaction in humans.
Any process in which an organelle is transported to, and/or maintained in, a specific location.
establishment and maintenance of organelle localization
A cellular localization process whereby a substance or cellular entity, such as a protein complex or organelle, is transported to, and/or maintained in, a specific location within a cell including the localization of substances or cellular entities to the cell membrane.
establishment and maintenance of cellular localization
establishment and maintenance of localization in cell or cell membrane
Any process in which a vesicle or vesicles are transported to, and/or maintained in, a specific location.
establishment and maintenance of vesicle localization
Any process, occuring in a cell, that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation.
establishment of intracellular localization
establishment of localization within cell
The directed movement of a vesicle to a specific location.
The directed movement of an organelle to a specific location.
Any process in which a cell is transported to, and/or maintained in, a specific location.
establishment and maintenance of cell localization
establishment and maintenance of localization of cell
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from another living organism.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus by a cell and ends with a change in state or activity or the cell.
The process in which a solute is transported across a lipid bilayer, from one side of a membrane to the other.
ATP hydrolysis coupled transmembrane transport
Transmembrane transport is the transport of a solute across a lipid bilayer. Note that transport through the nuclear pore complex is not transmembrane because the nuclear membrane is a double membrane and is not traversed. For transport through the nuclear pore, consider instead the term 'nucleocytoplasmic transport ; GO:0006913' and its children. Note also that this term is not intended for use in annotating lateral movement within membranes.
The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
The regulation of body fluids process in which parasympathetic nerves stimulate the bladder wall muscle to contract and expel urine from the body.
Any process that modulates the potential difference across a post-synaptic membrane.
regulation of post-synaptic membrane potential
regulation of postsynaptic membrane potential
A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential.
regulation of excitatory post-synaptic membrane potential
A compound molecular function in which an effector function is controlled by one or more regulatory components.
A homeostatic process involved in the maintenance of an internal steady state within a defined anatomical structure of an organism, including control of cellular proliferation and death and control of metabolic function. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
The assembly of a cilium, a specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface. Each cilium is bounded by an extrusion of the cytoplasmic membrane, and contains a regular longitudinal array of microtubules, anchored basally in a centriole.
Cell motility due to the motion of one or more eukaryotic cilia. A eukaryotic cilium is a specialized organelle that consists of a filiform extrusion of the cell surface. Each cilium is bounded by an extrusion of the cytoplasmic (plasma) membrane, and contains a regular longitudinal array of microtubules, anchored basally in a centriole.
microtubule-based flagellar cell motility
Note that we deem eukaryotic cilia and microtubule-based flagella to be equivalent.
Movement of cilia mediated by motor proteins that contributes to the movement of a cell.
cilium movement involved in cell motility
The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).
The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of a mast cell. A mast cell is a cell that is found in almost all tissues containing numerous basophilic granules and capable of releasing large amounts of histamine and heparin upon activation.
The process whose specific outcome is the progression of an epithelium over time, from its formation to the mature structure. An epithelium is a tissue that covers the internal or external surfaces of an anatomical structure.
The process in which the anatomical structures of a tube are generated and organized from an epithelium. Epithelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system.
The regulated release of a hormone into the circulatory system.
An system process carried out by any of the organs or tissues of the hepaticobiliary system. The hepaticobiliary system is responsible for metabolic and catabolic processing of small molecules absorbed from the blood or gut, hormones and serum proteins, detoxification, storage of glycogen, triglycerides, metals and lipid soluble vitamins and excretion of bile. Included are the synthesis of albumin, blood coagulation factors, complement, and specific binding proteins.
A process which results in the assembly, arrangement of constituent parts, or disassembly of a membrane. A membrane is a double layer of lipid molecules that encloses all cells, and, in eukaryotes, many organelles; may be a single or double lipid bilayer; also includes associated proteins.
The membrane organization process that joins two lipid bilayers to form a single membrane.
The process in which the anatomical structures of a branched epithelium are generated and organized.
A process in which a protein is transported to, or maintained in, a location within a cilium.
The controlled release of glutamate by a cell, in which the glutamate acts as a neurotransmitter.
An immune response against microbes mediated by anti-microbial peptides in body fluid.
peptide-mediated antimicrobial humoral response
antimicrobial peptide-mediated antimicrobial humoral response
antimicrobial humoral immune response mediated by antimicrobial peptide
A process that coontributes to the second meiotic division. The second meiotic division separates chromatids resulting in a haploid number of chromosomes.
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
collagen-containing extracellular matrix
The aggregation, arrangement and bonding together of a set of macromolecules to form a protein-containing complex.
cellular protein-containing complex assembly
Any process that modulates a measurable attribute of any biological process, quality or function.
Any process that modulates a qualitative or quantitative trait of a biological quality. A biological quality is a measurable attribute of an organism or part of an organism, such as size, mass, shape, color, etc.
Organized structure of distinctive morphology and function, bounded by a lipid bilayer membrane and occurring outside the cell.
extracellular membrane-enclosed organelle
extracellular membrane-bounded organelle
An organelle lumen that is part of an intracellular organelle.
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
The regulated release of glucagon from secretory granules in the A (alpha) cells of the pancreas (islets of Langerhans).
A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix.
The regulated release of somatostatin from secretory granules in the D cells of the pancreas.
The regulated release of mucus by the mucosa. Mucus is a viscous slimy secretion consisting of mucins and various inorganic salts dissolved in water, with suspended epithelial cells and leukocytes. The mucosa, or mucous membrane, is the membrane covered with epithelium that lines the tubular organs of the body. Mucins are carbohydrate-rich glycoproteins that have a lubricating and protective function.
A transport vesicle that mediates transport from an intracellular compartment to the plasma membrane, and fuses with the plasma membrane to release various cargo molecules, such as proteins or hormones, by exocytosis.
exocytic constitutive secretory pathway transport vesicle
The regulated release of prolactin, a peptide hormone that stimulates lactation, from secretory granules in the anterior pituitary.
The regulated release of thyroid-stimulating hormone, a peptide hormone that stimulates the activity of the thyroid gland, from secretory granules in the anterior pituitary.
Any process in which a macromolecule is transported to, and/or maintained in, a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell.
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus.
The aggregation, arrangement and bonding together of a set of components to form an organelle. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane.
A cellular process that results in a change in the spatial configuration of a DNA molecule. A conformation change can bend DNA, or alter the, twist, writhe, or linking number of a DNA molecule.
The movement of a granulocyte in response to an external stimulus.
Any process that modulates the rate, frequency or extent of granulocyte chemotaxis. Granulocyte chemotaxis is the movement of a granulocyte in response to an external stimulus.
Any process that increases the rate, frequency or extent of granulocyte chemotaxis. Granulocyte chemotaxis is the movement of a granulocyte in response to an external stimulus.
positive regulation of granulocyte chemotaxis
Any process in which a protein is transported from one specific location in the extracellular region to another, or maintained in a specific extracellular location.
protein localisation in extracellular region
protein localization in extracellular region
protein localization to extracellular region
The directed movement of organic substances into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore. An organic substance is a molecular entity that contains carbon.
The chemical reactions and pathways involving an organic substance, any molecular entity containing carbon.
organic molecular entity metabolic process
The directed movement of nitrogen-containing compounds into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
The process in which immunoglobulin heavy chain V, D, and J gene segments are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).
immunoglobulin heavy chain V-D-J recombination
The process in which immunoglobulin light chain V and J gene segments are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).
immunoglobulin light chain V-J recombination
A protein complex composed of two identical immunoglobulin heavy chains of the IgD isotype and two identical immunoglobulin light chains, held together by disulfide bonds. An IgD immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.
Note that an IgD immunoglobulin complex has the function of antigen binding if a suitable antigen is available.
A protein complex composed of two identical immunoglobulin heavy chains of the IgM isotype and two identical immunoglobulin light chains, held together by disulfide bonds, and in its circulating form complexed with J chain in polymeric forms. An IgM immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph.
Note that an IgM immunoglobulin complex has the function of antigen binding if a suitable antigen is available.
Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a ribonucleoprotein complex.
RNA-protein complex subunit organization
protein-RNA complex subunit organization
ribonucleoprotein complex subunit organisation
ribonucleoprotein complex subunit organization
A process that results in the biosynthesis of constituent macromolecules, assembly, arrangement of constituent parts, or disassembly of a cellular component.
cellular component organisation or biogenesis
cellular component organisation or biogenesis at cellular level
cellular component organization or biogenesis at cellular level
cellular component organization or biogenesis
The part of a cell encompassing the cell cortex, the plasma membrane, and any external encapsulating structures.
An supramolecular fiber that consists of an insoluble core of polymerized tropoelastin monomers and a surrounding mantle of microfibrils. Elastic fibers provide elasticity and recoiling to tissues and organs, and maintain structural integrity against mechanical strain.
The aggregation, arrangement and bonding together of a set of components to form an extracellular vesicular exosome, a membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Exosomes are defined by their size, which generally ranges from 30 nm to 100 nm.
extracellular vesicular exosome assembly
The developmental process pertaining to the initial formation of an epithelial tube.
The chemical reactions and pathways resulting in the formation of monocarboxylic acids, any organic acid containing one carboxyl (-COOH) group.
monocarboxylic acid biosynthetic process
The process whose specific outcome is the progression of the circulatory system over time, from its formation to the mature structure. The circulatory system is the organ system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells, etc. to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis.
Any process that modulates the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
Any process that increases the frequency, rate, or extent of neutrophil chemotaxis. Neutrophil chemotaxis is the directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding.
positive regulation of neutrophil chemotaxis
The joining of two lipid bilayers to form a single organelle membrane.
Any cellular metabolic process involving nucleic acids.
All of the contents of a cilium, excluding the plasma membrane surrounding the cilium.
Note that we deem cilium and microtubule-based flagellum to be equivalent. Also, researchers consider the composition of both the plasm and the membrane of the cilium to be detectably different from that in the non-ciliary cytosol and plasma membrane (e.g. in terms of calcium ion concentration, membrane lipid composition, and more). For this reason, the term "ciliary plasm" is not linked to "cytoplasm".
The process in which a precursor cell type acquires the specialized features of a dendritic cell. A dendritic cell is a leukocyte of dendritic lineage specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation.
Note that immunologists typically use the word 'maturation' to refer to dendritic cells undergoing the process that GO describes as 'cell differentiation'.
Binding to an organic cyclic compound, any molecular entity that contains carbon arranged in a cyclic molecular structure.
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
induction of apoptosis by extracellular signals
This term can be used to annotate gene products involved in apoptotic events happening downstream of the cross-talk point between the extrinsic and intrinsic apoptotic pathways. The cross-talk starts when caspase-8 cleaves Bid and truncated Bid interacts with mitochondria. From this point on it is not possible to distinguish between extrinsic and intrinsic pathways.
A stage of the apoptotic process that starts with the controlled breakdown of the cell through the action of effector caspases or other effector molecules (e.g. cathepsins, calpains etc.). Key steps of the execution phase are rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
A renal system process in which fluid circulating through the body is filtered through a barrier system.
An arrangement of closely apposed microtubules running parallel to each other.
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a supramolecular fiber, a polymer consisting of an indefinite number of protein or protein complex subunits that have polymerised to form a fiber-shaped structure.
extracellular fibril organization and biogenesis
The movement of a myeloid leukocyte within or between different tissues and organs of the body.
The movement of a granulocyte within or between different tissues and organs of the body.
Any vesicle that is part of the intracellular region.
The docking of a cytosolic centriole/basal body to the plasma membrane via the ciliary transition fibers. In some species this may happen via an intermediate step, by first docking to the ciliary vesicle via the ciliary transition fibers. The basal body-ciliary vesicle then relocates to the plasma membrane, followed by the ciliary vesicle fusing with the plasma membrane, effectively attaching the basal body to the plasma membrane.
anchoring of the basal body to the plasma membrane
Basal bodies in jawed vertebrates appear to first attach to a ciliary vesicle. It is unclear how specific this is to jawed vertebrates or if other organisms also employ this sequence. Some species like Giardia intestinalis do not relocate their basal bodies to the plasma membrane, but have their axonemes extend through the cytosol to then protrude out of the cell to form flagella.
ciliary basal body-plasma membrane docking
The process in which vesicles formed at the trans-Golgi network are directed to the plasma membrane surrounding the base of the cilium, including the ciliary pocket, mediated by molecules at the vesicle membrane and target membrane surfaces.
vesicle targeting, trans-Golgi to periciliary membrane compartment
Any process involved in the controlled movement of a sperm cell.
The assembly and secretion of an extracellular exosome, a membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane.
Reactions triggered in response to the presence of another organism that act to protect the cell or organism from damage caused by that organism.
defence response incompatible interaction
defence response to pathogen, incompatible interaction
defense response, incompatible interaction
The lipid bilayer that forms the outer-most layer of an organelle.
Examples include the outer membranes of double membrane bound organelles such as mitochondria as well as the bounding membranes of single-membrane bound organelles such as lysosomes.
A membrane that is a (regional) part of the plasma membrane.
Note that this term should not be used for direct manual annotation as it should always be possible to choose a more specific subclass.
A supramolecular assembly of fibrillar collagen complexes in the form of a long fiber (fibril) with transverse striations (bands).
A complex of collagen trimers such as a fibril or collagen network.
A supramolecular complex that consists of collagen triple helices associated to form a network.
Any collagen timer that is part of a basement membrane.
The process in which an anion is transported across a membrane.
ATP hydrolysis coupled anion transmembrane transport
Any process that reduces or removes the toxicity of a toxic substance. These may include transport of the toxic substance away from sensitive areas and to compartments or complexes whose purpose is sequestration of the toxic substance.
The part of a synapse that is part of the presynaptic cell.
The part of a synapse that is part of the post-synaptic cell.
Any protein complex that is part of a membrane.
Any protein complex that is part of the plasma membrane.
Any protein complex that is part of the plasma membrane and which functions as a signaling receptor.
plasma membrane signaling receptor complex
Cell-cell signaling from pre to post-synapse, across the synaptic cleft.
Synaptic transmission that results in an excitatory postsynaptic potential.
excitatory chemical synaptic transmission
A cellular component that consists of an indeterminate number of proteins or macromolecular complexes, organized into a regular, higher-order structure such as a polymer, sheet, network or a fiber.
A microtubule-based process that results in the transport of organelles, other microtubules, or other cellular components. Examples include motor-driven movement along microtubules and movement driven by polymerization or depolymerization of microtubules.
Fusion of the membrane of a vesicle with the plasma membrane, thereby releasing its contents into the extracellular space.
A cytoplasmic, membrane bound vesicle that is capable of fusing to the plasma membrane to release its contents into the extracellular space.
A polymer consisting of an indefinite number of protein or protein complex subunits that have polymerised to form a fiber-shaped structure.
A component of the cytoskeleton consisting of a homo or heteropolymeric fiber constructed from an indeterminate number of protein subunits.
Cell-cell signaling to, from or within a synapse.
Cell-cell signaling in either direction across the synaptic cleft.
The part of synaptic transmission occurring in the post-synapse: a signal transduction pathway consisting of neurotransmitter receptor activation and its effects on postsynaptic membrane potential and the ionic composition of the postsynaptic cytosol.
postsynaptic process involved in chemical synaptic transmission
chemical synaptic transmission, postsynaptic
Any (proper) part of the cytoplasm of a single cell of sufficient size to still be considered cytoplasm.
A part of a cellular organism that is either an immaterial entity or a material entity with granularity above the level of a protein complex but below that of an anatomical system. Or, a substance produced by a cellular organism with granularity above the level of a protein complex.
A prolongation or process extending from a cell and that is bounded by plasma membrane, e.g. a cilium, lamellipodium, or axon.
Formation of a prolongation or process extending and that is bounded by plasma membrane, e.g. a cilium, lamellipodium, or axon.
plasma membrane bounded cell projection assembly
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a plasma membrane bounded prolongation or process extending from a cell, e.g. a cilium or axon.
plasma membrane bounded cell projection organization
The assembly and organization of the sperm flagellum, the microtubule-based axoneme and associated structures that are part of a sperm flagellum (or cilium).
One of the two nuclear divisions that occur as part of the meiotic cell cycle.
A mitotic cell cycle process comprising the steps by which the nucleus of a eukaryotic cell divides; the process involves condensation of chromosomal DNA into a highly compacted form. Canonically, mitosis produces two daughter nuclei whose chromosome complement is identical to that of the mother cell.
The cellular processes that contribute to exocytosis.
The process by which an organelle membrane interacts with another membrane via molecular tethers that physically bridge the two membranes and attach them to each other.
organelle localization by membrane tethering
The assembly and secretion a set of components to form an extracellular vesicule, a membrane-bounded vesicle that is released into the extracellular region. Extracellular vesicles include exosomes, microvesicles and apoptotic bodies, based on the mechanism by which they are released from cells and differentiated based on their size and content.
The directed movement of some substance from a cell, into the extracellular region. This may occur via transport across the plasma membrane or via exocytosis.
The directed movement of a lipid from a cell, into the extracellular region.
The chemical reactions and pathways involving carbohydrate derivative.
carbohydrate derivative metabolic process
The chemical reactions and pathways resulting in the formation of carbohydrate derivative.
carbohydrate derivative biosynthetic process
The chemical reactions and pathways involving organic cyclic compound.
organic cyclic compound metabolic process
The chemical reactions and pathways resulting in the formation of organic cyclic compound.
organic cyclic compound biosynthetic process
The chemical reactions and pathways involving organonitrogen compound.
organonitrogen compound metabolic process
The chemical reactions and pathways resulting in the formation of organonitrogen compound.
organonitrogen compound biosynthetic process
The chemical reactions and pathways resulting in the breakdown of an organic substance, any molecular entity containing carbon.
organic molecular entity catabolic process
The chemical reactions and pathways resulting in the formation of an organic substance, any molecular entity containing carbon.
organic molecular entity biosynthetic process
The chemical reactions and pathways involving organic hydroxy compound.
organic hydroxy compound metabolic process
The chemical reactions and pathways resulting in the formation of organic hydroxy compound.
organic hydroxy compound biosynthetic process
Any process that modulates the frequency, rate or extent of leukocyte differentiation.
regulation of immune cell differentiation
Any process that modulates the frequency, rate or extent of neutrophil migration.
Any process that activates or increases the frequency, rate or extent of neutrophil migration.
positive regulation of neutrophil migration
A process that is part of the meiotic cell cycle.
A process that is part of the mitotic cell cycle.
The process in which a relatively unspecialized cell acquires the specialized features of a mononuclear cell.
The chemical reactions and pathways involving mucopolysaccharide.
Any process that modulates the frequency, rate or extent of blood circulation.
Any vesicle that is part of the extracellular region.
Any process that modulates the frequency, rate or extent of hemopoiesis.
An example of this is Atg7 in mouse (UniProt symbol, Q9D906) in PMID:20080761, inferred from mutant phenotype.
Any cell surface receptor signaling pathway that is involved in cell-cell signaling.
cell surface receptor linked signal transduction involved in cell-cell signaling
cell surface receptor linked signal transduction involved in cell-cell signalling
cell surface receptor linked signaling pathway involved in cell-cell signaling
cell surface receptor linked signaling pathway involved in cell-cell signalling
cell surface receptor linked signalling pathway involved in cell-cell signaling
cell surface receptor linked signalling pathway involved in cell-cell signalling
cell surface receptor signaling pathway involved in cell-cell signalling
cell surface receptor signaling pathway involved in cell-cell signaling
The aggregation, arrangement and bonding together of a set of components to form a ciliary transition zone.
The movement of a neutrophil within or between different tissues and organs of the body.
A macromolecular complex that contains both RNA and protein molecules.
Any process that modulates the frequency, rate or extent of multicellular organismal development.
regulation of multicellular organismal development
Any process that modulates the frequency, rate or extent of cell motility.
Any process that activates or increases the frequency, rate or extent of cell motility.
positive regulation of movement of a cell
conditional specification
a directive information entity that specifies what should happen if the trigger condition is fulfilled
PlanAndPlannedProcess Branch
OBI branch derived
measurement unit label
Examples of measurement unit labels are liters, inches, weight per volume.
A measurement unit label is as a label that is part of a scalar measurement datum and denotes a unit of measure.
2009-03-16: review of this term done during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI.
PERSON: Melanie Courtot
objective specification
In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction.
a directive information entity that describes an intended process endpoint. When part of a plan specification the concretization is realized in a planned process in which the bearer tries to effect the world so that the process endpoint is achieved.
2009-03-16: original definition when imported from OBI read: "objective is an non realizable information entity which can serve as that proper part of a plan towards which the realization of the plan is directed."
2014-03-31: In the example of usage ("In the protocol of a ChIP assay the objective specification says to identify protein and DNA interaction") there is a protocol which is the ChIP assay protocol. In addition to being concretized on paper, the protocol can be concretized as a realizable entity, such as a plan that inheres in a person. The objective specification is the part that says that some protein and DNA interactions are identified. This is a specification of a process endpoint: the boundary in the process before which they are not identified and after which they are. During the realization of the plan, the goal is to get to the point of having the interactions, and participants in the realization of the plan try to do that.
Answers the question, why did you do this experiment?
PERSON: Barry Smith
PERSON: Bjoern Peters
PERSON: Jennifer Fostel
goal specification
OBI Plan and Planned Process/Roles Branch
action specification
Pour the contents of flask 1 into flask 2
a directive information entity that describes an action the bearer will take
OBI Plan and Planned Process branch
A label is a symbol that is part of some other datum and is used to either partially define the denotation of that datum or to provide a means for identifying the datum as a member of the set of data with the same label
GROUP: IAO
journal article
Examples are articles published in the journals, Nature and Science. The content can often be cited by reference to a paper based encoding, e.g. Authors, Title of article, Journal name, date or year of publication, volume and page number.
a report that is published in a journal
person:Chris Stoeckert
data item
Data items include counts of things, analyte concentrations, and statistical summaries.
a data item is an information content entity that is intended to be a truthful statement about something (modulo, e.g., measurement precision or other systematic errors) and is constructed/acquired by a method which reliably tends to produce (approximately) truthful statements.
2/2/2009 Alan and Bjoern discussing FACS run output data. This is a data item because it is about the cell population. Each element records an event and is typically further composed a set of measurment data items that record the fluorescent intensity stimulated by one of the lasers.
2009-03-16: data item deliberatly ambiguous: we merged data set and datum to be one entity, not knowing how to define singular versus plural. So data item is more general than datum.
2009-03-16: removed datum as alternative term as datum specifically refers to singular form, and is thus not an exact synonym.
2014-03-31: See discussion at http://odontomachus.wordpress.com/2014/03/30/aboutness-objects-propositions/
JAR: datum -- well, this will be very tricky to define, but maybe some information-like stuff that might be put into a computer and that is meant, by someone, to denote and/or to be interpreted by some process... I would include lists, tables, sentences... I think I might defer to Barry, or to Brian Cantwell Smith JAR: A data item is an approximately justified approximately true approximate belief
PERSON: Chris Stoeckert
data
information content entity
Examples of information content entites include journal articles, data, graphical layouts, and graphs.
A generically dependent continuant that is about some thing.
an information content entity is an entity that is generically dependent on some artifact and stands in relation of aboutness to some entity
2014-03-10: The use of "thing" is intended to be general enough to include universals and configurations (see https://groups.google.com/d/msg/information-ontology/GBxvYZCk1oc/-L6B5fSBBTQJ).
information_content_entity 'is_encoded_in' some digital_entity in obi before split (040907). information_content_entity 'is_encoded_in' some physical_document in obi before split (040907). Previous. An information content entity is a non-realizable information entity that 'is encoded in' some digital or physical entity.
10 feet. 3 ml.
a scalar measurement datum is a measurement datum that is composed of two parts, numerals and a unit label.
Would write this as: has_part some 'measurement unit label' and has_part some numeral and has_part exactly 2, except for the fact that this won't let us take advantage of OWL reasoning over the numbers. Instead use has measurment value property to represent the same. Use has measurement unit label (subproperty of has_part) so we can easily say that there is only one of them.
scalar measurement datum
directive information entity
An information content entity whose concretizations indicate to their bearer how to realize them in a process.
2009-03-16: provenance: a term realizable information entity was proposed for OBI (OBI_0000337) , edited by the PlanAndPlannedProcess branch. Original definition was "is the specification of a process that can be concretized and realized by an actor" with alternative term "instruction".It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term.
2013-05-30 Alan Ruttenberg: What differentiates a directive information entity from an information concretization is that it can have concretizations that are either qualities or realizable entities. The concretizations that are realizable entities are created when an individual chooses to take up the direction, i.e. has the intention to (try to) realize it.
8/6/2009 Alan Ruttenberg: Changed label from "information entity about a realizable" after discussions at ICBO
Werner pushed back on calling it realizable information entity as it isn't realizable. However this name isn't right either. An example would be a recipe. The realizable entity would be a plan, but the information entity isn't about the plan, it, once concretized, *is* the plan. -Alan
curation status specification
The curation status of the term. The allowed values come from an enumerated list of predefined terms. See the specification of these instances for more detailed definitions of each enumerated value.
Better to represent curation as a process with parts and then relate labels to that process (in IAO meeting)
report
Examples of reports are gene lists and investigation reports. These are not published (journal) articles but may be included in a journal article.
a document assembled by an author for the purpose of providing information for the audience. A report is the output of a documenting process and has the objective to be consumed by a specific audience. Topic of the report is on something that has completed. A report is not a single figure. Examples of reports are journal article, patent application, grant progress report, case report (not patient record)
2009-03-16: this was report of results with definition: A report is a narrative object that is a formal statement of the results of an investigation, or of any matter on which definite information is required, made by some person or body instructed or required to do so.
2009-03-16: work has been done on this term during during the OBI workshop winter 2009 and the current definition was considered acceptable for use in OBI. If there is a need to modify this definition please notify OBI.
2009-08-10 Alan Ruttenberg: Larry Hunter suggests that this be obsoleted and replaced by 'document'. Alan restored as there are OBI dependencies and this merits further discussion
disagreement about where reports go. alan: only some gene lists are reports. Is a report all the content of some document? The example of usage suggests that a report may be part of some article. Term needs clarification
PERSON:Chris Stoeckert
GROUP: OBI
data set
Intensity values in a CEL file or from multiple CEL files comprise a data set (as opposed to the CEL files themselves).
A data item that is an aggregate of other data items of the same type that have something in common. Averages and distributions can be determined for data sets.
2009/10/23 Alan Ruttenberg. The intention is that this term represent collections of like data. So this isn't for, e.g. the whole contents of a cel file, which includes parameters, metadata etc. This is more like java arrays of a certain rather specific type
person:Allyson Lister
data about an ontology part
data about an ontology part is a data item about a part of an ontology, for example a term
plan specification
PMID: 18323827.Nat Med. 2008 Mar;14(3):226.New plan proposed to help resolve conflicting medical advice.
A directive information entity with action specifications and objective specifications as parts that, when concretized, is realized in a process in which the bearer tries to achieve the objectives by taking the actions specified.
2009-03-16: provenance: a term a plan was proposed for OBI (OBI_0000344) , edited by the PlanAndPlannedProcess branch. Original definition was " a plan is a specification of a process that is realized by an actor to achieve the objective specified as part of the plan". It has been subsequently moved to IAO where the objective for which the original term was defined was satisfied with the definitionof this, different, term.
2014-03-31: A plan specification can have other parts, such as conditional specifications.
Alternative previous definition: a plan is a set of instructions that specify how an objective should be achieved
2/3/2009 Comment from OBI review. Action specification not well enough specified. Conditional specification not well enough specified. Question whether all plan specifications have objective specifications. Request that IAO either clarify these or change definitions not to use them
measurement datum
Examples of measurement data are the recoding of the weight of a mouse as {40,mass,"grams"}, the recording of an observation of the behavior of the mouse {,process,"agitated"}, the recording of the expression level of a gene as measured through the process of microarray experiment {3.4,luminosity,}.
A measurement datum is an information content entity that is a recording of the output of a measurement such as produced by a device.
2/2/2009 is_specified_output of some assay?
document
A journal article, patent application, laboratory notebook, or a book
A collection of information content entities intended to be understood together as a whole
PERSON: Lawrence Hunter
Djungarian hamster also in use for Phodopus campbelli
African green monkey lymphotropic papovavirus LPV
whales, hippos, ruminants, pigs, camels etc.
planned process
Injecting mice with a vaccine in order to test its efficacy
A processual entity that realizes a plan which is the concretization of a plan specification.
'Plan' includes a future direction sense. That can be problematic if plans are changed during their execution. There are however implicit contingencies for protocols that an agent has in his mind that can be considered part of the plan, even if the agent didn't have them in mind before. Therefore, a planned process can diverge from what the agent would have said the plan was before executing it, by adjusting to problems encountered during execution (e.g. choosing another reagent with equivalent properties, if the originally planned one has run out.)
We are only considering successfully completed planned processes. A plan may be modified, and details added during execution. For a given planned process, the associated realized plan specification is the one encompassing all changes made during execution. This means that all processes in which an agent acts towards achieving some objectives is a planned process.
This class merges the previously separated objective driven process and planned process, as they the separation proved hard to maintain. (1/22/09, branch call)
6/11/9: Edited at workshop. Used to include: is initiated by an agent
processed material
Examples include gel matrices, filter paper, parafilm and buffer solutions, mass spectrometer, tissue samples
Is a material entity that is created or changed during material processing.
culture medium
A growth medium or culture medium is a substance in which microorganisms or cells can grow. Wikipedia, growth medium, Feb 29, 2008
a processed material that provides the needed nourishment for microorganisms or cells grown in vitro.
changed from a role to a processed material based on on Aug 22, 2011 dev call. Details see the tracker item: http://sourceforge.net/tracker/?func=detail&aid=3325270&group_id=177891&atid=886178 Modification made by JZ.
Person: Jennifer Fostel, Jie Zheng
OBI
reagent role
Buffer, dye, a catalyst, a solvating agent.
A role inhering in a biological or chemical entity that is intended to be applied in a scientific technique to participate (or have molecular components that participate) in a chemical reaction that facilitates the generation of data about some entity distinct from the bearer, or the generation of some specified material output distinct from the bearer.
PERSON:Matthew Brush
Feb 10, 2009. changes after discussion at OBI Consortium Workshop Feb 2-6, 2009. accepted as core term. May 28 2013. Updated definition taken from ReO based on discussions initiated in Philly 2011 workshop. Former defnition described a narrower view of reagents in chemistry that restricts bearers of the role to be chemical entities ("a role played by a molecular entity used to produce a chemical reaction to detect, measure, or produce other substances"). Updated definition allows for broader view of reagents in the domain of biomedical research to include larger materials that have parts that participate chemically in a molecular reaction or interaction.
(copied from ReO) Reagents are distinguished from instruments or devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in or have parts that participate in some chemical interaction or reaction during their intended participation in some technique. By contrast, instruments do not participate in a chemical reaction/interaction during the technique. Reagents are distinguished from study subjects/evaluants in that study subjects and evaluants are that about which conclusions are drawn and knowledge is sought in an investigation - while reagents, by definition, are not. It should be noted, however, that reagent and study subject/evaluant roles can be borne by instances of the same type of material entity - but a given instance will realize only one of these roles in the execution of a given assay or technique. For example, taq polymerase can bear a reagent role or an evaluant role. In a DNA sequencing assay aimed at generating sequence data about some plasmid, the reagent role of the taq polymerase is realized. In an assay to evaluate the quality of the taq polymerase itself, the evaluant/study subject role of the taq is realized, but not the reagent role since the taq is the subject about which data is generated. In regard to the statement that reagents are 'distinct' from the specified outputs of a technique, note that a reagent may be incorporated into a material output of a technique, as long as the IDENTITY of this output is distinct from that of the bearer of the reagent role. For example, dNTPs input into a PCR are reagents that become part of the material output of this technique, but this output has a new identity (ie that of a 'nucleic acid molecule') that is distinct from the identity of the dNTPs that comprise it. Similarly, a biotin molecule input into a cell labeling technique are reagents that become part of the specified output, but the identity of the output is that of some modified cell specimen which shares identity with the input unmodified cell specimen, and not with the biotin label. Thus, we see that an important criteria of 'reagent-ness' is that it is a facilitator, and not the primary focus of an investigation or material processing technique (ie not the specified subject/evaluant about which knowledge is sought, or the specified output material of the technique).
material processing
A cell lysis, production of a cloning vector, creating a buffer.
A planned process which results in physical changes in a specified input material
material transformation
organization
PMID: 16353909.AAPS J. 2005 Sep 22;7(2):E274-80. Review. The joint food and agriculture organization of the United Nations/World Health Organization Expert Committee on Food Additives and its role in the evaluation of the safety of veterinary drug residues in foods.
An entity that can bear roles, has members, and has a set of organization rules. Members of organizations are either organizations themselves or individual people. Members can bear specific organization member roles that are determined in the organization rules. The organization rules also determine how decisions are made on behalf of the organization by the organization members.
BP: The definition summarizes long email discussions on the OBI developer, roles, biomaterial and denrie branches. It leaves open if an organization is a material entity or a dependent continuant, as no consensus was reached on that. The current placement as material is therefore temporary, in order to move forward with development. Here is the entire email summary, on which the definition is based: 1) there are organization_member_roles (president, treasurer, branch editor), with individual persons as bearers 2) there are organization_roles (employer, owner, vendor, patent holder) 3) an organization has a charter / rules / bylaws, which specify what roles there are, how they should be realized, and how to modify the charter/rules/bylaws themselves. It is debatable what the organization itself is (some kind of dependent continuant or an aggregate of people). This also determines who/what the bearer of organization_roles' are. My personal favorite is still to define organization as a kind of 'legal entity', but thinking it through leads to all kinds of questions that are clearly outside the scope of OBI. Interestingly enough, it does not seem to matter much where we place organization itself, as long as we can subclass it (University, Corporation, Government Agency, Hospital), instantiate it (Affymetrix, NCBI, NIH, ISO, W3C, University of Oklahoma), and have it play roles. This leads to my proposal: We define organization through the statements 1 - 3 above, but without an 'is a' statement for now. We can leave it in its current place in the is_a hierarchy (material entity) or move it up to 'continuant'. We leave further clarifications to BFO, and close this issue for now.
An organization is a continuant entity which can play roles, has members, and has a set of organization rules. Members of organizations are either organizations themselves or individual people. Members can bear specific organization member roles that are determined in the organization rules. The organization rules also determine how decisions are made on behalf of the organization by the organization members.
EFO_URI: http://www.ebi.ac.uk/efo/EFO_0002010
solid support function
Taped, glued, pinned, dried or molecularly bonded to a solid support
A solid support function is a function of a device on which an entity is kept in a defined position and prevented in its movement
material transformation objective
The objective to create a mouse infected with LCM virus. The objective to create a defined solution of PBS.
an objective specifiction that creates an specific output object from input materials.
artifact creation objective
manufacturing
Manufacturing is a process with the intent to produce a processed material which will have a function for future use. A person or organization (having manufacturer role) is a participant in this process
This includes a single scientist making a processed material for personal use.
Manufacturing implies reproducibility and responsibility AR
manufacturing objective
is the objective to manufacture a material of a certain function (device)
With respect to The Accuri C6 Flow Cytometer System, the organization Accuri bears the role manufacturer role. With respect to a transformed line of tissue culture cells derived by a specific lab, the lab whose personnel isolated the cll line bears the role manufacturer role. With respect to a specific antibody produced by an individual scientist, the scientist who purifies, characterizes and distributes the anitbody bears the role manufacturer role.
Manufacturer role is a role which inheres in a person or organization and which is realized by a manufacturing process.
The objective to obtain multiple aliquots of an enzyme preparation. The objective to obtain cells contained in a sample of blood.
is an objective to transform a material entity into spatially separated components.
The objective to obtain multiple aliquots of an enzyme preparation.
A material separation objective aiming to separate material into multiple portions, each of which contains a similar composition of the input material.
separation into different composition objective
The objective to obtain cells contained in a sample of blood.
A material separation objective aiming to separate a material entity that has parts of different types, and end with at least one output that is a material with parts of fewer types (modulo impurities).
We should be using has the grain relations or concentrations to distinguish the portioning and other sub-objectives
An objective specification maintains some or all of the qualities of a material over time.
a process with that achieves the objective to maintain some or all of the characteristics of an input material over time
Establishment of HeLa immortal cell line
is a planned process in which the objective is to generate a cell line from a natural population of cancer cells which are already immortal
Production of a cell line for the purposes of experimentation e.g. EBV transformation of PBMs
an establishing cell line process whereby a mortal cell line is intentionally genetically modified to be capable of indefinite propagation and re-established as a new immortal cell line
4-20-13 MHB: This class was repositioned as a child of 'establishing cell line', based on the existing definition ("the planned process of experimentally creating a cell line which is capable of dividing indefinitely in vitro"), and examples and other annotations indicating the intent to describe a process through which a new immortal cell line is established from an existing mortal cell line using genetic modification techniques. The definition above was modified to clarify this perspective.
'establishing immortal cell line through directed genetic modification'
A immortalizing genetic transformation of an existing population of cell line cells is required as part of this process, as are additional steps for selecting and propagating the cells output form this process into a cell line.
A voltmeter is a measurement device which is intended to perform some measure function.
An autoclave is a device that sterlizes instruments or contaminated waste by applying high temperature and pressure.
A material entity that is designed to perform a function in a scientific investigation, but is not a reagent.
2012-12-17 JAO: In common lab usage, there is a distinction made between devices and reagents that is difficult to model. Therefore we have chosen to specifically exclude reagents from the definition of "device", and are enumerating the types of roles that a reagent can perform. 2013-6-5 MHB: The following clarifications are outcomes of the May 2013 Philly Workshop. Reagents are distinguished from devices that also participate in scientific techniques by the fact that reagents are chemical or biological in nature and necessarily participate in some chemical interaction or reaction during the realization of their experimental role. By contrast, devices do not participate in such chemical reactions/interactions. Note that there are cases where devices use reagent components during their operation, where the reagent-device distinction is less clear. For example: (1) An HPLC machine is considered a device, but has a column that holds a stationary phase resin as an operational component. This resin qualifies as a device if it participates purely in size exclusion, but bears a reagent role that is realized in the running of a column if it interacts electrostatically or chemically with the evaluant. The container the resin is in (“the column”) considered alone is a device. So the entire column as well as the entire HPLC machine are devices that have a reagent as an operating part. (2) A pH meter is a device, but its electrode component bears a reagent role in virtue of its interacting directly with the evaluant in execution of an assay. (3) A gel running box is a device that has a metallic lead as a component that participates in a chemical reaction with the running buffer when a charge is passed through it. This metallic lead is considered to have a reagent role as a component of this device realized in the running of a gel. In the examples above, a reagent is an operational component of a device, but the device itself does not realize a reagent role (as bearing a reagent role is not transitive across the part_of relation). In this way, the asserted disjointness between a reagent and device holds, as both roles are never realized in the same bearer during execution of an assay.
genetically modified material
a material entity, organism or cell, that is the output of a genetic transformation process.
PERSON: Jie Zheng
term is proposed by BP on Oct 25, 2010 dev call
genetic transformation objective
a material transformation objective aims to create genetically modified organism or cell
Person: Jie Zheng
suggested to be added by BP and AR during Oct 25, 2010 dev call
assay array
A device made to be used in an analyte assay for immobilization of substances that bind the analyte at regular spatial positions on a surface.
PERSON: Chris Stoeckert, Jie Zheng, Alan Ruttenberg
A cultured cell that has been passaged or derives from a cell that has been passaged in culture.
The term 'secondary cell culture' is generally used in biological texts/protocols to refer to any culture following an initial passage. We include it here because there are often a number of passages between a primary culture and the establishment of a stable, homogenous cell line. Such cultures are considered to be 'secondary cultures' but not 'cell lines' during this intermediate passaging/selection period between their derivation from a 'primary cell culture' and derivation into a 'cell line', which is a more specific type of secondary culture.
A secondary cultured cell has been passaged in culture or is a descendant of such a cell that is derived through propagation in culture.
a process whereby a new type of cell line is created, either through passaging of a primary cell culture to relative genetic stability and compositional homogeneity, or through some experimental modification of an existing cell line to produce a new line with novel characteristics (e.g. immortalization or some other stable genetic modification, or selection of some defined subset).
2013-4-20 MHB: For cases of initial establilshment of a line from a primary culture, successive passaging and/or selection processes can confer increasing degrees of genetic stability and compositional homogeneity as compared to the input primary culture. Historically, many texts consider the first passage as the clearest point to define the beginning of a line. However, in practice it is more often that case that more than one passage, and possibly additional selective techniques, may be required before a culture is deemed to have sufficient stability and homogeneity to be considered cell line. This is the view taken in OBI. Regardless, what is important is that some intentional, experimental step has been taken to establish a more homogenous and stable culture that can be characterized and progatated over time.
Illumina BeadChip
An array that consists of 3-micron silica beads that self assemble in microwells on either of two materials: fiber optic bundles or planar silica slides.
PERSON: Chris Stoeckert, Jie Zheng, Alan Ruttenberg, Venkat Malladi
A cultured cell population that is derived through one or more passages in culture.
The term 'secondary cell culture' is generally used in biological texts/protocols to refer to any culture of cells following an initial passage. We include it here because there are often a number of passages between a primary culture and the establishment of a stable, homogenous cell line. Such cultures are considered to be 'secondary cultures' but not 'cell lines' during this intermediate passaging/selection period between their derivation from a 'primary cell culture' and derivation into a 'cell line', which is a more specific type of secondary culture.
The concept of a 'secondary cultured cell population' covers cell lines as well as cultured cell populations more immediately derived from a primary culture which have yet to achieve adequate genetic stability and compositional homogeneity to be considered a cell line. The extent of the collection of cells in a 'secondary cultured cell population' is restricted only in that all cell members must share a propagation history (ie be derived through a common lineage of passages from an initial culture). Secondary cultured cell populations can be under active culture, stored in a quiescent state for future use, or applied experimentally.
An immortal cell line derived from a transformed cell that was part of a malignant tumor.
a genetic transformation of a cell line cell with transgenic constructs intended to confer the capability for indefinite propagation in culture
cell freezing medium
culture media or serum + 10% DMSO is often used as cell freezing media.
A processed material that serves as a liquid vehicle for freezing cells for long term quiescent stroage, which contains chemicls needed to sustain cell viability across freeze-thaw cycles.
organism
animal
fungus
plant
virus
A material entity that is an individual living system, such as animal, plant, bacteria or virus, that is capable of replicating or reproducing, growth and maintenance in the right environment. An organism may be unicellular or made up, like humans, of many billions of cells divided into specialized tissues and organs.
10/21/09: This is a placeholder term, that should ideally be imported from the NCBI taxonomy, but the high level hierarchy there does not suit our needs (includes plasmids and 'other organisms')
13-02-2009: OBI doesn't take position as to when an organism starts or ends being an organism - e.g. sperm, foetus. This issue is outside the scope of OBI.
WEB: http://en.wikipedia.org/wiki/Organism
A cultured cell population applied in an experiment: "293 cells expressing TrkA were serum-starved for 18 hours and then neurotrophins were added for 10 min before cell harvest." (Lee, Ramee, et al. "Regulation of cell survival by secreted proneurotrophins." Science 294.5548 (2001): 1945-1948). A cultured cell population maintained in vitro: "Rat cortical neurons from 15 day embryos are grown in dissociated cell culture and maintained in vitro for 8–12 weeks" (Dichter, Marc A. "Rat cortical neurons in cell culture: culture methods, cell morphology, electrophysiology, and synapse formation." Brain Research 149.2 (1978): 279-293).
A processed material comprised of a collection of cultured cells that has been continuously maintained together in culture and shares a common propagation history.
2013-6-5 MHB: This OBI class was formerly called 'cell culture', but label changed and definition updated following CLO alignment efforts in spring 2013, during which the intent of this class was clarified to refer to portions of a culture or line rather than a complete cell culture or line.
The extent of a 'cultured cell population' is restricted only in that all cell members must share a propagation history (ie be derived through a common lineage of passages from an initial culture). In being defined in this way, this class can be used to refer to the populations that researchers actually use in the practice of science - ie are the inputs to culturing, experimentation, and sharing. The cells in such populations will be a relatively uniform population as they have experienced similar selective pressures due to their continuous co-propagation. And this population will also have a single passage number, again owing to their common passaging history. Cultured cell populations represent only a collection of cells (ie do not include media, culture dishes, etc), and include populations of cultured unicellular organisms or cultured multicellular organism cells. They can exist under active culture, stored in a quiescent state for future use, or applied experimentally.
genetically modified organism
A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis. Nat Protoc. 2008;3(10):1550-8. PMID: 18802436
an organism that is the output of a genetic transformation process
OBI Biomaterial
material component separation
Using a cell sorter to separate a mixture of T cells into two fractions; one with surface receptor CD8 and the other lacking the receptor, or purification
a material processing in which components of an input material become segregated in space
Bjoern Peters
IEDB
maintaining cell culture
When harvesting blood from a human, isolating T cells, and then limited dilution cloning of the cells, the maintaining_cell_culture step comprises all steps after the initial dilution and plating of the cells into culture, e.g. placing the culture into an incubator, changing or adding media, and splitting a cell culture
a protocol application in which cells are kept alive in a defined environment outside of an organism. part of cell_culturing
a process through which a new type of cell culture or cell line is created, either through the isolation and culture of one or more cells from a fresh source, or the deliberate experimental modification of an existing cell culture (e.g passaging a primary culture to become a secondary culture or line, or the immortalization or stable genetic modification of an existing culture or line).
A 'cell culture' as used here referes to a new lineage of cells in culture deriving from a single biological source.. New cultures are established through the initial isolation and culturing of cells from an organismal source, or through changes in an existing cell culture or line that result in a new culture with unique characteristics. This can occur through the passaging/selection of a primary culture into a secondary culture or line, or experimental modifications of an existing cell culture or line such as an immortalization process or other stable genetic modification. This class covers establishment of cultures of either multicellular organism cells or unicellular organisms.
cell culture splitting
The act of taking a cell culture of high density, counting the cells, removing part of the cells, and re-seeding a select number of the cells into new flasks with fresh tissue culture media.
The act of taking part of a homogeneous cell culture and creating one or more additional separate cultures of similar qualities. input: cell_culture, output cell_culture min cardinality 2. part of cell culturing
An active cell culture is typically split when it has grown to confluence in its culture dish. Cell culture splitting of a cell culture sample results in an increase in its passage number, which measures how long a sample has been propagated in vitro, and therefore how many selective or genetic changes it is likely to have undergone.
genetic transformation
The transduction of E. coli through the introduction of a plasmid encoding for M. avium p35
the introduction. alteration or integration of genetic material into a cell or organism
PERSON:Kevin Clancy
genetic modification
A dependent entity that inheres in a bearer by virtue of how the bearer is related to other entities
A time quality inhering in a bearer by virtue of the bearer's expected maximum age.
A quality of a single physical entity inhering in the bearer by virtue of the bearer's size or shape or structure.
A morphological quality inhering in a bearer by virtue of the bearer's ratios of distances between its features (points, edges, surfaces and also holes etc).
Shapes are invariant on size transformations. Shapes can be subdivided into 2D and 3D shapes, We can also make a distinction between shapes of complete self-connected objects, and shapes of parts of objects.
TODO: define this or obsolete it and move children somewhere else.
A quality inhering in a bearer by virtue of the whether the bearer differs from normal or average.
A morphology quality inhering in a bearer by virtue of the bearer's physical magnitude.
A morphology quality inhering in a bearer by virtue of the bearer's relative position, shape, arrangements and connectivity of an organism's various parts; the pattern underlying its form.
A quality in which events occur in sequence.
A quality of a single physical entity which is held by a bearer when the latter exhibits a state of growth, differentiation, or development.
A branchiness quality inhering in a bearer by virtue of the bearer's having branches.
A shape quality inhering in a bearer by virtue of the bearer's being such that every part of the surface or the circumference is equidistant from the center.
A quality inhering in a bearer by virtue of the bearer's deviation from normal or average.
A quality inhering in a bearer by virtue of the bearer's exhibiting no deviation from normal or average.
A size quality which is relatively high.
A spheroid quality inhering in a bearer by virtue of the bearer's being oval with two axes of symmetry, as produced by a conical section.
An optical quality which obtains by virtue of the ability of the bearer to absorb visible light.
A optical quality inhering in a bearer by virtue of the bearer's not being clear; not transmitting or reflecting light or radiant energy.
A optical quality inhering in a bearer by virtue of the bearer's lacking opacity.
A physical quality of a fluid inhering in a bearer by virtue of the bearer's disposition to internal resistance to flow.
A viscosity quality inhering in a bearer by virtue of the bearer's having viscosity.
A quality of a physical entity that exists through action of continuants at the physical level of organisation in relation to other entities.
A quality which inheres in a continuant.
multiply inhering quality of a physical entity
Relational qualities are qualities that hold between multiple entities. Normal (monadic) qualities such as the shape of a eyeball exist purely as a quality of that eyeball. A relational quality such as sensitivity to light is a quality of that eyeball (and connecting nervous system) as it relates to incoming light waves/particles.
A physical quality that inheres in an bearer by virtue of how that bearer interacts with electromagnetic radiation.
An EM radiation quality in which the EM radiation is within the fiat range of the spectrum visible deemed to be light.
A cellular quality inhering in a bearer by virtue of the bearer's number of homologous sets of chromosomes in the nucleus or primary chromosome-containing compartment of the cell, each set essentially coding for all the biological traits of the organism.
A ploidy quality inhering in a bearer by virtue of the bearer's containing a single set of homologous chromosomes.
A ploidy quality inhering in a bearer by virtue of the bearer's containing an integral multiple of the monoploid number, possibly excluding the sex-determining chromosomes.
A ploidy quality inhering in a bearer by virtue of the bearer's having two copies (homologs) of each chromosome, usually one from the mother and one from the father.
The exact number may be one or two different from the 2n number and still be classified as diploidy (although with aneuploidy). Nearly all mammals are diploid organisms, although all individuals have some small fraction of cells that are polyploidy.
A monadic quality of continuant that exists at the cellular level of organisation.
A cellular quality that arises by virtue of whether the bearer's disposition to differentiate into one or more mature cell types.
A cellular potency that is the capacity to produce only one differentiated cell type.
Unipotent cells have the quality of self-renewal which distinguishes them from non-stem cells.
A cellular potency that is the capacity to form multiple differentiated cell types of a specific lineage and lack self renewing capacity.
Less potent than multipotent, often thought of as precursor or progenitor cell status.
A cellular potency that is the capacity to form multiple differentiated cell types.
A cellular quality inhering in a bearer by virtue of bearer's number of nuclei.
A nucleate quality inhering in a bearer by virtue of the bearer's having one nucleus.
A shape quality inhering in a bearer by virtue of the bearer's being marked by narrow lines or grooves, usually parallel.
A quality inhering in a bearer by virtue of the bearer's lacking complete growth, differentiation, or development.
A physical quality inhering in a bearer by virtue of the bearer's exhibiting the physical characteristics of an entity consisting of particles that have neither a defined volume nor defined shape.
A physical quality inhering in an entity exhibiting the physical characteristics of an amorphous (non-crystalline) form of matter between a gas and a solid that has a definite volume, but no definite shape.
A physical quality that is the ability to contract or shrink.
A contractility quality inhering in a bearer by virtue of the bearer's ability of contracting or being contracted.
This refers to the disposition of the bearer.
A physical quality inhering in a bearer by virtue of the bearer's parts having the arrangement which exhibits characteristics of liquids.
A quality that inheres in an bearer by virtue of how that bearer interacts with radiation.
A shape quality in a bearer by virtue of the bearer's curving inward.
A convex 3-D shape quality inhering in a bearer by virtue of the bearer's exhibiting a consistently-sized round cross section.
A nucleate quality inhering in a bearer by virtue of the bearer's having more than one nucleus.
A structural quality inhering in a bearer by virtue of the bearer's having a three dimensional cavity with a narrow or no opening, and often containing an anatomical substance.
An organismal quality inhering in a bearer by virtue of the bearer's consisting cells.
A cellularity quality inhering in a bearer by virtue of the bearer's consisting of more than one cell.
A quality that inheres in an entire organism or part of an organism.
Surface shape that refers to the inward or outward curvature of the surface.
A shape that inheres in a 2 dimensional entity, such as a cross section or projection of a 3 dimensional entity.
A complete three dimensional shape in which for every line connecting pair of points on the object is within the object. Or: a shape lacking cavities. Contrast: concave.
Use this term or an is_a child of this term when the entire shape of the object is known.
A complete three dimensional shape in which there is a line connecting pair of points on the object that lies outside the object. Or: a shape with cavities. Contrast: concave.
A shape quality inhering in a bearer by virtue of the degree to which there are subdivisions or offshoots in a bearer entity.
A structural quality that inheres in a bearer by virtue of the bearer's containing hollow areas.
A concave quality inhering in a bearer by virtue of the bearer's curving inward on both sides or surfaces.
A branched quality inhering in a bearer by virtue of the bearer's having smaller branches arising from larger branches. Resembling a tree in branching structure.
A quality inhering in a bearer by virtue of the bearer's having an empty space or cavity within.
An affinity inhering in an anatomical structure by virtue of the bearer exhibiting a molecular interaction for basic dyes under specific pH conditions.
A quality inhering in a bearer by virtue of the bearer's processing the form of a thin plate sheet or layer.
A quality inhering in a bearer by virtue of its constitution.
A cylindrical shape quality inhering in a bearer by virtue of the bearer's being imperfectly cylindrical or approximately cylindrical.
A shape that inheres in a 3 dimensional entity.
A quality that has a value that is increased compared to normal or average.
A quality that has a value that is decreased compared to normal or average.
A quality of an object that has a value that is decreased compared to normal or average.
A quality of an object that has a value that is increased compared to normal or average.
A convex 3-D shape quality inhering in a bearer by virtue of the bearer's exhibiting a by virtue of the bearer's exhibiting a consistently sized and approximately round cross-section along its length, which is many times larger than its diameter.
Note that a fiber shaped object may take any circuitous or straight path through space (think of a length of string or rope).
A shape constituting a transition between a rectangle and a circle; a closed curve, of which the circle and ellipse are special cases, whose parametric equation is x = a.cos2/rt, y = b.cos2/rt
An affinity inhering in an anatomical structure by virtue of the bearer exhibiting a molecular interaction for acidic dyes under specific pH conditions.
Pertaining to the individual parts making up an aggregate fruit like a many-lobed "berry," such as a raspberry.
A structure quality inhering in a bearer by virtue of the bearer's being capable of swelling or stretching.
A shape quality inhering in a bearer by virtue of the bearer's being marked by narrow lines or grooves, usually parallel, that are oriented transversely relative to the long axis of the bearer.
A nucleate quality inhering in a bearer by virtue of the bearer's having one or more nucleus.
A quality of a single cell inhering in the bearer by virtue of the bearer's size or shape or structure.
Use this term for morphologies that can *only* inhere in a cell, e.g. morphological qualities inhering in a cell by virtue of the presence, location or shape of one or more cell parts.
A quality inhering in a structure by virtue of it consisting of many of repeated, similar or identical subunits, arranged in some orderly array.
A complete coverage of this domain would subclasses homopolymeric, copolymeric, crystalline.
A quality inhering in a bearer by virtue of the extent to which the bearer is capable of being stretched or swollen.
A quality of an object that has a value that is normal or average.
A life span which is relatively normal or average.
A cell morphology that inheres in neurons which have two principal dendrites that emerge from the soma and begin to branch some distance from it, have few spines, and branch in narrow fields. This is in contrast to bitufted morphology where branching occurs close to the soma.
This is specific to cortical bipolar cells and are distinguished from retinal bipolar cell morphology which has an axon and dendrite emerging from opposite ends of the soma.
A cell morphology that inheres in neurons that have dendritic processes radiating from the cell body forming a star-like shape.
A cell morphology that inheres in neurons which possess three or more neurites, usually a single axon and many dendrites and dendritic branches.
A cell morphology that inheres in neurons with dendrites that are bidirectional, emerging from opposite ends of the soma, with the two arbors extending in radial or tangential directions.
This morphology type is distinct from bitufted cell morphology in that it refers to bitufted dendrite morphology rather than bitufted cell morphology.
A quality of continuant that exist at the anatomical level of organisation and anything under it. This includes, but is not limited to, cells , tissues, and components.
A quality inhering in an anotomical structure by virtue of its capacity to be stained by specific histological dyes.
An affinity inhering in an anatomical structure by virtue of the bearer exhibiting a molecular interaction that stains and colors, pale-pink, with Wright-Giemsa stain.
An affinity inhering in an anatomical structure by virtue of the bearer exhibiting a molecular interaction for both basic and acid stains under specific pH conditions.
An amino acid chain that is produced de novo by ribosome-mediated translation of a genetically-encoded mRNA, and any derivatives thereof.
The definition above excludes protein complexes, which some also consider a protein. Those who wish to refer to a class representing both senses of the word are directed to CHEBI:36080. Note that the definition allows for experimentally-manipulated genes, and allows for artifically-produced derivatives that mimic those found naturally. Proteins (in the sense defined here) that descended from a common ancestor can be classified into families and superfamilies composed of products of evolutionarily-related genes. The domain architecture of a protein is described by the order of its constituent domains. Proteins with the same domains in the same order are defined as homeomorphic [PRO:WCB].
A protein that is a translation product of the human CD19 gene or a 1:1 ortholog thereof. It is composed of an N-terminal extracellular domain containing two Ig-like C2-type (immunoglobulin-like) domains, followed by a single-pass transmembrane segment and a cytoplasmic C-terminal tail. CD19 expression is restricted to members of the B cell lineage. It functions as a co-receptor for B-cell antigen receptor (BCR), regulating signal transduction.
A protein that is a translation product of the human CD34 gene or a 1:1 ortholog thereof. It is a leukocyte membrane protein expressed specifically by lymphohematopoietic progenitor cells. It contains a single-pass transmembrane domain and that show distinct expression on early hematopoietic precursors and vascular-associated tissue. Acts as a scaffold that presents selectin carbohydrate ligands in a clustered, tissue specific manner to allow for higher avidity interactions between leukocytes and endothelial cells during the inflammatory process. In common with related sialomucins (endoglycan and podocalyxin), the extracellular region is dominated by an N-terminal mucin-like domain, which is densely substituted with sialylated O-linked carbohydrates. The mucin-like region is followed by a cysteine-containing and presumably globular domain. This domain may fold into an immunoglobulin-like structure as the positions of 2 of the cysteines are conserved in the C2 set of the immunoglobulin superfamily. The cytoplasmic domain is around 73-76 residues long and highly conserved.
hematopoietic progenitor cell antigen CD34
A protein that is a translation product of the human CD4 gene or a 1:1 ortholog thereof. CD4 is an accessory protein for MHC class-II antigen/T-cell receptor interaction. It is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence.
An integrin alpha that contains an A domain. A hallmark of this class is the presence of a von Willebrand factor type A domain (Pfam:PF00092) (I-domain) of approximately 200 amino acid residues at the N terminus, which confers divalent cation binding properties. Unlike other integrin alpha proteins, they do not undergo proteolytic cleavage.
A protein that is a translation product of the human PTPRC gene or a 1:1 ortholog thereof. It is composed of an extracellular domain, a single transmembrane segment and two tandem intracytoplasmic protein-tyrosine phosphatase domains. Contains 1 to 3 copies of the Fibronectin type III domain (Pfam:PF00041) followed by two copies of the Protein-tyrosine phosphatase (Pfam:PF00102) domain. Receptor-type tyrosine-protein phosphatase C (CD45) regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T and B cells. Multiple isoforms of CD45 (180-235 kDa) can be generated asa result of alternative splicing of three variable exons 4(A), 5(B) and 6(C), encoding sequences at the N-terminal extracellular domain of the molecule.
receptor-type tyrosine-protein phosphatase C
An integrin alpha with A domain that is a translation product of the human ITGAM gene or a 1:1 ortholog thereof. They constitute subunits of the integrin alpha-M/beta-2 receptor. This receptor is implicated in various adhesive interactions of monocytes, macrophages and granulocytes as well as in mediating the uptake of complement-coated particles. It is also a receptor for fibrinogen, factor X and ICAM1.
cell surface glycoprotein MAC-1 subunit alpha
An integrin alpha with A domain that is a translation product of the human ITGAX gene or a 1:1 ortholog thereof. Integrin alpha-X complexed with beta-2 is a receptor for fibrinogen. It recognizes the sequence GPR in fibrinogen. It mediates cell-cell interaction during inflammatory responses. It is especially important in monocyte adhesion and chemotaxis.
leukocyte adhesion glycoprotein p150,95 alpha chain
A receptor-type tyrosine-protein phosphatase C isoform CD45R that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P08575-8 or a 1:1 ortholog thereof.
Category=sequence. Requested by=CL. Note: This isoform includes the region encoded by the variable exon 4(A), and lacks the region encoded by exons 5(B) and 6(C).
receptor-type tyrosine-protein phosphatase C isoform CD45RA
A protein with a core domain composition consisting of an extracellular N-terminal domain that adopts an immunoglobulin fold, a transmembrane domain, and an intracellular C-terminal domain with a single copy of the Immunoreceptor tyrosine-based activation motif (Pfam:PF02189) (ITAM). It constitutes the invariant subunit of the T cell antigen receptor (TCR). TCR is a surface receptor on T cells responsible for recognizing MHC-restricted antigens and initiating the cellular immune response.
A CD3 subunit with immunoglobulin domain that is a translation product of the human CD3E gene or a 1:1 ortholog thereof.
T-cell surface antigen T3/Leu-4 epsilon chain
A protein with a domain composition consisting of a large extracellular domain, including five Ig-like C2-type domains followed by two copies of the Fibronectin type-III domain (Pfam:PF00041), a single-pass transmembrane domain and a short cytoplasmic C-terminal domain.
A neural cell adhesion molecule that is involved in neuronal development, synaptic plasticity, and regeneration.
A neural cell adhesion molecule NCAM that is a translation product of the human NCAM1 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human CD2 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human CD8A gene or a 1:1 ortholog thereof. CD8 is a transmembrane that is a co-receptor for MHC class-I antigen/T-cell receptor interaction. The most common form of CD8 is composed of a CD8 alpha and a CD8 beta chain.
T-lymphocyte differentiation antigen T8/Leu-2
T-cell surface glycoprotein CD8 alpha chain
A protein that is a translation product of the human CD8B gene or a 1:1 ortholog thereof. CD8 is a transmembrane receptor that is a co-receptor for MHC class-I antigen/T-cell receptor interaction. The most common form of CD8 is composed of a CD8 alpha and a CD8 beta chain.
T-cell surface glycoprotein CD8 beta chain
A G-protein coupled receptor with a 7 transmembrane (secretin family) domain (Pfam:PF00002) preceded by an amino-terminal region containing one or more functional domains with adhesion-like motifs.
secretin receptor-like G-protein coupled receptor
Category=family. Classification based on GRAFS system. [PMID:12761335]
A G-protein coupled receptor that contains the 7 transmembrane receptor (rhodopsin family) domain (Pfam:PF00001), which includes 7 transmembrane helices (TMI-TM7) with 3 intracellular loops (IL1-IL3) and 3 extracellular loops (EL1-EL3) between the helices. The amino-terminal region is extracellular and the carboxyl-terminal region is intracellular. Rhodopsin-like G-protein coupled receptors (GPCRs) are unique among the several classes of GPCRs in that most have a very short amino-terminal segment and several characteristic sequence motifs, particularly NSxxNPxxY in TM7 and D/E-R-Y/F between TM3 and loop IL2. Most bind their ligands within a cavity between the TM regions.
rhodopsin-like G-protein coupled receptor
A rhodopsin-like G-protein coupled receptor that in active form binds to one or more chemokines.
Category=family. Note: Only those that have been unequivocally shown to activate a G-protein coupled signaling pathway appear on the official IUPHAR list.
A chemokine receptor that is a translation product of the human CCR1 or CCR3 genes, the mouse CCR1L1 gene, 1:1 orthologs thereof, or a semi-ortholog thereof.
A chemokine receptor that is a translation product of the human CCR7 gene or a 1:1 ortholog thereof. The preferred ligands are CCL19 and CCL21.
EBV-induced G-protein coupled receptor 1
epstein-Barr virus-induced G-protein coupled receptor 1
A chemokine receptor CCR1/3/1L that is a translation product of the human CCR3 gene or a 1:1 ortholog thereof.
macrophage inflammatory protein 1-alpha receptor-like 2
A protein that contains the ADP-ribosyl cyclase domain (Pfam:PF02267).
A protein that is a translation product of the human MS4A1 gene or a 1:1 ortholog thereof.
membrane-spanning 4-domains subfamily A member 1
A protein that is a member of a family that includes translation products of genes CD86, CD276, ICOSLG, and others. These are membrane-anchored proteins with a small intracellular domain and an extracellular domain with signal sequence, an Immunoglobulin V-set domain (Pfam:PF07686), and a CD80-like C2-set immunoglobulin domain (Pfam:PF08205).
A protein that is a translation product of the human CD207 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human CD44 gene or a 1:1 ortholog thereof.
GP90 lymphocyte homing/adhesion receptor
A protein that is a translation product of the human SELL gene or a 1:1 ortholog thereof. It is a leukocyte adhesion receptor that play an important role in regulating the inflammatory response by mediating leukocyte tethering and rolling on adherent leukocytes.
leukocyte-endothelial cell adhesion molecule 1
A protein that has a core domain structure of signal sequence, propeptide, five Cadherin domains (Pfam:PF00028), a transmembrane region, and a Cadherin cytoplasmic region (Pfam:PF01049). Cadherins function as adhesion molecules that mediate Ca2+-dependent cell-cell adhesion in solid tissues.
A protein that is a translation product of the human CEACAM8 gene or a 1:1 ortholog thereof.
non-specific cross-reacting antigen NCA-95
carcinoembryonic antigen-related cell adhesion molecule 8
A protein that is a translation product of the human CD69 gene or a 1:1 ortholog thereof. A type II transmembrane protein with a C-type lectin binding domain in the extracellular portion of the molecule. Involved in lymphocyte proliferation and functions as a signal transmitting receptor in lymphocytes, natural killer (NK) cells, and platelets.
A protein that is a translation product of the human ENPP3 gene or a 1:1 ortholog thereof.
ectonucleotide pyrophosphatase/phosphodiesterase 3
phosphodiesterase I/nucleotide pyrophosphatase 3
ectonucleotide pyrophosphatase/phosphodiesterase family member 3
A protein that is a translation product of the human FOXP3 gene or a 1:1 ortholog thereof.
A protein with a core domain architecture consisting of an extracellular domain containing two copies of the Immunoglobulin domain (Pfam:PF00047), followed by a single-pass transmembrane region and a small intracellular domain. The active protein is a low affinity receptor for immunoglobulin gamma chain Fc region. Human II-a, II-b, and II-c represent a recent gene expansion and are equally related to mouse II, III, and IV. Human III-A and III-B are closely related and closer to mouse IV than to mouse III.
immunoglobulin gamma Fc receptor II/III/IV
A protein that is a translation product of the human IL2RA gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human IL2RB gene or a 1:1 ortholog thereof.
high affinity IL-2 receptor subunit beta
A protein with four transmembrane domains, small intracellular amino- and carboxyl-terminal regions, and two extracellular loops, a small one (EC1) and a larger one (EC2) of about 100 residues. The EC2 loop contains at least 4 cysteine residues, including a highly conserved 'CCG' motif.
An ADP-ribosyl cyclase that is a translation product of the human CD38 gene or a 1:1 ortholog thereof.
2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase
2'-phospho-cyclic-ADP-ribose transferase
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
A B7-related protein that is a translation product of the human CD86 gene or a 1:1 ortholog thereof.
A B7-related protein that is a translation product of the human CD80 gene or a 1:1 ortholog thereof.
A cadherin that is a translation product of the human CDH5 gene or a 1:1 ortholog thereof.
An immunoglobulin gamma Fc receptor II/III/IV that is a translation product of the mouse Fcgr2 gene or a 1:1 ortholog thereof.
low affinity immunoglobulin gamma Fc region receptor II
An immunoglobulin gamma Fc receptor II/III/IV that is a translation product of the mouse Fcgr3 gene or a 1:1 ortholog thereof.
low affinity immunoglobulin gamma Fc region receptor III
A protein with a core domain composition consisting of a Rel homology domain (RHD) (Pfam:PF00554), an IPT/TIG domain (Pfam:PF01833), six copies of the Ankyrin repeat (Pfam:PF00023), a Death domain (Pfam:PF00531) and a C-terminal PEST region.
A protein with core architecture consisting of one Prominin (Pfam:PF05478) domain. The prominins are an emerging family of proteins that, among the multispan membrane proteins, display a novel topology. Mouse and human prominin and prominin-like 1 are predicted to contain five membrane spanning domains, with an N-terminal domain exposed to the extracellular space followed by four, alternating small cytoplasmic and large extracellular, loops and a cytoplasmic C-terminal domain.
A prominin that is a translation product of the human PROM1 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human CLEC7A gene or a 1:1 ortholog thereof.
dendritic cell-associated C-type lectin 1
A protein that is a translation product of the human CD59 gene, a 1:1 ortholog thereof, or pro-orthologs thereof.
Category=gene. Requested by=CL. Pro-orthology refers to, in this case, after-speciation gene duplication in the non-human species (aka 1:many orthology). This gene is present as a single copy in human and has undergone a lineage-specific duplication in mouse. CD59 antigen has a core architecture consisting of one UPAR/Ly-6 domain (Pfam:PF00021), a small domain of about 70 amino acids and containing 5 conserved disulfide bonds. It is both N- and O-glycosylated and is a GPI-anchored protein that releases soluble forms in some tissues.
A protein with core architecture consisting of asignal sequence, 5 Ig-like domains, followed by a transmembrane sequence, followed by a Protein tyrosine kinase domain (Pfam:PF07714). However, only 1-3 of the Ig domains are detected by the Pfam HMMs in most of the sequences. Pfam:PF00047 is most common, but other members of the Ig domain clan, Pfam:PF07679 and Pfam:PF07686 can be identified instead. The fourth Ig domain lacks the disulfide-bonded cysteines.
CSF-1/PDGF receptor-type tyrosine-protein kinase
An adhesion G-protein coupled receptor that is a translation product of the human ADGRE1 gene or a 1:1 ortholog thereof.
EGF-like module-containing mucin-like hormone receptor-like 1
A protein that is a translation product of the human CD7 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human CD5 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human THY1 gene or a 1:1 ortholog thereof.
A cathepsin-like protease that is a translation product of the human CTSK gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human CTLA4 gene or a 1:1 ortholog thereof.
cytotoxic T-lymphocyte-associated antigen 4
A protein with core architecture consisting of a large extracellular region containing one Integrin, beta chain domain (Pfam:PF00362), up to four EGF-like domains (Pfam:PF07974), and an Integrin beta tail domain (Pfam:PF07965), followed by a single-pass transmembrane region and a small cytoplasmic region often containing an Integrin beta cytoplasmic domain (Pfam:PF08725).
A protein that is a translation product of the human IL3RA gene or a 1:1 ortholog thereof.
interleukin-3 receptor class II alpha chain
interleukin-3 receptor class 2 alpha chain
A protein that is a translation product of the human IL5RA gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human IL7R gene or a 1:1 ortholog thereof.
A protein that is a translation product of the KLRB1 gene or its closely related paralogs (KLRB1A-F). There are lineage-specific expansions in mouse and rat.
A protein that is a translation product of the human SPN gene or a 1:1 ortholog thereof.
A protein with core architecture consisting of a Lysosome-associated membrane glycoprotein (Pfam:PF01299) domain. It is a single-pass type I membrane protein that shuttles between lysosomes, endosomes, and the plasma membrane.
A protein that is a translation product of the human CD14 gene or a 1:1 ortholog thereof.
myeloid cell-specific leucine-rich glycoprotein
A protein that is a translation product of the human CD33 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human MME gene or a 1:1 ortholog thereof.
common acute lymphocytic leukemia antigen
A protein that is a translation product of the human PAX5 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human CD24 gene or a 1:1 ortholog thereof.
small cell lung carcinoma cluster 4 antigen
Category=gene. The mouse ortholog is Cd24a. Mouse protein Cd24b likely also orthologous. Currently it is not in UniProt. Requested by=CL.
A protein that is a translation product of the human SDC1 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human ACP5 gene or a 1:1 ortholog thereof.
tartrate-resistant acid phosphatase type 5
A protein that is a translation product of the human SPI1 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human TFRC gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human CD40LG gene or a 1:1 ortholog thereof.
tumor necrosis factor ligand superfamily member 5
A protein that is a translation product of the human TNFRSF11A gene or a 1:1 ortholog thereof.
osteoclast differentiation factor receptor
tumor necrosis factor receptor superfamily member 11A
A protein that is a translation product of the human CD27 gene or a 1:1 ortholog thereof.
tumor necrosis factor receptor superfamily member 7
A protein that is a translation product of the human PLAUR gene or a 1:1 ortholog thereof.
urokinase plasminogen activator surface receptor
A protein with core architecture consisting of a signal sequence, followed by 7 Ig-like domains (Pfam:PF00047, Pfam:PF07679, or Pfam:PF07686), a transmembrane region, and a cytoplasmic Protein tyrosine kinase domain.
vascular endothelial growth factor receptor
A CSF-1/PDGF receptor-type tyrosine-protein kinase that is a translation product of the human FLT3 gene or a 1:1 ortholog thereof.
receptor-type tyrosine-protein kinase FLT3
A CSF-1/PDGF receptor-type tyrosine-protein kinase that is a translation product of the human CSF1R gene or a 1:1 ortholog thereof.
macrophage colony-stimulating factor 1 receptor
A lysosome-associated membrane protein that is a translation product of the human CD68 gene or a 1:1 ortholog thereof.
A CSF-1/PDGF receptor-type tyrosine-protein kinase that is a translation product of the human KIT gene or a 1:1 ortholog thereof.
A vascular endothelial growth factor receptor that is a translation product of the human KDR gene or a 1:1 ortholog thereof.
vascular endothelial growth factor receptor 2
A protein that is the translation product of any of the LY6 genes (LY6A-LY6I).
An Ly-6-like protein that is a translation product of the mouse Ly6g gene or a 1:1 ortholog thereof.
An Ly-6-like protein that is a translation product of the mouse Ly6a gene or a 1:1 ortholog thereof.
An Ly-6-like protein that is a translation product of the mouse Ly6c2 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the Ly76 gene in mouse.
Category=organism-gene. Requested by=CL.
A protein that is a translation product of the human RAG1 gene or a 1:1 ortholog thereof.
V(D)J recombination-activating protein 1
A protein that is a translation product of the human RAG2 gene or a 1:1 ortholog thereof.
V(D)J recombination-activating protein 2
A tetraspanin that is a translation product of the human CD9 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human CEBPA gene or a 1:1 ortholog thereof.
A protein that is a translation product of the mouse Cd200r3 gene or a 1:1 ortholog thereof.
CD200 cell surface glycoprotein receptor-like 3
CD200 cell surface glycoprotein receptor-like b
cell surface glycoprotein OX2 receptor 3
cell surface glycoprotein CD200 receptor 3
A protein that is a translation product of the mouse Cd209b gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human DNTT gene or a 1:1 ortholog thereof.
An immunoglobulin gamma Fc receptor II/III/IV that is a translation product of the human FCER1A gene or a 1:1 ortholog thereof.
high affinity immunoglobulin epsilon receptor subunit alpha
A protein that is a translation product of the human FOS gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human FOXN1 gene or a 1:1 ortholog thereof.
hepatocyte nuclear factor 3 forkhead homolog 11
A protein that is a translation product of the human GATA1 gene or a 1:1 ortholog thereof.
A protein that is a translation product of the human GATA2 gene or a 1:1 ortholog thereof.
An integrin beta that is a translation product of the human ITGB7 gene or a 1:1 ortholog thereof.
A transcription factor NF-kappa-B subunit that is a translation product of the human NFKB2 gene or a 1:1 ortholog thereof.
lymphocyte translocation chromosome 10 protein
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2
A protein that is a translation product of the human SHH gene or a 1:1 ortholog thereof.
Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains
A protein that is a translation product of the human TAL1 gene or a 1:1 ortholog thereof.
class A basic helix-loop-helix protein 17
T-cell acute lymphocytic leukemia protein 1
A protein that is a translation product of the human TMED1 gene or a 1:1 ortholog thereof.
putative T1/ST2 receptor-binding protein
transmembrane emp24 domain-containing protein 1
An organic amino compound that consists of amino acid residues (unmodified amino-acid residues and/or modified amino-acid residues) linked by peptide bonds or derivatives of such bonds.
A T-cell surface glycoprotein CD8 alpha chain that has had the signal peptide removed.
T-cell surface glycoprotein CD8 alpha chain, signal peptide removed form
A T-cell surface glycoprotein CD8 beta chain that has had the signal peptide removed.
T-cell surface glycoprotein CD8 beta chain, signal peptide removed form
A protein-containing complex that is a membrane-bound heterodimeric co-receptor for MHC class-I antigen/T-cell receptor interaction.
A T-cell surface glycoprotein CD8 alpha chain that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01732-1 or a 1:1 ortholog thereof. Having a single-pass transmembrane domain, this form is membrane bound.
T-cell surface glycoprotein CD8 alpha chain isoform 1
A T-cell surface glycoprotein CD8 beta chain that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P10966-1 or a 1:1 ortholog thereof.
T-cell surface glycoprotein CD8 beta chain isoform 1
A T-cell surface glycoprotein CD8 alpha chain isoform 1 that has had the signal peptide removed to yield the mature form.
T-cell surface glycoprotein CD8 alpha chain isoform 1, signal peptide removed form
A T-cell surface glycoprotein CD8 beta chain isoform 1 that has had the signal peptide removed to yield the mature form.
T-cell surface glycoprotein CD8 beta chain isoform 1, signal peptide removed form
A T-cell surface glycoprotein CD8 alpha chain isoform 1, signal peptide removed form that includes at least one glycosylated residue.
T-cell surface glycoprotein CD8 alpha chain isoform 1, signal peptide removed glycosylated form
A T-cell surface glycoprotein CD8 beta chain isoform 1, signal peptide removed form that includes at least one glycosylated residue.
T-cell surface glycoprotein CD8 beta chain isoform 1, signal peptide removed glycosylated form
A protein that is composed of a long N-terminal extracellular domain, a transmembrane domain and a short cytoplasmic C-terminal domain. The N-terminal domain contains beta-propeller repeats (interrupted by an A domain in a subset of integrins alpha), while the C-terminal domain contains a GFFxR motif.
Category=family. Integrins are heterodimeric complexes of an alpha and a beta subunit. They are a structurally elaborate family of adhesion molecules that transmit signals bidirectionally across the plasma membrane by undergoing large-scale structural rearrangements. By regulating cell-cell and cell-matrix contacts, integrins participate in a wide-range of biological interactions including development, tissue repair, angiogenesis, inflammation and hemostasis. [PMID:10402956, PMID:11988479, PMID:9676575].
A protein that is encoded in the genome of Mus musculus.
A protein that has G protein-coupled receptor (GPCR) activity. Each GPCR consists of a single polypeptide with an extracellular N-terminus, an intracellular C-terminus and seven hydrophobic transmembrane domains (TM1-TM7) linked by three extracellular loops (ECL1-ECL3) and three intracellular loops (ICL1-ICL3). GPCRs function as part of a heterotrimeric complex to transmit an extracellular signal across the membrane by activating an associated G-protein via the exchange of GDP for GTP on the alpha subunit.
A protein that is encoded in the genome of some Eukaryota.
A protein that includes at least one glycosylated residue.
A protein that is a translation product of some metazoan gene that encodes a signal peptide followed by a single Cathepsin propeptide inhibitor domain (Pfam:PF08246) followed by a single Papain family cysteine protease (Pfam:PF00112) domain at the C terminus.
A receptor-type tyrosine-protein phosphatase C that is a translation product of a transcript that minimally includes the region encoded by the variable exon 4(A).
receptor-type tyrosine-protein phosphatase C isoform CD45R
A material entity consisting of multiple components that are causally integrated.
May be replaced by a BFO class, as discussed in http://www.jbiomedsem.com/content/4/1/43
Lower, narrow portion of the uterus where it joins with the top end of the vagina.
The narrow caudal end of the uterus that opens into the vagina. [TFD][VHOG]
The evolution of mammals is associated with radical changes in their reproductive biology, particularly the structure and function of the female reproductive organs. These changes include the evolution of the uterus, cervix, vagina, placenta and specialized cell types associated with each of those structures.[well established][VHOG]
The olfactory organ of vertebrates, consisting of nares, olfactory epithelia and the structures and skeletal framework of the nasal cavity.
Organ that is the specialized structure of the face that contains olfactory neurons. The peripheral olfactory organ is paired[ZFA:0000047].
a protuberance in vertebrates that houses the nostrils, or nares, which admit and expel air for respiration in conjunction with the mouth. Behind the nose are the olfactory mucosa and the sinuses. Behind the nasal cavity, air next passes through the pharynx, shared with the digestive system, and then into the rest of the respiratory system. In humans, the nose is located centrally on the face; on most other mammals, it is on the upper tip of the snout[WP]. GO: The nose is the specialized structure of the face that serves as the organ of the sense of smell and as part of the respiratory system. Includes the nasi externus (external nose) and cavitas nasi (nasal cavity)[Wikipedia:Nose].
the organ that is specialized for smell and is part of the respiratory system
the structure of the nose varies across vertebrates. In tetrapods the nose is part of the respiratory system.[PMID:25312359]
The clusters of hormone-producing cells that are scattered throughout the pancreas.
Anatomical structure which consists of glands developed from pancreatic ducts in the larvae and secrete insulin.[AAO]
Mammals, birds, reptiles and amphibians have a pancreas with similar histology and mode of development, while in some fish, the islet cells are segregated as Brockmann bodies.[well established][VHOG]
A primitive exocrine pancreas can be found in holocephalan cartilaginous fish; a pancreatic duct directly ending in the gut lumen is connected to a glandular structure made of exocrine cells and associated with cell islets, which comprises three different hormone-producing cell types: insulin, somatostatin and glucagon (Yui and Fujita, 1986)
The pituitary gland is an endocrine gland that secretes hormones that regulate many other glands [GO]. An endocrine gland located ventral to the diencephalon and derived from mixed neuroectodermal and non neuroectodermal origin [ZFIN].
An endocrine gland derived from infundibulum of the floor of the diencephalon and an ectodermal dorsal protrusion from the buccal cavity which controls the secretion of many hormones influencing the function of various organs of the body.[AAO]
An endocrine gland located ventral to the diencephalon and derived from mixed neuroectodermal and non neuroectodermal origin.[TAO]
It (the hypophysis) develops embryonically in all vertebrates from two ectodermal evaginations that meet and unite. (...) A well-developed hypophyseal system with functional connections to the hypothalamus is unique to craniates.[well established][VHOG]
The lamprey possesses a distinct pituitary organ and hormones, the ascidian does not show distinct evidence of them [Sower S, Freamat M, Kavanaugh S. The origins of the vertebrate hypothalamic-pituitary-gonadal (HPG) and hypothalamic-pituitary-thyroid (HPT) endocrine systems: new insights from lampreys. Gen Comp Endocrinol 2009;161:20-9]
Terminology note: hypophysis and pituitary gland are often used informally as synonyms, but the hypophysis also includes the small infundibular or pituitary stalk[Neumann 2020]
A layer of dense irregular connective tissue that lines organs and supports the mucosa, as well as joins the mucosa to the bulk of underlying smooth muscle. [WP,unvetted].
A major division of the nervous system that contains nerves which connect the central nervous system (CNS) with sensory organs, other organs, muscles, blood vessels and glands.
Nervous structures including ganglia outside of the central nervous system. Kimmel et al, 1995.[TAO]
Part of nervous system in which nerves extend throughout the body outside of the brain and spinal cord.[AAO]
The peripheral nervous system (PNS) is the part of the nervous system connected to the CNS which contains cranial nerves III - XII, spinal, peripheral and autonomic nerves. (CUMBO)
(...) specific vertebrate traits within the chordate phylum such as skeletal tissues, PNS, and spectacular head and brain development, are linked to the NC (neural crest) and its derivatives.[well established][VHOG]
Part of peripheral nervous system that includes the somatic parts of the cranial and spinal nerves and their ganglia and the peripheral sensory receptors.
somatic nervous system, somatic division
somatic part of peripheral nervous system
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
Note the distinction between the entire skin of the body, of which there is only 1 in an organism, and zones of skin, of which there can be many. Examples: skin of knee
(...) it is well-established that neural crest cells contribute to both the dermal skeleton (craniofacial bone, teeth, and the caudal fin rays of teleosts) and the integument, including craniofacial dermis and all pigment cells outside the retina (...).[well established][VHOG]
we assume that mouse, HOG and GAID all mean zone of skin when they say skin. We also choose skin as an exact synonym, as it is more intuitive
A non-material anatomical entity of two dimensions. Anatomical boundaries are contiguous structures.
Except in the case of abstracted fiat boundaries such as the midline plane of an organism, all 2D anatomical entities have a 3 dimensional projection. For example, the surface of the shell of a muscle has a distinct shape that projects into the third dimension. Note that boundaries are 2D structures. They have no thickness - and so can not be sites of gene expression or gene product localisation. For this, use boundary region terms.
The part of the pancreas that is part of the endocrine system and is made up of islet cells, which produce insulin, glucagon and somatostatin.
create a separate class for distributed pancreas, eg cyclostomes?
The part of the pancreas that acts as an endocrine gland, consisting of the islets of Langerhans, which secrete insulin and other hormones. [TFD][VHOG]
The zebrafish endocrine pancreas is composed of small groups of islet cells that are distributed throughout the exocrine pancreas. The islet cells produce insulin, glucagon and somatostatin.[TAO]
In the hagfish and lampreys (our most primitive vertebrate species of today), the first sign of 'a new organ' is found as collections of endocrine cells around the area of the bile duct connection with the duodenum. These endocrine organs are composed of 99% beta cells and 1% somatostatin-producing delta cells. Compared to the more primitive protochordates (e.g. amphioxus), this represents a stage where all previously scattered insulin-producing cells of the intestinal tissue have now quantitatively migrated to found a new organ involved in sensing blood glucose rather than gut glucose. Only later in evolution, the beta cells are joined by exocrine tissue and alpha cells (exemplified by the rat-, rabbit- and elephant-fishes). Finally, from sharks and onwards in evolution, we have the islet PP-cell entering to complete the pancreas.[well established][VHOG]
endocrine and exocrine pancreas are not co-associated in hagfishes or lampreys
The part of the pancreas that is part of the exocrine system and which produces and store zymogens of digestive enzymes, such as chymotrypsinogen and trypsinogen in the acinar cells [GO].
The exocrine pancreas is composed of acinar epithelial cells and ductal epithelium that manufacture the proteolytic enzymes and bicarbonate required for digestion.[TAO]
The part of the pancreas that acts as an exocrine gland, consisting of the pancreatic acini, which produce pancreatic juice and secrete it into the intestine to aid in protein digestion. [TFD][VHOG]